data_2mu3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mu3 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.353 0 N-CA-C 112.823 -0.111 . . . . 0.0 112.823 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.69 80.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.203 0.525 . . . . 0.0 110.759 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.4 p -68.44 -17.75 64.27 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -18.28 63.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.49 11.74 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.815 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.3 pp -85.99 -22.89 27.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 14' ' ' SER . 17.6 pt -42.46 -55.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 2.4 m -68.69 -21.74 64.4 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.0 111.677 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.563 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -88.57 -24.46 22.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.961 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 17' ' ' LEU . 85.1 t -57.19 168.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.759 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.47 -27.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.0 m-80 -60.27 -24.22 64.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.571 0.224 . . . . 0.0 111.498 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.71 -36.98 82.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.076 0.465 . . . . 0.0 110.306 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.415 ' N ' HD21 ' A' ' 25' ' ' LEU . 3.1 mm? -83.58 -13.36 54.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.448 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.17 -44.11 13.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 55.16 13.0 0.74 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.841 0.856 . . . . 0.0 112.263 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -72.41 165.49 24.46 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.931 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.8 m -61.67 -15.31 38.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p -56.04 -25.94 46.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.785 0.834 . . . . 0.0 113.143 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.83 -17.62 11.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.157 0.504 . . . . 0.0 110.672 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -77.51 -48.68 16.45 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.745 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -167.06 -32.14 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -80.65 137.21 21.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -52.91 138.67 29.41 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.999 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 47.3 ptt85 -64.43 155.59 32.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.944 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -70.74 114.85 9.23 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.65 40.18 9.97 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -47.37 145.95 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.585 0.754 . . . . 0.0 112.307 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.4 m -71.48 140.29 49.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.406 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.87 -12.81 27.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -57.06 -38.06 72.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.855 0.359 . . . . 0.0 110.757 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 40' ' ' SER . 2.8 pp -84.4 -35.62 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.484 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -82.97 -73.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.962 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 75.5 -18.92 0.42 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.639 0.776 . . . . 0.0 112.403 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -67.61 -79.88 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.16 0.505 . . . . 0.0 112.024 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -130.93 -27.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.313 0.578 . . . . 0.0 110.848 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.92 94.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.184 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 81.6 mm-40 -82.54 -50.23 9.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 0.0 110.256 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 20.7 ttm180 -132.77 -3.93 3.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.941 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.03 -50.49 0.7 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.258 0.623 . . . . 0.0 110.17 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.63 131.45 45.23 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -46.6 -30.78 2.45 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m -49.58 -71.56 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 55' ' ' LEU . 6.6 tt -86.38 -23.84 26.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.43 -20.69 62.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.2 p -48.56 112.74 0.64 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.565 0.541 . . . . 0.0 110.697 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -161.73 -40.41 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.91 18.83 10.96 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.677 0.275 . . . . 0.0 110.996 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 66.12 1.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.134 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.73 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 37.5 t -89.3 104.97 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.385 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -173.62 76.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.499 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.22 -63.07 1.22 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.981 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -63.04 -69.49 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.73 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 p-10 -82.18 7.2 14.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.462 . . . . 0.0 110.444 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 tp -88.02 -53.17 4.87 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.735 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.8 29.02 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.499 0.666 . . . . 0.0 110.086 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.58 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 35.6 mmt180 -107.99 173.13 6.46 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 64.14 -62.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.63 -61.95 2.24 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.717 0.407 . . . . 0.0 111.716 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 75' ' ' SER . 39.1 t -59.66 -42.26 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.58 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 2.6 mp0 -65.78 -36.48 83.65 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.619 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.92 64.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.803 0.335 . . . . 0.0 110.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.46 -34.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.486 0.66 . . . . 0.0 110.239 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 3.7 m -75.5 -19.78 59.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 20.8 mtm180 -86.87 -13.1 45.89 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.543 0.211 . . . . 0.0 110.551 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--O 1.238 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.122 178.55 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.426 ' C ' ' H ' ' A' ' 88' ' ' GLN . 8.0 m-85 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.668 0.27 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.47 41.45 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.01 0.433 . . . . 0.0 111.215 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 91' ' ' SER . 8.1 tp-100 -90.14 -59.03 2.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.919 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.86 94.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.825 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 74.6 m-85 -80.66 12.04 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.541 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 15.6 t -50.61 -45.12 57.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.659 0.383 . . . . 0.0 111.556 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.42 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 55.4 m -61.54 -41.89 98.02 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.55 37.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.0 111.414 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 74.8 mt -84.94 -28.06 26.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -85.18 -36.43 21.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.209 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 50.45 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.98 -22.41 45.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.26 -14.09 63.92 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.82 32.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.968 0.889 . . . . 0.0 108.955 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -116.9 -169.16 1.59 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.053 -178.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.588 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 14.6 t30 -78.39 106.69 10.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.37 -29.33 70.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.451 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 p -72.26 -18.15 61.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.226 0.536 . . . . 0.0 110.276 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.588 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 6.2 t30 -63.81 -50.75 67.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.654 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.438 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.0 mp -73.43 -35.3 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.855 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.48 -35.09 78.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.401 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -93.61 -60.6 1.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 1.1 pp -104.53 -35.99 7.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -52.86 -58.49 11.39 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.897 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 114' ' ' SER . 13.7 p -71.19 -21.05 62.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 107' ' ' THR . 8.4 mpt_? -88.13 -52.76 5.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.28 -50.56 20.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.9 mp -79.3 -29.94 42.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.147 0.499 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 110' ' ' SER . 32.1 t 50.97 -100.28 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.688 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.71 -34.68 73.23 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 120' ' ' VAL . 51.8 tp -61.75 -59.36 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.743 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -29.22 70.46 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.931 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -61.1 -42.83 99.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.078 0.466 . . . . 0.0 110.035 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -29.27 58.82 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.822 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 116' ' ' LEU . 82.3 t -72.69 -30.22 32.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 122.816 -0.226 . . . . 0.0 110.757 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 53.2 m -55.99 -39.45 71.85 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.566 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.1 p -85.68 -25.87 26.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.061 0.458 . . . . 0.0 111.155 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.76 -90.98 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.85 69.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 111.548 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 53.2 tt0 -77.24 -24.59 51.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.82 -65.12 1.63 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.448 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.58 -23.84 8.05 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.799 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.81 104.37 2.2 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.842 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.4 mt -68.75 130.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.959 0.409 . . . . 0.0 111.885 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -120.78 128.35 52.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.2 t -98.57 167.58 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.317 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.45 151.83 19.27 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.344 0.592 . . . . 0.0 111.747 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.58 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 15.2 m -75.37 -2.25 27.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.083 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.37 -72.07 0.64 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.184 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 m -106.5 -58.21 1.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -52.32 -55.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.58 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 5.4 tp-100 -60.02 -42.45 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m -58.46 -41.04 84.27 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.086 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.1 -54.61 8.08 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.639 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.46 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -64.44 -45.29 88.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.993 0.425 . . . . 0.0 110.72 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.4 m -76.91 -20.74 55.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.294 0.569 . . . . 0.0 111.134 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.4 t -86.5 -60.17 2.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.781 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.253 -174.431 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.217 0 N-CA-C 113.53 0.172 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.97 89.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.12 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.587 ' O ' HG22 ' A' ' 18' ' ' ILE . 70.0 m -72.1 -30.6 65.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.717 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.04 -26.75 50.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.98 7.09 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.672 ' O ' HG21 ' A' ' 21' ' ' VAL . 3.2 pp -83.88 -22.55 31.59 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 14' ' ' SER . 10.6 pt -43.25 -43.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 23.3 t -74.38 -27.55 60.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.0 -23.41 23.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 17' ' ' LEU . 56.4 t -58.52 176.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.832 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.483 ' H ' ' CG1' ' A' ' 21' ' ' VAL . . . -36.67 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 5.7 m-80 -63.29 -24.77 68.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.244 0.474 . . . . 0.0 111.404 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -64.04 -28.25 69.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 tp -83.41 -40.98 18.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.06 73.55 8.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.43 19.89 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.911 1.284 . . . . 0.0 114.2 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -63.46 -178.76 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 m -66.51 -20.48 66.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -51.13 -62.53 1.56 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.78 -20.55 42.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.28 0.562 . . . . 0.0 110.148 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -68.41 -46.45 69.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.474 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -177.34 -35.43 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.17 139.97 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.619 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HA ' ' CD ' ' A' ' 88' ' ' GLN . 4.0 pp -51.42 140.43 17.61 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 123.787 0.679 . . . . 0.0 112.6 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 36' ' ' ARG . 15.9 ttt180 -50.76 137.72 19.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.564 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -66.27 111.39 3.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.644 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 93.78 31.63 8.09 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.7 p -51.11 137.13 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 110.72 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 13.0 m -105.17 161.9 13.86 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 3.1 pt20 -60.44 -14.98 22.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.404 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -53.92 -48.72 69.9 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.263 0.554 . . . . 0.0 109.758 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 pp -85.99 -39.41 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.241 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 -62.03 1.71 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 74.63 -20.96 0.3 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -71.02 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.761 0.315 . . . . 0.0 111.771 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.91 -22.49 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.194 0.521 . . . . 0.0 110.832 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.6 t -75.72 96.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 76.8 mt-30 -81.97 -47.46 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.139 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 33.8 ttm-85 -144.8 4.13 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.402 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.53 -53.86 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.479 0.712 . . . . 0.0 111.18 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 129' ' ' ILE . . . -61.26 141.28 57.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 14.0 mp0 -58.83 -18.46 32.7 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.081 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -63.05 -76.96 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.85 -24.79 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.32 -18.11 61.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 77.6 p -45.7 104.05 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.856 0.722 . . . . 0.0 111.156 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 56' ' ' ALA . 10.5 t -149.97 -40.92 0.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.089 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.27 19.34 13.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.975 0.417 . . . . 0.0 110.235 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.24 67.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.454 HG23 HD22 ' A' ' 65' ' ' ASN . 6.1 t -87.85 109.01 19.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 120.706 0.289 . . . . 0.0 110.653 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -163.37 80.04 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.51 -48.85 2.94 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.73 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 20.9 p-10 -52.64 -80.07 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.829 0.851 . . . . 0.0 112.862 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.537 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 3.9 p-10 -85.81 9.17 17.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.215 0.531 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 59.1 tp -88.31 -50.85 6.08 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.128 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.14 -49.81 14.39 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.545 0.688 . . . . 0.0 109.31 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -90.87 162.38 14.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 68.32 -61.72 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' LEU . . . -64.42 -62.92 1.3 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -36.13 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.81 -43.37 88.82 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.301 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -67.34 -44.93 77.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.509 0.195 . . . . 0.0 111.286 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.9 -43.45 85.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -65.12 -30.17 71.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.039 0.447 . . . . 0.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -98.32 6.28 47.49 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.645 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 14.4 mt . . . . . 0 CA--C 1.51 -0.591 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.081 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.91 1.59 1.35 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.539 ' CD ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -69.96 -47.15 63.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.33 -40.24 77.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.794 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.503 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -83.92 10.54 9.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.419 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.8 m -49.79 -38.48 34.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.469 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 72.6 m -56.41 -50.4 71.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.12 31.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.5 mt -80.42 -33.08 37.22 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -84.56 -37.41 21.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 56.0 85.74 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.852 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.58 -2.61 43.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.578 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.54 34.53 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.529 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.93 -13.38 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.464 0.649 . . . . 0.0 110.097 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -179.69 7.14 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.524 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -75.21 118.66 18.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.98 61.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m -74.99 -31.36 61.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.855 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -61.87 -53.28 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.488 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.49 -39.97 87.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.129 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.34 -38.1 85.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.2 m -78.59 -55.22 5.37 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.14 -22.32 6.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.22 -65.29 3.47 Favored Glycine 0 C--N 1.32 -0.336 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.778 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 m -72.96 -9.71 59.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.107 0.479 . . . . 0.0 110.973 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.54 -55.94 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.629 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.96 -57.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.91 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -68.32 -49.8 57.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.923 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.4 t 52.9 -93.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.57 -40.78 60.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.241 0.616 . . . . 0.0 112.428 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 120' ' ' VAL . 59.7 tp -60.87 -47.32 86.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 30.2 mt -71.3 -25.77 62.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.53 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -60.28 -44.36 95.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.42 -31.1 57.45 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.558 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 116' ' ' LEU . 52.1 t -63.82 -41.26 91.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 122.848 -0.207 . . . . 0.0 110.712 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 54.2 m -52.82 -45.75 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.813 0.696 . . . . 0.0 112.352 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 p -83.74 -36.38 23.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.9 -76.1 0.31 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.69 50.94 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.707 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 52.6 mt-30 -72.52 -24.6 61.17 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.94 -53.39 3.02 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.732 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.18 -19.27 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.39 79.84 0.86 Allowed Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.065 -1.064 . . . . 0.0 110.488 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 52' ' ' ALA . 35.0 mm -64.6 136.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -134.62 125.9 28.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.44 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 t -89.48 113.93 26.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.494 0.664 . . . . 0.0 111.669 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.24 42.97 1.08 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.458 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 56.4 p -78.7 2.97 17.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.562 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.25 -27.37 20.66 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.15 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 m -105.95 -42.84 5.01 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 131' ' ' VAL . 20.6 t -70.43 -63.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -59.55 -43.5 93.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.954 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.6 m -58.33 -38.01 76.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.947 0.403 . . . . 0.0 111.025 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.62 -56.65 5.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.49 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.439 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 44.2 pt -61.83 -27.63 42.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.526 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -75.43 -35.83 60.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.03 0.443 . . . . 0.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.3 m -79.2 -29.42 42.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.178 0.513 . . . . 0.0 110.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 140' ' ' ILE . 98.9 p -86.73 -21.0 26.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.258 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.921 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.096 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.23 -19.13 62.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.844 0.354 . . . . 0.0 111.885 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.541 ' O ' HG21 ' A' ' 18' ' ' ILE . 15.5 m -63.9 -20.38 65.8 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.953 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.95 65.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.987 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.29 -34.88 22.19 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.303 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.4 pp -87.74 -31.78 19.49 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 14' ' ' SER . 16.3 pt -42.23 -57.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.7 m -66.56 -20.36 66.0 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -88.9 -31.23 18.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 17' ' ' LEU . 83.7 t -49.53 158.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 O-C-N 123.597 0.561 . . . . 0.0 111.384 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -40.31 -25.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.73 -28.67 69.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 0.0 109.938 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 19' ' ' SER . . . -58.97 -46.19 88.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.511 0.672 . . . . 0.0 109.934 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.06 -28.66 67.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.297 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.99 87.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 0.0 110.133 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 59.4 2.99 0.35 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.899 0.88 . . . . 0.0 112.535 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.601 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 5.5 m -68.53 163.44 23.5 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.266 0.555 . . . . 0.0 111.289 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 m -58.94 -15.34 12.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.8 p -54.59 -30.43 54.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.644 0.777 . . . . 0.0 112.992 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.57 -18.6 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.214 0.53 . . . . 0.0 110.507 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -76.2 -60.17 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.067 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -155.25 -31.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.57 137.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.79 145.66 23.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.224 0.535 . . . . 0.0 112.016 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -52.84 130.21 32.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.556 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.409 HG23 HG21 ' A' ' 136' ' ' VAL . 3.3 m -66.02 111.84 3.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.414 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.88 31.46 9.98 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.182 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 4.3 p -59.58 163.15 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.386 0.674 . . . . 0.0 112.265 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -109.52 161.39 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.781 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.7 pt20 -64.78 -15.22 61.36 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -53.14 -46.41 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.024 0.44 . . . . 0.0 111.106 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' CD2' ' A' ' 86' ' ' TYR . 2.4 pp -84.35 -35.98 11.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.989 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -77.89 -60.68 2.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.574 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 t 70.83 -21.06 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.631 0.772 . . . . 0.0 112.87 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 44' ' ' ALA . 33.3 t -69.33 -79.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.38 -37.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.265 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 2.4 p -71.11 99.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.459 0.647 . . . . 0.0 110.714 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 40.6 mt-30 -82.99 -38.01 23.22 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.539 ' HE ' HD11 ' A' ' 55' ' ' LEU . 23.8 ttm-85 -148.23 -1.61 0.55 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.784 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.0 -46.63 0.64 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.247 0.619 . . . . 0.0 111.128 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' HG23 ' A' ' 129' ' ' ILE . . . -65.31 142.05 58.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.2 mm-40 -64.5 -16.46 62.57 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.104 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 p -63.08 -76.74 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.141 0.496 . . . . 0.0 112.26 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.539 HD11 ' HE ' ' A' ' 50' ' ' ARG . 7.1 tt -85.36 -23.65 27.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.741 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.17 -21.05 39.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.5 t -62.94 94.92 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.756 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.476 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 9.6 t -119.99 -34.73 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 58' ' ' THR . 96.2 mt -118.07 19.5 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.25 67.69 1.46 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.477 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.7 t -88.49 126.31 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.81 0.338 . . . . 0.0 110.28 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 177.01 89.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.574 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.07 -60.12 4.48 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.125 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -50.14 -79.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 0.0 112.131 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 21.5 p-10 -85.77 14.0 6.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.998 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 tp -88.07 -58.41 2.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.746 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.62 48.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.456 0.646 . . . . 0.0 109.785 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -99.08 162.85 12.83 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.918 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 70.14 -61.92 0.44 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.415 0.447 . . . . 0.0 111.715 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . . . -64.59 -62.7 1.42 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.335 0.254 . . . . 0.0 111.586 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.69 -41.94 90.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.86 -37.33 76.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.69 63.08 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.539 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.4 t -85.42 -16.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.4 p -90.74 -23.88 20.55 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.243 0.544 . . . . 0.0 110.176 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -117.93 22.34 12.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.167 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.247 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 88' ' ' GLN . 3.1 m-85 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.402 0.62 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.98 31.19 0.11 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.114 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 86' ' ' TYR . 87.8 mm-40 -89.65 -60.12 2.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.145 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.69 -37.1 56.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.277 0.56 . . . . 0.0 110.155 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.566 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.82 5.38 25.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.571 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 t -52.17 -39.42 60.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.03 0.443 . . . . 0.0 110.794 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.464 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 3.3 m -58.37 -53.19 61.15 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.437 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.88 -22.6 53.21 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.873 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 78.1 mt -82.77 -45.86 13.84 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -70.79 -43.45 68.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.49 88.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.394 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.74 46.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.787 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.34 -13.81 31.84 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.442 ' HB ' ' CB ' ' A' ' 22' ' ' ALA . 3.5 t -101.07 28.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.461 0.648 . . . . 0.0 109.982 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.95 172.56 8.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.235 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -73.84 99.61 3.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -17.76 64.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -70.89 -30.56 66.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.421 ' O ' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.96 -35.37 76.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.722 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.82 -35.46 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.753 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.53 -24.09 45.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.63 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.7 m -75.18 -60.72 2.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.276 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 104' ' ' ASN . 1.7 pt? -121.4 -21.17 6.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.772 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.515 ' CA ' HD12 ' A' ' 117' ' ' LEU . . . -53.07 -61.07 7.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.769 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -82.58 -15.0 53.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -87.95 -60.06 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.9 t -78.02 -58.21 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.334 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -69.34 -26.77 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.011 0.434 . . . . 0.0 110.03 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.7 t 45.34 -105.0 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.471 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.96 -36.27 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.67 0.788 . . . . 0.0 112.635 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . 25.7 tp -59.27 -62.37 1.93 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.278 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' CA ' ' A' ' 109' ' ' GLY . 45.8 mt -79.99 -22.89 41.99 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -62.96 -44.2 96.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 109.957 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.79 -34.65 72.24 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.318 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 94' ' ' LEU . 53.0 t -69.28 -39.76 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.748 0.308 . . . . 0.0 111.204 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 34.0 t -57.04 -35.91 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 m -83.72 -39.33 20.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.97 -72.91 0.44 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.87 58.21 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.925 0.393 . . . . 0.0 111.847 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 121' ' ' SER . 27.0 tt0 -71.01 -24.53 62.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.11 -66.34 1.4 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.768 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.2 mt -109.34 -24.58 10.99 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 122.621 -0.341 . . . . 0.0 111.898 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.86 104.08 1.74 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.612 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.422 HG23 ' HB3' ' A' ' 52' ' ' ALA . 13.8 mt -79.58 136.38 23.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.591 0.234 . . . . 0.0 111.483 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -121.63 129.12 52.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.902 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 24.5 t -82.2 168.74 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.442 ' O ' HG11 ' A' ' 136' ' ' VAL . 24.1 t70 -59.38 137.19 58.08 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.305 0.574 . . . . 0.0 111.238 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.6 m -58.33 -23.07 55.49 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.824 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.28 -41.08 99.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.733 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 p -106.49 -45.55 4.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 140' ' ' ILE . 10.8 p -78.76 -55.4 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.51 ' N ' HG13 ' A' ' 136' ' ' VAL . 8.7 tt0 -59.62 -44.26 93.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 p -56.22 -41.87 76.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.996 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.83 -49.8 8.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.7 pt -62.05 -33.37 58.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -60.71 -29.59 69.43 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 m -83.94 -32.99 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 0.0 110.94 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -87.84 -27.78 22.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.319 -0.756 0 C-N-CA 123.339 0.656 . . . . 0.0 111.727 -178.469 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 CA-C-O 120.214 -0.214 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . . . -60.1 -35.73 75.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 111.247 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 18' ' ' ILE . 24.9 t -74.84 -22.08 58.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.113 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.99 -22.51 66.96 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.9 12.67 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.062 -1.065 . . . . 0.0 112.164 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.37 -32.73 24.05 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 14' ' ' SER . 10.0 pt -44.16 -51.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.9 m -67.81 -20.61 65.2 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -89.24 -24.51 22.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -72.33 -162.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.13 -37.42 6.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.551 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.84 -24.95 67.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.44 -53.46 56.23 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 109.66 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.07 -33.82 76.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.28 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.562 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 53.31 17.94 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.355 0.662 . . . . 0.0 111.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -76.31 157.61 32.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -62.22 -16.87 56.12 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.338 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -54.06 -34.54 60.35 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -112.28 -18.29 12.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 32' ' ' ARG . 1.2 tpt85 -79.0 -43.76 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.147 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . 0.414 HG22 HG22 ' A' ' 34' ' ' VAL . 7.6 t -164.44 -37.75 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 33' ' ' THR . 98.1 t -88.38 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.39 140.12 34.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 111.489 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.441 ' NH1' ' HB3' ' A' ' 94' ' ' LEU . 2.0 ptm180 -58.88 154.1 15.83 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -70.07 124.13 23.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.237 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.8 40.77 64.21 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 p -47.4 149.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.704 0.802 . . . . 0.0 112.523 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.599 ' O ' HG13 ' A' ' 43' ' ' ILE . 8.6 m -69.86 127.63 33.57 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.244 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.53 -14.03 26.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.025 0.44 . . . . 0.0 111.115 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.86 -32.0 73.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 40' ' ' SER . 2.5 pp -83.76 -35.52 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.71 -72.49 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.446 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m 76.01 -19.62 0.4 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.969 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.0 p -68.18 -88.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.236 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -126.62 -32.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.793 0.33 . . . . 0.0 111.634 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.468 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.7 p -79.31 91.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.726 0.774 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.6 mt-30 -83.04 -68.58 0.69 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.732 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.488 ' HD2' ' CB ' ' A' ' 123' ' ' ALA . 26.0 ttp180 -108.46 -3.06 18.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.425 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.13 -55.76 0.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.109 0.564 . . . . 0.0 109.85 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 129' ' ' ILE . . . -67.29 142.31 56.9 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.265 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 22.3 mp0 -46.89 -51.16 17.42 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -46.54 -62.88 1.17 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 50' ' ' ARG . 28.8 tp -86.65 -27.6 23.7 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.036 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.56 -20.58 39.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 6.2 t -62.91 89.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.602 0.715 . . . . 0.0 111.466 -176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -113.18 -36.43 5.05 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.785 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -121.88 18.57 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.06 68.05 1.13 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.95 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.45 103.2 13.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -151.3 14.04 0.68 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.065 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 134.85 -47.95 0.96 Allowed Glycine 0 C--N 1.28 -2.583 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 92.8 m-20 -62.7 -65.34 0.7 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.489 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -84.71 4.23 33.62 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 52.9 tp -88.88 -67.14 0.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.945 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.56 58.21 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.544 0.688 . . . . 0.0 110.137 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 94.5 mtt180 -100.91 162.2 13.07 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.815 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 67.77 -62.28 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -61.48 -62.43 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 122.664 0.386 . . . . 0.0 111.356 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.0 -39.23 84.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 85.1 mm-40 -60.94 -47.3 87.06 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.548 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.21 -39.81 70.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -86.41 -34.27 7.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.959 0.409 . . . . 0.0 111.306 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -71.97 -26.5 62.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 17.6 mmt180 -101.02 9.25 42.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.456 0.646 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 9.9 tt . . . . . 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.91 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.74 44.54 0.46 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -89.62 -61.46 1.69 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.765 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.18 -26.79 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 m-85 -78.13 3.83 14.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.678 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -50.45 -40.28 50.19 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.355 0.409 . . . . 0.0 111.638 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 15.2 m -57.29 -49.46 76.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.74 -23.82 36.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.693 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 83.3 mt -84.63 -29.97 25.3 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -81.14 -38.49 27.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.605 0.241 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 m120 63.99 91.89 0.07 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.03 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.31 -10.84 45.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.375 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 4.38 71.41 Favored Glycine 0 N--CA 1.459 0.227 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.525 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.39 -14.05 8.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.639 0.733 . . . . 0.0 109.076 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.7 pp -81.64 -179.26 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.057 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.45 110.73 4.29 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.072 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -26.4 65.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.752 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -73.99 -27.66 61.09 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.055 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -62.52 -46.74 87.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.101 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.08 -31.5 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.59 -43.09 70.1 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.021 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.2 m -71.27 -56.04 6.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 13' ' ' ALA . 4.4 pp -115.55 -13.31 11.55 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.823 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.61 -65.2 3.0 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.254 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.5 p -73.79 -19.5 60.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.802 0.335 . . . . 0.0 111.641 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -87.42 -58.23 2.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.2 t -81.2 -54.8 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.254 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.6 mp -67.35 -45.2 77.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 t 46.03 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.096 1.359 . . . . 0.0 113.686 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.27 73.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.533 0.333 . . . . 0.0 111.57 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.4 tp -61.96 -50.23 72.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.492 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 121' ' ' SER . 17.4 mt -68.95 -24.16 64.23 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -66.18 -36.79 84.01 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.554 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.33 -39.44 7.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 83.1 t -70.16 -22.99 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.619 0.247 . . . . 0.0 111.322 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 28.9 t -55.16 -44.03 74.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -84.39 -23.2 30.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.119 0.485 . . . . 0.0 110.608 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.488 ' CB ' ' HD2' ' A' ' 50' ' ' ARG . . . -83.43 -97.48 0.05 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.892 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.03 67.85 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.762 0.315 . . . . 0.0 111.769 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 34.2 tt0 -65.13 -42.45 93.86 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.767 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.62 -48.24 4.81 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.436 0.618 . . . . 0.0 112.246 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.65 99.05 0.5 Allowed Glycine 0 C--N 1.312 -0.78 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 37' ' ' THR . 34.6 mm -86.63 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.025 0.44 . . . . 0.0 112.176 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -116.59 135.43 53.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 t -86.2 173.06 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.97 145.5 41.41 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.174 0.512 . . . . 0.0 111.384 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.512 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 47.8 m -64.04 -22.19 66.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.57 -69.07 1.05 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 123.37 0.419 . . . . 0.0 114.133 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -99.42 -34.91 10.09 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 140' ' ' ILE . 86.5 t -83.18 -62.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.512 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 8.8 tp-100 -56.82 -45.97 81.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.7 m -54.62 -38.92 67.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.36 -48.33 10.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 136' ' ' VAL . 43.9 pt -65.7 -27.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 p -67.45 -48.59 66.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.1 m -84.27 -20.22 32.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.1 t -85.54 -20.16 30.04 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -174.312 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.339 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.54 86.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.601 ' O ' HG22 ' A' ' 18' ' ' ILE . 15.9 p -63.32 -32.97 74.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.597 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.51 -19.13 65.41 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.3 -38.91 7.02 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.342 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.3 pp -84.69 -22.08 29.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 14' ' ' SER . 11.5 pt -46.96 -50.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -84.77 -19.73 32.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -86.47 -30.81 21.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 17' ' ' LEU . 21.3 t -80.96 -101.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.89 35.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.31 -22.99 66.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.81 81.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.066 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.57 -31.77 36.73 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.441 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.85 82.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.212 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 61.83 6.03 1.53 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.859 0.864 . . . . 0.0 113.083 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.531 ' O ' HD23 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -68.48 177.93 2.21 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.087 0.47 . . . . 0.0 111.292 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.43 ' H ' HG21 ' A' ' 28' ' ' THR . 9.7 m -69.66 -16.03 63.29 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 p -51.62 -50.39 60.33 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 28' ' ' THR . 1.9 pt? -87.29 -19.98 27.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.326 0.584 . . . . 0.0 110.358 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -74.69 -48.23 27.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.086 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -172.71 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.61 135.52 27.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.02 139.19 35.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.346 0.593 . . . . 0.0 111.77 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.521 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 3.1 ptm180 -62.71 160.04 15.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.995 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -74.19 111.67 9.59 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.644 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.15 47.13 11.51 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.342 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.6 p -54.99 150.04 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 122.93 0.492 . . . . 0.0 111.364 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 t -81.78 164.36 21.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.1 pt20 -70.06 -12.42 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.763 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -50.95 -33.05 22.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.113 0.483 . . . . 0.0 110.609 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.703 HG13 ' N ' ' A' ' 44' ' ' ALA . 6.7 pt -83.77 -52.77 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.703 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.47 -66.98 0.83 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m 78.82 -20.5 0.38 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.555 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.5 p -83.1 -82.97 0.14 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.25 -52.53 8.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.594 0.711 . . . . 0.0 110.258 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.33 89.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.461 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 77.9 mt-30 -82.82 -36.93 25.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.777 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 5.7 ttt180 -156.5 5.64 0.17 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.937 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.91 -58.93 0.39 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.162 0.585 . . . . 0.0 110.783 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' CB ' HG22 ' A' ' 129' ' ' ILE . . . -62.97 138.54 58.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.54 -18.87 8.28 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.611 -175.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -60.02 -71.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.6 tp -87.36 -24.05 24.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.752 0.311 . . . . 0.0 111.604 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.96 -18.91 55.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -53.96 99.97 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.183 0.516 . . . . 0.0 110.886 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -137.68 -36.25 0.63 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.744 HD12 ' ND2' ' A' ' 65' ' ' ASN . 4.1 pp -123.03 11.46 9.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.022 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.04 52.76 1.58 Allowed Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.143 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 65' ' ' ASN . 3.3 t -87.17 114.25 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -156.54 14.29 0.29 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 112.017 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.44 -43.71 0.91 Allowed Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.01 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -59.12 -68.45 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.181 0.515 . . . . 0.0 110.598 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.744 ' ND2' HD12 ' A' ' 59' ' ' LEU . 25.8 p-10 -85.92 9.61 16.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -88.12 -50.67 6.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.993 0.425 . . . . 0.0 110.438 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.95 -26.55 33.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -127.08 169.42 13.41 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 69.8 -62.29 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.105 0.562 . . . . 0.0 112.492 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -62.19 2.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.012 0.434 . . . . 0.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.04 -33.2 62.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.815 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.6 -22.76 66.13 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.937 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.66 -51.08 6.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.102 0.477 . . . . 0.0 110.831 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 61.9 t -71.1 -36.46 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.427 -176.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -83.2 1.37 41.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.856 0.36 . . . . 0.0 111.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -106.37 -21.69 13.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.317 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 4.5 pp . . . . . 0 C--O 1.236 0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 111.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 120.97 0.414 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.97 12.97 0.95 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 1.8 mp0 -67.43 -48.15 68.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.057 0.456 . . . . 0.0 111.109 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -71.73 -30.71 65.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.967 0.413 . . . . 0.0 110.681 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 84.9 m-85 -83.54 8.76 13.12 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.954 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.521 ' OG ' ' HB3' ' A' ' 36' ' ' ARG . 71.9 m -51.8 -43.52 63.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.3 m -61.69 -48.76 79.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.02 -31.05 68.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 41.8 mt -84.17 -19.0 34.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.775 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -87.44 -36.94 17.42 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.096 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.423 ' HA ' HD22 ' A' ' 100' ' ' LEU . 14.5 m120 55.19 64.86 1.65 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.584 0.707 . . . . 0.0 110.378 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.71 62.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.747 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.83 66.51 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.213 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.9 t -74.72 -24.99 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.319 0.58 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.453 ' CB ' HG13 ' A' ' 21' ' ' VAL . 1.6 pt? -84.4 150.52 25.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -54.67 107.78 0.32 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.801 0.688 . . . . 0.0 110.986 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -17.49 63.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.936 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.8 m -80.18 -18.04 50.75 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.034 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.471 ' O ' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -78.62 -29.17 45.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.426 HD11 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -64.86 -32.46 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.878 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.8 m -67.94 -61.34 1.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.67 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.471 HD22 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -129.0 -9.96 4.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.995 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -58.9 -72.04 0.67 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 m -73.95 -12.26 60.59 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.805 0.336 . . . . 0.0 111.365 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.16 -57.83 2.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.28 -53.75 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.56 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.52 -33.39 64.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.182 -178.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.2 t 49.49 -103.57 0.12 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.033 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.69 -33.29 60.67 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.115 0.566 . . . . 0.0 112.206 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.51 ' O ' HG21 ' A' ' 120' ' ' VAL . 43.2 tp -57.39 -53.26 60.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 19.2 mt -78.69 -23.72 45.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.724 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.3 -45.44 93.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.1 -29.72 62.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.752 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 116' ' ' LEU . 40.5 t -69.25 -46.11 78.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 122.766 -0.255 . . . . 0.0 111.198 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -58.05 -39.17 77.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.482 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -80.51 -40.19 26.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.876 0.369 . . . . 0.0 111.804 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.2 -70.07 0.6 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.15 -51.2 18.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -69.95 -35.01 74.17 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.89 0.376 . . . . 0.0 110.508 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.37 -56.66 3.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.141 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.38 -23.53 15.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.57 77.57 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.235 -0.984 . . . . 0.0 111.002 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.446 HG22 ' CB ' ' A' ' 52' ' ' ALA . 36.9 mm -68.47 132.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.65 140.36 48.14 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.76 116.28 46.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.341 0.591 . . . . 0.0 111.333 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.69 43.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 p -75.49 -4.99 42.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.028 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 -17.85 58.51 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.5 p -107.4 -56.88 2.15 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.06 -62.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.02 -40.49 85.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.8 m -60.84 -49.08 78.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.24 -52.29 62.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.819 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 42.7 pt -61.45 -34.87 63.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.459 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 t -67.79 -42.11 82.14 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.97 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 m -77.42 -45.97 24.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.3 m -66.11 -38.73 88.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 p . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.394 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.879 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.02 68.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 18' ' ' ILE . 18.4 m -63.38 -34.39 77.62 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -19.05 65.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.96 -39.47 6.49 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.778 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 21' ' ' VAL . 2.9 pp -84.52 -20.97 30.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 14' ' ' SER . 9.7 pt -41.46 -42.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 8.3 p -78.99 -30.28 44.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -87.28 -23.62 24.61 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 17' ' ' LEU . 17.3 t -80.62 -101.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.13 -53.34 7.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -170.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.418 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -63.63 -23.03 67.21 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -57.3 -41.48 79.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.95 -19.97 39.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.995 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.63 -40.57 41.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.73 19.42 2.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.663 0.744 . . . . 0.0 111.432 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.585 ' O ' HD21 ' A' ' 31' ' ' LEU . 5.6 m -74.22 165.88 24.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -60.78 -18.25 53.96 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.054 0.542 . . . . 0.0 111.7 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 36' ' ' ARG . 34.4 p -52.99 -43.2 66.28 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 124.045 0.938 . . . . 0.0 113.085 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.585 HD21 ' O ' ' A' ' 28' ' ' THR . 1.6 pt? -96.59 -20.46 18.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.926 0.393 . . . . 0.0 111.19 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -72.07 -50.95 24.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.166 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -168.64 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.13 138.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -56.43 142.04 40.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.301 0.375 . . . . 0.0 110.785 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HA ' HG22 ' A' ' 30' ' ' THR . 31.4 ptt85 -66.84 159.31 28.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.793 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -70.95 111.44 6.34 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.81 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.34 41.26 7.49 Favored Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.642 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 p -47.56 136.3 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.484 0.659 . . . . 0.0 111.831 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -70.23 143.75 52.08 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.538 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 15.4 pm0 -65.57 -12.68 55.21 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -47.09 -44.66 21.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.501 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.79 -40.71 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.83 -75.81 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m 78.86 -19.65 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 111.772 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 p -65.39 -82.04 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.61 -39.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.986 0.422 . . . . 0.0 111.261 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.5 p -80.31 95.42 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.793 0.806 . . . . 0.0 110.33 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 50.4 mt-30 -79.18 -37.57 38.02 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.546 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 8.1 ttm180 -153.66 0.22 0.23 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.08 -48.39 0.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.61 0.364 . . . . 0.0 110.272 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' HG23 ' A' ' 129' ' ' ILE . . . -61.67 141.08 58.05 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.919 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 57' ' ' SER . 42.4 mm-40 -56.71 -30.66 63.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.479 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.3 m -53.89 -62.2 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.546 ' HG ' ' CZ ' ' A' ' 50' ' ' ARG . 4.3 mm? -88.06 -35.82 17.3 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -79.72 -21.46 44.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.7 t -65.25 93.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.622 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.47 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.7 t -139.23 -31.36 0.7 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.917 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.47 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.7 mt -118.19 19.14 13.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.39 65.61 1.46 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.532 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 96.9 t -89.52 122.48 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.262 0.553 . . . . 0.0 111.368 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -178.2 85.91 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.136 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.88 -54.98 3.46 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.191 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -50.79 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.376 0.67 . . . . 0.0 111.81 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 27.3 p-10 -86.63 14.57 6.75 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.122 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.2 tp -87.91 -65.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.38 -36.63 58.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.549 0.69 . . . . 0.0 109.749 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -98.95 160.16 14.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.733 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 69.41 -62.27 0.41 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.997 0.519 . . . . 0.0 111.975 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -62.78 -63.14 1.3 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.746 0.307 . . . . 0.0 111.507 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 75' ' ' SER . 59.6 t -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 41.6 mt-30 -60.78 -47.59 85.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.484 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.89 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.8 -38.33 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.929 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 33.2 m -77.31 1.23 19.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.6 mmp_? -111.83 -4.21 14.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.806 0.336 . . . . 0.0 110.169 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.243 -179.632 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 11.6 1.62 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.55 -59.98 2.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.523 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -69.42 -30.91 68.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.042 0.449 . . . . 0.0 110.991 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 96.1 m-85 -82.64 4.03 26.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.307 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -51.25 -39.8 57.48 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.6 m -58.69 -44.88 90.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.11 -30.98 27.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 33.5 mt -84.58 -28.94 26.24 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -87.13 -29.67 21.65 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.785 0.326 . . . . 0.0 110.486 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.7 m120 51.15 69.57 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.054 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.77 -8.56 56.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.068 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.47 -6.76 83.24 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.734 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.9 t -80.44 -19.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.492 0.663 . . . . 0.0 109.725 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.521 ' CB ' HG13 ' A' ' 21' ' ' VAL . 2.2 pt? -85.47 174.87 9.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.937 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -83.32 143.9 30.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.057 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.27 -18.84 40.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 p -67.75 -30.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.482 0.658 . . . . 0.0 109.827 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.534 ' O ' HD23 ' A' ' 108' ' ' LEU . 19.2 t30 -62.84 -50.44 70.95 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.124 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.488 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.7 mp -72.4 -28.13 27.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.326 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.55 -33.67 66.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.898 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.587 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 86.9 m -85.5 -40.23 16.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.2 pt? -139.94 -27.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.836 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -50.83 -63.98 4.09 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.178 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.5 m -75.57 -17.0 60.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.94 0.4 . . . . 0.0 111.913 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 107' ' ' THR . 66.6 mtt180 -87.2 -58.0 2.75 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.088 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.7 -49.35 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.535 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -70.86 -13.75 62.15 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.111 0.481 . . . . 0.0 110.572 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.0 t 47.74 -104.07 0.11 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 113.657 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.92 76.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 120' ' ' VAL . 37.3 tp -53.88 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 16.6 mt -69.07 -23.56 64.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.33 -46.68 76.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.194 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.6 -27.27 63.51 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.899 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 116' ' ' LEU . 25.3 t -68.39 -36.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.795 0.331 . . . . 0.0 110.316 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.0 t -54.47 -41.21 69.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.457 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -83.74 -49.16 9.37 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.53 -58.49 3.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.46 ' O ' ' HA2' ' A' ' 128' ' ' GLY . . . -82.12 -60.27 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -69.18 -35.7 76.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.445 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.28 -69.57 1.39 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.945 -0.645 . . . . 0.0 114.074 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.21 -23.61 24.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.974 0.416 . . . . 0.0 111.269 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 124' ' ' ALA . . . 82.2 91.32 0.6 Allowed Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.025 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.494 HG23 ' HB1' ' A' ' 52' ' ' ALA . 63.7 mt -59.64 134.94 24.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -139.56 118.84 12.79 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.245 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.81 156.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.61 163.09 14.35 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.9 m -74.11 84.19 1.81 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.53 -114.94 2.01 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -87.83 -18.73 28.64 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.72 -62.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.928 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -52.54 -51.67 58.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 p -56.1 -43.97 78.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.88 -40.44 39.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.51 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.3 pt -67.31 -35.92 75.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.523 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.9 m -57.05 -53.28 59.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.4 m -61.2 -43.59 98.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.496 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 65.0 m -66.09 -39.11 89.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.638 -178.496 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.149 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.44 -37.44 85.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.975 0.417 . . . . 0.0 110.831 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.582 ' O ' HG21 ' A' ' 18' ' ' ILE . 12.6 m -66.97 -31.37 71.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.334 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.68 -25.74 29.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.66 -35.41 8.49 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.149 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -85.46 -22.42 28.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 14' ' ' SER . 14.9 pt -46.88 -37.31 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 t -84.63 -20.75 30.85 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.679 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -88.0 -34.9 17.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.55 178.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.73 -32.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB2' ' CB ' ' A' ' 92' ' ' SER . 1.7 t-20 -65.59 -24.01 66.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.352 -0.217 . . . . 0.0 111.393 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.11 86.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.742 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.95 -28.03 57.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.13 0.49 . . . . 0.0 110.392 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -82.92 66.83 8.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.75 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.474 1.51 . . . . 0.0 114.537 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 26' ' ' ALA . 6.6 m -59.8 165.72 2.98 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.053 0.541 . . . . 0.0 110.196 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -59.49 -15.18 16.0 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.764 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -53.16 -29.34 31.03 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.38 1.072 . . . . 0.0 113.595 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -114.98 -19.54 10.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.098 0.475 . . . . 0.0 110.176 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -79.64 -43.35 22.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.773 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -160.79 -49.16 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 m -74.3 157.46 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.199 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.34 142.62 56.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.187 0.517 . . . . 0.0 111.188 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HE ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 ptm85 -62.68 159.34 16.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.209 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p -76.84 111.86 12.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.118 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.434 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 80.03 48.32 6.58 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.518 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 14.2 p -51.87 141.99 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.142 0.496 . . . . 0.0 111.63 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -76.34 147.41 38.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -65.31 -13.77 59.23 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.847 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -56.51 -38.22 71.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.94 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.76 -43.69 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.975 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.04 -69.42 0.63 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.497 0.189 . . . . 0.0 111.19 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t 74.73 -29.09 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.721 0.809 . . . . 0.0 112.743 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.5 m -66.43 -67.63 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.75 -35.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -80.72 89.96 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.951 0.405 . . . . 0.0 110.428 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 8.9 mm100 -82.75 -48.25 11.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.68 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.551 ' NH2' ' HB3' ' A' ' 54' ' ' SER . 8.2 ttp180 -136.69 -1.11 2.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.832 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.37 -51.01 0.61 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 110.588 -174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' HE ' ' A' ' 50' ' ' ARG . . . -69.27 128.47 36.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.095 0.474 . . . . 0.0 110.972 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.698 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -49.1 -19.71 0.47 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . 0.551 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 44.0 t -63.21 -62.46 1.68 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 118.803 0.728 . . . . 0.0 110.963 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.487 ' CB ' ' HD3' ' A' ' 50' ' ' ARG . 15.7 tp -87.52 -25.59 23.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 110.589 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.3 -13.89 60.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.85 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 11.4 p -42.71 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -44.32 -38.45 3.92 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.688 0.795 . . . . 0.0 111.852 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.77 12.9 9.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.664 0.269 . . . . 0.0 111.128 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.33 63.73 3.61 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.212 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.698 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 50.7 t -88.08 101.71 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -161.78 100.52 1.14 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.444 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.04 -59.37 4.28 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.646 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -62.57 -76.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.146 0.498 . . . . 0.0 111.031 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 12.3 p-10 -86.69 10.93 14.23 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.4 tp -88.98 -57.7 2.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.332 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.09 54.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 110.186 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -107.71 170.01 8.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 67.8 -61.53 0.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.84 0.456 . . . . 0.0 111.687 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.45 -58.41 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.535 0.334 . . . . 0.0 111.052 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 91.2 t -60.13 -37.23 72.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -70.17 -34.47 73.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.155 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 -43.93 36.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.71 -40.12 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.836 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.6 t -69.58 -6.68 32.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -79.96 -20.71 44.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.919 0.39 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.24 0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.506 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 46.86 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.376 0.608 . . . . 0.0 109.406 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.466 ' O ' ' HB2' ' A' ' 91' ' ' SER . 7.8 tp-100 -77.57 -59.58 2.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.54 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.28 89.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.725 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.52 17.12 1.85 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.544 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 8.6 t -54.93 -40.96 70.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.763 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 23' ' ' ASN . 6.6 t -72.72 -38.83 67.33 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.4 63.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.4 -20.88 31.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.431 ' HB2' HH12 ' A' ' 36' ' ' ARG . 48.0 t80 -87.88 -50.2 6.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.194 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 56.15 87.02 0.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.973 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.03 -5.12 42.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.555 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.64 -5.39 78.53 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.914 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.52 -7.44 10.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.451 ' H ' HD21 ' A' ' 100' ' ' LEU . 2.1 pt? -84.71 -177.68 6.66 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.634 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 12.5 p-10 -75.05 125.5 29.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -176.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.7 -24.58 61.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.367 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -68.29 -29.74 68.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.671 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.469 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 21.2 t30 -59.86 -51.93 67.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.737 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.558 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.1 mp -74.52 -37.85 44.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.442 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.72 -34.56 78.11 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.843 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -89.21 -49.14 6.91 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.33 -15.3 5.18 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.085 -1.046 . . . . 0.0 113.453 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -65.65 -75.74 0.39 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.926 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 114' ' ' SER . 16.3 m -67.77 -16.81 64.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 107' ' ' THR . 60.9 mtp180 -86.76 -46.59 9.85 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -83.81 -52.39 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.0 mp -67.59 -33.59 75.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' SER . 72.3 m 45.64 -99.63 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.48 -35.07 60.17 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.289 0.636 . . . . 0.0 112.306 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.53 -52.66 43.35 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.115 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 12.6 mt -72.43 -26.54 61.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.97 -36.93 73.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 109.836 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.96 -43.19 6.07 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.65 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 117' ' ' LEU . 37.3 t -61.0 -42.23 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.7 t -85.17 -39.85 17.38 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.38 -81.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 129' ' ' ILE . . . -69.08 -44.99 71.42 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 48.2 tt0 -70.5 -38.05 74.26 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.131 0.491 . . . . 0.0 111.183 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.73 -40.97 7.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.455 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.66 -22.48 9.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.36 95.38 0.21 Allowed Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.52 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' THR . 15.8 mm -76.76 132.99 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.473 HD22 ' NE2' ' A' ' 137' ' ' GLN . 10.8 t30 -115.49 132.01 56.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.782 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.434 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.5 t -99.11 120.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.98 35.8 1.97 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 67.3 p -70.82 -8.06 49.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.077 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.1 -19.75 51.5 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.198 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 p -105.98 -46.96 3.97 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 140' ' ' ILE . 54.2 t -66.28 -62.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.538 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.473 ' NE2' HD22 ' A' ' 130' ' ' ASN . 8.1 tt0 -56.3 -39.23 72.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -62.43 -40.35 96.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.78 -47.12 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.905 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.7 pt -57.4 -38.46 62.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.3 p -56.61 -42.14 78.27 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 111.66 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -84.67 -39.76 18.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 0.0 111.05 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.6 m -69.69 -39.58 76.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.444 -178.062 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.346 0 CA-C-O 120.499 -0.056 . . . . 0.0 113.04 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.96 -18.03 62.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.788 0.327 . . . . 0.0 111.618 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 18' ' ' ILE . 75.8 m -65.34 -21.83 66.74 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.008 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.78 41.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.931 0.396 . . . . 0.0 111.958 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.78 -41.75 8.07 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.1 pp -87.94 -20.62 25.66 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 14' ' ' SER . 12.0 pt -43.39 -47.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 35.4 t -73.06 -20.19 61.03 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 121.267 -0.173 . . . . 0.0 111.101 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -86.32 -32.24 21.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 17' ' ' LEU . 39.3 t -54.15 169.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.115 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.73 -32.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 31.7 m-80 -60.79 -24.39 65.76 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.63 -53.05 59.84 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.985 0.421 . . . . 0.0 111.332 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.91 -25.77 37.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.333 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' HD22 ' A' ' 31' ' ' LEU . . . -75.72 90.36 2.86 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . 0.54 ' HA ' ' NH2' ' A' ' 32' ' ' ARG . 5.2 m-80 -75.3 17.98 0.23 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.7 m -65.8 148.26 52.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.1 m -58.07 -14.54 6.9 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 p -48.5 -35.72 13.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 26' ' ' ALA . 1.2 pt? -108.41 -18.25 13.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.197 0.522 . . . . 0.0 110.679 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.54 ' NH2' ' HA ' ' A' ' 27' ' ' ASN . 17.0 mmt180 -76.73 -49.86 15.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -163.45 -29.76 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.4 t -87.49 144.87 8.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.5 145.58 32.77 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -70.59 153.53 42.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -68.84 120.8 15.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.93 37.14 20.04 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.514 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 7.5 p -51.31 148.37 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.153 0.501 . . . . 0.0 111.29 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.452 ' HG ' HD11 ' A' ' 116' ' ' LEU . 15.3 m -93.0 153.93 18.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -65.41 -12.72 55.01 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.422 -178.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -48.96 -38.58 23.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.198 0.523 . . . . 0.0 109.979 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.693 HG13 ' N ' ' A' ' 44' ' ' ALA . 3.9 pt -85.12 -44.47 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.907 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.693 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.14 -67.46 0.79 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.7 m 75.95 -18.57 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.808 0.843 . . . . 0.0 112.627 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.1 t -57.14 -96.2 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.88 0.472 . . . . 0.0 112.153 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.35 -23.21 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.371 0.605 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -79.52 98.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.2 mm-40 -73.41 -47.23 43.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.713 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.4 ttm-85 -149.47 9.02 0.71 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.418 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 -53.31 0.57 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.447 0.699 . . . . 0.0 110.982 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.54 142.82 55.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.573 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.582 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.03 -19.05 6.12 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -55.55 -71.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.862 0.363 . . . . 0.0 111.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -25.92 23.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.25 -18.39 57.67 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 19.3 t -52.42 106.04 0.14 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.028 0.442 . . . . 0.0 110.516 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 56' ' ' ALA . 12.4 t -165.39 -40.8 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.459 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.69 19.47 11.09 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.36 64.23 1.12 Allowed Glycine 0 C--N 1.316 -0.554 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.795 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.02 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -163.46 13.46 0.06 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.879 0.847 . . . . 0.0 109.461 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.87 -50.74 0.61 Allowed Glycine 0 C--N 1.294 -1.794 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.159 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.34 -55.23 37.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 120.782 0.325 . . . . 0.0 110.551 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.63 -41.79 16.01 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.482 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.58 -58.27 7.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.396 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 -5.74 59.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -128.25 -86.04 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -57.89 -31.91 67.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.48 -52.04 15.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 111.131 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 9.2 p -69.04 -40.77 81.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 75.1 mt-30 -62.91 -39.15 93.66 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.358 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.71 71.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.96 0.41 . . . . 0.0 111.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 77' ' ' LEU . 39.7 t -86.36 -32.37 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.002 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -70.81 -23.27 62.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.164 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 24.7 mmt180 -85.18 1.65 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.776 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.604 HD13 ' HH ' ' A' ' 86' ' ' TYR . 77.0 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.019 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.604 ' HH ' HD13 ' A' ' 77' ' ' LEU . 18.3 m-30 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -72.55 53.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.237 0.615 . . . . 0.0 111.352 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -90.6 -59.2 2.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.117 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.26 -26.27 30.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.657 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -83.51 6.68 19.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.528 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.3 m -52.84 -31.44 39.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.435 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 73.6 m -61.22 -47.68 84.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.54 32.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.789 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.15 -32.19 22.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -84.85 -36.52 21.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.769 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.01 86.47 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 112.022 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.04 56.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.755 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.9 -13.63 42.46 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.73 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.17 -1.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.612 0.72 . . . . 0.0 110.434 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.15 179.32 6.41 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.896 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.78 141.19 30.68 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.529 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.21 -23.64 57.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.814 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m -69.05 -34.78 75.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.469 0.652 . . . . 0.0 110.386 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.581 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 31.5 t30 -60.21 -51.71 68.41 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.487 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.61 -33.9 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.22 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.86 -48.41 76.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.966 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 71.1 m -73.1 -56.54 4.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -174.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.3 pp -102.18 -24.37 13.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.067 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.28 -65.91 2.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.274 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -65.61 -28.18 68.94 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.547 ' HD3' ' O ' ' A' ' 107' ' ' THR . 11.5 mpt_? -86.57 -55.31 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.54 -48.77 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.13 -42.64 65.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.6 m 48.46 -95.09 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.6 -33.28 54.38 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.206 0.602 . . . . 0.0 112.031 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 120' ' ' VAL . 60.7 tp -62.19 -53.59 53.04 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.503 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.6 -28.34 68.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.777 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -59.49 -43.99 93.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.963 0.411 . . . . 0.0 110.038 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.24 -31.73 41.31 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.98 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 116' ' ' LEU . 69.4 t -68.43 -38.9 79.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 122.863 -0.198 . . . . 0.0 111.269 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.9 m -57.55 -41.95 82.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.845 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -83.85 -39.24 20.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.94 -80.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HB2' HG13 ' A' ' 120' ' ' VAL . . . -64.22 -55.61 20.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.12 -29.23 66.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.197 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.68 -64.73 2.01 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.091 -0.575 . . . . 0.0 114.185 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.7 mt -104.35 -23.78 13.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.859 0.362 . . . . 0.0 111.656 -175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.94 97.72 1.12 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.1 mm -75.37 129.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -127.84 131.92 49.46 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.962 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.97 118.31 50.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.471 0.653 . . . . 0.0 111.405 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -97.63 43.97 1.06 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.455 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 21.0 p -78.62 1.14 23.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 120.855 0.36 . . . . 0.0 111.256 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.36 -21.96 29.28 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.567 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.2 t -106.0 -58.67 1.88 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 122.927 -0.16 . . . . 0.0 111.285 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -50.63 -51.97 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 137' ' ' GLN . 8.3 tt0 -61.76 -44.44 96.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -60.69 -46.78 89.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.952 0.406 . . . . 0.0 110.302 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -62.8 -51.1 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.578 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 136' ' ' VAL . 39.4 pt -69.32 -38.09 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -63.05 -52.35 63.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.465 0.174 . . . . 0.0 111.316 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.9 p -62.85 -43.34 99.04 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -65.18 -40.52 94.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.311 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.144 0.497 . . . . 0.0 110.946 179.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 CA-C-O 120.401 -0.11 . . . . 0.0 113.242 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.84 90.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.976 0.388 . . . . 0.0 111.211 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.544 ' O ' HG21 ' A' ' 18' ' ' ILE . 18.7 m -60.22 -28.6 68.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.754 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.11 -21.44 22.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.93 -39.42 7.51 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.407 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.611 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.1 pp -85.98 -25.46 26.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' O ' ' A' ' 14' ' ' SER . 14.1 pt -45.38 -50.34 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 14.1 m -84.78 -18.74 34.08 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.699 0.285 . . . . 0.0 111.586 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.74 -24.24 28.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -78.71 -106.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.442 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -77.97 -50.14 12.74 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -60.51 -21.42 62.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -57.13 -40.83 77.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.176 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.14 -37.05 15.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.255 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -79.41 83.02 5.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 18.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.853 0.861 . . . . 0.0 113.069 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.3 m -62.38 164.85 6.68 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.432 0.634 . . . . 0.0 111.346 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.1 t -65.45 -14.92 62.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.896 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -48.13 -44.03 31.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.742 0.817 . . . . 0.0 112.838 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.5 pt? -99.15 -19.86 16.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.496 0.665 . . . . 0.0 109.8 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -70.64 -53.39 15.99 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.761 -174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -167.16 -24.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.93 141.39 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -54.72 150.03 10.23 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 111.91 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.49 163.49 26.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.169 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.416 HG22 HG21 ' A' ' 131' ' ' VAL . 18.4 p -77.12 147.4 36.61 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.1 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.489 ' H ' HG12 ' A' ' 131' ' ' VAL . . . 73.71 24.38 74.59 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.313 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.8 165.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.76 0.424 . . . . 0.0 110.782 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.563 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.9 m -134.95 165.04 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.147 -0.346 . . . . 0.0 111.525 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.4 pp0? -66.77 -12.54 59.18 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG3' ' HB2' ' A' ' 116' ' ' LEU . 82.9 mm-40 -53.44 -38.8 63.87 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -86.63 -44.11 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' N ' HD13 ' A' ' 43' ' ' ILE . . . -81.89 -65.25 1.03 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.614 0.245 . . . . 0.0 111.362 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m 81.81 -19.02 0.44 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.911 0.884 . . . . 0.0 112.152 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -70.91 -90.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.005 0.431 . . . . 0.0 111.705 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.61 -19.69 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.404 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.38 81.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.169 0.509 . . . . 0.0 110.105 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 1.8 mp0 -64.41 -48.93 73.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.231 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.523 ' HE ' HD11 ' A' ' 55' ' ' LEU . 46.4 ttm-85 -148.31 4.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.061 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.482 ' HB2' HG13 ' A' ' 131' ' ' VAL . . . 67.63 -51.3 0.51 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -175.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.499 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -67.46 140.82 57.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.375 0.607 . . . . 0.0 110.857 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.678 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.6 mt-30 -59.52 -17.5 32.56 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.415 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -62.35 -74.06 0.1 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.848 0.356 . . . . 0.0 111.747 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.523 HD11 ' HE ' ' A' ' 50' ' ' ARG . 9.0 tt -87.22 -25.03 24.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.653 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.22 -19.51 43.06 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.678 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -50.06 108.11 0.2 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -150.02 -41.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.738 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.4 mt -118.22 19.33 13.54 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.338 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.48 56.34 1.27 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.811 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HG2' ' A' ' 53' ' ' GLN . 2.9 t -90.23 104.09 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -156.18 15.14 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.08 -37.37 2.16 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.026 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -54.49 -74.0 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.44 0.296 . . . . 0.0 111.458 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.5 p-10 -81.11 -20.83 40.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.013 0.435 . . . . 0.0 110.216 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.5 -55.05 35.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.655 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' SER . . . -82.79 1.66 37.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -126.08 -87.55 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -57.35 -38.43 74.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.47 92.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.958 0.409 . . . . 0.0 110.824 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.35 -46.26 71.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.13 -40.38 81.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.655 0.264 . . . . 0.0 111.584 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.04 88.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.835 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.59 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.2 t -85.31 -17.69 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -93.35 -19.6 21.18 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 121.946 -0.471 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -118.55 22.46 12.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.491 0.662 . . . . 0.0 110.744 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.106 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.494 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 4.2 m-85 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 121.272 0.558 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.62 17.62 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 77.7 mt-30 -88.89 -55.45 3.69 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.364 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -72.41 -40.96 66.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.302 0.572 . . . . 0.0 109.592 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.573 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.7 m-85 -81.64 16.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.082 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -51.63 -57.2 9.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.2 m -55.12 -36.68 66.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.93 -39.15 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 18.9 mt -81.9 -30.32 31.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.825 0.345 . . . . 0.0 111.68 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -85.06 -28.56 25.58 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 52.77 84.28 0.06 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.81 -7.45 57.87 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.128 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.18 -11.93 40.67 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.035 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 t -78.53 -8.54 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.552 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.53 -171.42 3.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.487 -177.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.07 129.41 42.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.29 61.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.14 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -67.9 -32.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.519 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 11.5 t30 -62.7 -54.01 45.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -69.06 -35.96 71.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.384 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.86 -30.81 67.31 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.709 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.1 m -92.74 -34.55 13.87 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 2.2 pp -137.47 -29.61 0.87 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.812 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -53.17 -68.56 1.56 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.987 -0.625 . . . . 0.0 114.326 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 114' ' ' SER . 8.1 m -60.89 -20.6 62.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.714 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -88.14 -54.59 4.14 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.356 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.59 -45.89 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.812 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.4 mm? -81.5 -29.87 33.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 110' ' ' SER . 35.3 t 44.7 -96.68 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.39 68.31 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.908 0.483 . . . . 0.0 111.8 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 39.5 tp -65.32 -60.12 3.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.69 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.57 -29.26 68.58 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.57 -43.85 93.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.788 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 -37.13 28.66 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.999 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 94' ' ' LEU . 63.1 t -68.65 -41.11 82.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 8.1 t -55.73 -46.52 77.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.076 0.465 . . . . 0.0 111.201 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -74.66 -49.56 20.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.108 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.41 -70.88 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.59 -47.6 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 121' ' ' SER . 32.5 tt0 -68.64 -35.49 77.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.055 0.455 . . . . 0.0 110.428 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.62 -71.32 1.28 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.77 -0.65 . . . . 0.0 114.034 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.43 -24.16 23.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.816 0.341 . . . . 0.0 111.371 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.49 92.92 0.98 Allowed Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.191 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.499 HG23 ' CB ' ' A' ' 52' ' ' ALA . 20.7 mm -78.17 129.6 37.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -108.9 131.14 55.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.486 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 136' ' ' VAL . 7.3 m -98.73 90.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.04 0.924 . . . . 0.0 111.14 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.57 46.01 1.02 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.279 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.3 m -68.37 -6.05 22.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.566 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 -23.42 30.18 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.122 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -105.55 -31.99 8.7 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 131' ' ' VAL . 40.6 t -67.27 -57.18 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.712 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.5 -53.36 30.53 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.46 0.475 . . . . 0.0 111.804 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -54.23 -37.73 64.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.171 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.58 -47.0 10.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.652 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.5 pt -64.99 -39.17 84.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.8 p -61.91 -49.07 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.429 . . . . 0.0 110.67 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.2 m -65.63 -28.95 69.48 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.329 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.1 t -89.06 -20.37 24.44 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.7 p . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.178 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 N-CA-C 113.59 0.196 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.91 87.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 18' ' ' ILE . 67.4 m -62.78 -24.62 67.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.67 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.91 -33.03 10.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.493 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 3.4 pp -84.48 -19.26 33.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 14' ' ' SER . 18.3 pt -30.77 -56.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.3 m -84.53 -20.04 32.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -86.29 -44.58 12.0 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 100' ' ' LEU . 15.9 t -59.02 -97.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -171.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.26 -48.62 13.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -65.45 -25.11 67.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -67.85 -39.62 83.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.353 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -71.92 -33.7 68.47 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.922 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.64 69.19 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.892 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.49 8.58 4.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.736 0.814 . . . . 0.0 112.031 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 m -72.43 172.83 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.649 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 m -63.24 -15.68 57.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -54.5 -22.52 13.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.026 0.93 . . . . 0.0 113.433 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.53 -21.86 6.63 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.209 0.528 . . . . 0.0 110.393 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -79.66 -37.69 35.36 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -164.58 -26.12 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.7 t -99.76 141.23 17.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.72 163.18 5.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 87' ' ' ALA . 4.3 ptm180 -69.42 141.84 53.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.447 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -68.46 124.6 24.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.88 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.409 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 85.08 29.78 27.4 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.587 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.78 145.74 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 20.4 t -104.65 166.33 10.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 112.024 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 51.5 tt0 -73.23 -14.93 61.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.189 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.37 -48.79 65.37 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -85.72 -47.79 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.12 175.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.542 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -58.08 -32.02 67.65 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m 72.18 -38.84 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -71.09 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.61 -19.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.34 82.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 116.905 -0.134 . . . . 0.0 111.321 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 40' ' ' SER . 47.8 mm-40 -63.58 -43.95 95.49 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.154 0.502 . . . . 0.0 110.35 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.659 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 20.0 ttm180 -157.25 0.47 0.12 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.48 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.98 -53.18 0.46 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.402 0.681 . . . . 0.0 110.756 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.32 133.98 55.85 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.956 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.2 mp0 -59.21 -18.17 34.31 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.372 0.669 . . . . 0.0 112.759 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.8 t -55.89 -68.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.659 HD21 ' CZ ' ' A' ' 50' ' ' ARG . 4.0 tp -87.74 -30.1 20.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.243 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -65.61 -18.7 65.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 18.1 t -64.56 83.71 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -136.29 -37.24 0.71 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.024 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.2 13.48 9.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.34 49.08 2.08 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.084 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.26 118.56 34.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.513 0.197 . . . . 0.0 110.86 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.94 21.64 1.6 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.977 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.42 -31.4 6.0 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.986 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.519 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 13.9 p-10 -52.47 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.997 0.919 . . . . 0.0 111.786 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.519 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 2.9 p-10 -86.97 26.16 1.2 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.971 0.415 . . . . 0.0 110.243 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 5.6 tt -88.02 -78.19 0.33 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.177 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.93 74.71 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.66 160.76 16.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . 0.427 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 98.1 m-85 69.53 -62.62 0.41 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.016 0.527 . . . . 0.0 111.787 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 65' ' ' ASN . . . -62.65 -62.64 1.6 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -63.59 -38.81 83.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.671 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 21.1 mt-30 -63.46 -32.32 73.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.921 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.54 -40.94 22.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.686 0.279 . . . . 0.0 111.614 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.2 -35.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.185 0.516 . . . . 0.0 111.094 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -78.11 -4.89 49.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.282 0.563 . . . . 0.0 110.25 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 47.5 ttp180 -90.0 -6.77 55.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.592 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.24 0.574 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.859 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.611 ' HD1' ' N ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.611 ' N ' ' HD1' ' A' ' 86' ' ' TYR . . . -88.14 -17.87 30.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.894 0.378 . . . . 0.0 111.397 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.58 -45.44 90.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.337 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.45 -62.51 1.63 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.271 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.583 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 61.4 m-85 -84.27 32.94 0.49 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.801 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 p -54.82 -61.5 2.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -68.59 -38.37 80.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 117' ' ' LEU . . . -64.69 -39.86 94.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 36.5 mt -83.77 -34.33 24.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -76.22 -47.04 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.335 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.505 ' ND2' HG12 ' A' ' 105' ' ' ILE . 37.9 t-20 57.21 92.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.983 0.802 . . . . 0.0 111.119 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.41 -2.15 48.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.6 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.03 -13.47 31.62 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.733 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 t -80.46 -8.95 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.64 0.734 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -84.4 -179.23 7.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.257 -176.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -77.26 113.83 15.43 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.549 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.39 64.27 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.717 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -41.32 77.86 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.475 ' HB3' ' ND2' ' A' ' 101' ' ' ASN . 2.1 t30 -62.14 -33.23 74.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.715 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.505 HG12 ' ND2' ' A' ' 96' ' ' ASN . 1.5 mp -78.15 -43.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.541 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.57 -19.02 56.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.459 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -84.31 -55.48 4.15 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.015 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 3.3 pp -123.47 -32.57 3.36 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -50.33 -75.21 0.22 Allowed Glycine 0 C--O 1.223 -0.541 0 C-N-CA 121.596 -0.335 . . . . 0.0 113.772 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.5 m -62.4 -18.37 61.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.796 0.331 . . . . 0.0 111.841 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -81.0 -54.27 5.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.447 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.02 -40.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.994 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 3.3 mm? -70.08 -16.68 63.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.6 p 45.44 -118.24 0.71 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.918 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.8 69.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 120' ' ' VAL . 11.6 tp -59.38 -62.88 1.55 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.519 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 93' ' ' ALA . 15.8 mt -71.9 -29.99 64.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.564 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -61.19 -40.23 93.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.284 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.92 -32.63 56.6 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.661 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 116' ' ' LEU . 54.2 t -68.51 -35.99 72.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.651 -0.323 . . . . 0.0 110.962 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 59.0 m -53.03 -47.36 68.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.1 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 p -80.85 -43.25 20.25 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.79 -72.51 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.426 ' HB3' HG11 ' A' ' 120' ' ' VAL . . . -71.24 -50.43 32.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 121' ' ' SER . 45.4 tt0 -64.62 -35.87 82.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.054 0.454 . . . . 0.0 110.769 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.21 -53.37 3.14 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.9 -0.667 . . . . 0.0 114.618 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.5 mt -105.48 -24.12 12.68 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.9 94.5 0.73 Allowed Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.879 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.539 HG13 ' HD3' ' A' ' 50' ' ' ARG . 30.1 mm -77.87 141.12 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.253 0.549 . . . . 0.0 112.429 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -123.23 152.13 41.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.73 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 132' ' ' ASP . 46.3 t -107.88 163.31 5.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.417 ' N ' HG13 ' A' ' 131' ' ' VAL . 35.8 t70 -58.8 160.05 6.19 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 15.4 m -74.64 29.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.11 -87.17 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -106.23 -48.47 3.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.818 0.342 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' ILE . 45.1 t -52.15 -63.16 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -172.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.6 tt0 -62.59 -41.21 98.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -60.1 -44.0 95.17 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.083 0.468 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.87 -51.99 14.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.924 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 136' ' ' VAL . 34.4 pt -62.01 -34.47 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -64.74 -47.8 76.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 0.0 110.752 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -34.93 71.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.362 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.4 t -67.88 -56.59 8.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.875 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.94 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.28 -10.98 60.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.796 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 18' ' ' ILE . 20.3 m -78.55 -22.18 47.63 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.552 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -55.43 -30.44 60.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.15 -38.93 24.8 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.432 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' HG21 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -32.29 22.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 14' ' ' SER . 19.9 pt -47.79 -47.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 11.7 m -70.83 -24.58 62.56 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.68 0.276 . . . . 0.0 111.599 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -87.56 -24.37 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.882 0.372 . . . . 0.0 111.576 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 17' ' ' LEU . 84.3 t -59.92 173.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.51 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.437 ' H ' ' CG1' ' A' ' 21' ' ' VAL . . . -37.45 -33.51 0.07 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.753 1.221 . . . . 0.0 114.189 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.19 -23.0 61.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -61.58 -38.17 86.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.9 -41.95 12.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.31 69.54 7.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.41 19.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.4 1.08 . . . . 0.0 112.39 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 26' ' ' ALA . 24.2 m -55.98 161.52 2.27 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 123.556 0.743 . . . . 0.0 111.482 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.404 ' N ' HG23 ' A' ' 28' ' ' THR . 20.2 m -52.69 -19.51 2.45 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 p -51.79 -44.83 63.6 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.895 . . . . 0.0 113.253 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -100.09 -20.23 16.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.375 0.607 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -66.72 -56.14 11.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.301 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -163.85 -34.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.859 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.62 146.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.89 139.86 57.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.105 0.478 . . . . 0.0 110.849 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 48.7 ptt85 -63.57 157.37 23.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.166 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.03 112.21 4.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.894 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.435 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.71 35.72 7.16 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.687 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.9 p -45.12 143.6 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.44 0.696 . . . . 0.0 112.415 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.2 p -82.13 139.81 34.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.077 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.55 -14.12 11.91 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.44 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -65.04 -32.02 73.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.746 0.307 . . . . 0.0 111.216 -177.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.01 -34.08 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -84.0 -76.94 0.28 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.567 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m 75.21 -18.92 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.838 0.855 . . . . 0.0 111.629 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' ALA . 16.8 p -68.04 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.296 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.56 -32.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.5 p -79.15 89.43 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 121.931 0.872 . . . . 0.0 110.795 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.53 -43.49 17.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.021 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -133.88 -4.82 2.81 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.497 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.61 -50.12 0.66 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.305 0.642 . . . . 0.0 112.722 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.42 -90.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -172.74 -45.15 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -50.31 -62.11 1.78 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 tt -86.06 -23.64 26.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.415 0.626 . . . . 0.0 110.138 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.98 -17.92 58.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 p -62.72 65.33 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.528 0.68 . . . . 0.0 112.724 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.444 HG22 ' HG ' ' A' ' 59' ' ' LEU . 9.9 t -102.5 -37.32 8.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' A' ' 58' ' ' THR . 81.2 mt -121.76 19.16 11.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 65.33 1.57 Allowed Glycine 0 C--O 1.217 -0.968 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.24 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.9 t -90.07 110.17 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.98 0.419 . . . . 0.0 109.979 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -141.77 18.0 2.16 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.41 -34.71 4.3 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.09 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.3 -70.53 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 110.375 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 26.7 p-10 -86.04 18.88 2.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.454 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 6.7 tt -88.14 -74.41 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.529 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.41 -27.25 66.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -111.71 162.88 14.75 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 66.82 -61.74 0.32 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.85 -61.54 2.11 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.761 0.315 . . . . 0.0 110.73 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.76 -35.77 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -69.88 -21.37 63.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.446 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -42.85 29.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.83 0.348 . . . . 0.0 110.152 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 27.3 t -78.23 -33.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -70.97 -18.11 62.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.275 0.56 . . . . 0.0 110.431 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -116.58 18.95 14.86 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.182 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . 10.7 tp . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.278 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 . . . . . 0 N--CA 1.443 -0.814 0 CA-C-O 121.085 0.469 . . . . 0.0 110.251 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.01 12.84 0.78 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 86' ' ' TYR . 4.1 mp0 -74.55 -59.86 2.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.95 71.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.086 0.47 . . . . 0.0 110.827 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 93.0 m-85 -83.24 12.38 5.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.522 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 47.8 t -51.19 -43.27 61.31 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.524 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.9 m -58.16 -44.64 88.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.69 30.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.781 0.324 . . . . 0.0 111.803 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 68.2 mt -81.59 -32.16 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -84.97 -34.72 22.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.447 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 49.05 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.979 0.8 . . . . 0.0 111.093 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.72 -6.34 51.77 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.598 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.16 -2.85 87.27 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.833 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 32.8 t -92.71 -13.33 8.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.646 0.736 . . . . 0.0 109.818 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 2.6 pt? -91.29 -176.08 4.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -84.54 105.17 15.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.76 -16.93 64.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.176 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -81.34 -19.76 42.12 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.465 ' ND2' HD11 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.97 -26.52 64.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.465 HD11 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -69.67 -33.17 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.564 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -77.48 -27.18 51.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.109 0.48 . . . . 0.0 109.959 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.59 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 89.9 m -78.54 -46.65 18.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.838 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.449 HD11 ' OG ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -133.51 -40.99 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -48.5 -71.88 0.52 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' SER . 10.3 t -67.32 -14.05 62.56 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.097 0.475 . . . . 0.0 111.494 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HD3' ' O ' ' A' ' 107' ' ' THR . 80.4 mtp180 -87.19 -49.51 7.23 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.4 -42.81 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.258 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.486 HD21 HD22 ' A' ' 116' ' ' LEU . 6.0 mp -80.09 -29.46 39.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 110' ' ' SER . 19.5 m 47.72 -99.09 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.473 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.22 -36.79 63.89 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.486 HD22 HD21 ' A' ' 113' ' ' LEU . 55.5 tp -62.47 -57.08 12.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.601 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 121' ' ' SER . 25.9 mt -71.47 -23.78 61.88 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.165 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.12 -34.11 76.9 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.19 -43.22 6.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.455 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.42 -28.99 45.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 122.358 0.263 . . . . 0.0 111.11 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.453 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 9.3 t -57.35 -40.51 78.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.267 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' SER . . . . . 0.461 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 23.7 m -85.57 -28.83 24.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.0 -83.82 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.17 -47.49 61.37 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 42.9 tt0 -75.71 -17.57 59.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.326 0.584 . . . . 0.0 109.793 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 122' ' ' SER . . . -85.13 -64.06 1.55 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.207 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -127.69 -4.93 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.37 119.43 1.32 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.593 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.46 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.967 0.413 . . . . 0.0 111.261 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -101.02 152.19 20.89 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.28 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.435 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -116.61 -149.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -85.44 147.44 26.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.491 0.663 . . . . 0.0 110.871 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 p -80.53 15.38 1.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.301 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.05 -64.43 0.48 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.499 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.6 m -85.25 -49.86 7.84 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 140' ' ' ILE . 99.5 t -72.23 -51.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.82 -48.25 73.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 p -58.79 -41.78 87.49 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.831 0.348 . . . . 0.0 111.86 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -50.4 16.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.996 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.3 pt -65.27 -31.73 55.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -61.41 -43.94 97.99 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.2 p -86.52 -40.57 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 22.8 t -78.09 -18.36 55.83 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.773 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.24 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.59 77.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.556 ' O ' HG21 ' A' ' 18' ' ' ILE . 15.3 p -76.21 -27.99 57.04 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.291 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.99 -23.02 52.21 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.01 -41.8 6.17 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.511 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.606 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.5 pp -84.41 -22.64 30.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 5.1 pt -40.22 -55.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 t -85.06 -19.71 31.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.712 0.291 . . . . 0.0 111.632 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -83.14 -27.42 30.13 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 17' ' ' LEU . 23.8 t -71.28 -100.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.99 35.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' HD22 ' A' ' 31' ' ' LEU . 4.4 m-80 -70.91 -24.56 62.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.7 87.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.167 0.508 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 25' ' ' LEU . 6.0 tt -75.91 -40.21 54.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.05 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.73 90.41 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.741 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 53.77 16.97 1.14 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.793 0.837 . . . . 0.0 111.794 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.44 HG21 ' N ' ' A' ' 29' ' ' SER . 19.7 m -75.66 165.59 24.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.27 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.44 ' N ' HG21 ' A' ' 28' ' ' THR . 16.3 m -60.08 -17.63 41.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.819 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -53.48 -31.26 44.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.687 0.795 . . . . 0.0 112.73 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -110.08 -20.28 12.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.525 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -79.87 -38.61 32.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.878 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -174.64 -26.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.08 139.64 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.42 145.37 22.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -63.12 155.25 28.5 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 m -71.22 114.45 9.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.262 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 40.13 9.19 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.762 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.86 151.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.203 0.525 . . . . 0.0 111.605 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -91.31 159.51 15.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.599 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.0 pt20 -67.42 -13.37 61.96 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.285 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -55.62 -47.78 76.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.043 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.94 -29.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.784 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -82.32 -55.36 4.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.118 -176.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 m 75.53 -18.9 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.866 0.866 . . . . 0.0 111.821 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 44' ' ' ALA . 28.4 p -68.43 -88.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -145.01 -27.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.947 0.403 . . . . 0.0 111.814 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.62 98.21 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.342 0.591 . . . . 0.0 111.824 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 31.2 mt-30 -82.54 -48.27 11.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.351 177.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.713 ' NH1' ' HA ' ' A' ' 123' ' ' ALA . 54.7 ttt180 -134.31 -3.14 2.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.879 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.07 -58.26 0.54 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.354 0.662 . . . . 0.0 110.306 -174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.43 137.61 57.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.274 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -50.29 -24.38 2.89 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -50.93 -74.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.465 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 47.5 tp -87.94 -24.53 23.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.514 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.85 59.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 14.3 t -58.67 84.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 111.65 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.4 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.7 t -123.3 -35.99 2.88 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.73 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 58' ' ' THR . 84.0 mt -120.82 18.57 11.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.948 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.43 59.69 2.35 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.391 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.692 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 33.0 t -89.43 103.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 120.929 0.395 . . . . 0.0 110.834 -177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -169.2 96.77 0.34 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.502 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.77 -63.87 4.18 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.21 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.55 -75.52 0.05 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.914 0.486 . . . . 0.0 111.664 -175.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.692 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.5 p-10 -85.8 15.16 5.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.26 -56.1 3.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.442 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.01 46.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.246 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -121.24 161.09 22.54 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 66.95 -63.11 0.28 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.89 -31.24 52.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 110.349 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -68.61 -29.5 68.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.65 65.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.122 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -77.5 -38.92 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.7 t -66.37 -21.92 66.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -113.32 15.44 19.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.9 tp . . . . . 0 C--N 1.317 -0.825 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.661 -177.122 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 88' ' ' GLN . 74.9 m-85 . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.81 35.6 0.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.235 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 85.6 mm-40 -74.43 -60.39 2.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.331 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -78.67 -32.67 47.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.409 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 56.6 m-85 -80.68 9.03 6.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.055 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 p -52.15 -56.53 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 t -61.53 -36.04 79.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.61 -36.54 62.95 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.39 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 50.1 mt -83.62 -20.68 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.164 0.507 . . . . 0.0 111.163 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . 0.474 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 78.9 t80 -85.13 -25.27 27.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m120 48.57 65.59 1.3 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.972 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.92 64.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.098 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.13 -15.45 61.0 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.113 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.17 -12.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.98 0.895 . . . . 0.0 109.02 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HB3' HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -83.6 175.29 9.85 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 -178.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 39.1 t30 -72.17 109.51 5.99 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.833 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.53 -24.43 63.74 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.865 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.1 m -69.46 -26.88 64.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.527 0.68 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -64.62 -46.56 82.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.606 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.68 -36.95 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.019 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.59 -39.06 92.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.407 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 93.4 m -74.87 -62.89 1.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.493 HD23 ' OD1' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -113.21 -33.22 6.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.9 -56.87 14.3 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.188 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.9 t -69.49 -26.44 64.56 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.764 0.316 . . . . 0.0 111.573 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 107' ' ' THR . 3.6 mpt_? -83.09 -47.39 11.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.24 -50.08 15.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 9.0 mp -67.87 -41.27 83.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.925 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.7 t 46.72 -95.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.761 0.824 . . . . 0.0 113.104 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.8 66.0 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.092 0.557 . . . . 0.0 112.121 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 120' ' ' VAL . 35.2 tp -65.93 -48.22 72.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.524 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.75 -23.49 62.44 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.718 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -58.46 -34.78 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.55 -41.42 6.88 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.555 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 116' ' ' LEU . 76.4 t -61.18 -32.55 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.8 m -54.43 -45.67 73.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -84.33 -23.9 30.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.827 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.17 -84.96 0.14 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 95' ' ' PHE . . . -76.51 -45.91 28.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.835 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -72.52 -20.38 61.36 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.089 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.73 -70.96 1.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.62 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.69 -9.07 5.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.653 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.63 120.78 3.12 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.895 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 mt -85.27 146.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.051 0.453 . . . . 0.0 111.863 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.52 149.37 42.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.2 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.7 t -120.89 161.72 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 156.22 14.31 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.261 0.553 . . . . 0.0 111.74 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 14.5 m -78.97 20.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.477 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.84 -77.97 0.35 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.183 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.9 m -107.83 -31.15 8.14 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.8 t -86.58 -64.46 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.566 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.2 tt0 -67.59 -23.0 65.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.358 . . . . 0.0 111.96 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -68.85 -44.97 72.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.065 0.46 . . . . 0.0 111.084 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.48 -50.23 14.54 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.511 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 137' ' ' GLN . 44.9 pt -58.79 -40.47 79.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -36.95 70.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.755 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.1 t -84.42 -45.53 12.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.0 110.568 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.6 t -59.14 -45.41 91.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.905 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 -179.023 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.21 -1.1 24.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.305 0.574 . . . . 0.0 110.437 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.519 ' O ' HG23 ' A' ' 18' ' ' ILE . 27.5 p -76.5 -25.01 53.78 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.27 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.47 43.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.49 -38.93 6.91 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.53 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -83.77 -25.02 30.84 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 9.5 pt -45.44 -42.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 46.2 m -83.12 -19.83 35.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -86.71 -23.84 25.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.556 HG12 ' CB ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -72.14 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.405 ' H ' HG11 ' A' ' 21' ' ' VAL . . . -51.79 -33.26 34.69 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.439 0.696 . . . . 0.0 112.76 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -65.69 -24.29 66.97 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -70.95 -42.42 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.23 -16.1 53.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.57 -36.99 21.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.26 18.25 0.59 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.683 1.193 . . . . 0.0 112.228 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.471 ' O ' HD22 ' A' ' 31' ' ' LEU . 7.1 m -66.26 164.11 16.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.201 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.9 m -63.85 -16.3 61.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.832 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -51.31 -41.04 60.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.762 0.825 . . . . 0.0 112.289 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -99.84 -19.31 16.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.394 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -74.47 -59.58 2.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.199 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -162.78 -28.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.82 136.06 24.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.6 138.29 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.81 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -64.07 152.46 40.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.669 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -67.65 111.63 4.32 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.418 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.93 38.37 8.68 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.215 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.9 148.29 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.131 0.491 . . . . 0.0 111.105 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -87.86 157.37 19.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.073 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 18.8 pt20 -63.52 -19.39 64.73 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.302 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -51.5 -46.18 63.12 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 111.458 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -84.08 -32.66 8.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -83.67 -48.91 9.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.8 p 67.48 -18.84 0.13 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.292 1.437 . . . . 0.0 113.095 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 44' ' ' ALA . 20.8 p -68.38 -75.69 0.1 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.61 -34.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.836 0.351 . . . . 0.0 111.903 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.52 97.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.1 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 72.8 mt-30 -82.84 -51.01 8.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.349 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.539 HH22 ' HB2' ' A' ' 127' ' ' LEU . 41.1 ttt180 -130.69 -5.72 4.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.673 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 66' ' ' LEU . . . 71.08 -55.74 0.64 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.599 -172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 136.07 54.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.901 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.568 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -51.01 -29.86 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -173.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.3 t -46.84 -69.25 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.106 0.412 . . . . 0.0 112.079 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.4 tp -88.6 -24.19 22.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 111.602 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.26 -18.91 51.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.0 t -48.48 98.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.089 0.471 . . . . 0.0 111.662 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -142.04 -37.72 0.39 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.557 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.92 18.7 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.02 67.63 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.419 HG22 HD22 ' A' ' 65' ' ' ASN . 46.7 t -87.35 110.23 20.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.14 0.495 . . . . 0.0 110.998 -175.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -158.94 20.92 0.2 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.991 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 123.48 -37.75 2.65 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.814 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.28 -74.47 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.552 0.176 . . . . 0.0 110.928 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.419 HD22 HG22 ' A' ' 61' ' ' VAL . 2.5 p-10 -85.48 9.69 15.07 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 19.5 tp -87.97 -56.6 3.27 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.963 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 -35.52 40.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.508 0.671 . . . . 0.0 109.899 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.81 162.87 12.94 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 68.89 -61.68 0.41 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.65 -62.16 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.817 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -40.34 86.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.125 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.38 -44.6 95.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.722 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.51 74.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.02 -38.18 78.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -74.79 -21.78 59.12 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.979 0.419 . . . . 0.0 110.76 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -92.06 -8.9 44.59 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.15 0.5 . . . . 0.0 110.11 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--N 1.32 -0.714 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.276 -179.705 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 88' ' ' GLN . 16.9 m-30 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 109.769 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.18 41.33 0.37 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.297 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 tp60 -64.81 -61.59 2.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.911 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -80.34 -27.1 38.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.69 10.45 2.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t -52.03 -51.07 59.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.1 m -59.14 -34.96 72.68 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -32.84 31.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.94 -35.38 18.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -78.74 -30.84 46.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.0 m120 52.07 82.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.85 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.64 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.74 -13.71 60.16 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.135 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.27 -2.07 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.645 0.736 . . . . 0.0 109.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.556 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.2 pt? -84.92 173.81 10.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.355 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 16.1 t30 -68.39 103.74 1.71 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.733 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.36 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.813 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 p -74.84 -16.67 60.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.057 0.456 . . . . 0.0 110.673 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -68.06 -47.32 68.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.406 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.48 -41.93 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.17 -30.72 70.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.147 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.1 m -91.42 -52.46 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -117.48 -27.86 6.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.75 -64.89 3.97 Favored Glycine 0 C--O 1.234 0.103 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.961 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 p -76.71 -11.8 59.9 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -54.73 4.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.33 -54.48 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.164 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.96 -57.92 3.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m 67.24 -86.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.1 -36.92 61.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 120' ' ' VAL . 27.6 tp -65.29 -50.97 63.68 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.743 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 120' ' ' VAL . 5.4 mp -67.95 -23.22 65.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.05 -42.65 7.01 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.822 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 116' ' ' LEU . 2.7 m -67.71 -32.46 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.828 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -62.21 -34.18 75.98 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.755 0.312 . . . . 0.0 110.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 t -85.34 -38.5 18.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.471 0.653 . . . . 0.0 110.303 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.22 -79.43 0.21 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HA ' HG13 ' A' ' 129' ' ' ILE . . . -65.23 -60.93 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.414 -175.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -31.86 70.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 109.965 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.94 2.22 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.484 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HH22 ' A' ' 50' ' ' ARG . 73.0 mt -115.02 -5.54 12.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.0 105.07 0.07 OUTLIER Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.3 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.435 HG13 ' HA ' ' A' ' 124' ' ' ALA . 27.9 mt -77.57 134.88 27.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -128.1 115.74 18.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.082 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -82.75 166.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.936 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.35 158.18 9.78 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.104 0.478 . . . . 0.0 111.252 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 33.1 m -79.86 16.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.345 -177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.58 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.934 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.0 p -106.83 -30.14 9.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.39 -63.97 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tp-100 -59.17 -41.77 89.21 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 m -57.63 -45.7 85.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.877 0.37 . . . . 0.0 111.885 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.71 -52.87 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.459 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.4 pt -55.75 -38.91 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -62.87 -35.26 79.41 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 m -84.82 -38.24 19.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 111.009 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.9 m -72.28 -40.73 67.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.353 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.024 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 N-CA-C 112.712 -0.155 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.89 74.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.22 0.534 . . . . 0.0 110.682 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.6 m -62.82 -26.78 68.91 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.86 -18.31 4.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.79 -45.9 5.01 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.422 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 21' ' ' VAL . 2.2 pp -86.63 -21.63 26.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 4.7 pt -35.49 -58.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.455 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 18.1 t -79.41 -20.23 48.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.65 -32.96 20.28 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 17' ' ' LEU . 45.7 t -62.0 -94.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -53.39 6.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -65.75 -24.41 66.95 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 19' ' ' SER . . . -63.16 -35.91 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.725 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.74 -21.6 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.482 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.68 33.74 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.96 18.09 2.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.714 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 m -81.32 148.38 29.42 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 -17.18 1.01 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.882 1.273 . . . . 0.0 114.101 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -61.2 -21.99 64.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 pp -93.83 -26.99 16.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.217 0.532 . . . . 0.0 110.379 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -82.42 -45.88 14.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 -26.58 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' A' ' 139' ' ' ASP . 25.8 t -84.35 161.47 3.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -85.1 159.27 20.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.696 0.284 . . . . 0.0 110.523 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -89.39 166.47 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.296 0.569 . . . . 0.0 111.514 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -74.87 124.87 27.66 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.601 177.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 73.31 38.26 53.6 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.451 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.93 149.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.042 0.937 . . . . 0.0 112.66 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.537 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.3 m -77.83 142.65 38.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.003 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -68.87 -13.09 62.2 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -58.98 -35.43 73.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.93 -42.35 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.795 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -83.39 -69.15 0.65 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.591 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m 74.9 -21.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.968 0.907 . . . . 0.0 112.347 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 44' ' ' ALA . 25.6 p -70.2 -82.24 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 -22.88 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.58 85.0 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 46.5 mt-30 -83.16 -43.62 15.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.514 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -126.51 -13.22 6.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.436 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.21 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.591 0.756 . . . . 0.0 110.255 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.27 144.34 50.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.03 -19.21 6.47 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -175.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -56.28 -81.72 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' ARG . 9.9 tt -86.04 -22.81 27.04 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.903 0.382 . . . . 0.0 111.123 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.32 -18.44 61.19 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.9 t -52.22 97.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.105 0.478 . . . . 0.0 110.94 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 t -131.81 -37.37 1.17 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.88 19.65 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.395 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 67.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.855 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.412 HG23 HD22 ' A' ' 65' ' ' ASN . 42.6 t -87.88 102.33 12.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -150.62 17.58 0.81 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 110.583 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 127.7 -42.44 1.45 Allowed Glycine 0 C--N 1.288 -2.095 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.521 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.571 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . 52.2 m-80 -55.06 -79.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.713 0.302 . . . . 0.0 111.723 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 3.2 p-10 -85.3 12.95 7.13 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.297 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.438 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 39.3 tp -88.61 -57.34 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.07 -32.63 56.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -109.76 160.61 16.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 68.91 -62.32 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -56.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 135' ' ' SER . 9.6 p -72.69 -37.2 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.74 -27.79 65.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.3 -47.45 13.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.425 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.13 -35.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.048 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.7 p -72.41 -21.41 61.27 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.056 0.455 . . . . 0.0 110.545 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -91.11 -14.48 31.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.445 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 34.1 mt . . . . . 0 C--O 1.235 0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.83 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.452 ' C ' ' H ' ' A' ' 88' ' ' GLN . 77.8 m-85 . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.61 25.11 0.2 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.646 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.468 ' HA ' ' O ' ' A' ' 30' ' ' THR . 65.0 mt-30 -87.17 -59.34 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.105 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -70.28 -48.13 58.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.0 m-85 -79.09 23.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 89' ' ' ALA . 6.9 p -51.01 -60.29 3.25 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.415 0.686 . . . . 0.0 112.696 -177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -65.26 -32.66 74.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.95 56.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.704 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.3 mt -84.35 -28.2 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.617 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.99 -38.2 22.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.065 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.2 m120 53.69 73.0 0.4 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.681 0.613 . . . . 0.0 111.118 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.36 -2.76 33.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.742 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.77 -5.7 68.88 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.127 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.87 21.75 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 109.737 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.514 ' CB ' HG13 ' A' ' 21' ' ' VAL . 1.8 pt? -117.4 163.71 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.82 128.15 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.467 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.61 -20.67 62.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.9 t -65.98 -36.63 83.82 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.496 ' O ' HD23 ' A' ' 108' ' ' LEU . 9.2 t30 -61.8 -49.32 76.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.061 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 35.8 mm -68.94 -38.44 78.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.166 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.67 -24.55 61.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -79.79 -55.83 4.71 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.417 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -130.83 -23.49 2.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.68 -65.5 3.14 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.1 p -78.58 -11.62 59.97 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.442 -0.446 . . . . 0.0 111.924 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -87.54 -52.58 5.27 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -83.75 -44.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.915 0.388 . . . . 0.0 111.259 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.0 mp -78.39 -51.73 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.1 m 53.18 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.78 29.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.76 0.824 . . . . 0.0 112.878 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.491 ' O ' HG21 ' A' ' 120' ' ' VAL . 61.6 tp -63.47 -55.7 22.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.855 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.0 mt -66.06 -28.76 69.08 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.156 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.3 -49.83 75.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 109.903 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.82 -36.49 61.46 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.105 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 116' ' ' LEU . 78.2 t -64.48 -38.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.606 0.241 . . . . 0.0 110.708 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -58.12 -46.31 85.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -70.86 -42.72 69.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.3 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.411 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -84.35 -80.19 0.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.41 -49.51 66.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 25.7 tm0? -71.03 -28.39 64.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.989 0.423 . . . . 0.0 110.87 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.1 -55.87 2.55 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.053 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.7 tp -102.13 -26.13 13.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.905 0.353 . . . . 0.0 111.796 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.8 73.38 1.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.572 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 123' ' ' ALA . 1.3 mp -68.18 139.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -130.88 131.8 44.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.46 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 37' ' ' THR . 22.4 t -89.5 120.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.026 0.441 . . . . 0.0 111.306 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -100.82 49.72 0.88 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.979 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -79.77 0.33 31.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.811 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.82 -25.71 20.13 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.904 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 71' ' ' VAL . 6.2 m -105.64 -49.05 3.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 140' ' ' ILE . 84.0 t -52.74 -62.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 137' ' ' GLN . 1.0 OUTLIER -57.31 -44.11 83.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.526 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.3 m -58.65 -45.57 89.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.855 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . 0.468 ' OD1' HG22 ' A' ' 34' ' ' VAL . 12.0 t70 -69.09 -53.17 21.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.728 0.299 . . . . 0.0 111.496 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 136' ' ' VAL . 44.0 pt -65.08 -42.02 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -66.14 -39.5 89.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 t -72.54 -45.5 59.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.866 0.365 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.3 m -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.704 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.186 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.34 -16.34 60.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.523 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 18' ' ' ILE . 42.5 m -60.46 -34.77 74.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.14 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.16 -22.83 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.35 -43.18 5.64 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.551 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.434 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.0 pp -85.28 -25.18 27.38 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 3.0 pt -34.3 -63.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 42.5 t -75.07 -19.14 60.12 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.96 -21.51 37.16 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.66 0.384 . . . . 0.0 112.026 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' A' ' 100' ' ' LEU . 1.8 t -71.68 -142.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.427 ' H ' HG11 ' A' ' 21' ' ' VAL . . . -62.02 -23.41 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.9 OUTLIER -66.68 -26.56 67.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.986 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -64.41 -44.13 92.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.536 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.11 -28.75 38.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.649 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.83 87.73 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.26 17.87 3.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.864 0.866 . . . . 0.0 112.057 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.433 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 2.3 m -76.7 164.57 25.76 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.492 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.447 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 29.6 m -62.66 -16.49 57.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.035 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -52.3 -38.73 59.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.664 0.785 . . . . 0.0 112.515 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.02 -20.9 13.7 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.409 0.623 . . . . 0.0 110.538 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 13.1 ttm180 -72.81 -40.72 65.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.708 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 t -173.3 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.2 139.89 16.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -54.14 141.68 28.15 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.007 0.432 . . . . 0.0 110.695 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 46.5 ptt85 -67.55 162.72 22.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.506 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.74 129.84 38.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.431 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' HB ' ' A' ' 129' ' ' ILE . . . 72.1 35.49 60.9 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.731 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -44.99 149.84 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.125 0.97 . . . . 0.0 112.771 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.8 m -88.11 149.43 23.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.289 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.477 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 7.7 pm0 -70.64 -12.99 61.91 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.627 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -55.48 -31.94 62.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.759 0.314 . . . . 0.0 110.988 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -85.03 -44.73 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.029 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -84.57 -71.49 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.703 0.287 . . . . 0.0 111.696 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 t 79.63 -20.49 0.38 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.543 1.137 . . . . 0.0 111.022 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -78.91 -96.59 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.891 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -99.41 -35.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 0.0 111.291 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.71 81.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 41' ' ' GLN . 42.4 mt-30 -83.01 -47.85 11.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.597 0.713 . . . . 0.0 110.392 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 2.5 tpm_? -125.16 -12.71 6.87 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.514 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 -52.17 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.404 0.681 . . . . 0.0 110.054 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.487 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -74.44 155.46 38.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.434 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.649 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.7 mp0 -60.38 -18.82 53.02 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.372 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -58.32 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 19.3 mt -86.08 -22.14 27.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.42 -20.25 54.86 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -56.2 101.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.172 0.511 . . . . 0.0 110.594 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.461 HG21 ' HG ' ' A' ' 59' ' ' LEU . 9.3 t -145.99 -32.46 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HG ' HG21 ' A' ' 58' ' ' THR . 75.4 mt -121.4 18.88 11.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.0 0.429 . . . . 0.0 109.9 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 67.18 1.46 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.088 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.44 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 61.9 t -97.44 113.6 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.377 0.271 . . . . 0.0 110.756 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -170.92 78.69 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.148 0.499 . . . . 0.0 110.456 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 -46.07 2.07 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.991 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.5 p-10 -52.04 -74.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.018 0.927 . . . . 0.0 112.796 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.464 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 31.6 p-10 -85.03 -16.71 39.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.181 0.515 . . . . 0.0 109.875 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 132' ' ' ASP . 61.4 tp -63.59 -47.25 82.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.705 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.21 -15.0 60.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 91.0 mtt180 -120.65 -84.44 0.66 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.875 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -52.17 -39.19 59.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.62 -57.12 9.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.655 0.264 . . . . 0.0 111.68 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.29 -38.3 82.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 68' ' ' ARG . 24.5 mt-30 -65.43 -35.11 79.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.99 94.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.0 t -86.23 -41.11 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.568 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -64.46 -28.54 69.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -102.84 5.04 38.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.373 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.355 -177.497 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.471 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 121.434 0.635 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.64 22.26 0.1 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.673 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 86' ' ' TYR . 70.7 mt-30 -86.42 -60.29 2.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 120.989 0.424 . . . . 0.0 109.927 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.575 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.9 -41.55 82.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.107 0.479 . . . . 0.0 109.957 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.521 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.0 m-85 -83.88 15.64 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.67 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . 0.518 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . 47.1 t -56.47 -50.75 70.83 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -60.14 -30.1 69.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.8 -40.65 22.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.748 0.308 . . . . 0.0 111.388 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 37.9 mt -83.25 -29.47 28.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.903 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -79.24 -36.78 39.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.31 90.35 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.56 -16.44 60.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.649 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 -14.01 52.13 Favored Glycine 0 C--O 1.227 -0.322 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.749 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -93.61 1.35 9.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.203 1.002 . . . . 0.0 109.527 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -83.94 173.76 10.92 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.129 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -81.27 135.9 35.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.094 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.26 54.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.25 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.1 p -68.36 -30.67 69.68 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 121.217 0.532 . . . . 0.0 110.698 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.557 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.1 t30 -60.24 -53.79 53.45 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.51 -38.02 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.86 -31.7 71.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.839 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 m -91.68 -53.82 4.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -111.76 -35.24 5.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.79 -52.67 40.93 Favored Glycine 0 N--CA 1.46 0.293 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.121 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.497 ' HA ' HD13 ' A' ' 117' ' ' LEU . 33.0 t -66.09 -24.11 66.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.735 0.302 . . . . 0.0 111.551 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -87.13 -40.75 14.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.88 0.371 . . . . 0.0 111.42 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.12 -55.79 6.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.87 0.367 . . . . 0.0 111.376 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.57 -42.29 64.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 49.53 -94.86 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.563 ' HA ' ' ND2' ' A' ' 118' ' ' ASN . . . -66.74 -19.08 65.68 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -73.87 -36.81 64.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.741 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 110' ' ' SER . 33.0 mt -68.06 -43.51 78.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 115' ' ' ALA . 11.8 p30 -62.68 -24.38 67.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.054 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.77 -30.1 21.89 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.572 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t -84.7 -34.66 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.4 p -53.38 -49.25 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.13 0.49 . . . . 0.0 111.627 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.2 t -76.26 -28.8 57.23 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.56 -85.3 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.85 -41.57 74.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -76.58 -21.89 55.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.197 0.522 . . . . 0.0 110.201 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.18 -81.04 1.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.375 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.67 -23.87 19.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.24 88.1 0.77 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.487 HG23 ' CB ' ' A' ' 52' ' ' ALA . 48.8 mm -58.06 136.98 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.66 152.32 24.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.167 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.42 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 5.3 t -116.9 163.49 14.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . 0.418 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 23.3 t70 -59.97 152.04 24.68 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.316 0.579 . . . . 0.0 112.073 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.537 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 24.0 m -73.71 -11.54 60.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -45.86 -74.54 0.22 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 123.266 0.354 . . . . 0.0 113.275 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.8 t -106.56 -57.24 2.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.309 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 140' ' ' ILE . 60.8 t -48.68 -60.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.537 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -58.16 -48.93 78.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.543 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -61.46 -41.93 97.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.27 -49.73 63.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.566 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.5 pt -68.57 -35.94 72.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -62.96 -50.28 71.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.654 0.264 . . . . 0.0 110.731 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.5 t -59.45 -43.9 93.06 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.213 0.53 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -64.72 -41.77 95.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.059 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 120.931 0.396 . . . . 0.0 110.971 -178.846 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.16 -13.05 23.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.017 0.437 . . . . 0.0 111.558 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 18' ' ' ILE . 7.9 m -54.3 -41.02 68.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.636 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.8 59.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.37 -43.9 5.43 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.503 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.0 pp -83.66 -20.15 34.09 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 8.5 pt -42.84 -49.82 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 p -84.77 -18.93 33.52 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -85.66 -36.15 20.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.523 HG12 ' HB3' ' A' ' 100' ' ' LEU . 21.1 t -72.8 -102.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.83 22.1 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB3' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -61.41 -24.95 66.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.14 91.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.57 -28.18 28.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.19 89.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.85 17.65 3.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.184 176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.515 ' O ' HD23 ' A' ' 31' ' ' LEU . 3.5 m -71.59 169.26 15.9 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.048 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -61.89 -18.28 59.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.4 p -56.44 -40.71 75.24 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -97.15 -20.13 18.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.235 0.541 . . . . 0.0 110.233 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -74.98 -43.95 51.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.573 -174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 t -176.47 -25.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.89 139.41 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.03 145.17 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 123.186 0.303 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -60.13 152.12 25.15 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.256 0.551 . . . . 0.0 111.302 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -67.28 114.7 6.2 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.608 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.0 9.21 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.474 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -50.62 146.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 14.6 m -92.8 154.96 17.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.232 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.441 ' OE1' ' HG2' ' A' ' 49' ' ' GLN . 8.5 pt20 -67.07 -12.15 59.12 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -53.93 -42.58 68.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.31 -31.2 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.748 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.38 -50.39 8.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 m 78.43 -18.69 0.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.413 1.085 . . . . 0.0 111.737 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 p -71.42 -101.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 -22.04 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.14 89.64 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.279 0.561 . . . . 0.0 111.769 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 68.4 mt-30 -77.47 -61.46 1.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.39 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 63.3 ttt180 -118.58 -2.06 11.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.552 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.93 -59.79 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.597 0.759 . . . . 0.0 112.055 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.03 -84.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER 178.56 -44.57 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -178.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -49.19 -69.41 0.12 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.428 0.691 . . . . 0.0 112.362 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.93 -23.07 27.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.225 0.536 . . . . 0.0 110.475 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.13 -19.72 62.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.821 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 p -47.93 107.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.733 0.646 . . . . 0.0 111.614 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -154.37 -42.23 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.088 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -122.59 19.38 10.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.332 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.11 63.96 1.49 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.128 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.407 HG21 HD22 ' A' ' 65' ' ' ASN . 10.8 t -89.7 114.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.457 -177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -178.46 86.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.19 -58.65 4.73 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.935 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -61.78 -76.2 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.407 HD22 HG21 ' A' ' 61' ' ' VAL . 3.2 p-10 -85.39 18.45 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.223 0.535 . . . . 0.0 110.838 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.6 tp -87.23 -56.12 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.888 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -37.23 49.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.143 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -104.04 172.82 6.59 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 63.07 -62.29 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.43 -59.66 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 110.879 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.66 -41.49 92.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.25 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -59.58 -43.21 93.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.613 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.87 -47.52 82.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.61 -41.12 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -66.28 -25.24 66.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.304 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -107.6 9.23 29.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 14.2 tp . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.28 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 121.098 0.475 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.7 46.7 0.68 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.813 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 mm-40 -91.75 -62.72 1.36 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.563 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.617 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -86.32 -33.56 20.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HA ' ' CG2' ' A' ' 18' ' ' ILE . 97.7 m-85 -72.72 2.38 6.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -51.79 -49.2 63.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 m -58.79 -39.75 82.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.29 33.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.35 -31.52 24.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -86.47 -31.1 21.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.799 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.1 m120 53.19 68.82 0.78 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.791 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.05 4.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.2 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.51 -13.51 40.69 Favored Glycine 0 C--O 1.225 -0.409 0 C-N-CA 121.314 -0.469 . . . . 0.0 112.855 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.04 -19.26 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.21 0.529 . . . . 0.0 110.295 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -85.16 156.0 21.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.286 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.36 132.0 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.161 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.79 65.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 p -66.2 -33.49 75.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -63.44 -47.73 80.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.104 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.97 -37.9 77.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.307 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -66.66 -33.87 76.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.305 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -85.24 -58.62 2.61 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.44 -26.78 6.98 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -58.38 -60.05 9.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.955 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -76.93 -11.13 59.77 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.607 -0.349 . . . . 0.0 111.507 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.33 -48.83 7.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 0.0 111.337 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.51 -57.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.2 mp -72.01 -42.95 65.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.308 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m 55.57 -101.76 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.35 -34.88 64.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.119 0.568 . . . . 0.0 112.448 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 120' ' ' VAL . 22.2 tp -59.78 -55.24 36.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.18 -29.47 67.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.63 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.53 -43.09 97.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.83 -40.34 75.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.466 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 116' ' ' LEU . 89.5 t -62.85 -38.36 81.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 75.6 m -55.88 -33.42 64.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 111.427 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 t -85.09 -35.82 21.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.222 0.534 . . . . 0.0 110.429 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.99 -84.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.24 -49.5 34.68 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.843 0.354 . . . . 0.0 111.712 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 40.8 tt0 -67.72 -28.77 67.94 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.53 -61.57 1.78 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.247 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -118.63 -17.82 9.18 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 117.306 0.553 . . . . 0.0 111.455 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.27 120.04 2.37 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.54 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.7 mt -88.32 124.29 41.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.658 0.266 . . . . 0.0 110.813 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -124.32 120.21 31.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.88 157.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.67 174.39 2.33 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.401 0.62 . . . . 0.0 112.155 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.516 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 13.1 m -80.49 33.38 0.3 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.879 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.81 -91.16 0.11 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.2 m -107.0 -21.26 13.06 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.06 -64.6 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -61.27 -39.76 91.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -59.94 -44.13 94.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.981 0.42 . . . . 0.0 111.738 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.25 -48.42 34.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.744 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 137' ' ' GLN . 47.2 pt -64.25 -35.36 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.0 p -65.23 -35.72 81.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.405 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -74.89 -40.75 60.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.14 0.495 . . . . 0.0 110.608 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 24.5 t -82.69 -20.39 36.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.525 -176.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.22 -0.476 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.84 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 112.275 -0.33 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.43 -6.96 44.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 18' ' ' ILE . 11.7 m -54.04 -30.33 47.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.994 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.22 -23.67 15.52 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 -41.47 6.39 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.7 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -22.52 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 14' ' ' SER . 11.7 pt -46.13 -50.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 6.4 m -67.57 -21.14 65.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.714 0.292 . . . . 0.0 111.374 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -89.96 -22.43 21.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 17' ' ' LEU . 46.4 t -61.38 169.34 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.386 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.946 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -45.88 -21.55 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.2 m-80 -69.05 -22.69 64.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.75 0.309 . . . . 0.0 111.253 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 19' ' ' SER . . . -54.88 -55.03 34.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -16.65 59.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.056 0.455 . . . . 0.0 110.304 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.51 45.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.65 18.0 0.29 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 175.619 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -74.32 173.46 10.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.76 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 4.1 m -46.42 -28.54 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.377 1.071 . . . . 0.0 113.037 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -54.46 -32.53 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -112.57 -18.76 12.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.426 0.631 . . . . 0.0 109.863 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 5.6 tpp180 -67.68 -56.19 10.3 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.819 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -168.77 -36.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.31 136.69 24.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -49.63 139.79 12.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.439 0.638 . . . . 0.0 112.282 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 36' ' ' ARG . 6.9 ptm180 -58.77 164.65 2.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.34 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.2 111.36 9.29 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.549 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.91 47.34 8.63 Favored Glycine 0 N--CA 1.426 -2.014 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.068 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.41 143.75 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.035 0.445 . . . . 0.0 109.897 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 17.4 m -101.6 157.02 17.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -61.79 -12.83 19.02 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.861 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.85 -46.34 81.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.773 0.321 . . . . 0.0 110.368 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.93 -36.01 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.523 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.5 -65.9 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.802 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m 77.29 -18.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.856 0.862 . . . . 0.0 112.188 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -61.21 -73.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.658 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.14 -64.43 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.282 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -41.71 107.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.219 1.008 . . . . 0.0 113.652 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 20.6 mp0 -73.75 -53.66 9.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.579 ' HE ' HG13 ' A' ' 129' ' ' ILE . 26.1 ttt85 -145.36 4.39 1.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.856 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.73 -55.87 0.53 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.143 0.577 . . . . 0.0 110.779 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.451 ' HB3' HG21 ' A' ' 129' ' ' ILE . . . -65.41 131.34 46.19 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 57' ' ' SER . 9.3 mp0 -56.21 -18.09 9.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.699 -174.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -56.25 -69.9 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.839 0.352 . . . . 0.0 111.235 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 tp -87.9 -23.82 23.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.911 0.386 . . . . 0.0 111.14 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -76.73 -18.16 58.65 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 32.3 t -54.11 91.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.256 0.551 . . . . 0.0 111.339 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.511 HG21 ' HG ' ' A' ' 59' ' ' LEU . 1.9 t -151.6 -35.52 0.13 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.469 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.511 ' HG ' HG21 ' A' ' 58' ' ' THR . 58.3 mt -115.57 19.79 15.12 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.41 54.55 7.6 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.584 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 38.7 t -89.6 107.97 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.801 -0.199 . . . . 0.0 110.666 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.16 82.36 0.22 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.27 -51.14 4.44 Favored Glycine 0 C--N 1.32 -0.319 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.359 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 17.2 p-10 -55.49 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.696 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.0 p-10 -85.73 14.82 5.32 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.278 0.561 . . . . 0.0 110.088 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.53 ' O ' HG22 ' A' ' 71' ' ' VAL . 26.0 tp -87.63 -60.41 1.98 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.52 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.74 64.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.356 0.598 . . . . 0.0 109.513 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.0 mpt_? -93.18 157.4 16.29 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 69.16 -62.66 0.4 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' LEU . . . -67.46 -62.36 1.46 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 66' ' ' LEU . 82.0 t -56.24 -41.02 68.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -68.39 -37.14 80.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.24 84.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.99 -35.02 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.204 0.526 . . . . 0.0 110.284 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 t -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.689 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -89.18 -0.59 57.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.736 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 33.7 mt . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 7.9 m-85 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.874 0.368 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.11 36.88 0.24 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.54 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 86' ' ' TYR . 32.0 mm-40 -89.63 -59.7 2.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.05 82.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.107 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 94.1 m-85 -83.68 10.24 9.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.609 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 t -56.94 -40.79 77.05 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.226 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.532 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 69.9 m -57.98 -43.96 86.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.182 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.92 -31.89 64.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.411 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 22.1 mt -84.31 -21.54 30.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.978 0.418 . . . . 0.0 111.291 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -87.42 -38.52 16.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.139 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . 0.599 ' O ' HD23 ' A' ' 100' ' ' LEU . 17.7 m120 68.47 -74.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.894 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 75.33 -30.89 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.106 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 96' ' ' ASN . . . 96.48 -4.35 64.14 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 13.7 t -101.78 42.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.342 1.068 . . . . 0.0 108.581 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 96' ' ' ASN . 2.6 pt? -137.81 -171.23 2.95 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.396 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.8 115.5 26.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.233 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.54 63.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.266 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 p -64.38 -37.35 87.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.83 -43.17 90.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.655 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.42 -44.95 94.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.09 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.78 -18.38 60.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.587 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 m -88.74 -62.29 1.52 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.53 -23.12 8.39 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.0 -176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.496 ' CA ' HD11 ' A' ' 117' ' ' LEU . . . -56.25 -63.52 5.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.997 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.0 m -77.71 -9.62 59.09 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.663 0.268 . . . . 0.0 111.496 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -89.46 -58.77 2.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.57 -58.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.938 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.3 mp -70.0 -45.77 66.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 t 52.65 -94.8 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.46 -1.245 . . . . 0.0 113.39 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.31 -37.23 35.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 120' ' ' VAL . 53.1 tp -68.22 -58.7 4.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.214 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.496 HD11 ' CA ' ' A' ' 109' ' ' GLY . 23.6 mt -66.49 -27.42 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.63 -37.46 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 109.784 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.44 -32.48 34.29 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 116' ' ' LEU . 96.4 t -63.09 -44.11 99.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.498 0.19 . . . . 0.0 110.735 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 69.2 m -54.62 -39.06 67.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.62 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.8 m -80.98 -41.86 22.1 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.446 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.84 -70.49 0.56 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.77 -41.79 61.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 58.5 tt0 -80.49 -17.53 51.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 109.841 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.53 -70.44 1.33 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.955 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.62 -24.25 14.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.738 0.304 . . . . 0.0 111.199 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.4 100.66 2.17 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.672 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.579 HG13 ' HE ' ' A' ' 50' ' ' ARG . 15.0 mm -80.03 132.07 32.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.154 0.502 . . . . 0.0 111.569 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -148.23 145.97 28.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.271 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.19 142.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.03 -172.08 0.17 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 112.878 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.557 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 39.0 m -79.88 29.31 0.27 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.64 -79.09 0.22 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 t -110.25 -59.76 1.89 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.205 0.526 . . . . 0.0 110.822 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 140' ' ' ILE . 96.6 t -47.77 -63.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.1 tp-100 -56.34 -39.96 73.68 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.5 m -72.9 -26.9 61.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.804 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.52 -40.82 22.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.837 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.4 pt -79.38 -27.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 p -55.97 -62.13 1.91 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -63.94 -37.7 88.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.097 0.475 . . . . 0.0 111.227 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.4 m -66.09 -34.33 77.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.213 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.3 t . . . . . 0 C--N 1.318 -0.794 0 CA-C-O 121.051 0.453 . . . . 0.0 110.88 -179.45 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.362 0 N-CA-C 114.328 0.491 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.01 72.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.639 0.376 . . . . 0.0 111.615 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' HG21 ' A' ' 18' ' ' ILE . 9.6 m -58.67 -31.45 68.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.396 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.3 62.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.41 -35.82 8.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.564 ' O ' HG21 ' A' ' 21' ' ' VAL . 2.8 pp -85.63 -21.94 28.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.647 HG21 ' O ' ' A' ' 14' ' ' SER . 11.9 pt -37.75 -52.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.0 m -71.61 -24.67 61.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.58 -23.13 24.42 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 17' ' ' LEU . 31.6 t -62.34 174.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.425 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.433 ' H ' ' CG1' ' A' ' 21' ' ' VAL . . . -37.57 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . 0.425 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 10.6 m-80 -63.5 -24.56 67.87 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.102 -0.374 . . . . 0.0 111.851 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.89 -35.91 79.74 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.354 0.597 . . . . 0.0 109.437 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 tp -80.23 -35.06 36.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.715 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.99 77.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.021 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 59.2 13.25 2.92 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.172 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -83.56 168.54 16.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.283 0.563 . . . . 0.0 112.066 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' SER . . . . . 0.558 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 1.8 m -51.92 -26.22 9.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.62 1.168 . . . . 0.0 112.927 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 p -53.29 -40.82 65.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.872 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.63 -19.52 16.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.598 0.713 . . . . 0.0 109.646 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 16.1 tpp180 -66.22 -64.62 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.605 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 t -164.77 -23.74 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.122 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.94 137.59 20.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.99 140.43 25.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.063 0.459 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -65.82 164.52 14.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.681 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 2.4 p -70.7 111.88 6.5 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.16 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.0 43.23 8.93 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.07 138.65 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 111.815 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.6 m -70.78 137.99 50.05 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.37 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 48.4 tt0 -62.69 -13.44 32.25 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.165 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -52.62 -42.21 64.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.006 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.62 -39.53 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.539 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -83.24 -68.0 0.74 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 5.9 m 71.64 -33.74 0.28 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -66.24 -79.26 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.74 -30.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.259 0.552 . . . . 0.0 111.526 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.37 92.78 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -81.11 -40.44 24.05 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.162 0.506 . . . . 0.0 110.126 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.613 ' NH1' HD12 ' A' ' 55' ' ' LEU . 11.2 ttm180 -149.03 -1.4 0.48 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.656 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.23 -55.74 0.6 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.094 0.557 . . . . 0.0 110.259 -175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.46 131.0 47.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.378 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -54.9 -17.77 4.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.852 -177.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.613 HD12 ' NH1' ' A' ' 50' ' ' ARG . 2.2 tt -88.59 -24.09 22.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 111.385 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.5 62.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.611 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.3 t -55.34 96.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.299 0.571 . . . . 0.0 110.729 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.459 HG22 ' HG ' ' A' ' 59' ' ' LEU . 11.0 t -132.99 -30.06 1.4 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.171 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.459 ' HG ' HG22 ' A' ' 58' ' ' THR . 94.4 mt -120.26 20.09 12.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.804 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.58 66.85 1.64 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.38 109.73 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.38 87.02 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.6 -53.05 3.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.734 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.1 p-10 -61.45 -73.72 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.386 0.674 . . . . 0.0 112.321 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.529 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 66.2 t30 -84.75 11.66 8.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.675 0.75 . . . . 0.0 109.622 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.83 -70.48 0.63 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.279 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 -34.03 39.75 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.42 0.629 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 56.5 mtm180 -99.46 157.72 16.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.622 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 68.03 -57.05 0.48 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.511 0.725 . . . . 0.0 112.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.17 0.91 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.703 0.287 . . . . 0.0 111.355 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.64 -35.5 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -68.08 -25.51 65.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.342 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.71 23.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.382 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.98 -32.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.245 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -69.89 -14.74 62.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.229 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 44.5 ttp180 -87.62 -15.71 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.111 178.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.647 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 9.4 mp . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.29 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.647 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 64.3 m-85 . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.083 0.468 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.11 25.63 0.16 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.582 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.501 ' H ' ' C ' ' A' ' 86' ' ' TYR . 76.3 mt-30 -86.18 -56.73 3.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.632 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.73 -29.34 68.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.376 0.607 . . . . 0.0 110.036 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.0 m-85 -84.31 3.76 34.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -50.71 -35.89 33.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 70.3 m -53.92 -53.41 53.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.73 -24.03 33.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 51.1 mt -84.82 -36.13 21.84 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -85.2 -41.1 15.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.93 90.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.501 0.667 . . . . 0.0 111.648 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.76 -0.97 55.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.823 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.02 -3.14 85.36 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.712 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 t -100.57 -13.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 109.929 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -84.02 167.42 16.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.365 -177.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -77.44 104.4 7.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.674 0.75 . . . . 0.0 110.385 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -13.04 61.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.682 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -69.21 -34.46 74.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -35.78 77.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.74 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.59 -41.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.211 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.83 -18.09 51.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.031 0.443 . . . . 0.0 111.463 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.1 m -81.82 -58.63 2.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.391 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.2 -20.92 4.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.426 ' C ' HD12 ' A' ' 117' ' ' LEU . . . -57.37 -68.41 1.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.158 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 114' ' ' SER . 6.5 p -67.4 -16.82 64.45 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -84.64 -45.54 12.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.666 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.47 -50.79 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.597 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.59 -34.36 72.08 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.006 0.431 . . . . 0.0 110.317 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 110' ' ' SER . 50.8 m 48.16 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.96 -36.77 50.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.3 -60.16 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.991 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 109' ' ' GLY . 49.0 mt -64.34 -34.23 77.68 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -69.77 -22.67 63.32 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.109 0.481 . . . . 0.0 110.907 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.13 -32.78 11.65 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.936 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 94' ' ' LEU . 54.2 t -76.24 -29.92 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.996 0.518 . . . . 0.0 111.914 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 p -52.2 -44.04 64.53 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.306 0.642 . . . . 0.0 112.592 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.1 p -84.47 -26.46 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.923 0.392 . . . . 0.0 111.481 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.83 -78.45 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.16 45.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.07 -21.33 61.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.09 -56.13 2.5 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.204 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.6 mt -126.95 -25.01 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.998 0.399 . . . . 0.0 111.786 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.55 107.95 3.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.001 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 37' ' ' THR . 32.6 mt -76.37 126.83 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -120.81 135.57 55.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 37' ' ' THR . 12.7 t -89.09 172.83 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.45 162.61 6.07 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.548 0.689 . . . . 0.0 112.018 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.4 t -80.16 6.61 11.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.301 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.27 -78.94 0.61 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.295 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 m -93.73 -39.89 10.52 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.27 -62.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.406 ' HA ' HG12 ' A' ' 140' ' ' ILE . 9.4 tt0 -59.18 -39.79 83.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -59.4 -43.98 92.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.442 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.58 -50.01 19.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 137' ' ' GLN . 42.0 pt -60.67 -38.46 78.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.812 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 t -65.7 -40.03 91.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.3 m -70.8 -42.44 70.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 t -72.42 -42.44 65.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.634 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 111.445 -177.869 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.6 71.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.142 0.496 . . . . 0.0 110.732 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.6 m -66.91 -21.58 65.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.83 -18.52 44.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.8 -43.59 5.69 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.334 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.561 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.0 pp -84.21 -21.88 31.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 89' ' ' ALA . 8.9 pt -46.2 -47.31 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 10.9 m -73.39 -20.0 60.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.749 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -86.03 -33.5 21.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.696 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 17' ' ' LEU . 58.0 t -50.16 168.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.088 0.555 . . . . 0.0 111.406 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.72 -28.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.39 -28.9 68.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.729 0.241 . . . . 0.0 111.436 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -63.21 -44.93 93.91 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.292 0.568 . . . . 0.0 109.85 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.2 -38.21 66.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.156 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.96 80.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 54.55 17.84 1.79 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.446 174.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 m -77.76 166.33 23.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.496 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.8 m -61.11 -16.98 50.18 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 122.78 0.432 . . . . 0.0 112.105 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -52.23 -34.44 45.79 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -108.14 -21.58 12.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -79.85 -42.78 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t -158.19 -50.5 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.211 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.6 129.97 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 1.5 pt? -50.32 139.9 14.27 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.456 0.472 . . . . 0.0 111.808 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -60.75 159.75 10.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.867 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 1.7 p -77.47 142.71 39.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.064 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.57 71.46 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.538 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 147.81 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.799 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 10.3 m -106.75 161.83 14.32 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.95 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -66.23 -13.75 60.83 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.555 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -54.95 -43.72 73.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.526 HD11 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -86.62 -36.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.526 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -83.48 -39.96 19.86 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m 78.32 -18.36 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.108 0.963 . . . . 0.0 111.476 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 m -76.51 -162.24 0.24 Allowed 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 122.212 1.006 . . . . 0.0 110.721 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.64 -20.55 16.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.516 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.38 84.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.551 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' A' ' 40' ' ' SER . 74.5 mt-30 -83.62 -43.99 15.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 0.0 111.86 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 52' ' ' ALA . 51.0 ttt180 -132.19 -10.11 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.63 -36.69 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.294 0.638 . . . . 0.0 110.646 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 129' ' ' ILE . . . -80.22 150.95 29.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.795 0.331 . . . . 0.0 110.11 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.587 ' O ' ' HB2' ' A' ' 57' ' ' SER . 21.2 mp0 -56.28 -34.3 66.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -174.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.9 m -54.48 -70.85 0.09 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -86.18 -25.02 25.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.42 -18.82 47.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -65.92 79.82 0.08 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.72 0.772 . . . . 0.0 111.46 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -100.97 -28.51 12.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.038 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.37 19.17 10.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.019 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.62 1.41 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.765 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.672 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 65.7 t -88.38 120.07 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.882 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 t70 178.46 90.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.504 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.03 -57.4 3.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.954 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -55.85 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.266 0.626 . . . . 0.0 111.547 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.672 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.3 p-10 -87.38 21.25 2.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.059 0.456 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.15 -72.73 0.54 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.689 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.32 -7.98 50.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.303 0.573 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.32 170.61 13.91 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 66.05 -62.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.59 -64.02 1.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.769 0.318 . . . . 0.0 110.882 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 98.3 mt-30 -63.35 -37.1 85.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.602 0.239 . . . . 0.0 111.49 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.58 -48.6 25.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.089 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.74 -42.15 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.589 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.0 p -74.06 -4.96 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 111.032 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 34.1 ttm180 -98.11 -0.5 44.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.195 0.521 . . . . 0.0 110.535 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.237 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.227 177.538 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.409 ' C ' ' H ' ' A' ' 88' ' ' GLN . 57.5 m-85 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.107 0.48 . . . . 0.0 111.339 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.4 14.98 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.998 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.502 ' OE1' ' HA ' ' A' ' 35' ' ' LEU . 8.2 mm100 -71.71 -37.54 70.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.001 0.429 . . . . 0.0 111.288 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.536 ' O ' HD13 ' A' ' 18' ' ' ILE . . . -67.89 -62.16 1.54 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.84 32.41 0.48 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.142 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.7 m -50.54 -55.7 14.95 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.6 m -63.97 -36.3 83.5 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.97 70.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.538 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 40.0 mt -84.57 -23.49 29.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.505 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -85.56 -47.36 9.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.743 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.36 61.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.241 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.17 1.99 71.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.86 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.35 -15.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.481 0.657 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' HG12 ' A' ' 21' ' ' VAL . 2.2 pt? -85.51 179.28 7.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.255 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -75.23 125.77 29.64 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 111.662 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.65 61.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.276 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.7 t -65.18 -35.01 79.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.497 ' O ' HD11 ' A' ' 108' ' ' LEU . 11.1 t30 -61.01 -50.42 73.45 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.047 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . 0.5 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -66.69 -38.09 80.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.827 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -30.41 69.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.875 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -80.1 -62.96 1.52 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.513 HD22 ' OG ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -122.22 -15.5 7.68 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.731 -176.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -56.11 -72.02 0.64 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.795 -0.716 . . . . 0.0 113.638 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 m -70.82 -10.35 59.37 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.68 -53.99 4.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.35 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.27 -54.66 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.017 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.4 mp -63.13 -31.97 73.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.612 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.1 p 38.71 -93.14 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.25 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.427 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 120' ' ' VAL . 65.4 tp -68.61 -52.63 29.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.042 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.416 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 18.8 mt -61.44 -28.18 69.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -59.13 -36.98 76.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.402 . . . . 0.0 110.208 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.45 -33.58 11.45 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.969 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.1 t -60.99 -31.7 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.3 m -48.65 -52.04 25.26 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.294 0.371 . . . . 0.0 111.936 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 p -83.68 -21.42 32.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 111.09 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 120' ' ' VAL . . . -81.31 -93.76 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.13 29.43 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.01 -29.77 71.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.18 -90.91 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.4 mt -112.56 -8.29 13.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.774 0.321 . . . . 0.0 111.553 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.14 98.85 0.94 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.153 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.563 ' O ' ' HB ' ' A' ' 37' ' ' THR . 25.1 mm -67.66 139.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . 0.406 HD22 ' HG3' ' A' ' 137' ' ' GLN . 18.7 t-20 -90.55 136.06 33.3 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . 0.495 HG11 ' H ' ' A' ' 133' ' ' SER . 30.7 t -75.66 146.07 9.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.906 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.47 -37.31 83.14 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 122.083 0.944 . . . . 0.0 111.068 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.495 ' H ' HG11 ' A' ' 131' ' ' VAL . 38.9 t -58.65 107.59 0.53 Allowed 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.026 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.75 -17.91 29.76 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.199 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.1 m -65.57 -37.44 86.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.993 0.425 . . . . 0.0 110.197 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 140' ' ' ILE . 46.4 t -77.99 -50.69 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.796 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.406 ' HG3' HD22 ' A' ' 130' ' ' ASN . 7.8 tt0 -59.25 -49.62 77.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.708 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -65.75 -28.74 69.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.04 -54.9 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.451 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 136' ' ' VAL . 42.6 pt -58.92 -34.77 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.255 -177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.6 t -50.59 -49.34 56.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.262 0.351 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -84.84 -42.47 15.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.852 0.358 . . . . 0.0 111.831 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 62.9 m -57.79 -38.84 76.2 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.8 p . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.777 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.281 -0.177 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.43 75.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.935 0.398 . . . . 0.0 110.997 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.7 m -68.06 -22.63 64.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.044 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.66 58.61 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.16 -38.84 7.12 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.117 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.4 pp -84.83 -22.35 29.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 14' ' ' SER . 10.1 pt -44.75 -48.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 t -84.67 -20.14 31.73 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.552 0.215 . . . . 0.0 111.377 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -86.89 -25.94 24.19 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 17' ' ' LEU . 21.9 t -74.21 -107.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ALA . . . . . 0.413 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -79.1 -35.81 41.73 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.98 -24.25 66.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.25 -45.37 88.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.068 0.461 . . . . 0.0 110.316 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.16 -18.95 44.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.787 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.56 -38.33 70.97 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.922 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.58 16.98 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' HD21 ' A' ' 31' ' ' LEU . 5.1 m -75.82 167.68 21.44 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.7 m -72.23 -14.26 61.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' GLN . 19.0 p -50.2 -53.3 28.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 28' ' ' THR . 1.3 pt? -78.71 -19.73 51.73 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.151 0.5 . . . . 0.0 110.985 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -76.74 -52.98 8.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.631 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -169.05 -19.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.84 136.26 23.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.91 149.61 14.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 87' ' ' ALA . 7.7 ptm180 -76.06 164.45 26.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.405 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.01 109.3 9.54 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.984 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 94.49 37.69 5.24 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.841 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.38 124.94 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.251 0.548 . . . . 0.0 109.957 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 16.5 m -85.67 167.0 15.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 14.7 pt20 -69.14 -13.15 62.26 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.243 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -63.02 -55.0 29.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.305 0.574 . . . . 0.0 109.869 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -85.27 -32.19 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.717 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . 0.429 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . . . -78.54 -61.69 1.93 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.499 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 87.0 p 68.82 -31.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.687 1.595 . . . . 0.0 115.291 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.5 m -66.27 -73.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.79 -27.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.838 0.351 . . . . 0.0 111.841 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -80.47 100.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.351 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.672 ' O ' ' HA ' ' A' ' 40' ' ' SER . 44.6 mt-30 -82.17 -34.85 28.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.082 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.626 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 16.5 ttt85 -158.03 4.34 0.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.731 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ALA . . . . . 0.458 ' N ' ' HB2' ' A' ' 56' ' ' ALA . . . 67.87 -52.83 0.52 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.067 0.547 . . . . 0.0 110.841 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' HG13 ' A' ' 129' ' ' ILE . . . -63.51 137.41 58.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.222 177.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 57' ' ' SER . 17.5 mp0 -53.49 -26.89 22.47 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -60.83 -67.57 0.39 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.815 0.34 . . . . 0.0 111.885 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.427 ' HB3' ' CB ' ' A' ' 50' ' ' ARG . 25.9 tp -87.83 -24.01 23.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -78.57 -19.1 53.55 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 5.8 t -62.39 88.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.406 0.622 . . . . 0.0 111.491 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.598 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 8.2 t -112.23 -32.46 6.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.819 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.1 mt -121.6 18.83 11.22 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.946 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 67.56 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.89 120.84 39.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.712 0.292 . . . . 0.0 111.158 -176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -170.85 83.89 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.883 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -47.29 3.55 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 18.0 p-10 -54.33 -83.19 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.735 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.488 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 29.2 p-10 -87.99 24.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.303 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 tp -87.0 -66.4 0.91 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.067 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.26 62.02 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.479 0.657 . . . . 0.0 110.412 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.439 HH21 ' HA ' ' A' ' 64' ' ' ASN . 29.9 mtm180 -110.39 165.63 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 68.05 -61.91 0.37 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.69 3.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.864 0.364 . . . . 0.0 111.492 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.525 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -65.27 -35.77 82.06 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.644 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.14 -47.71 60.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.857 0.36 . . . . 0.0 111.397 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.67 -34.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.987 0.422 . . . . 0.0 110.932 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.0 p -73.94 -23.06 59.46 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.158 0.504 . . . . 0.0 110.457 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -87.08 -15.03 39.74 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.919 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' CD2' ' HH ' ' A' ' 86' ' ' TYR . 19.1 tp . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.126 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.503 ' HH ' ' CD2' ' A' ' 77' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 121.376 0.607 . . . . 0.0 109.971 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -77.85 18.48 0.47 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.49 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 33.9 mt-30 -80.83 -56.63 4.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.144 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.38 -35.88 82.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.085 0.469 . . . . 0.0 110.278 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.478 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -82.4 13.37 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.556 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -59.21 -44.3 92.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -62.96 -41.06 99.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.66 69.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.687 0.28 . . . . 0.0 111.48 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 28.3 mt -84.78 -19.54 32.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.022 0.439 . . . . 0.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.88 -36.98 19.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.59 80.84 0.14 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.989 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.03 -12.2 60.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.811 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.62 -11.93 64.8 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.95 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.65 -15.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.325 0.583 . . . . 0.0 109.977 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.562 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.0 pt? -84.8 161.39 19.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.801 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -67.82 107.25 2.54 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.526 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.63 -15.84 63.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.951 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -74.52 -27.6 60.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASN . . . . . 0.47 ' O ' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -71.41 -33.99 69.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 34.8 mm -66.11 -34.23 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.21 -32.37 66.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.196 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.4 m -68.55 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.853 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 104' ' ' ASN . 2.3 pt? -121.28 -21.09 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -56.2 -65.21 3.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.944 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -71.91 -11.54 60.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.802 0.334 . . . . 0.0 111.603 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -87.04 -61.07 1.81 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.19 -56.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.548 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.42 -55.23 29.81 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.181 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.7 t 55.42 -87.04 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.107 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.34 66.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 122.947 0.499 . . . . 0.0 111.459 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.59 ' O ' HG22 ' A' ' 120' ' ' VAL . 53.3 tp -67.02 -49.88 63.86 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' LEU . . . . . 0.431 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 21.3 mt -66.97 -25.1 66.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.928 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.76 -36.57 81.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 109.666 175.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.13 -17.69 58.82 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.227 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 116' ' ' LEU . 93.8 t -85.25 -44.02 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 11.8 p -52.49 -61.82 2.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 t -76.0 -23.84 55.28 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.085 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.487 ' C ' HD11 ' A' ' 129' ' ' ILE . . . -83.57 -80.21 0.19 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB1' HH21 ' A' ' 50' ' ' ARG . . . -72.51 -44.67 61.9 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLN . . . . . 0.509 ' HB3' ' O ' ' A' ' 121' ' ' SER . 42.6 tt0 -70.96 -34.76 71.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.281 0.562 . . . . 0.0 110.097 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.43 -63.2 2.54 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.043 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.87 -23.98 11.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.92 97.3 1.22 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ILE . . . . . 0.496 HG13 ' CB ' ' A' ' 52' ' ' ALA . 1.2 mp -81.54 136.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.539 0.685 . . . . 0.0 112.229 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -135.14 137.33 42.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.105 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -80.85 156.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.4 169.15 1.79 Allowed 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 3.0 m -74.31 39.42 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.63 -93.86 0.2 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.9 t -106.44 -43.38 4.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.887 0.375 . . . . 0.0 110.273 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.1 t -51.96 -62.48 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.409 -173.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.7 tt0 -59.04 -37.46 77.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.656 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.1 m -65.95 -48.32 71.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.902 0.382 . . . . 0.0 110.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.66 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.584 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.1 pt -76.09 -29.8 19.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -56.47 -45.72 80.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.334 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 p -82.0 -42.78 18.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.356 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.4 m -68.9 -19.99 64.23 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.321 -0.668 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.13 123.96 3.25 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.428 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.71 119.6 6.19 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.575 2.183 . . . . 0.0 111.897 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.427 ' O ' ' HD2' ' A' ' 7' ' ' PHE . 22.9 mp0 -58.44 101.96 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.287 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.31 22.36 60.92 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.766 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.49 66.69 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.993 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.427 ' HD2' ' O ' ' A' ' 4' ' ' GLN . 1.6 m-85 -55.28 -57.61 11.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.67 0.235 . . . . 0.0 111.457 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.26 75.41 0.28 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' HG1' ' A' ' 10' ' ' THR . . . -85.47 98.97 10.9 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.52 0.676 . . . . 0.0 111.418 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.413 ' HG1' ' C ' ' A' ' 9' ' ' ALA . 11.0 m -162.67 143.45 9.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.7 -178.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.2 125.42 5.08 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.04 -26.34 45.17 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.823 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.69 80.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.203 0.525 . . . . 0.0 110.759 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.593 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.4 p -68.44 -17.75 64.27 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -18.28 63.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.49 11.74 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.815 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.531 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.3 pp -85.99 -22.89 27.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 14' ' ' SER . 17.6 pt -42.46 -55.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 2.4 m -68.69 -21.74 64.4 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.0 111.677 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.619 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -88.57 -24.46 22.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.961 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 17' ' ' LEU . 85.1 t -57.19 168.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.759 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -39.47 -27.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -178.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.42 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.0 m-80 -60.27 -24.22 64.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.571 0.224 . . . . 0.0 111.498 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.71 -36.98 82.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.076 0.465 . . . . 0.0 110.306 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.415 ' N ' HD21 ' A' ' 25' ' ' LEU . 3.1 mm? -83.58 -13.36 54.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.448 -179.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.17 -44.11 13.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.594 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 14.3 t-20 55.16 13.0 0.74 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.841 0.856 . . . . 0.0 112.263 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -72.41 165.49 24.46 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.931 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 27.8 m -61.67 -15.31 38.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p -56.04 -25.94 46.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.785 0.834 . . . . 0.0 113.143 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.83 -17.62 11.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.157 0.504 . . . . 0.0 110.672 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 11.4 ttm180 -77.51 -48.68 16.45 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.745 -176.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -167.06 -32.14 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -80.65 137.21 21.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -52.91 138.67 29.41 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.999 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.403 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 47.3 ptt85 -64.43 155.59 32.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.944 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -70.74 114.85 9.23 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.65 40.18 9.97 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -47.37 145.95 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.585 0.754 . . . . 0.0 112.307 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.513 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.4 m -71.48 140.29 49.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.406 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.546 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.87 -12.81 27.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 89.2 mm-40 -57.06 -38.06 72.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.855 0.359 . . . . 0.0 110.757 178.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.513 HG13 ' O ' ' A' ' 40' ' ' SER . 2.8 pp -84.4 -35.62 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.484 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -82.97 -73.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.962 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 75.5 -18.92 0.42 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.639 0.776 . . . . 0.0 112.403 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -67.61 -79.88 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.16 0.505 . . . . 0.0 112.024 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -130.93 -27.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.313 0.578 . . . . 0.0 110.848 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.92 94.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.184 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 81.6 mm-40 -82.54 -50.23 9.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 0.0 110.256 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 20.7 ttm180 -132.77 -3.93 3.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.941 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.03 -50.49 0.7 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.258 0.623 . . . . 0.0 110.17 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.63 131.45 45.23 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.435 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -46.6 -30.78 2.45 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.101 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m -49.58 -71.56 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' O ' HD21 ' A' ' 55' ' ' LEU . 6.6 tt -86.38 -23.84 26.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.43 -20.69 62.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.2 p -48.56 112.74 0.64 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.565 0.541 . . . . 0.0 110.697 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 15.1 t -161.73 -40.41 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 91.8 mt -121.91 18.83 10.96 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.677 0.275 . . . . 0.0 110.996 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 66.12 1.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.134 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.73 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 37.5 t -89.3 104.97 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.385 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -173.62 76.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.499 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.22 -63.07 1.22 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.981 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -63.04 -69.49 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.73 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 p-10 -82.18 7.2 14.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.462 . . . . 0.0 110.444 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 tp -88.02 -53.17 4.87 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.735 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.8 29.02 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.499 0.666 . . . . 0.0 110.086 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.58 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 35.6 mmt180 -107.99 173.13 6.46 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 64.14 -62.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.63 -61.95 2.24 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.717 0.407 . . . . 0.0 111.716 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.544 ' O ' ' HB2' ' A' ' 75' ' ' SER . 39.1 t -59.66 -42.26 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.58 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 2.6 mp0 -65.78 -36.48 83.65 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.619 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.92 64.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.803 0.335 . . . . 0.0 110.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.46 -34.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.486 0.66 . . . . 0.0 110.239 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.544 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 3.7 m -75.5 -19.78 59.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.517 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 20.8 mtm180 -86.87 -13.1 45.89 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.543 0.211 . . . . 0.0 110.551 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.81 142.09 92.39 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.122 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.34 127.74 23.92 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.176 1.917 . . . . 0.0 111.142 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.7 17.62 23.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.62 0.724 . . . . 0.0 110.579 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.06 -25.31 73.36 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.617 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.1 m -79.72 -6.73 57.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.28 0.232 . . . . 0.0 110.637 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 76.92 154.95 0.16 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.937 0.895 . . . . 0.0 110.557 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.9 p -65.33 -28.07 69.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 p -67.3 -25.58 66.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.736 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.72 60.97 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.426 ' C ' ' H ' ' A' ' 88' ' ' GLN . 8.0 m-85 -76.67 -164.36 0.41 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.538 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.47 41.45 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.01 0.433 . . . . 0.0 111.215 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.428 ' O ' ' HB2' ' A' ' 91' ' ' SER . 8.1 tp-100 -90.14 -59.03 2.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.919 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.86 94.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.825 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.504 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 74.6 m-85 -80.66 12.04 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.541 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.428 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 15.6 t -50.61 -45.12 57.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.659 0.383 . . . . 0.0 111.556 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.42 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 55.4 m -61.54 -41.89 98.02 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.55 37.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.0 111.414 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 74.8 mt -84.94 -28.06 26.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -85.18 -36.43 21.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.209 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 50.45 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.98 -22.41 45.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.26 -14.09 63.92 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.82 32.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.968 0.889 . . . . 0.0 108.955 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -116.9 -169.16 1.59 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.053 -178.425 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.588 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 14.6 t30 -78.39 106.69 10.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.37 -29.33 70.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.451 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 p -72.26 -18.15 61.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.226 0.536 . . . . 0.0 110.276 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.588 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 6.2 t30 -63.81 -50.75 67.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.654 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.438 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.0 mp -73.43 -35.3 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.855 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.48 -35.09 78.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.401 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.405 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -93.61 -60.6 1.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.169 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.48 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 1.1 pp -104.53 -35.99 7.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -52.86 -58.49 11.39 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.897 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.546 ' O ' ' HA ' ' A' ' 114' ' ' SER . 13.7 p -71.19 -21.05 62.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.405 ' HD3' ' O ' ' A' ' 107' ' ' THR . 8.4 mpt_? -88.13 -52.76 5.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.28 -50.56 20.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.431 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.9 mp -79.3 -29.94 42.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.147 0.499 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.546 ' HA ' ' O ' ' A' ' 110' ' ' SER . 32.1 t 50.97 -100.28 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.688 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.71 -34.68 73.23 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' O ' HG22 ' A' ' 120' ' ' VAL . 51.8 tp -61.75 -59.36 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.743 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -29.22 70.46 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.931 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -61.1 -42.83 99.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.078 0.466 . . . . 0.0 110.035 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -29.27 58.82 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.822 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 116' ' ' LEU . 82.3 t -72.69 -30.22 32.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 122.816 -0.226 . . . . 0.0 110.757 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 53.2 m -55.99 -39.45 71.85 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.566 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.1 p -85.68 -25.87 26.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.061 0.458 . . . . 0.0 111.155 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.76 -90.98 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.85 69.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 111.548 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.454 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 53.2 tt0 -77.24 -24.59 51.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.82 -65.12 1.63 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.448 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.58 -23.84 8.05 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.799 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.81 104.37 2.2 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.842 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.4 mt -68.75 130.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.959 0.409 . . . . 0.0 111.885 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -120.78 128.35 52.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.2 t -98.57 167.58 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.317 -178.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -58.45 151.83 19.27 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.344 0.592 . . . . 0.0 111.747 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.58 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 15.2 m -75.37 -2.25 27.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.083 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.37 -72.07 0.64 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.184 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 m -106.5 -58.21 1.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 69.3 t -52.32 -55.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.094 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.58 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 5.4 tp-100 -60.02 -42.45 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m -58.46 -41.04 84.27 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.086 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.1 -54.61 8.08 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.639 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 38.7 pt -61.46 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -64.44 -45.29 88.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.993 0.425 . . . . 0.0 110.72 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.4 m -76.91 -20.74 55.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.294 0.569 . . . . 0.0 111.134 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.503 ' OG ' HD13 ' A' ' 147' ' ' LEU . 43.4 t -86.5 -60.17 2.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.781 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.3 t -57.84 -30.46 65.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.253 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -62.69 -52.01 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.22 -35.85 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.114 0.483 . . . . 0.0 111.362 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.594 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 76.7 mt -82.29 8.01 12.37 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 60.3 m -46.8 -48.57 20.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.068 0.461 . . . . 0.0 111.205 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -141.46 32.63 1.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.806 0.812 . . . . 0.0 109.047 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 9.6 t -86.16 27.7 0.89 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -176.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.528 ' HB2' ' OE1' ' A' ' 158' ' ' GLN . 15.0 m -62.38 -36.08 81.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.18 0.514 . . . . 0.0 110.185 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.8 m -151.75 -52.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -135.3 98.7 4.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.577 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.11 -34.6 59.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.965 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 50.7 m -59.04 -40.11 84.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -97.55 0.82 48.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.893 0.378 . . . . 0.0 110.364 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.4 m 55.81 23.87 6.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.59 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.528 ' OE1' ' HB2' ' A' ' 151' ' ' SER . 10.9 pt20 43.65 30.03 0.33 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.46 1.104 . . . . 0.0 112.878 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.7 -28.12 61.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.79 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m -72.99 -27.2 61.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.385 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.532 ' HA ' ' O ' ' A' ' 176' ' ' SER . . . 67.26 150.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.809 0.844 . . . . 0.0 112.503 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.4 p -93.03 27.89 2.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.5 m -73.63 -14.21 61.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.567 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.5 m -61.2 -33.52 73.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.158 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.2 m -91.33 11.15 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.389 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 64.82 49.49 63.24 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.998 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.84 78.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.591 0.234 . . . . 0.0 111.208 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.77 -73.18 1.7 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.428 ' HA ' ' HA2' ' A' ' 174' ' ' GLY . 46.1 p90 -153.31 133.38 13.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.69 ' OG1' ' HA ' ' A' ' 175' ' ' PRO . 62.9 m -105.46 -47.77 3.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.2 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 -85.37 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.027 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.563 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 21.1 Cg_exo -70.71 94.48 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.557 2.171 . . . . 0.0 111.97 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.9 m 72.21 -52.08 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.684 0.794 . . . . 0.0 112.256 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . 0.453 ' C ' ' H ' ' A' ' 170' ' ' THR . . . -153.53 -145.57 4.18 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.059 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.69 ' HA ' ' OG1' ' A' ' 170' ' ' THR . 15.1 Cg_exo -70.02 -162.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.558 2.839 . . . . 0.0 112.791 -178.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.532 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 15.7 m -71.8 91.82 1.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.419 HG23 ' O ' ' A' ' 175' ' ' PRO . 9.4 t -147.88 -173.83 4.4 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.307 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.9 80.98 0.61 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.419 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 2.8 Cg_exo -76.42 139.47 20.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.519 2.146 . . . . 0.0 111.751 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.2 m -76.23 -7.47 54.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 0.0 110.268 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 182' ' ' TYR . . . -127.03 -171.55 13.08 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HB2' ' O ' ' A' ' 181' ' ' GLY . 79.3 m-85 71.94 150.38 0.13 Allowed Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.241 0.616 . . . . 0.0 111.403 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.33 125.39 14.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.981 1.787 . . . . 0.0 110.93 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.37 67.3 1.6 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.636 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.419 ' HB3' ' O ' ' A' ' 179' ' ' PRO . 29.7 Cg_exo -64.89 -11.27 28.69 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.958 2.439 . . . . 0.0 111.827 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.02 -1.97 31.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.136 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.11 102.14 0.69 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.403 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.76 -60.0 4.7 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.588 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.13 63.3 4.39 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.076 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -124.93 133.41 24.79 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.619 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 22.7 Cg_exo -63.42 155.47 62.1 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.808 2.339 . . . . 0.0 112.332 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -76.94 -19.13 57.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -123.51 86.4 0.38 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -135.42 129.08 32.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 0.0 110.855 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.1 t -128.76 144.64 51.22 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.06 69.89 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.367 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -71.38 142.57 50.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 121.73 174.26 14.68 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.056 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.06 -179.674 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.797 0.332 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.84 124.98 4.58 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.637 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.01 -161.81 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.856 2.37 . . . . 0.0 110.789 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.555 ' HB2' ' HB2' ' A' ' 7' ' ' PHE . 94.3 mt-30 -123.34 158.29 31.37 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.596 0.236 . . . . 0.0 110.457 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.43 106.53 1.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.237 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.22 2.88 82.78 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.938 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.555 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 92.3 m-85 -135.77 102.91 5.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.108 0.48 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.41 123.76 5.5 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -75.67 -171.28 1.51 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.05 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.8 p 61.71 103.66 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.501 1.121 . . . . 0.0 113.378 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.03 149.84 19.91 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.99 53.57 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.53 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.97 89.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.12 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.587 ' O ' HG22 ' A' ' 18' ' ' ILE . 70.0 m -72.1 -30.6 65.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.717 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.04 -26.75 50.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.98 7.09 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.672 ' O ' HG21 ' A' ' 21' ' ' VAL . 3.2 pp -83.88 -22.55 31.59 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.587 HG22 ' O ' ' A' ' 14' ' ' SER . 10.6 pt -43.25 -43.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 23.3 t -74.38 -27.55 60.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.492 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 98.6 mtt180 -88.0 -23.41 23.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.672 HG21 ' O ' ' A' ' 17' ' ' LEU . 56.4 t -58.52 176.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.832 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.483 ' H ' ' CG1' ' A' ' 21' ' ' VAL . . . -36.67 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 5.7 m-80 -63.29 -24.77 68.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.244 0.474 . . . . 0.0 111.404 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.445 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -64.04 -28.25 69.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 tp -83.41 -40.98 18.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.426 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.06 73.55 8.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.43 19.89 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.911 1.284 . . . . 0.0 114.2 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.426 ' H ' ' C ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -63.46 -178.76 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.0 m -66.51 -20.48 66.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -51.13 -62.53 1.56 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.8 pt? -80.78 -20.55 42.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.28 0.562 . . . . 0.0 110.148 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.4 ttm180 -68.41 -46.45 69.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.474 -176.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -177.34 -35.43 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.17 139.97 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.619 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.539 ' HA ' ' CD ' ' A' ' 88' ' ' GLN . 4.0 pp -51.42 140.43 17.61 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 123.787 0.679 . . . . 0.0 112.6 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.425 HH11 ' HD3' ' A' ' 36' ' ' ARG . 15.9 ttt180 -50.76 137.72 19.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.564 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -66.27 111.39 3.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.644 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 93.78 31.63 8.09 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.466 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.7 p -51.11 137.13 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 110.72 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 13.0 m -105.17 161.9 13.86 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 3.1 pt20 -60.44 -14.98 22.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.404 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.2 mm-40 -53.92 -48.72 69.9 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.263 0.554 . . . . 0.0 109.758 177.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.1 pp -85.99 -39.41 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.241 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.86 -62.03 1.71 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 74.63 -20.96 0.3 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -71.02 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.761 0.315 . . . . 0.0 111.771 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.91 -22.49 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.194 0.521 . . . . 0.0 110.832 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.6 t -75.72 96.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.526 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 76.8 mt-30 -81.97 -47.46 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.139 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.466 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 33.8 ttm-85 -144.8 4.13 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.402 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.53 -53.86 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.479 0.712 . . . . 0.0 111.18 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.498 ' HB3' HG22 ' A' ' 129' ' ' ILE . . . -61.26 141.28 57.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.495 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 14.0 mp0 -58.83 -18.46 32.7 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.081 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -63.05 -76.96 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.85 -24.79 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.32 -18.11 61.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.444 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 77.6 p -45.7 104.05 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.856 0.722 . . . . 0.0 111.156 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.4 HG22 ' O ' ' A' ' 56' ' ' ALA . 10.5 t -149.97 -40.92 0.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.089 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.27 19.34 13.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.975 0.417 . . . . 0.0 110.235 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.24 67.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.454 HG23 HD22 ' A' ' 65' ' ' ASN . 6.1 t -87.85 109.01 19.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 120.706 0.289 . . . . 0.0 110.653 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -163.37 80.04 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.51 -48.85 2.94 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.73 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.537 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 20.9 p-10 -52.64 -80.07 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.829 0.851 . . . . 0.0 112.862 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.537 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 3.9 p-10 -85.81 9.17 17.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.215 0.531 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.489 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 59.1 tp -88.31 -50.85 6.08 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.128 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.14 -49.81 14.39 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.545 0.688 . . . . 0.0 109.31 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -90.87 162.38 14.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 68.32 -61.72 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.489 ' HB2' ' O ' ' A' ' 66' ' ' LEU . . . -64.42 -62.92 1.3 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -36.13 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.81 -43.37 88.82 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.301 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.475 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -67.34 -44.93 77.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.509 0.195 . . . . 0.0 111.286 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.9 -43.45 85.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -65.12 -30.17 71.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.039 0.447 . . . . 0.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -98.32 6.28 47.49 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.645 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.475 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -62.08 125.61 85.7 Favored Pre-proline 0 CA--C 1.51 -0.591 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.73 127.55 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.08 1.853 . . . . 0.0 109.608 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.8 95.12 5.93 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.133 0.492 . . . . 0.0 111.552 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.99 -50.62 5.78 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 15.9 m -90.43 -61.7 1.62 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 81' ' ' SER . 21.4 t70 168.97 161.57 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.562 0.745 . . . . 0.0 109.172 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.7 m -67.09 -39.1 86.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.775 0.321 . . . . 0.0 110.988 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.9 p -79.69 -18.5 51.15 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.74 65.12 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.86 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -64.15 -168.96 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.225 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -65.91 1.59 1.35 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.539 ' CD ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -69.96 -47.15 63.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.33 -40.24 77.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.794 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.503 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -83.92 10.54 9.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.419 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.8 m -49.79 -38.48 34.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.469 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 72.6 m -56.41 -50.4 71.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.12 31.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.5 mt -80.42 -33.08 37.22 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -84.56 -37.41 21.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 56.0 85.74 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.852 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.58 -2.61 43.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.578 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.54 34.53 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.529 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.93 -13.38 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.464 0.649 . . . . 0.0 110.097 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -179.69 7.14 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.524 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -75.21 118.66 18.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.98 61.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m -74.99 -31.36 61.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.855 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -61.87 -53.28 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.488 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.49 -39.97 87.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.129 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.34 -38.1 85.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.2 m -78.59 -55.22 5.37 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.14 -22.32 6.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.22 -65.29 3.47 Favored Glycine 0 C--N 1.32 -0.336 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.778 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 m -72.96 -9.71 59.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.107 0.479 . . . . 0.0 110.973 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.54 -55.94 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.629 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.96 -57.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.91 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -68.32 -49.8 57.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.923 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.4 t 52.9 -93.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.57 -40.78 60.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.241 0.616 . . . . 0.0 112.428 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.545 ' O ' HG22 ' A' ' 120' ' ' VAL . 59.7 tp -60.87 -47.32 86.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.462 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 30.2 mt -71.3 -25.77 62.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.53 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -60.28 -44.36 95.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.42 -31.1 57.45 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.558 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 116' ' ' LEU . 52.1 t -63.82 -41.26 91.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 122.848 -0.207 . . . . 0.0 110.712 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.434 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 54.2 m -52.82 -45.75 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.813 0.696 . . . . 0.0 112.352 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 p -83.74 -36.38 23.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.9 -76.1 0.31 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.7 -49.69 50.94 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.707 -175.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.434 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 52.6 mt-30 -72.52 -24.6 61.17 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.94 -53.39 3.02 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.732 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.18 -19.27 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.39 79.84 0.86 Allowed Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.065 -1.064 . . . . 0.0 110.488 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.498 HG22 ' HB3' ' A' ' 52' ' ' ALA . 35.0 mm -64.6 136.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -134.62 125.9 28.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.44 ' O ' ' HB ' ' A' ' 136' ' ' VAL . 21.8 t -89.48 113.93 26.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.494 0.664 . . . . 0.0 111.669 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.24 42.97 1.08 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.458 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 56.4 p -78.7 2.97 17.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.562 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.25 -27.37 20.66 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.15 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 m -105.95 -42.84 5.01 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.44 ' HB ' ' O ' ' A' ' 131' ' ' VAL . 20.6 t -70.43 -63.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -59.55 -43.5 93.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.954 -176.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.6 m -58.33 -38.01 76.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.947 0.403 . . . . 0.0 111.025 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.62 -56.65 5.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.49 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.439 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 44.2 pt -61.83 -27.63 42.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.526 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -75.43 -35.83 60.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.03 0.443 . . . . 0.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.3 m -79.2 -29.42 42.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.178 0.513 . . . . 0.0 110.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.439 ' OG ' ' HA ' ' A' ' 140' ' ' ILE . 98.9 p -86.73 -21.0 26.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.258 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.501 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 40.5 t -63.13 -19.57 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.921 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.5 p -61.65 -19.72 62.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.202 0.525 . . . . 0.0 110.982 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.21 -6.37 57.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.731 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.501 ' HG ' ' HA ' ' A' ' 144' ' ' SER . 23.2 mt -64.84 -3.98 3.95 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.436 ' C ' ' HG1' ' A' ' 149' ' ' THR . 29.1 t -55.23 -62.77 1.45 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.522 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 148' ' ' SER . 0.2 OUTLIER -172.69 82.77 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.763 174.206 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -92.11 -16.06 26.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.424 0.631 . . . . 0.0 110.173 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -90.66 -57.57 2.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.764 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -122.92 -154.97 0.63 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.668 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.422 ' CB ' ' HB2' ' A' ' 158' ' ' GLN . 78.4 p -115.78 178.1 4.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -158.86 25.05 0.22 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.545 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 27.6 t -134.78 -78.1 0.45 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.706 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.43 -176.48 5.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.2 p 58.41 -72.01 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.981 1.313 . . . . 0.0 113.341 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.422 ' HB2' ' CB ' ' A' ' 153' ' ' SER . 78.9 mt-30 -64.85 -27.64 69.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.204 0.526 . . . . 0.0 110.285 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.08 2.87 25.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.268 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 m -84.89 6.72 23.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.7 35.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.021 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 t -115.23 150.06 36.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.17 0.51 . . . . 0.0 111.408 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.4 m -102.64 -46.87 4.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.697 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 t -63.39 -39.13 93.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.934 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.0 p -124.53 29.09 6.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -133.56 -109.06 1.09 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.22 -0.991 . . . . 0.0 113.381 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.03 5.78 39.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.26 -69.49 2.74 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -173.05 150.21 1.95 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.5 m -134.96 74.71 1.53 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.5 0.667 . . . . 0.0 110.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 66.6 -156.93 50.76 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.633 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.48 ' O ' ' HA3' ' A' ' 188' ' ' GLY . 3.4 Cg_exo -81.61 -2.96 11.74 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 123.496 2.797 . . . . 0.0 112.298 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.1 p -105.14 -42.71 5.22 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.985 0.422 . . . . 0.0 111.305 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 83.21 171.59 47.67 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.816 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.79 47.97 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.252 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.5 m 68.17 19.3 9.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.515 0.726 . . . . 0.0 111.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -109.98 150.87 27.87 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.63 87.22 1.21 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.78 151.16 82.99 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.75 2.3 . . . . 0.0 112.318 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.5 t -97.33 -1.42 44.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.719 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.456 ' O ' ' HB2' ' A' ' 182' ' ' TYR . . . -72.56 147.76 40.92 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.509 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.456 ' HB2' ' O ' ' A' ' 181' ' ' GLY . 26.5 m-85 75.43 122.23 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 123.335 0.654 . . . . 0.0 110.589 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.83 124.09 15.38 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.254 1.969 . . . . 0.0 111.383 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.23 71.03 0.85 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -84.36 -74.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.531 2.154 . . . . 0.0 112.074 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.92 -63.75 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.756 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.04 -161.08 25.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.757 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.48 ' HA3' ' O ' ' A' ' 172' ' ' PRO . . . -74.91 101.22 1.29 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.41 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.88 5.01 86.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.089 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 64.36 82.93 0.21 Allowed Pre-proline 0 N--CA 1.462 0.138 0 C-N-CA 123.837 0.855 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 27.8 Cg_endo -67.46 139.75 50.26 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.988 1.792 . . . . 0.0 111.384 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.39 32.45 0.56 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.706 0.765 . . . . 0.0 110.712 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -146.85 46.96 0.71 Allowed Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -127.72 166.2 18.6 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.3 t -98.32 -176.76 3.49 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.64 -36.37 5.87 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.627 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 78.5 t80 67.69 -72.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.685 0.794 . . . . 0.0 112.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 177.87 -116.71 0.55 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.898 0 CA-C-O 119.035 -0.869 . . . . 0.0 111.433 -179.571 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.04 0.447 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.77 -147.69 18.05 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.54 147.72 22.65 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.247 1.965 . . . . 0.0 112.425 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -86.53 137.3 32.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.7 100.77 0.52 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.916 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.0 -9.85 8.43 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -120.23 -45.39 2.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.737 0.303 . . . . 0.0 111.256 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.75 41.77 62.99 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.041 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.437 ' HA ' HD13 ' A' ' 113' ' ' LEU . . . -61.39 147.46 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.1 m 66.49 92.58 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.69 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.44 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . 143.1 -172.7 24.5 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.938 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.31 -162.9 12.62 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.03 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.23 -19.13 62.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.844 0.354 . . . . 0.0 111.885 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.541 ' O ' HG21 ' A' ' 18' ' ' ILE . 15.5 m -63.9 -20.38 65.8 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.953 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.95 65.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.987 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.29 -34.88 22.19 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.303 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.532 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.4 pp -87.74 -31.78 19.49 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.541 HG21 ' O ' ' A' ' 14' ' ' SER . 16.3 pt -42.23 -57.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.522 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 12.7 m -66.56 -20.36 66.0 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.424 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 57.0 mtt180 -88.9 -31.23 18.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.532 HG23 ' O ' ' A' ' 17' ' ' LEU . 83.7 t -49.53 158.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 O-C-N 123.597 0.561 . . . . 0.0 111.384 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -40.31 -25.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 20.4 t-20 -61.73 -28.67 69.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 0.0 109.938 178.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.522 ' HB1' ' O ' ' A' ' 19' ' ' SER . . . -58.97 -46.19 88.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.511 0.672 . . . . 0.0 109.934 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.06 -28.66 67.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.297 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.99 87.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 0.0 110.133 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 59.4 2.99 0.35 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.899 0.88 . . . . 0.0 112.535 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.601 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 5.5 m -68.53 163.44 23.5 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.266 0.555 . . . . 0.0 111.289 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 m -58.94 -15.34 12.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.8 p -54.59 -30.43 54.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.644 0.777 . . . . 0.0 112.992 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 pt? -106.57 -18.6 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.214 0.53 . . . . 0.0 110.507 178.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -76.2 -60.17 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.067 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -155.25 -31.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.0 t -75.57 137.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -55.79 145.66 23.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.224 0.535 . . . . 0.0 112.016 -177.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -52.84 130.21 32.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.556 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.409 HG23 HG21 ' A' ' 136' ' ' VAL . 3.3 m -66.02 111.84 3.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.414 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.88 31.46 9.98 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.182 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 4.3 p -59.58 163.15 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.386 0.674 . . . . 0.0 112.265 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -109.52 161.39 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.781 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.534 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.7 pt20 -64.78 -15.22 61.36 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 81.3 mm-40 -53.14 -46.41 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.024 0.44 . . . . 0.0 111.106 -178.286 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.413 ' HB ' ' CD2' ' A' ' 86' ' ' TYR . 2.4 pp -84.35 -35.98 11.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.989 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -77.89 -60.68 2.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.574 -176.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 t 70.83 -21.06 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.631 0.772 . . . . 0.0 112.87 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 44' ' ' ALA . 33.3 t -69.33 -79.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.38 -37.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.265 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.416 ' HB ' ' HB3' ' A' ' 70' ' ' ALA . 2.4 p -71.11 99.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.459 0.647 . . . . 0.0 110.714 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 40.6 mt-30 -82.99 -38.01 23.22 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.539 ' HE ' HD11 ' A' ' 55' ' ' LEU . 23.8 ttm-85 -148.23 -1.61 0.55 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.784 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.0 -46.63 0.64 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.247 0.619 . . . . 0.0 111.128 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' HB3' HG23 ' A' ' 129' ' ' ILE . . . -65.31 142.05 58.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.518 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.2 mm-40 -64.5 -16.46 62.57 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.104 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 p -63.08 -76.74 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.141 0.496 . . . . 0.0 112.26 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.539 HD11 ' HE ' ' A' ' 50' ' ' ARG . 7.1 tt -85.36 -23.65 27.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.741 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.17 -21.05 39.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.518 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.5 t -62.94 94.92 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.756 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.476 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 9.6 t -119.99 -34.73 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.414 ' HG ' HG23 ' A' ' 58' ' ' THR . 96.2 mt -118.07 19.5 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.25 67.69 1.46 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.477 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.7 t -88.49 126.31 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.81 0.338 . . . . 0.0 110.28 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 177.01 89.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.574 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.07 -60.12 4.48 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.125 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -50.14 -79.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 0.0 112.131 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.477 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 21.5 p-10 -85.77 14.0 6.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.998 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 tp -88.07 -58.41 2.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.746 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.62 48.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.456 0.646 . . . . 0.0 109.785 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -99.08 162.85 12.83 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.918 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 70.14 -61.92 0.44 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.415 0.447 . . . . 0.0 111.715 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.416 ' HB3' ' HB ' ' A' ' 48' ' ' VAL . . . -64.59 -62.7 1.42 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.335 0.254 . . . . 0.0 111.586 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.69 -41.94 90.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.86 -37.33 76.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.69 63.08 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.539 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.4 t -85.42 -16.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.4 p -90.74 -23.88 20.55 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.243 0.544 . . . . 0.0 110.176 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 34.6 ttp180 -117.93 22.34 12.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.167 -178.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -64.25 145.1 98.35 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.247 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 127.97 23.61 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.438 2.092 . . . . 0.0 111.632 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.48 6.13 9.23 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.396 0.617 . . . . 0.0 111.881 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.73 -15.44 80.75 Favored Glycine 0 C--N 1.297 -1.598 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.903 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 m -86.37 -7.91 58.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.13 122.91 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.141 0.977 . . . . 0.0 112.614 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 p -66.77 -36.07 81.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.447 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -67.06 -19.5 65.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.746 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.72 -21.64 28.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.415 ' C ' ' H ' ' A' ' 88' ' ' GLN . 3.1 m-85 -78.41 -169.41 1.66 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.089 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.98 31.19 0.11 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.114 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' H ' ' C ' ' A' ' 86' ' ' TYR . 87.8 mm-40 -89.65 -60.12 2.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.145 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.69 -37.1 56.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.277 0.56 . . . . 0.0 110.155 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.566 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.82 5.38 25.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.571 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 t -52.17 -39.42 60.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.03 0.443 . . . . 0.0 110.794 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.464 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 3.3 m -58.37 -53.19 61.15 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.437 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.88 -22.6 53.21 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.873 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.566 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 78.1 mt -82.77 -45.86 13.84 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -70.79 -43.45 68.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.49 88.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.394 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.74 46.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.787 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.34 -13.81 31.84 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.483 HG12 HE22 ' A' ' 194' ' ' GLN . 3.5 t -101.07 28.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.461 0.648 . . . . 0.0 109.982 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 pt? -122.95 172.56 8.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.235 -179.505 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -73.84 99.61 3.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -17.76 64.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -70.89 -30.56 66.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.421 ' O ' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.96 -35.37 76.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.722 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.82 -35.46 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.753 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.53 -24.09 45.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.63 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.7 m -75.18 -60.72 2.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.276 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD22 ' O ' ' A' ' 104' ' ' ASN . 1.7 pt? -121.4 -21.17 6.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.772 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.515 ' CA ' HD12 ' A' ' 117' ' ' LEU . . . -53.07 -61.07 7.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.769 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -82.58 -15.0 53.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -87.95 -60.06 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.9 t -78.02 -58.21 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.334 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.445 HD21 ' HA2' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -69.34 -26.77 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.011 0.434 . . . . 0.0 110.03 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.7 t 45.34 -105.0 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.471 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.96 -36.27 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.67 0.788 . . . . 0.0 112.635 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.459 ' O ' HG22 ' A' ' 120' ' ' VAL . 25.7 tp -59.27 -62.37 1.93 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.278 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.515 HD12 ' CA ' ' A' ' 109' ' ' GLY . 45.8 mt -79.99 -22.89 41.99 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -62.96 -44.2 96.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 109.957 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.79 -34.65 72.24 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.318 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 94' ' ' LEU . 53.0 t -69.28 -39.76 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.748 0.308 . . . . 0.0 111.204 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.44 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 34.0 t -57.04 -35.91 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 m -83.72 -39.33 20.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.97 -72.91 0.44 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.54 -47.87 58.21 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.925 0.393 . . . . 0.0 111.847 -176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.44 ' HB3' ' O ' ' A' ' 121' ' ' SER . 27.0 tt0 -71.01 -24.53 62.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.11 -66.34 1.4 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.768 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.2 mt -109.34 -24.58 10.99 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 122.621 -0.341 . . . . 0.0 111.898 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.86 104.08 1.74 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.612 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.422 HG23 ' HB3' ' A' ' 52' ' ' ALA . 13.8 mt -79.58 136.38 23.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.591 0.234 . . . . 0.0 111.483 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -121.63 129.12 52.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.902 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.414 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 24.5 t -82.2 168.74 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.442 ' O ' HG11 ' A' ' 136' ' ' VAL . 24.1 t70 -59.38 137.19 58.08 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.305 0.574 . . . . 0.0 111.238 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.6 m -58.33 -23.07 55.49 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.824 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.28 -41.08 99.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.733 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 p -106.49 -45.55 4.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.559 ' O ' HG12 ' A' ' 140' ' ' ILE . 10.8 p -78.76 -55.4 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.51 ' N ' HG13 ' A' ' 136' ' ' VAL . 8.7 tt0 -59.62 -44.26 93.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 p -56.22 -41.87 76.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.996 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.83 -49.8 8.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.7 pt -62.05 -33.37 58.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -60.71 -29.59 69.43 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 m -83.94 -32.99 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 0.0 110.94 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.601 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -87.84 -27.78 22.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.756 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 34.7 t -62.5 -17.47 59.76 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.339 0.656 . . . . 0.0 111.727 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 m -47.4 -19.7 0.18 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -65.37 -10.15 30.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.58 0.229 . . . . 0.0 111.472 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 144' ' ' SER . 77.8 mt -59.18 -30.06 67.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.026 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.3 m -66.7 -39.4 88.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.844 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.6 m -66.1 -33.0 74.8 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.567 0.698 . . . . 0.0 109.168 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.8 t -68.17 -14.37 62.93 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.18 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 m -104.01 -46.29 4.5 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.523 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.1 t -153.37 148.71 27.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.4 m -81.68 39.23 0.54 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.247 0.546 . . . . 0.0 110.967 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.83 -18.98 60.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.286 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 21.1 m -57.87 113.41 1.85 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 61.21 23.18 13.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m 56.81 69.12 0.77 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 53.1 15.09 0.55 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.404 1.482 . . . . 0.0 113.852 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.8 10.95 40.45 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.572 0.701 . . . . 0.0 109.667 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 p -69.58 -33.03 72.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.523 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' A' ' 175' ' ' PRO . . . -82.58 7.26 15.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.844 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 m -89.11 156.27 18.93 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 72.0 m -70.82 82.43 0.64 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.097 0.475 . . . . 0.0 111.899 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.8 m -58.78 124.43 19.76 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.301 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.0 m 68.58 4.86 4.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.641 0.588 . . . . 0.0 111.369 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.53 41.95 6.3 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.894 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.51 -60.55 3.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.35 -64.85 3.72 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.024 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -114.38 137.91 51.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.98 0.419 . . . . 0.0 110.518 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.1 m -154.38 76.39 1.03 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.63 -171.95 40.13 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -70.11 -17.52 35.95 Favored 'Trans proline' 0 C--N 1.33 -0.403 0 C-N-CA 122.484 2.122 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.457 ' HA ' ' HA3' ' A' ' 189' ' ' GLY . 46.6 t -75.48 -65.49 0.89 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.214 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.69 174.08 13.26 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.43 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.408 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 73.5 Cg_exo -55.45 99.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.094 2.529 . . . . 0.0 113.621 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.5 m 41.82 71.61 0.2 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.1 t -135.4 168.55 19.0 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.35 -165.28 36.14 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.473 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.41 ' HG3' ' HA ' ' A' ' 183' ' ' PRO . 53.6 Cg_endo -70.68 -26.86 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.918 2.412 . . . . 0.0 113.559 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.0 t 54.96 74.57 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.048 0.451 . . . . 0.0 110.526 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 144.13 -89.17 0.17 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.897 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.402 ' HA ' ' HD3' ' A' ' 183' ' ' PRO . 75.6 m-85 -117.16 118.09 36.21 Favored Pre-proline 0 C--N 1.318 -0.8 0 O-C-N 122.874 -0.192 . . . . 0.0 110.895 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.41 ' HA ' ' HG3' ' A' ' 179' ' ' PRO . 14.2 Cg_exo -70.72 124.79 11.01 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.31 2.007 . . . . 0.0 111.223 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.46 ' C ' ' H ' ' A' ' 186' ' ' LEU . . . 137.14 -62.08 0.59 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.386 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.7 34.93 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.51 2.806 . . . . 0.0 114.069 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.46 ' H ' ' C ' ' A' ' 184' ' ' GLY . 91.9 mt 68.92 135.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.949 0.88 . . . . 0.0 112.789 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.499 ' H ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.67 -171.77 20.47 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.07 109.35 1.63 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.102 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.457 ' HA3' ' HA ' ' A' ' 173' ' ' SER . . . 72.48 32.77 61.74 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.108 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.499 ' HB2' ' H ' ' A' ' 187' ' ' GLY . . . -75.46 156.14 85.37 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.645 0.223 . . . . 0.0 110.505 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.424 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 6.2 Cg_exo -76.69 152.08 32.75 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.485 2.123 . . . . 0.0 111.896 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.55 -21.12 35.45 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -103.05 45.3 1.35 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 177.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.483 HE22 HG12 ' A' ' 99' ' ' VAL . 56.4 tp60 -81.16 144.96 31.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -99.9 154.51 18.3 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.436 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -74.41 94.48 0.83 Allowed Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.037 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -98.93 -48.21 4.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.021 0.439 . . . . 0.0 110.08 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -85.1 -21.61 54.69 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.291 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.519 -1.156 . . . . 0.0 111.117 179.435 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.542 0 CA-C-O 120.65 0.262 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.19 137.29 6.38 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.883 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.13 120.68 7.86 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.163 1.909 . . . . 0.0 111.088 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -63.58 118.77 8.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.349 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.68 -135.33 29.5 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.821 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.77 15.66 44.62 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -69.91 -52.95 20.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.2 70.22 1.11 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.363 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -171.68 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 p 54.31 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.742 0.817 . . . . 0.0 111.531 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.16 148.12 40.49 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.391 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.95 86.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.62 -0.324 . . . . 0.0 113.153 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.408 ' HB2' ' CD2' ' A' ' 108' ' ' LEU . . . -60.1 -35.73 75.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 111.247 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.489 ' O ' HG23 ' A' ' 18' ' ' ILE . 24.9 t -74.84 -22.08 58.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.113 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.99 -22.51 66.96 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.9 12.67 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.062 -1.065 . . . . 0.0 112.164 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.37 -32.73 24.05 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.489 HG23 ' O ' ' A' ' 14' ' ' SER . 10.0 pt -44.16 -51.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.601 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.9 m -67.81 -20.61 65.2 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.502 ' HA ' ' HG3' ' A' ' 172' ' ' PRO . 79.0 mtt180 -89.24 -24.51 22.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.436 HG11 ' HB3' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -72.33 -162.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.063 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.13 -37.42 6.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.551 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.84 -24.95 67.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.601 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.44 -53.46 56.23 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 109.66 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.07 -33.82 76.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.28 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.562 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 53.31 17.94 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.355 0.662 . . . . 0.0 111.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -76.31 157.61 32.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -62.22 -16.87 56.12 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.338 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -54.06 -34.54 60.35 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -112.28 -18.29 12.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 179.127 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.416 HH11 ' HD2' ' A' ' 32' ' ' ARG . 1.2 tpt85 -79.0 -43.76 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.147 -174.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.414 HG22 HG22 ' A' ' 34' ' ' VAL . 7.6 t -164.44 -37.75 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.414 HG22 HG22 ' A' ' 33' ' ' THR . 98.1 t -88.38 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.1 pt? -54.39 140.12 34.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 111.489 -179.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.441 ' NH1' ' HB3' ' A' ' 94' ' ' LEU . 2.0 ptm180 -58.88 154.1 15.83 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.489 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -70.07 124.13 23.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.237 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.8 40.77 64.21 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.4 p -47.4 149.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.704 0.802 . . . . 0.0 112.523 -178.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.599 ' O ' HG13 ' A' ' 43' ' ' ILE . 8.6 m -69.86 127.63 33.57 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.244 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -61.53 -14.03 26.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.025 0.44 . . . . 0.0 111.115 179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.86 -32.0 73.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.599 HG13 ' O ' ' A' ' 40' ' ' SER . 2.5 pp -83.76 -35.52 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.71 -72.49 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.446 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m 76.01 -19.62 0.4 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.969 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.0 p -68.18 -88.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.236 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.0 m -126.62 -32.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.793 0.33 . . . . 0.0 111.634 -179.075 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.468 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.7 p -79.31 91.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.726 0.774 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.6 mt-30 -83.04 -68.58 0.69 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.732 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.488 ' HD2' ' CB ' ' A' ' 123' ' ' ALA . 26.0 ttp180 -108.46 -3.06 18.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.425 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.13 -55.76 0.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.109 0.564 . . . . 0.0 109.85 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' HB2' HG21 ' A' ' 129' ' ' ILE . . . -67.29 142.31 56.9 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.265 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.445 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 22.3 mp0 -46.89 -51.16 17.42 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.088 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -46.54 -62.88 1.17 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HB3' ' HD3' ' A' ' 50' ' ' ARG . 28.8 tp -86.65 -27.6 23.7 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.036 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.56 -20.58 39.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 6.2 t -62.91 89.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.602 0.715 . . . . 0.0 111.466 -176.508 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.7 t -113.18 -36.43 5.05 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.785 178.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 93.0 mt -121.88 18.57 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.095 178.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.06 68.05 1.13 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.95 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.45 103.2 13.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -151.3 14.04 0.68 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.065 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.478 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 134.85 -47.95 0.96 Allowed Glycine 0 C--N 1.28 -2.583 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 92.8 m-20 -62.7 -65.34 0.7 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.489 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -84.71 4.23 33.62 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 178.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.478 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 52.9 tp -88.88 -67.14 0.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.945 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.56 58.21 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.544 0.688 . . . . 0.0 110.137 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 94.5 mtt180 -100.91 162.2 13.07 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.815 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 67.77 -62.28 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.468 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -61.48 -62.43 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 122.664 0.386 . . . . 0.0 111.356 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.0 -39.23 84.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.467 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 85.1 mm-40 -60.94 -47.3 87.06 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.548 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.438 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.21 -39.81 70.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -86.41 -34.27 7.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.959 0.409 . . . . 0.0 111.306 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -71.97 -26.5 62.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.467 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 17.6 mmt180 -101.02 9.25 42.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.456 0.646 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 9.9 tt -82.02 124.61 78.78 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.91 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -71.62 128.02 13.85 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.593 2.195 . . . . 0.0 111.265 179.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.34 63.84 3.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.62 -28.62 68.99 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.349 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.1 m -92.25 -5.4 52.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 76.71 157.04 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.517 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 p -62.02 -32.64 73.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.513 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 m -59.08 -27.16 65.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.913 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.14 -22.27 49.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.932 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -85.38 -170.03 2.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.004 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.74 44.54 0.46 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.2 tp-100 -89.62 -61.46 1.69 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.765 -177.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.18 -26.79 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 m-85 -78.13 3.83 14.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.678 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -50.45 -40.28 50.19 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.355 0.409 . . . . 0.0 111.638 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.551 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 15.2 m -57.29 -49.46 76.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.74 -23.82 36.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.693 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 83.3 mt -84.63 -29.97 25.3 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -81.14 -38.49 27.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.605 0.241 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 m120 63.99 91.89 0.07 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.03 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.31 -10.84 45.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.375 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 4.38 71.41 Favored Glycine 0 N--CA 1.459 0.227 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.525 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.39 -14.05 8.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.639 0.733 . . . . 0.0 109.076 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.436 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.7 pp -81.64 -179.26 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.057 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.403 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 44.1 t30 -68.45 110.73 4.29 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.072 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -26.4 65.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.752 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -73.99 -27.66 61.09 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.055 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -62.52 -46.74 87.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.101 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.08 -31.5 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.59 -43.09 70.1 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.021 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.2 m -71.27 -56.04 6.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.408 ' CD2' ' HB2' ' A' ' 13' ' ' ALA . 4.4 pp -115.55 -13.31 11.55 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.823 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.61 -65.2 3.0 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.254 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.5 p -73.79 -19.5 60.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.802 0.335 . . . . 0.0 111.641 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -87.42 -58.23 2.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.2 t -81.2 -54.8 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.254 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.543 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.6 mp -67.35 -45.2 77.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 t 46.03 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.096 1.359 . . . . 0.0 113.686 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.27 73.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.533 0.333 . . . . 0.0 111.57 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.4 tp -61.96 -50.23 72.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.492 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.474 ' O ' ' HB2' ' A' ' 121' ' ' SER . 17.4 mt -68.95 -24.16 64.23 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -66.18 -36.79 84.01 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.554 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.33 -39.44 7.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.44 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 83.1 t -70.16 -22.99 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.619 0.247 . . . . 0.0 111.322 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.474 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 28.9 t -55.16 -44.03 74.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -84.39 -23.2 30.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.119 0.485 . . . . 0.0 110.608 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.488 ' CB ' ' HD2' ' A' ' 50' ' ' ARG . . . -83.43 -97.48 0.05 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.892 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.03 67.85 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.762 0.315 . . . . 0.0 111.769 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.449 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 34.2 tt0 -65.13 -42.45 93.86 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.767 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.62 -48.24 4.81 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.436 0.618 . . . . 0.0 112.246 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.65 99.05 0.5 Allowed Glycine 0 C--N 1.312 -0.78 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.489 ' O ' ' HB ' ' A' ' 37' ' ' THR . 34.6 mm -86.63 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.025 0.44 . . . . 0.0 112.176 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -116.59 135.43 53.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 18.5 t -86.2 173.06 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.634 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -58.97 145.5 41.41 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.174 0.512 . . . . 0.0 111.384 -179.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.512 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 47.8 m -64.04 -22.19 66.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.57 -69.07 1.05 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 123.37 0.419 . . . . 0.0 114.133 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -99.42 -34.91 10.09 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.429 ' O ' HG12 ' A' ' 140' ' ' ILE . 86.5 t -83.18 -62.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.512 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 8.8 tp-100 -56.82 -45.97 81.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.7 m -54.62 -38.92 67.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.36 -48.33 10.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 136' ' ' VAL . 43.9 pt -65.7 -27.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 p -67.45 -48.59 66.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.1 m -84.27 -20.22 32.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.414 ' HA ' HD12 ' A' ' 147' ' ' LEU . 42.1 t -85.54 -20.16 30.04 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.6 p -72.2 -65.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.1 t -86.05 -34.59 20.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -66.01 -27.03 67.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.414 HD12 ' HA ' ' A' ' 143' ' ' SER . 11.0 mp -78.22 -62.67 1.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -91.52 -66.41 0.93 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 52.6 p -87.0 54.47 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.7 p -101.49 171.02 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.042 0.449 . . . . 0.0 111.223 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.3 m -84.8 11.0 9.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.393 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 21.9 t -139.44 174.7 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.569 ' CB ' ' HB3' ' A' ' 158' ' ' GLN . 50.5 m -95.73 128.85 42.95 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.26 -96.76 0.19 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.4 p -98.13 101.7 13.24 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 2.9 t80 56.9 19.55 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.021 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.487 ' HB3' ' OG ' ' A' ' 176' ' ' SER . 10.8 m -74.1 -29.33 61.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.7 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.569 ' HB3' ' CB ' ' A' ' 153' ' ' SER . 18.8 pt20 -89.1 1.39 55.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.247 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.05 28.59 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.599 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t 65.58 74.43 0.37 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.211 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.456 ' O ' ' HB ' ' A' ' 177' ' ' THR . . . -104.35 78.43 1.49 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.473 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 p -95.25 25.3 4.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.291 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.4 m 67.41 -49.01 0.5 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.186 0.995 . . . . 0.0 112.557 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.8 t -63.58 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.742 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.0 m -92.94 0.07 57.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 120.96 164.84 12.5 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.47 ' HB3' ' O ' ' A' ' 170' ' ' THR . . . -139.18 20.77 2.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.01 0.433 . . . . 0.0 110.798 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.47 -84.84 0.34 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.794 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -105.43 -39.2 6.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.396 0.617 . . . . 0.0 109.823 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 2.2 p -83.52 -179.86 7.46 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.079 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -122.2 -83.46 0.67 Allowed Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.037 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.502 ' HG3' ' HA ' ' A' ' 20' ' ' ARG . 10.6 Cg_endo -58.07 -53.32 4.41 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.039 2.493 . . . . 0.0 112.043 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p -148.42 156.63 42.73 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.014 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.08 -58.58 0.2 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.4 ' C ' ' H ' ' A' ' 177' ' ' THR . 57.9 Cg_endo -73.4 -156.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.17 1.913 . . . . 0.0 111.194 175.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.487 ' OG ' ' HB3' ' A' ' 157' ' ' SER . 9.5 p -77.4 36.96 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.122 0.487 . . . . 0.0 111.487 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.456 ' HB ' ' O ' ' A' ' 161' ' ' ALA . 9.4 t -100.02 152.42 20.22 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.731 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.07 -139.07 21.53 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.925 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.495 ' HA ' ' O ' ' A' ' 182' ' ' TYR . 17.1 Cg_exo -70.9 40.55 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.616 2.877 . . . . 0.0 113.533 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 32.9 p -72.54 -46.08 56.22 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.06 -1.91 7.29 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.387 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.495 ' O ' ' HA ' ' A' ' 179' ' ' PRO . 4.3 m-85 -121.61 90.54 48.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -83.95 125.62 3.69 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 122.098 1.865 . . . . 0.0 112.352 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 122.18 -74.64 0.36 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.874 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.404 ' C ' ' H ' ' A' ' 187' ' ' GLY . 57.5 Cg_endo -68.81 5.74 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.268 2.645 . . . . 0.0 114.366 -176.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.424 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 98.3 mt 73.43 -28.85 0.19 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.322 0.649 . . . . 0.0 112.745 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.404 ' H ' ' C ' ' A' ' 185' ' ' PRO . . . 76.2 -147.77 35.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.307 179.307 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -89.47 -37.73 6.91 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.581 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.43 62.66 3.76 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.891 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.424 ' HB2' ' HB3' ' A' ' 186' ' ' LEU . . . -128.32 131.22 23.65 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.498 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 59.4 Cg_endo -73.59 5.18 3.45 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.1 t80 71.71 -41.12 0.5 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.882 0.873 . . . . 0.0 112.572 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -70.34 73.59 0.57 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.622 -0.323 . . . . 0.0 113.663 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.407 HE21 ' HG2' ' A' ' 191' ' ' PRO . 78.2 mm-40 -125.14 148.73 48.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.403 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 28.8 m -123.99 -12.55 7.47 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.699 0.285 . . . . 0.0 111.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.58 59.93 0.67 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.648 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.96 -172.1 2.49 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 176.52 101.6 0.15 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.009 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.315 0 CA-C-O 118.587 -1.118 . . . . 0.0 111.805 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 120.612 0.244 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.84 176.35 46.36 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.01 165.94 23.62 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.98 2.453 . . . . 0.0 112.427 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.5 mt-30 -77.22 90.72 3.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.246 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.03 -112.94 4.87 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.597 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 1.07 34.35 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.751 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -65.38 -48.76 71.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.936 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.66 171.65 43.81 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.21 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.29 18.07 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.5 p 52.74 90.91 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.734 0.646 . . . . 0.0 112.465 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.33 161.1 31.11 Favored Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.22 -61.58 6.49 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.627 -0.321 . . . . 0.0 113.452 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.54 86.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.601 ' O ' HG22 ' A' ' 18' ' ' ILE . 15.9 p -63.32 -32.97 74.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.597 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.51 -19.13 65.41 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.3 -38.91 7.02 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.342 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.565 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.3 pp -84.69 -22.08 29.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.601 HG22 ' O ' ' A' ' 14' ' ' SER . 11.5 pt -46.96 -50.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -84.77 -19.73 32.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -86.47 -30.81 21.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.565 HG22 ' O ' ' A' ' 17' ' ' LEU . 21.3 t -80.96 -101.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.89 35.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.412 ' HB3' HD21 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.31 -22.99 66.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.853 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.81 81.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.066 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 178' ' ' GLY . 1.8 tt -80.57 -31.77 36.73 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.441 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.85 82.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.212 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.466 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 11.2 t-20 61.83 6.03 1.53 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.859 0.864 . . . . 0.0 113.083 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.531 ' O ' HD23 ' A' ' 31' ' ' LEU . 0.3 OUTLIER -68.48 177.93 2.21 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.087 0.47 . . . . 0.0 111.292 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.43 ' H ' HG21 ' A' ' 28' ' ' THR . 9.7 m -69.66 -16.03 63.29 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 p -51.62 -50.39 60.33 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 28' ' ' THR . 1.9 pt? -87.29 -19.98 27.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.326 0.584 . . . . 0.0 110.358 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -74.69 -48.23 27.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.086 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -172.71 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.61 135.52 27.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -54.02 139.19 35.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.346 0.593 . . . . 0.0 111.77 -177.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.521 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 3.1 ptm180 -62.71 160.04 15.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.995 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -74.19 111.67 9.59 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.644 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.15 47.13 11.51 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.342 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.641 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.6 p -54.99 150.04 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 122.93 0.492 . . . . 0.0 111.364 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 t -81.78 164.36 21.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.1 pt20 -70.06 -12.42 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.763 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -50.95 -33.05 22.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.113 0.483 . . . . 0.0 110.609 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.703 HG13 ' N ' ' A' ' 44' ' ' ALA . 6.7 pt -83.77 -52.77 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.703 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.47 -66.98 0.83 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m 78.82 -20.5 0.38 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.555 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.5 p -83.1 -82.97 0.14 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.25 -52.53 8.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.594 0.711 . . . . 0.0 110.258 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.33 89.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.461 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.513 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 77.9 mt-30 -82.82 -36.93 25.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.777 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.641 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 5.7 ttt180 -156.5 5.64 0.17 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.937 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.91 -58.93 0.39 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.162 0.585 . . . . 0.0 110.783 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' CB ' HG22 ' A' ' 129' ' ' ILE . . . -62.97 138.54 58.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.675 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.54 -18.87 8.28 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.611 -175.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -60.02 -71.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.6 tp -87.36 -24.05 24.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.752 0.311 . . . . 0.0 111.604 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.513 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.96 -18.91 55.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.675 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -53.96 99.97 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.183 0.516 . . . . 0.0 110.886 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -137.68 -36.25 0.63 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.744 HD12 ' ND2' ' A' ' 65' ' ' ASN . 4.1 pp -123.03 11.46 9.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.022 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.04 52.76 1.58 Allowed Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.143 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.465 HG21 HD22 ' A' ' 65' ' ' ASN . 3.3 t -87.17 114.25 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -156.54 14.29 0.29 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 112.017 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.44 -43.71 0.91 Allowed Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.01 -179.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -59.12 -68.45 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.181 0.515 . . . . 0.0 110.598 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.744 ' ND2' HD12 ' A' ' 59' ' ' LEU . 25.8 p-10 -85.92 9.61 16.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.9 tp -88.12 -50.67 6.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.993 0.425 . . . . 0.0 110.438 178.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.95 -26.55 33.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.43 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -127.08 169.42 13.41 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 69.8 -62.29 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.105 0.562 . . . . 0.0 112.492 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -62.19 2.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.012 0.434 . . . . 0.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 6.7 p -65.04 -33.2 62.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.815 179.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.6 -22.76 66.13 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.937 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.66 -51.08 6.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.102 0.477 . . . . 0.0 110.831 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.56 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 61.9 t -71.1 -36.46 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.427 -176.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -83.2 1.37 41.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.856 0.36 . . . . 0.0 111.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -106.37 -21.69 13.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.317 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 4.5 pp -63.71 144.77 97.84 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 111.515 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.408 ' C ' ' H ' ' A' ' 80' ' ' GLY . 35.6 Cg_endo -64.73 146.22 88.09 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.777 2.318 . . . . 0.0 111.855 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 18.76 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.24 0.543 . . . . 0.0 111.395 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' H ' ' C ' ' A' ' 78' ' ' PRO . . . -71.85 -23.32 78.16 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.357 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -79.87 -6.07 56.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 t70 73.66 123.85 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 111.168 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -67.74 -37.81 82.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.62 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 m -72.4 -24.99 61.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.422 . . . . 0.0 110.457 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.33 -21.32 65.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.73 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -76.97 -169.41 1.31 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.362 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.97 12.97 0.95 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.512 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 1.8 mp0 -67.43 -48.15 68.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.057 0.456 . . . . 0.0 111.109 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.527 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -71.73 -30.71 65.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.967 0.413 . . . . 0.0 110.681 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 84.9 m-85 -83.54 8.76 13.12 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.954 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.521 ' OG ' ' HB3' ' A' ' 36' ' ' ARG . 71.9 m -51.8 -43.52 63.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.3 m -61.69 -48.76 79.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.02 -31.05 68.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 41.8 mt -84.17 -19.0 34.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.775 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -87.44 -36.94 17.42 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.096 178.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.423 ' HA ' HD22 ' A' ' 100' ' ' LEU . 14.5 m120 55.19 64.86 1.65 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.584 0.707 . . . . 0.0 110.378 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.71 62.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.747 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.83 66.51 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.213 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.9 t -74.72 -24.99 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.319 0.58 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' O ' ' HB2' ' A' ' 195' ' ' SER . 1.6 pt? -84.4 150.52 25.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.441 ' HA ' ' CB ' ' A' ' 195' ' ' SER . 40.3 t30 -54.67 107.78 0.32 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.801 0.688 . . . . 0.0 110.986 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -17.49 63.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.936 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.8 m -80.18 -18.04 50.75 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.034 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.471 ' O ' HD22 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -78.62 -29.17 45.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.426 HD11 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -64.86 -32.46 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.878 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.8 m -67.94 -61.34 1.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.67 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.471 HD22 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -129.0 -9.96 4.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.995 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.45 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -58.9 -72.04 0.67 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 m -73.95 -12.26 60.59 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.805 0.336 . . . . 0.0 111.365 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.16 -57.83 2.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.28 -53.75 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.56 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.491 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.52 -33.39 64.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.182 -178.407 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.2 t 49.49 -103.57 0.12 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.033 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.69 -33.29 60.67 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.115 0.566 . . . . 0.0 112.206 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.51 ' O ' HG21 ' A' ' 120' ' ' VAL . 43.2 tp -57.39 -53.26 60.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 19.2 mt -78.69 -23.72 45.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.724 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.3 -45.44 93.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.1 -29.72 62.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.752 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.51 HG21 ' O ' ' A' ' 116' ' ' LEU . 40.5 t -69.25 -46.11 78.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 122.766 -0.255 . . . . 0.0 111.198 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -58.05 -39.17 77.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.482 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -80.51 -40.19 26.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.876 0.369 . . . . 0.0 111.804 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.2 -70.07 0.6 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.15 -51.2 18.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -69.95 -35.01 74.17 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.89 0.376 . . . . 0.0 110.508 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.37 -56.66 3.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.141 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.38 -23.53 15.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.57 77.57 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.235 -0.984 . . . . 0.0 111.002 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.446 HG22 ' CB ' ' A' ' 52' ' ' ALA . 36.9 mm -68.47 132.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.65 140.36 48.14 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.76 116.28 46.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.341 0.591 . . . . 0.0 111.333 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.69 43.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 46.0 p -75.49 -4.99 42.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.028 -179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 -17.85 58.51 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.5 p -107.4 -56.88 2.15 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.06 -62.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.02 -40.49 85.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.8 m -60.84 -49.08 78.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.24 -52.29 62.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.819 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 42.7 pt -61.45 -34.87 63.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.459 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 t -67.79 -42.11 82.14 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.97 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 m -77.42 -45.97 24.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.3 m -66.11 -38.73 88.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 p -57.7 -27.55 63.03 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -58.21 -46.87 85.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.991 0.424 . . . . 0.0 110.873 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.84 -35.54 16.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.466 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 71.1 mt -82.19 8.62 10.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.755 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.6 m -49.28 -43.07 42.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.479 0.657 . . . . 0.0 109.386 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.469 HG22 ' C ' ' A' ' 179' ' ' PRO . 10.7 m -145.37 -13.66 0.51 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t 64.11 -163.43 0.26 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.48 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.5 p 56.32 -159.78 0.22 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.618 0.767 . . . . 0.0 111.101 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.2 m -99.06 2.9 46.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.853 0.359 . . . . 0.0 110.308 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.9 m -135.62 117.77 15.47 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -127.76 -48.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.857 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.0 p -103.51 7.79 37.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.237 0.541 . . . . 0.0 110.473 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.59 160.11 14.51 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.8 t -67.62 -13.09 61.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.335 0.588 . . . . 0.0 109.801 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -70.54 -22.14 62.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.073 175.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.89 -9.2 58.95 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.046 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.3 m -74.84 -41.99 58.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.856 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.573 ' HA ' ' HB ' ' A' ' 177' ' ' THR . . . -159.05 -67.94 0.08 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.9 t 61.83 24.98 14.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 37.2 t -79.1 -10.6 59.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.7 m -65.39 -30.58 71.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.273 0.559 . . . . 0.0 110.104 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.6 m -89.03 -0.04 57.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.444 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . 148.53 153.4 5.97 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.89 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.45 74.42 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.109 0.48 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.28 74.65 2.41 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.656 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 97.2 m-85 74.25 179.98 0.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.768 0.827 . . . . 0.0 110.526 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -146.58 122.18 10.45 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.155 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.92 -148.61 19.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.061 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.99 -6.78 13.52 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.219 2.613 . . . . 0.0 113.503 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.6 p -141.6 27.01 1.89 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -91.71 -138.21 7.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.847 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.656 ' HD3' ' O ' ' A' ' 169' ' ' TYR . 7.5 Cg_exo -75.03 -171.42 0.98 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.91 2.406 . . . . 0.0 110.747 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 12.2 p -76.85 82.89 3.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.573 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 7.2 t -163.35 139.96 7.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.511 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' A' ' 25' ' ' LEU . . . 121.01 -66.77 0.44 Allowed Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.469 ' C ' HG22 ' A' ' 149' ' ' THR . 3.4 Cg_exo -82.22 23.55 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.189 2.592 . . . . 0.0 112.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.2 m -45.7 118.52 1.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.0 111.043 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -50.28 -68.95 1.21 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.523 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 60.3 t80 -123.1 -58.69 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.523 ' HD2' ' H ' ' A' ' 182' ' ' TYR . 42.5 Cg_endo -67.91 123.66 10.94 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 121.313 1.342 . . . . 0.0 111.596 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 55.62 74.79 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.707 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -43.1 -50.76 6.13 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.377 2.718 . . . . 0.0 112.166 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.72 88.73 6.81 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.49 58.9 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.897 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.73 -39.93 0.39 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.465 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.28 49.92 4.22 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.774 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.06 152.76 49.22 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.37 -177.73 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.552 2.168 . . . . 0.0 112.242 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -99.35 10.93 40.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -91.34 30.27 6.52 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.524 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.96 123.19 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.537 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 2.3 t -74.66 -20.31 59.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.785 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 109.0 36.14 2.22 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.109 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -119.58 -55.82 2.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.019 0.437 . . . . 0.0 109.929 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.69 65.42 2.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.784 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.4 0 CA-C-O 118.486 -1.174 . . . . 0.0 111.525 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.603 0.239 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -106.57 101.52 1.76 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.977 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -59.85 -36.01 92.17 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 122.614 2.209 . . . . 0.0 112.002 -178.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.4 ' C ' ' H ' ' A' ' 6' ' ' GLY . 61.9 tt0 -69.87 -11.02 60.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.302 0.641 . . . . 0.0 111.9 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.19 44.27 2.37 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.426 ' HA2' ' HB2' ' A' ' 115' ' ' ALA . . . 151.93 -30.04 0.91 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 81.41 103.31 0.06 Allowed 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.588 1.555 . . . . 0.0 113.751 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.04 55.69 27.95 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.187 -1.369 . . . . 0.0 114.348 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.401 ' HA ' ' CD2' ' A' ' 113' ' ' LEU . . . -95.98 172.6 7.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.795 0.331 . . . . 0.0 111.381 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.8 p 51.3 84.1 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.234 1.014 . . . . 0.0 112.851 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.13 -167.93 41.07 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.249 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.79 -158.26 51.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.374 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.02 68.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.621 ' O ' HG22 ' A' ' 18' ' ' ILE . 18.4 m -63.38 -34.39 77.62 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -19.05 65.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.96 -39.47 6.49 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.778 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.57 ' O ' HG22 ' A' ' 21' ' ' VAL . 2.9 pp -84.52 -20.97 30.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.621 HG22 ' O ' ' A' ' 14' ' ' SER . 9.7 pt -41.46 -42.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 8.3 p -78.99 -30.28 44.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -87.28 -23.62 24.61 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.57 HG22 ' O ' ' A' ' 17' ' ' LEU . 17.3 t -80.62 -101.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.13 -53.34 7.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -170.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.418 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -63.63 -23.03 67.21 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.369 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.456 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -57.3 -41.48 79.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.95 -19.97 39.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.995 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.63 -40.57 41.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.73 19.42 2.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.663 0.744 . . . . 0.0 111.432 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.585 ' O ' HD21 ' A' ' 31' ' ' LEU . 5.6 m -74.22 165.88 24.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -60.78 -18.25 53.96 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.054 0.542 . . . . 0.0 111.7 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 HG22 ' HA ' ' A' ' 36' ' ' ARG . 34.4 p -52.99 -43.2 66.28 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 124.045 0.938 . . . . 0.0 113.085 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.585 HD21 ' O ' ' A' ' 28' ' ' THR . 1.6 pt? -96.59 -20.46 18.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.926 0.393 . . . . 0.0 111.19 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -72.07 -50.95 24.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.166 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -168.64 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.13 138.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -56.43 142.04 40.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.301 0.375 . . . . 0.0 110.785 -179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.411 ' HA ' HG22 ' A' ' 30' ' ' THR . 31.4 ptt85 -66.84 159.31 28.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.793 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -70.95 111.44 6.34 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.81 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.34 41.26 7.49 Favored Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.642 -178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 10.1 p -47.56 136.3 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.484 0.659 . . . . 0.0 111.831 179.076 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -70.23 143.75 52.08 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.538 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.512 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 15.4 pm0 -65.57 -12.68 55.21 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -47.09 -44.66 21.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.501 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.47 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.79 -40.71 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.47 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.83 -75.81 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m 78.86 -19.65 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 111.772 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 p -65.39 -82.04 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.61 -39.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.986 0.422 . . . . 0.0 111.261 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.427 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.5 p -80.31 95.42 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.793 0.806 . . . . 0.0 110.33 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.512 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 50.4 mt-30 -79.18 -37.57 38.02 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.546 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 8.1 ttm180 -153.66 0.22 0.23 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.08 -48.39 0.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.61 0.364 . . . . 0.0 110.272 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' HG23 ' A' ' 129' ' ' ILE . . . -61.67 141.08 58.05 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.919 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.439 ' O ' ' HB2' ' A' ' 57' ' ' SER . 42.4 mm-40 -56.71 -30.66 63.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.479 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.3 m -53.89 -62.2 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.546 ' HG ' ' CZ ' ' A' ' 50' ' ' ARG . 4.3 mm? -88.06 -35.82 17.3 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -79.72 -21.46 44.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.439 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.7 t -65.25 93.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.622 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.47 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.7 t -139.23 -31.36 0.7 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.917 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.47 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.7 mt -118.19 19.14 13.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.39 65.61 1.46 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.532 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 96.9 t -89.52 122.48 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.262 0.553 . . . . 0.0 111.368 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -178.2 85.91 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.136 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.88 -54.98 3.46 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.191 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -50.79 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.376 0.67 . . . . 0.0 111.81 -177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.532 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 27.3 p-10 -86.63 14.57 6.75 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.122 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.2 tp -87.91 -65.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.38 -36.63 58.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.549 0.69 . . . . 0.0 109.749 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 60.1 mtm180 -98.95 160.16 14.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.733 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 69.41 -62.27 0.41 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.997 0.519 . . . . 0.0 111.975 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.427 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -62.78 -63.14 1.3 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.746 0.307 . . . . 0.0 111.507 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.508 ' O ' ' HB2' ' A' ' 75' ' ' SER . 59.6 t -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.432 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 41.6 mt-30 -60.78 -47.59 85.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.484 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.89 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.8 -38.33 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.929 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.508 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 33.2 m -77.31 1.23 19.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.447 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.6 mmp_? -111.83 -4.21 14.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.806 0.336 . . . . 0.0 110.169 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.63 123.51 89.1 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.243 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.26 128.64 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.76 2.307 . . . . 0.0 111.46 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.17 94.2 9.47 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.976 0.417 . . . . 0.0 110.154 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.3 -55.28 24.49 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.101 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 m -72.54 -60.44 2.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 178.36 162.81 0.68 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.57 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -67.38 -26.43 66.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.091 0.472 . . . . 0.0 110.778 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -65.63 -17.77 64.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.904 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.23 -21.99 62.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 110.827 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -82.0 -166.37 1.22 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.813 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -76.71 11.6 1.62 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.55 -59.98 2.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.523 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.501 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -69.42 -30.91 68.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.042 0.449 . . . . 0.0 110.991 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 96.1 m-85 -82.64 4.03 26.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.307 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -51.25 -39.8 57.48 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.6 m -58.69 -44.88 90.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.11 -30.98 27.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 33.5 mt -84.58 -28.94 26.24 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -87.13 -29.67 21.65 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.785 0.326 . . . . 0.0 110.486 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.7 m120 51.15 69.57 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.054 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.77 -8.56 56.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.068 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.47 -6.76 83.24 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.734 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.9 t -80.44 -19.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.492 0.663 . . . . 0.0 109.725 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.521 ' CB ' HG13 ' A' ' 21' ' ' VAL . 2.2 pt? -85.47 174.87 9.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.937 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -83.32 143.9 30.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.057 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.27 -18.84 40.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 p -67.75 -30.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.482 0.658 . . . . 0.0 109.827 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.534 ' O ' HD23 ' A' ' 108' ' ' LEU . 19.2 t30 -62.84 -50.44 70.95 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.124 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.488 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.7 mp -72.4 -28.13 27.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.326 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.55 -33.67 66.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.898 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.587 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 86.9 m -85.5 -40.23 16.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.534 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.2 pt? -139.94 -27.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.836 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.488 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -50.83 -63.98 4.09 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.178 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.5 m -75.57 -17.0 60.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.94 0.4 . . . . 0.0 111.913 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.587 ' HD2' ' O ' ' A' ' 107' ' ' THR . 66.6 mtt180 -87.2 -58.0 2.75 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.088 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.7 -49.35 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.535 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.401 ' CD2' ' HA ' ' A' ' 9' ' ' ALA . 22.3 mt -70.86 -13.75 62.15 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.111 0.481 . . . . 0.0 110.572 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.0 t 47.74 -104.07 0.11 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 113.657 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.426 ' HB2' ' HA2' ' A' ' 6' ' ' GLY . . . -65.86 -33.92 76.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.303 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.441 ' O ' HG22 ' A' ' 120' ' ' VAL . 37.3 tp -53.88 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.441 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 16.6 mt -69.07 -23.56 64.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.33 -46.68 76.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.194 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.6 -27.27 63.51 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.899 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.441 HG22 ' O ' ' A' ' 116' ' ' LEU . 25.3 t -68.39 -36.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.795 0.331 . . . . 0.0 110.316 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.0 t -54.47 -41.21 69.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.457 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -83.74 -49.16 9.37 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.53 -58.49 3.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.46 ' O ' ' HA2' ' A' ' 128' ' ' GLY . . . -82.12 -60.27 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -69.18 -35.7 76.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.445 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.28 -69.57 1.39 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.945 -0.645 . . . . 0.0 114.074 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.21 -23.61 24.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.974 0.416 . . . . 0.0 111.269 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 124' ' ' ALA . . . 82.2 91.32 0.6 Allowed Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.025 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.494 HG23 ' HB1' ' A' ' 52' ' ' ALA . 63.7 mt -59.64 134.94 24.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -139.56 118.84 12.79 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.245 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.81 156.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.61 163.09 14.35 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.9 m -74.11 84.19 1.81 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.53 -114.94 2.01 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -87.83 -18.73 28.64 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.9 t -78.72 -62.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.928 -176.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -52.54 -51.67 58.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 p -56.1 -43.97 78.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.88 -40.44 39.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.51 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 47.3 pt -67.31 -35.92 75.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.523 -179.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.9 m -57.05 -53.28 59.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.4 m -61.2 -43.59 98.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.496 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 65.0 m -66.09 -39.11 89.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.5 p -77.9 -19.1 55.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.638 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.4 m -84.27 -60.19 2.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.003 0.43 . . . . 0.0 111.19 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -89.71 -59.82 2.1 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.57 -24.25 65.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 53.2 m -52.61 -34.5 51.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.955 0.407 . . . . 0.0 112.085 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -135.08 26.84 3.55 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.5 t -149.4 156.09 41.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.059 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.1 t 62.75 -167.49 0.21 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.5 m 54.52 39.38 31.07 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 110.784 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.434 ' HB2' ' HB2' ' A' ' 158' ' ' GLN . 52.2 p 55.01 19.47 2.73 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.158 0.983 . . . . 0.0 112.895 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 183' ' ' PRO . . . -82.99 19.19 1.44 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.229 0.538 . . . . 0.0 110.565 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.0 p -81.13 4.91 18.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.6 p90 49.57 20.82 0.54 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.213 1.405 . . . . 0.0 114.39 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.8 t -115.31 -0.27 13.25 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.434 ' HB2' ' HB2' ' A' ' 153' ' ' SER . 60.5 mm-40 -120.87 -171.61 2.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.455 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 69.59 -68.44 0.19 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.151 0.58 . . . . 0.0 111.168 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -156.63 -45.29 0.07 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 72.46 -76.97 0.06 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.647 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.4 m -82.38 86.77 6.66 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 120.828 0.347 . . . . 0.0 110.985 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 t -87.53 75.04 9.18 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.296 0.57 . . . . 0.0 109.649 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 m -86.25 -55.64 3.82 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.127 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.4 m -82.56 -55.0 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.191 0.519 . . . . 0.0 109.611 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 173.29 142.19 3.77 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.81 115.32 27.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.956 0.407 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.02 -17.22 63.47 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.796 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.16 22.67 1.4 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.659 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.6 t -71.86 158.17 36.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.54 -139.82 6.02 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.057 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -65.08 -16.55 55.72 Favored 'Trans proline' 0 N--CA 1.48 0.689 0 C-N-CA 123.327 2.685 . . . . 0.0 112.869 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -118.87 -61.46 1.64 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.17 149.84 1.75 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.991 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 72.5 Cg_endo -87.49 -162.97 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.996 2.464 . . . . 0.0 111.082 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.409 ' HA ' ' O ' ' A' ' 182' ' ' TYR . 4.3 m -63.15 92.73 0.06 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.41 ' O ' ' HB3' ' A' ' 186' ' ' LEU . 15.1 t -175.91 28.98 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.09 -149.05 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.536 ' HG3' ' OXT' ' A' ' 199' ' ' GLY . 2.7 Cg_exo -77.94 -150.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.277 2.651 . . . . 0.0 111.863 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 57.7 m 54.47 30.07 12.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 123.111 0.564 . . . . 0.0 111.655 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 96.99 -49.7 1.53 Allowed Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.195 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.409 ' O ' ' HA ' ' A' ' 176' ' ' SER . 4.9 m-85 -165.47 -57.87 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 122.808 0.443 . . . . 0.0 110.11 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.456 ' HG3' ' O ' ' A' ' 154' ' ' ALA . 43.4 Cg_endo -67.43 122.94 10.23 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.232 1.288 . . . . 0.0 109.189 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.35 147.56 15.52 Favored Glycine 0 N--CA 1.407 -3.243 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.447 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.88 10.69 1.91 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.097 3.198 . . . . 0.0 112.127 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.547 ' HG ' ' CA ' ' A' ' 190' ' ' ALA . 1.2 tt -68.48 -66.19 0.6 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.744 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.87 -124.59 7.06 Favored Glycine 0 C--N 1.32 -0.359 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.648 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -71.8 -47.27 33.63 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.607 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -156.3 39.32 0.58 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.547 ' CA ' ' HG ' ' A' ' 186' ' ' LEU . . . 72.84 159.45 0.16 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 123.487 0.715 . . . . 0.0 110.636 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.84 90.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.3 t80 72.76 -57.21 0.64 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.076 0.951 . . . . 0.0 111.272 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 167.28 177.42 38.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -128.77 174.12 9.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -106.64 16.36 24.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.112 0.482 . . . . 0.0 110.312 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 94.17 93.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.284 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -137.85 -41.39 0.54 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.804 0.335 . . . . 0.0 110.639 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 124.12 -3.79 9.03 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.82 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.536 ' OXT' ' HG3' ' A' ' 179' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.82 0 CA-C-O 118.487 -1.174 . . . . 0.0 111.817 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.513 0.197 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.06 161.91 30.63 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.475 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.0 177.75 8.35 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.895 2.397 . . . . 0.0 111.674 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.445 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 95.5 mt-30 -98.54 -5.09 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.596 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.19 -75.85 2.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.527 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.28 59.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.085 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -99.17 -88.66 0.33 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.826 0.346 . . . . 0.0 110.683 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.445 ' H ' ' HB2' ' A' ' 4' ' ' GLN . . . 108.9 -158.67 14.51 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.872 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.426 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -163.56 177.0 9.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.9 p 52.07 94.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.859 0.864 . . . . 0.0 113.109 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.27 141.59 30.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.812 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.26 -38.4 95.6 Favored Glycine 0 C--O 1.23 -0.149 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.486 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.44 -37.44 85.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.975 0.417 . . . . 0.0 110.831 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.582 ' O ' HG21 ' A' ' 18' ' ' ILE . 12.6 m -66.97 -31.37 71.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.334 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.68 -25.74 29.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.66 -35.41 8.49 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.149 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -85.46 -22.42 28.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.582 HG21 ' O ' ' A' ' 14' ' ' SER . 14.9 pt -46.88 -37.31 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 t -84.63 -20.75 30.85 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.679 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -88.0 -34.9 17.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.55 178.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.73 -32.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.483 ' HB2' ' CB ' ' A' ' 92' ' ' SER . 1.7 t-20 -65.59 -24.01 66.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.352 -0.217 . . . . 0.0 111.393 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.11 86.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.742 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.444 HD23 ' HG ' ' A' ' 180' ' ' SER . 44.1 tp -75.95 -28.03 57.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.13 0.49 . . . . 0.0 110.392 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.495 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -82.92 66.83 8.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.75 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.474 1.51 . . . . 0.0 114.537 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.495 ' H ' ' C ' ' A' ' 26' ' ' ALA . 6.6 m -59.8 165.72 2.98 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.053 0.541 . . . . 0.0 110.196 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -59.49 -15.18 16.0 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.764 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -53.16 -29.34 31.03 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.38 1.072 . . . . 0.0 113.595 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -114.98 -19.54 10.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.098 0.475 . . . . 0.0 110.176 178.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -79.64 -43.35 22.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.773 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -160.79 -49.16 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 m -74.3 157.46 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.199 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -61.34 142.62 56.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.187 0.517 . . . . 0.0 111.188 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.518 ' HE ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 ptm85 -62.68 159.34 16.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.209 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.492 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p -76.84 111.86 12.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.118 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 80.03 48.32 6.58 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.518 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 14.2 p -51.87 141.99 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.142 0.496 . . . . 0.0 111.63 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -76.34 147.41 38.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.494 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -65.31 -13.77 59.23 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.847 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -56.51 -38.22 71.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.94 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.468 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.76 -43.69 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.975 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.468 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.04 -69.42 0.63 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.497 0.189 . . . . 0.0 111.19 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t 74.73 -29.09 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.721 0.809 . . . . 0.0 112.743 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.5 m -66.43 -67.63 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.75 -35.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -80.72 89.96 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.951 0.405 . . . . 0.0 110.428 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.494 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 8.9 mm100 -82.75 -48.25 11.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.68 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.551 ' NH2' ' HB3' ' A' ' 54' ' ' SER . 8.2 ttp180 -136.69 -1.11 2.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.832 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.37 -51.01 0.61 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 110.588 -174.473 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' HB3' ' HE ' ' A' ' 50' ' ' ARG . . . -69.27 128.47 36.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.095 0.474 . . . . 0.0 110.972 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.698 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -49.1 -19.71 0.47 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . 0.551 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 44.0 t -63.21 -62.46 1.68 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 118.803 0.728 . . . . 0.0 110.963 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.487 ' CB ' ' HD3' ' A' ' 50' ' ' ARG . 15.7 tp -87.52 -25.59 23.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 110.589 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.3 -13.89 60.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.85 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.445 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 11.4 p -42.71 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -44.32 -38.45 3.92 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.688 0.795 . . . . 0.0 111.852 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.77 12.9 9.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.664 0.269 . . . . 0.0 111.128 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.33 63.73 3.61 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.212 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.698 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 50.7 t -88.08 101.71 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -161.78 100.52 1.14 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.444 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.04 -59.37 4.28 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.646 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -62.57 -76.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.146 0.498 . . . . 0.0 111.031 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.586 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 12.3 p-10 -86.69 10.93 14.23 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.4 tp -88.98 -57.7 2.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.332 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.09 54.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 110.186 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -107.71 170.01 8.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 67.8 -61.53 0.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.84 0.456 . . . . 0.0 111.687 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.45 -58.41 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.535 0.334 . . . . 0.0 111.052 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.518 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 91.2 t -60.13 -37.23 72.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -70.17 -34.47 73.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.155 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 -43.93 36.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.71 -40.12 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.836 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.6 t -69.58 -6.68 32.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -79.96 -20.71 44.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.919 0.39 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.71 148.42 98.2 Favored Pre-proline 0 C--O 1.24 0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 126.66 15.5 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.468 2.112 . . . . 0.0 112.9 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.99 30.65 5.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.348 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.1 -53.55 17.95 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.124 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.3 p -78.3 -39.91 38.38 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.45 ' OD2' ' HB3' ' A' ' 84' ' ' SER . 6.6 p-10 -170.61 155.77 5.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -81.57 -18.07 46.16 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.554 0.692 . . . . 0.0 109.333 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.505 ' HA ' ' CB ' ' A' ' 88' ' ' GLN . 28.9 t -58.73 -17.29 21.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.546 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.51 -21.99 29.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.836 0.454 . . . . 0.0 111.25 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -80.33 -164.62 0.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 46.86 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.376 0.608 . . . . 0.0 109.406 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.505 ' CB ' ' HA ' ' A' ' 84' ' ' SER . 7.8 tp-100 -77.57 -59.58 2.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.54 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.28 89.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.725 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.52 17.12 1.85 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.544 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.466 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 8.6 t -54.93 -40.96 70.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.763 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.483 ' CB ' ' HB2' ' A' ' 23' ' ' ASN . 6.6 t -72.72 -38.83 67.33 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.4 63.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.4 -20.88 31.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.431 ' HB2' HH12 ' A' ' 36' ' ' ARG . 48.0 t80 -87.88 -50.2 6.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.194 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 56.15 87.02 0.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.973 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.03 -5.12 42.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.555 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.64 -5.39 78.53 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.914 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.428 ' CG1' ' HA2' ' A' ' 193' ' ' GLY . 18.4 t -94.52 -7.44 10.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.451 ' H ' HD21 ' A' ' 100' ' ' LEU . 2.1 pt? -84.71 -177.68 6.66 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.634 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.469 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 12.5 p-10 -75.05 125.5 29.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -176.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.7 -24.58 61.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.367 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -68.29 -29.74 68.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.671 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.469 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 21.2 t30 -59.86 -51.93 67.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.737 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.558 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.1 mp -74.52 -37.85 44.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.442 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.72 -34.56 78.11 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.843 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.467 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -89.21 -49.14 6.91 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.409 HD22 ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.33 -15.3 5.18 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.085 -1.046 . . . . 0.0 113.453 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.558 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -65.65 -75.74 0.39 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.926 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 114' ' ' SER . 16.3 m -67.77 -16.81 64.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.467 ' HD3' ' O ' ' A' ' 107' ' ' THR . 60.9 mtp180 -86.76 -46.59 9.85 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -83.81 -52.39 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.426 ' HG ' ' HA ' ' A' ' 9' ' ' ALA . 7.0 mp -67.59 -33.59 75.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' SER . 72.3 m 45.64 -99.63 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.48 -35.07 60.17 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.289 0.636 . . . . 0.0 112.306 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.53 -52.66 43.35 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.115 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.505 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 12.6 mt -72.43 -26.54 61.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.97 -36.93 73.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 109.836 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.96 -43.19 6.07 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.65 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.505 ' HB ' ' HA ' ' A' ' 117' ' ' LEU . 37.3 t -61.0 -42.23 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.407 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.7 t -85.17 -39.85 17.38 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.38 -81.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 129' ' ' ILE . . . -69.08 -44.99 71.42 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.407 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 48.2 tt0 -70.5 -38.05 74.26 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.131 0.491 . . . . 0.0 111.183 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.73 -40.97 7.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.455 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.66 -22.48 9.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.36 95.38 0.21 Allowed Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.52 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.492 ' O ' ' HB ' ' A' ' 37' ' ' THR . 15.8 mm -76.76 132.99 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.473 HD22 ' NE2' ' A' ' 137' ' ' GLN . 10.8 t30 -115.49 132.01 56.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.782 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.434 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.5 t -99.11 120.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -99.98 35.8 1.97 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.515 -179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.518 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 67.3 p -70.82 -8.06 49.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.077 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.1 -19.75 51.5 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.198 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 p -105.98 -46.96 3.97 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.457 ' O ' HG12 ' A' ' 140' ' ' ILE . 54.2 t -66.28 -62.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.538 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.473 ' NE2' HD22 ' A' ' 130' ' ' ASN . 8.1 tt0 -56.3 -39.23 72.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -62.43 -40.35 96.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.78 -47.12 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.905 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.457 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.7 pt -57.4 -38.46 62.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.3 p -56.61 -42.14 78.27 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 111.66 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -84.67 -39.76 18.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 0.0 111.05 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.6 m -69.69 -39.58 76.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.0 t -71.37 -23.69 61.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.444 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.3 p -87.83 -49.52 7.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' HA ' ' HB2' ' A' ' 150' ' ' SER . 83.7 m-85 -86.32 -59.47 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.4 mp -61.27 -8.74 4.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.7 p -90.68 -67.21 0.86 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.995 0.426 . . . . 0.0 111.672 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.402 HG23 ' CE1' ' A' ' 156' ' ' TYR . 12.6 p -131.24 28.25 4.73 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.436 ' HB2' ' HA ' ' A' ' 146' ' ' PHE . 32.8 t -65.93 158.04 29.12 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 m 59.88 -154.34 0.37 Allowed 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -72.09 -51.83 19.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.474 ' HA ' ' CE1' ' A' ' 156' ' ' TYR . 51.9 m -153.77 86.98 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.092 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.53 -62.06 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.9 m -128.96 22.1 5.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.474 ' CE1' ' HA ' ' A' ' 153' ' ' SER . 33.0 p90 -135.69 141.45 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.441 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.7 m 65.67 -65.89 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.931 0.893 . . . . 0.0 112.846 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -71.54 3.19 4.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.25 -27.71 68.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.296 0.57 . . . . 0.0 109.585 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' SER . . . . . 0.419 ' HB2' ' HA ' ' A' ' 175' ' ' PRO . 15.0 m -148.11 -41.13 0.17 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.015 176.402 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 68.16 -61.26 0.39 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.059 0.943 . . . . 0.0 113.286 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 m -75.33 105.36 6.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.926 0.394 . . . . 0.0 111.981 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 p -83.02 -46.82 12.39 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.9 m -69.18 129.36 39.63 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.0 p 55.88 30.01 15.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.41 0.624 . . . . 0.0 111.237 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -149.03 -97.16 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.673 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -101.86 99.79 10.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.557 0.217 . . . . 0.0 110.695 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.52 -15.63 80.58 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.842 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.48 -45.51 59.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.526 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.417 ' HA ' ' CD ' ' A' ' 175' ' ' PRO . 3.5 m 55.57 89.06 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.537 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.0 -144.76 9.86 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.63 -36.79 96.76 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.424 2.083 . . . . 0.0 111.183 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 p -91.19 10.67 26.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.411 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.68 -141.28 5.79 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.419 ' HA ' ' HB2' ' A' ' 160' ' ' SER . 7.7 Cg_exo -74.54 -8.24 20.35 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.833 2.356 . . . . 0.0 112.993 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.6 m 53.39 48.26 22.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.455 0.645 . . . . 0.0 109.627 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.0 t -85.07 147.52 26.62 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.878 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.37 61.77 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.276 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.435 ' HA ' ' CE2' ' A' ' 156' ' ' TYR . 19.6 Cg_endo -58.4 122.14 11.16 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.494 2.13 . . . . 0.0 112.683 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.444 ' HG ' HD23 ' A' ' 25' ' ' LEU . 9.0 m -75.97 96.36 3.76 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.08 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.448 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -105.55 118.44 55.55 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.21 135.02 48.38 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.506 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.466 ' HA2' ' CA ' ' A' ' 199' ' ' GLY . . . 141.67 -104.76 0.39 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.926 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.23 -19.4 38.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.414 2.076 . . . . 0.0 111.675 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.8 mt 60.63 -82.31 0.02 OUTLIER 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.549 0.739 . . . . 0.0 111.129 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -150.78 48.08 0.58 Allowed Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.68 36.97 12.48 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 119.46 -86.72 0.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.425 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . . . 64.93 143.13 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.819 0.848 . . . . 0.0 112.745 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 190' ' ' ALA . 35.1 Cg_endo -96.37 15.92 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.203 2.602 . . . . 0.0 111.931 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -83.96 -68.83 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.815 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.428 ' HA2' ' CG1' ' A' ' 99' ' ' VAL . . . -113.98 63.47 0.3 Allowed Glycine 0 CA--C 1.486 -1.74 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.789 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -115.31 6.57 14.95 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.904 -176.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.9 t -139.75 -57.49 0.57 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.429 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -112.07 51.28 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.975 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.59 -53.72 1.01 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.908 0.385 . . . . 0.0 110.785 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 105.41 86.09 1.88 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . 0.466 ' CA ' ' HA2' ' A' ' 184' ' ' GLY . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.808 -0.996 . . . . 0.0 112.411 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.727 0.298 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.49 166.39 25.46 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.569 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.496 ' HB3' ' HA2' ' A' ' 8' ' ' GLY . 24.2 Cg_exo -66.02 171.15 10.47 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 123.015 2.477 . . . . 0.0 111.973 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -101.97 93.72 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.482 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.94 -109.76 2.91 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.885 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.99 59.73 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.018 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -91.48 87.24 6.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.257 0.551 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.496 ' HA2' ' HB3' ' A' ' 3' ' ' PRO . . . -83.13 55.8 5.05 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.847 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -66.09 103.9 1.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.659 0.383 . . . . 0.0 111.204 -178.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -145.5 -75.38 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.493 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.5 -40.17 0.12 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.99 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.85 -109.77 2.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.04 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.96 -18.03 62.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.788 0.327 . . . . 0.0 111.618 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.55 ' O ' HG23 ' A' ' 18' ' ' ILE . 75.8 m -65.34 -21.83 66.74 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.008 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.78 41.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.931 0.396 . . . . 0.0 111.958 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.78 -41.75 8.07 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.1 pp -87.94 -20.62 25.66 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.55 HG23 ' O ' ' A' ' 14' ' ' SER . 12.0 pt -43.39 -47.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.49 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 35.4 t -73.06 -20.19 61.03 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 121.267 -0.173 . . . . 0.0 111.101 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.446 ' O ' ' HB2' ' A' ' 191' ' ' PRO . 50.4 mtt180 -86.32 -32.24 21.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG23 ' O ' ' A' ' 17' ' ' LEU . 39.3 t -54.15 169.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.115 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.73 -32.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.435 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 31.7 m-80 -60.79 -24.39 65.76 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.63 -53.05 59.84 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.985 0.421 . . . . 0.0 111.332 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.91 -25.77 37.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.333 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.435 ' O ' HD22 ' A' ' 31' ' ' LEU . . . -75.72 90.36 2.86 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.54 ' HA ' ' NH2' ' A' ' 32' ' ' ARG . 5.2 m-80 -75.3 17.98 0.23 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.7 m -65.8 148.26 52.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.1 m -58.07 -14.54 6.9 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 p -48.5 -35.72 13.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.435 HD22 ' O ' ' A' ' 26' ' ' ALA . 1.2 pt? -108.41 -18.25 13.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.197 0.522 . . . . 0.0 110.679 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.54 ' NH2' ' HA ' ' A' ' 27' ' ' ASN . 17.0 mmt180 -76.73 -49.86 15.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -163.45 -29.76 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.4 t -87.49 144.87 8.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.5 145.58 32.77 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -70.59 153.53 42.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -68.84 120.8 15.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.93 37.14 20.04 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.514 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . 0.439 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 7.5 p -51.31 148.37 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.153 0.501 . . . . 0.0 111.29 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.452 ' HG ' HD11 ' A' ' 116' ' ' LEU . 15.3 m -93.0 153.93 18.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 -178.007 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.545 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -65.41 -12.72 55.01 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.422 -178.994 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -48.96 -38.58 23.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.198 0.523 . . . . 0.0 109.979 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.693 HG13 ' N ' ' A' ' 44' ' ' ALA . 3.9 pt -85.12 -44.47 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.907 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.693 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.14 -67.46 0.79 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.7 m 75.95 -18.57 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.808 0.843 . . . . 0.0 112.627 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.1 t -57.14 -96.2 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.88 0.472 . . . . 0.0 112.153 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.35 -23.21 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.371 0.605 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -79.52 98.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.2 mm-40 -73.41 -47.23 43.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.713 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.439 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.4 ttm-85 -149.47 9.02 0.71 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.418 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 -53.31 0.57 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.447 0.699 . . . . 0.0 110.982 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.54 142.82 55.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.573 177.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.582 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.03 -19.05 6.12 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -55.55 -71.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.862 0.363 . . . . 0.0 111.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -25.92 23.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.558 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.25 -18.39 57.67 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.582 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 19.3 t -52.42 106.04 0.14 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.028 0.442 . . . . 0.0 110.516 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.466 HG21 ' O ' ' A' ' 56' ' ' ALA . 12.4 t -165.39 -40.8 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.459 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.69 19.47 11.09 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.36 64.23 1.12 Allowed Glycine 0 C--N 1.316 -0.554 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.795 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.02 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -163.46 13.46 0.06 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.879 0.847 . . . . 0.0 109.461 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.87 -50.74 0.61 Allowed Glycine 0 C--N 1.294 -1.794 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.159 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.34 -55.23 37.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 120.782 0.325 . . . . 0.0 110.551 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.63 -41.79 16.01 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.482 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.58 -58.27 7.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.396 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 -5.74 59.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -128.25 -86.04 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -57.89 -31.91 67.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.48 -52.04 15.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 111.131 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.503 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 9.2 p -69.04 -40.77 81.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.494 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 75.1 mt-30 -62.91 -39.15 93.66 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.358 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.71 71.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.96 0.41 . . . . 0.0 111.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.41 ' HA ' HD11 ' A' ' 77' ' ' LEU . 39.7 t -86.36 -32.37 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.002 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -70.81 -23.27 62.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.164 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 24.7 mmt180 -85.18 1.65 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.776 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.604 HD13 ' HH ' ' A' ' 86' ' ' TYR . 77.0 mt -85.52 154.64 59.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.019 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -52.52 160.49 3.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.993 2.462 . . . . 0.0 112.624 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.12 -148.62 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.53 -37.64 1.28 Allowed Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.3 m -56.55 -29.91 62.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.222 0.511 . . . . 0.0 111.804 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.45 -23.43 10.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.289 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -63.21 -41.44 99.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 m -69.31 -23.74 63.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.246 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -22.65 50.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.595 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.604 ' HH ' HD13 ' A' ' 77' ' ' LEU . 18.3 m-30 -85.29 -164.71 1.04 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.359 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -72.55 53.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.237 0.615 . . . . 0.0 111.352 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -90.6 -59.2 2.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.117 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.26 -26.27 30.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.657 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -83.51 6.68 19.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.528 -178.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.3 m -52.84 -31.44 39.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.435 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 73.6 m -61.22 -47.68 84.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.54 32.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.789 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 84.0 mt -85.15 -32.19 22.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -84.85 -36.52 21.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.769 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.01 86.47 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 112.022 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.04 56.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.755 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.9 -13.63 42.46 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.73 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.532 ' CG1' ' HA2' ' A' ' 193' ' ' GLY . 5.1 t -84.17 -1.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.612 0.72 . . . . 0.0 110.434 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -88.15 179.32 6.41 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.896 -179.653 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.78 141.19 30.68 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.529 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.21 -23.64 57.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.814 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m -69.05 -34.78 75.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.469 0.652 . . . . 0.0 110.386 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.581 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 31.5 t30 -60.21 -51.71 68.41 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.487 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.61 -33.9 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.22 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.86 -48.41 76.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.966 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.547 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 71.1 m -73.1 -56.54 4.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -174.145 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.581 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.3 pp -102.18 -24.37 13.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.067 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.28 -65.91 2.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.274 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -65.61 -28.18 68.94 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.547 ' HD3' ' O ' ' A' ' 107' ' ' THR . 11.5 mpt_? -86.57 -55.31 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.54 -48.77 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.13 -42.64 65.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.6 m 48.46 -95.09 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.6 -33.28 54.38 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.206 0.602 . . . . 0.0 112.031 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 120' ' ' VAL . 60.7 tp -62.19 -53.59 53.04 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.503 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 13.7 mt -66.6 -28.34 68.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.777 -177.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -59.49 -43.99 93.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.963 0.411 . . . . 0.0 110.038 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.24 -31.73 41.31 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.98 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.482 HG21 ' O ' ' A' ' 116' ' ' LEU . 69.4 t -68.43 -38.9 79.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 122.863 -0.198 . . . . 0.0 111.269 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 64.9 m -57.55 -41.95 82.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.845 -178.48 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -83.85 -39.24 20.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.94 -80.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HB2' HG13 ' A' ' 120' ' ' VAL . . . -64.22 -55.61 20.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -175.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 70.0 mt-30 -70.12 -29.23 66.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.197 -179.334 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.68 -64.73 2.01 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.091 -0.575 . . . . 0.0 114.185 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.7 mt -104.35 -23.78 13.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.859 0.362 . . . . 0.0 111.656 -175.192 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.94 97.72 1.12 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 30.1 mm -75.37 129.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -127.84 131.92 49.46 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.962 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.97 118.31 50.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.471 0.653 . . . . 0.0 111.405 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -97.63 43.97 1.06 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.455 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.503 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 21.0 p -78.62 1.14 23.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 120.855 0.36 . . . . 0.0 111.256 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.36 -21.96 29.28 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.567 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.2 t -106.0 -58.67 1.88 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 122.927 -0.16 . . . . 0.0 111.285 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.49 ' O ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -50.63 -51.97 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.422 HE21 ' HB2' ' A' ' 137' ' ' GLN . 8.3 tt0 -61.76 -44.44 96.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -60.69 -46.78 89.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.952 0.406 . . . . 0.0 110.302 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -62.8 -51.1 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.578 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 136' ' ' VAL . 39.4 pt -69.32 -38.09 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -63.05 -52.35 63.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.465 0.174 . . . . 0.0 111.316 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.9 p -62.85 -43.34 99.04 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -65.18 -40.52 94.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.311 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 m -77.53 -19.52 55.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.144 0.497 . . . . 0.0 110.946 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -81.61 -60.49 2.23 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.85 0.357 . . . . 0.0 110.857 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.98 -46.2 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.2 mt -85.7 -4.42 59.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -54.27 -54.19 43.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 111.173 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.5 m -146.31 83.93 1.63 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.127 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.6 t -85.04 121.56 27.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.95 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p 51.39 -95.95 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.904 . . . . 0.0 112.269 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -134.14 -17.93 2.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.354 0.597 . . . . 0.0 109.782 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.411 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . 45.1 m -153.21 145.87 24.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.353 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.41 77.39 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.3 m -85.72 -1.76 57.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.0 t80 67.65 -59.5 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.876 0.87 . . . . 0.0 112.791 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.7 m -58.46 -22.07 53.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.908 0.483 . . . . 0.0 111.556 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.411 ' OE1' ' HB3' ' A' ' 153' ' ' SER . 84.0 mt-30 -66.02 -44.61 84.2 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.472 ' C ' ' H ' ' A' ' 161' ' ' ALA . . . 40.22 75.73 0.08 Allowed 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.164 0.986 . . . . 0.0 112.258 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.4 p 65.71 -24.12 0.09 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.385 1.474 . . . . 0.0 113.187 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.472 ' H ' ' C ' ' A' ' 159' ' ' ALA . . . 57.72 -165.91 0.15 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.163 0.585 . . . . 0.0 110.674 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.4 t -130.82 82.75 2.07 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.146 0.498 . . . . 0.0 109.901 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.5 m -64.85 -14.28 58.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.165 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.0 m -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.444 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.4 t -102.32 -8.16 21.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.354 0.597 . . . . 0.0 109.677 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 117.56 125.25 3.57 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.401 ' HB1' ' HD3' ' A' ' 175' ' ' PRO . . . -71.49 -43.48 66.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 111.733 -177.496 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.68 -59.25 3.79 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.234 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -63.73 -25.98 68.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.948 0.404 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 m -153.53 113.24 3.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.024 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.48 -54.33 32.67 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.932 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.56 83.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.048 2.499 . . . . 0.0 113.88 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.424 ' CB ' ' HA ' ' A' ' 190' ' ' ALA . 39.3 t 69.91 -13.51 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.92 0.888 . . . . 0.0 113.278 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.43 174.33 14.79 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.147 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.401 ' HD3' ' HB1' ' A' ' 167' ' ' ALA . 4.4 Cg_exo -80.44 83.76 2.16 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.143 2.562 . . . . 0.0 113.137 -176.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 t 58.78 28.77 17.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.468 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 t -78.13 -5.06 50.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.227 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -92.95 153.41 21.48 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -77.62 123.95 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.406 2.071 . . . . 0.0 112.044 -179.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.2 p -83.96 -75.4 0.34 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.818 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -112.87 63.41 0.29 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -139.26 153.95 71.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.64 128.86 30.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.609 2.206 . . . . 0.0 110.82 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.19 74.44 0.89 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.78 -153.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.238 2.625 . . . . 0.0 112.419 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.413 ' CB ' ' HB3' ' A' ' 190' ' ' ALA . 1.1 pt? -52.56 120.58 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -86.35 41.24 3.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.0 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.02 -25.44 14.12 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.06 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.07 -51.51 44.35 Favored Glycine 0 C--O 1.238 0.382 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.276 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.424 ' HA ' ' CB ' ' A' ' 173' ' ' SER . . . -67.82 148.17 98.5 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-O 120.435 0.16 . . . . 0.0 110.604 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.492 ' O ' ' HG2' ' A' ' 194' ' ' GLN . 28.0 Cg_endo -97.19 17.5 0.59 Allowed 'Trans proline' 0 N--CA 1.435 -1.959 0 C-N-CA 123.091 2.527 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -69.5 -73.29 0.16 Allowed 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.018 179.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.532 ' HA2' ' CG1' ' A' ' 99' ' ' VAL . . . -98.09 38.11 3.22 Favored Glycine 0 CA--C 1.5 -0.887 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 191' ' ' PRO . 5.0 pt20 -54.83 -43.46 73.01 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 40.2 m -79.09 1.9 22.57 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.27 34.02 6.93 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.148 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -119.79 153.57 35.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -178.721 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.94 -75.87 2.15 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.978 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.445 0 CA-C-O 118.689 -1.062 . . . . 0.0 111.068 179.606 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.62 129.03 7.53 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.945 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.78 144.61 49.08 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.546 2.164 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -92.55 98.36 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.046 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.42 27.9 70.23 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.91 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.59 -10.32 56.07 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.183 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.96 109.06 20.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.759 0.314 . . . . 0.0 110.486 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.85 -161.71 18.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.093 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.83 -172.66 3.37 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.514 0.197 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.1 p 61.2 104.06 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.893 1.277 . . . . 0.0 113.014 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.62 155.38 22.62 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.195 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.0 -45.45 20.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.242 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.84 90.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.976 0.388 . . . . 0.0 111.211 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.544 ' O ' HG21 ' A' ' 18' ' ' ILE . 18.7 m -60.22 -28.6 68.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.754 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.11 -21.44 22.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.93 -39.42 7.51 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.407 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.611 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.1 pp -85.98 -25.46 26.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.544 HG21 ' O ' ' A' ' 14' ' ' SER . 14.1 pt -45.38 -50.34 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.402 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 14.1 m -84.78 -18.74 34.08 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.699 0.285 . . . . 0.0 111.586 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.74 -24.24 28.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.611 HG22 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -78.71 -106.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.442 ' N ' HG13 ' A' ' 21' ' ' VAL . . . -77.97 -50.14 12.74 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 19.6 m-80 -60.51 -21.42 62.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -57.13 -40.83 77.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.176 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.14 -37.05 15.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.255 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -79.41 83.02 5.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 18.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.853 0.861 . . . . 0.0 113.069 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.473 ' O ' HD23 ' A' ' 31' ' ' LEU . 2.3 m -62.38 164.85 6.68 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.432 0.634 . . . . 0.0 111.346 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.1 t -65.45 -14.92 62.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.896 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -48.13 -44.03 31.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.742 0.817 . . . . 0.0 112.838 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.5 pt? -99.15 -19.86 16.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.496 0.665 . . . . 0.0 109.8 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -70.64 -53.39 15.99 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.761 -174.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -167.16 -24.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.93 141.39 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 1.9 pt? -54.72 150.03 10.23 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 111.91 -178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.49 163.49 26.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.169 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.416 HG22 HG21 ' A' ' 131' ' ' VAL . 18.4 p -77.12 147.4 36.61 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.1 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.489 ' H ' HG12 ' A' ' 131' ' ' VAL . . . 73.71 24.38 74.59 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.313 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.8 165.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.76 0.424 . . . . 0.0 110.782 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.563 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.9 m -134.95 165.04 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.147 -0.346 . . . . 0.0 111.525 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.558 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.4 pp0? -66.77 -12.54 59.18 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG3' ' HB2' ' A' ' 116' ' ' LEU . 82.9 mm-40 -53.44 -38.8 63.87 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.563 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -86.63 -44.11 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' N ' HD13 ' A' ' 43' ' ' ILE . . . -81.89 -65.25 1.03 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.614 0.245 . . . . 0.0 111.362 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m 81.81 -19.02 0.44 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.911 0.884 . . . . 0.0 112.152 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -70.91 -90.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.005 0.431 . . . . 0.0 111.705 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.61 -19.69 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.404 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.38 81.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.169 0.509 . . . . 0.0 110.105 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 1.8 mp0 -64.41 -48.93 73.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.231 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.523 ' HE ' HD11 ' A' ' 55' ' ' LEU . 46.4 ttm-85 -148.31 4.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.061 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.482 ' HB2' HG13 ' A' ' 131' ' ' VAL . . . 67.63 -51.3 0.51 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -175.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.499 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -67.46 140.82 57.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.375 0.607 . . . . 0.0 110.857 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.678 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.6 mt-30 -59.52 -17.5 32.56 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.415 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -62.35 -74.06 0.1 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.848 0.356 . . . . 0.0 111.747 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.523 HD11 ' HE ' ' A' ' 50' ' ' ARG . 9.0 tt -87.22 -25.03 24.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.653 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.22 -19.51 43.06 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.678 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -50.06 108.11 0.2 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -150.02 -41.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.738 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.4 mt -118.22 19.33 13.54 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.338 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.48 56.34 1.27 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.811 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.627 ' O ' ' HG2' ' A' ' 53' ' ' GLN . 2.9 t -90.23 104.09 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -156.18 15.14 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.08 -37.37 2.16 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.026 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -54.49 -74.0 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.44 0.296 . . . . 0.0 111.458 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.404 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.5 p-10 -81.11 -20.83 40.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.013 0.435 . . . . 0.0 110.216 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.5 -55.05 35.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.655 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . 0.552 ' HA ' ' O ' ' A' ' 133' ' ' SER . . . -82.79 1.66 37.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -126.08 -87.55 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -57.35 -38.43 74.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.47 92.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.958 0.409 . . . . 0.0 110.824 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.35 -46.26 71.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.13 -40.38 81.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.655 0.264 . . . . 0.0 111.584 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.04 88.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.835 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.59 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.2 t -85.31 -17.69 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.005 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -93.35 -19.6 21.18 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 121.946 -0.471 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -118.55 22.46 12.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.491 0.662 . . . . 0.0 110.744 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.59 HD22 ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -73.39 158.21 86.92 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.106 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.94 128.04 11.99 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.874 1.716 . . . . 0.0 111.224 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.75 70.83 10.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.91 -57.32 2.87 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.741 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 p -81.89 -6.18 58.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.431 0.157 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 87.25 149.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.55 1.14 . . . . 0.0 110.487 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.408 HG22 HE22 ' A' ' 88' ' ' GLN . 4.1 m -60.34 -37.58 81.08 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.442 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 79.2 p -71.34 -32.02 68.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.63 -20.13 59.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.113 0.482 . . . . 0.0 111.483 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.494 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 4.2 m-85 -69.45 -165.71 0.08 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.468 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.62 17.62 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 77.7 mt-30 -88.89 -55.45 3.69 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.364 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.472 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -72.41 -40.96 66.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.302 0.572 . . . . 0.0 109.592 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.573 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.7 m-85 -81.64 16.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.082 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -51.63 -57.2 9.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.2 m -55.12 -36.68 66.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.93 -39.15 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.573 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 18.9 mt -81.9 -30.32 31.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.825 0.345 . . . . 0.0 111.68 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -85.06 -28.56 25.58 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 52.77 84.28 0.06 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.81 -7.45 57.87 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.128 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.18 -11.93 40.67 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.035 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 t -78.53 -8.54 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.552 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.53 -171.42 3.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.487 -177.088 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.07 129.41 42.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.29 61.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.14 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -67.9 -32.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.519 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 11.5 t30 -62.7 -54.01 45.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.527 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -69.06 -35.96 71.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.384 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.86 -30.81 67.31 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.709 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.1 m -92.74 -34.55 13.87 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.519 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 2.2 pp -137.47 -29.61 0.87 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.812 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.527 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -53.17 -68.56 1.56 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.987 -0.625 . . . . 0.0 114.326 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.503 ' O ' ' HA ' ' A' ' 114' ' ' SER . 8.1 m -60.89 -20.6 62.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.714 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -88.14 -54.59 4.14 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.356 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.59 -45.89 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.812 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.4 mm? -81.5 -29.87 33.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 110' ' ' SER . 35.3 t 44.7 -96.68 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.39 68.31 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.908 0.483 . . . . 0.0 111.8 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 39.5 tp -65.32 -60.12 3.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.69 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.57 -29.26 68.58 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.57 -43.85 93.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.788 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 -37.13 28.66 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.999 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.478 HG12 ' O ' ' A' ' 94' ' ' LEU . 63.1 t -68.65 -41.11 82.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.495 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 8.1 t -55.73 -46.52 77.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.076 0.465 . . . . 0.0 111.201 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -74.66 -49.56 20.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.108 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.41 -70.88 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.436 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.59 -47.6 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.495 ' HB3' ' O ' ' A' ' 121' ' ' SER . 32.5 tt0 -68.64 -35.49 77.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.055 0.455 . . . . 0.0 110.428 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.62 -71.32 1.28 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.77 -0.65 . . . . 0.0 114.034 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.43 -24.16 23.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.816 0.341 . . . . 0.0 111.371 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.49 92.92 0.98 Allowed Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.191 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.499 HG23 ' CB ' ' A' ' 52' ' ' ALA . 20.7 mm -78.17 129.6 37.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -108.9 131.14 55.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.486 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.527 ' CG2' HG11 ' A' ' 136' ' ' VAL . 7.3 m -98.73 90.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.04 0.924 . . . . 0.0 111.14 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.57 46.01 1.02 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.279 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.3 m -68.37 -6.05 22.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.566 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 -23.42 30.18 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.122 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -105.55 -31.99 8.7 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.527 HG11 ' CG2' ' A' ' 131' ' ' VAL . 40.6 t -67.27 -57.18 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.712 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.5 -53.36 30.53 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.46 0.475 . . . . 0.0 111.804 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -54.23 -37.73 64.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.171 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.58 -47.0 10.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.652 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.484 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.5 pt -64.99 -39.17 84.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.8 p -61.91 -49.07 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.429 . . . . 0.0 110.67 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.2 m -65.63 -28.95 69.48 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.329 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.1 t -89.06 -20.37 24.44 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.7 p -64.64 -19.18 65.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 p -56.61 -23.99 44.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.098 0.475 . . . . 0.0 111.181 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -72.97 -10.22 59.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.18 -32.4 73.46 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.206 0.527 . . . . 0.0 110.398 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.3 m -70.01 -10.52 58.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.083 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.2 m 78.67 90.79 0.06 Allowed 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.594 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.9 t -96.36 8.58 43.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.225 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 p -85.91 -175.36 5.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.282 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.5 m -71.34 -18.09 62.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.797 0.332 . . . . 0.0 111.533 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.524 ' O ' ' HG2' ' A' ' 158' ' ' GLN . 18.2 m -59.44 -32.89 70.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.94 71.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.9 p -85.31 41.46 0.89 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.807 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 62.61 14.96 7.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.565 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.5 t -71.45 -24.38 62.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.089 0.471 . . . . 0.0 109.807 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.524 ' HG2' ' O ' ' A' ' 153' ' ' SER . 8.4 pt20 -71.44 -62.22 1.49 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.095 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.508 ' H ' ' HG3' ' A' ' 158' ' ' GLN . . . 53.94 23.11 3.73 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.211 0.604 . . . . 0.0 111.962 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 9.2 t 56.57 79.54 0.18 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.253 -177.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.52 134.34 55.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.388 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.9 m -83.42 44.35 0.95 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.0 m -65.57 -21.46 66.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.223 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.1 m -62.97 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.4 m -79.46 -19.41 49.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.016 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 179.75 116.79 0.52 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.711 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.13 150.05 32.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.646 0.26 . . . . 0.0 110.513 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.24 -61.1 1.5 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.456 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.13 107.08 9.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.554 ' HA ' ' CD ' ' A' ' 175' ' ' PRO . 14.6 t -110.76 164.06 13.14 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.134 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.82 -162.92 29.89 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.009 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.31 115.82 3.54 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.027 2.485 . . . . 0.0 111.772 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.6 t 69.0 20.53 7.75 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.32 -116.58 0.7 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.554 ' CD ' ' HA ' ' A' ' 170' ' ' THR . 31.9 Cg_exo -63.47 155.26 63.52 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.196 1.931 . . . . 0.0 110.853 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 60.95 2.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.246 0.546 . . . . 0.0 111.241 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.3 t -103.9 149.19 25.32 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.66 70.26 1.25 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.309 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.436 ' C ' ' H ' ' A' ' 181' ' ' GLY . 19.3 Cg_exo -67.63 155.65 69.23 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.859 2.373 . . . . 0.0 112.747 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.6 m -76.74 28.48 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.418 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.436 ' H ' ' C ' ' A' ' 179' ' ' PRO . . . -84.46 84.84 1.57 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.164 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.448 ' O ' ' HD2' ' A' ' 185' ' ' PRO . 95.3 m-85 68.39 91.0 0.08 OUTLIER Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 123.215 0.606 . . . . 0.0 110.875 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.69 124.72 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.059 1.84 . . . . 0.0 111.496 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 154.65 -63.9 0.34 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.412 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.448 ' HD2' ' O ' ' A' ' 182' ' ' TYR . 38.2 Cg_endo -65.18 173.09 6.55 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.531 2.154 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 73.0 mt -83.09 81.41 8.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.95 0.405 . . . . 0.0 111.289 -177.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.44 123.15 11.5 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.022 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 64.89 22.35 68.4 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.169 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.18 -35.48 4.43 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 67.28 155.36 0.14 Allowed Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 123.766 0.826 . . . . 0.0 111.958 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.26 106.03 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.283 1.989 . . . . 0.0 111.587 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 68.21 -72.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.497 0.719 . . . . 0.0 111.554 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.98 112.16 0.27 Allowed Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.052 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -65.17 140.26 58.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 73.7 m -83.73 59.83 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.47 44.8 Favored Glycine 0 CA--C 1.502 -0.759 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.631 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -75.39 -38.41 59.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -164.85 25.87 0.18 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.842 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.08 0 CA-C-O 117.949 -1.473 . . . . 0.0 110.938 -179.753 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.653 0.263 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.69 -84.13 0.12 Allowed Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.89 100.09 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.414 2.076 . . . . 0.0 111.088 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.86 153.95 18.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.15 98.0 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.639 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.27 -15.7 20.32 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -139.51 76.46 1.57 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.15 92.4 1.56 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.831 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -174.44 2.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.5 0.19 . . . . 0.0 110.943 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.423 ' H ' HD11 ' A' ' 113' ' ' LEU . 61.7 p 62.48 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.9 1.28 . . . . 0.0 112.901 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.56 153.54 24.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.179 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.77 -50.9 58.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.59 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.91 87.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.507 ' O ' HG23 ' A' ' 18' ' ' ILE . 67.4 m -62.78 -24.62 67.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.67 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.91 -33.03 10.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.493 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 3.4 pp -84.48 -19.26 33.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.507 HG23 ' O ' ' A' ' 14' ' ' SER . 18.3 pt -30.77 -56.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.443 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.3 m -84.53 -20.04 32.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -86.29 -44.58 12.0 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.503 HG12 ' HB3' ' A' ' 100' ' ' LEU . 15.9 t -59.02 -97.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -171.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.26 -48.62 13.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -65.45 -25.11 67.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -67.85 -39.62 83.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.353 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -71.92 -33.7 68.47 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.922 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.64 69.19 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.892 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.491 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 3.1 t-20 64.49 8.58 4.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.736 0.814 . . . . 0.0 112.031 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.9 m -72.43 172.83 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.649 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.1 m -63.24 -15.68 57.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.688 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -54.5 -22.52 13.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.026 0.93 . . . . 0.0 113.433 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -120.53 -21.86 6.63 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.209 0.528 . . . . 0.0 110.393 178.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -79.66 -37.69 35.36 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -164.58 -26.12 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 87.7 t -99.76 141.23 17.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.72 163.18 5.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.495 ' HG2' ' HB2' ' A' ' 87' ' ' ALA . 4.3 ptm180 -69.42 141.84 53.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.447 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -68.46 124.6 24.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.88 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.409 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 85.08 29.78 27.4 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.587 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.78 145.74 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 20.4 t -104.65 166.33 10.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 112.024 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.479 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 51.5 tt0 -73.23 -14.93 61.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.189 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.37 -48.79 65.37 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.542 HD12 ' N ' ' A' ' 44' ' ' ALA . 0.0 OUTLIER -85.72 -47.79 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.12 175.154 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.542 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -58.08 -32.02 67.65 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m 72.18 -38.84 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -71.09 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.61 -19.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.1 t -62.34 82.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 116.905 -0.134 . . . . 0.0 111.321 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.522 ' O ' ' HA ' ' A' ' 40' ' ' SER . 47.8 mm-40 -63.58 -43.95 95.49 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.154 0.502 . . . . 0.0 110.35 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.659 ' CZ ' HD21 ' A' ' 55' ' ' LEU . 20.0 ttm180 -157.25 0.47 0.12 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.48 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.98 -53.18 0.46 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.402 0.681 . . . . 0.0 110.756 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.32 133.98 55.85 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.956 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.471 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.2 mp0 -59.21 -18.17 34.31 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.372 0.669 . . . . 0.0 112.759 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.8 t -55.89 -68.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.659 HD21 ' CZ ' ' A' ' 50' ' ' ARG . 4.0 tp -87.74 -30.1 20.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.243 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.487 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -65.61 -18.7 65.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.471 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 18.1 t -64.56 83.71 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -136.29 -37.24 0.71 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.024 -178.43 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.2 pp -123.2 13.48 9.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.314 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.34 49.08 2.08 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.084 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.26 118.56 34.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.513 0.197 . . . . 0.0 110.86 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.94 21.64 1.6 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.977 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.42 -31.4 6.0 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.986 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.519 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 13.9 p-10 -52.47 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.997 0.919 . . . . 0.0 111.786 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.519 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 2.9 p-10 -86.97 26.16 1.2 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.971 0.415 . . . . 0.0 110.243 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.436 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 5.6 tt -88.02 -78.19 0.33 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.177 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.93 74.71 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.66 160.76 16.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . 0.427 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 98.1 m-85 69.53 -62.62 0.41 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.016 0.527 . . . . 0.0 111.787 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.477 ' HB1' ' O ' ' A' ' 65' ' ' ASN . . . -62.65 -62.64 1.6 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -63.59 -38.81 83.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.671 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.486 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 21.1 mt-30 -63.46 -32.32 73.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.921 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.54 -40.94 22.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.686 0.279 . . . . 0.0 111.614 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.2 -35.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.185 0.516 . . . . 0.0 111.094 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -78.11 -4.89 49.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.282 0.563 . . . . 0.0 110.25 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.486 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 47.5 ttp180 -90.0 -6.77 55.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.592 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.88 140.68 89.97 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.859 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -52.34 128.5 27.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.789 2.326 . . . . 0.0 111.616 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.04 84.79 2.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.644 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.68 -55.43 5.44 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -87.17 -53.74 4.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 178.68 174.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.569 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 m -81.2 -47.69 13.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -64.85 -16.44 63.16 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.34 11.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.611 ' HD1' ' N ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -58.61 -46.24 87.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.611 ' N ' ' HD1' ' A' ' 86' ' ' TYR . . . -88.14 -17.87 30.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.894 0.378 . . . . 0.0 111.397 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.58 -45.44 90.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.337 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.45 -62.51 1.63 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.271 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.583 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 61.4 m-85 -84.27 32.94 0.49 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.801 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 p -54.82 -61.5 2.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -68.59 -38.37 80.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . 0.441 ' O ' HD22 ' A' ' 117' ' ' LEU . . . -64.69 -39.86 94.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 36.5 mt -83.77 -34.33 24.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -76.22 -47.04 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.335 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.505 ' ND2' HG12 ' A' ' 105' ' ' ILE . 37.9 t-20 57.21 92.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.983 0.802 . . . . 0.0 111.119 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.41 -2.15 48.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.6 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.03 -13.47 31.62 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.733 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.471 ' HA ' ' O ' ' A' ' 196' ' ' GLY . 12.0 t -80.46 -8.95 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.64 0.734 . . . . 0.0 109.921 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.503 ' HB3' HG12 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -84.4 -179.23 7.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.257 -176.284 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.475 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -77.26 113.83 15.43 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.549 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.39 64.27 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.717 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -41.32 77.86 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.475 ' HB3' ' ND2' ' A' ' 101' ' ' ASN . 2.1 t30 -62.14 -33.23 74.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.715 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.505 HG12 ' ND2' ' A' ' 96' ' ' ASN . 1.5 mp -78.15 -43.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.541 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.57 -19.02 56.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.459 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -84.31 -55.48 4.15 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.015 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.406 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 3.3 pp -123.47 -32.57 3.36 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -50.33 -75.21 0.22 Allowed Glycine 0 C--O 1.223 -0.541 0 C-N-CA 121.596 -0.335 . . . . 0.0 113.772 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.5 m -62.4 -18.37 61.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.796 0.331 . . . . 0.0 111.841 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -81.0 -54.27 5.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.447 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.02 -40.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.994 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 3.3 mm? -70.08 -16.68 63.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.6 p 45.44 -118.24 0.71 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.918 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.8 69.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 120' ' ' VAL . 11.6 tp -59.38 -62.88 1.55 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.519 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 93' ' ' ALA . 15.8 mt -71.9 -29.99 64.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.564 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -61.19 -40.23 93.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.284 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.92 -32.63 56.6 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.661 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.548 HG23 ' O ' ' A' ' 116' ' ' LEU . 54.2 t -68.51 -35.99 72.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.651 -0.323 . . . . 0.0 110.962 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.48 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 59.0 m -53.03 -47.36 68.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.1 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 p -80.85 -43.25 20.25 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.79 -72.51 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.426 ' HB3' HG11 ' A' ' 120' ' ' VAL . . . -71.24 -50.43 32.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HB3' ' O ' ' A' ' 121' ' ' SER . 45.4 tt0 -64.62 -35.87 82.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.054 0.454 . . . . 0.0 110.769 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.21 -53.37 3.14 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.9 -0.667 . . . . 0.0 114.618 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.5 mt -105.48 -24.12 12.68 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.9 94.5 0.73 Allowed Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.879 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.539 HG13 ' HD3' ' A' ' 50' ' ' ARG . 30.1 mm -77.87 141.12 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.253 0.549 . . . . 0.0 112.429 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -123.23 152.13 41.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.73 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 132' ' ' ASP . 46.3 t -107.88 163.31 5.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.417 ' N ' HG13 ' A' ' 131' ' ' VAL . 35.8 t70 -58.8 160.05 6.19 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 15.4 m -74.64 29.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . 0.407 ' H ' ' C ' ' A' ' 132' ' ' ASP . . . -72.11 -87.17 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -106.23 -48.47 3.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.818 0.342 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.477 ' O ' HG12 ' A' ' 140' ' ' ILE . 45.1 t -52.15 -63.16 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -172.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.6 tt0 -62.59 -41.21 98.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -60.1 -44.0 95.17 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.083 0.468 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.87 -51.99 14.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.924 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.477 HG12 ' O ' ' A' ' 136' ' ' VAL . 34.4 pt -62.01 -34.47 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -64.74 -47.8 76.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 0.0 110.752 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -34.93 71.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.362 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.4 t -67.88 -56.59 8.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.875 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.5 p -51.16 -30.3 16.36 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.2 m -62.14 -56.38 19.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -89.0 -40.66 12.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 111.891 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 4.3 mm? -74.0 9.88 1.39 Allowed 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.62 0.768 . . . . 0.0 112.885 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.0 t -46.62 -46.93 20.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.358 0.599 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.487 ' HB ' ' NE2' ' A' ' 158' ' ' GLN . 7.4 m -161.01 81.71 0.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.8 t -84.75 121.94 28.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.115 0.484 . . . . 0.0 111.175 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -172.53 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.007 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.9 p -137.96 -150.59 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -62.15 101.53 0.23 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.66 89.1 0.72 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.659 0.743 . . . . 0.0 111.486 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -173.98 -160.57 0.11 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.61 -1.177 . . . . 0.0 107.945 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -66.15 -19.93 65.99 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 t -56.37 -41.19 75.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.065 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.487 ' NE2' ' HB ' ' A' ' 149' ' ' THR . 12.7 pt20 -96.92 9.26 42.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 111.166 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.38 139.43 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.653 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.4 m 60.29 22.64 12.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.319 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.54 ' HB2' ' O ' ' A' ' 176' ' ' SER . . . -73.52 111.37 8.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.082 0.468 . . . . 0.0 110.328 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.4 m -110.47 169.63 8.62 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.433 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -74.58 -1.02 19.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.843 0.354 . . . . 0.0 111.379 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.1 m -60.78 -25.1 66.29 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.595 0.758 . . . . 0.0 111.402 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.1 m -72.46 -7.3 49.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.931 0.396 . . . . 0.0 110.852 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.8 60.19 0.66 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.626 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -123.03 105.09 9.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.84 0.352 . . . . 0.0 111.045 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -94.87 -20.07 29.62 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.61 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 53.1 t80 -87.43 95.17 9.92 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.4 p -124.8 172.03 9.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.829 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 142.48 -162.0 27.32 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.64 -19.08 60.01 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.766 2.311 . . . . 0.0 111.377 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.5 p -144.2 84.13 1.75 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.256 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -139.63 -113.76 1.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.61 ' HD3' ' O ' ' A' ' 169' ' ' TYR . 88.0 Cg_endo -81.2 172.69 12.53 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.313 2.009 . . . . 0.0 111.171 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.54 ' O ' ' HB2' ' A' ' 161' ' ' ALA . 40.1 p -81.05 86.45 6.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.3 t -119.0 156.94 28.73 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.33 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.503 ' N ' ' HD3' ' A' ' 179' ' ' PRO . . . 63.24 56.73 18.55 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.014 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.503 ' HD3' ' N ' ' A' ' 178' ' ' GLY . 5.6 Cg_exo -77.9 105.4 2.01 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.556 2.171 . . . . 0.0 112.259 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.6 m -74.89 135.02 41.53 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.901 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 142.4 -23.73 2.36 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.816 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -129.71 162.9 50.47 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 122.605 -0.35 . . . . 0.0 111.082 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.59 125.77 20.11 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.082 2.521 . . . . 0.0 112.464 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.94 61.9 2.94 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.302 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.08 -18.09 56.04 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 111.986 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.36 82.07 5.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.058 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -136.72 149.15 20.07 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.777 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 87.57 -93.29 1.87 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.742 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -138.1 121.74 2.28 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -140.42 158.79 65.5 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.99 146.47 16.91 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.878 2.385 . . . . 0.0 112.349 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -91.02 21.91 3.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.813 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -128.88 59.77 0.68 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -102.75 147.33 26.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -149.95 7.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.471 ' O ' ' HA ' ' A' ' 99' ' ' VAL . . . -175.33 72.88 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -110.61 143.14 41.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.948 0.404 . . . . 0.0 111.09 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.79 77.98 2.05 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.791 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.201 0 CA-C-O 118.417 -1.213 . . . . 0.0 111.934 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.96 153.77 21.41 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.745 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.02 130.69 9.55 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.541 2.161 . . . . 0.0 110.921 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.91 94.23 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.993 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.28 -75.99 0.63 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.698 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.17 28.18 1.97 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -123.56 105.35 9.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.886 0.374 . . . . 0.0 111.732 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.4 81.53 0.76 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.46 ' HB1' ' HG3' ' A' ' 42' ' ' GLN . . . -72.73 93.9 1.71 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.38 138.03 10.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.617 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.59 96.89 2.25 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.896 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.1 -51.45 50.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.824 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.28 -10.98 60.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.796 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.467 ' O ' HG23 ' A' ' 18' ' ' ILE . 20.3 m -78.55 -22.18 47.63 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.552 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -55.43 -30.44 60.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.15 -38.93 24.8 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.432 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.62 ' O ' HG21 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -32.29 22.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.467 HG23 ' O ' ' A' ' 14' ' ' SER . 19.9 pt -47.79 -47.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.588 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 11.7 m -70.83 -24.58 62.56 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.68 0.276 . . . . 0.0 111.599 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -87.56 -24.37 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.882 0.372 . . . . 0.0 111.576 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.62 HG21 ' O ' ' A' ' 17' ' ' LEU . 84.3 t -59.92 173.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.51 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.437 ' H ' ' CG1' ' A' ' 21' ' ' VAL . . . -37.45 -33.51 0.07 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.753 1.221 . . . . 0.0 114.189 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.19 -23.0 61.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.588 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -61.58 -38.17 86.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.9 -41.95 12.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.504 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.31 69.54 7.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.42 ' HB3' ' CG ' ' A' ' 146' ' ' PHE . 2.8 t-20 -68.41 19.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.4 1.08 . . . . 0.0 112.39 -175.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.504 ' H ' ' C ' ' A' ' 26' ' ' ALA . 24.2 m -55.98 161.52 2.27 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 123.556 0.743 . . . . 0.0 111.482 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.404 ' N ' HG23 ' A' ' 28' ' ' THR . 20.2 m -52.69 -19.51 2.45 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 p -51.79 -44.83 63.6 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.895 . . . . 0.0 113.253 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -100.09 -20.23 16.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.375 0.607 . . . . 0.0 110.166 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -66.72 -56.14 11.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.301 -175.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -163.85 -34.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.859 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.62 146.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.89 139.86 57.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.105 0.478 . . . . 0.0 110.849 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.418 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 48.7 ptt85 -63.57 157.37 23.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.166 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.03 112.21 4.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.894 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.435 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.71 35.72 7.16 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.687 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.9 p -45.12 143.6 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.44 0.696 . . . . 0.0 112.415 -179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.2 p -82.13 139.81 34.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.077 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -59.55 -14.12 11.91 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.44 179.721 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.46 ' HG3' ' HB1' ' A' ' 9' ' ' ALA . 72.7 mm-40 -65.04 -32.02 73.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.746 0.307 . . . . 0.0 111.216 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.01 -34.08 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -84.0 -76.94 0.28 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.567 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m 75.21 -18.92 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.838 0.855 . . . . 0.0 111.629 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.442 ' H ' ' C ' ' A' ' 44' ' ' ALA . 16.8 p -68.04 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.296 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.56 -32.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.488 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.5 p -79.15 89.43 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 121.931 0.872 . . . . 0.0 110.795 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 10.9 mm100 -82.53 -43.49 17.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.021 -179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -133.88 -4.82 2.81 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.497 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.61 -50.12 0.66 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.305 0.642 . . . . 0.0 112.722 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.42 -90.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 2.6 pt20 -172.74 -45.15 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -50.31 -62.11 1.78 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 tt -86.06 -23.64 26.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.415 0.626 . . . . 0.0 110.138 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.98 -17.92 58.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 p -62.72 65.33 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.528 0.68 . . . . 0.0 112.724 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.444 HG22 ' HG ' ' A' ' 59' ' ' LEU . 9.9 t -102.5 -37.32 8.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.444 ' HG ' HG22 ' A' ' 58' ' ' THR . 81.2 mt -121.76 19.16 11.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 65.33 1.57 Allowed Glycine 0 C--O 1.217 -0.968 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.24 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.558 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.9 t -90.07 110.17 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.98 0.419 . . . . 0.0 109.979 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -141.77 18.0 2.16 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.41 -34.71 4.3 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.09 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.3 -70.53 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 110.375 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.558 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 26.7 p-10 -86.04 18.88 2.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.454 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.421 ' O ' ' HB2' ' A' ' 70' ' ' ALA . 6.7 tt -88.14 -74.41 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.529 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.41 -27.25 66.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -111.71 162.88 14.75 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 66.82 -61.74 0.32 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.488 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.85 -61.54 2.11 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.761 0.315 . . . . 0.0 110.73 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.76 -35.77 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -69.88 -21.37 63.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.446 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -42.85 29.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.83 0.348 . . . . 0.0 110.152 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.46 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 27.3 t -78.23 -33.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -70.97 -18.11 62.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.275 0.56 . . . . 0.0 110.431 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -116.58 18.95 14.86 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.182 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.46 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . 10.7 tp -82.24 140.0 45.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.278 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.21 127.74 22.99 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.427 2.084 . . . . 0.0 111.244 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.23 20.81 6.56 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.271 0.558 . . . . 0.0 111.106 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.87 -22.31 79.17 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.636 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 m -72.3 -15.48 61.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.5 t70 75.69 141.79 0.07 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.898 0.879 . . . . 0.0 111.598 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 p -61.33 -33.72 74.08 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.5 t -70.37 -18.49 63.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.334 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.84 -21.71 26.24 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 -71.98 -174.16 1.17 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.251 177.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.01 12.84 0.78 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.405 ' H ' ' C ' ' A' ' 86' ' ' TYR . 4.1 mp0 -74.55 -59.86 2.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.95 71.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.086 0.47 . . . . 0.0 110.827 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.45 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 93.0 m-85 -83.24 12.38 5.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.522 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.418 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 47.8 t -51.19 -43.27 61.31 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.524 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.9 m -58.16 -44.64 88.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.69 30.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.781 0.324 . . . . 0.0 111.803 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 68.2 mt -81.59 -32.16 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -84.97 -34.72 22.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.447 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 49.05 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.979 0.8 . . . . 0.0 111.093 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.72 -6.34 51.77 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.598 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.16 -2.85 87.27 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.833 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.417 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 32.8 t -92.71 -13.33 8.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.646 0.736 . . . . 0.0 109.818 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.494 ' HB3' ' CG1' ' A' ' 21' ' ' VAL . 2.6 pt? -91.29 -176.08 4.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.594 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 31.9 t30 -84.54 105.17 15.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.76 -16.93 64.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.176 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -81.34 -19.76 42.12 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.465 ' ND2' HD11 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.97 -26.52 64.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.141 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.465 HD11 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -69.67 -33.17 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.564 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -77.48 -27.18 51.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.109 0.48 . . . . 0.0 109.959 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.59 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 89.9 m -78.54 -46.65 18.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.838 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.449 HD11 ' OG ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -133.51 -40.99 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.439 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -48.5 -71.88 0.52 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' SER . 10.3 t -67.32 -14.05 62.56 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.097 0.475 . . . . 0.0 111.494 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.59 ' HD3' ' O ' ' A' ' 107' ' ' THR . 80.4 mtp180 -87.19 -49.51 7.23 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.4 -42.81 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.258 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.486 HD21 HD22 ' A' ' 116' ' ' LEU . 6.0 mp -80.09 -29.46 39.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 110' ' ' SER . 19.5 m 47.72 -99.09 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.473 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.22 -36.79 63.89 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.486 HD22 HD21 ' A' ' 113' ' ' LEU . 55.5 tp -62.47 -57.08 12.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.601 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' O ' ' HB2' ' A' ' 121' ' ' SER . 25.9 mt -71.47 -23.78 61.88 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.165 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.12 -34.11 76.9 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.19 -43.22 6.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.455 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 56.0 t -62.42 -28.99 45.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 122.358 0.263 . . . . 0.0 111.11 179.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.453 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 9.3 t -57.35 -40.51 78.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.267 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' SER . . . . . 0.461 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 23.7 m -85.57 -28.83 24.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.0 -83.82 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -70.17 -47.49 61.37 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 -176.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 42.9 tt0 -75.71 -17.57 59.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.326 0.584 . . . . 0.0 109.793 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.461 ' HA3' ' O ' ' A' ' 122' ' ' SER . . . -85.13 -64.06 1.55 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.207 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -127.69 -4.93 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.37 119.43 1.32 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.593 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.46 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.967 0.413 . . . . 0.0 111.261 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -101.02 152.19 20.89 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.28 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.435 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -116.61 -149.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -85.44 147.44 26.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.491 0.663 . . . . 0.0 110.871 -176.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 p -80.53 15.38 1.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.301 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.05 -64.43 0.48 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.499 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.6 m -85.25 -49.86 7.84 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.45 ' O ' HG12 ' A' ' 140' ' ' ILE . 99.5 t -72.23 -51.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.82 -48.25 73.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 p -58.79 -41.78 87.49 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.831 0.348 . . . . 0.0 111.86 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -50.4 16.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.996 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.45 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.3 pt -65.27 -31.73 55.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -61.41 -43.94 97.99 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.2 p -86.52 -40.57 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.475 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 22.8 t -78.09 -18.36 55.83 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.6 p -57.32 -18.14 15.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 p -45.87 -30.62 1.78 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.42 ' CG ' ' HB3' ' A' ' 27' ' ' ASN . 94.7 m-85 -62.1 -17.16 56.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.64 -11.71 5.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 111.205 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -63.85 -37.91 89.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.7 p -80.46 -8.81 59.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.889 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -73.77 -6.07 44.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.675 0.75 . . . . 0.0 109.052 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.3 m -148.34 -147.24 0.22 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.2 m -56.34 111.58 1.01 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.239 0.472 . . . . 0.0 110.03 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -38.67 -59.73 0.9 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.413 1.085 . . . . 0.0 113.728 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -167.78 -148.82 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.6 m -51.95 -41.1 61.81 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.237 0.541 . . . . 0.0 110.229 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -92.09 126.02 37.0 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.1 m -74.86 70.06 1.91 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.831 0.348 . . . . 0.0 111.208 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 44.19 26.06 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.91 1.284 . . . . 0.0 114.074 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.09 -10.14 59.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.547 0.689 . . . . 0.0 109.924 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 p -84.38 -8.92 58.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.444 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -124.52 89.06 3.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.187 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.3 t -88.4 94.57 9.89 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.318 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.1 p -79.64 -20.95 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.5 t -70.3 -20.5 63.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.21 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.9 t -95.89 6.93 47.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.875 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.03 103.13 1.72 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.28 -28.47 16.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.93 0.395 . . . . 0.0 110.529 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.29 -64.32 0.69 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.462 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -102.18 -66.0 0.95 Allowed 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.739 -0.271 . . . . 0.0 111.031 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.407 HG23 ' N ' ' A' ' 171' ' ' GLY . 22.1 m 72.22 159.56 0.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.625 0.578 . . . . 0.0 110.961 -178.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.407 ' N ' HG23 ' A' ' 170' ' ' THR . . . 72.44 -135.66 22.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.352 -0.451 . . . . 0.0 113.401 176.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.38 -8.56 22.45 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.276 2.651 . . . . 0.0 112.973 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.4 p -123.13 12.23 9.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.224 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.56 -164.87 10.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.65 174.91 12.07 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.953 2.435 . . . . 0.0 112.301 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.5 p -76.68 86.36 3.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.351 0.596 . . . . 0.0 110.393 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.0 t -140.76 162.16 36.07 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.262 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.403 ' HA2' ' O ' ' A' ' 186' ' ' LEU . . . 110.22 -114.76 3.92 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.172 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.03 -13.7 41.21 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.671 2.247 . . . . 0.0 112.596 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.4 m -62.57 -31.82 72.69 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.27 146.78 18.33 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.486 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 87.7 m-85 -85.21 -53.33 0.46 Allowed Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 182' ' ' TYR . 16.9 Cg_exo -68.32 123.07 10.14 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.412 1.408 . . . . 0.0 110.299 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.12 2.38 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.78 158.59 37.02 Favored 'Trans proline' 0 CA--C 1.505 -0.973 0 C-N-CA 122.218 1.945 . . . . 0.0 111.261 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.413 ' HB3' ' CB ' ' A' ' 190' ' ' ALA . 88.6 mt 67.46 -140.36 0.12 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.735 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 170.45 -154.98 24.13 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.615 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.35 3.37 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.183 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.44 57.21 5.03 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.413 ' CB ' ' HB3' ' A' ' 186' ' ' LEU . . . -77.54 130.92 72.57 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.56 134.76 59.32 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.707 2.272 . . . . 0.0 111.468 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.89 52.76 1.28 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.421 0.629 . . . . 0.0 110.69 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 101' ' ' ASN . . . -128.4 -118.48 2.11 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.128 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 50.4 89.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.594 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 45.4 m -111.16 23.88 13.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 130.36 57.83 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.353 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -147.58 -64.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 0.0 110.162 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -96.1 98.17 2.17 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.375 0 CA-C-O 118.471 -1.183 . . . . 0.0 111.254 -179.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 121.059 0.456 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.7 -155.52 16.16 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.17 136.47 64.95 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.309 2.006 . . . . 0.0 111.784 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -89.23 150.97 22.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.3 81.62 0.58 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -28.46 2.48 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -130.82 84.47 2.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.35 87.48 0.91 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.417 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.17 156.19 7.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.127 0.171 . . . . 0.0 110.864 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.41 ' H ' ' HG ' ' A' ' 113' ' ' LEU . 28.5 p 61.9 130.37 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.495 1.118 . . . . 0.0 112.305 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.2 167.65 13.81 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.649 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 -44.38 76.02 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.056 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.59 77.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.556 ' O ' HG21 ' A' ' 18' ' ' ILE . 15.3 p -76.21 -27.99 57.04 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.291 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.99 -23.02 52.21 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.01 -41.8 6.17 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.511 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.606 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.5 pp -84.41 -22.64 30.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.633 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 5.1 pt -40.22 -55.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 t -85.06 -19.71 31.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.712 0.291 . . . . 0.0 111.632 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -83.14 -27.42 30.13 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.606 HG21 ' O ' ' A' ' 17' ' ' LEU . 23.8 t -71.28 -100.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.99 35.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' HD22 ' A' ' 31' ' ' LEU . 4.4 m-80 -70.91 -24.56 62.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -174.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.7 87.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.167 0.508 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.428 HD23 ' O ' ' A' ' 25' ' ' LEU . 6.0 tt -75.91 -40.21 54.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.05 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.73 90.41 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.741 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 53.77 16.97 1.14 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.793 0.837 . . . . 0.0 111.794 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.44 HG21 ' N ' ' A' ' 29' ' ' SER . 19.7 m -75.66 165.59 24.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.27 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.44 ' N ' HG21 ' A' ' 28' ' ' THR . 16.3 m -60.08 -17.63 41.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.819 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -53.48 -31.26 44.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.687 0.795 . . . . 0.0 112.73 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.501 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -110.08 -20.28 12.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.525 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 15.5 ttm180 -79.87 -38.61 32.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.878 -175.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -174.64 -26.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.08 139.64 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.42 145.37 22.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -63.12 155.25 28.5 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 m -71.22 114.45 9.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.262 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 40.13 9.19 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.762 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.86 151.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.203 0.525 . . . . 0.0 111.605 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -91.31 159.51 15.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.599 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.0 pt20 -67.42 -13.37 61.96 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.285 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.4 mm-40 -55.62 -47.78 76.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.043 -179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.94 -29.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.784 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.411 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -82.32 -55.36 4.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.118 -176.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 m 75.53 -18.9 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.866 0.866 . . . . 0.0 111.821 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.411 ' H ' ' C ' ' A' ' 44' ' ' ALA . 28.4 p -68.43 -88.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -145.01 -27.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.947 0.403 . . . . 0.0 111.814 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.62 98.21 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.342 0.591 . . . . 0.0 111.824 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 31.2 mt-30 -82.54 -48.27 11.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.351 177.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.713 ' NH1' ' HA ' ' A' ' 123' ' ' ALA . 54.7 ttt180 -134.31 -3.14 2.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.879 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.07 -58.26 0.54 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.354 0.662 . . . . 0.0 110.306 -174.695 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.43 137.61 57.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.274 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.602 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -50.29 -24.38 2.89 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -50.93 -74.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.465 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 47.5 tp -87.94 -24.53 23.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.514 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.85 59.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.602 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 14.3 t -58.67 84.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 111.65 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.4 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.7 t -123.3 -35.99 2.88 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.73 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 58' ' ' THR . 84.0 mt -120.82 18.57 11.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.948 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.43 59.69 2.35 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.391 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.692 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 33.0 t -89.43 103.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 120.929 0.395 . . . . 0.0 110.834 -177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -169.2 96.77 0.34 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.502 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.77 -63.87 4.18 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.21 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.55 -75.52 0.05 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.914 0.486 . . . . 0.0 111.664 -175.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.692 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.5 p-10 -85.8 15.16 5.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.26 -56.1 3.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.442 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.01 46.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.246 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -121.24 161.09 22.54 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 66.95 -63.11 0.28 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.89 -31.24 52.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 110.349 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -68.61 -29.5 68.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.65 65.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.122 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -77.5 -38.92 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.7 t -66.37 -21.92 66.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -113.32 15.44 19.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.431 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.9 tp -80.31 119.22 75.77 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.661 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 27.5 Cg_exo -63.27 128.73 23.44 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.56 83.51 7.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.102 0.477 . . . . 0.0 110.377 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.29 -35.9 56.21 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.16 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.3 p -88.56 -62.59 1.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.747 0.308 . . . . 0.0 110.479 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 176.03 159.65 0.29 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -69.5 -30.8 68.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.969 0.414 . . . . 0.0 110.356 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -70.04 -18.42 63.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.042 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -21.49 63.77 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.405 ' C ' ' H ' ' A' ' 88' ' ' GLN . 74.9 m-85 -78.44 -174.44 3.79 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.523 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.81 35.6 0.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.235 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 85.6 mm-40 -74.43 -60.39 2.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.331 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.633 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -78.67 -32.67 47.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.409 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.42 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 56.6 m-85 -80.68 9.03 6.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.055 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 p -52.15 -56.53 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 11.7 t -61.53 -36.04 79.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -74.61 -36.54 62.95 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.39 -177.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 50.1 mt -83.62 -20.68 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.164 0.507 . . . . 0.0 111.163 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . 0.474 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 78.9 t80 -85.13 -25.27 27.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m120 48.57 65.59 1.3 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.972 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.92 64.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.098 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.13 -15.45 61.0 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.113 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 197' ' ' PHE . 12.5 p -84.17 -12.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.98 0.895 . . . . 0.0 109.02 177.241 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.522 ' HB3' HG13 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -83.6 175.29 9.85 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 -178.025 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.5 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 39.1 t30 -72.17 109.51 5.99 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.833 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.53 -24.43 63.74 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.865 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.1 m -69.46 -26.88 64.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.527 0.68 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -64.62 -46.56 82.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.606 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.68 -36.95 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.019 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.59 -39.06 92.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 176.535 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.407 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 93.4 m -74.87 -62.89 1.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.493 HD23 ' OD1' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -113.21 -33.22 6.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.9 -56.87 14.3 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.188 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.9 t -69.49 -26.44 64.56 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.764 0.316 . . . . 0.0 111.573 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.407 ' HD3' ' O ' ' A' ' 107' ' ' THR . 3.6 mpt_? -83.09 -47.39 11.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.24 -50.08 15.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 9.0 mp -67.87 -41.27 83.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.925 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.7 t 46.72 -95.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.761 0.824 . . . . 0.0 113.104 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.8 66.0 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.092 0.557 . . . . 0.0 112.121 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.494 ' O ' HG23 ' A' ' 120' ' ' VAL . 35.2 tp -65.93 -48.22 72.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.524 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 17.0 mt -70.75 -23.49 62.44 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.718 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -58.46 -34.78 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.55 -41.42 6.88 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.555 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 116' ' ' LEU . 76.4 t -61.18 -32.55 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.8 m -54.43 -45.67 73.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -84.33 -23.9 30.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.827 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.713 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.17 -84.96 0.14 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 95' ' ' PHE . . . -76.51 -45.91 28.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.835 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -72.52 -20.38 61.36 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.089 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.73 -70.96 1.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.62 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.69 -9.07 5.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.653 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.63 120.78 3.12 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.895 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 mt -85.27 146.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.051 0.453 . . . . 0.0 111.863 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.52 149.37 42.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.2 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 20.7 t -120.89 161.72 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -59.72 156.22 14.31 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.261 0.553 . . . . 0.0 111.74 -178.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.566 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 14.5 m -78.97 20.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.477 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.84 -77.97 0.35 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.183 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.9 m -107.83 -31.15 8.14 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.409 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.8 t -86.58 -64.46 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.566 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.2 tt0 -67.59 -23.0 65.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.358 . . . . 0.0 111.96 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -68.85 -44.97 72.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.065 0.46 . . . . 0.0 111.084 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.48 -50.23 14.54 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.511 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.453 HG12 ' HA ' ' A' ' 137' ' ' GLN . 44.9 pt -58.79 -40.47 79.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -36.95 70.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.755 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.1 t -84.42 -45.53 12.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.0 110.568 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.42 ' HA ' HD23 ' A' ' 147' ' ' LEU . 45.6 t -59.14 -45.41 91.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.905 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.1 m -65.52 -19.93 66.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.5 t -85.72 -49.87 7.62 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -89.09 -60.3 1.99 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.42 HD23 ' HA ' ' A' ' 143' ' ' SER . 3.7 mm? -54.98 -29.91 58.06 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -172.092 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.3 m -54.07 -37.24 63.99 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.7 p -129.84 14.82 5.85 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.159 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.7 m -80.83 142.11 34.01 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.76 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.6 t 68.62 -70.12 0.14 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.586 0.754 . . . . 0.0 109.914 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.8 t -105.12 104.5 14.25 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.455 ' HB2' ' HB2' ' A' ' 158' ' ' GLN . 13.2 m -68.32 165.87 17.7 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.703 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB3' ' O ' ' A' ' 178' ' ' GLY . . . -80.68 -31.52 36.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.821 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.464 ' HA ' ' HB3' ' A' ' 179' ' ' PRO . 15.0 m -51.53 132.78 30.37 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.17 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -54.28 -40.67 68.07 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 p -73.59 -7.47 52.04 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.999 0.428 . . . . 0.0 111.674 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 153' ' ' SER . 75.9 mt-30 -126.55 13.21 7.54 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.089 0.471 . . . . 0.0 110.124 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.17 168.11 14.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.703 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.2 p 52.07 30.35 7.42 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.435 0.694 . . . . 0.0 111.951 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -72.6 -24.89 61.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.18 0.514 . . . . 0.0 110.873 -179.034 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 175' ' ' PRO . 47.0 t -111.59 143.08 43.04 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.4 ' OG ' ' HB1' ' A' ' 167' ' ' ALA . 37.7 p 47.24 46.39 16.63 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.871 0.468 . . . . 0.0 112.195 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.5 m -55.88 110.75 0.78 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.181 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.9 p 55.3 18.83 2.69 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.964 0.905 . . . . 0.0 112.174 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -127.45 4.13 7.16 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.4 ' HB1' ' OG ' ' A' ' 163' ' ' SER . . . -78.77 -56.72 4.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.752 0.311 . . . . 0.0 110.635 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.88 -36.86 2.31 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.474 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -89.83 -49.09 6.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.548 0.213 . . . . 0.0 110.842 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.4 m 63.43 95.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.107 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 117.83 -89.13 0.47 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.555 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.18 -32.17 79.06 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.113 2.542 . . . . 0.0 111.499 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m -150.56 70.67 1.02 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.04 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.77 -157.45 17.07 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.147 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.422 ' HB3' ' O ' ' A' ' 162' ' ' SER . 49.8 Cg_endo -99.99 -178.46 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.359 2.706 . . . . 0.0 112.887 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.7 t -93.1 168.36 11.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.7 t -177.75 12.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.172 0.511 . . . . 0.0 110.62 -176.043 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 154' ' ' ALA . . . -115.53 85.34 0.39 Allowed Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.551 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 14.8 Cg_endo -57.01 121.2 9.65 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.597 2.198 . . . . 0.0 112.916 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.2 m -88.78 105.27 17.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.327 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 130.28 168.0 12.17 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.36 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 69.78 154.88 0.15 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.796 0.838 . . . . 0.0 112.027 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -58.83 126.87 22.44 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.639 2.226 . . . . 0.0 111.222 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.4 65.21 2.93 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.348 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.551 ' O ' ' HG2' ' A' ' 179' ' ' PRO . 22.3 Cg_exo -66.05 -52.56 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.856 2.371 . . . . 0.0 112.514 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.81 107.5 15.47 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.797 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -116.99 -149.89 9.14 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.464 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.85 121.18 21.22 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.982 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 130.88 -35.18 2.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.78 94.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.83 124.02 11.76 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.077 1.852 . . . . 0.0 110.877 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.86 62.85 3.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.659 0.742 . . . . 0.0 110.902 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -121.84 29.37 5.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -119.84 161.23 21.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.331 -0.935 . . . . 0.0 109.75 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 m -89.39 11.66 18.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.974 0.416 . . . . 0.0 111.618 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 120.27 -46.34 1.14 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.755 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' A' ' 99' ' ' VAL . 33.6 t80 59.04 51.47 7.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.887 0.851 . . . . 0.0 108.982 -176.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 110.48 -102.93 1.58 Allowed Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.547 0 CA-C-O 118.516 -1.158 . . . . 0.0 112.282 178.773 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.93 -150.59 34.33 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 140.54 52.42 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.204 1.936 . . . . 0.0 111.175 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -103.39 174.56 5.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.13 -64.43 3.26 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.666 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.05 -26.15 42.01 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.603 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -103.22 108.84 20.2 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.93 0.395 . . . . 0.0 110.277 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.77 155.53 48.31 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.359 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.04 142.47 4.16 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p 46.11 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.13 179.57 42.36 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.542 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.32 -166.38 14.45 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.951 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.21 -1.1 24.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.305 0.574 . . . . 0.0 110.437 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.519 ' O ' HG23 ' A' ' 18' ' ' ILE . 27.5 p -76.5 -25.01 53.78 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.27 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.47 43.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.49 -38.93 6.91 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.53 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -83.77 -25.02 30.84 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.595 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 9.5 pt -45.44 -42.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.529 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 46.2 m -83.12 -19.83 35.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -86.71 -23.84 25.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.556 HG12 ' CB ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -72.14 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.149 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.405 ' H ' HG11 ' A' ' 21' ' ' VAL . . . -51.79 -33.26 34.69 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.439 0.696 . . . . 0.0 112.76 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 10.0 m-80 -65.69 -24.29 66.97 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.529 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -70.95 -42.42 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.23 -16.1 53.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 148' ' ' SER . . . -84.57 -36.99 21.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.477 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 3.1 t-20 51.26 18.25 0.59 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.683 1.193 . . . . 0.0 112.228 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.471 ' O ' HD22 ' A' ' 31' ' ' LEU . 7.1 m -66.26 164.11 16.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.201 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 54.9 m -63.85 -16.3 61.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.832 179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -51.31 -41.04 60.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.762 0.825 . . . . 0.0 112.289 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.565 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -99.84 -19.31 16.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.394 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.5 ttm180 -74.47 -59.58 2.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.199 -176.287 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -162.78 -28.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.82 136.06 24.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.6 138.29 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.81 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -64.07 152.46 40.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.669 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -67.65 111.63 4.32 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.418 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.93 38.37 8.68 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.215 179.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.9 148.29 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.131 0.491 . . . . 0.0 111.105 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -87.86 157.37 19.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.073 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.535 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 18.8 pt20 -63.52 -19.39 64.73 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.302 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -51.5 -46.18 63.12 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 111.458 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.407 HD13 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -84.08 -32.66 8.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.477 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -83.67 -48.91 9.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.8 p 67.48 -18.84 0.13 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.292 1.437 . . . . 0.0 113.095 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.477 ' H ' ' C ' ' A' ' 44' ' ' ALA . 20.8 p -68.38 -75.69 0.1 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.61 -34.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.836 0.351 . . . . 0.0 111.903 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.52 97.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.1 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 72.8 mt-30 -82.84 -51.01 8.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.349 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.539 HH22 ' HB2' ' A' ' 127' ' ' LEU . 41.1 ttt180 -130.69 -5.72 4.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.673 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.417 ' O ' HD11 ' A' ' 66' ' ' LEU . . . 71.08 -55.74 0.64 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.599 -172.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 136.07 54.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.901 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.568 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -51.01 -29.86 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -173.488 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.3 t -46.84 -69.25 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.106 0.412 . . . . 0.0 112.079 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.4 tp -88.6 -24.19 22.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 111.602 179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -79.26 -18.91 51.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.568 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.0 t -48.48 98.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.089 0.471 . . . . 0.0 111.662 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 8.9 t -142.04 -37.72 0.39 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.557 -179.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.92 18.7 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.02 67.63 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.419 HG22 HD22 ' A' ' 65' ' ' ASN . 46.7 t -87.35 110.23 20.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.14 0.495 . . . . 0.0 110.998 -175.231 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -158.94 20.92 0.2 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.991 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 123.48 -37.75 2.65 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.814 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.28 -74.47 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.552 0.176 . . . . 0.0 110.928 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.419 HD22 HG22 ' A' ' 61' ' ' VAL . 2.5 p-10 -85.48 9.69 15.07 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.433 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 19.5 tp -87.97 -56.6 3.27 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.963 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 -35.52 40.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.508 0.671 . . . . 0.0 109.899 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.81 162.87 12.94 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 68.89 -61.68 0.41 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.65 -62.16 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.817 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -40.34 86.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.125 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.38 -44.6 95.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.722 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.51 74.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.02 -38.18 78.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -74.79 -21.78 59.12 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.979 0.419 . . . . 0.0 110.76 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 4.8 tpm_? -92.06 -8.9 44.59 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.15 0.5 . . . . 0.0 110.11 178.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.45 142.67 98.44 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.38 128.36 20.17 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.37 2.713 . . . . 0.0 112.997 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.97 20.0 12.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.078 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.51 -40.19 78.8 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 14.9 m -88.52 -6.65 57.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.348 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' SER . 8.8 m-20 72.69 168.9 0.32 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 p -73.86 -19.38 60.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.237 0.541 . . . . 0.0 109.732 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -63.66 -17.58 63.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.081 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.7 -21.35 61.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.352 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.404 ' C ' ' H ' ' A' ' 88' ' ' GLN . 16.9 m-30 -77.6 -162.4 0.31 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 109.769 178.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.18 41.33 0.37 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.297 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.565 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 tp60 -64.81 -61.59 2.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.911 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.595 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -80.34 -27.1 38.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.69 10.45 2.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t -52.03 -51.07 59.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.1 m -59.14 -34.96 72.68 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -32.84 31.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.94 -35.38 18.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -78.74 -30.84 46.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.0 m120 52.07 82.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.85 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.64 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.74 -13.71 60.16 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.135 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.27 -2.07 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.645 0.736 . . . . 0.0 109.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.556 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.2 pt? -84.92 173.81 10.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.355 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.567 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 16.1 t30 -68.39 103.74 1.71 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.733 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.36 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.813 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 p -74.84 -16.67 60.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.057 0.456 . . . . 0.0 110.673 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.567 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -68.06 -47.32 68.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.406 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.48 -41.93 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.17 -30.72 70.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.147 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.1 m -91.42 -52.46 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.496 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -117.48 -27.86 6.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.75 -64.89 3.97 Favored Glycine 0 C--O 1.234 0.103 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.961 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 p -76.71 -11.8 59.9 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -54.73 4.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.33 -54.48 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.164 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.1 mp -72.96 -57.92 3.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m 67.24 -86.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.1 -36.92 61.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.459 ' O ' HG12 ' A' ' 120' ' ' VAL . 27.6 tp -65.29 -50.97 63.68 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.743 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 120' ' ' VAL . 5.4 mp -67.95 -23.22 65.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.05 -42.65 7.01 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.822 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.459 HG12 ' O ' ' A' ' 116' ' ' LEU . 2.7 m -67.71 -32.46 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.828 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -62.21 -34.18 75.98 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.755 0.312 . . . . 0.0 110.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 t -85.34 -38.5 18.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.471 0.653 . . . . 0.0 110.303 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.475 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.22 -79.43 0.21 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.435 ' HA ' HG13 ' A' ' 129' ' ' ILE . . . -65.23 -60.93 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.414 -175.078 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -31.86 70.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 109.965 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.94 2.22 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.484 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . 0.539 ' HB2' HH22 ' A' ' 50' ' ' ARG . 73.0 mt -115.02 -5.54 12.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.0 105.07 0.07 OUTLIER Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.3 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.435 HG13 ' HA ' ' A' ' 124' ' ' ALA . 27.9 mt -77.57 134.88 27.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.686 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -128.1 115.74 18.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.082 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 16.2 t -82.75 166.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.936 179.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -59.35 158.18 9.78 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.104 0.478 . . . . 0.0 111.252 -179.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 33.1 m -79.86 16.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.345 -177.479 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.58 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.934 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.0 p -106.83 -30.14 9.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.39 -63.97 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tp-100 -59.17 -41.77 89.21 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.162 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 m -57.63 -45.7 85.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.877 0.37 . . . . 0.0 111.885 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.71 -52.87 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.459 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.4 pt -55.75 -38.91 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -62.87 -35.26 79.41 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 m -84.82 -38.24 19.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 111.009 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 50.9 m -72.28 -40.73 67.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.353 -177.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t -72.86 -21.79 60.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -86.93 -53.15 5.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.88 -56.06 3.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 3.2 mm? -79.18 6.33 9.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.313 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 2.5 p -62.68 -66.26 0.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.331 0.586 . . . . 0.0 111.622 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.452 HG22 ' HA ' ' A' ' 180' ' ' SER . 3.7 m -144.37 63.2 1.32 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.401 ' HB3' ' HB3' ' A' ' 154' ' ' ALA . 35.2 t -57.21 131.7 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.159 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.3 m -59.28 133.86 56.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.769 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.71 ' O ' ' HB3' ' A' ' 158' ' ' GLN . 48.0 m 71.65 25.15 3.34 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 123.739 0.649 . . . . 0.0 110.443 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 14.6 t 70.08 177.4 0.27 Allowed 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.966 0.906 . . . . 0.0 112.945 177.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 150' ' ' SER . . . -152.46 12.99 0.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.899 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 39.6 t -117.17 137.16 52.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.335 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 t80 52.06 57.51 6.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.827 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 m 60.92 20.92 11.2 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.114 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.71 ' HB3' ' O ' ' A' ' 152' ' ' SER . 12.8 mt-30 69.86 18.08 7.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.098 0.559 . . . . 0.0 111.543 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.57 -44.25 67.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.1 p -82.86 90.09 6.9 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.719 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -133.05 -48.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.384 -178.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.7 m -96.42 117.24 30.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.586 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m -89.86 3.71 52.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.7 m -58.61 -32.06 68.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.4 m -72.28 -5.54 36.79 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.388 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.09 77.77 1.38 Allowed Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.411 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.06 -55.8 3.77 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.41 12.53 80.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.197 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -97.02 -71.92 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.793 0.296 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.6 p 53.18 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.261 1.024 . . . . 0.0 112.473 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 104.62 -107.33 2.89 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.435 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.5 117.03 3.71 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.412 2.075 . . . . 0.0 110.946 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p 52.62 30.62 8.9 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.592 0.757 . . . . 0.0 111.253 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.44 165.81 12.79 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.552 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.88 140.32 16.1 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.119 2.546 . . . . 0.0 112.015 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 p -78.57 79.1 5.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.15 0.5 . . . . 0.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 12.9 t -118.61 12.8 13.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.772 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 -166.35 33.47 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.372 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.62 104.94 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.936 2.424 . . . . 0.0 111.483 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.452 ' HA ' HG22 ' A' ' 149' ' ' THR . 13.1 t -54.4 127.03 25.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.014 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.76 -68.53 3.04 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.339 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -130.91 131.46 23.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 O-C-N 122.859 -0.201 . . . . 0.0 111.21 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_exo -65.41 125.24 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.37 2.046 . . . . 0.0 110.827 176.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.94 -77.58 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.467 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.54 -17.58 57.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.645 2.23 . . . . 0.0 112.122 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.67 19.24 11.61 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.764 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.16 156.11 45.0 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.822 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.77 -119.27 6.4 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.512 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -113.7 95.76 0.77 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.583 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -140.36 161.56 54.4 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -67.03 125.29 13.39 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.25 1.966 . . . . 0.0 111.157 178.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -78.39 77.41 4.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.055 0.455 . . . . 0.0 110.807 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.95 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 64.76 163.64 0.14 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.715 0.806 . . . . 0.0 111.868 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.556 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 29.2 p -84.54 -32.12 24.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.48 0.657 . . . . 0.0 109.761 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 118.69 -11.07 12.29 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.66 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.97 107.14 3.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 90.82 129.21 4.18 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.311 -178.926 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.569 0.223 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.81 74.18 0.42 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.92 144.48 53.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.373 2.048 . . . . 0.0 111.437 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.452 ' HB2' ' HB2' ' A' ' 7' ' ' PHE . 14.8 mm100 -63.45 135.13 56.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.585 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.95 112.14 3.9 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.871 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.01 -6.98 81.68 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.324 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.452 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 91.0 m-85 -126.53 20.37 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.884 0.373 . . . . 0.0 110.263 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.33 94.19 0.26 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.416 ' C ' ' HG1' ' A' ' 10' ' ' THR . . . -68.64 120.88 15.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.383 0.611 . . . . 0.0 111.869 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.416 ' HG1' ' C ' ' A' ' 9' ' ' ALA . 7.8 m -161.17 136.44 7.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.293 -178.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.21 109.51 3.82 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.684 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.37 -60.69 4.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.712 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.89 74.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.22 0.534 . . . . 0.0 110.682 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.563 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.6 m -62.82 -26.78 68.91 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.86 -18.31 4.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.79 -45.9 5.01 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.422 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.543 ' O ' HG22 ' A' ' 21' ' ' VAL . 2.2 pp -86.63 -21.63 26.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.579 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 4.7 pt -35.49 -58.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.455 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 18.1 t -79.41 -20.23 48.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.671 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 99.5 mtt180 -86.65 -32.96 20.28 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG22 ' O ' ' A' ' 17' ' ' LEU . 45.7 t -62.0 -94.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -53.39 6.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -65.75 -24.41 66.95 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 19' ' ' SER . . . -63.16 -35.91 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.725 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.74 -21.6 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.482 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.68 33.74 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 2.8 t-20 55.96 18.09 2.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.714 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 m -81.32 148.38 29.42 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 -17.18 1.01 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.882 1.273 . . . . 0.0 114.101 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -61.2 -21.99 64.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 pp -93.83 -26.99 16.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.217 0.532 . . . . 0.0 110.379 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -82.42 -45.88 14.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 -26.58 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.468 HG22 ' OD1' ' A' ' 139' ' ' ASP . 25.8 t -84.35 161.47 3.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -85.1 159.27 20.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.696 0.284 . . . . 0.0 110.523 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -89.39 166.47 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.296 0.569 . . . . 0.0 111.514 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.437 HG23 ' H ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -74.87 124.87 27.66 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.601 177.719 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.514 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 73.31 38.26 53.6 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.451 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.93 149.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.042 0.937 . . . . 0.0 112.66 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.537 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.3 m -77.83 142.65 38.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.003 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.473 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -68.87 -13.09 62.2 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -58.98 -35.43 73.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.537 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.93 -42.35 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.795 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -83.39 -69.15 0.65 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.591 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m 74.9 -21.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.968 0.907 . . . . 0.0 112.347 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . 0.405 ' H ' ' C ' ' A' ' 44' ' ' ALA . 25.6 p -70.2 -82.24 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 -22.88 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.58 85.0 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.473 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 46.5 mt-30 -83.16 -43.62 15.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.514 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 0.1 OUTLIER -126.51 -13.22 6.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.436 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.21 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.591 0.756 . . . . 0.0 110.255 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.27 144.34 50.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.03 -19.21 6.47 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -175.493 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -56.28 -81.72 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.49 ' HB3' ' HB2' ' A' ' 50' ' ' ARG . 9.9 tt -86.04 -22.81 27.04 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.903 0.382 . . . . 0.0 111.123 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -73.32 -18.44 61.19 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.515 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.9 t -52.22 97.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.105 0.478 . . . . 0.0 110.94 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 t -131.81 -37.37 1.17 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.88 19.65 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.395 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 67.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.855 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.412 HG23 HD22 ' A' ' 65' ' ' ASN . 42.6 t -87.88 102.33 12.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -150.62 17.58 0.81 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 110.583 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 127.7 -42.44 1.45 Allowed Glycine 0 C--N 1.288 -2.095 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.521 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.571 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . 52.2 m-80 -55.06 -79.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.713 0.302 . . . . 0.0 111.723 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.442 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 3.2 p-10 -85.3 12.95 7.13 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.297 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.438 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 39.3 tp -88.61 -57.34 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.07 -32.63 56.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.571 ' NH2' ' HA ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -109.76 160.61 16.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 68.91 -62.32 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HB3' ' O ' ' A' ' 65' ' ' ASN . . . -56.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.435 HG22 ' HB2' ' A' ' 135' ' ' SER . 9.6 p -72.69 -37.2 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.74 -27.79 65.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.3 -47.45 13.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.425 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.13 -35.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.048 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.7 p -72.41 -21.41 61.27 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.056 0.455 . . . . 0.0 110.545 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -91.11 -14.48 31.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.449 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.1 mt -56.48 113.2 5.49 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.83 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 3.1 Cg_exo -77.41 128.73 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.766 2.311 . . . . 0.0 111.154 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.4 111.12 16.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.84 -50.46 18.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.748 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -83.47 -57.52 3.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.023 0.439 . . . . 0.0 110.36 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -169.69 151.26 4.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.497 HG22 HE22 ' A' ' 88' ' ' GLN . 11.4 m -73.44 -20.52 60.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.8 0.334 . . . . 0.0 111.81 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 m -66.18 -17.18 64.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.02 -21.4 61.29 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.725 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.452 ' C ' ' H ' ' A' ' 88' ' ' GLN . 77.8 m-85 -76.17 -168.81 1.0 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.61 25.11 0.2 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.646 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.497 HE22 HG22 ' A' ' 83' ' ' THR . 65.0 mt-30 -87.17 -59.34 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.105 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.579 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -70.28 -48.13 58.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.479 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.0 m-85 -79.09 23.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.434 ' H ' ' C ' ' A' ' 89' ' ' ALA . 6.9 p -51.01 -60.29 3.25 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.415 0.686 . . . . 0.0 112.696 -177.276 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -65.26 -32.66 74.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.95 56.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.704 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.479 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.3 mt -84.35 -28.2 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.617 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.99 -38.2 22.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.065 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.2 m120 53.69 73.0 0.4 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.681 0.613 . . . . 0.0 111.118 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.36 -2.76 33.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.742 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.77 -5.7 68.88 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.127 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.87 21.75 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 109.737 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.514 ' CB ' HG13 ' A' ' 21' ' ' VAL . 1.8 pt? -117.4 163.71 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.82 128.15 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.467 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.61 -20.67 62.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.9 t -65.98 -36.63 83.82 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.496 ' O ' HD23 ' A' ' 108' ' ' LEU . 9.2 t30 -61.8 -49.32 76.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.061 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.412 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 35.8 mm -68.94 -38.44 78.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.166 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.67 -24.55 61.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -79.79 -55.83 4.71 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.417 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.496 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -130.83 -23.49 2.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.472 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.68 -65.5 3.14 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.1 p -78.58 -11.62 59.97 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.442 -0.446 . . . . 0.0 111.924 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -87.54 -52.58 5.27 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -83.75 -44.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.915 0.388 . . . . 0.0 111.259 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.0 mp -78.39 -51.73 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.1 m 53.18 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.78 29.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.76 0.824 . . . . 0.0 112.878 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.491 ' O ' HG21 ' A' ' 120' ' ' VAL . 61.6 tp -63.47 -55.7 22.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.855 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.0 mt -66.06 -28.76 69.08 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.156 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.3 -49.83 75.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 109.903 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.82 -36.49 61.46 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.105 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.491 HG21 ' O ' ' A' ' 116' ' ' LEU . 78.2 t -64.48 -38.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.606 0.241 . . . . 0.0 110.708 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.436 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -58.12 -46.31 85.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -70.86 -42.72 69.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.3 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.411 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -84.35 -80.19 0.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -66.41 -49.51 66.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 25.7 tm0? -71.03 -28.39 64.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.989 0.423 . . . . 0.0 110.87 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.1 -55.87 2.55 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.053 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.7 tp -102.13 -26.13 13.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.905 0.353 . . . . 0.0 111.796 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.8 73.38 1.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.572 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.411 HD13 ' C ' ' A' ' 123' ' ' ALA . 1.3 mp -68.18 139.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -130.88 131.8 44.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.46 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.437 ' H ' HG23 ' A' ' 37' ' ' THR . 22.4 t -89.5 120.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.026 0.441 . . . . 0.0 111.306 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -100.82 49.72 0.88 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.979 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -79.77 0.33 31.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.811 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.82 -25.71 20.13 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.904 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . 0.435 ' HB2' HG22 ' A' ' 71' ' ' VAL . 6.2 m -105.64 -49.05 3.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.512 ' O ' HG12 ' A' ' 140' ' ' ILE . 84.0 t -52.74 -62.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.403 HE21 ' HB3' ' A' ' 137' ' ' GLN . 1.0 OUTLIER -57.31 -44.11 83.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.526 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.3 m -58.65 -45.57 89.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.855 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . 0.468 ' OD1' HG22 ' A' ' 34' ' ' VAL . 12.0 t70 -69.09 -53.17 21.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.728 0.299 . . . . 0.0 111.496 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.512 HG12 ' O ' ' A' ' 136' ' ' VAL . 44.0 pt -65.08 -42.02 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -66.14 -39.5 89.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 t -72.54 -45.5 59.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.866 0.365 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.3 m -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.704 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -61.02 -22.05 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -64.89 -45.41 86.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.738 0.304 . . . . 0.0 110.657 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -88.99 -42.0 12.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.396 0.617 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.573 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 4.3 mm? -75.18 8.87 2.34 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.131 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.5 m -46.79 -47.22 20.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.24 0.543 . . . . 0.0 109.663 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.431 ' HB ' ' O ' ' A' ' 152' ' ' SER . 11.8 p -154.01 104.31 2.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 p -95.64 -55.36 3.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.1 m -71.87 -15.72 62.13 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 111.592 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 176' ' ' SER . 9.4 m -137.46 160.43 39.13 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.512 ' HB3' ' HB2' ' A' ' 158' ' ' GLN . 23.2 t -105.11 141.64 36.3 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.12 24.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.412 ' H ' ' C ' ' A' ' 153' ' ' SER . 50.9 m -93.51 14.33 19.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 111.068 179.05 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 69.63 -62.38 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.666 0.786 . . . . 0.0 112.881 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.4 t -60.28 -33.79 72.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.479 . . . . 0.0 110.535 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.512 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 83.1 mm-40 -92.04 15.94 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.06 24.87 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.696 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 m -153.74 69.18 0.79 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.223 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 111.7 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.161 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 98.0 p 54.28 -165.34 0.1 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 0.0 111.554 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 20.3 m 64.28 2.4 1.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.244 0.617 . . . . 0.0 112.248 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.9 t -80.0 -27.96 39.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.8 m -120.12 23.47 10.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.258 0.551 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . 142.27 134.61 2.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.52 105.18 7.9 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.44 -31.28 54.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.18 127.82 54.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 t -160.0 158.99 31.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.687 0.28 . . . . 0.0 110.376 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.95 -177.12 30.79 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.44 -14.0 42.69 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.875 2.383 . . . . 0.0 111.581 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -149.77 101.98 3.11 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -146.84 -130.5 2.09 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.381 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.17 164.12 35.17 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.675 2.25 . . . . 0.0 111.319 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.507 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 46.6 m -75.41 68.51 2.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.484 0.659 . . . . 0.0 111.274 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.414 HG23 ' O ' ' A' ' 177' ' ' THR . 9.8 t -130.33 113.4 14.33 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.33 178.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.94 -173.14 50.64 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.861 -176.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -80.11 4.9 6.39 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 123.073 2.515 . . . . 0.0 112.663 179.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.7 m -139.25 -73.9 0.38 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 159.66 56.85 0.01 OUTLIER Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.029 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.22 165.26 35.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.697 ' O ' ' HD3' ' A' ' 185' ' ' PRO . 50.3 Cg_exo -56.79 163.61 7.05 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.257 1.971 . . . . 0.0 110.255 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -107.59 89.05 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.175 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.697 ' HD3' ' O ' ' A' ' 183' ' ' PRO . 9.5 Cg_endo -90.42 -42.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.605 2.203 . . . . 0.0 110.887 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.505 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 54.5 mt -94.33 -69.32 0.76 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.096 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.62 -135.3 7.17 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.66 75.37 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.697 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . 0.516 ' HA2' ' O ' ' A' ' 183' ' ' PRO . . . -177.72 127.91 1.24 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.216 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -162.08 154.63 16.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.671 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.0 Cg_endo -69.34 170.75 15.35 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.065 1.843 . . . . 0.0 112.378 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.71 32.8 3.46 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.975 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.15 35.73 2.0 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.437 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -107.44 179.43 4.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 23.8 p -97.26 18.18 15.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.77 79.51 0.89 Allowed Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.434 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -84.04 -20.25 33.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 84.53 -169.93 45.76 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.62 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.317 179.795 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.4 119.5 15.84 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.067 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.18 123.36 12.37 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.4 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.82 107.16 2.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.777 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.4 -110.03 1.24 Allowed Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.259 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.71 18.65 7.59 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -66.37 -61.55 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.368 0.127 . . . . 0.0 110.899 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 72.58 0.61 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.398 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 176.6 6.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.685 0.279 . . . . 0.0 111.196 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.463 ' H ' ' CD2' ' A' ' 113' ' ' LEU . 29.8 p 53.81 92.78 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.153 0.981 . . . . 0.0 113.299 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.85 -160.74 33.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.606 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.33 -163.44 51.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.378 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.34 -16.34 60.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.523 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.504 ' O ' HG23 ' A' ' 18' ' ' ILE . 42.5 m -60.46 -34.77 74.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.14 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.16 -22.83 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.35 -43.18 5.64 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.551 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.434 HD13 ' N ' ' A' ' 18' ' ' ILE . 4.0 pp -85.28 -25.18 27.38 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.575 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 3.0 pt -34.3 -63.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.453 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 42.5 t -75.07 -19.14 60.12 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.96 -21.51 37.16 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.66 0.384 . . . . 0.0 112.026 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.474 HG12 ' HB3' ' A' ' 100' ' ' LEU . 1.8 t -71.68 -142.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.427 ' H ' HG11 ' A' ' 21' ' ' VAL . . . -62.02 -23.41 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.518 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.9 OUTLIER -66.68 -26.56 67.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.986 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.453 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -64.41 -44.13 92.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.536 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.11 -28.75 38.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.649 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.83 87.73 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.26 17.87 3.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.864 0.866 . . . . 0.0 112.057 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.433 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 2.3 m -76.7 164.57 25.76 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.492 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.447 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 29.6 m -62.66 -16.49 57.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.035 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -52.3 -38.73 59.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.664 0.785 . . . . 0.0 112.515 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -104.02 -20.9 13.7 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.409 0.623 . . . . 0.0 110.538 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.447 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 13.1 ttm180 -72.81 -40.72 65.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.708 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.2 t -173.3 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.036 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 47.4 t -87.2 139.89 16.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -54.14 141.68 28.15 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.007 0.432 . . . . 0.0 110.695 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.439 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 46.5 ptt85 -67.55 162.72 22.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.506 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.74 129.84 38.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.431 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.429 ' HA3' ' HB ' ' A' ' 129' ' ' ILE . . . 72.1 35.49 60.9 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.731 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 p -44.99 149.84 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.125 0.97 . . . . 0.0 112.771 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.465 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.8 m -88.11 149.43 23.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.289 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.477 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 7.7 pm0 -70.64 -12.99 61.91 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.627 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -55.48 -31.94 62.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.759 0.314 . . . . 0.0 110.988 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -85.03 -44.73 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.029 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.435 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -84.57 -71.49 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.703 0.287 . . . . 0.0 111.696 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 t 79.63 -20.49 0.38 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.543 1.137 . . . . 0.0 111.022 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -78.91 -96.59 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.891 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -99.41 -35.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 0.0 111.291 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.71 81.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.477 ' HA ' ' CB ' ' A' ' 41' ' ' GLN . 42.4 mt-30 -83.01 -47.85 11.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.597 0.713 . . . . 0.0 110.392 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.519 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 2.5 tpm_? -125.16 -12.71 6.87 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.514 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 -52.17 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.404 0.681 . . . . 0.0 110.054 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.487 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -74.44 155.46 38.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.434 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.649 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.7 mp0 -60.38 -18.82 53.02 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.372 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -58.32 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.519 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 19.3 mt -86.08 -22.14 27.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.414 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.42 -20.25 54.86 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.649 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -56.2 101.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.172 0.511 . . . . 0.0 110.594 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.461 HG21 ' HG ' ' A' ' 59' ' ' LEU . 9.3 t -145.99 -32.46 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 ' HG ' HG21 ' A' ' 58' ' ' THR . 75.4 mt -121.4 18.88 11.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.0 0.429 . . . . 0.0 109.9 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 67.18 1.46 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.088 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.44 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 61.9 t -97.44 113.6 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.377 0.271 . . . . 0.0 110.756 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -170.92 78.69 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.148 0.499 . . . . 0.0 110.456 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 -46.07 2.07 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.991 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.464 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.5 p-10 -52.04 -74.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.018 0.927 . . . . 0.0 112.796 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.464 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 31.6 p-10 -85.03 -16.71 39.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.181 0.515 . . . . 0.0 109.875 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.418 ' HG ' ' HB2' ' A' ' 132' ' ' ASP . 61.4 tp -63.59 -47.25 82.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.705 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.21 -15.0 60.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.453 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 91.0 mtt180 -120.65 -84.44 0.66 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.875 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -52.17 -39.19 59.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.62 -57.12 9.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.655 0.264 . . . . 0.0 111.68 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.29 -38.3 82.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 68' ' ' ARG . 24.5 mt-30 -65.43 -35.11 79.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.99 94.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.0 t -86.23 -41.11 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.568 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -64.46 -28.54 69.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -102.84 5.04 38.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.373 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.23 119.28 75.62 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.355 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.99 128.79 18.31 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.663 2.242 . . . . 0.0 112.032 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.4 133.54 38.65 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.98 -54.51 4.11 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.345 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.4 p -92.26 -60.83 1.75 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.017 0.437 . . . . 0.0 110.336 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -164.46 164.1 22.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.496 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.7 m -67.01 -29.77 69.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 p -67.72 -17.65 64.63 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.345 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.77 66.4 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.526 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.471 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 -68.13 -174.43 0.49 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.434 0.635 . . . . 0.0 111.255 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -74.64 22.26 0.1 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.673 -178.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.471 ' H ' ' C ' ' A' ' 86' ' ' TYR . 70.7 mt-30 -86.42 -60.29 2.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 120.989 0.424 . . . . 0.0 109.927 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.575 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.9 -41.55 82.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.107 0.479 . . . . 0.0 109.957 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.521 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.0 m-85 -83.88 15.64 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.67 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . 0.518 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . 47.1 t -56.47 -50.75 70.83 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -60.14 -30.1 69.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.8 -40.65 22.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.748 0.308 . . . . 0.0 111.388 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.521 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 37.9 mt -83.25 -29.47 28.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.903 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -79.24 -36.78 39.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.31 90.35 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.56 -16.44 60.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.649 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 -14.01 52.13 Favored Glycine 0 C--O 1.227 -0.322 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.749 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.414 ' CG2' ' HA ' ' A' ' 197' ' ' PHE . 9.0 p -93.61 1.35 9.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.203 1.002 . . . . 0.0 109.527 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.474 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -83.94 173.76 10.92 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.129 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -81.27 135.9 35.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.094 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.26 54.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.25 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.1 p -68.36 -30.67 69.68 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 121.217 0.532 . . . . 0.0 110.698 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.557 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.1 t30 -60.24 -53.79 53.45 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.51 -38.02 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.86 -31.7 71.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.839 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 m -91.68 -53.82 4.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -111.76 -35.24 5.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.79 -52.67 40.93 Favored Glycine 0 N--CA 1.46 0.293 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.121 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.497 ' HA ' HD13 ' A' ' 117' ' ' LEU . 33.0 t -66.09 -24.11 66.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.735 0.302 . . . . 0.0 111.551 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -87.13 -40.75 14.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.88 0.371 . . . . 0.0 111.42 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.12 -55.79 6.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.87 0.367 . . . . 0.0 111.376 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.463 ' CD2' ' H ' ' A' ' 10' ' ' THR . 17.9 mt -72.57 -42.29 64.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 49.53 -94.86 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.563 ' HA ' ' ND2' ' A' ' 118' ' ' ASN . . . -66.74 -19.08 65.68 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 58.1 tp -73.87 -36.81 64.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.741 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.497 HD13 ' HA ' ' A' ' 110' ' ' SER . 33.0 mt -68.06 -43.51 78.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . 0.563 ' ND2' ' HA ' ' A' ' 115' ' ' ALA . 11.8 p30 -62.68 -24.38 67.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.054 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.77 -30.1 21.89 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.572 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . . . . . . . . . 49.5 t -84.7 -34.66 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.4 p -53.38 -49.25 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.13 0.49 . . . . 0.0 111.627 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.2 t -76.26 -28.8 57.23 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.56 -85.3 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -69.85 -41.57 74.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -175.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -76.58 -21.89 55.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.197 0.522 . . . . 0.0 110.201 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.18 -81.04 1.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.375 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.67 -23.87 19.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.24 88.1 0.77 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.487 HG23 ' CB ' ' A' ' 52' ' ' ALA . 48.8 mm -58.06 136.98 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.66 152.32 24.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.167 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.42 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 5.3 t -116.9 163.49 14.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.418 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 23.3 t70 -59.97 152.04 24.68 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.316 0.579 . . . . 0.0 112.073 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.537 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 24.0 m -73.71 -11.54 60.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -45.86 -74.54 0.22 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 123.266 0.354 . . . . 0.0 113.275 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.8 t -106.56 -57.24 2.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.309 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.47 ' O ' HG12 ' A' ' 140' ' ' ILE . 60.8 t -48.68 -60.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.254 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.537 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -58.16 -48.93 78.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.543 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -61.46 -41.93 97.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.27 -49.73 63.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.566 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.47 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.5 pt -68.57 -35.94 72.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -62.96 -50.28 71.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.654 0.264 . . . . 0.0 110.731 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.5 t -59.45 -43.9 93.06 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.213 0.53 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.433 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -64.72 -41.77 95.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.059 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.6 t -69.85 -24.39 63.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.931 0.396 . . . . 0.0 110.971 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.0 m -85.86 -58.82 2.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.637 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.424 ' O ' ' HB2' ' A' ' 150' ' ' SER . 90.1 m-85 -89.82 -56.65 3.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.97 -4.41 28.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.435 ' C ' ' HG1' ' A' ' 149' ' ' THR . 0.3 OUTLIER -60.61 -49.92 75.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.836 0.35 . . . . 0.0 111.745 -179.23 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.435 ' HG1' ' C ' ' A' ' 148' ' ' SER . 1.3 m -147.9 -11.99 0.38 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.732 177.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.424 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 40.0 m -77.79 69.45 4.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.405 0.621 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.2 m -152.62 130.58 11.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.323 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.3 m -70.88 1.2 5.83 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -90.64 -78.32 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.1 -27.9 62.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -102.68 7.83 39.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.01 -76.47 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.642 -0.823 . . . . 0.0 113.088 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.9 m -60.06 -33.44 72.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -94.96 2.58 55.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.436 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.1 175.25 6.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.3 m 52.14 45.83 27.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.587 0.708 . . . . 0.0 109.668 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -100.76 136.56 40.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.836 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.9 m -99.78 86.63 3.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 -20.67 60.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -56.24 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.858 0.361 . . . . 0.0 111.599 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.4 m 61.92 20.47 11.54 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.502 0.721 . . . . 0.0 111.735 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 36.28 1.59 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.023 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -158.8 160.58 36.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.602 0.239 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 48.01 3.95 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.246 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 70.52 131.48 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.937 0.895 . . . . 0.0 111.697 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.4 p -67.38 146.36 54.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 101.83 -123.26 7.84 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.78 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.31 115.43 2.65 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.685 2.257 . . . . 0.0 112.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.2 m 67.59 17.88 9.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.64 -167.89 15.24 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.481 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -68.93 154.92 70.06 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.725 2.283 . . . . 0.0 111.909 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.8 m -87.52 87.81 7.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.272 0.558 . . . . 0.0 110.837 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -83.5 -14.21 52.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.41 ' HA2' ' O ' ' A' ' 186' ' ' LEU . . . -129.08 71.62 0.49 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.188 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 -174.89 2.24 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.32 2.013 . . . . 0.0 111.088 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.9 p -76.05 -75.52 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.884 0.373 . . . . 0.0 111.291 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.09 -106.92 2.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -129.77 146.83 62.88 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.44 125.01 14.3 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.253 2.635 . . . . 0.0 112.649 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 144.22 -99.43 0.22 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -87.16 176.73 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.642 2.228 . . . . 0.0 110.063 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.41 ' O ' ' HA2' ' A' ' 178' ' ' GLY . 7.1 mp -101.43 81.03 2.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.351 0.596 . . . . 0.0 110.346 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 77.77 -62.58 3.55 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.4 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.66 -40.57 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -112.67 68.57 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.131 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.56 133.72 76.76 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.301 0.096 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.42 138.99 87.47 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.48 2.12 . . . . 0.0 111.417 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -79.02 43.73 0.53 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.24 0.543 . . . . 0.0 111.847 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.11 -5.59 19.56 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -106.5 152.71 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.5 m -83.49 52.84 2.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.097 0.475 . . . . 0.0 111.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.1 -34.33 3.24 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.867 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.414 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 72.2 t80 72.57 -67.42 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.013 0.925 . . . . 0.0 111.068 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -141.95 -164.3 9.99 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 CA-C-O 118.358 -1.245 . . . . 0.0 111.561 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 120.591 0.234 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.46 -117.3 3.16 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.783 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -80.45 177.62 7.94 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.684 2.256 . . . . 0.0 111.862 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -138.67 107.44 5.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.821 0.343 . . . . 0.0 110.171 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.28 -122.48 27.21 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.888 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.57 -3.64 71.32 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.82 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.89 131.28 34.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.809 0.338 . . . . 0.0 110.324 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.431 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -97.05 77.74 0.68 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.277 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -64.98 142.08 58.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.402 ' H ' ' HG ' ' A' ' 113' ' ' LEU . 39.2 p 52.59 82.64 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.428 0.691 . . . . 0.0 112.323 -178.077 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.52 174.22 37.18 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.075 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.91 -160.29 36.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.122 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.16 -13.05 23.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.017 0.437 . . . . 0.0 111.558 -179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.611 ' O ' HG21 ' A' ' 18' ' ' ILE . 7.9 m -54.3 -41.02 68.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.636 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.8 59.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.37 -43.9 5.43 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.503 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.482 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.0 pp -83.66 -20.15 34.09 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.617 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 8.5 pt -42.84 -49.82 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 p -84.77 -18.93 33.52 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.564 ' O ' ' HG2' ' A' ' 191' ' ' PRO . 98.4 mtt180 -85.66 -36.15 20.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.523 HG12 ' HB3' ' A' ' 100' ' ' LEU . 21.1 t -72.8 -102.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -71.33 -51.83 22.1 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -173.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.417 ' HB3' HD21 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -61.41 -24.95 66.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.116 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.14 91.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.57 -28.18 28.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.19 89.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.85 17.65 3.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.184 176.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.515 ' O ' HD23 ' A' ' 31' ' ' LEU . 3.5 m -71.59 169.26 15.9 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.048 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.0 m -61.89 -18.28 59.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 58.4 p -56.44 -40.71 75.24 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.613 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -97.15 -20.13 18.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.235 0.541 . . . . 0.0 110.233 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -74.98 -43.95 51.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.573 -174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 t -176.47 -25.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.4 t -91.89 139.41 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.03 145.17 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 123.186 0.303 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.5 ptt85 -60.13 152.12 25.15 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.256 0.551 . . . . 0.0 111.302 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -67.28 114.7 6.2 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.608 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.67 40.0 9.21 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.474 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -50.62 146.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.448 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 14.6 m -92.8 154.96 17.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.232 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.441 ' OE1' ' HG2' ' A' ' 49' ' ' GLN . 8.5 pt20 -67.07 -12.15 59.12 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.7 mm-40 -53.93 -42.58 68.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.31 -31.2 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.748 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.38 -50.39 8.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 m 78.43 -18.69 0.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.413 1.085 . . . . 0.0 111.737 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 p -71.42 -101.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 -22.04 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.14 89.64 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.279 0.561 . . . . 0.0 111.769 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.459 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 68.4 mt-30 -77.47 -61.46 1.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.39 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.468 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 63.3 ttt180 -118.58 -2.06 11.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.552 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.93 -59.79 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.597 0.759 . . . . 0.0 112.055 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.03 -84.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.412 HE21 ' HB3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER 178.56 -44.57 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -178.026 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -49.19 -69.41 0.12 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.428 0.691 . . . . 0.0 112.362 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.93 -23.07 27.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.225 0.536 . . . . 0.0 110.475 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.459 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.13 -19.72 62.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.821 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 p -47.93 107.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.733 0.646 . . . . 0.0 111.614 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -154.37 -42.23 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.088 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -122.59 19.38 10.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.332 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.11 63.96 1.49 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.128 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.407 HG21 HD22 ' A' ' 65' ' ' ASN . 10.8 t -89.7 114.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.457 -177.405 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -178.46 86.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.19 -58.65 4.73 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.935 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -61.78 -76.2 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.407 HD22 HG21 ' A' ' 61' ' ' VAL . 3.2 p-10 -85.39 18.45 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.223 0.535 . . . . 0.0 110.838 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.6 tp -87.23 -56.12 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.888 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -37.23 49.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.143 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -104.04 172.82 6.59 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 63.07 -62.29 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.43 -59.66 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 110.879 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.66 -41.49 92.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.25 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -59.58 -43.21 93.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.613 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . 0.498 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.87 -47.52 82.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.61 -41.12 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -66.28 -25.24 66.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.304 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -107.6 9.23 29.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.498 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 14.2 tp -84.13 115.0 58.01 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.28 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.53 129.92 23.73 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.619 2.213 . . . . 0.0 111.761 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.14 115.87 15.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.22 47.35 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -92.72 -60.5 1.8 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.011 0.434 . . . . 0.0 110.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -171.68 159.28 5.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.67 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.7 m -64.06 -26.73 68.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.91 0.386 . . . . 0.0 110.657 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -65.61 -18.6 65.45 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.25 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.07 60.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.04 0.448 . . . . 0.0 110.779 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -74.84 -170.27 1.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.871 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.7 46.7 0.68 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.813 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.613 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 mm-40 -91.75 -62.72 1.36 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.563 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.617 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -86.32 -33.56 20.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.419 ' HA ' ' CG2' ' A' ' 18' ' ' ILE . 97.7 m-85 -72.72 2.38 6.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -51.79 -49.2 63.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 m -58.79 -39.75 82.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.29 33.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.35 -31.52 24.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -86.47 -31.1 21.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.799 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.1 m120 53.19 68.82 0.78 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.791 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.05 4.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.2 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.51 -13.51 40.69 Favored Glycine 0 C--O 1.225 -0.409 0 C-N-CA 121.314 -0.469 . . . . 0.0 112.855 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 21.6 t -72.04 -19.26 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.21 0.529 . . . . 0.0 110.295 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.523 ' HB3' HG12 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -85.16 156.0 21.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.286 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 9.5 p-10 -70.36 132.0 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.161 -179.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.79 65.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 p -66.2 -33.49 75.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 28.5 t30 -63.44 -47.73 80.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.104 179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.97 -37.9 77.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.307 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -66.66 -33.87 76.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.305 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -85.24 -58.62 2.61 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.8 pp -116.44 -26.78 6.98 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -58.38 -60.05 9.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.955 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -76.93 -11.13 59.77 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.607 -0.349 . . . . 0.0 111.507 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.33 -48.83 7.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 0.0 111.337 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . 0.431 HG12 ' O ' ' A' ' 8' ' ' GLY . 48.4 t -84.51 -57.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.413 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.2 mp -72.01 -42.95 65.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.308 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m 55.57 -101.76 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.35 -34.88 64.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.119 0.568 . . . . 0.0 112.448 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.457 ' O ' HG21 ' A' ' 120' ' ' VAL . 22.2 tp -59.78 -55.24 36.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.18 -29.47 67.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.63 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.53 -43.09 97.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.83 -40.34 75.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.466 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.457 HG21 ' O ' ' A' ' 116' ' ' LEU . 89.5 t -62.85 -38.36 81.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.5 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 75.6 m -55.88 -33.42 64.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 111.427 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 t -85.09 -35.82 21.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.222 0.534 . . . . 0.0 110.429 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.99 -84.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.24 -49.5 34.68 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.843 0.354 . . . . 0.0 111.712 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 40.8 tt0 -67.72 -28.77 67.94 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.53 -61.57 1.78 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.247 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -118.63 -17.82 9.18 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 117.306 0.553 . . . . 0.0 111.455 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.27 120.04 2.37 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.54 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 18.7 mt -88.32 124.29 41.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.658 0.266 . . . . 0.0 110.813 177.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -124.32 120.21 31.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.88 157.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.67 174.39 2.33 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.401 0.62 . . . . 0.0 112.155 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.516 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 13.1 m -80.49 33.38 0.3 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.879 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.81 -91.16 0.11 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.2 m -107.0 -21.26 13.06 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.06 -64.6 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.516 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -61.27 -39.76 91.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -59.94 -44.13 94.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.981 0.42 . . . . 0.0 111.738 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.25 -48.42 34.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.744 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.422 HG12 ' HA ' ' A' ' 137' ' ' GLN . 47.2 pt -64.25 -35.36 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.0 p -65.23 -35.72 81.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.405 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -74.89 -40.75 60.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.14 0.495 . . . . 0.0 110.608 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 24.5 t -82.69 -20.39 36.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.525 -176.564 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 77.6 p -64.15 -16.38 61.78 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 p -47.63 -19.65 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.452 ' O ' HG21 ' A' ' 149' ' ' THR . 71.2 m-85 -69.29 -16.51 63.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.959 -0.463 . . . . 0.0 111.327 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.66 -17.82 63.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.9 m -66.9 -45.97 76.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.873 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.452 HG21 ' O ' ' A' ' 146' ' ' PHE . 10.2 t -70.05 -30.33 67.58 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.799 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.9 t -59.98 -25.15 65.0 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.024 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 m -94.84 -48.29 6.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.694 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.2 m -160.51 120.16 2.76 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.083 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.408 ' OG ' ' HB3' ' A' ' 159' ' ' ALA . 20.2 m -68.36 108.74 3.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.863 0.363 . . . . 0.0 110.084 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.38 -52.38 16.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.806 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.8 p -87.27 -1.86 58.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.588 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 t80 70.64 -38.62 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.74 0.816 . . . . 0.0 112.589 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -60.96 -17.51 51.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.176 0.513 . . . . 0.0 111.332 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.38 -18.08 62.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.068 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.408 ' HB3' ' OG ' ' A' ' 153' ' ' SER . . . -113.96 6.09 16.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.973 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 56.6 m -149.46 104.26 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.964 0.412 . . . . 0.0 111.309 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.22 33.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.9 t -77.69 93.68 4.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.305 0.574 . . . . 0.0 111.308 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.9 t -87.73 -14.63 39.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.188 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.8 t -76.75 -9.95 59.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.131 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.2 m -94.42 6.23 49.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.866 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 121.78 103.39 1.8 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.205 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -122.16 -34.42 3.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.949 0.404 . . . . 0.0 110.751 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.18 -74.01 1.48 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.996 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -111.06 -34.69 6.12 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.515 0.198 . . . . 0.0 111.054 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.4 HG21 ' HB ' ' A' ' 177' ' ' THR . 23.0 m 64.86 88.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.128 0.49 . . . . 0.0 110.752 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.42 ' HA3' ' HD2' ' A' ' 172' ' ' PRO . . . 177.79 -148.76 8.83 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.666 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.42 ' HD2' ' HA3' ' A' ' 171' ' ' GLY . 4.9 Cg_endo -51.03 -40.17 59.38 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.261 2.64 . . . . 0.0 113.22 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.4 m -102.3 27.15 6.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.27 -163.86 11.31 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.843 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.76 168.77 24.07 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.724 2.283 . . . . 0.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 21.7 m -77.92 61.49 2.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.757 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' THR . . . . . 0.4 ' HB ' HG21 ' A' ' 170' ' ' THR . 88.4 m -97.93 95.93 7.83 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.449 ' HA2' ' O ' ' A' ' 187' ' ' GLY . . . -179.92 79.04 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.311 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.403 ' HD2' ' C ' ' A' ' 187' ' ' GLY . 72.7 Cg_exo -39.77 104.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.398 2.732 . . . . 0.0 112.538 178.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.6 m -66.28 106.92 1.82 Allowed 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 162.61 -129.16 2.0 Allowed Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.462 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.653 ' N ' ' HD3' ' A' ' 183' ' ' PRO . 24.9 m-85 -151.41 36.43 0.1 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.653 ' HD3' ' N ' ' A' ' 182' ' ' TYR . 64.8 Cg_endo -85.4 124.78 2.83 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 C-N-CA 121.439 1.426 . . . . 0.0 112.156 -174.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.29 -106.93 2.02 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.051 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.523 ' HD2' ' O ' ' A' ' 183' ' ' PRO . 72.9 Cg_endo -88.42 -63.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.936 2.424 . . . . 0.0 112.576 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' A' ' 198' ' ' GLY . 5.1 tt -145.37 -63.76 0.33 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.449 ' O ' ' HA2' ' A' ' 178' ' ' GLY . . . 179.1 78.83 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.92 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 74.12 -61.4 2.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.847 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -147.07 -78.53 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 67.4 158.71 0.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.596 . . . . 0.0 111.263 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.564 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 17.3 Cg_exo -70.49 -20.55 31.23 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.476 2.118 . . . . 0.0 111.539 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.7 t80 72.39 -13.17 0.65 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.783 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.413 ' H ' ' C ' ' A' ' 191' ' ' PRO . . . -77.5 55.67 3.72 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.708 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -110.63 173.55 6.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.507 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 13.6 t -93.91 11.6 28.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.985 0.421 . . . . 0.0 110.271 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 88.11 49.14 3.85 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -91.07 -27.68 18.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . 0.492 ' O ' ' HG ' ' A' ' 186' ' ' LEU . . . -157.66 133.58 3.59 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.281 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.993 179.359 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.52 88.7 0.26 Allowed Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.462 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.21 144.52 69.1 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.602 2.202 . . . . 0.0 110.744 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -93.58 -39.93 10.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.066 0.46 . . . . 0.0 111.32 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.79 -65.52 0.33 Allowed Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.39 -32.35 57.99 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.69 120.17 41.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.0 79.2 0.28 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 140.88 51.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.49 0.186 . . . . 0.0 110.898 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m 69.07 89.69 0.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.803 0.689 . . . . 0.0 111.222 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.84 -153.11 24.09 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.183 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.93 39.74 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.275 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.43 -6.96 44.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 178.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.525 ' O ' HG23 ' A' ' 18' ' ' ILE . 11.7 m -54.04 -30.33 47.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.994 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.22 -23.67 15.52 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 -41.47 6.39 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.7 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG22 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -22.52 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.525 HG23 ' O ' ' A' ' 14' ' ' SER . 11.7 pt -46.13 -50.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.48 ' O ' ' HB1' ' A' ' 24' ' ' ALA . 6.4 m -67.57 -21.14 65.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.714 0.292 . . . . 0.0 111.374 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' HA ' ' HD3' ' A' ' 172' ' ' PRO . 69.1 mtt180 -89.96 -22.43 21.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.54 HG22 ' O ' ' A' ' 17' ' ' LEU . 46.4 t -61.38 169.34 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.386 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.946 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.51 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -45.88 -21.55 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.416 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.2 m-80 -69.05 -22.69 64.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.75 0.309 . . . . 0.0 111.253 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.48 ' HB1' ' O ' ' A' ' 19' ' ' SER . . . -54.88 -55.03 34.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -16.65 59.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.056 0.455 . . . . 0.0 110.304 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . 0.516 ' O ' ' HA ' ' A' ' 148' ' ' SER . . . -71.91 -48.51 45.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.431 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER 49.65 18.0 0.29 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 175.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 2.1 m -74.32 173.46 10.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.76 -177.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.545 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 4.1 m -46.42 -28.54 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.377 1.071 . . . . 0.0 113.037 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -54.46 -32.53 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -112.57 -18.76 12.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.426 0.631 . . . . 0.0 109.863 176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.545 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 5.6 tpp180 -67.68 -56.19 10.3 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.819 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -168.77 -36.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.31 136.69 24.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -49.63 139.79 12.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.439 0.638 . . . . 0.0 112.282 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.422 HH11 ' HD2' ' A' ' 36' ' ' ARG . 6.9 ptm180 -58.77 164.65 2.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.34 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.2 111.36 9.29 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.549 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.91 47.34 8.63 Favored Glycine 0 N--CA 1.426 -2.014 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.068 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.2 p -56.41 143.75 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.035 0.445 . . . . 0.0 109.897 176.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 17.4 m -101.6 157.02 17.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.426 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -61.79 -12.83 19.02 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.861 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.85 -46.34 81.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.773 0.321 . . . . 0.0 110.368 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.3 pp -85.93 -36.01 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.523 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.5 -65.9 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.802 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m 77.29 -18.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.856 0.862 . . . . 0.0 112.188 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -61.21 -73.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.658 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.14 -64.43 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.282 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -41.71 107.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.219 1.008 . . . . 0.0 113.652 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.551 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 20.6 mp0 -73.75 -53.66 9.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.579 ' HE ' HG13 ' A' ' 129' ' ' ILE . 26.1 ttt85 -145.36 4.39 1.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.856 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.73 -55.87 0.53 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.143 0.577 . . . . 0.0 110.779 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.451 ' HB3' HG21 ' A' ' 129' ' ' ILE . . . -65.41 131.34 46.19 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' A' ' 57' ' ' SER . 9.3 mp0 -56.21 -18.09 9.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.699 -174.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -56.25 -69.9 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.839 0.352 . . . . 0.0 111.235 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 tp -87.9 -23.82 23.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.911 0.386 . . . . 0.0 111.14 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.551 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -76.73 -18.16 58.65 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.549 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 32.3 t -54.11 91.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.256 0.551 . . . . 0.0 111.339 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.511 HG21 ' HG ' ' A' ' 59' ' ' LEU . 1.9 t -151.6 -35.52 0.13 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.469 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.511 ' HG ' HG21 ' A' ' 58' ' ' THR . 58.3 mt -115.57 19.79 15.12 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.41 54.55 7.6 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.584 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 38.7 t -89.6 107.97 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.801 -0.199 . . . . 0.0 110.666 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.16 82.36 0.22 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.27 -51.14 4.44 Favored Glycine 0 C--N 1.32 -0.319 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.359 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.515 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 17.2 p-10 -55.49 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.696 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.584 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.0 p-10 -85.73 14.82 5.32 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.278 0.561 . . . . 0.0 110.088 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.53 ' O ' HG22 ' A' ' 71' ' ' VAL . 26.0 tp -87.63 -60.41 1.98 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.52 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.74 64.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.356 0.598 . . . . 0.0 109.513 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.0 mpt_? -93.18 157.4 16.29 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 69.16 -62.66 0.4 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 66' ' ' LEU . . . -67.46 -62.36 1.46 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 66' ' ' LEU . 82.0 t -56.24 -41.02 68.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -68.39 -37.14 80.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.24 84.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.99 -35.02 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.204 0.526 . . . . 0.0 110.284 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 t -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.689 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -89.18 -0.59 57.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.736 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.488 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 33.7 mt -67.25 134.33 93.39 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_exo -57.77 127.92 27.08 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.53 2.153 . . . . 0.0 111.908 -178.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.42 19.19 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.519 0.676 . . . . 0.0 110.034 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.62 -28.99 70.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.181 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 p -80.67 -5.38 56.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.947 0.404 . . . . 0.0 109.973 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.1 t70 77.71 153.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.377 1.071 . . . . 0.0 111.274 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -65.13 -28.29 69.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.761 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.4 t -63.73 -22.74 67.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.19 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.73 -21.31 55.46 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.86 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.488 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 7.9 m-85 -82.85 -166.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.11 36.88 0.24 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.54 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' H ' ' C ' ' A' ' 86' ' ' TYR . 32.0 mm-40 -89.63 -59.7 2.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.05 82.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.107 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.548 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 94.1 m-85 -83.68 10.24 9.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.609 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 t -56.94 -40.79 77.05 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.226 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.532 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 69.9 m -57.98 -43.96 86.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.182 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.92 -31.89 64.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.411 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.548 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 22.1 mt -84.31 -21.54 30.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.978 0.418 . . . . 0.0 111.291 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 67.4 t80 -87.42 -38.52 16.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.139 178.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . 0.599 ' O ' HD23 ' A' ' 100' ' ' LEU . 17.7 m120 68.47 -74.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.894 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 75.33 -30.89 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.106 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . 0.402 ' H ' ' C ' ' A' ' 96' ' ' ASN . . . 96.48 -4.35 64.14 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -178.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.51 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 13.7 t -101.78 42.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.342 1.068 . . . . 0.0 108.581 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.599 HD23 ' O ' ' A' ' 96' ' ' ASN . 2.6 pt? -137.81 -171.23 2.95 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.396 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.8 115.5 26.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.233 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.54 63.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.266 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 p -64.38 -37.35 87.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.83 -43.17 90.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.655 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.42 -44.95 94.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.09 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.78 -18.38 60.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.587 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 m -88.74 -62.29 1.52 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.0 pp -116.53 -23.12 8.39 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.0 -176.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.496 ' CA ' HD11 ' A' ' 117' ' ' LEU . . . -56.25 -63.52 5.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.997 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.0 m -77.71 -9.62 59.09 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.663 0.268 . . . . 0.0 111.496 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -89.46 -58.77 2.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.57 -58.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.938 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.402 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.3 mp -70.0 -45.77 66.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 t 52.65 -94.8 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.46 -1.245 . . . . 0.0 113.39 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.31 -37.23 35.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.579 ' O ' HG22 ' A' ' 120' ' ' VAL . 53.1 tp -68.22 -58.7 4.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.214 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.496 HD11 ' CA ' ' A' ' 109' ' ' GLY . 23.6 mt -66.49 -27.42 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.63 -37.46 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 109.784 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.44 -32.48 34.29 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.579 HG22 ' O ' ' A' ' 116' ' ' LEU . 96.4 t -63.09 -44.11 99.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.498 0.19 . . . . 0.0 110.735 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.468 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 69.2 m -54.62 -39.06 67.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.62 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.8 m -80.98 -41.86 22.1 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.446 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.84 -70.49 0.56 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -73.77 -41.79 61.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.468 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 58.5 tt0 -80.49 -17.53 51.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 109.841 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.53 -70.44 1.33 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.955 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.62 -24.25 14.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.738 0.304 . . . . 0.0 111.199 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.4 100.66 2.17 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.672 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.579 HG13 ' HE ' ' A' ' 50' ' ' ARG . 15.0 mm -80.03 132.07 32.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.154 0.502 . . . . 0.0 111.569 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -148.23 145.97 28.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.271 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.19 142.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.03 -172.08 0.17 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 112.878 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.557 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 39.0 m -79.88 29.31 0.27 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.64 -79.09 0.22 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 t -110.25 -59.76 1.89 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.205 0.526 . . . . 0.0 110.822 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.445 ' O ' HG12 ' A' ' 140' ' ' ILE . 96.6 t -47.77 -63.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.365 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.557 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.1 tp-100 -56.34 -39.96 73.68 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -174.944 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.5 m -72.9 -26.9 61.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.804 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.52 -40.82 22.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.837 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.4 pt -79.38 -27.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 p -55.97 -62.13 1.91 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -63.94 -37.7 88.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.097 0.475 . . . . 0.0 111.227 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.4 m -66.09 -34.33 77.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.213 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.3 t -69.6 -21.06 63.62 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.051 0.453 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.6 m -70.55 -58.28 3.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.128 0.489 . . . . 0.0 110.303 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -90.78 -56.1 3.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.527 ' HB3' ' NH2' ' A' ' 32' ' ' ARG . 85.0 mt -68.83 -6.21 25.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -170.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 72.0 m -62.11 -54.43 41.43 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.662 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.7 p -113.11 -30.88 6.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.585 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 t 58.56 23.1 10.47 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.7 0.762 . . . . 0.0 110.193 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.2 t -105.95 176.61 5.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.587 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.6 p -73.2 -11.1 60.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.379 0.609 . . . . 0.0 110.101 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.446 ' O ' ' HB3' ' A' ' 157' ' ' SER . 8.0 m -93.71 -0.16 56.14 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.792 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.83 129.57 42.52 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.18 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.8 m 72.9 117.88 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.794 0.837 . . . . 0.0 112.063 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.19 -51.76 0.71 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.045 0.938 . . . . 0.0 112.936 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.446 ' HB3' ' O ' ' A' ' 153' ' ' SER . 34.9 t -70.65 -41.22 72.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.982 0.42 . . . . 0.0 111.223 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.11 -16.26 63.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.527 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.23 20.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -76.31 -15.21 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.281 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.98 -176.12 3.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.8 m -77.57 37.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.945 0.402 . . . . 0.0 111.428 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' SER . . . . . 0.452 ' HA ' ' O ' ' A' ' 167' ' ' ALA . 16.7 t -73.7 -41.85 62.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.7 m -77.71 -8.83 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.121 0.486 . . . . 0.0 110.847 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.9 m -68.87 -21.69 64.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 149.27 -37.14 1.0 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.947 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.452 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . -101.13 102.28 13.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.78 -48.03 84.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.972 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -140.15 145.21 37.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.508 HG23 ' H ' ' A' ' 171' ' ' GLY . 1.6 m -125.73 -147.13 0.36 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . 0.508 ' H ' HG23 ' A' ' 170' ' ' THR . . . -69.74 -162.56 3.53 Favored Glycine 0 C--O 1.218 -0.898 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.905 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.464 ' HD3' ' HA ' ' A' ' 20' ' ' ARG . 52.0 Cg_exo -59.94 -16.61 39.62 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.013 2.476 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' SER . . . . . 0.458 ' HB3' ' HA3' ' A' ' 187' ' ' GLY . 48.5 m -105.24 0.99 27.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.837 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 45.58 -156.27 0.41 Allowed Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.77 177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.37 76.68 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 122.976 2.451 . . . . 0.0 111.486 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 13.8 t 67.72 31.33 6.0 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.014 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.1 t -108.0 -28.15 9.74 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.364 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.418 ' HA2' ' HA3' ' A' ' 187' ' ' GLY . . . 62.45 -165.82 22.31 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.039 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.01 56.86 5.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.845 2.364 . . . . 0.0 110.78 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.9 t 65.93 25.7 11.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.487 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -173.97 170.59 43.73 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.22 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.423 ' N ' ' HD3' ' A' ' 183' ' ' PRO . 3.1 t80 60.91 51.53 2.44 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.042 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.423 ' HD3' ' N ' ' A' ' 182' ' ' TYR . 53.0 Cg_endo -84.83 157.85 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.139 1.893 . . . . 0.0 111.521 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.94 -69.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.026 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.96 -66.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.088 1.858 . . . . 0.0 111.488 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 12.0 tp -158.79 -41.24 0.06 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.483 177.669 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . 0.458 ' HA3' ' HB3' ' A' ' 173' ' ' SER . . . 147.28 34.99 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.231 -0.985 . . . . 0.0 113.566 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.29 -85.52 1.23 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.635 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -74.29 -68.43 1.57 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.217 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 64.38 150.47 0.11 Allowed Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.688 0.795 . . . . 0.0 111.456 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -66.77 126.41 15.3 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.09 1.86 . . . . 0.0 111.749 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -71.38 -12.13 61.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 109.874 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -105.95 78.25 0.26 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.871 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -125.28 147.52 49.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.038 0.447 . . . . 0.0 111.413 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 17.2 t -91.51 6.17 46.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.472 177.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 112.36 2.89 26.05 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.283 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -88.92 100.28 13.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.939 0.4 . . . . 0.0 110.875 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 156.45 164.97 13.99 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.227 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.809 0 CA-C-O 118.727 -1.041 . . . . 0.0 111.46 179.676 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.708 0.29 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.97 92.11 0.21 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.1 172.11 16.99 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.573 2.182 . . . . 0.0 111.363 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -82.71 29.62 0.45 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.667 0.27 . . . . 0.0 111.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.96 -111.24 3.78 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.529 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -13.0 62.5 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.302 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.05 23.13 14.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.145 0.498 . . . . 0.0 109.974 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 113' ' ' LEU . . . -78.11 170.41 54.88 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.598 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -79.02 -168.76 1.56 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.9 p 62.42 105.85 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.661 1.184 . . . . 0.0 112.616 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -108.76 43.11 1.78 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.972 -176.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.92 -85.1 0.16 Allowed Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.328 0.491 . . . . 0.0 114.328 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.01 72.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.639 0.376 . . . . 0.0 111.615 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.647 ' O ' HG21 ' A' ' 18' ' ' ILE . 9.6 m -58.67 -31.45 68.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.396 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.3 62.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.41 -35.82 8.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.564 ' O ' HG21 ' A' ' 21' ' ' VAL . 2.8 pp -85.63 -21.94 28.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.647 HG21 ' O ' ' A' ' 14' ' ' SER . 11.9 pt -37.75 -52.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.0 m -71.61 -24.67 61.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.498 ' NH2' ' HA ' ' A' ' 169' ' ' TYR . 93.9 mtt180 -87.58 -23.13 24.42 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 17' ' ' LEU . 31.6 t -62.34 174.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.425 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.433 ' H ' ' CG1' ' A' ' 21' ' ' VAL . . . -37.57 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . 0.425 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 10.6 m-80 -63.5 -24.56 67.87 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.102 -0.374 . . . . 0.0 111.851 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.577 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.89 -35.91 79.74 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.354 0.597 . . . . 0.0 109.437 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 tp -80.23 -35.06 36.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.715 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.99 77.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.021 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.504 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 9.6 t-20 59.2 13.25 2.92 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.172 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 1.5 m -83.56 168.54 16.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.283 0.563 . . . . 0.0 112.066 -175.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.558 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 1.8 m -51.92 -26.22 9.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.62 1.168 . . . . 0.0 112.927 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 p -53.29 -40.82 65.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.872 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.63 -19.52 16.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.598 0.713 . . . . 0.0 109.646 178.234 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.558 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 16.1 tpp180 -66.22 -64.62 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.605 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . 0.411 ' OG1' HG23 ' A' ' 83' ' ' THR . 12.3 t -164.77 -23.74 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.122 -174.255 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.94 137.59 20.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.99 140.43 25.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.063 0.459 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -65.82 164.52 14.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.681 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.46 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 2.4 p -70.7 111.88 6.5 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.16 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.0 43.23 8.93 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.2 p -46.07 138.65 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 111.815 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.504 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.6 m -70.78 137.99 50.05 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.37 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.453 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 48.4 tt0 -62.69 -13.44 32.25 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.165 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -52.62 -42.21 64.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.006 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.504 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.62 -39.53 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.539 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -83.24 -68.0 0.74 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.453 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 5.9 m 71.64 -33.74 0.28 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -66.24 -79.26 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.5 p -118.74 -30.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.259 0.552 . . . . 0.0 111.526 -177.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.37 92.78 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 74.9 mt-30 -81.11 -40.44 24.05 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.162 0.506 . . . . 0.0 110.126 176.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.613 ' NH1' HD12 ' A' ' 55' ' ' LEU . 11.2 ttm180 -149.03 -1.4 0.48 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.656 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.23 -55.74 0.6 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.094 0.557 . . . . 0.0 110.259 -175.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.46 131.0 47.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.378 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.611 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -54.9 -17.77 4.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.852 -177.721 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.613 HD12 ' NH1' ' A' ' 50' ' ' ARG . 2.2 tt -88.59 -24.09 22.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 111.385 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -71.8 -18.5 62.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.611 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.3 t -55.34 96.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.299 0.571 . . . . 0.0 110.729 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.459 HG22 ' HG ' ' A' ' 59' ' ' LEU . 11.0 t -132.99 -30.06 1.4 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.171 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.459 ' HG ' HG22 ' A' ' 58' ' ' THR . 94.4 mt -120.26 20.09 12.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.804 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.58 66.85 1.64 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.38 109.73 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.38 87.02 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.6 -53.05 3.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.734 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.529 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.1 p-10 -61.45 -73.72 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.386 0.674 . . . . 0.0 112.321 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.529 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 66.2 t30 -84.75 11.66 8.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.675 0.75 . . . . 0.0 109.622 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.83 -70.48 0.63 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.279 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 -34.03 39.75 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.42 0.629 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 56.5 mtm180 -99.46 157.72 16.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.622 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 68.03 -57.05 0.48 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.511 0.725 . . . . 0.0 112.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.17 0.91 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.703 0.287 . . . . 0.0 111.355 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.64 -35.5 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -68.08 -25.51 65.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.342 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.71 23.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.382 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.98 -32.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.245 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -69.89 -14.74 62.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.229 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.42 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 44.5 ttp180 -87.62 -15.71 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.111 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.647 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 9.4 mp -84.23 108.17 13.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.29 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 76' ' ' ARG . 73.8 Cg_endo -76.81 128.46 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.205 1.937 . . . . 0.0 111.781 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.59 86.32 7.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.97 -50.41 6.4 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -63.8 -61.69 2.13 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 120.628 0.251 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -179.46 159.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.699 ' HB ' ' OE1' ' A' ' 88' ' ' GLN . 12.6 p -77.4 -23.43 50.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.225 0.536 . . . . 0.0 110.674 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 m -63.08 -18.0 62.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.464 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.4 64.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.131 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.647 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 64.3 m-85 -84.94 -171.99 3.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.083 0.468 . . . . 0.0 110.35 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.11 25.63 0.16 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.582 179.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.699 ' OE1' ' HB ' ' A' ' 83' ' ' THR . 76.3 mt-30 -86.18 -56.73 3.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.632 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.482 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.73 -29.34 68.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.376 0.607 . . . . 0.0 110.036 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.537 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.0 m-85 -84.31 3.76 34.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -50.71 -35.89 33.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.425 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 70.3 m -53.92 -53.41 53.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.73 -24.03 33.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.537 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 51.1 mt -84.82 -36.13 21.84 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -85.2 -41.1 15.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.93 90.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.501 0.667 . . . . 0.0 111.648 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.76 -0.97 55.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.823 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.02 -3.14 85.36 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.712 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . 0.412 HG23 ' CD1' ' A' ' 197' ' ' PHE . 10.5 t -100.57 -13.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 109.929 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.445 ' HA ' ' HA3' ' A' ' 193' ' ' GLY . 2.6 pt? -84.02 167.42 16.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.365 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -77.44 104.4 7.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.674 0.75 . . . . 0.0 110.385 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -13.04 61.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.682 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -69.21 -34.46 74.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -35.78 77.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.74 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.59 -41.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.211 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.83 -18.09 51.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.031 0.443 . . . . 0.0 111.463 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.1 m -81.82 -58.63 2.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.391 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.2 -20.92 4.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.426 ' C ' HD12 ' A' ' 117' ' ' LEU . . . -57.37 -68.41 1.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.158 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.416 ' O ' ' HA ' ' A' ' 114' ' ' SER . 6.5 p -67.4 -16.82 64.45 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -84.64 -45.54 12.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.666 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.47 -50.79 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.597 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.504 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 6.5 mp -70.59 -34.36 72.08 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.006 0.431 . . . . 0.0 110.317 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 110' ' ' SER . 50.8 m 48.16 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.96 -36.77 50.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.3 -60.16 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.991 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.426 HD12 ' C ' ' A' ' 109' ' ' GLY . 49.0 mt -64.34 -34.23 77.68 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -69.77 -22.67 63.32 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.109 0.481 . . . . 0.0 110.907 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.13 -32.78 11.65 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.936 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.524 HG12 ' O ' ' A' ' 94' ' ' LEU . 54.2 t -76.24 -29.92 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.996 0.518 . . . . 0.0 111.914 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 15.8 p -52.2 -44.04 64.53 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.306 0.642 . . . . 0.0 112.592 -177.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.1 p -84.47 -26.46 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.923 0.392 . . . . 0.0 111.481 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.83 -78.45 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.34 -49.16 45.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -176.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -72.07 -21.33 61.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.09 -56.13 2.5 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.204 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.6 mt -126.95 -25.01 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.998 0.399 . . . . 0.0 111.786 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.55 107.95 3.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.001 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.46 ' O ' ' HB ' ' A' ' 37' ' ' THR . 32.6 mt -76.37 126.83 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -120.81 135.57 55.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.411 HG22 ' HA ' ' A' ' 37' ' ' THR . 12.7 t -89.09 172.83 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -60.45 162.61 6.07 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.548 0.689 . . . . 0.0 112.018 -178.438 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.4 t -80.16 6.61 11.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.301 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.27 -78.94 0.61 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.295 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 m -93.73 -39.89 10.52 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.27 -62.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.406 ' HA ' HG12 ' A' ' 140' ' ' ILE . 9.4 tt0 -59.18 -39.79 83.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -59.4 -43.98 92.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.442 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.58 -50.01 19.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 137' ' ' GLN . 42.0 pt -60.67 -38.46 78.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.812 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 t -65.7 -40.03 91.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.3 m -70.8 -42.44 70.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 t -72.42 -42.44 65.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.634 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.657 ' HA ' ' OG ' ' A' ' 148' ' ' SER . 23.5 t -60.33 -41.82 94.36 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 111.445 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.0 m -67.43 -43.94 79.97 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.887 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -89.97 -58.19 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.53 -42.63 34.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -171.574 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.657 ' OG ' ' HA ' ' A' ' 144' ' ' SER . 18.5 m -58.96 -32.02 69.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.468 ' C ' ' HG ' ' A' ' 150' ' ' SER . 39.6 p -130.81 -45.05 1.05 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.251 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . 0.468 ' HG ' ' C ' ' A' ' 149' ' ' THR . 53.7 p 54.66 -85.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.088 0.955 . . . . 0.0 112.822 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -144.19 105.03 4.18 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t 70.49 -76.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.429 ' HB3' ' HB3' ' A' ' 158' ' ' GLN . 8.6 t -127.23 158.93 35.83 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.8 166.88 20.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.601 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 156' ' ' TYR . 21.9 m -59.98 146.29 43.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . 0.43 ' HB3' ' O ' ' A' ' 155' ' ' SER . 89.5 t80 76.12 -37.85 0.32 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.432 0.693 . . . . 0.0 111.293 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' SER . . . . . 0.478 ' HA ' ' OG ' ' A' ' 176' ' ' SER . 46.0 t -59.06 -61.77 2.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.429 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 11.0 pt20 -69.96 -16.43 63.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.56 -23.72 42.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.676 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -105.53 -89.88 0.42 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.865 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.442 ' O ' ' HB3' ' A' ' 175' ' ' PRO . . . 53.66 -166.08 0.08 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 122.955 0.502 . . . . 0.0 111.95 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t 61.07 87.59 0.09 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.492 0.717 . . . . 0.0 112.264 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 t -77.14 -5.28 48.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.63 0.729 . . . . 0.0 109.268 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -83.42 -45.66 13.42 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.61 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.9 t -65.47 -32.29 73.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.452 0.644 . . . . 0.0 109.775 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.12 138.48 5.79 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.82 156.05 38.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.953 0.376 . . . . 0.0 110.72 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 137.13 9.56 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.498 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 49.9 m-85 74.84 17.55 2.81 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.764 0.826 . . . . 0.0 109.344 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.2 p -51.19 121.58 6.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.516 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 128.55 -121.7 3.74 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.631 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.18 -7.22 11.08 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.967 2.445 . . . . 0.0 113.576 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.5 t -115.46 -2.68 12.51 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.562 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.03 -133.29 1.47 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.64 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.442 ' HB3' ' O ' ' A' ' 161' ' ' ALA . 3.0 Cg_exo -75.51 106.63 2.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.087 1.858 . . . . 0.0 110.896 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' SER . . . . . 0.478 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 3.5 m -67.03 93.36 0.28 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.6 t -92.54 18.27 8.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.927 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.73 75.13 0.43 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.883 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -86.63 150.42 8.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.842 2.361 . . . . 0.0 112.905 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.2 m -87.79 2.12 52.14 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.828 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.75 -11.51 85.16 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.241 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.8 152.55 77.26 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.13 124.63 14.26 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 110.817 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.4 ' C ' ' H ' ' A' ' 186' ' ' LEU . . . 73.75 92.4 0.13 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.267 -177.138 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.84 20.26 0.54 Allowed 'Trans proline' 0 N--CA 1.475 0.429 0 C-N-CA 122.916 2.411 . . . . 0.0 112.551 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.4 ' H ' ' C ' ' A' ' 184' ' ' GLY . 75.0 mt -92.86 87.93 6.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.991 0.424 . . . . 0.0 110.18 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.97 71.93 2.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.772 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.65 -99.92 1.05 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -91.74 89.48 1.43 Allowed Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.661 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -99.9 147.73 33.85 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.405 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 88.8 Cg_endo -92.4 1.33 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.281 1.987 . . . . 0.0 112.775 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -63.07 -21.28 66.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.715 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.445 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . 136.3 -61.96 0.61 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.832 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 57.35 38.23 28.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.281 0.633 . . . . 0.0 111.586 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 40.6 p -79.08 23.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.652 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 89.16 51.99 2.84 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.49 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.412 ' CD1' HG23 ' A' ' 99' ' ' VAL . 79.6 t80 -75.11 -38.08 61.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.023 0.44 . . . . 0.0 110.737 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 97.44 -126.37 8.84 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.793 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.117 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.56 -179.492 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.573 0.225 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.5 93.24 0.61 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.23 174.93 8.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.68 2.254 . . . . 0.0 111.688 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.19 62.28 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.633 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.85 64.02 4.77 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.005 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.47 -42.78 1.86 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.585 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -81.87 89.78 6.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.989 0.424 . . . . 0.0 109.963 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.31 118.8 5.8 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.521 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.466 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . . . -71.07 126.66 30.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.83 154.74 18.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.755 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.24 151.25 19.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.231 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.94 -65.33 0.2 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.998 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.6 71.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.142 0.496 . . . . 0.0 110.732 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.523 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.6 m -66.91 -21.58 65.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.83 -18.52 44.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.8 -43.59 5.69 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.334 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.561 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.0 pp -84.21 -21.88 31.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.536 HD13 ' O ' ' A' ' 89' ' ' ALA . 8.9 pt -46.2 -47.31 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.571 ' O ' ' HB3' ' A' ' 24' ' ' ALA . 10.9 m -73.39 -20.0 60.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.749 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.525 ' O ' ' HB2' ' A' ' 191' ' ' PRO . 32.3 mtm180 -86.03 -33.5 21.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.696 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.561 HG21 ' O ' ' A' ' 17' ' ' LEU . 58.0 t -50.16 168.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.088 0.555 . . . . 0.0 111.406 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -36.72 -28.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.571 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 26.8 m-80 -60.39 -28.9 68.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.729 0.241 . . . . 0.0 111.436 177.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.571 ' HB3' ' O ' ' A' ' 19' ' ' SER . . . -63.21 -44.93 93.91 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.292 0.568 . . . . 0.0 109.85 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.2 -38.21 66.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.156 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.96 80.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 1.6 t-20 54.55 17.84 1.79 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.446 174.042 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 m -77.76 166.33 23.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.496 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.8 m -61.11 -16.98 50.18 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 122.78 0.432 . . . . 0.0 112.105 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -52.23 -34.44 45.79 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -108.14 -21.58 12.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -178.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -79.85 -42.78 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t -158.19 -50.5 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.211 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.6 129.97 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . 0.502 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 1.5 pt? -50.32 139.9 14.27 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.456 0.472 . . . . 0.0 111.808 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -60.75 159.75 10.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.867 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.563 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 1.7 p -77.47 142.71 39.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.064 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.57 71.46 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.538 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 147.81 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.799 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.548 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 10.3 m -106.75 161.83 14.32 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.95 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -66.23 -13.75 60.83 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.555 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -54.95 -43.72 73.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.526 HD11 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -86.62 -36.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.526 ' N ' HD11 ' A' ' 43' ' ' ILE . . . -83.48 -39.96 19.86 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m 78.32 -18.36 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.108 0.963 . . . . 0.0 111.476 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 m -76.51 -162.24 0.24 Allowed 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 122.212 1.006 . . . . 0.0 110.721 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 35.0 m -74.64 -20.55 16.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.516 -176.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.38 84.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.551 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.548 ' O ' ' HA ' ' A' ' 40' ' ' SER . 74.5 mt-30 -83.62 -43.99 15.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 0.0 111.86 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.434 ' C ' ' H ' ' A' ' 52' ' ' ALA . 51.0 ttt180 -132.19 -10.11 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.63 -36.69 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.294 0.638 . . . . 0.0 110.646 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.446 ' HB2' HG22 ' A' ' 129' ' ' ILE . . . -80.22 150.95 29.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.795 0.331 . . . . 0.0 110.11 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.587 ' O ' ' HB2' ' A' ' 57' ' ' SER . 21.2 mp0 -56.28 -34.3 66.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -174.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.9 m -54.48 -70.85 0.09 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -86.18 -25.02 25.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -80.42 -18.82 47.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.728 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.587 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -65.92 79.82 0.08 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.72 0.772 . . . . 0.0 111.46 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -100.97 -28.51 12.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.038 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.6 mt -122.37 19.17 10.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.019 178.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.62 1.41 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.765 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.672 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 65.7 t -88.38 120.07 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.882 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 t70 178.46 90.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.504 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.03 -57.4 3.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.954 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -55.85 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.266 0.626 . . . . 0.0 111.547 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.672 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.3 p-10 -87.38 21.25 2.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.059 0.456 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.15 -72.73 0.54 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.689 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.32 -7.98 50.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.303 0.573 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.32 170.61 13.91 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 66.05 -62.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.59 -64.02 1.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.769 0.318 . . . . 0.0 110.882 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 98.3 mt-30 -63.35 -37.1 85.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.602 0.239 . . . . 0.0 111.49 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.58 -48.6 25.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.089 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.74 -42.15 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.589 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.0 p -74.06 -4.96 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 111.032 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 34.1 ttm180 -98.11 -0.5 44.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.195 0.521 . . . . 0.0 110.535 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.96 144.37 87.71 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.227 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.93 144.03 46.75 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.558 2.172 . . . . 0.0 112.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.51 22.33 13.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.201 0.524 . . . . 0.0 110.938 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.01 63.77 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -76.43 -6.39 51.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.477 -0.362 . . . . 0.0 110.54 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 75.89 157.51 0.19 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.891 0.876 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.3 m -66.49 -25.91 66.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.759 -177.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.2 m -65.22 -18.78 65.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.55 -21.06 61.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.02 0.438 . . . . 0.0 110.606 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.409 ' C ' ' H ' ' A' ' 88' ' ' GLN . 57.5 m-85 -77.83 -167.58 1.02 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.607 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.4 14.98 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.998 -178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.502 ' OE1' ' HA ' ' A' ' 35' ' ' LEU . 8.2 mm100 -71.71 -37.54 70.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.001 0.429 . . . . 0.0 111.288 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.536 ' O ' HD13 ' A' ' 18' ' ' ILE . . . -67.89 -62.16 1.54 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.472 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.84 32.41 0.48 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.142 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.7 m -50.54 -55.7 14.95 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.6 m -63.97 -36.3 83.5 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.97 70.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.538 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.472 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 40.0 mt -84.57 -23.49 29.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.505 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -85.56 -47.36 9.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.743 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.36 61.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.241 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.17 1.99 71.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.86 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.35 -15.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.481 0.657 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.462 ' HB3' HG12 ' A' ' 21' ' ' VAL . 2.2 pt? -85.51 179.28 7.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.255 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -75.23 125.77 29.64 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 111.662 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.65 61.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.276 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.7 t -65.18 -35.01 79.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.497 ' O ' HD11 ' A' ' 108' ' ' LEU . 11.1 t30 -61.01 -50.42 73.45 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.047 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . 0.5 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -66.69 -38.09 80.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.827 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -30.41 69.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.875 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -80.1 -62.96 1.52 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.513 HD22 ' OG ' ' A' ' 14' ' ' SER . 0.0 OUTLIER -122.22 -15.5 7.68 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.731 -176.764 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . 0.5 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -56.11 -72.02 0.64 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.795 -0.716 . . . . 0.0 113.638 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 m -70.82 -10.35 59.37 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -86.68 -53.99 4.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.35 -178.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.27 -54.66 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.017 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.466 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mp -63.13 -31.97 73.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.1 p 38.71 -93.14 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.25 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.427 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 120' ' ' VAL . 65.4 tp -68.61 -52.63 29.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.042 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.416 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 18.8 mt -61.44 -28.18 69.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -59.13 -36.98 76.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.402 . . . . 0.0 110.208 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.45 -33.58 11.45 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.969 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.1 t -60.99 -31.7 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.3 m -48.65 -52.04 25.26 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.294 0.371 . . . . 0.0 111.936 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 p -83.68 -21.42 32.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 111.09 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.405 ' HB1' ' HA ' ' A' ' 120' ' ' VAL . . . -81.31 -93.76 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.13 29.43 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.01 -29.77 71.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.18 -90.91 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.4 mt -112.56 -8.29 13.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.774 0.321 . . . . 0.0 111.553 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.14 98.85 0.94 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.153 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.563 ' O ' ' HB ' ' A' ' 37' ' ' THR . 25.1 mm -67.66 139.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . 0.406 HD22 ' HG3' ' A' ' 137' ' ' GLN . 18.7 t-20 -90.55 136.06 33.3 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . 0.495 HG11 ' H ' ' A' ' 133' ' ' SER . 30.7 t -75.66 146.07 9.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.906 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.47 -37.31 83.14 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 122.083 0.944 . . . . 0.0 111.068 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.495 ' H ' HG11 ' A' ' 131' ' ' VAL . 38.9 t -58.65 107.59 0.53 Allowed 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.026 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.75 -17.91 29.76 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.199 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.1 m -65.57 -37.44 86.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.993 0.425 . . . . 0.0 110.197 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.463 ' O ' HG12 ' A' ' 140' ' ' ILE . 46.4 t -77.99 -50.69 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.796 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.406 ' HG3' HD22 ' A' ' 130' ' ' ASN . 7.8 tt0 -59.25 -49.62 77.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.708 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -65.75 -28.74 69.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.04 -54.9 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.451 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.463 HG12 ' O ' ' A' ' 136' ' ' VAL . 42.6 pt -58.92 -34.77 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.255 -177.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.6 t -50.59 -49.34 56.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.262 0.351 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -84.84 -42.47 15.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.852 0.358 . . . . 0.0 111.831 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' SER . . . . . 0.409 ' HA ' HD23 ' A' ' 147' ' ' LEU . 62.9 m -57.79 -38.84 76.2 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 148' ' ' SER . 43.8 p -65.78 -20.53 66.29 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -82.44 -55.51 4.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.697 0.284 . . . . 0.0 111.238 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.6 -46.23 17.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.415 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 2.9 mm? -82.03 6.81 15.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 144' ' ' SER . 23.8 t -51.34 -29.37 15.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.489 HG22 ' H ' ' A' ' 153' ' ' SER . 4.0 m -157.7 24.42 0.28 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.526 0.679 . . . . 0.0 109.254 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 p -54.99 -64.31 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.263 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.4 t -84.67 35.31 0.56 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.417 ' HA ' ' O ' ' A' ' 175' ' ' PRO . 32.4 t -132.96 -87.98 0.43 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.477 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . 0.489 ' H ' HG22 ' A' ' 149' ' ' THR . 33.1 m -156.67 52.1 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.649 0.261 . . . . 0.0 110.71 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.42 65.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.553 0.692 . . . . 0.0 109.548 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.4 t -108.77 144.41 36.63 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -58.71 -33.19 69.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.172 0.511 . . . . 0.0 110.312 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.2 m -69.56 -10.92 60.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.516 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . 0.456 ' HB2' ' HA ' ' A' ' 153' ' ' SER . 97.7 mt-30 -94.86 -9.42 34.39 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 110.403 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.91 -20.9 60.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.33 0.586 . . . . 0.0 109.612 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 t -94.92 36.7 1.18 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.834 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.54 161.45 27.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.351 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 m -70.11 90.81 0.67 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.193 0.521 . . . . 0.0 111.268 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 p -137.29 15.81 2.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.123 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.2 m -63.38 -29.43 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.147 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 p -81.98 1.08 37.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.27 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 99.47 -9.06 60.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 72.59 -50.69 0.7 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.881 . . . . 0.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.5 -69.18 3.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.582 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -73.54 -60.41 2.26 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.336 0.112 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 48.5 m 56.75 82.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.241 0.543 . . . . 0.0 111.913 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 122.24 -79.99 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.812 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.64 -44.21 49.34 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.545 2.83 . . . . 0.0 112.582 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.4 m -146.33 43.45 1.21 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -142.4 -173.85 14.56 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.489 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.417 ' O ' ' HA ' ' A' ' 152' ' ' SER . 89.4 Cg_endo -83.61 9.9 3.91 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.839 2.36 . . . . 0.0 112.142 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 13.4 m 49.8 42.1 23.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 t -59.87 143.23 51.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.59 0.71 . . . . 0.0 111.962 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.38 68.24 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.79 115.34 2.55 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.139 2.56 . . . . 0.0 113.381 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.5 m -78.76 135.77 37.2 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.699 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.56 30.28 14.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.475 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . 0.406 ' HA ' ' HD3' ' A' ' 183' ' ' PRO . 36.8 m-85 -132.1 151.0 77.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . 0.406 ' HD3' ' HA ' ' A' ' 182' ' ' TYR . 2.5 Cg_endo -80.38 141.92 14.54 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.601 2.201 . . . . 0.0 111.72 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.38 67.09 1.55 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.5 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.1 175.41 9.24 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.66 2.24 . . . . 0.0 112.267 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . 0.436 ' HA ' ' HA ' ' A' ' 190' ' ' ALA . 3.7 mm? 63.61 18.67 11.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.502 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -111.93 113.69 3.38 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.63 -64.39 4.07 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -102.11 128.32 9.51 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . 0.469 ' H ' ' HD2' ' A' ' 191' ' ' PRO . . . -119.36 -50.58 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -174.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.525 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 57.0 Cg_endo -67.02 13.28 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.934 1.756 . . . . 0.0 114.75 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . 0.403 ' H ' ' C ' ' A' ' 190' ' ' ALA . 11.4 p90 -94.46 -7.03 42.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 179.25 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.416 ' O ' HD22 ' A' ' 186' ' ' LEU . . . -163.18 62.98 0.26 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 32.6 mt-30 -77.81 -32.34 52.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.002 0.43 . . . . 0.0 111.786 -173.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.4 p -85.1 19.22 2.25 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.119 0.485 . . . . 0.0 110.288 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.57 21.01 75.91 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -176.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -69.28 134.19 48.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.586 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.75 162.07 32.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.63 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.431 -1.205 . . . . 0.0 111.726 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.14 104.41 0.26 Allowed Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.424 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.5 Cg_endo -73.81 179.27 5.83 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.584 2.19 . . . . 0.0 111.713 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . 0.447 ' HB3' ' HB2' ' A' ' 7' ' ' PHE . 6.6 tp-100 -89.15 150.36 22.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.7 98.89 0.17 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.583 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.73 -3.26 52.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.282 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.447 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 45.3 m-85 -135.48 87.52 2.33 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.071 0.462 . . . . 0.0 110.145 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.23 129.9 9.91 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.286 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' HB1' HD21 ' A' ' 116' ' ' LEU . . . -86.59 -176.64 5.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.719 0.295 . . . . 0.0 111.007 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p 53.14 86.55 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.688 0.795 . . . . 0.0 112.255 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.37 163.87 54.54 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.652 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.22 -40.8 6.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.066 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.47 -45.43 75.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.935 0.398 . . . . 0.0 110.997 -179.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.553 ' O ' HG22 ' A' ' 18' ' ' ILE . 16.7 m -68.06 -22.63 64.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.044 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.66 58.61 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.16 -38.84 7.12 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.117 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.601 ' O ' HG21 ' A' ' 21' ' ' VAL . 4.4 pp -84.83 -22.35 29.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ILE . . . . . 0.553 HG22 ' O ' ' A' ' 14' ' ' SER . 10.1 pt -44.75 -48.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 t -84.67 -20.14 31.73 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.552 0.215 . . . . 0.0 111.377 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.464 ' HG2' ' HG3' ' A' ' 172' ' ' PRO . 62.0 mtt180 -86.89 -25.94 24.19 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' VAL . . . . . 0.601 HG21 ' O ' ' A' ' 17' ' ' LEU . 21.9 t -74.21 -107.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ALA . . . . . 0.413 ' N ' HG11 ' A' ' 21' ' ' VAL . . . -79.1 -35.81 41.73 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -66.98 -24.25 66.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.482 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.25 -45.37 88.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.068 0.461 . . . . 0.0 110.316 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.16 -18.95 44.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.787 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.56 -38.33 70.97 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.922 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASN . . . . . 0.477 ' HB3' ' CB ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER 57.58 16.98 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 176.934 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' THR . . . . . 0.438 ' O ' HD21 ' A' ' 31' ' ' LEU . 5.1 m -75.82 167.68 21.44 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 -178.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.7 m -72.23 -14.26 61.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.428 ' O ' ' HB3' ' A' ' 88' ' ' GLN . 19.0 p -50.2 -53.3 28.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.438 HD21 ' O ' ' A' ' 28' ' ' THR . 1.3 pt? -78.71 -19.73 51.73 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.151 0.5 . . . . 0.0 110.985 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -76.74 -52.98 8.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.631 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -169.05 -19.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.84 136.26 23.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.91 149.61 14.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 0.0 111.243 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.414 ' HD2' ' O ' ' A' ' 87' ' ' ALA . 7.7 ptm180 -76.06 164.45 26.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.405 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.01 109.3 9.54 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.984 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.626 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 94.49 37.69 5.24 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.841 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 2.3 p -48.38 124.94 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.251 0.548 . . . . 0.0 109.957 174.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.672 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 16.5 m -85.67 167.0 15.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.484 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 14.7 pt20 -69.14 -13.15 62.26 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.243 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLN . . . . . 0.424 ' OE1' ' HA ' ' A' ' 3' ' ' PRO . 65.8 mm-40 -63.02 -55.0 29.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.305 0.574 . . . . 0.0 109.869 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.655 HD12 ' O ' ' A' ' 40' ' ' SER . 0.2 OUTLIER -85.27 -32.19 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.717 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . 0.429 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . . . -78.54 -61.69 1.93 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.499 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 87.0 p 68.82 -31.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.687 1.595 . . . . 0.0 115.291 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.5 m -66.27 -73.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.79 -27.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.838 0.351 . . . . 0.0 111.841 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -80.47 100.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.351 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.672 ' O ' ' HA ' ' A' ' 40' ' ' SER . 44.6 mt-30 -82.17 -34.85 28.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.082 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.626 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 16.5 ttt85 -158.03 4.34 0.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.731 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ALA . . . . . 0.458 ' N ' ' HB2' ' A' ' 56' ' ' ALA . . . 67.87 -52.83 0.52 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.067 0.547 . . . . 0.0 110.841 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' CB ' HG13 ' A' ' 129' ' ' ILE . . . -63.51 137.41 58.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.222 177.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLN . . . . . 0.529 ' O ' ' HB2' ' A' ' 57' ' ' SER . 17.5 mp0 -53.49 -26.89 22.47 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -60.83 -67.57 0.39 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.815 0.34 . . . . 0.0 111.885 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.427 ' HB3' ' CB ' ' A' ' 50' ' ' ARG . 25.9 tp -87.83 -24.01 23.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.585 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -78.57 -19.1 53.55 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.529 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 5.8 t -62.39 88.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.406 0.622 . . . . 0.0 111.491 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.598 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 8.2 t -112.23 -32.46 6.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.819 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.439 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.1 mt -121.6 18.83 11.22 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.946 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 67.56 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.89 120.84 39.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.712 0.292 . . . . 0.0 111.158 -176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -170.85 83.89 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.883 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -47.29 3.55 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ASN . . . . . 0.488 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 18.0 p-10 -54.33 -83.19 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.735 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.488 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 29.2 p-10 -87.99 24.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.303 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 tp -87.0 -66.4 0.91 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.067 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.26 62.02 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.479 0.657 . . . . 0.0 110.412 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.439 HH21 ' HA ' ' A' ' 64' ' ' ASN . 29.9 mtm180 -110.39 165.63 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 68.05 -61.91 0.37 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.69 3.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.864 0.364 . . . . 0.0 111.492 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.525 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -65.27 -35.77 82.06 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.644 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.14 -47.71 60.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.857 0.36 . . . . 0.0 111.397 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.67 -34.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.987 0.422 . . . . 0.0 110.932 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.0 p -73.94 -23.06 59.46 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.158 0.504 . . . . 0.0 110.457 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -87.08 -15.03 39.74 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.919 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' CD2' ' HH ' ' A' ' 86' ' ' TYR . 19.1 tp -73.32 123.78 89.83 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.126 -179.583 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.94 157.46 23.93 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.608 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.54 121.09 38.6 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.0 -60.4 4.21 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.6 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -80.31 -60.3 2.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.857 0.361 . . . . 0.0 111.755 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.99 160.47 42.07 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.9 m -70.25 -35.09 73.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.077 0.465 . . . . 0.0 110.262 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 p -68.7 -17.02 64.0 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.701 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.82 -21.31 56.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.852 0.461 . . . . 0.0 111.399 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.503 ' HH ' ' CD2' ' A' ' 77' ' ' LEU . 1.0 OUTLIER -72.14 -161.71 0.08 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.971 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.414 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -77.85 18.48 0.47 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.49 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 33.9 mt-30 -80.83 -56.63 4.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.144 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ALA . . . . . 0.513 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.38 -35.88 82.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.085 0.469 . . . . 0.0 110.278 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.478 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -82.4 13.37 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.556 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -59.21 -44.3 92.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -62.96 -41.06 99.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.66 69.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.687 0.28 . . . . 0.0 111.48 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.478 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 28.3 mt -84.78 -19.54 32.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.022 0.439 . . . . 0.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.88 -36.98 19.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.59 80.84 0.14 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.989 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.03 -12.2 60.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.811 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.62 -11.93 64.8 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.95 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.65 -15.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.325 0.583 . . . . 0.0 109.977 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.562 ' CB ' HG12 ' A' ' 21' ' ' VAL . 2.0 pt? -84.8 161.39 19.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.801 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASN . . . . . 0.466 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 46.2 t30 -67.82 107.25 2.54 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.526 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.63 -15.84 63.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.951 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -74.52 -27.6 60.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASN . . . . . 0.47 ' O ' HD21 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -71.41 -33.99 69.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.166 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 34.8 mm -66.11 -34.23 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.21 -32.37 66.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.196 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.4 m -68.55 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.853 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.47 HD21 ' O ' ' A' ' 104' ' ' ASN . 2.3 pt? -121.28 -21.09 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -56.2 -65.21 3.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.944 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -71.91 -11.54 60.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.802 0.334 . . . . 0.0 111.603 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -87.04 -61.07 1.81 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.19 -56.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.548 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.0 mt -62.42 -55.23 29.81 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.181 -177.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.7 t 55.42 -87.04 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.107 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.34 66.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 122.947 0.499 . . . . 0.0 111.459 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.59 ' O ' HG22 ' A' ' 120' ' ' VAL . 53.3 tp -67.02 -49.88 63.86 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' LEU . . . . . 0.431 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 21.3 mt -66.97 -25.1 66.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.928 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.76 -36.57 81.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 109.666 175.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.13 -17.69 58.82 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.227 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' VAL . . . . . 0.59 HG22 ' O ' ' A' ' 116' ' ' LEU . 93.8 t -85.25 -44.02 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.509 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 11.8 p -52.49 -61.82 2.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 t -76.0 -23.84 55.28 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.085 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.487 ' C ' HD11 ' A' ' 129' ' ' ILE . . . -83.57 -80.21 0.19 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ALA . . . . . 0.529 ' HB1' HH21 ' A' ' 50' ' ' ARG . . . -72.51 -44.67 61.9 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.662 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLN . . . . . 0.509 ' HB3' ' O ' ' A' ' 121' ' ' SER . 42.6 tt0 -70.96 -34.76 71.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.281 0.562 . . . . 0.0 110.097 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.43 -63.2 2.54 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.043 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.87 -23.98 11.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.92 97.3 1.22 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ILE . . . . . 0.496 HG13 ' CB ' ' A' ' 52' ' ' ALA . 1.2 mp -81.54 136.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.539 0.685 . . . . 0.0 112.229 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -135.14 137.33 42.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.105 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -80.85 156.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.4 169.15 1.79 Allowed 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' SER . . . . . 0.46 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 3.0 m -74.31 39.42 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.63 -93.86 0.2 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.9 t -106.44 -43.38 4.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.887 0.375 . . . . 0.0 110.273 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.442 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.1 t -51.96 -62.48 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.409 -173.948 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLN . . . . . 0.46 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.7 tt0 -59.04 -37.46 77.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.656 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.1 m -65.95 -48.32 71.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.902 0.382 . . . . 0.0 110.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.66 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.584 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.442 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.1 pt -76.09 -29.8 19.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -56.47 -45.72 80.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.334 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 p -82.0 -42.78 18.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.356 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.4 m -68.9 -19.99 64.23 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' SER . . . . . 0.732 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.7 p -70.98 -16.55 62.64 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 p -50.87 -23.72 3.02 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PHE . . . . . 0.477 ' CB ' ' HB3' ' A' ' 27' ' ' ASN . 78.8 m-85 -67.98 -9.12 42.97 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' A' ' 144' ' ' SER . 68.7 mt -60.8 -16.32 39.41 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.382 177.268 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 m -66.44 -33.29 75.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.566 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.446 ' HA ' ' O ' ' A' ' 152' ' ' SER . 0.2 OUTLIER -74.89 -27.5 60.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.751 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.6 p -62.35 -17.66 59.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.406 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 180' ' ' SER . 3.4 p -112.13 -20.76 11.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' SER . . . . . 0.446 ' O ' ' HA ' ' A' ' 149' ' ' THR . 25.9 t -164.41 148.0 9.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 111.058 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -80.17 69.84 6.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.81 -27.93 68.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.684 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.0 p -65.16 -36.21 83.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.957 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -114.47 14.4 17.81 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 111.006 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.0 m 53.55 33.64 16.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.555 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 47.96 27.16 1.11 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.746 1.218 . . . . 0.0 112.921 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.98 -81.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -140.09 118.85 12.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.795 0.331 . . . . 0.0 110.396 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.422 ' HB1' ' HB2' ' A' ' 175' ' ' PRO . . . -125.96 22.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.068 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . 0.401 ' HG ' ' C ' ' A' ' 161' ' ' ALA . 76.2 p 50.29 34.32 8.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.392 -178.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 p -92.13 123.74 35.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.058 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 49.7 m -147.12 92.74 2.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.8 m 63.09 19.76 11.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.559 0.695 . . . . 0.0 110.065 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 135.42 -168.87 23.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.484 ' HB2' ' O ' ' A' ' 170' ' ' THR . . . -130.03 160.53 33.4 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.996 0.398 . . . . 0.0 110.755 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.34 -31.37 34.26 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.939 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' TYR . . . . . 0.407 ' C ' ' HG1' ' A' ' 170' ' ' THR . 68.5 t80 -77.63 -29.95 52.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.157 0.504 . . . . 0.0 110.491 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' THR . . . . . 0.484 ' O ' ' HB2' ' A' ' 167' ' ' ALA . 51.7 m -153.28 137.58 16.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -65.16 -92.92 0.03 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PRO . . . . . 0.464 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 44.3 Cg_endo -84.61 16.17 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 123.121 2.547 . . . . 0.0 113.894 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.6 t -162.87 -161.31 0.69 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 100.15 -105.87 3.05 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.19 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PRO . . . . . 0.422 ' HB2' ' HB1' ' A' ' 161' ' ' ALA . 98.2 Cg_endo -77.69 40.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.884 2.389 . . . . 0.0 112.414 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.3 p 50.45 42.1 25.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.504 0.722 . . . . 0.0 112.238 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 t -82.9 104.72 13.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.366 0.603 . . . . 0.0 111.394 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . 0.484 ' H ' ' HD3' ' A' ' 179' ' ' PRO . . . 97.33 62.91 0.9 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.245 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . 0.484 ' HD3' ' H ' ' A' ' 178' ' ' GLY . 3.0 Cg_exo -78.94 153.27 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.503 2.136 . . . . 0.0 110.943 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 t -107.48 -174.77 2.61 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.807 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.59 -63.14 0.52 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.9 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -78.06 157.41 78.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.79 125.38 15.72 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.973 2.449 . . . . 0.0 111.901 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' GLY . . . . . 0.426 ' N ' ' HD3' ' A' ' 185' ' ' PRO . . . 81.96 61.72 2.0 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.843 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PRO . . . . . 0.426 ' HD3' ' N ' ' A' ' 184' ' ' GLY . 37.1 Cg_exo -63.9 -23.59 68.27 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.913 2.409 . . . . 0.0 111.919 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.25 4.8 47.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.014 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -35.98 91.33 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.28 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.45 -11.93 84.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.275 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 107.04 44.83 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.632 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.06 152.81 39.14 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.632 -0.136 . . . . 0.0 110.632 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.65 147.31 94.93 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.802 2.334 . . . . 0.0 111.426 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.15 22.91 0.5 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.874 0.368 . . . . 0.0 111.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.86 -2.88 87.15 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.873 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -84.76 150.66 24.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 67.1 m -92.59 17.89 9.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.947 0.403 . . . . 0.0 111.162 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 112.54 -68.25 0.23 Allowed Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 69.1 t80 68.64 -67.65 0.2 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.765 0.826 . . . . 0.0 112.296 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.04 75.18 2.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.681 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.992 0 CA-C-O 118.807 -0.996 . . . . 0.0 111.742 178.802 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.353 0 N-CA-C 112.823 -0.111 . . . . 0.0 112.823 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.69 80.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.203 0.525 . . . . 0.0 110.759 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.4 p -68.44 -17.75 64.27 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -18.28 63.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.49 11.74 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.815 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.3 pp -85.99 -22.89 27.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 14' ' ' SER . 17.6 pt -42.46 -55.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 2.4 m -68.69 -21.74 64.4 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.0 111.677 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -88.57 -24.46 22.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.961 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 100' ' ' LEU . 85.1 t -57.19 168.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.759 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -39.47 -27.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.0 m-80 -60.27 -24.22 64.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.571 0.224 . . . . 0.0 111.498 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.71 -36.98 82.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.076 0.465 . . . . 0.0 110.306 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.58 -13.36 54.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.448 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.17 -44.11 13.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 55.16 13.0 0.74 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.841 0.856 . . . . 0.0 112.263 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -72.41 165.49 24.46 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.931 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 27.8 m -61.67 -15.31 38.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p -56.04 -25.94 46.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.785 0.834 . . . . 0.0 113.143 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.83 -17.62 11.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.157 0.504 . . . . 0.0 110.672 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 11.4 ttm180 -77.51 -48.68 16.45 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.745 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -167.06 -32.14 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -80.65 137.21 21.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -52.91 138.67 29.41 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.999 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 47.3 ptt85 -64.43 155.59 32.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.944 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -70.74 114.85 9.23 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.65 40.18 9.97 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -47.37 145.95 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.585 0.754 . . . . 0.0 112.307 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.525 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.4 m -71.48 140.29 49.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.406 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.569 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.87 -12.81 27.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 116' ' ' LEU . 89.2 mm-40 -57.06 -38.06 72.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.855 0.359 . . . . 0.0 110.757 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 40' ' ' SER . 2.8 pp -84.4 -35.62 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.97 -73.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.962 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 75.5 -18.92 0.42 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.639 0.776 . . . . 0.0 112.403 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -67.61 -79.88 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.16 0.505 . . . . 0.0 112.024 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -130.93 -27.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.313 0.578 . . . . 0.0 110.848 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.92 94.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.184 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 mm-40 -82.54 -50.23 9.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 0.0 110.256 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 20.7 ttm180 -132.77 -3.93 3.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.941 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.03 -50.49 0.7 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.258 0.623 . . . . 0.0 110.17 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.63 131.45 45.23 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -46.6 -30.78 2.45 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m -49.58 -71.56 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 55' ' ' LEU . 6.6 tt -86.38 -23.84 26.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.43 -20.69 62.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.2 p -48.56 112.74 0.64 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.565 0.541 . . . . 0.0 110.697 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.403 HG23 ' HG ' ' A' ' 59' ' ' LEU . 15.1 t -161.73 -40.41 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 58' ' ' THR . 91.8 mt -121.91 18.83 10.96 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.677 0.275 . . . . 0.0 110.996 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 66.12 1.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.134 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.745 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 37.5 t -89.3 104.97 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.385 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -173.62 76.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.499 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.22 -63.07 1.22 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.981 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -63.04 -69.49 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.745 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 p-10 -82.18 7.2 14.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.462 . . . . 0.0 110.444 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 tp -88.02 -53.17 4.87 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.735 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.8 29.02 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.499 0.666 . . . . 0.0 110.086 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.436 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 35.6 mmt180 -107.99 173.13 6.46 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 64.14 -62.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.63 -61.95 2.24 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.717 0.407 . . . . 0.0 111.716 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' SER . 39.1 t -59.66 -42.26 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.507 ' O ' ' HG3' ' A' ' 76' ' ' ARG . 1.6 mp0 -65.78 -36.48 83.65 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.619 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.92 64.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.803 0.335 . . . . 0.0 110.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.46 -34.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.486 0.66 . . . . 0.0 110.239 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 3.7 m -75.5 -19.78 59.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 20.8 mtm180 -86.87 -13.1 45.89 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.543 0.211 . . . . 0.0 110.551 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--O 1.238 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.122 178.55 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 88' ' ' GLN . 8.0 m-85 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.668 0.27 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.47 41.45 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.01 0.433 . . . . 0.0 111.215 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 91' ' ' SER . 8.1 tp-100 -90.14 -59.03 2.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.919 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.86 94.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.825 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 74.6 m-85 -80.66 12.04 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.541 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 15.6 t -50.61 -45.12 57.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.659 0.383 . . . . 0.0 111.556 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 55.4 m -61.54 -41.89 98.02 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.55 37.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.0 111.414 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 74.8 mt -84.94 -28.06 26.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -85.18 -36.43 21.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.209 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 50.45 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.98 -22.41 45.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.26 -14.09 63.92 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.82 32.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.968 0.889 . . . . 0.0 108.955 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -116.9 -169.16 1.59 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.053 -178.425 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 24.6 t-20 -78.39 106.69 10.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.37 -29.33 70.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.451 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 p -72.26 -18.15 61.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.226 0.536 . . . . 0.0 110.276 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 6.2 t30 -63.81 -50.75 67.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.654 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.454 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.0 mp -73.43 -35.3 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.855 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.48 -35.09 78.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.401 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.2 m -93.61 -60.6 1.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 1.1 pp -104.53 -35.99 7.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -52.86 -58.49 11.39 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.897 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 114' ' ' SER . 13.7 p -71.19 -21.05 62.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -88.13 -52.76 5.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.28 -50.56 20.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.9 mp -79.3 -29.94 42.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.147 0.499 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 110' ' ' SER . 32.1 t 50.97 -100.28 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.688 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.71 -34.68 73.23 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 120' ' ' VAL . 51.8 tp -61.75 -59.36 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.743 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -29.22 70.46 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.931 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -61.1 -42.83 99.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.078 0.466 . . . . 0.0 110.035 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -29.27 58.82 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.822 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 116' ' ' LEU . 82.3 t -72.69 -30.22 32.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 122.816 -0.226 . . . . 0.0 110.757 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 53.2 m -55.99 -39.45 71.85 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.566 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.1 p -85.68 -25.87 26.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.061 0.458 . . . . 0.0 111.155 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.76 -90.98 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.85 69.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 111.548 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 53.2 tt0 -77.24 -24.59 51.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.82 -65.12 1.63 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.448 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.58 -23.84 8.05 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.799 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.81 104.37 2.2 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.842 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.4 mt -68.75 130.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.959 0.409 . . . . 0.0 111.885 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -120.78 128.35 52.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 132' ' ' ASP . 18.2 t -98.57 167.58 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.317 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 131' ' ' VAL . 27.6 t70 -58.45 151.83 19.27 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.344 0.592 . . . . 0.0 111.747 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.591 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 15.2 m -75.37 -2.25 27.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.083 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.37 -72.07 0.64 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.184 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 m -106.5 -58.21 1.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.42 HG21 HG11 ' A' ' 131' ' ' VAL . 69.3 t -52.32 -55.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.591 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 34.7 tp60 -60.02 -42.45 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m -58.46 -41.04 84.27 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.086 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.1 -54.61 8.08 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.639 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 136' ' ' VAL . 38.7 pt -61.46 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -64.44 -45.29 88.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.993 0.425 . . . . 0.0 110.72 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.4 m -76.91 -20.74 55.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.294 0.569 . . . . 0.0 111.134 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.4 t -86.5 -60.17 2.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.781 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.253 -174.431 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.217 0 N-CA-C 113.53 0.172 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.97 89.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.12 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' ILE . 70.0 m -72.1 -30.6 65.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.717 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.04 -26.75 50.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.98 7.09 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.683 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 pp -83.88 -22.55 31.59 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' SER . 10.6 pt -43.25 -43.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.3 t -74.38 -27.55 60.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.0 -23.41 23.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 17' ' ' LEU . 56.4 t -58.52 176.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.832 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.577 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -36.67 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 2.3 m120 -63.29 -24.77 68.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.244 0.474 . . . . 0.0 111.404 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.04 -28.25 69.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 tp -83.41 -40.98 18.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.06 73.55 8.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.43 19.89 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.911 1.284 . . . . 0.0 114.2 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -63.46 -178.76 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 13.0 m -66.51 -20.48 66.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -51.13 -62.53 1.56 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.8 pt? -80.78 -20.55 42.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.28 0.562 . . . . 0.0 110.148 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 22.4 ttm180 -68.41 -46.45 69.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.474 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -177.34 -35.43 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.17 139.97 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.619 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 88' ' ' GLN . 4.0 pp -51.42 140.43 17.61 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 123.787 0.679 . . . . 0.0 112.6 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 36' ' ' ARG . 15.9 ttt180 -50.76 137.72 19.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.564 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -66.27 111.39 3.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.644 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 93.78 31.63 8.09 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.7 p -51.11 137.13 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 110.72 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 13.0 m -105.17 161.9 13.86 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 8.9 pt20 -60.44 -14.98 22.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.404 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 116' ' ' LEU . 83.2 mm-40 -53.92 -48.72 69.9 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.263 0.554 . . . . 0.0 109.758 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.1 pp -85.99 -39.41 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.241 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.86 -62.03 1.71 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 74.63 -20.96 0.3 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -71.02 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.761 0.315 . . . . 0.0 111.771 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.91 -22.49 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.194 0.521 . . . . 0.0 110.832 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.6 t -75.72 96.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 76.8 mt-30 -81.97 -47.46 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.139 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 33.8 ttm-85 -144.8 4.13 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.402 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.53 -53.86 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.479 0.712 . . . . 0.0 111.18 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.674 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.26 141.28 57.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.569 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 14.0 mp0 -58.83 -18.46 32.7 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.081 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -63.05 -76.96 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.85 -24.79 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.32 -18.11 61.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 77.6 p -45.7 104.05 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.856 0.722 . . . . 0.0 111.156 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 56' ' ' ALA . 10.5 t -149.97 -40.92 0.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.089 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.27 19.34 13.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.975 0.417 . . . . 0.0 110.235 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.24 67.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG22 HD21 ' A' ' 65' ' ' ASN . 6.1 t -87.85 109.01 19.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 120.706 0.289 . . . . 0.0 110.653 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -163.37 80.04 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.51 -48.85 2.94 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.73 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 20.9 p-10 -52.64 -80.07 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.829 0.851 . . . . 0.0 112.862 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.607 HD21 HG22 ' A' ' 61' ' ' VAL . 3.9 p-10 -85.81 9.17 17.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.215 0.531 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.1 tp -88.31 -50.85 6.08 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.128 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.14 -49.81 14.39 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.545 0.688 . . . . 0.0 109.31 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -90.87 162.38 14.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 68.32 -61.72 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -64.42 -62.92 1.3 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -36.13 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.81 -43.37 88.82 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.301 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -67.34 -44.93 77.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.509 0.195 . . . . 0.0 111.286 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.9 -43.45 85.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -65.12 -30.17 71.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.039 0.447 . . . . 0.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -98.32 6.28 47.49 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.645 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 14.4 mt . . . . . 0 CA--C 1.51 -0.591 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.081 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 36' ' ' ARG . . . -65.91 1.59 1.35 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -69.96 -47.15 63.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.33 -40.24 77.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.794 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -83.92 10.54 9.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.419 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.8 m -49.79 -38.48 34.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 72.6 m -56.41 -50.4 71.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.12 31.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.5 mt -80.42 -33.08 37.22 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -84.56 -37.41 21.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.0 85.74 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.852 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.58 -2.61 43.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.578 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.54 34.53 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.529 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.93 -13.38 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.464 0.649 . . . . 0.0 110.097 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -179.69 7.14 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.524 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -75.21 118.66 18.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.98 61.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m -74.99 -31.36 61.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.855 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -61.87 -53.28 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.488 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.49 -39.97 87.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.129 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.34 -38.1 85.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.2 m -78.59 -55.22 5.37 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.14 -22.32 6.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.22 -65.29 3.47 Favored Glycine 0 C--N 1.32 -0.336 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.778 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 m -72.96 -9.71 59.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.107 0.479 . . . . 0.0 110.973 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.54 -55.94 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.629 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.96 -57.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.91 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -68.32 -49.8 57.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.923 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.4 t 52.9 -93.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.57 -40.78 60.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.241 0.616 . . . . 0.0 112.428 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 120' ' ' VAL . 59.7 tp -60.87 -47.32 86.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 30.2 mt -71.3 -25.77 62.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.53 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -60.28 -44.36 95.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.42 -31.1 57.45 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.558 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 116' ' ' LEU . 52.1 t -63.82 -41.26 91.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 122.848 -0.207 . . . . 0.0 110.712 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 54.2 m -52.82 -45.75 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.813 0.696 . . . . 0.0 112.352 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 p -83.74 -36.38 23.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.9 -76.1 0.31 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.7 -49.69 50.94 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.707 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 52.6 mt-30 -72.52 -24.6 61.17 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.94 -53.39 3.02 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.732 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.18 -19.27 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.39 79.84 0.86 Allowed Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.065 -1.064 . . . . 0.0 110.488 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 52' ' ' ALA . 35.0 mm -64.6 136.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -134.62 125.9 28.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.8 t -89.48 113.93 26.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.494 0.664 . . . . 0.0 111.669 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.24 42.97 1.08 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.466 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 56.4 p -78.7 2.97 17.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.562 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.25 -27.37 20.66 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.15 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 m -105.95 -42.84 5.01 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 131' ' ' VAL . 20.6 t -70.43 -63.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.432 ' HA ' HG12 ' A' ' 140' ' ' ILE . 44.7 tt0 -59.55 -43.5 93.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.954 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.6 m -58.33 -38.01 76.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.947 0.403 . . . . 0.0 111.025 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.62 -56.65 5.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.49 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.444 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 44.2 pt -61.83 -27.63 42.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.526 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -75.43 -35.83 60.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.03 0.443 . . . . 0.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.3 m -79.2 -29.42 42.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.178 0.513 . . . . 0.0 110.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 140' ' ' ILE . 98.9 p -86.73 -21.0 26.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.258 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.921 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.096 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.23 -19.13 62.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.844 0.354 . . . . 0.0 111.885 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.5 m -63.9 -20.38 65.8 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.953 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.95 65.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.987 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.29 -34.88 22.19 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.303 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.4 pp -87.74 -31.78 19.49 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 14' ' ' SER . 16.3 pt -42.23 -57.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.7 m -66.56 -20.36 66.0 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -88.9 -31.23 18.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 17' ' ' LEU . 83.7 t -49.53 158.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 O-C-N 123.597 0.561 . . . . 0.0 111.384 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -40.31 -25.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.408 ' HB3' ' OG ' ' A' ' 92' ' ' SER . 20.4 t-20 -61.73 -28.67 69.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 0.0 109.938 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -58.97 -46.19 88.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.511 0.672 . . . . 0.0 109.934 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.06 -28.66 67.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.297 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.99 87.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 0.0 110.133 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 59.4 2.99 0.35 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.899 0.88 . . . . 0.0 112.535 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 5.5 m -68.53 163.44 23.5 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.266 0.555 . . . . 0.0 111.289 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 m -58.94 -15.34 12.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.8 p -54.59 -30.43 54.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.644 0.777 . . . . 0.0 112.992 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.1 pt? -106.57 -18.6 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.214 0.53 . . . . 0.0 110.507 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -76.2 -60.17 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.067 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -155.25 -31.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' C ' HE22 ' A' ' 88' ' ' GLN . 96.0 t -75.57 137.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 74' ' ' VAL . 2.6 pt? -55.79 145.66 23.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.224 0.535 . . . . 0.0 112.016 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -52.84 130.21 32.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.556 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.445 HG23 HG21 ' A' ' 136' ' ' VAL . 3.3 m -66.02 111.84 3.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.88 31.46 9.98 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.182 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 4.3 p -59.58 163.15 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.386 0.674 . . . . 0.0 112.265 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -109.52 161.39 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.781 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.7 pt20 -64.78 -15.22 61.36 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HG3' HD13 ' A' ' 116' ' ' LEU . 81.3 mm-40 -53.14 -46.41 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.024 0.44 . . . . 0.0 111.106 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' HB ' ' CD2' ' A' ' 86' ' ' TYR . 2.4 pp -84.35 -35.98 11.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.989 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.89 -60.68 2.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.574 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 t 70.83 -21.06 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.631 0.772 . . . . 0.0 112.87 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -69.33 -79.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.38 -37.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.265 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.503 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.4 p -71.11 99.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.459 0.647 . . . . 0.0 110.714 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 40.6 mt-30 -82.99 -38.01 23.22 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HE ' HD13 ' A' ' 55' ' ' LEU . 23.8 ttm-85 -148.23 -1.61 0.55 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.784 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.0 -46.63 0.64 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.247 0.619 . . . . 0.0 111.128 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.31 142.05 58.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.2 mm-40 -64.5 -16.46 62.57 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.104 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 p -63.08 -76.74 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.141 0.496 . . . . 0.0 112.26 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.576 HD13 ' HE ' ' A' ' 50' ' ' ARG . 7.1 tt -85.36 -23.65 27.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.741 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.17 -21.05 39.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.5 t -62.94 94.92 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.756 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 9.6 t -119.99 -34.73 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 58' ' ' THR . 96.2 mt -118.07 19.5 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.25 67.69 1.46 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.487 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.7 t -88.49 126.31 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.81 0.338 . . . . 0.0 110.28 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 177.01 89.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.574 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.07 -60.12 4.48 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.125 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -50.14 -79.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 0.0 112.131 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 21.5 p-10 -85.77 14.0 6.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.998 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 tp -88.07 -58.41 2.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.746 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.62 48.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.456 0.646 . . . . 0.0 109.785 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -99.08 162.85 12.83 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.918 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 70.14 -61.92 0.44 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.415 0.447 . . . . 0.0 111.715 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.59 -62.7 1.42 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.335 0.254 . . . . 0.0 111.586 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.69 -41.94 90.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.86 -37.33 76.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.69 63.08 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.4 t -85.42 -16.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.4 p -90.74 -23.88 20.55 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.243 0.544 . . . . 0.0 110.176 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 76' ' ' ARG . 34.6 ttp180 -117.93 22.34 12.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.167 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.247 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.424 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 3.1 m-85 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.402 0.62 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.98 31.19 0.11 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.114 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.425 HE22 ' C ' ' A' ' 34' ' ' VAL . 87.8 mm-40 -89.65 -60.12 2.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.145 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.69 -37.1 56.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.277 0.56 . . . . 0.0 110.155 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.82 5.38 25.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.571 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 t -52.17 -39.42 60.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.03 0.443 . . . . 0.0 110.794 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 3.3 m -58.37 -53.19 61.15 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.437 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.88 -22.6 53.21 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.873 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.599 ' O ' HG11 ' A' ' 120' ' ' VAL . 78.1 mt -82.77 -45.86 13.84 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -70.79 -43.45 68.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.49 88.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.394 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.74 46.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.787 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.34 -13.81 31.84 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 22' ' ' ALA . 3.5 t -101.07 28.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.461 0.648 . . . . 0.0 109.982 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.7 pt? -122.95 172.56 8.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.235 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -73.84 99.61 3.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -17.76 64.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -70.89 -30.56 66.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.423 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.96 -35.37 76.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.722 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.82 -35.46 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.753 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.53 -24.09 45.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.63 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.7 m -75.18 -60.72 2.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.276 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 104' ' ' ASN . 1.7 pt? -121.4 -21.17 6.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.772 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -53.07 -61.07 7.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.769 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -82.58 -15.0 53.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -87.95 -60.06 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.9 t -78.02 -58.21 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.334 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.536 HD23 ' HA2' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -69.34 -26.77 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.011 0.434 . . . . 0.0 110.03 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.7 t 45.34 -105.0 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.471 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.96 -36.27 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.67 0.788 . . . . 0.0 112.635 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 120' ' ' VAL . 25.7 tp -59.27 -62.37 1.93 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.278 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' CA ' ' A' ' 109' ' ' GLY . 45.8 mt -79.99 -22.89 41.99 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -62.96 -44.2 96.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 109.957 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.79 -34.65 72.24 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.318 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 94' ' ' LEU . 53.0 t -69.28 -39.76 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.748 0.308 . . . . 0.0 111.204 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 34.0 t -57.04 -35.91 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 m -83.72 -39.33 20.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.97 -72.91 0.44 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 129' ' ' ILE . . . -70.54 -47.87 58.21 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.925 0.393 . . . . 0.0 111.847 -176.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' SER . 27.0 tt0 -71.01 -24.53 62.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.11 -66.34 1.4 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.768 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.2 mt -109.34 -24.58 10.99 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 122.621 -0.341 . . . . 0.0 111.898 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.86 104.08 1.74 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.612 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 124' ' ' ALA . 13.8 mt -79.58 136.38 23.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.591 0.234 . . . . 0.0 111.483 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -121.63 129.12 52.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.902 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.488 ' HB ' HG11 ' A' ' 136' ' ' VAL . 24.5 t -82.2 168.74 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.466 ' N ' HG12 ' A' ' 131' ' ' VAL . 24.1 t70 -59.38 137.19 58.08 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.305 0.574 . . . . 0.0 111.238 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.6 m -58.33 -23.07 55.49 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.824 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.28 -41.08 99.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.733 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 p -106.49 -45.55 4.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 140' ' ' ILE . 10.8 p -78.76 -55.4 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . 51.4 tt0 -59.62 -44.26 93.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 p -56.22 -41.87 76.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.996 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.83 -49.8 8.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.7 pt -62.05 -33.37 58.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -60.71 -29.59 69.43 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 m -83.94 -32.99 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 0.0 110.94 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -87.84 -27.78 22.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.319 -0.756 0 C-N-CA 123.339 0.656 . . . . 0.0 111.727 -178.469 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 CA-C-O 120.214 -0.214 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -60.1 -35.73 75.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 111.247 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' ILE . 24.9 t -74.84 -22.08 58.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.113 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.99 -22.51 66.96 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.9 12.67 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.062 -1.065 . . . . 0.0 112.164 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.37 -32.73 24.05 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' SER . 10.0 pt -44.16 -51.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.9 m -67.81 -20.61 65.2 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -89.24 -24.51 22.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -72.33 -162.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.063 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.13 -37.42 6.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.84 -24.95 67.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.44 -53.46 56.23 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 109.66 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.07 -33.82 76.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.28 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.562 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 53.31 17.94 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.355 0.662 . . . . 0.0 111.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -76.31 157.61 32.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -62.22 -16.87 56.12 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.338 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -54.06 -34.54 60.35 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.6 pt? -112.28 -18.29 12.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -79.0 -43.76 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.147 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 34' ' ' VAL . 7.6 t -164.44 -37.75 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 33' ' ' THR . 98.1 t -88.38 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -54.39 140.12 34.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 111.489 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 94' ' ' LEU . 2.0 ptm180 -58.88 154.1 15.83 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -70.07 124.13 23.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.237 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.8 40.77 64.21 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 36' ' ' ARG . 8.4 p -47.4 149.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.704 0.802 . . . . 0.0 112.523 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' ILE . 8.6 m -69.86 127.63 33.57 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.244 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.1 pt20 -61.53 -14.03 26.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.025 0.44 . . . . 0.0 111.115 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.86 -32.0 73.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 40' ' ' SER . 2.5 pp -83.76 -35.52 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.71 -72.49 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.446 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m 76.01 -19.62 0.4 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.969 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.0 p -68.18 -88.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.236 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 65' ' ' ASN . 30.0 m -126.62 -32.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.793 0.33 . . . . 0.0 111.634 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.7 p -79.31 91.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.726 0.774 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.6 mt-30 -83.04 -68.58 0.69 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.732 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.519 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 26.0 ttp180 -108.46 -3.06 18.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.425 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.13 -55.76 0.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.109 0.564 . . . . 0.0 109.85 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -67.29 142.31 56.9 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.265 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 22.3 mp0 -46.89 -51.16 17.42 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.088 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -46.54 -62.88 1.17 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 50' ' ' ARG . 28.8 tp -86.65 -27.6 23.7 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.036 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.56 -20.58 39.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 6.2 t -62.91 89.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.602 0.715 . . . . 0.0 111.466 -176.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.7 t -113.18 -36.43 5.05 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.785 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.88 18.57 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.095 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.06 68.05 1.13 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.95 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.45 103.2 13.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -151.3 14.04 0.68 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.065 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.497 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 134.85 -47.95 0.96 Allowed Glycine 0 C--N 1.28 -2.583 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 92.8 m-20 -62.7 -65.34 0.7 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.489 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 47' ' ' VAL . 66.2 t30 -84.71 4.23 33.62 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 52.9 tp -88.88 -67.14 0.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.945 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.56 58.21 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.544 0.688 . . . . 0.0 110.137 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 94.5 mtt180 -100.91 162.2 13.07 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.815 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 67.77 -62.28 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -61.48 -62.43 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 122.664 0.386 . . . . 0.0 111.356 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.0 -39.23 84.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 85.1 mm-40 -60.94 -47.3 87.06 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.548 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.21 -39.81 70.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -86.41 -34.27 7.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.959 0.409 . . . . 0.0 111.306 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -71.97 -26.5 62.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 17.6 mmt180 -101.02 9.25 42.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.456 0.646 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 9.9 tt . . . . . 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.91 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -77.74 44.54 0.46 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 8.2 tp-100 -89.62 -61.46 1.69 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.765 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.18 -26.79 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 m-85 -78.13 3.83 14.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.678 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -50.45 -40.28 50.19 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.355 0.409 . . . . 0.0 111.638 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 15.2 m -57.29 -49.46 76.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.74 -23.82 36.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.693 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 83.3 mt -84.63 -29.97 25.3 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -81.14 -38.49 27.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.605 0.241 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 m120 63.99 91.89 0.07 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.03 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.31 -10.84 45.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.375 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 4.38 71.41 Favored Glycine 0 N--CA 1.459 0.227 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.525 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.39 -14.05 8.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.639 0.733 . . . . 0.0 109.076 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.537 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.7 pp -81.64 -179.26 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.057 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.45 110.73 4.29 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.072 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -26.4 65.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.752 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -73.99 -27.66 61.09 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.055 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -62.52 -46.74 87.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.101 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.08 -31.5 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.59 -43.09 70.1 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.021 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.2 m -71.27 -56.04 6.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 13' ' ' ALA . 4.4 pp -115.55 -13.31 11.55 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.823 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.61 -65.2 3.0 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.254 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.5 p -73.79 -19.5 60.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.802 0.335 . . . . 0.0 111.641 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -87.42 -58.23 2.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.2 t -81.2 -54.8 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.254 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.6 mp -67.35 -45.2 77.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 t 46.03 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.096 1.359 . . . . 0.0 113.686 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.27 73.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.533 0.333 . . . . 0.0 111.57 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.4 tp -61.96 -50.23 72.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.492 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' SER . 17.4 mt -68.95 -24.16 64.23 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -66.18 -36.79 84.01 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.554 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.33 -39.44 7.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 83.1 t -70.16 -22.99 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.619 0.247 . . . . 0.0 111.322 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 28.9 t -55.16 -44.03 74.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -84.39 -23.2 30.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.119 0.485 . . . . 0.0 110.608 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 50' ' ' ARG . . . -83.43 -97.48 0.05 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.892 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.03 67.85 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.762 0.315 . . . . 0.0 111.769 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 34.2 tt0 -65.13 -42.45 93.86 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.767 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.62 -48.24 4.81 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.436 0.618 . . . . 0.0 112.246 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.65 99.05 0.5 Allowed Glycine 0 C--N 1.312 -0.78 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 52' ' ' ALA . 34.6 mm -86.63 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.025 0.44 . . . . 0.0 112.176 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -116.59 135.43 53.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 132' ' ' ASP . 18.5 t -86.2 173.06 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 131' ' ' VAL . 30.4 t70 -58.97 145.5 41.41 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.174 0.512 . . . . 0.0 111.384 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 47.8 m -64.04 -22.19 66.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.57 -69.07 1.05 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 123.37 0.419 . . . . 0.0 114.133 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -99.42 -34.91 10.09 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 140' ' ' ILE . 86.5 t -83.18 -62.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 56.6 tp60 -56.82 -45.97 81.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.7 m -54.62 -38.92 67.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.36 -48.33 10.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 137' ' ' GLN . 43.9 pt -65.7 -27.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 p -67.45 -48.59 66.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.1 m -84.27 -20.22 32.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.1 t -85.54 -20.16 30.04 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -174.312 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.339 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.54 86.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.623 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.9 p -63.32 -32.97 74.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.597 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.51 -19.13 65.41 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.3 -38.91 7.02 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.342 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.3 pp -84.69 -22.08 29.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 14' ' ' SER . 11.5 pt -46.96 -50.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -84.77 -19.73 32.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -86.47 -30.81 21.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.3 t -80.96 -101.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.89 35.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.611 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.31 -22.99 66.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.81 81.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.066 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.57 -31.77 36.73 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.441 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.85 82.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.212 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 61.83 6.03 1.53 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.859 0.864 . . . . 0.0 113.083 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 29' ' ' SER . 0.3 OUTLIER -68.48 177.93 2.21 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.087 0.47 . . . . 0.0 111.292 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.527 ' H ' HG22 ' A' ' 28' ' ' THR . 9.7 m -69.66 -16.03 63.29 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 p -51.62 -50.39 60.33 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.754 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.9 pt? -87.29 -19.98 27.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.326 0.584 . . . . 0.0 110.358 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -74.69 -48.23 27.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.086 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -172.71 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.61 135.52 27.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -54.02 139.19 35.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.346 0.593 . . . . 0.0 111.77 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 3.1 ptm180 -62.71 160.04 15.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.995 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -74.19 111.67 9.59 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.644 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.15 47.13 11.51 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.342 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.6 p -54.99 150.04 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 122.93 0.492 . . . . 0.0 111.364 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 t -81.78 164.36 21.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -70.06 -12.42 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.763 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -50.95 -33.05 22.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.113 0.483 . . . . 0.0 110.609 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.717 HG13 ' N ' ' A' ' 44' ' ' ALA . 6.7 pt -83.77 -52.77 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.717 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.47 -66.98 0.83 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m 78.82 -20.5 0.38 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.555 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.5 p -83.1 -82.97 0.14 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.25 -52.53 8.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.594 0.711 . . . . 0.0 110.258 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.33 89.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.461 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 77.9 mt-30 -82.82 -36.93 25.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.777 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 5.7 ttt180 -156.5 5.64 0.17 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.937 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.91 -58.93 0.39 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.162 0.585 . . . . 0.0 110.783 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -62.97 138.54 58.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' SER . 5.0 pm0 -55.54 -18.87 8.28 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.611 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -60.02 -71.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.6 tp -87.36 -24.05 24.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.752 0.311 . . . . 0.0 111.604 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.96 -18.91 55.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -53.96 99.97 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.183 0.516 . . . . 0.0 110.886 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -137.68 -36.25 0.63 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.738 HD11 ' ND2' ' A' ' 65' ' ' ASN . 4.1 pp -123.03 11.46 9.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.022 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.04 52.76 1.58 Allowed Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.143 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 65' ' ' ASN . 3.3 t -87.17 114.25 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -156.54 14.29 0.29 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 112.017 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 145.44 -43.71 0.91 Allowed Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.01 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -59.12 -68.45 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.181 0.515 . . . . 0.0 110.598 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.738 ' ND2' HD11 ' A' ' 59' ' ' LEU . 25.8 p-10 -85.92 9.61 16.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 23.9 tp -88.12 -50.67 6.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.993 0.425 . . . . 0.0 110.438 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 133' ' ' SER . . . -81.95 -26.55 33.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -127.08 169.42 13.41 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 69.8 -62.29 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.105 0.562 . . . . 0.0 112.492 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -62.19 2.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.012 0.434 . . . . 0.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 6.7 p -65.04 -33.2 62.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.6 -22.76 66.13 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.937 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.66 -51.08 6.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.102 0.477 . . . . 0.0 110.831 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 61.9 t -71.1 -36.46 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.427 -176.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -83.2 1.37 41.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.856 0.36 . . . . 0.0 111.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -106.37 -21.69 13.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.317 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 4.5 pp . . . . . 0 C--O 1.236 0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 111.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 120.97 0.414 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.97 12.97 0.95 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 1.8 mp0 -67.43 -48.15 68.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.057 0.456 . . . . 0.0 111.109 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.542 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -71.73 -30.71 65.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.967 0.413 . . . . 0.0 110.681 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 84.9 m-85 -83.54 8.76 13.12 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.954 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 36' ' ' ARG . 71.9 m -51.8 -43.52 63.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.3 m -61.69 -48.76 79.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.02 -31.05 68.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 41.8 mt -84.17 -19.0 34.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.775 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HB2' HH21 ' A' ' 36' ' ' ARG . 55.6 t80 -87.44 -36.94 17.42 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.096 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.436 ' HA ' HD21 ' A' ' 100' ' ' LEU . 92.6 m-20 55.19 64.86 1.65 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.584 0.707 . . . . 0.0 110.378 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.71 62.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.747 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.83 66.51 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.213 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.9 t -74.72 -24.99 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.319 0.58 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -84.4 150.52 25.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -54.67 107.78 0.32 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.801 0.688 . . . . 0.0 110.986 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -17.49 63.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.936 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.8 m -80.18 -18.04 50.75 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.034 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.482 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -78.62 -29.17 45.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.433 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -64.86 -32.46 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.878 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.8 m -67.94 -61.34 1.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.67 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -129.0 -9.96 4.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.995 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -58.9 -72.04 0.67 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 m -73.95 -12.26 60.59 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.805 0.336 . . . . 0.0 111.365 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.16 -57.83 2.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.28 -53.75 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.56 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.52 -33.39 64.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.182 -178.407 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.2 t 49.49 -103.57 0.12 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.033 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.69 -33.29 60.67 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.115 0.566 . . . . 0.0 112.206 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 120' ' ' VAL . 43.2 tp -57.39 -53.26 60.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 19.2 mt -78.69 -23.72 45.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.724 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.3 -45.44 93.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.1 -29.72 62.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.752 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 116' ' ' LEU . 40.5 t -69.25 -46.11 78.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 122.766 -0.255 . . . . 0.0 111.198 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -58.05 -39.17 77.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.482 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -80.51 -40.19 26.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.876 0.369 . . . . 0.0 111.804 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.2 -70.07 0.6 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.404 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.15 -51.2 18.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -69.95 -35.01 74.17 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.89 0.376 . . . . 0.0 110.508 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.37 -56.66 3.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.141 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.38 -23.53 15.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.57 77.57 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.235 -0.984 . . . . 0.0 111.002 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.49 HG23 ' CB ' ' A' ' 52' ' ' ALA . 36.9 mm -68.47 132.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.464 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.65 140.36 48.14 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.76 116.28 46.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.341 0.591 . . . . 0.0 111.333 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.69 43.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 46.0 p -75.49 -4.99 42.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.028 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 -17.85 58.51 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.5 p -107.4 -56.88 2.15 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.06 -62.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.02 -40.49 85.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.8 m -60.84 -49.08 78.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.24 -52.29 62.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.819 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 42.7 pt -61.45 -34.87 63.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.459 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 t -67.79 -42.11 82.14 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.97 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 m -77.42 -45.97 24.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.3 m -66.11 -38.73 88.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 p . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.394 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.879 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.02 68.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.4 m -63.38 -34.39 77.62 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -19.05 65.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.96 -39.47 6.49 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.778 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.9 pp -84.52 -20.97 30.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' SER . 9.7 pt -41.46 -42.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 8.3 p -78.99 -30.28 44.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -87.28 -23.62 24.61 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 17' ' ' LEU . 17.3 t -80.62 -101.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.13 -53.34 7.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -170.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -63.63 -23.03 67.21 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.369 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.3 -41.48 79.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.95 -19.97 39.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.995 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.63 -40.57 41.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.73 19.42 2.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.663 0.744 . . . . 0.0 111.432 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 5.6 m -74.22 165.88 24.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -60.78 -18.25 53.96 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.054 0.542 . . . . 0.0 111.7 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 36' ' ' ARG . 34.4 p -52.99 -43.2 66.28 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 124.045 0.938 . . . . 0.0 113.085 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.642 HD22 ' HB3' ' A' ' 23' ' ' ASN . 1.6 pt? -96.59 -20.46 18.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.926 0.393 . . . . 0.0 111.19 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -72.07 -50.95 24.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.166 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -168.64 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.13 138.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.6 pt? -56.43 142.04 40.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.301 0.375 . . . . 0.0 110.785 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HA ' HG22 ' A' ' 30' ' ' THR . 31.4 ptt85 -66.84 159.31 28.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.793 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -70.95 111.44 6.34 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.81 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.681 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 85.34 41.26 7.49 Favored Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.642 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 87' ' ' ALA . 10.1 p -47.56 136.3 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.484 0.659 . . . . 0.0 111.831 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -70.23 143.75 52.08 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.538 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 15.4 pm0 -65.57 -12.68 55.21 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -47.09 -44.66 21.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.501 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.79 -40.71 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.83 -75.81 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m 78.86 -19.65 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 111.772 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 p -65.39 -82.04 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.61 -39.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.986 0.422 . . . . 0.0 111.261 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.53 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.5 p -80.31 95.42 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.793 0.806 . . . . 0.0 110.33 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 50.4 mt-30 -79.18 -37.57 38.02 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 8.1 ttm180 -153.66 0.22 0.23 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.08 -48.39 0.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.61 0.364 . . . . 0.0 110.272 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.67 141.08 58.05 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.919 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 57' ' ' SER . 42.4 mm-40 -56.71 -30.66 63.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.479 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.3 m -53.89 -62.2 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' CZ ' ' A' ' 50' ' ' ARG . 4.3 mm? -88.06 -35.82 17.3 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -79.72 -21.46 44.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.7 t -65.25 93.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.622 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.518 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.7 t -139.23 -31.36 0.7 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.917 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.7 mt -118.19 19.14 13.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.39 65.61 1.46 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 96.9 t -89.52 122.48 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.262 0.553 . . . . 0.0 111.368 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -178.2 85.91 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.136 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.88 -54.98 3.46 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.191 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.425 ' HA ' HH21 ' A' ' 68' ' ' ARG . 92.7 m-20 -50.79 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.376 0.67 . . . . 0.0 111.81 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.541 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 27.3 p-10 -86.63 14.57 6.75 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.122 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.2 tp -87.91 -65.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.38 -36.63 58.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.549 0.69 . . . . 0.0 109.749 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 64' ' ' ASN . 60.1 mtm180 -98.95 160.16 14.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.733 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 69.41 -62.27 0.41 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.997 0.519 . . . . 0.0 111.975 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -62.78 -63.14 1.3 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.746 0.307 . . . . 0.0 111.507 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' SER . 59.6 t -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 41.6 mt-30 -60.78 -47.59 85.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.484 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.89 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.8 -38.33 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.929 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 33.2 m -77.31 1.23 19.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.6 mmp_? -111.83 -4.21 14.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.806 0.336 . . . . 0.0 110.169 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.243 -179.632 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -76.71 11.6 1.62 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.55 -59.98 2.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.523 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -69.42 -30.91 68.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.042 0.449 . . . . 0.0 110.991 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 96.1 m-85 -82.64 4.03 26.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.307 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -51.25 -39.8 57.48 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.6 m -58.69 -44.88 90.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.11 -30.98 27.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 116' ' ' LEU . 33.5 mt -84.58 -28.94 26.24 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -87.13 -29.67 21.65 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.785 0.326 . . . . 0.0 110.486 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.7 m120 51.15 69.57 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.054 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.77 -8.56 56.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.068 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.47 -6.76 83.24 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.734 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.9 t -80.44 -19.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.492 0.663 . . . . 0.0 109.725 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.47 174.87 9.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.937 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -83.32 143.9 30.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.057 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.27 -18.84 40.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 p -67.75 -30.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.482 0.658 . . . . 0.0 109.827 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 108' ' ' LEU . 19.2 t30 -62.84 -50.44 70.95 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.124 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.526 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.7 mp -72.4 -28.13 27.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.326 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.55 -33.67 66.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.898 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.617 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 86.9 m -85.5 -40.23 16.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.2 pt? -139.94 -27.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.836 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -50.83 -63.98 4.09 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.178 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.5 m -75.57 -17.0 60.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.94 0.4 . . . . 0.0 111.913 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 107' ' ' THR . 66.6 mtt180 -87.2 -58.0 2.75 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.088 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.7 -49.35 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.535 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -70.86 -13.75 62.15 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.111 0.481 . . . . 0.0 110.572 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.0 t 47.74 -104.07 0.11 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 113.657 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.92 76.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 94' ' ' LEU . 37.3 tp -53.88 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.463 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 16.6 mt -69.07 -23.56 64.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.33 -46.68 76.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.194 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.6 -27.27 63.51 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.899 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' A' ' 124' ' ' ALA . 25.3 t -68.39 -36.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.795 0.331 . . . . 0.0 110.316 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.0 t -54.47 -41.21 69.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.457 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -83.74 -49.16 9.37 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.53 -58.49 3.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -82.12 -60.27 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -69.18 -35.7 76.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.445 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.28 -69.57 1.39 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.945 -0.645 . . . . 0.0 114.074 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.21 -23.61 24.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.974 0.416 . . . . 0.0 111.269 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 124' ' ' ALA . . . 82.2 91.32 0.6 Allowed Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.025 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 52' ' ' ALA . 63.7 mt -59.64 134.94 24.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -139.56 118.84 12.79 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.245 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.81 156.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.61 163.09 14.35 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.9 m -74.11 84.19 1.81 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.53 -114.94 2.01 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -87.83 -18.73 28.64 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 140' ' ' ILE . 48.9 t -78.72 -62.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.928 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -52.54 -51.67 58.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 p -56.1 -43.97 78.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.88 -40.44 39.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.51 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 136' ' ' VAL . 47.3 pt -67.31 -35.92 75.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.523 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.9 m -57.05 -53.28 59.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.4 m -61.2 -43.59 98.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.496 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 65.0 m -66.09 -39.11 89.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.638 -178.496 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.149 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.44 -37.44 85.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.975 0.417 . . . . 0.0 110.831 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 18' ' ' ILE . 12.6 m -66.97 -31.37 71.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.334 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.68 -25.74 29.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.66 -35.41 8.49 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.149 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.5 pp -85.46 -22.42 28.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 14' ' ' SER . 14.9 pt -46.88 -37.31 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 t -84.63 -20.75 30.85 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.679 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -88.0 -34.9 17.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.55 178.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.73 -32.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 92' ' ' SER . 1.7 t-20 -65.59 -24.01 66.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.352 -0.217 . . . . 0.0 111.393 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.11 86.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.742 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.95 -28.03 57.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.13 0.49 . . . . 0.0 110.392 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -82.92 66.83 8.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.75 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.474 1.51 . . . . 0.0 114.537 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' ALA . 6.6 m -59.8 165.72 2.98 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.053 0.541 . . . . 0.0 110.196 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -59.49 -15.18 16.0 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.764 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -53.16 -29.34 31.03 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.38 1.072 . . . . 0.0 113.595 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -114.98 -19.54 10.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.098 0.475 . . . . 0.0 110.176 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -79.64 -43.35 22.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.773 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -160.79 -49.16 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 m -74.3 157.46 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.199 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.4 pt? -61.34 142.62 56.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.187 0.517 . . . . 0.0 111.188 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 ptm85 -62.68 159.34 16.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.209 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p -76.84 111.86 12.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.118 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 80.03 48.32 6.58 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 14.2 p -51.87 141.99 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.142 0.496 . . . . 0.0 111.63 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -76.34 147.41 38.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -65.31 -13.77 59.23 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.847 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -56.51 -38.22 71.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.94 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.76 -43.69 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.975 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.04 -69.42 0.63 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.497 0.189 . . . . 0.0 111.19 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t 74.73 -29.09 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.721 0.809 . . . . 0.0 112.743 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.5 m -66.43 -67.63 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.75 -35.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -80.72 89.96 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.951 0.405 . . . . 0.0 110.428 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 8.9 mm100 -82.75 -48.25 11.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.68 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HE ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 ttp180 -136.69 -1.11 2.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.832 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 131' ' ' VAL . . . 69.37 -51.01 0.61 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 110.588 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.608 ' HB3' ' HE ' ' A' ' 50' ' ' ARG . . . -69.27 128.47 36.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.095 0.474 . . . . 0.0 110.972 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -49.1 -19.71 0.47 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . 0.569 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 44.0 t -63.21 -62.46 1.68 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 118.803 0.728 . . . . 0.0 110.963 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HD3' ' A' ' 50' ' ' ARG . 15.7 tp -87.52 -25.59 23.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 110.589 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.3 -13.89 60.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.85 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 11.4 p -42.71 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -44.32 -38.45 3.92 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.688 0.795 . . . . 0.0 111.852 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.77 12.9 9.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.664 0.269 . . . . 0.0 111.128 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.33 63.73 3.61 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.212 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 50.7 t -88.08 101.71 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -161.78 100.52 1.14 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.444 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.04 -59.37 4.28 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.646 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -62.57 -76.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.146 0.498 . . . . 0.0 111.031 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 12.3 p-10 -86.69 10.93 14.23 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 132' ' ' ASP . 23.4 tp -88.98 -57.7 2.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.332 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.09 54.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 110.186 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -107.71 170.01 8.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 67.8 -61.53 0.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.84 0.456 . . . . 0.0 111.687 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.45 -58.41 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.535 0.334 . . . . 0.0 111.052 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 91.2 t -60.13 -37.23 72.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -70.17 -34.47 73.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.155 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 -43.93 36.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.71 -40.12 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.836 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.6 t -69.58 -6.68 32.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -79.96 -20.71 44.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.919 0.39 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.24 0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.506 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 46.86 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.376 0.608 . . . . 0.0 109.406 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 91' ' ' SER . 7.8 tp-100 -77.57 -59.58 2.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.54 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.28 89.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.725 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.52 17.12 1.85 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.544 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 8.6 t -54.93 -40.96 70.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.763 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 23' ' ' ASN . 6.6 t -72.72 -38.83 67.33 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.4 63.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.4 -20.88 31.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB2' HH12 ' A' ' 36' ' ' ARG . 48.0 t80 -87.88 -50.2 6.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.194 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 56.15 87.02 0.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.973 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.03 -5.12 42.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.555 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.64 -5.39 78.53 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.914 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.52 -7.44 10.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -84.71 -177.68 6.66 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.634 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 12.5 p-10 -75.05 125.5 29.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.7 -24.58 61.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.367 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -68.29 -29.74 68.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.671 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.488 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 21.2 t30 -59.86 -51.93 67.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.737 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.1 mp -74.52 -37.85 44.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.442 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.72 -34.56 78.11 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.843 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -89.21 -49.14 6.91 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.33 -15.3 5.18 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.085 -1.046 . . . . 0.0 113.453 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -65.65 -75.74 0.39 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.926 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 114' ' ' SER . 16.3 m -67.77 -16.81 64.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 107' ' ' THR . 60.9 mtp180 -86.76 -46.59 9.85 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -83.81 -52.39 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.0 mp -67.59 -33.59 75.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' SER . 72.3 m 45.64 -99.63 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.48 -35.07 60.17 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.289 0.636 . . . . 0.0 112.306 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.53 -52.66 43.35 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.115 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 12.6 mt -72.43 -26.54 61.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -57.97 -36.93 73.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 109.836 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.96 -43.19 6.07 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.65 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 117' ' ' LEU . 37.3 t -61.0 -42.23 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.7 t -85.17 -39.85 17.38 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.38 -81.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 129' ' ' ILE . . . -69.08 -44.99 71.42 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 48.2 tt0 -70.5 -38.05 74.26 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.131 0.491 . . . . 0.0 111.183 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.73 -40.97 7.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.455 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.66 -22.48 9.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.36 95.38 0.21 Allowed Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.52 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 37' ' ' THR . 15.8 mm -76.76 132.99 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -115.49 132.01 56.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.782 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.466 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.5 t -99.11 120.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' HD21 ' A' ' 66' ' ' LEU . 5.9 m-20 -99.98 35.8 1.97 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.515 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 67.3 p -70.82 -8.06 49.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.077 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.1 -19.75 51.5 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.198 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 p -105.98 -46.96 3.97 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 140' ' ' ILE . 54.2 t -66.28 -62.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.538 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.0 tt0 -56.3 -39.23 72.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -62.43 -40.35 96.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.78 -47.12 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.905 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.7 pt -57.4 -38.46 62.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.3 p -56.61 -42.14 78.27 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 111.66 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -84.67 -39.76 18.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 0.0 111.05 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.6 m -69.69 -39.58 76.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.444 -178.062 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.346 0 CA-C-O 120.499 -0.056 . . . . 0.0 113.04 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -62.96 -18.03 62.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.788 0.327 . . . . 0.0 111.618 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 18' ' ' ILE . 75.8 m -65.34 -21.83 66.74 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.008 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.78 41.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.931 0.396 . . . . 0.0 111.958 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.78 -41.75 8.07 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.1 pp -87.94 -20.62 25.66 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 14' ' ' SER . 12.0 pt -43.39 -47.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 35.4 t -73.06 -20.19 61.03 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 121.267 -0.173 . . . . 0.0 111.101 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -86.32 -32.24 21.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 17' ' ' LEU . 39.3 t -54.15 169.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.115 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.522 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.73 -32.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 31.7 m-80 -60.79 -24.39 65.76 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.63 -53.05 59.84 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.985 0.421 . . . . 0.0 111.332 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.91 -25.77 37.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.333 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -75.72 90.36 2.86 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 32' ' ' ARG . 5.2 m-80 -75.3 17.98 0.23 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.7 m -65.8 148.26 52.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.1 m -58.07 -14.54 6.9 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 p -48.5 -35.72 13.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -108.41 -18.25 13.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.197 0.522 . . . . 0.0 110.679 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 27' ' ' ASN . 17.0 mmt180 -76.73 -49.86 15.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -163.45 -29.76 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.4 t -87.49 144.87 8.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.5 145.58 32.77 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -70.59 153.53 42.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -68.84 120.8 15.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.93 37.14 20.04 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.514 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 7.5 p -51.31 148.37 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.153 0.501 . . . . 0.0 111.29 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -93.0 153.93 18.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -65.41 -12.72 55.01 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.422 -178.994 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -48.96 -38.58 23.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.198 0.523 . . . . 0.0 109.979 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.702 HG13 ' N ' ' A' ' 44' ' ' ALA . 3.9 pt -85.12 -44.47 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.907 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.702 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.14 -67.46 0.79 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.7 m 75.95 -18.57 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.808 0.843 . . . . 0.0 112.627 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.1 t -57.14 -96.2 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.88 0.472 . . . . 0.0 112.153 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.35 -23.21 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.371 0.605 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -79.52 98.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.2 mm-40 -73.41 -47.23 43.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.713 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.4 ttm-85 -149.47 9.02 0.71 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.418 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 -53.31 0.57 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.447 0.699 . . . . 0.0 110.982 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -68.54 142.82 55.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.573 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 57' ' ' SER . 4.8 pm0 -55.03 -19.05 6.12 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -55.55 -71.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.862 0.363 . . . . 0.0 111.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -25.92 23.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.25 -18.39 57.67 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 19.3 t -52.42 106.04 0.14 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.028 0.442 . . . . 0.0 110.516 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.539 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.4 t -165.39 -40.8 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.69 19.47 11.09 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.36 64.23 1.12 Allowed Glycine 0 C--N 1.316 -0.554 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.795 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.02 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -163.46 13.46 0.06 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.879 0.847 . . . . 0.0 109.461 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.87 -50.74 0.61 Allowed Glycine 0 C--N 1.294 -1.794 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.159 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.34 -55.23 37.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 120.782 0.325 . . . . 0.0 110.551 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.63 -41.79 16.01 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.482 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.58 -58.27 7.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.396 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 -5.74 59.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -128.25 -86.04 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -57.89 -31.91 67.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.48 -52.04 15.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 111.131 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 9.2 p -69.04 -40.77 81.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 75.1 mt-30 -62.91 -39.15 93.66 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.358 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.71 71.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.96 0.41 . . . . 0.0 111.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 77' ' ' LEU . 39.7 t -86.36 -32.37 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.002 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -70.81 -23.27 62.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.164 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 24.7 mmt180 -85.18 1.65 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.776 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 86' ' ' TYR . 77.0 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.019 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.54 ' CE2' HD13 ' A' ' 77' ' ' LEU . 18.3 m-30 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -72.55 53.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.237 0.615 . . . . 0.0 111.352 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -90.6 -59.2 2.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.117 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.26 -26.27 30.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.657 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.3 m-85 -83.51 6.68 19.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.528 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.3 m -52.84 -31.44 39.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.425 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 73.6 m -61.22 -47.68 84.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.54 32.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.789 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 84.0 mt -85.15 -32.19 22.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -84.85 -36.52 21.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.769 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.01 86.47 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 112.022 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.04 56.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.755 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.9 -13.63 42.46 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.73 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.17 -1.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.612 0.72 . . . . 0.0 110.434 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.15 179.32 6.41 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.896 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.78 141.19 30.68 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.529 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.21 -23.64 57.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.814 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m -69.05 -34.78 75.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.469 0.652 . . . . 0.0 110.386 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.59 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 31.5 t30 -60.21 -51.71 68.41 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.487 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.61 -33.9 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.22 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.86 -48.41 76.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.966 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 71.1 m -73.1 -56.54 4.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -174.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.3 pp -102.18 -24.37 13.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.067 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.28 -65.91 2.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.274 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -65.61 -28.18 68.94 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 107' ' ' THR . 11.5 mpt_? -86.57 -55.31 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.54 -48.77 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.13 -42.64 65.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.6 m 48.46 -95.09 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.6 -33.28 54.38 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.206 0.602 . . . . 0.0 112.031 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 120' ' ' VAL . 60.7 tp -62.19 -53.59 53.04 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.503 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 13.7 mt -66.6 -28.34 68.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.777 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -59.49 -43.99 93.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.963 0.411 . . . . 0.0 110.038 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.24 -31.73 41.31 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.98 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 124' ' ' ALA . 69.4 t -68.43 -38.9 79.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 122.863 -0.198 . . . . 0.0 111.269 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 64.9 m -57.55 -41.95 82.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.845 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -83.85 -39.24 20.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.94 -80.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -64.22 -55.61 20.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 70.0 mt-30 -70.12 -29.23 66.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.197 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.68 -64.73 2.01 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.091 -0.575 . . . . 0.0 114.185 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.7 mt -104.35 -23.78 13.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.859 0.362 . . . . 0.0 111.656 -175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.94 97.72 1.12 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.422 HG23 ' CB ' ' A' ' 52' ' ' ALA . 30.1 mm -75.37 129.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -127.84 131.92 49.46 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.962 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.97 118.31 50.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.471 0.653 . . . . 0.0 111.405 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -97.63 43.97 1.06 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.455 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 21.0 p -78.62 1.14 23.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 120.855 0.36 . . . . 0.0 111.256 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.36 -21.96 29.28 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.567 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.2 t -106.0 -58.67 1.88 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 122.927 -0.16 . . . . 0.0 111.285 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -50.63 -51.97 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 137' ' ' GLN . 8.3 tt0 -61.76 -44.44 96.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -60.69 -46.78 89.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.952 0.406 . . . . 0.0 110.302 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -62.8 -51.1 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.578 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 136' ' ' VAL . 39.4 pt -69.32 -38.09 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -63.05 -52.35 63.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.465 0.174 . . . . 0.0 111.316 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.9 p -62.85 -43.34 99.04 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -65.18 -40.52 94.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.311 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.144 0.497 . . . . 0.0 110.946 179.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 CA-C-O 120.401 -0.11 . . . . 0.0 113.242 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.84 90.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.976 0.388 . . . . 0.0 111.211 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.7 m -60.22 -28.6 68.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.754 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.11 -21.44 22.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.93 -39.42 7.51 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.407 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.1 pp -85.98 -25.46 26.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' SER . 14.1 pt -45.38 -50.34 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 14.1 m -84.78 -18.74 34.08 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.699 0.285 . . . . 0.0 111.586 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.74 -24.24 28.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -78.71 -106.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -77.97 -50.14 12.74 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' HD22 ' A' ' 31' ' ' LEU . 19.6 m-80 -60.51 -21.42 62.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.13 -40.83 77.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.176 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.14 -37.05 15.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.255 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -79.41 83.02 5.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 18.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.853 0.861 . . . . 0.0 113.069 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 26' ' ' ALA . 2.3 m -62.38 164.85 6.68 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.432 0.634 . . . . 0.0 111.346 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.1 t -65.45 -14.92 62.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.896 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -48.13 -44.03 31.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.742 0.817 . . . . 0.0 112.838 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -99.15 -19.86 16.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.496 0.665 . . . . 0.0 109.8 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -70.64 -53.39 15.99 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.761 -174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -167.16 -24.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.93 141.39 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 35' ' ' LEU . 1.9 pt? -54.72 150.03 10.23 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 111.91 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.49 163.49 26.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.169 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 131' ' ' VAL . 18.4 p -77.12 147.4 36.61 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.1 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 131' ' ' VAL . . . 73.71 24.38 74.59 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.313 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.8 165.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.76 0.424 . . . . 0.0 110.782 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.9 m -134.95 165.04 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.147 -0.346 . . . . 0.0 111.525 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.4 pp0? -66.77 -12.54 59.18 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' A' ' 116' ' ' LEU . 82.9 mm-40 -53.44 -38.8 63.87 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -86.63 -44.11 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -81.89 -65.25 1.03 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.614 0.245 . . . . 0.0 111.362 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m 81.81 -19.02 0.44 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.911 0.884 . . . . 0.0 112.152 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -70.91 -90.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.005 0.431 . . . . 0.0 111.705 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.61 -19.69 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.404 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.38 81.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.169 0.509 . . . . 0.0 110.105 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 1.8 mp0 -64.41 -48.93 73.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.231 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 46.4 ttm-85 -148.31 4.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.061 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . 67.63 -51.3 0.51 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -67.46 140.82 57.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.375 0.607 . . . . 0.0 110.857 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.6 mt-30 -59.52 -17.5 32.56 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.415 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -62.35 -74.06 0.1 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.848 0.356 . . . . 0.0 111.747 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.581 HD13 ' HE ' ' A' ' 50' ' ' ARG . 9.0 tt -87.22 -25.03 24.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.653 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.22 -19.51 43.06 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -50.06 108.11 0.2 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -150.02 -41.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.738 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.4 mt -118.22 19.33 13.54 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.338 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.48 56.34 1.27 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.811 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 53' ' ' GLN . 2.9 t -90.23 104.09 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -156.18 15.14 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.08 -37.37 2.16 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.026 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -54.49 -74.0 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.44 0.296 . . . . 0.0 111.458 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.5 p-10 -81.11 -20.83 40.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.013 0.435 . . . . 0.0 110.216 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.5 -55.05 35.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.655 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 133' ' ' SER . . . -82.79 1.66 37.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -126.08 -87.55 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -57.35 -38.43 74.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.47 92.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.958 0.409 . . . . 0.0 110.824 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.35 -46.26 71.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.13 -40.38 81.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.655 0.264 . . . . 0.0 111.584 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.04 88.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.835 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.598 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.2 t -85.31 -17.69 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -93.35 -19.6 21.18 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 121.946 -0.471 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -118.55 22.46 12.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.491 0.662 . . . . 0.0 110.744 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.106 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.509 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 4.2 m-85 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 121.272 0.558 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.62 17.62 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 77.7 mt-30 -88.89 -55.45 3.69 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.364 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -72.41 -40.96 66.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.302 0.572 . . . . 0.0 109.592 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.7 m-85 -81.64 16.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.082 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -51.63 -57.2 9.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.2 m -55.12 -36.68 66.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.93 -39.15 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 18.9 mt -81.9 -30.32 31.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.825 0.345 . . . . 0.0 111.68 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -85.06 -28.56 25.58 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 t30 52.77 84.28 0.06 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.81 -7.45 57.87 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.128 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.18 -11.93 40.67 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.035 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 t -78.53 -8.54 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.53 -171.42 3.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.487 -177.088 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.07 129.41 42.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.29 61.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.14 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -67.9 -32.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.529 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 11.5 t30 -62.7 -54.01 45.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -69.06 -35.96 71.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.384 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.86 -30.81 67.31 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.709 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.1 m -92.74 -34.55 13.87 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 2.2 pp -137.47 -29.61 0.87 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.812 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -53.17 -68.56 1.56 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.987 -0.625 . . . . 0.0 114.326 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 114' ' ' SER . 8.1 m -60.89 -20.6 62.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.714 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -88.14 -54.59 4.14 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.356 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.59 -45.89 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.812 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.4 mm? -81.5 -29.87 33.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 110' ' ' SER . 35.3 t 44.7 -96.68 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.39 68.31 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.908 0.483 . . . . 0.0 111.8 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 39.5 tp -65.32 -60.12 3.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.69 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.57 -29.26 68.58 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.57 -43.85 93.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.788 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 -37.13 28.66 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.999 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 124' ' ' ALA . 63.1 t -68.65 -41.11 82.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 8.1 t -55.73 -46.52 77.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.076 0.465 . . . . 0.0 111.201 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -74.66 -49.56 20.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.108 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.41 -70.88 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.646 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -73.59 -47.6 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 121' ' ' SER . 32.5 tt0 -68.64 -35.49 77.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.055 0.455 . . . . 0.0 110.428 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.62 -71.32 1.28 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.77 -0.65 . . . . 0.0 114.034 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.43 -24.16 23.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.816 0.341 . . . . 0.0 111.371 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.49 92.92 0.98 Allowed Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.191 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.518 HG23 ' CB ' ' A' ' 52' ' ' ALA . 20.7 mm -78.17 129.6 37.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -108.9 131.14 55.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.486 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 51' ' ' ALA . 7.3 m -98.73 90.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.04 0.924 . . . . 0.0 111.14 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.57 46.01 1.02 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.279 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.3 m -68.37 -6.05 22.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.566 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 -23.42 30.18 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.122 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -105.55 -31.99 8.7 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.548 HG11 ' CG2' ' A' ' 131' ' ' VAL . 40.6 t -67.27 -57.18 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.712 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -50.5 -53.36 30.53 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.46 0.475 . . . . 0.0 111.804 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -54.23 -37.73 64.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.171 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.58 -47.0 10.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.652 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.5 pt -64.99 -39.17 84.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.8 p -61.91 -49.07 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.429 . . . . 0.0 110.67 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.2 m -65.63 -28.95 69.48 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.329 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.1 t -89.06 -20.37 24.44 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.7 p . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.178 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 N-CA-C 113.59 0.196 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.91 87.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' ILE . 67.4 m -62.78 -24.62 67.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.67 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.91 -33.03 10.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 3.4 pp -84.48 -19.26 33.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' SER . 18.3 pt -30.77 -56.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.3 m -84.53 -20.04 32.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -86.29 -44.58 12.0 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.679 HG11 ' HB3' ' A' ' 100' ' ' LEU . 15.9 t -59.02 -97.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -171.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.26 -48.62 13.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -65.45 -25.11 67.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -67.85 -39.62 83.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.353 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -71.92 -33.7 68.47 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.922 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.64 69.19 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.892 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.49 8.58 4.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.736 0.814 . . . . 0.0 112.031 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 29' ' ' SER . 1.9 m -72.43 172.83 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 28' ' ' THR . 33.1 m -63.24 -15.68 57.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -54.5 -22.52 13.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.026 0.93 . . . . 0.0 113.433 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.4 pt? -120.53 -21.86 6.63 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.209 0.528 . . . . 0.0 110.393 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -79.66 -37.69 35.36 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 34' ' ' VAL . 9.9 t -164.58 -26.12 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.444 HG23 HG23 ' A' ' 33' ' ' THR . 87.7 t -99.76 141.23 17.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.72 163.18 5.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.553 ' HG2' ' HB1' ' A' ' 87' ' ' ALA . 4.3 ptm180 -69.42 141.84 53.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.447 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -68.46 124.6 24.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.88 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 85.08 29.78 27.4 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.587 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.78 145.74 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 20.4 t -104.65 166.33 10.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 112.024 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 51.5 tt0 -73.23 -14.93 61.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.189 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.37 -48.79 65.37 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD11 ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -85.72 -47.79 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.12 175.154 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . . . -58.08 -32.02 67.65 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m 72.18 -38.84 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -71.09 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.61 -19.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.671 HG22 ' HB1' ' A' ' 70' ' ' ALA . 46.1 t -62.34 82.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 116.905 -0.134 . . . . 0.0 111.321 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 40' ' ' SER . 47.8 mm-40 -63.58 -43.95 95.49 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.154 0.502 . . . . 0.0 110.35 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.668 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 20.0 ttm180 -157.25 0.47 0.12 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.48 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.98 -53.18 0.46 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.402 0.681 . . . . 0.0 110.756 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.32 133.98 55.85 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.956 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 18.2 mp0 -59.21 -18.17 34.31 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.372 0.669 . . . . 0.0 112.759 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.8 t -55.89 -68.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.668 HD22 ' CZ ' ' A' ' 50' ' ' ARG . 4.0 tp -87.74 -30.1 20.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.243 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -65.61 -18.7 65.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 18.1 t -64.56 83.71 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 59' ' ' LEU . 8.9 t -136.29 -37.24 0.71 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.024 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' THR . 1.2 pp -123.2 13.48 9.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.34 49.08 2.08 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.084 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.26 118.56 34.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.513 0.197 . . . . 0.0 110.86 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.94 21.64 1.6 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.977 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.42 -31.4 6.0 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.986 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 13.9 p-10 -52.47 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.997 0.919 . . . . 0.0 111.786 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 8.3 p30 -86.97 26.16 1.2 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.971 0.415 . . . . 0.0 110.243 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 5.6 tt -88.02 -78.19 0.33 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.177 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.93 74.71 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.66 160.76 16.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 69.53 -62.62 0.41 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.016 0.527 . . . . 0.0 111.787 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.671 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -62.65 -62.64 1.6 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -63.59 -38.81 83.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.671 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 85.8 mt-30 -63.46 -32.32 73.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.921 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.54 -40.94 22.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.686 0.279 . . . . 0.0 111.614 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.2 -35.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.185 0.516 . . . . 0.0 111.094 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -78.11 -4.89 49.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.282 0.563 . . . . 0.0 110.25 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 47.5 ttp180 -90.0 -6.77 55.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.592 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.24 0.574 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.859 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.61 ' HD1' ' N ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.61 ' N ' ' HD1' ' A' ' 86' ' ' TYR . . . -88.14 -17.87 30.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.894 0.378 . . . . 0.0 111.397 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.58 -45.44 90.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.337 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.45 -62.51 1.63 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.271 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 61.4 m-85 -84.27 32.94 0.49 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.801 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 p -54.82 -61.5 2.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -68.59 -38.37 80.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' O ' HD21 ' A' ' 117' ' ' LEU . . . -64.69 -39.86 94.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 36.5 mt -83.77 -34.33 24.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -76.22 -47.04 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.335 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.517 ' ND2' HG12 ' A' ' 105' ' ' ILE . 37.9 t-20 57.21 92.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.983 0.802 . . . . 0.0 111.119 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.41 -2.15 48.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.6 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.03 -13.47 31.62 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.733 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 t -80.46 -8.95 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.64 0.734 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -84.4 -179.23 7.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.257 -176.284 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -77.26 113.83 15.43 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.549 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.39 64.27 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.717 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -41.32 77.86 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 2.7 t-20 -62.14 -33.23 74.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.715 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.517 HG12 ' ND2' ' A' ' 96' ' ' ASN . 1.5 mp -78.15 -43.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.541 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.57 -19.02 56.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.459 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -84.31 -55.48 4.15 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.015 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 3.3 pp -123.47 -32.57 3.36 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -50.33 -75.21 0.22 Allowed Glycine 0 C--O 1.223 -0.541 0 C-N-CA 121.596 -0.335 . . . . 0.0 113.772 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.5 m -62.4 -18.37 61.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.796 0.331 . . . . 0.0 111.841 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -81.0 -54.27 5.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.447 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.02 -40.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.994 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 3.3 mm? -70.08 -16.68 63.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.6 p 45.44 -118.24 0.71 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.918 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.8 69.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 120' ' ' VAL . 11.6 tp -59.38 -62.88 1.55 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.519 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 117' ' ' LEU . 15.8 mt -71.9 -29.99 64.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.564 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -61.19 -40.23 93.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.284 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.92 -32.63 56.6 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.661 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 124' ' ' ALA . 54.2 t -68.51 -35.99 72.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.651 -0.323 . . . . 0.0 110.962 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 59.0 m -53.03 -47.36 68.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.1 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 p -80.85 -43.25 20.25 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.79 -72.51 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.651 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.24 -50.43 32.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' SER . 45.4 tt0 -64.62 -35.87 82.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.054 0.454 . . . . 0.0 110.769 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.21 -53.37 3.14 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.9 -0.667 . . . . 0.0 114.618 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.5 mt -105.48 -24.12 12.68 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.9 94.5 0.73 Allowed Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.879 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.558 HG13 ' HD3' ' A' ' 50' ' ' ARG . 30.1 mm -77.87 141.12 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.253 0.549 . . . . 0.0 112.429 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -123.23 152.13 41.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.73 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 46.3 t -107.88 163.31 5.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 131' ' ' VAL . 35.8 t70 -58.8 160.05 6.19 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.508 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 15.4 m -74.64 29.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.11 -87.17 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -106.23 -48.47 3.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.818 0.342 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 140' ' ' ILE . 45.1 t -52.15 -63.16 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -172.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 36.5 tt0 -62.59 -41.21 98.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -60.1 -44.0 95.17 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.083 0.468 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.87 -51.99 14.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.924 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 136' ' ' VAL . 34.4 pt -62.01 -34.47 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -64.74 -47.8 76.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 0.0 110.752 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -34.93 71.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.362 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.4 t -67.88 -56.59 8.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.875 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.94 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB3' HD22 ' A' ' 108' ' ' LEU . . . -72.28 -10.98 60.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.796 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 18' ' ' ILE . 20.3 m -78.55 -22.18 47.63 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.552 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -55.43 -30.44 60.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.15 -38.93 24.8 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.432 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -32.29 22.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' SER . 19.9 pt -47.79 -47.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 11.7 m -70.83 -24.58 62.56 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.68 0.276 . . . . 0.0 111.599 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -87.56 -24.37 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.882 0.372 . . . . 0.0 111.576 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 17' ' ' LEU . 84.3 t -59.92 173.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.51 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -37.45 -33.51 0.07 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.753 1.221 . . . . 0.0 114.189 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.19 -23.0 61.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.58 -38.17 86.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.9 -41.95 12.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.31 69.54 7.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.41 19.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.4 1.08 . . . . 0.0 112.39 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 24.2 m -55.98 161.52 2.27 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 123.556 0.743 . . . . 0.0 111.482 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -52.69 -19.51 2.45 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 p -51.79 -44.83 63.6 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.895 . . . . 0.0 113.253 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -100.09 -20.23 16.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.375 0.607 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 1.2 tpt180 -66.72 -56.14 11.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.301 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -163.85 -34.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.859 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.62 146.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.89 139.86 57.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.105 0.478 . . . . 0.0 110.849 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 48.7 ptt85 -63.57 157.37 23.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.166 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.03 112.21 4.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.894 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.5 ' H ' HG22 ' A' ' 131' ' ' VAL . . . 90.71 35.72 7.16 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.687 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.9 p -45.12 143.6 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.44 0.696 . . . . 0.0 112.415 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.2 p -82.13 139.81 34.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.077 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.6 pt20 -59.55 -14.12 11.91 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.44 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' HG3' HD22 ' A' ' 116' ' ' LEU . 72.7 mm-40 -65.04 -32.02 73.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.746 0.307 . . . . 0.0 111.216 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.01 -34.08 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.413 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . -84.0 -76.94 0.28 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.567 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m 75.21 -18.92 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.838 0.855 . . . . 0.0 111.629 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 44' ' ' ALA . 16.8 p -68.04 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.296 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.56 -32.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.5 p -79.15 89.43 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 121.931 0.872 . . . . 0.0 110.795 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 10.9 mm100 -82.53 -43.49 17.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.021 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -133.88 -4.82 2.81 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.497 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.61 -50.12 0.66 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.305 0.642 . . . . 0.0 112.722 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.42 -90.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -172.74 -45.15 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -50.31 -62.11 1.78 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 tt -86.06 -23.64 26.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.415 0.626 . . . . 0.0 110.138 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' THR . . . -76.98 -17.92 58.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 p -62.72 65.33 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.528 0.68 . . . . 0.0 112.724 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.496 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.9 t -102.5 -37.32 8.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 58' ' ' THR . 81.2 mt -121.76 19.16 11.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 65.33 1.57 Allowed Glycine 0 C--O 1.217 -0.968 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.24 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.572 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.9 t -90.07 110.17 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.98 0.419 . . . . 0.0 109.979 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -141.77 18.0 2.16 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.41 -34.71 4.3 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.09 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.3 -70.53 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 110.375 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 26.7 p-10 -86.04 18.88 2.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.454 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.7 tt -88.14 -74.41 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.529 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.41 -27.25 66.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -111.71 162.88 14.75 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 66.82 -61.74 0.32 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.85 -61.54 2.11 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.761 0.315 . . . . 0.0 110.73 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.76 -35.77 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -69.88 -21.37 63.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.446 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -42.85 29.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.83 0.348 . . . . 0.0 110.152 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 27.3 t -78.23 -33.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -70.97 -18.11 62.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.275 0.56 . . . . 0.0 110.431 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -116.58 18.95 14.86 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.182 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . 10.7 tp . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.278 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.443 -0.814 0 CA-C-O 121.085 0.469 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -75.01 12.84 0.78 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 4.1 mp0 -74.55 -59.86 2.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.95 71.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.086 0.47 . . . . 0.0 110.827 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 93.0 m-85 -83.24 12.38 5.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.522 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 47.8 t -51.19 -43.27 61.31 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.524 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.9 m -58.16 -44.64 88.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.69 30.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.781 0.324 . . . . 0.0 111.803 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 68.2 mt -81.59 -32.16 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -84.97 -34.72 22.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.447 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 49.05 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.979 0.8 . . . . 0.0 111.093 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.72 -6.34 51.77 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.598 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.16 -2.85 87.27 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.833 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 32.8 t -92.71 -13.33 8.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.646 0.736 . . . . 0.0 109.818 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.7 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -91.29 -176.08 4.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -84.54 105.17 15.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.76 -16.93 64.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.176 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -81.34 -19.76 42.12 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.476 ' ND2' HD12 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.97 -26.52 64.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.141 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.476 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -69.67 -33.17 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.564 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -77.48 -27.18 51.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.109 0.48 . . . . 0.0 109.959 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 89.9 m -78.54 -46.65 18.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.838 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -133.51 -40.99 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -48.5 -71.88 0.52 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' SER . 10.3 t -67.32 -14.05 62.56 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.097 0.475 . . . . 0.0 111.494 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 107' ' ' THR . 80.4 mtp180 -87.19 -49.51 7.23 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.4 -42.81 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.258 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 116' ' ' LEU . 6.0 mp -80.09 -29.46 39.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 110' ' ' SER . 19.5 m 47.72 -99.09 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.473 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.22 -36.79 63.89 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 113' ' ' LEU . 55.5 tp -62.47 -57.08 12.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.601 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' SER . 25.9 mt -71.47 -23.78 61.88 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.165 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -67.12 -34.11 76.9 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.19 -43.22 6.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.455 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 124' ' ' ALA . 56.0 t -62.42 -28.99 45.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 122.358 0.263 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 9.3 t -57.35 -40.51 78.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.267 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 23.7 m -85.57 -28.83 24.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.0 -83.82 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -70.17 -47.49 61.37 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 42.9 tt0 -75.71 -17.57 59.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.326 0.584 . . . . 0.0 109.793 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 122' ' ' SER . . . -85.13 -64.06 1.55 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.207 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -127.69 -4.93 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.37 119.43 1.32 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.593 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.46 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.967 0.413 . . . . 0.0 111.261 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -101.02 152.19 20.89 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.28 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -116.61 -149.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' H ' HG12 ' A' ' 131' ' ' VAL . 2.8 p-10 -85.44 147.44 26.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.491 0.663 . . . . 0.0 110.871 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 p -80.53 15.38 1.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.301 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.05 -64.43 0.48 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.499 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.6 m -85.25 -49.86 7.84 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' ILE . 99.5 t -72.23 -51.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.82 -48.25 73.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 p -58.79 -41.78 87.49 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.831 0.348 . . . . 0.0 111.86 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -50.4 16.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.996 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.3 pt -65.27 -31.73 55.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -61.41 -43.94 97.99 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.2 p -86.52 -40.57 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 22.8 t -78.09 -18.36 55.83 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.773 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.24 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.59 77.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.3 p -76.21 -27.99 57.04 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.291 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.99 -23.02 52.21 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.01 -41.8 6.17 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.511 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -84.41 -22.64 30.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 5.1 pt -40.22 -55.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 t -85.06 -19.71 31.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.712 0.291 . . . . 0.0 111.632 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -83.14 -27.42 30.13 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 100' ' ' LEU . 23.8 t -71.28 -100.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.99 35.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB3' HD22 ' A' ' 31' ' ' LEU . 4.4 m-80 -70.91 -24.56 62.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.7 87.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.167 0.508 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 25' ' ' LEU . 6.0 tt -75.91 -40.21 54.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.05 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.73 90.41 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.741 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 53.77 16.97 1.14 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.793 0.837 . . . . 0.0 111.794 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 29' ' ' SER . 19.7 m -75.66 165.59 24.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.27 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 16.3 m -60.08 -17.63 41.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.819 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -53.48 -31.26 44.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.687 0.795 . . . . 0.0 112.73 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -110.08 -20.28 12.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.525 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 15.5 ttm180 -79.87 -38.61 32.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.878 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -174.64 -26.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.08 139.64 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.42 145.37 22.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -63.12 155.25 28.5 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 m -71.22 114.45 9.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.262 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 40.13 9.19 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.762 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.86 151.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.203 0.525 . . . . 0.0 111.605 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -91.31 159.51 15.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.599 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.0 pt20 -67.42 -13.37 61.96 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.285 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.415 ' CG ' HD13 ' A' ' 116' ' ' LEU . 83.4 mm-40 -55.62 -47.78 76.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.043 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.94 -29.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.784 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.32 -55.36 4.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.118 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 m 75.53 -18.9 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.866 0.866 . . . . 0.0 111.821 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -68.43 -88.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -145.01 -27.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.947 0.403 . . . . 0.0 111.814 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.62 98.21 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.342 0.591 . . . . 0.0 111.824 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 31.2 mt-30 -82.54 -48.27 11.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.351 177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.726 ' NH1' ' HA ' ' A' ' 123' ' ' ALA . 54.7 ttt180 -134.31 -3.14 2.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.879 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.07 -58.26 0.54 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.354 0.662 . . . . 0.0 110.306 -174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.43 137.61 57.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.274 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' SER . 4.6 pm0 -50.29 -24.38 2.89 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -50.93 -74.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.56 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 47.5 tp -87.94 -24.53 23.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.514 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.85 59.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 14.3 t -58.67 84.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 111.65 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.7 t -123.3 -35.99 2.88 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.73 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' THR . 84.0 mt -120.82 18.57 11.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.948 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.43 59.69 2.35 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.391 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.707 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 33.0 t -89.43 103.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 120.929 0.395 . . . . 0.0 110.834 -177.114 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -169.2 96.77 0.34 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.502 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.77 -63.87 4.18 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.21 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.55 -75.52 0.05 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.914 0.486 . . . . 0.0 111.664 -175.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.707 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.5 p-10 -85.8 15.16 5.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.26 -56.1 3.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.442 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.01 46.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.246 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -121.24 161.09 22.54 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 66.95 -63.11 0.28 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.89 -31.24 52.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 110.349 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -68.61 -29.5 68.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.65 65.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.122 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -77.5 -38.92 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.7 t -66.37 -21.92 66.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -113.32 15.44 19.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 77' ' ' LEU . 11.9 tp . . . . . 0 C--N 1.317 -0.825 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.661 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.81 35.6 0.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.235 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 85.6 mm-40 -74.43 -60.39 2.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.331 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -78.67 -32.67 47.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.409 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.43 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 56.6 m-85 -80.68 9.03 6.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.055 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 p -52.15 -56.53 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 11.7 t -61.53 -36.04 79.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.968 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -74.61 -36.54 62.95 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.39 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.438 HD22 HD21 ' A' ' 116' ' ' LEU . 50.1 mt -83.62 -20.68 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.164 0.507 . . . . 0.0 111.163 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 78.9 t80 -85.13 -25.27 27.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 48.57 65.59 1.3 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.972 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.92 64.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.098 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.13 -15.45 61.0 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.113 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.17 -12.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.98 0.895 . . . . 0.0 109.02 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -83.6 175.29 9.85 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 -178.025 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 39.1 t30 -72.17 109.51 5.99 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.833 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.53 -24.43 63.74 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.865 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.1 m -69.46 -26.88 64.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.527 0.68 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -64.62 -46.56 82.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.606 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.68 -36.95 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.019 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.59 -39.06 92.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 93.4 m -74.87 -62.89 1.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' OD1' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -113.21 -33.22 6.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.9 -56.87 14.3 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.188 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.9 t -69.49 -26.44 64.56 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.764 0.316 . . . . 0.0 111.573 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 107' ' ' THR . 3.6 mpt_? -83.09 -47.39 11.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.24 -50.08 15.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 9.0 mp -67.87 -41.27 83.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.925 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.7 t 46.72 -95.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.761 0.824 . . . . 0.0 113.104 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.8 66.0 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.092 0.557 . . . . 0.0 112.121 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 120' ' ' VAL . 35.2 tp -65.93 -48.22 72.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.524 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 17.0 mt -70.75 -23.49 62.44 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.718 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -58.46 -34.78 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.55 -41.42 6.88 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.555 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 116' ' ' LEU . 76.4 t -61.18 -32.55 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.8 m -54.43 -45.67 73.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -84.33 -23.9 30.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.827 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.726 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.17 -84.96 0.14 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 95' ' ' PHE . . . -76.51 -45.91 28.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.835 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -72.52 -20.38 61.36 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.089 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.73 -70.96 1.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.62 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.69 -9.07 5.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.653 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.63 120.78 3.12 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.895 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 mt -85.27 146.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.051 0.453 . . . . 0.0 111.863 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.52 149.37 42.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.2 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 20.7 t -120.89 161.72 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 131' ' ' VAL . 21.2 t70 -59.72 156.22 14.31 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.261 0.553 . . . . 0.0 111.74 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 14.5 m -78.97 20.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.477 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.84 -77.97 0.35 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.183 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.9 m -107.83 -31.15 8.14 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.8 t -86.58 -64.46 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.3 tt0 -67.59 -23.0 65.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.358 . . . . 0.0 111.96 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -68.85 -44.97 72.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.065 0.46 . . . . 0.0 111.084 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.48 -50.23 14.54 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.511 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 137' ' ' GLN . 44.9 pt -58.79 -40.47 79.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -36.95 70.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.755 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.1 t -84.42 -45.53 12.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.0 110.568 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.6 t -59.14 -45.41 91.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.905 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 -179.023 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.21 -1.1 24.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.305 0.574 . . . . 0.0 110.437 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 18' ' ' ILE . 27.5 p -76.5 -25.01 53.78 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.27 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.47 43.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.49 -38.93 6.91 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.53 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -83.77 -25.02 30.84 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 9.5 pt -45.44 -42.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.2 m -83.12 -19.83 35.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -86.71 -23.84 25.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -72.14 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.149 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -51.79 -33.26 34.69 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.439 0.696 . . . . 0.0 112.76 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB3' HD22 ' A' ' 31' ' ' LEU . 10.0 m-80 -65.69 -24.29 66.97 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -70.95 -42.42 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.23 -16.1 53.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.57 -36.99 21.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.26 18.25 0.59 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.683 1.193 . . . . 0.0 112.228 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 143' ' ' SER . 7.1 m -66.26 164.11 16.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.201 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 54.9 m -63.85 -16.3 61.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.832 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -51.31 -41.04 60.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.762 0.825 . . . . 0.0 112.289 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -99.84 -19.31 16.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.394 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 17.5 ttm180 -74.47 -59.58 2.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.199 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -162.78 -28.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.82 136.06 24.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.6 138.29 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.81 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -64.07 152.46 40.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.669 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -67.65 111.63 4.32 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.418 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 129' ' ' ILE . . . 85.93 38.37 8.68 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.215 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.9 148.29 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.131 0.491 . . . . 0.0 111.105 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -87.86 157.37 19.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.073 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 18.8 pt20 -63.52 -19.39 64.73 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.302 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -51.5 -46.18 63.12 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 111.458 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -84.08 -32.66 8.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -83.67 -48.91 9.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.8 p 67.48 -18.84 0.13 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.292 1.437 . . . . 0.0 113.095 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ALA . 20.8 p -68.38 -75.69 0.1 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.61 -34.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.836 0.351 . . . . 0.0 111.903 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.52 97.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.1 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 72.8 mt-30 -82.84 -51.01 8.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.349 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.59 HH22 ' HB2' ' A' ' 127' ' ' LEU . 41.1 ttt180 -130.69 -5.72 4.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.673 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' O ' HD13 ' A' ' 66' ' ' LEU . . . 71.08 -55.74 0.64 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.599 -172.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 136.07 54.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.901 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -51.01 -29.86 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -173.488 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.3 t -46.84 -69.25 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.106 0.412 . . . . 0.0 112.079 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.448 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 57.4 tp -88.6 -24.19 22.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 111.602 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' THR . . . -79.26 -18.91 51.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.0 t -48.48 98.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.089 0.471 . . . . 0.0 111.662 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ALA . 8.9 t -142.04 -37.72 0.39 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.557 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.92 18.7 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.02 67.63 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.35 110.23 20.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.14 0.495 . . . . 0.0 110.998 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -158.94 20.92 0.2 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.991 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 123.48 -37.75 2.65 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.814 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.28 -74.47 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.552 0.176 . . . . 0.0 110.928 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -85.48 9.69 15.07 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 19.5 tp -87.97 -56.6 3.27 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.963 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 -35.52 40.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.508 0.671 . . . . 0.0 109.899 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.81 162.87 12.94 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 68.89 -61.68 0.41 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.65 -62.16 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.817 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -40.34 86.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.125 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.38 -44.6 95.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.722 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.51 74.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.02 -38.18 78.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -74.79 -21.78 59.12 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.979 0.419 . . . . 0.0 110.76 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 4.8 tpm_? -92.06 -8.9 44.59 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.15 0.5 . . . . 0.0 110.11 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--N 1.32 -0.714 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.276 -179.705 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.18 41.33 0.37 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.297 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 tp60 -64.81 -61.59 2.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.911 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -80.34 -27.1 38.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.69 10.45 2.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t -52.03 -51.07 59.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.1 m -59.14 -34.96 72.68 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -32.84 31.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.94 -35.38 18.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -78.74 -30.84 46.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 52.07 82.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.85 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.64 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.74 -13.71 60.16 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.135 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.27 -2.07 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.645 0.736 . . . . 0.0 109.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -84.92 173.81 10.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.355 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 18.8 t-20 -68.39 103.74 1.71 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.733 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.36 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.813 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 p -74.84 -16.67 60.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.057 0.456 . . . . 0.0 110.673 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -68.06 -47.32 68.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.406 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.48 -41.93 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.17 -30.72 70.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.147 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.1 m -91.42 -52.46 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -117.48 -27.86 6.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.75 -64.89 3.97 Favored Glycine 0 C--O 1.234 0.103 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.961 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 p -76.71 -11.8 59.9 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -54.73 4.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.33 -54.48 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.164 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 113' ' ' LEU . 6.1 mp -72.96 -57.92 3.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m 67.24 -86.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.1 -36.92 61.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' VAL . 27.6 tp -65.29 -50.97 63.68 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.743 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HA ' HG22 ' A' ' 120' ' ' VAL . 5.4 mp -67.95 -23.22 65.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.05 -42.65 7.01 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.822 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.769 HG22 ' HA ' ' A' ' 117' ' ' LEU . 2.7 m -67.71 -32.46 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.828 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -62.21 -34.18 75.98 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.755 0.312 . . . . 0.0 110.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 t -85.34 -38.5 18.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.471 0.653 . . . . 0.0 110.303 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.22 -79.43 0.21 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 129' ' ' ILE . . . -65.23 -60.93 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.414 -175.078 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -31.86 70.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 109.965 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.94 2.22 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.484 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' LEU . . . . . 0.59 ' HB2' HH22 ' A' ' 50' ' ' ARG . 73.0 mt -115.02 -5.54 12.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.0 105.07 0.07 OUTLIER Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.3 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 124' ' ' ALA . 27.9 mt -77.57 134.88 27.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -128.1 115.74 18.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.082 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 132' ' ' ASP . 16.2 t -82.75 166.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.936 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 131' ' ' VAL . 18.9 t70 -59.35 158.18 9.78 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.104 0.478 . . . . 0.0 111.252 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 33.1 m -79.86 16.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.345 -177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.58 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.934 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.0 p -106.83 -30.14 9.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.39 -63.97 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 34.8 tp60 -59.17 -41.77 89.21 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 m -57.63 -45.7 85.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.877 0.37 . . . . 0.0 111.885 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.71 -52.87 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.459 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.4 pt -55.75 -38.91 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -62.87 -35.26 79.41 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 m -84.82 -38.24 19.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 111.009 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 28' ' ' THR . 50.9 m -72.28 -40.73 67.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.353 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.024 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 N-CA-C 112.712 -0.155 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.89 74.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.22 0.534 . . . . 0.0 110.682 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.6 m -62.82 -26.78 68.91 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.86 -18.31 4.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.79 -45.9 5.01 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.422 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.2 pp -86.63 -21.63 26.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 4.7 pt -35.49 -58.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.1 t -79.41 -20.23 48.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.65 -32.96 20.28 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' LEU . 45.7 t -62.0 -94.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -53.39 6.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -65.75 -24.41 66.95 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.16 -35.91 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.725 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.74 -21.6 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.482 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.68 33.74 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 63.9 t30 55.96 18.09 2.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.714 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 m -81.32 148.38 29.42 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 -17.18 1.01 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.882 1.273 . . . . 0.0 114.101 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -61.2 -21.99 64.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 pp -93.83 -26.99 16.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.217 0.532 . . . . 0.0 110.379 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -82.42 -45.88 14.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 -26.58 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 ' OD1' ' A' ' 139' ' ' ASP . 25.8 t -84.35 161.47 3.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.6 pt? -85.1 159.27 20.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.696 0.284 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -89.39 166.47 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.296 0.569 . . . . 0.0 111.514 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -74.87 124.87 27.66 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.601 177.719 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 73.31 38.26 53.6 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.451 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.93 149.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.042 0.937 . . . . 0.0 112.66 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.3 m -77.83 142.65 38.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.003 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -68.87 -13.09 62.2 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -58.98 -35.43 73.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.93 -42.35 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.795 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.39 -69.15 0.65 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.591 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m 74.9 -21.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.968 0.907 . . . . 0.0 112.347 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 p -70.2 -82.24 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 -22.88 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.58 85.0 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 46.5 mt-30 -83.16 -43.62 15.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.51 -13.22 6.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.436 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.21 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.591 0.756 . . . . 0.0 110.255 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.27 144.34 50.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 57' ' ' SER . 5.1 pm0 -55.03 -19.21 6.47 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -56.28 -81.72 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 50' ' ' ARG . 9.9 tt -86.04 -22.81 27.04 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.903 0.382 . . . . 0.0 111.123 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -73.32 -18.44 61.19 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.9 t -52.22 97.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.105 0.478 . . . . 0.0 110.94 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 t -131.81 -37.37 1.17 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.88 19.65 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.395 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 67.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.855 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.88 102.33 12.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -150.62 17.58 0.81 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 110.583 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 127.7 -42.44 1.45 Allowed Glycine 0 C--N 1.288 -2.095 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.521 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . 52.2 m-80 -55.06 -79.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.713 0.302 . . . . 0.0 111.723 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -85.3 12.95 7.13 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.297 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 39.3 tp -88.61 -57.34 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.07 -32.63 56.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -109.76 160.61 16.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.19 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 68.91 -62.32 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 135' ' ' SER . 9.6 p -72.69 -37.2 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.74 -27.79 65.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.3 -47.45 13.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.425 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.13 -35.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.048 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.7 p -72.41 -21.41 61.27 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.056 0.455 . . . . 0.0 110.545 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -91.11 -14.48 31.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 34.1 mt . . . . . 0 C--O 1.235 0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.83 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 77.8 m-85 . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.61 25.11 0.2 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.646 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 30' ' ' THR . 65.0 mt-30 -87.17 -59.34 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.105 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.596 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -70.28 -48.13 58.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.0 m-85 -79.09 23.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 89' ' ' ALA . 6.9 p -51.01 -60.29 3.25 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.415 0.686 . . . . 0.0 112.696 -177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -65.26 -32.66 74.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.95 56.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.704 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.3 mt -84.35 -28.2 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.617 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.99 -38.2 22.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.065 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.2 m120 53.69 73.0 0.4 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.681 0.613 . . . . 0.0 111.118 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.36 -2.76 33.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.742 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.77 -5.7 68.88 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.127 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.87 21.75 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 109.737 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.515 ' CB ' HG11 ' A' ' 21' ' ' VAL . 1.8 pt? -117.4 163.71 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.82 128.15 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.467 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.61 -20.67 62.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.9 t -65.98 -36.63 83.82 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 108' ' ' LEU . 9.2 t30 -61.8 -49.32 76.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.061 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 35.8 mm -68.94 -38.44 78.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.166 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.67 -24.55 61.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -79.79 -55.83 4.71 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.417 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -130.83 -23.49 2.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.68 -65.5 3.14 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.1 p -78.58 -11.62 59.97 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.442 -0.446 . . . . 0.0 111.924 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -87.54 -52.58 5.27 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -83.75 -44.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.915 0.388 . . . . 0.0 111.259 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.0 mp -78.39 -51.73 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.1 m 53.18 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.78 29.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.76 0.824 . . . . 0.0 112.878 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 120' ' ' VAL . 61.6 tp -63.47 -55.7 22.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.855 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.0 mt -66.06 -28.76 69.08 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.156 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -58.3 -49.83 75.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 109.903 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.82 -36.49 61.46 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.105 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 116' ' ' LEU . 78.2 t -64.48 -38.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.606 0.241 . . . . 0.0 110.708 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -58.12 -46.31 85.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -70.86 -42.72 69.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.3 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.427 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -84.35 -80.19 0.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -66.41 -49.51 66.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 25.7 tm0? -71.03 -28.39 64.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.989 0.423 . . . . 0.0 110.87 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.1 -55.87 2.55 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.053 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.7 tp -102.13 -26.13 13.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.905 0.353 . . . . 0.0 111.796 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.8 73.38 1.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.572 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.444 ' H ' ' HA ' ' A' ' 124' ' ' ALA . 1.3 mp -68.18 139.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -130.88 131.8 44.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.46 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.493 ' H ' HG22 ' A' ' 37' ' ' THR . 22.4 t -89.5 120.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.026 0.441 . . . . 0.0 111.306 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -100.82 49.72 0.88 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.979 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -79.77 0.33 31.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.811 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.82 -25.71 20.13 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.904 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 71' ' ' VAL . 6.2 m -105.64 -49.05 3.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 140' ' ' ILE . 84.0 t -52.74 -62.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -57.31 -44.11 83.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.526 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.3 m -58.65 -45.57 89.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.855 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASP . . . . . 0.478 ' OD1' HG21 ' A' ' 34' ' ' VAL . 12.0 t70 -69.09 -53.17 21.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.728 0.299 . . . . 0.0 111.496 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 136' ' ' VAL . 44.0 pt -65.08 -42.02 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -66.14 -39.5 89.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 t -72.54 -45.5 59.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.866 0.365 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.3 m -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.704 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.186 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.34 -16.34 60.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.523 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 18' ' ' ILE . 42.5 m -60.46 -34.77 74.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.14 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.16 -22.83 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.35 -43.18 5.64 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.551 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -85.28 -25.18 27.38 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 3.0 pt -34.3 -63.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 42.5 t -75.07 -19.14 60.12 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.96 -21.51 37.16 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.66 0.384 . . . . 0.0 112.026 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 100' ' ' LEU . 1.8 t -71.68 -142.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -62.02 -23.41 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.9 OUTLIER -66.68 -26.56 67.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.986 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.41 -44.13 92.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.536 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.11 -28.75 38.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.649 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.83 87.73 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.26 17.87 3.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.864 0.866 . . . . 0.0 112.057 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.457 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 2.3 m -76.7 164.57 25.76 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.492 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 29.6 m -62.66 -16.49 57.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.035 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -52.3 -38.73 59.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.664 0.785 . . . . 0.0 112.515 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -104.02 -20.9 13.7 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.409 0.623 . . . . 0.0 110.538 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 13.1 ttm180 -72.81 -40.72 65.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.708 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 34' ' ' VAL . 8.2 t -173.3 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 33' ' ' THR . 47.4 t -87.2 139.89 16.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.2 pt? -54.14 141.68 28.15 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.007 0.432 . . . . 0.0 110.695 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 46.5 ptt85 -67.55 162.72 22.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.506 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.74 129.84 38.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.431 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' HA3' ' HB ' ' A' ' 129' ' ' ILE . . . 72.1 35.49 60.9 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.731 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.4 p -44.99 149.84 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.125 0.97 . . . . 0.0 112.771 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.8 m -88.11 149.43 23.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.289 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 7.7 pm0 -70.64 -12.99 61.91 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.627 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -55.48 -31.94 62.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.759 0.314 . . . . 0.0 110.988 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -85.03 -44.73 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.029 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.57 -71.49 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.703 0.287 . . . . 0.0 111.696 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 t 79.63 -20.49 0.38 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.543 1.137 . . . . 0.0 111.022 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -78.91 -96.59 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.891 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -99.41 -35.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 0.0 111.291 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.71 81.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HA ' ' CB ' ' A' ' 41' ' ' GLN . 42.4 mt-30 -83.01 -47.85 11.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.597 0.713 . . . . 0.0 110.392 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 2.5 tpm_? -125.16 -12.71 6.87 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.514 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 -52.17 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.404 0.681 . . . . 0.0 110.054 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -74.44 155.46 38.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.434 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.665 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.7 mp0 -60.38 -18.82 53.02 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.372 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -58.32 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 19.3 mt -86.08 -22.14 27.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -77.42 -20.25 54.86 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -56.2 101.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.172 0.511 . . . . 0.0 110.594 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.3 t -145.99 -32.46 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 75.4 mt -121.4 18.88 11.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.0 0.429 . . . . 0.0 109.9 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 67.18 1.46 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.088 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 65' ' ' ASN . 61.9 t -97.44 113.6 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.377 0.271 . . . . 0.0 110.756 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -170.92 78.69 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.148 0.499 . . . . 0.0 110.456 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 -46.07 2.07 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.991 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.442 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.5 p-10 -52.04 -74.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.018 0.927 . . . . 0.0 112.796 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.475 HD21 HG22 ' A' ' 61' ' ' VAL . 31.6 p-10 -85.03 -16.71 39.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.181 0.515 . . . . 0.0 109.875 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 132' ' ' ASP . 61.4 tp -63.59 -47.25 82.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.705 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.21 -15.0 60.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 91.0 mtt180 -120.65 -84.44 0.66 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.875 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -52.17 -39.19 59.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.62 -57.12 9.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.655 0.264 . . . . 0.0 111.68 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.29 -38.3 82.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 68' ' ' ARG . 96.8 mt-30 -65.43 -35.11 79.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.99 94.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.0 t -86.23 -41.11 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.568 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -64.46 -28.54 69.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -102.84 5.04 38.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.373 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.355 -177.497 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 121.434 0.635 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -74.64 22.26 0.1 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.673 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 86' ' ' TYR . 70.7 mt-30 -86.42 -60.29 2.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 120.989 0.424 . . . . 0.0 109.927 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.9 -41.55 82.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.107 0.479 . . . . 0.0 109.957 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.0 m-85 -83.88 15.64 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.67 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . 0.516 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . 47.1 t -56.47 -50.75 70.83 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -60.14 -30.1 69.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.8 -40.65 22.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.748 0.308 . . . . 0.0 111.388 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 37.9 mt -83.25 -29.47 28.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.903 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -79.24 -36.78 39.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.31 90.35 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.56 -16.44 60.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.649 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 -14.01 52.13 Favored Glycine 0 C--O 1.227 -0.322 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.749 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -93.61 1.35 9.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.203 1.002 . . . . 0.0 109.527 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -83.94 173.76 10.92 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.129 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -81.27 135.9 35.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.094 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.26 54.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.25 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.1 p -68.36 -30.67 69.68 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 121.217 0.532 . . . . 0.0 110.698 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.562 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.1 t30 -60.24 -53.79 53.45 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.51 -38.02 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.86 -31.7 71.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.839 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 m -91.68 -53.82 4.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -111.76 -35.24 5.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.79 -52.67 40.93 Favored Glycine 0 N--CA 1.46 0.293 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.121 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.625 ' HA ' HD12 ' A' ' 117' ' ' LEU . 33.0 t -66.09 -24.11 66.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.735 0.302 . . . . 0.0 111.551 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -87.13 -40.75 14.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.88 0.371 . . . . 0.0 111.42 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.12 -55.79 6.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.87 0.367 . . . . 0.0 111.376 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.57 -42.29 64.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 49.53 -94.86 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.432 ' HA ' ' OD1' ' A' ' 118' ' ' ASN . . . -66.74 -19.08 65.68 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.447 HD21 HD22 ' A' ' 94' ' ' LEU . 58.1 tp -73.87 -36.81 64.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.741 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 110' ' ' SER . 33.0 mt -68.06 -43.51 78.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 115' ' ' ALA . 1.9 p-10 -62.68 -24.38 67.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.054 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.77 -30.1 21.89 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.572 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 124' ' ' ALA . 49.5 t -84.7 -34.66 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.4 p -53.38 -49.25 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.13 0.49 . . . . 0.0 111.627 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.2 t -76.26 -28.8 57.23 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB1' ' HD3' ' A' ' 50' ' ' ARG . . . -84.56 -85.3 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.85 -41.57 74.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -76.58 -21.89 55.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.197 0.522 . . . . 0.0 110.201 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.18 -81.04 1.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.375 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.67 -23.87 19.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.24 88.1 0.77 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.64 HG23 ' HB2' ' A' ' 52' ' ' ALA . 48.8 mm -58.06 136.98 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.66 152.32 24.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.167 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 136' ' ' VAL . 5.3 t -116.9 163.49 14.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 23.3 t70 -59.97 152.04 24.68 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.316 0.579 . . . . 0.0 112.073 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 24.0 m -73.71 -11.54 60.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -45.86 -74.54 0.22 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 123.266 0.354 . . . . 0.0 113.275 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.8 t -106.56 -57.24 2.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.309 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.509 HG21 HG11 ' A' ' 131' ' ' VAL . 60.8 t -48.68 -60.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.254 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.544 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 45.9 tp60 -58.16 -48.93 78.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.543 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -61.46 -41.93 97.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.27 -49.73 63.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.566 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.5 pt -68.57 -35.94 72.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -62.96 -50.28 71.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.654 0.264 . . . . 0.0 110.731 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.5 t -59.45 -43.9 93.06 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.213 0.53 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -64.72 -41.77 95.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.059 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 120.931 0.396 . . . . 0.0 110.971 -178.846 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -62.16 -13.05 23.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.017 0.437 . . . . 0.0 111.558 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' ILE . 7.9 m -54.3 -41.02 68.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.636 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.8 59.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.37 -43.9 5.43 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.503 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -83.66 -20.15 34.09 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' SER . 8.5 pt -42.84 -49.82 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 p -84.77 -18.93 33.52 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -85.66 -36.15 20.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 100' ' ' LEU . 21.1 t -72.8 -102.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -71.33 -51.83 22.1 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.465 ' HB3' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -61.41 -24.95 66.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.116 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.14 91.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.57 -28.18 28.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.19 89.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.85 17.65 3.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.184 176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 3.5 m -71.59 169.26 15.9 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.048 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 20.0 m -61.89 -18.28 59.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ARG . 58.4 p -56.44 -40.71 75.24 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -97.15 -20.13 18.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.235 0.541 . . . . 0.0 110.233 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -74.98 -43.95 51.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.573 -174.714 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 t -176.47 -25.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.4 t -91.89 139.41 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.03 145.17 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 123.186 0.303 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HA ' HG22 ' A' ' 30' ' ' THR . 36.5 ptt85 -60.13 152.12 25.15 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.256 0.551 . . . . 0.0 111.302 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -67.28 114.7 6.2 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.608 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 83.67 40.0 9.21 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.474 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -50.62 146.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 14.6 m -92.8 154.96 17.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.232 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 49' ' ' GLN . 8.5 pt20 -67.07 -12.15 59.12 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' A' ' 116' ' ' LEU . 84.7 mm-40 -53.93 -42.58 68.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.31 -31.2 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.748 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.38 -50.39 8.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 m 78.43 -18.69 0.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.413 1.085 . . . . 0.0 111.737 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 p -71.42 -101.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 -22.04 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.14 89.64 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.279 0.561 . . . . 0.0 111.769 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 68.4 mt-30 -77.47 -61.46 1.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.39 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 63.3 ttt180 -118.58 -2.06 11.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.552 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.93 -59.79 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.597 0.759 . . . . 0.0 112.055 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.03 -84.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 178.56 -44.57 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -49.19 -69.41 0.12 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.428 0.691 . . . . 0.0 112.362 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.93 -23.07 27.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.225 0.536 . . . . 0.0 110.475 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.13 -19.72 62.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.821 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 p -47.93 107.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.733 0.646 . . . . 0.0 111.614 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -154.37 -42.23 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.088 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -122.59 19.38 10.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.332 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.11 63.96 1.49 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.128 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.7 114.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.457 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -178.46 86.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.19 -58.65 4.73 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.935 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -61.78 -76.2 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.39 18.45 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.223 0.535 . . . . 0.0 110.838 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.6 tp -87.23 -56.12 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.888 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -37.23 49.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.143 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -104.04 172.82 6.59 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 63.07 -62.29 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.43 -59.66 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 110.879 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.66 -41.49 92.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.25 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -59.58 -43.21 93.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.613 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.87 -47.52 82.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.61 -41.12 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -66.28 -25.24 66.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.304 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -107.6 9.23 29.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 14.2 tp . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.28 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 121.098 0.475 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.7 46.7 0.68 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.813 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.621 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 mm-40 -91.75 -62.72 1.36 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.563 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -86.32 -33.56 20.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' ILE . 97.7 m-85 -72.72 2.38 6.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -51.79 -49.2 63.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 m -58.79 -39.75 82.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.29 33.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.35 -31.52 24.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -86.47 -31.1 21.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.799 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.1 m120 53.19 68.82 0.78 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.791 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.05 4.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.2 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.51 -13.51 40.69 Favored Glycine 0 C--O 1.225 -0.409 0 C-N-CA 121.314 -0.469 . . . . 0.0 112.855 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 21.6 t -72.04 -19.26 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.21 0.529 . . . . 0.0 110.295 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -85.16 156.0 21.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.286 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 9.5 p-10 -70.36 132.0 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.161 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.79 65.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 p -66.2 -33.49 75.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 28.5 t30 -63.44 -47.73 80.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.104 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.97 -37.9 77.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.307 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -66.66 -33.87 76.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.305 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -85.24 -58.62 2.61 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.8 pp -116.44 -26.78 6.98 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -58.38 -60.05 9.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.955 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -76.93 -11.13 59.77 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.607 -0.349 . . . . 0.0 111.507 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.33 -48.83 7.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 0.0 111.337 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.51 -57.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 116' ' ' LEU . 6.2 mp -72.01 -42.95 65.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.308 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m 55.57 -101.76 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.35 -34.88 64.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.119 0.568 . . . . 0.0 112.448 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 113' ' ' LEU . 22.2 tp -59.78 -55.24 36.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.18 -29.47 67.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.63 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -60.53 -43.09 97.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.83 -40.34 75.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.466 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 116' ' ' LEU . 89.5 t -62.85 -38.36 81.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 75.6 m -55.88 -33.42 64.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 111.427 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 t -85.09 -35.82 21.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.222 0.534 . . . . 0.0 110.429 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.99 -84.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.24 -49.5 34.68 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.843 0.354 . . . . 0.0 111.712 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 40.8 tt0 -67.72 -28.77 67.94 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.53 -61.57 1.78 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.247 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -118.63 -17.82 9.18 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 117.306 0.553 . . . . 0.0 111.455 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.27 120.04 2.37 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.54 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.444 HG21 ' HA3' ' A' ' 38' ' ' GLY . 18.7 mt -88.32 124.29 41.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.658 0.266 . . . . 0.0 110.813 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -124.32 120.21 31.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.88 157.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.67 174.39 2.33 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.401 0.62 . . . . 0.0 112.155 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 13.1 m -80.49 33.38 0.3 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.879 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.81 -91.16 0.11 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.2 m -107.0 -21.26 13.06 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.06 -64.6 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 46.3 tp60 -61.27 -39.76 91.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -59.94 -44.13 94.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.981 0.42 . . . . 0.0 111.738 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.25 -48.42 34.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.744 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 137' ' ' GLN . 47.2 pt -64.25 -35.36 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.0 p -65.23 -35.72 81.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.405 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -74.89 -40.75 60.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.14 0.495 . . . . 0.0 110.608 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 24.5 t -82.69 -20.39 36.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.525 -176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.22 -0.476 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.84 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 112.275 -0.33 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 108' ' ' LEU . . . -71.43 -6.96 44.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' ILE . 11.7 m -54.04 -30.33 47.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.994 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.22 -23.67 15.52 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 -41.47 6.39 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.7 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -22.52 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' SER . 11.7 pt -46.13 -50.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m -67.57 -21.14 65.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.714 0.292 . . . . 0.0 111.374 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -89.96 -22.43 21.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 46.4 t -61.38 169.34 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.386 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.946 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -45.88 -21.55 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -69.05 -22.69 64.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.75 0.309 . . . . 0.0 111.253 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.88 -55.03 34.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -16.65 59.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.056 0.455 . . . . 0.0 110.304 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.51 45.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.65 18.0 0.29 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 175.619 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 29' ' ' SER . 2.1 m -74.32 173.46 10.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.76 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 4.1 m -46.42 -28.54 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.377 1.071 . . . . 0.0 113.037 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -54.46 -32.53 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -112.57 -18.76 12.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.426 0.631 . . . . 0.0 109.863 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 5.6 tpp180 -67.68 -56.19 10.3 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.819 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -168.77 -36.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.31 136.69 24.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -49.63 139.79 12.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.439 0.638 . . . . 0.0 112.282 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 36' ' ' ARG . 6.9 ptm180 -58.77 164.65 2.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.34 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.2 111.36 9.29 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.549 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 77.91 47.34 8.63 Favored Glycine 0 N--CA 1.426 -2.014 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.068 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG21 HD11 ' A' ' 43' ' ' ILE . 8.2 p -56.41 143.75 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.035 0.445 . . . . 0.0 109.897 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 17.4 m -101.6 157.02 17.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -61.79 -12.83 19.02 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.861 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.85 -46.34 81.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.773 0.321 . . . . 0.0 110.368 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 39' ' ' VAL . 2.3 pp -85.93 -36.01 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.523 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.5 -65.9 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.802 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m 77.29 -18.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.856 0.862 . . . . 0.0 112.188 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -61.21 -73.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.658 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.14 -64.43 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.282 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -41.71 107.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.219 1.008 . . . . 0.0 113.652 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 20.6 mp0 -73.75 -53.66 9.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.628 ' HE ' HG13 ' A' ' 129' ' ' ILE . 26.1 ttt85 -145.36 4.39 1.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.856 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.73 -55.87 0.53 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.143 0.577 . . . . 0.0 110.779 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.41 131.34 46.19 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.62 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 9.3 mp0 -56.21 -18.09 9.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.699 -174.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -56.25 -69.9 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.839 0.352 . . . . 0.0 111.235 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 tp -87.9 -23.82 23.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.911 0.386 . . . . 0.0 111.14 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -76.73 -18.16 58.65 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 32.3 t -54.11 91.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.256 0.551 . . . . 0.0 111.339 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' HG ' ' A' ' 59' ' ' LEU . 1.9 t -151.6 -35.52 0.13 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.469 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 58' ' ' THR . 58.3 mt -115.57 19.79 15.12 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.41 54.55 7.6 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 38.7 t -89.6 107.97 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.801 -0.199 . . . . 0.0 110.666 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.16 82.36 0.22 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.27 -51.14 4.44 Favored Glycine 0 C--N 1.32 -0.319 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.359 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 17.2 p-10 -55.49 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.696 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.0 p-10 -85.73 14.82 5.32 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.278 0.561 . . . . 0.0 110.088 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 71' ' ' VAL . 26.0 tp -87.63 -60.41 1.98 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.52 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.74 64.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.356 0.598 . . . . 0.0 109.513 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.0 mpt_? -93.18 157.4 16.29 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 69.16 -62.66 0.4 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -67.46 -62.36 1.46 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' LEU . 82.0 t -56.24 -41.02 68.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -68.39 -37.14 80.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.24 84.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.99 -35.02 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.204 0.526 . . . . 0.0 110.284 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 t -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.689 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -89.18 -0.59 57.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.736 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 33.7 mt . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.502 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 7.9 m-85 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.874 0.368 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.11 36.88 0.24 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.54 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -89.63 -59.7 2.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.05 82.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.107 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.557 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 94.1 m-85 -83.68 10.24 9.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.609 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 t -56.94 -40.79 77.05 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.226 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 69.9 m -57.98 -43.96 86.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.182 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.92 -31.89 64.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.411 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 22.1 mt -84.31 -21.54 30.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.978 0.418 . . . . 0.0 111.291 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' PHE . . . . . 0.422 ' HB2' HH12 ' A' ' 36' ' ' ARG . 67.4 t80 -87.42 -38.52 16.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.139 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . 0.608 ' O ' HD22 ' A' ' 100' ' ' LEU . 17.7 m120 68.47 -74.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.894 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 75.33 -30.89 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.106 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.48 -4.35 64.14 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 13.7 t -101.78 42.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.342 1.068 . . . . 0.0 108.581 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.608 HD22 ' O ' ' A' ' 96' ' ' ASN . 2.6 pt? -137.81 -171.23 2.95 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.396 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.8 115.5 26.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.233 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.54 63.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.266 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 p -64.38 -37.35 87.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.83 -43.17 90.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.655 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.42 -44.95 94.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.09 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.78 -18.38 60.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.587 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 m -88.74 -62.29 1.52 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 13' ' ' ALA . 4.0 pp -116.53 -23.12 8.39 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.0 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' CA ' HD12 ' A' ' 117' ' ' LEU . . . -56.25 -63.52 5.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.997 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.0 m -77.71 -9.62 59.09 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.663 0.268 . . . . 0.0 111.496 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -89.46 -58.77 2.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.57 -58.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.938 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.3 mp -70.0 -45.77 66.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 t 52.65 -94.8 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.46 -1.245 . . . . 0.0 113.39 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.31 -37.23 35.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.1 tp -68.22 -58.7 4.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.214 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CA ' ' A' ' 109' ' ' GLY . 23.6 mt -66.49 -27.42 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -37.46 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 109.784 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.44 -32.48 34.29 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 116' ' ' LEU . 96.4 t -63.09 -44.11 99.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.498 0.19 . . . . 0.0 110.735 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 69.2 m -54.62 -39.06 67.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.62 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.8 m -80.98 -41.86 22.1 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.446 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.84 -70.49 0.56 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.77 -41.79 61.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 58.5 tt0 -80.49 -17.53 51.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 109.841 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.53 -70.44 1.33 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.955 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.62 -24.25 14.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.738 0.304 . . . . 0.0 111.199 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.4 100.66 2.17 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.672 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HE ' ' A' ' 50' ' ' ARG . 15.0 mm -80.03 132.07 32.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.154 0.502 . . . . 0.0 111.569 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -148.23 145.97 28.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.271 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.19 142.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.03 -172.08 0.17 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 112.878 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 39.0 m -79.88 29.31 0.27 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.64 -79.09 0.22 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 t -110.25 -59.76 1.89 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.205 0.526 . . . . 0.0 110.822 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 140' ' ' ILE . 96.6 t -47.77 -63.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.365 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.1 tp-100 -56.34 -39.96 73.68 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.5 m -72.9 -26.9 61.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.804 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.52 -40.82 22.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.837 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.4 pt -79.38 -27.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 p -55.97 -62.13 1.91 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -63.94 -37.7 88.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.097 0.475 . . . . 0.0 111.227 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.4 m -66.09 -34.33 77.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.213 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.3 t . . . . . 0 C--N 1.318 -0.794 0 CA-C-O 121.051 0.453 . . . . 0.0 110.88 -179.45 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.362 0 N-CA-C 114.328 0.491 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.01 72.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.639 0.376 . . . . 0.0 111.615 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' ILE . 9.6 m -58.67 -31.45 68.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.396 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.3 62.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.41 -35.82 8.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.8 pp -85.63 -21.94 28.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' SER . 11.9 pt -37.75 -52.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.0 m -71.61 -24.67 61.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.58 -23.13 24.42 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 22' ' ' ALA . 31.6 t -62.34 174.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.425 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.582 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -37.57 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.421 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 10.6 m-80 -63.5 -24.56 67.87 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.102 -0.374 . . . . 0.0 111.851 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.89 -35.91 79.74 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.354 0.597 . . . . 0.0 109.437 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 tp -80.23 -35.06 36.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.715 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.99 77.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.021 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 59.2 13.25 2.92 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.172 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 29' ' ' SER . 1.5 m -83.56 168.54 16.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.283 0.563 . . . . 0.0 112.066 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' SER . . . . . 0.648 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 1.8 m -51.92 -26.22 9.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.62 1.168 . . . . 0.0 112.927 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 p -53.29 -40.82 65.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.872 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -99.63 -19.52 16.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.598 0.713 . . . . 0.0 109.646 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.648 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 16.1 tpp180 -66.22 -64.62 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.605 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 t -164.77 -23.74 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.122 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.94 137.59 20.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.99 140.43 25.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.063 0.459 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -65.82 164.52 14.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.681 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 131' ' ' VAL . 2.4 p -70.7 111.88 6.5 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.16 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.0 43.23 8.93 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 87' ' ' ALA . 9.2 p -46.07 138.65 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 111.815 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.6 m -70.78 137.99 50.05 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.37 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 48.4 tt0 -62.69 -13.44 32.25 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.165 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -52.62 -42.21 64.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.006 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.62 -39.53 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.539 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.24 -68.0 0.74 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.471 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 5.9 m 71.64 -33.74 0.28 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -66.24 -79.26 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' CG2' HD21 ' A' ' 65' ' ' ASN . 7.5 p -118.74 -30.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.259 0.552 . . . . 0.0 111.526 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.37 92.78 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 74.9 mt-30 -81.11 -40.44 24.05 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.162 0.506 . . . . 0.0 110.126 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.619 ' NH1' HD13 ' A' ' 55' ' ' LEU . 11.2 ttm180 -149.03 -1.4 0.48 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.656 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.23 -55.74 0.6 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.094 0.557 . . . . 0.0 110.259 -175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.46 131.0 47.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.378 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' SER . 4.8 pm0 -54.9 -17.77 4.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.852 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.619 HD13 ' NH1' ' A' ' 50' ' ' ARG . 2.2 tt -88.59 -24.09 22.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 111.385 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.8 -18.5 62.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.3 t -55.34 96.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.299 0.571 . . . . 0.0 110.729 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.0 t -132.99 -30.06 1.4 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.171 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 94.4 mt -120.26 20.09 12.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.804 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.58 66.85 1.64 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.38 109.73 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.38 87.02 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.6 -53.05 3.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.734 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.1 p-10 -61.45 -73.72 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.386 0.674 . . . . 0.0 112.321 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 66.2 t30 -84.75 11.66 8.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.675 0.75 . . . . 0.0 109.622 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.83 -70.48 0.63 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.279 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 -34.03 39.75 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.42 0.629 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 56.5 mtm180 -99.46 157.72 16.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.622 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 68.03 -57.05 0.48 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.511 0.725 . . . . 0.0 112.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.17 0.91 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.703 0.287 . . . . 0.0 111.355 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.64 -35.5 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -68.08 -25.51 65.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.342 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.71 23.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.382 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.98 -32.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.245 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -69.89 -14.74 62.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.229 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 76' ' ' ARG . 44.5 ttp180 -87.62 -15.71 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.111 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.66 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 9.4 mp . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.29 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.66 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 64.3 m-85 . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.083 0.468 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -77.11 25.63 0.16 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.582 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 86' ' ' TYR . 76.3 mt-30 -86.18 -56.73 3.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.632 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.73 -29.34 68.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.376 0.607 . . . . 0.0 110.036 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.545 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.0 m-85 -84.31 3.76 34.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -50.71 -35.89 33.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 70.3 m -53.92 -53.41 53.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.73 -24.03 33.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 51.1 mt -84.82 -36.13 21.84 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -85.2 -41.1 15.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.93 90.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.501 0.667 . . . . 0.0 111.648 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.76 -0.97 55.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.823 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.02 -3.14 85.36 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.712 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 t -100.57 -13.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 109.929 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -84.02 167.42 16.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.365 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -77.44 104.4 7.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.674 0.75 . . . . 0.0 110.385 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -13.04 61.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.682 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -69.21 -34.46 74.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -35.78 77.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.74 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.59 -41.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.211 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.83 -18.09 51.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.031 0.443 . . . . 0.0 111.463 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.1 m -81.82 -58.63 2.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.391 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.2 -20.92 4.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 117' ' ' LEU . . . -57.37 -68.41 1.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.158 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' SER . 6.5 p -67.4 -16.82 64.45 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -84.64 -45.54 12.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.666 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.47 -50.79 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.597 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.59 -34.36 72.08 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.006 0.431 . . . . 0.0 110.317 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' SER . 50.8 m 48.16 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.96 -36.77 50.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.3 -60.16 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.991 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 109' ' ' GLY . 49.0 mt -64.34 -34.23 77.68 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -69.77 -22.67 63.32 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.109 0.481 . . . . 0.0 110.907 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.13 -32.78 11.65 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.936 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 94' ' ' LEU . 54.2 t -76.24 -29.92 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.996 0.518 . . . . 0.0 111.914 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 15.8 p -52.2 -44.04 64.53 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.306 0.642 . . . . 0.0 112.592 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.1 p -84.47 -26.46 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.923 0.392 . . . . 0.0 111.481 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.83 -78.45 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.449 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.34 -49.16 45.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 37.2 tt0 -72.07 -21.33 61.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.09 -56.13 2.5 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.204 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.6 mt -126.95 -25.01 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.998 0.399 . . . . 0.0 111.786 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.55 107.95 3.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.001 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' THR . 32.6 mt -76.37 126.83 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -120.81 135.57 55.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 132' ' ' ASP . 12.7 t -89.09 172.83 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 131' ' ' VAL . 3.5 p-10 -60.45 162.61 6.07 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.548 0.689 . . . . 0.0 112.018 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.4 t -80.16 6.61 11.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.301 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.27 -78.94 0.61 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.295 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 m -93.73 -39.89 10.52 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.27 -62.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.435 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.3 tt0 -59.18 -39.79 83.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -59.4 -43.98 92.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.442 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.58 -50.01 19.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 137' ' ' GLN . 42.0 pt -60.67 -38.46 78.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.812 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 t -65.7 -40.03 91.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.3 m -70.8 -42.44 70.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 t -72.42 -42.44 65.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.634 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 111.445 -177.869 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.6 71.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.142 0.496 . . . . 0.0 110.732 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.6 m -66.91 -21.58 65.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.83 -18.52 44.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.8 -43.59 5.69 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.334 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -84.21 -21.88 31.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 89' ' ' ALA . 8.9 pt -46.2 -47.31 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m -73.39 -20.0 60.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.749 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -86.03 -33.5 21.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.696 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 100' ' ' LEU . 58.0 t -50.16 168.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.088 0.555 . . . . 0.0 111.406 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.516 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.72 -28.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 m-80 -60.39 -28.9 68.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.729 0.241 . . . . 0.0 111.436 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.21 -44.93 93.91 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.292 0.568 . . . . 0.0 109.85 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.2 -38.21 66.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.156 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.96 80.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 54.55 17.84 1.79 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.446 174.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 m -77.76 166.33 23.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.496 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.8 m -61.11 -16.98 50.18 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 122.78 0.432 . . . . 0.0 112.105 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -52.23 -34.44 45.79 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -108.14 -21.58 12.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -79.85 -42.78 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t -158.19 -50.5 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.211 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.6 129.97 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 1.5 pt? -50.32 139.9 14.27 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.456 0.472 . . . . 0.0 111.808 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -60.75 159.75 10.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.867 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 1.7 p -77.47 142.71 39.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.064 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.57 71.46 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.538 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 147.81 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.799 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 10.3 m -106.75 161.83 14.32 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.95 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -66.23 -13.75 60.83 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.555 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -54.95 -43.72 73.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -86.62 -36.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.525 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.48 -39.96 19.86 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m 78.32 -18.36 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.108 0.963 . . . . 0.0 111.476 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 m -76.51 -162.24 0.24 Allowed 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 122.212 1.006 . . . . 0.0 110.721 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 59' ' ' LEU . 35.0 m -74.64 -20.55 16.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.516 -176.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.38 84.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.551 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 40' ' ' SER . 74.5 mt-30 -83.62 -43.99 15.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 0.0 111.86 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 51.0 ttt180 -132.19 -10.11 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.63 -36.69 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.294 0.638 . . . . 0.0 110.646 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -80.22 150.95 29.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.795 0.331 . . . . 0.0 110.11 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' SER . 21.2 mp0 -56.28 -34.3 66.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.9 m -54.48 -70.85 0.09 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -86.18 -25.02 25.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -80.42 -18.82 47.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -65.92 79.82 0.08 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.72 0.772 . . . . 0.0 111.46 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -100.97 -28.51 12.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.038 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 47' ' ' VAL . 89.6 mt -122.37 19.17 10.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.019 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.62 1.41 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.765 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.685 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 65.7 t -88.38 120.07 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.882 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 t70 178.46 90.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.504 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.03 -57.4 3.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.954 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -55.85 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.266 0.626 . . . . 0.0 111.547 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.685 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.3 p-10 -87.38 21.25 2.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.059 0.456 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.15 -72.73 0.54 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.689 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.32 -7.98 50.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.303 0.573 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.32 170.61 13.91 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 66.05 -62.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.59 -64.02 1.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.769 0.318 . . . . 0.0 110.882 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 98.3 mt-30 -63.35 -37.1 85.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.602 0.239 . . . . 0.0 111.49 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.58 -48.6 25.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.089 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.74 -42.15 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.589 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.0 p -74.06 -4.96 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 111.032 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 34.1 ttm180 -98.11 -0.5 44.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.195 0.521 . . . . 0.0 110.535 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.237 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.227 177.538 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.107 0.48 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.4 14.98 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.998 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 35' ' ' LEU . 8.2 mm100 -71.71 -37.54 70.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.001 0.429 . . . . 0.0 111.288 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' O ' HD12 ' A' ' 18' ' ' ILE . . . -67.89 -62.16 1.54 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.84 32.41 0.48 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.142 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.7 m -50.54 -55.7 14.95 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.6 m -63.97 -36.3 83.5 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.97 70.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.538 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 40.0 mt -84.57 -23.49 29.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.505 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -85.56 -47.36 9.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.743 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.36 61.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.241 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.17 1.99 71.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.86 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.35 -15.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.481 0.657 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.51 179.28 7.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.255 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -75.23 125.77 29.64 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 111.662 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.65 61.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.276 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.7 t -65.18 -35.01 79.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.513 ' O ' HD13 ' A' ' 108' ' ' LEU . 11.1 t30 -61.01 -50.42 73.45 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.047 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ILE . . . . . 0.522 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -66.69 -38.09 80.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.827 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -30.41 69.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.875 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -80.1 -62.96 1.52 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -122.22 -15.5 7.68 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.731 -176.764 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -56.11 -72.02 0.64 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.795 -0.716 . . . . 0.0 113.638 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 m -70.82 -10.35 59.37 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 111' ' ' ARG . 6.0 mpt_? -86.68 -53.99 4.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.35 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.27 -54.66 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.017 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.424 HD13 ' HA2' ' A' ' 109' ' ' GLY . 6.4 mp -63.13 -31.97 73.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.1 p 38.71 -93.14 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.25 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.427 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 120' ' ' VAL . 65.4 tp -68.61 -52.63 29.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.042 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 18.8 mt -61.44 -28.18 69.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -59.13 -36.98 76.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.402 . . . . 0.0 110.208 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.45 -33.58 11.45 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.969 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.1 t -60.99 -31.7 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.3 m -48.65 -52.04 25.26 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.294 0.371 . . . . 0.0 111.936 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 p -83.68 -21.42 32.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 111.09 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 120' ' ' VAL . . . -81.31 -93.76 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.13 29.43 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.01 -29.77 71.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.18 -90.91 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.4 mt -112.56 -8.29 13.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.774 0.321 . . . . 0.0 111.553 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.14 98.85 0.94 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.153 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 37' ' ' THR . 25.1 mm -67.66 139.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 137' ' ' GLN . 18.7 t-20 -90.55 136.06 33.3 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 133' ' ' SER . 30.7 t -75.66 146.07 9.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.906 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.47 -37.31 83.14 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 122.083 0.944 . . . . 0.0 111.068 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 131' ' ' VAL . 38.9 t -58.65 107.59 0.53 Allowed 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.026 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.75 -17.91 29.76 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.199 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.1 m -65.57 -37.44 86.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.993 0.425 . . . . 0.0 110.197 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 140' ' ' ILE . 46.4 t -77.99 -50.69 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.796 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.433 ' HG3' HD21 ' A' ' 130' ' ' ASN . 46.7 tt0 -59.25 -49.62 77.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.708 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -65.75 -28.74 69.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.04 -54.9 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.451 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 136' ' ' VAL . 42.6 pt -58.92 -34.77 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.255 -177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.6 t -50.59 -49.34 56.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.262 0.351 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -84.84 -42.47 15.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.852 0.358 . . . . 0.0 111.831 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 62.9 m -57.79 -38.84 76.2 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.8 p . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.777 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.281 -0.177 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' HD13 ' A' ' 108' ' ' LEU . . . -67.47 -45.43 75.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.935 0.398 . . . . 0.0 110.997 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 18' ' ' ILE . 16.7 m -68.06 -22.63 64.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.044 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.66 58.61 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.16 -38.84 7.12 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.117 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 pp -84.83 -22.35 29.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 14' ' ' SER . 10.1 pt -44.75 -48.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 t -84.67 -20.14 31.73 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.552 0.215 . . . . 0.0 111.377 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -86.89 -25.94 24.19 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.9 t -74.21 -107.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -79.1 -35.81 41.73 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.98 -24.25 66.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.482 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.25 -45.37 88.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.068 0.461 . . . . 0.0 110.316 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.16 -18.95 44.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.787 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.56 -38.33 70.97 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.922 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.58 16.98 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -75.82 167.68 21.44 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.7 m -72.23 -14.26 61.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLN . 19.0 p -50.2 -53.3 28.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.753 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -78.71 -19.73 51.73 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.151 0.5 . . . . 0.0 110.985 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -76.74 -52.98 8.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.631 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -169.05 -19.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.84 136.26 23.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -55.91 149.61 14.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 0.0 111.243 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 87' ' ' ALA . 7.7 ptm180 -76.06 164.45 26.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.405 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.01 109.3 9.54 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.984 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 94.49 37.69 5.24 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.841 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG23 HD11 ' A' ' 43' ' ' ILE . 2.3 p -48.38 124.94 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.251 0.548 . . . . 0.0 109.957 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 16.5 m -85.67 167.0 15.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 14.7 pt20 -69.14 -13.15 62.26 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.243 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -63.02 -55.0 29.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.305 0.574 . . . . 0.0 109.869 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -85.27 -32.19 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.717 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . . . -78.54 -61.69 1.93 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.499 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 87.0 p 68.82 -31.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.687 1.595 . . . . 0.0 115.291 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.5 m -66.27 -73.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.79 -27.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.838 0.351 . . . . 0.0 111.841 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -80.47 100.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.351 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' SER . 44.6 mt-30 -82.17 -34.85 28.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.082 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . 0.638 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 16.5 ttt85 -158.03 4.34 0.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.731 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' N ' ' HB2' ' A' ' 56' ' ' ALA . . . 67.87 -52.83 0.52 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.067 0.547 . . . . 0.0 110.841 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' CB ' HG13 ' A' ' 129' ' ' ILE . . . -63.51 137.41 58.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.222 177.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLN . . . . . 0.566 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 17.5 mp0 -53.49 -26.89 22.47 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -60.83 -67.57 0.39 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.815 0.34 . . . . 0.0 111.885 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.468 HD23 ' HD2' ' A' ' 50' ' ' ARG . 25.9 tp -87.83 -24.01 23.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -78.57 -19.1 53.55 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 5.8 t -62.39 88.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.406 0.622 . . . . 0.0 111.491 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.607 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 8.2 t -112.23 -32.46 6.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.819 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.486 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.1 mt -121.6 18.83 11.22 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.946 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 67.56 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 HD21 ' A' ' 65' ' ' ASN . 36.9 t -89.89 120.84 39.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.712 0.292 . . . . 0.0 111.158 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -170.85 83.89 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.883 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -47.29 3.55 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ASN . . . . . 0.478 ' HA ' HH21 ' A' ' 68' ' ' ARG . 18.0 p-10 -54.33 -83.19 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.735 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.458 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 29.2 p-10 -87.99 24.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.303 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 tp -87.0 -66.4 0.91 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.067 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.26 62.02 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.479 0.657 . . . . 0.0 110.412 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.478 HH21 ' HA ' ' A' ' 64' ' ' ASN . 29.9 mtm180 -110.39 165.63 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 68.05 -61.91 0.37 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.69 3.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.864 0.364 . . . . 0.0 111.492 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.525 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -65.27 -35.77 82.06 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.644 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.14 -47.71 60.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.857 0.36 . . . . 0.0 111.397 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.67 -34.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.987 0.422 . . . . 0.0 110.932 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.0 p -73.94 -23.06 59.46 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.158 0.504 . . . . 0.0 110.457 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -87.08 -15.03 39.74 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.919 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.126 -179.583 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 121.376 0.607 . . . . 0.0 109.971 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -77.85 18.48 0.47 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 33.9 mt-30 -80.83 -56.63 4.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.144 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.38 -35.88 82.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.085 0.469 . . . . 0.0 110.278 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -82.4 13.37 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.556 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -59.21 -44.3 92.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -62.96 -41.06 99.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.66 69.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.687 0.28 . . . . 0.0 111.48 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 28.3 mt -84.78 -19.54 32.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.022 0.439 . . . . 0.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.88 -36.98 19.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.59 80.84 0.14 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.989 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.03 -12.2 60.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.811 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.62 -11.93 64.8 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.95 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.65 -15.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.325 0.583 . . . . 0.0 109.977 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -84.8 161.39 19.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.801 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -67.82 107.25 2.54 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.526 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.63 -15.84 63.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.951 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -74.52 -27.6 60.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -71.41 -33.99 69.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 34.8 mm -66.11 -34.23 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.21 -32.37 66.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.196 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.4 m -68.55 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.853 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -121.28 -21.09 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -56.2 -65.21 3.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.944 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -71.91 -11.54 60.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.802 0.334 . . . . 0.0 111.603 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -87.04 -61.07 1.81 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.19 -56.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.548 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 17.0 mt -62.42 -55.23 29.81 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.181 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.7 t 55.42 -87.04 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.107 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.34 66.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 122.947 0.499 . . . . 0.0 111.459 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.3 tp -67.02 -49.88 63.86 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 21.3 mt -66.97 -25.1 66.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.928 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.76 -36.57 81.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 109.666 175.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.13 -17.69 58.82 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.227 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.8 t -85.25 -44.02 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 11.8 p -52.49 -61.82 2.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 t -76.0 -23.84 55.28 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.085 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.499 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -83.57 -80.21 0.19 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ALA . . . . . 0.626 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -72.51 -44.67 61.9 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.662 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 121' ' ' SER . 42.6 tt0 -70.96 -34.76 71.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.281 0.562 . . . . 0.0 110.097 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.43 -63.2 2.54 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.043 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.87 -23.98 11.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.92 97.3 1.22 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ILE . . . . . 0.514 HG13 ' CB ' ' A' ' 52' ' ' ALA . 1.2 mp -81.54 136.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.539 0.685 . . . . 0.0 112.229 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -135.14 137.33 42.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.105 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -80.85 156.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.4 169.15 1.79 Allowed 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 3.0 m -74.31 39.42 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.63 -93.86 0.2 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.9 t -106.44 -43.38 4.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.887 0.375 . . . . 0.0 110.273 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.1 t -51.96 -62.48 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.409 -173.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 41.8 tt0 -59.04 -37.46 77.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.656 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.1 m -65.95 -48.32 71.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.902 0.382 . . . . 0.0 110.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.66 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.584 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.1 pt -76.09 -29.8 19.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -56.47 -45.72 80.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.334 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 p -82.0 -42.78 18.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.356 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.4 m -68.9 -19.99 64.23 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.321 -0.668 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.13 123.96 3.25 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.428 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.71 119.6 6.19 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.575 2.183 . . . . 0.0 111.897 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 22.9 mp0 -58.44 101.96 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.287 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.31 22.36 60.92 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.766 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.49 66.69 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.993 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.425 ' HD2' ' O ' ' A' ' 4' ' ' GLN . 1.6 m-85 -55.28 -57.61 11.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.67 0.235 . . . . 0.0 111.457 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.26 75.41 0.28 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . . . -85.47 98.97 10.9 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.52 0.676 . . . . 0.0 111.418 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 m -162.67 143.45 9.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.7 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.2 125.42 5.08 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.04 -26.34 45.17 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.823 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.69 80.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.203 0.525 . . . . 0.0 110.759 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.4 p -68.44 -17.75 64.27 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -18.28 63.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.49 11.74 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.815 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.3 pp -85.99 -22.89 27.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 14' ' ' SER . 17.6 pt -42.46 -55.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 2.4 m -68.69 -21.74 64.4 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.0 111.677 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.642 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -88.57 -24.46 22.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.961 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 100' ' ' LEU . 85.1 t -57.19 168.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.759 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -39.47 -27.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.0 m-80 -60.27 -24.22 64.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.571 0.224 . . . . 0.0 111.498 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.71 -36.98 82.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.076 0.465 . . . . 0.0 110.306 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.58 -13.36 54.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.448 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.17 -44.11 13.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 14.3 t-20 55.16 13.0 0.74 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.841 0.856 . . . . 0.0 112.263 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -72.41 165.49 24.46 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.931 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 27.8 m -61.67 -15.31 38.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p -56.04 -25.94 46.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.785 0.834 . . . . 0.0 113.143 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.83 -17.62 11.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.157 0.504 . . . . 0.0 110.672 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 11.4 ttm180 -77.51 -48.68 16.45 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.745 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -167.06 -32.14 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -80.65 137.21 21.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -52.91 138.67 29.41 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.999 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 47.3 ptt85 -64.43 155.59 32.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.944 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -70.74 114.85 9.23 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.65 40.18 9.97 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -47.37 145.95 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.585 0.754 . . . . 0.0 112.307 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.525 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.4 m -71.48 140.29 49.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.406 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.569 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.87 -12.81 27.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 116' ' ' LEU . 89.2 mm-40 -57.06 -38.06 72.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.855 0.359 . . . . 0.0 110.757 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 40' ' ' SER . 2.8 pp -84.4 -35.62 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.97 -73.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.962 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 75.5 -18.92 0.42 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.639 0.776 . . . . 0.0 112.403 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -67.61 -79.88 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.16 0.505 . . . . 0.0 112.024 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -130.93 -27.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.313 0.578 . . . . 0.0 110.848 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.92 94.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.184 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 mm-40 -82.54 -50.23 9.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 0.0 110.256 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 20.7 ttm180 -132.77 -3.93 3.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.941 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.03 -50.49 0.7 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.258 0.623 . . . . 0.0 110.17 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.63 131.45 45.23 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 4.9 pm0 -46.6 -30.78 2.45 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.101 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m -49.58 -71.56 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 55' ' ' LEU . 6.6 tt -86.38 -23.84 26.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.43 -20.69 62.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.2 p -48.56 112.74 0.64 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.565 0.541 . . . . 0.0 110.697 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.403 HG23 ' HG ' ' A' ' 59' ' ' LEU . 15.1 t -161.73 -40.41 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 58' ' ' THR . 91.8 mt -121.91 18.83 10.96 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.677 0.275 . . . . 0.0 110.996 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 66.12 1.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.134 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.745 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 37.5 t -89.3 104.97 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.385 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -173.62 76.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.499 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.22 -63.07 1.22 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.981 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -63.04 -69.49 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.745 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 p-10 -82.18 7.2 14.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.462 . . . . 0.0 110.444 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 tp -88.02 -53.17 4.87 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.735 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.8 29.02 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.499 0.666 . . . . 0.0 110.086 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.436 ' HA ' ' OE1' ' A' ' 72' ' ' GLN . 35.6 mmt180 -107.99 173.13 6.46 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 64.14 -62.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.63 -61.95 2.24 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.717 0.407 . . . . 0.0 111.716 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' SER . 39.1 t -59.66 -42.26 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.507 ' O ' ' HG3' ' A' ' 76' ' ' ARG . 1.6 mp0 -65.78 -36.48 83.65 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.619 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.92 64.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.803 0.335 . . . . 0.0 110.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.46 -34.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.486 0.66 . . . . 0.0 110.239 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 3.7 m -75.5 -19.78 59.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 20.8 mtm180 -86.87 -13.1 45.89 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.543 0.211 . . . . 0.0 110.551 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.81 142.09 92.39 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.122 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.34 127.74 23.92 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.176 1.917 . . . . 0.0 111.142 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.7 17.62 23.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.62 0.724 . . . . 0.0 110.579 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.06 -25.31 73.36 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.617 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.1 m -79.72 -6.73 57.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.28 0.232 . . . . 0.0 110.637 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 76.92 154.95 0.16 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.937 0.895 . . . . 0.0 110.557 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.9 p -65.33 -28.07 69.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 p -67.3 -25.58 66.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.736 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.72 60.97 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 88' ' ' GLN . 8.0 m-85 -76.67 -164.36 0.41 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.538 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.47 41.45 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.01 0.433 . . . . 0.0 111.215 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 91' ' ' SER . 8.1 tp-100 -90.14 -59.03 2.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.919 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.86 94.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.825 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 74.6 m-85 -80.66 12.04 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.541 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 15.6 t -50.61 -45.12 57.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.659 0.383 . . . . 0.0 111.556 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 55.4 m -61.54 -41.89 98.02 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.55 37.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.0 111.414 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 74.8 mt -84.94 -28.06 26.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -85.18 -36.43 21.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.209 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 50.45 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.98 -22.41 45.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.26 -14.09 63.92 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.82 32.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.968 0.889 . . . . 0.0 108.955 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -116.9 -169.16 1.59 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.053 -178.425 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 24.6 t-20 -78.39 106.69 10.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.37 -29.33 70.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.451 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 p -72.26 -18.15 61.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.226 0.536 . . . . 0.0 110.276 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 6.2 t30 -63.81 -50.75 67.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.654 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.454 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.0 mp -73.43 -35.3 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.855 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.48 -35.09 78.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.401 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.2 m -93.61 -60.6 1.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 1.1 pp -104.53 -35.99 7.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -52.86 -58.49 11.39 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.897 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 114' ' ' SER . 13.7 p -71.19 -21.05 62.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -88.13 -52.76 5.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.28 -50.56 20.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.9 mp -79.3 -29.94 42.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.147 0.499 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 110' ' ' SER . 32.1 t 50.97 -100.28 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.688 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.71 -34.68 73.23 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 120' ' ' VAL . 51.8 tp -61.75 -59.36 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.743 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -29.22 70.46 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.931 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -61.1 -42.83 99.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.078 0.466 . . . . 0.0 110.035 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -29.27 58.82 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.822 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 116' ' ' LEU . 82.3 t -72.69 -30.22 32.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 122.816 -0.226 . . . . 0.0 110.757 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 53.2 m -55.99 -39.45 71.85 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.566 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.1 p -85.68 -25.87 26.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.061 0.458 . . . . 0.0 111.155 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.76 -90.98 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.85 69.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 111.548 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 53.2 tt0 -77.24 -24.59 51.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.82 -65.12 1.63 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.448 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.58 -23.84 8.05 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.799 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.81 104.37 2.2 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.842 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.4 mt -68.75 130.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.959 0.409 . . . . 0.0 111.885 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -120.78 128.35 52.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 132' ' ' ASP . 18.2 t -98.57 167.58 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.317 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 131' ' ' VAL . 27.6 t70 -58.45 151.83 19.27 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.344 0.592 . . . . 0.0 111.747 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.591 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 15.2 m -75.37 -2.25 27.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.083 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.37 -72.07 0.64 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.184 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 m -106.5 -58.21 1.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.42 HG21 HG11 ' A' ' 131' ' ' VAL . 69.3 t -52.32 -55.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.591 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 34.7 tp60 -60.02 -42.45 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m -58.46 -41.04 84.27 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.086 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.1 -54.61 8.08 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.639 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 136' ' ' VAL . 38.7 pt -61.46 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -64.44 -45.29 88.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.993 0.425 . . . . 0.0 110.72 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.4 m -76.91 -20.74 55.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.294 0.569 . . . . 0.0 111.134 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.511 ' OG ' HD12 ' A' ' 147' ' ' LEU . 43.4 t -86.5 -60.17 2.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.781 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.3 t -57.84 -30.46 65.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.253 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -62.69 -52.01 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.22 -35.85 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.114 0.483 . . . . 0.0 111.362 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 76.7 mt -82.29 8.01 12.37 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 60.3 m -46.8 -48.57 20.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.068 0.461 . . . . 0.0 111.205 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -141.46 32.63 1.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.806 0.812 . . . . 0.0 109.047 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.434 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 9.6 t -86.16 27.7 0.89 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.53 ' HB2' ' OE1' ' A' ' 158' ' ' GLN . 15.0 m -62.38 -36.08 81.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.18 0.514 . . . . 0.0 110.185 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.8 m -151.75 -52.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -135.3 98.7 4.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.577 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.11 -34.6 59.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.965 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 50.7 m -59.04 -40.11 84.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -97.55 0.82 48.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.893 0.378 . . . . 0.0 110.364 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.4 m 55.81 23.87 6.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.59 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 151' ' ' SER . 10.9 pt20 43.65 30.03 0.33 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.46 1.104 . . . . 0.0 112.878 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.7 -28.12 61.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.79 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m -72.99 -27.2 61.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.385 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 176' ' ' SER . . . 67.26 150.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.809 0.844 . . . . 0.0 112.503 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.4 p -93.03 27.89 2.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.5 m -73.63 -14.21 61.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.567 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.5 m -61.2 -33.52 73.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.158 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.2 m -91.33 11.15 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.389 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 64.82 49.49 63.24 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.998 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.84 78.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.591 0.234 . . . . 0.0 111.208 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.77 -73.18 1.7 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.476 ' HA ' ' HA2' ' A' ' 174' ' ' GLY . 46.1 p90 -153.31 133.38 13.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.677 ' OG1' ' HA ' ' A' ' 175' ' ' PRO . 62.9 m -105.46 -47.77 3.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.2 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 -85.37 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.027 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.609 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 21.1 Cg_exo -70.71 94.48 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.557 2.171 . . . . 0.0 111.97 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.9 m 72.21 -52.08 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.684 0.794 . . . . 0.0 112.256 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 169' ' ' TYR . . . -153.53 -145.57 4.18 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.059 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.677 ' HA ' ' OG1' ' A' ' 170' ' ' THR . 15.1 Cg_exo -70.02 -162.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.558 2.839 . . . . 0.0 112.791 -178.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 15.7 m -71.8 91.82 1.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 175' ' ' PRO . 9.4 t -147.88 -173.83 4.4 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.307 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.9 80.98 0.61 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 2.8 Cg_exo -76.42 139.47 20.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.519 2.146 . . . . 0.0 111.751 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.2 m -76.23 -7.47 54.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 0.0 110.268 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 182' ' ' TYR . . . -127.03 -171.55 13.08 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 181' ' ' GLY . 79.3 m-85 71.94 150.38 0.13 Allowed Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.241 0.616 . . . . 0.0 111.403 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.33 125.39 14.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.981 1.787 . . . . 0.0 110.93 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.37 67.3 1.6 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.636 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 179' ' ' PRO . 29.7 Cg_exo -64.89 -11.27 28.69 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.958 2.439 . . . . 0.0 111.827 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.02 -1.97 31.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.136 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.11 102.14 0.69 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.403 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.76 -60.0 4.7 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.588 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.13 63.3 4.39 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.076 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . . . -124.93 133.41 24.79 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.642 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 22.7 Cg_exo -63.42 155.47 62.1 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.808 2.339 . . . . 0.0 112.332 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -76.94 -19.13 57.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -123.51 86.4 0.38 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -135.42 129.08 32.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 0.0 110.855 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.1 t -128.76 144.64 51.22 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.06 69.89 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.367 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -71.38 142.57 50.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 121.73 174.26 14.68 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.056 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.06 -179.674 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.797 0.332 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.84 124.98 4.58 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.637 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.01 -161.81 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.856 2.37 . . . . 0.0 110.789 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 7' ' ' PHE . 94.3 mt-30 -123.34 158.29 31.37 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.596 0.236 . . . . 0.0 110.457 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.43 106.53 1.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.237 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.22 2.88 82.78 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.938 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 92.3 m-85 -135.77 102.91 5.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.108 0.48 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.41 123.76 5.5 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -75.67 -171.28 1.51 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.8 p 61.71 103.66 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.501 1.121 . . . . 0.0 113.378 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.03 149.84 19.91 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.99 53.57 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.53 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.97 89.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.12 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' ILE . 70.0 m -72.1 -30.6 65.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.717 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.04 -26.75 50.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.98 7.09 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.683 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 pp -83.88 -22.55 31.59 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' SER . 10.6 pt -43.25 -43.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.3 t -74.38 -27.55 60.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 98.6 mtt180 -88.0 -23.41 23.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 17' ' ' LEU . 56.4 t -58.52 176.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.832 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.577 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -36.67 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 2.3 m120 -63.29 -24.77 68.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.244 0.474 . . . . 0.0 111.404 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.04 -28.25 69.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 tp -83.41 -40.98 18.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.06 73.55 8.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.43 19.89 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.911 1.284 . . . . 0.0 114.2 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -63.46 -178.76 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 13.0 m -66.51 -20.48 66.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -51.13 -62.53 1.56 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.8 pt? -80.78 -20.55 42.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.28 0.562 . . . . 0.0 110.148 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 22.4 ttm180 -68.41 -46.45 69.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.474 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -177.34 -35.43 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.17 139.97 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.619 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 88' ' ' GLN . 4.0 pp -51.42 140.43 17.61 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 123.787 0.679 . . . . 0.0 112.6 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 36' ' ' ARG . 15.9 ttt180 -50.76 137.72 19.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.564 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -66.27 111.39 3.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.644 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 93.78 31.63 8.09 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.7 p -51.11 137.13 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 110.72 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 13.0 m -105.17 161.9 13.86 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 8.9 pt20 -60.44 -14.98 22.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.404 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 116' ' ' LEU . 83.2 mm-40 -53.92 -48.72 69.9 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.263 0.554 . . . . 0.0 109.758 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.1 pp -85.99 -39.41 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.241 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.86 -62.03 1.71 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 74.63 -20.96 0.3 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -71.02 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.761 0.315 . . . . 0.0 111.771 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.91 -22.49 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.194 0.521 . . . . 0.0 110.832 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.6 t -75.72 96.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 76.8 mt-30 -81.97 -47.46 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.139 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 33.8 ttm-85 -144.8 4.13 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.402 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.53 -53.86 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.479 0.712 . . . . 0.0 111.18 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.674 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.26 141.28 57.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.569 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 14.0 mp0 -58.83 -18.46 32.7 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.081 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -63.05 -76.96 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.85 -24.79 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.32 -18.11 61.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 77.6 p -45.7 104.05 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.856 0.722 . . . . 0.0 111.156 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 56' ' ' ALA . 10.5 t -149.97 -40.92 0.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.089 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.27 19.34 13.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.975 0.417 . . . . 0.0 110.235 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.24 67.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG22 HD21 ' A' ' 65' ' ' ASN . 6.1 t -87.85 109.01 19.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 120.706 0.289 . . . . 0.0 110.653 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -163.37 80.04 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.51 -48.85 2.94 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.73 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 20.9 p-10 -52.64 -80.07 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.829 0.851 . . . . 0.0 112.862 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.607 HD21 HG22 ' A' ' 61' ' ' VAL . 3.9 p-10 -85.81 9.17 17.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.215 0.531 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.1 tp -88.31 -50.85 6.08 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.128 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.14 -49.81 14.39 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.545 0.688 . . . . 0.0 109.31 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -90.87 162.38 14.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 68.32 -61.72 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -64.42 -62.92 1.3 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -36.13 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.81 -43.37 88.82 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.301 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -67.34 -44.93 77.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.509 0.195 . . . . 0.0 111.286 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.9 -43.45 85.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -65.12 -30.17 71.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.039 0.447 . . . . 0.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -98.32 6.28 47.49 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.645 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -62.08 125.61 85.7 Favored Pre-proline 0 CA--C 1.51 -0.591 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.73 127.55 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.08 1.853 . . . . 0.0 109.608 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.8 95.12 5.93 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.133 0.492 . . . . 0.0 111.552 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.99 -50.62 5.78 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 15.9 m -90.43 -61.7 1.62 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 81' ' ' SER . 21.4 t70 168.97 161.57 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.562 0.745 . . . . 0.0 109.172 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.7 m -67.09 -39.1 86.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.775 0.321 . . . . 0.0 110.988 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.9 p -79.69 -18.5 51.15 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.74 65.12 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.86 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -64.15 -168.96 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.225 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 36' ' ' ARG . . . -65.91 1.59 1.35 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -69.96 -47.15 63.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.33 -40.24 77.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.794 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -83.92 10.54 9.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.419 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.8 m -49.79 -38.48 34.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 72.6 m -56.41 -50.4 71.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.12 31.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.5 mt -80.42 -33.08 37.22 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -84.56 -37.41 21.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 2.0 t30 56.0 85.74 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.852 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.58 -2.61 43.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.578 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.54 34.53 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.529 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.93 -13.38 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.464 0.649 . . . . 0.0 110.097 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -179.69 7.14 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.524 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -75.21 118.66 18.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.98 61.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m -74.99 -31.36 61.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.855 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -61.87 -53.28 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.488 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.49 -39.97 87.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.129 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.34 -38.1 85.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.2 m -78.59 -55.22 5.37 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.14 -22.32 6.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.22 -65.29 3.47 Favored Glycine 0 C--N 1.32 -0.336 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.778 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 m -72.96 -9.71 59.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.107 0.479 . . . . 0.0 110.973 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.54 -55.94 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.629 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.96 -57.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.91 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -68.32 -49.8 57.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.923 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.4 t 52.9 -93.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.57 -40.78 60.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.241 0.616 . . . . 0.0 112.428 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 120' ' ' VAL . 59.7 tp -60.87 -47.32 86.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 30.2 mt -71.3 -25.77 62.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.53 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -60.28 -44.36 95.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.42 -31.1 57.45 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.558 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 116' ' ' LEU . 52.1 t -63.82 -41.26 91.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 122.848 -0.207 . . . . 0.0 110.712 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 54.2 m -52.82 -45.75 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.813 0.696 . . . . 0.0 112.352 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 p -83.74 -36.38 23.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.9 -76.1 0.31 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.7 -49.69 50.94 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.707 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 52.6 mt-30 -72.52 -24.6 61.17 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.94 -53.39 3.02 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.732 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.18 -19.27 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.39 79.84 0.86 Allowed Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.065 -1.064 . . . . 0.0 110.488 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 52' ' ' ALA . 35.0 mm -64.6 136.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -134.62 125.9 28.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.8 t -89.48 113.93 26.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.494 0.664 . . . . 0.0 111.669 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.24 42.97 1.08 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.466 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 56.4 p -78.7 2.97 17.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.562 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.25 -27.37 20.66 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.15 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 m -105.95 -42.84 5.01 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 131' ' ' VAL . 20.6 t -70.43 -63.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.432 ' HA ' HG12 ' A' ' 140' ' ' ILE . 44.7 tt0 -59.55 -43.5 93.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.954 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.6 m -58.33 -38.01 76.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.947 0.403 . . . . 0.0 111.025 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.62 -56.65 5.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.49 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.444 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 44.2 pt -61.83 -27.63 42.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.526 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -75.43 -35.83 60.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.03 0.443 . . . . 0.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.3 m -79.2 -29.42 42.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.178 0.513 . . . . 0.0 110.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 140' ' ' ILE . 98.9 p -86.73 -21.0 26.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.258 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.538 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 40.5 t -63.13 -19.57 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.921 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.5 p -61.65 -19.72 62.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.202 0.525 . . . . 0.0 110.982 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.21 -6.37 57.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.731 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 144' ' ' SER . 23.2 mt -64.84 -3.98 3.95 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 29.1 t -55.23 -62.77 1.45 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.69 82.77 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.763 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -92.11 -16.06 26.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.424 0.631 . . . . 0.0 110.173 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -90.66 -57.57 2.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.764 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -122.92 -154.97 0.63 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.668 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 158' ' ' GLN . 78.4 p -115.78 178.1 4.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -158.86 25.05 0.22 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.545 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 27.6 t -134.78 -78.1 0.45 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.706 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.43 -176.48 5.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.2 p 58.41 -72.01 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.981 1.313 . . . . 0.0 113.341 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.447 ' HB2' ' CB ' ' A' ' 153' ' ' SER . 78.9 mt-30 -64.85 -27.64 69.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.204 0.526 . . . . 0.0 110.285 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.08 2.87 25.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.268 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 m -84.89 6.72 23.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.7 35.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.021 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 t -115.23 150.06 36.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.17 0.51 . . . . 0.0 111.408 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.4 m -102.64 -46.87 4.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.697 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 t -63.39 -39.13 93.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.934 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.0 p -124.53 29.09 6.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -133.56 -109.06 1.09 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.22 -0.991 . . . . 0.0 113.381 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.03 5.78 39.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.26 -69.49 2.74 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -173.05 150.21 1.95 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.5 m -134.96 74.71 1.53 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.5 0.667 . . . . 0.0 110.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 66.6 -156.93 50.76 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.633 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.493 ' O ' ' HA3' ' A' ' 188' ' ' GLY . 3.4 Cg_exo -81.61 -2.96 11.74 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 123.496 2.797 . . . . 0.0 112.298 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.1 p -105.14 -42.71 5.22 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.985 0.422 . . . . 0.0 111.305 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 83.21 171.59 47.67 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.816 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.79 47.97 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.252 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.5 m 68.17 19.3 9.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.515 0.726 . . . . 0.0 111.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -109.98 150.87 27.87 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.63 87.22 1.21 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.78 151.16 82.99 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.75 2.3 . . . . 0.0 112.318 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.5 t -97.33 -1.42 44.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.719 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 182' ' ' TYR . . . -72.56 147.76 40.92 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.509 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 181' ' ' GLY . 26.5 m-85 75.43 122.23 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 123.335 0.654 . . . . 0.0 110.589 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.83 124.09 15.38 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.254 1.969 . . . . 0.0 111.383 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.23 71.03 0.85 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -84.36 -74.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.531 2.154 . . . . 0.0 112.074 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.92 -63.75 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.756 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.04 -161.08 25.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.757 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 172' ' ' PRO . . . -74.91 101.22 1.29 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.41 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.88 5.01 86.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.089 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 64.36 82.93 0.21 Allowed Pre-proline 0 N--CA 1.462 0.138 0 C-N-CA 123.837 0.855 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.493 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 27.8 Cg_endo -67.46 139.75 50.26 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.988 1.792 . . . . 0.0 111.384 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.39 32.45 0.56 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.706 0.765 . . . . 0.0 110.712 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -146.85 46.96 0.71 Allowed Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -127.72 166.2 18.6 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.3 t -98.32 -176.76 3.49 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.64 -36.37 5.87 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.627 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 78.5 t80 67.69 -72.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.685 0.794 . . . . 0.0 112.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 177.87 -116.71 0.55 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.898 0 CA-C-O 119.035 -0.869 . . . . 0.0 111.433 -179.571 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.04 0.447 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.77 -147.69 18.05 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.54 147.72 22.65 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.247 1.965 . . . . 0.0 112.425 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -86.53 137.3 32.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.7 100.77 0.52 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.916 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.0 -9.85 8.43 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -120.23 -45.39 2.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.737 0.303 . . . . 0.0 111.256 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.75 41.77 62.99 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.041 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.51 ' HA ' HD12 ' A' ' 113' ' ' LEU . . . -61.39 147.46 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.1 m 66.49 92.58 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.69 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . 143.1 -172.7 24.5 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.938 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.31 -162.9 12.62 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.03 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.23 -19.13 62.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.844 0.354 . . . . 0.0 111.885 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.5 m -63.9 -20.38 65.8 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.953 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.95 65.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.987 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.29 -34.88 22.19 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.303 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.4 pp -87.74 -31.78 19.49 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 14' ' ' SER . 16.3 pt -42.23 -57.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.7 m -66.56 -20.36 66.0 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 57.0 mtt180 -88.9 -31.23 18.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 17' ' ' LEU . 83.7 t -49.53 158.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 O-C-N 123.597 0.561 . . . . 0.0 111.384 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -40.31 -25.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' HB3' ' OG ' ' A' ' 92' ' ' SER . 20.4 t-20 -61.73 -28.67 69.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 0.0 109.938 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -58.97 -46.19 88.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.511 0.672 . . . . 0.0 109.934 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' A' ' 179' ' ' PRO . 61.9 tp -68.06 -28.66 67.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.297 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.99 87.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 0.0 110.133 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 59.4 2.99 0.35 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.899 0.88 . . . . 0.0 112.535 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 5.5 m -68.53 163.44 23.5 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.266 0.555 . . . . 0.0 111.289 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 m -58.94 -15.34 12.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.8 p -54.59 -30.43 54.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.644 0.777 . . . . 0.0 112.992 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.1 pt? -106.57 -18.6 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.214 0.53 . . . . 0.0 110.507 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -76.2 -60.17 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.067 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -155.25 -31.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' C ' HE22 ' A' ' 88' ' ' GLN . 96.0 t -75.57 137.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 74' ' ' VAL . 2.6 pt? -55.79 145.66 23.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.224 0.535 . . . . 0.0 112.016 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -52.84 130.21 32.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.556 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.445 HG23 HG21 ' A' ' 136' ' ' VAL . 3.3 m -66.02 111.84 3.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.88 31.46 9.98 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.182 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 4.3 p -59.58 163.15 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.386 0.674 . . . . 0.0 112.265 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -109.52 161.39 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.781 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.7 pt20 -64.78 -15.22 61.36 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HG3' HD13 ' A' ' 116' ' ' LEU . 81.3 mm-40 -53.14 -46.41 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.024 0.44 . . . . 0.0 111.106 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' HB ' ' CD2' ' A' ' 86' ' ' TYR . 2.4 pp -84.35 -35.98 11.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.989 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.89 -60.68 2.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.574 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 t 70.83 -21.06 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.631 0.772 . . . . 0.0 112.87 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -69.33 -79.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.38 -37.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.265 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.503 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.4 p -71.11 99.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.459 0.647 . . . . 0.0 110.714 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 40.6 mt-30 -82.99 -38.01 23.22 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HE ' HD13 ' A' ' 55' ' ' LEU . 23.8 ttm-85 -148.23 -1.61 0.55 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.784 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.0 -46.63 0.64 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.247 0.619 . . . . 0.0 111.128 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.31 142.05 58.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.2 mm-40 -64.5 -16.46 62.57 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.104 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 p -63.08 -76.74 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.141 0.496 . . . . 0.0 112.26 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.576 HD13 ' HE ' ' A' ' 50' ' ' ARG . 7.1 tt -85.36 -23.65 27.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.741 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.17 -21.05 39.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.5 t -62.94 94.92 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.756 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 9.6 t -119.99 -34.73 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 58' ' ' THR . 96.2 mt -118.07 19.5 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.25 67.69 1.46 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.487 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.7 t -88.49 126.31 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.81 0.338 . . . . 0.0 110.28 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 177.01 89.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.574 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.07 -60.12 4.48 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.125 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -50.14 -79.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 0.0 112.131 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 21.5 p-10 -85.77 14.0 6.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.998 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 tp -88.07 -58.41 2.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.746 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.62 48.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.456 0.646 . . . . 0.0 109.785 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -99.08 162.85 12.83 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.918 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 70.14 -61.92 0.44 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.415 0.447 . . . . 0.0 111.715 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.59 -62.7 1.42 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.335 0.254 . . . . 0.0 111.586 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.69 -41.94 90.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.86 -37.33 76.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.69 63.08 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.4 t -85.42 -16.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.4 p -90.74 -23.88 20.55 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.243 0.544 . . . . 0.0 110.176 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 76' ' ' ARG . 34.6 ttp180 -117.93 22.34 12.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.167 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -64.25 145.1 98.35 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.247 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 127.97 23.61 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.438 2.092 . . . . 0.0 111.632 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.48 6.13 9.23 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.396 0.617 . . . . 0.0 111.881 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.73 -15.44 80.75 Favored Glycine 0 C--N 1.297 -1.598 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.903 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 m -86.37 -7.91 58.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.13 122.91 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.141 0.977 . . . . 0.0 112.614 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 p -66.77 -36.07 81.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.447 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -67.06 -19.5 65.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.746 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.72 -21.64 28.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.424 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 3.1 m-85 -78.41 -169.41 1.66 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.089 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.98 31.19 0.11 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.114 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.425 HE22 ' C ' ' A' ' 34' ' ' VAL . 87.8 mm-40 -89.65 -60.12 2.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.145 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.69 -37.1 56.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.277 0.56 . . . . 0.0 110.155 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.82 5.38 25.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.571 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 t -52.17 -39.42 60.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.03 0.443 . . . . 0.0 110.794 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 3.3 m -58.37 -53.19 61.15 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.437 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.88 -22.6 53.21 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.873 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.599 ' O ' HG11 ' A' ' 120' ' ' VAL . 78.1 mt -82.77 -45.86 13.84 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -70.79 -43.45 68.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.49 88.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.394 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.74 46.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.787 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.34 -13.81 31.84 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.5 HG12 HE22 ' A' ' 194' ' ' GLN . 3.5 t -101.07 28.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.461 0.648 . . . . 0.0 109.982 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.7 pt? -122.95 172.56 8.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.235 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 193' ' ' GLY . 37.0 t30 -73.84 99.61 3.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -17.76 64.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -70.89 -30.56 66.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.423 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.96 -35.37 76.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.722 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.82 -35.46 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.753 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.53 -24.09 45.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.63 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.7 m -75.18 -60.72 2.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.276 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 104' ' ' ASN . 1.7 pt? -121.4 -21.17 6.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.772 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -53.07 -61.07 7.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.769 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -82.58 -15.0 53.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -87.95 -60.06 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.9 t -78.02 -58.21 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.334 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.536 HD23 ' HA2' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -69.34 -26.77 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.011 0.434 . . . . 0.0 110.03 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.7 t 45.34 -105.0 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.471 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.96 -36.27 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.67 0.788 . . . . 0.0 112.635 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 120' ' ' VAL . 25.7 tp -59.27 -62.37 1.93 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.278 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' CA ' ' A' ' 109' ' ' GLY . 45.8 mt -79.99 -22.89 41.99 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -62.96 -44.2 96.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 109.957 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.79 -34.65 72.24 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.318 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 94' ' ' LEU . 53.0 t -69.28 -39.76 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.748 0.308 . . . . 0.0 111.204 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 34.0 t -57.04 -35.91 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 m -83.72 -39.33 20.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.97 -72.91 0.44 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 129' ' ' ILE . . . -70.54 -47.87 58.21 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.925 0.393 . . . . 0.0 111.847 -176.137 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' SER . 27.0 tt0 -71.01 -24.53 62.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.11 -66.34 1.4 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.768 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.2 mt -109.34 -24.58 10.99 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 122.621 -0.341 . . . . 0.0 111.898 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.86 104.08 1.74 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.612 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 124' ' ' ALA . 13.8 mt -79.58 136.38 23.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.591 0.234 . . . . 0.0 111.483 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -121.63 129.12 52.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.902 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.488 ' HB ' HG11 ' A' ' 136' ' ' VAL . 24.5 t -82.2 168.74 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.466 ' N ' HG12 ' A' ' 131' ' ' VAL . 24.1 t70 -59.38 137.19 58.08 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.305 0.574 . . . . 0.0 111.238 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.6 m -58.33 -23.07 55.49 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.824 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.28 -41.08 99.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.733 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 p -106.49 -45.55 4.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 140' ' ' ILE . 10.8 p -78.76 -55.4 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . 51.4 tt0 -59.62 -44.26 93.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 p -56.22 -41.87 76.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.996 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.83 -49.8 8.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.7 pt -62.05 -33.37 58.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -60.71 -29.59 69.43 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 m -83.94 -32.99 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 0.0 110.94 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -87.84 -27.78 22.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.767 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 34.7 t -62.5 -17.47 59.76 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.339 0.656 . . . . 0.0 111.727 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 m -47.4 -19.7 0.18 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -65.37 -10.15 30.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.58 0.229 . . . . 0.0 111.472 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 144' ' ' SER . 77.8 mt -59.18 -30.06 67.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.026 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.3 m -66.7 -39.4 88.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.844 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.6 m -66.1 -33.0 74.8 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.567 0.698 . . . . 0.0 109.168 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.8 t -68.17 -14.37 62.93 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.18 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 m -104.01 -46.29 4.5 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.523 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.1 t -153.37 148.71 27.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.4 m -81.68 39.23 0.54 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.247 0.546 . . . . 0.0 110.967 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.83 -18.98 60.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.286 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 21.1 m -57.87 113.41 1.85 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 61.21 23.18 13.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m 56.81 69.12 0.77 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 53.1 15.09 0.55 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.404 1.482 . . . . 0.0 113.852 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.8 10.95 40.45 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.572 0.701 . . . . 0.0 109.667 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 p -69.58 -33.03 72.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.523 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 175' ' ' PRO . . . -82.58 7.26 15.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.844 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 m -89.11 156.27 18.93 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 72.0 m -70.82 82.43 0.64 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.097 0.475 . . . . 0.0 111.899 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.8 m -58.78 124.43 19.76 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.301 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.0 m 68.58 4.86 4.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.641 0.588 . . . . 0.0 111.369 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.53 41.95 6.3 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.894 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.51 -60.55 3.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.35 -64.85 3.72 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.024 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -114.38 137.91 51.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.98 0.419 . . . . 0.0 110.518 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.1 m -154.38 76.39 1.03 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.63 -171.95 40.13 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -70.11 -17.52 35.95 Favored 'Trans proline' 0 C--N 1.33 -0.403 0 C-N-CA 122.484 2.122 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.51 ' HA ' ' HA3' ' A' ' 189' ' ' GLY . 46.6 t -75.48 -65.49 0.89 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.214 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.69 174.08 13.26 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.43 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 73.5 Cg_exo -55.45 99.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.094 2.529 . . . . 0.0 113.621 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.5 m 41.82 71.61 0.2 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.1 t -135.4 168.55 19.0 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.35 -165.28 36.14 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.473 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 25' ' ' LEU . 53.6 Cg_endo -70.68 -26.86 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.918 2.412 . . . . 0.0 113.559 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.0 t 54.96 74.57 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.048 0.451 . . . . 0.0 110.526 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 144.13 -89.17 0.17 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.897 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 183' ' ' PRO . 75.6 m-85 -117.16 118.09 36.21 Favored Pre-proline 0 C--N 1.318 -0.8 0 O-C-N 122.874 -0.192 . . . . 0.0 110.895 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 182' ' ' TYR . 14.2 Cg_exo -70.72 124.79 11.01 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.31 2.007 . . . . 0.0 111.223 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 186' ' ' LEU . . . 137.14 -62.08 0.59 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.386 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.7 34.93 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.51 2.806 . . . . 0.0 114.069 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 184' ' ' GLY . 91.9 mt 68.92 135.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.949 0.88 . . . . 0.0 112.789 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.67 -171.77 20.47 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.07 109.35 1.63 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.102 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 173' ' ' SER . . . 72.48 32.77 61.74 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.108 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.575 ' HB2' ' H ' ' A' ' 187' ' ' GLY . . . -75.46 156.14 85.37 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.645 0.223 . . . . 0.0 110.505 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.436 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 6.2 Cg_exo -76.69 152.08 32.75 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.485 2.123 . . . . 0.0 111.896 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.55 -21.12 35.45 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -103.05 45.3 1.35 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.5 HE22 HG12 ' A' ' 99' ' ' VAL . 56.4 tp60 -81.16 144.96 31.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -99.9 154.51 18.3 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.436 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -74.41 94.48 0.83 Allowed Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.037 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -98.93 -48.21 4.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.021 0.439 . . . . 0.0 110.08 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -85.1 -21.61 54.69 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.291 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.519 -1.156 . . . . 0.0 111.117 179.435 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.542 0 CA-C-O 120.65 0.262 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.19 137.29 6.38 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.883 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.13 120.68 7.86 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.163 1.909 . . . . 0.0 111.088 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -63.58 118.77 8.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.349 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.68 -135.33 29.5 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.821 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.77 15.66 44.62 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -69.91 -52.95 20.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.2 70.22 1.11 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.363 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -171.68 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 p 54.31 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.742 0.817 . . . . 0.0 111.531 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.16 148.12 40.49 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.391 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.95 86.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.62 -0.324 . . . . 0.0 113.153 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -60.1 -35.73 75.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 111.247 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' ILE . 24.9 t -74.84 -22.08 58.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.113 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.99 -22.51 66.96 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.9 12.67 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.062 -1.065 . . . . 0.0 112.164 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.37 -32.73 24.05 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' SER . 10.0 pt -44.16 -51.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.9 m -67.81 -20.61 65.2 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HA ' ' HG3' ' A' ' 172' ' ' PRO . 79.0 mtt180 -89.24 -24.51 22.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -72.33 -162.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.063 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.13 -37.42 6.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.84 -24.95 67.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.44 -53.46 56.23 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 109.66 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.07 -33.82 76.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.28 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.562 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 53.31 17.94 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.355 0.662 . . . . 0.0 111.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -76.31 157.61 32.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -62.22 -16.87 56.12 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.338 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -54.06 -34.54 60.35 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.6 pt? -112.28 -18.29 12.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -79.0 -43.76 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.147 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 34' ' ' VAL . 7.6 t -164.44 -37.75 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 33' ' ' THR . 98.1 t -88.38 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -54.39 140.12 34.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 111.489 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 94' ' ' LEU . 2.0 ptm180 -58.88 154.1 15.83 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -70.07 124.13 23.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.237 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.8 40.77 64.21 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 36' ' ' ARG . 8.4 p -47.4 149.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.704 0.802 . . . . 0.0 112.523 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' ILE . 8.6 m -69.86 127.63 33.57 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.244 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.1 pt20 -61.53 -14.03 26.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.025 0.44 . . . . 0.0 111.115 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.86 -32.0 73.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 40' ' ' SER . 2.5 pp -83.76 -35.52 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.71 -72.49 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.446 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m 76.01 -19.62 0.4 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.969 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.0 p -68.18 -88.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.236 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 65' ' ' ASN . 30.0 m -126.62 -32.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.793 0.33 . . . . 0.0 111.634 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.7 p -79.31 91.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.726 0.774 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.6 mt-30 -83.04 -68.58 0.69 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.732 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.519 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 26.0 ttp180 -108.46 -3.06 18.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.425 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.13 -55.76 0.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.109 0.564 . . . . 0.0 109.85 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -67.29 142.31 56.9 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.265 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 22.3 mp0 -46.89 -51.16 17.42 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.088 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -46.54 -62.88 1.17 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 50' ' ' ARG . 28.8 tp -86.65 -27.6 23.7 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.036 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.56 -20.58 39.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 6.2 t -62.91 89.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.602 0.715 . . . . 0.0 111.466 -176.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.7 t -113.18 -36.43 5.05 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.785 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.88 18.57 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.095 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.06 68.05 1.13 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.95 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.45 103.2 13.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -151.3 14.04 0.68 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.065 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 134.85 -47.95 0.96 Allowed Glycine 0 C--N 1.28 -2.583 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 92.8 m-20 -62.7 -65.34 0.7 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.489 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 47' ' ' VAL . 66.2 t30 -84.71 4.23 33.62 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 52.9 tp -88.88 -67.14 0.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.945 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.56 58.21 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.544 0.688 . . . . 0.0 110.137 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 94.5 mtt180 -100.91 162.2 13.07 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.815 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 67.77 -62.28 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -61.48 -62.43 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 122.664 0.386 . . . . 0.0 111.356 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.0 -39.23 84.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 85.1 mm-40 -60.94 -47.3 87.06 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.548 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.21 -39.81 70.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -86.41 -34.27 7.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.959 0.409 . . . . 0.0 111.306 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -71.97 -26.5 62.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 17.6 mmt180 -101.02 9.25 42.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.456 0.646 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 9.9 tt -82.02 124.61 78.78 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.91 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 13.0 Cg_exo -71.62 128.02 13.85 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.593 2.195 . . . . 0.0 111.265 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.34 63.84 3.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.62 -28.62 68.99 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.349 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.1 m -92.25 -5.4 52.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 76.71 157.04 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.517 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 p -62.02 -32.64 73.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.513 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 m -59.08 -27.16 65.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.913 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.14 -22.27 49.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.932 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -85.38 -170.03 2.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.004 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -77.74 44.54 0.46 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 8.2 tp-100 -89.62 -61.46 1.69 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.765 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.18 -26.79 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 m-85 -78.13 3.83 14.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.678 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -50.45 -40.28 50.19 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.355 0.409 . . . . 0.0 111.638 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 15.2 m -57.29 -49.46 76.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.74 -23.82 36.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.693 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 83.3 mt -84.63 -29.97 25.3 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -81.14 -38.49 27.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.605 0.241 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 m120 63.99 91.89 0.07 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.03 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.31 -10.84 45.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.375 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 4.38 71.41 Favored Glycine 0 N--CA 1.459 0.227 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.525 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.39 -14.05 8.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.639 0.733 . . . . 0.0 109.076 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.7 pp -81.64 -179.26 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.057 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 44.1 t30 -68.45 110.73 4.29 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.072 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -26.4 65.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.752 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -73.99 -27.66 61.09 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.055 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -62.52 -46.74 87.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.101 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.08 -31.5 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.59 -43.09 70.1 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.021 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.2 m -71.27 -56.04 6.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 13' ' ' ALA . 4.4 pp -115.55 -13.31 11.55 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.823 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.61 -65.2 3.0 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.254 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.5 p -73.79 -19.5 60.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.802 0.335 . . . . 0.0 111.641 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -87.42 -58.23 2.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.2 t -81.2 -54.8 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.254 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.6 mp -67.35 -45.2 77.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 t 46.03 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.096 1.359 . . . . 0.0 113.686 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.27 73.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.533 0.333 . . . . 0.0 111.57 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.4 tp -61.96 -50.23 72.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.492 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' SER . 17.4 mt -68.95 -24.16 64.23 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -66.18 -36.79 84.01 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.554 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.33 -39.44 7.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 83.1 t -70.16 -22.99 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.619 0.247 . . . . 0.0 111.322 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 28.9 t -55.16 -44.03 74.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -84.39 -23.2 30.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.119 0.485 . . . . 0.0 110.608 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 50' ' ' ARG . . . -83.43 -97.48 0.05 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.892 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.03 67.85 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.762 0.315 . . . . 0.0 111.769 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 34.2 tt0 -65.13 -42.45 93.86 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.767 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.62 -48.24 4.81 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.436 0.618 . . . . 0.0 112.246 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.65 99.05 0.5 Allowed Glycine 0 C--N 1.312 -0.78 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 52' ' ' ALA . 34.6 mm -86.63 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.025 0.44 . . . . 0.0 112.176 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -116.59 135.43 53.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 132' ' ' ASP . 18.5 t -86.2 173.06 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 131' ' ' VAL . 30.4 t70 -58.97 145.5 41.41 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.174 0.512 . . . . 0.0 111.384 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 47.8 m -64.04 -22.19 66.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.57 -69.07 1.05 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 123.37 0.419 . . . . 0.0 114.133 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -99.42 -34.91 10.09 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 140' ' ' ILE . 86.5 t -83.18 -62.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 56.6 tp60 -56.82 -45.97 81.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.7 m -54.62 -38.92 67.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.36 -48.33 10.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 137' ' ' GLN . 43.9 pt -65.7 -27.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 p -67.45 -48.59 66.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.1 m -84.27 -20.22 32.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.496 ' HA ' HD13 ' A' ' 147' ' ' LEU . 42.1 t -85.54 -20.16 30.04 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.6 p -72.2 -65.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.1 t -86.05 -34.59 20.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -66.01 -27.03 67.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 143' ' ' SER . 11.0 mp -78.22 -62.67 1.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -91.52 -66.41 0.93 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 52.6 p -87.0 54.47 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.7 p -101.49 171.02 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.042 0.449 . . . . 0.0 111.223 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.3 m -84.8 11.0 9.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.393 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 21.9 t -139.44 174.7 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.557 ' CB ' ' HB3' ' A' ' 158' ' ' GLN . 50.5 m -95.73 128.85 42.95 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.26 -96.76 0.19 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.4 p -98.13 101.7 13.24 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 2.9 t80 56.9 19.55 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.021 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.502 ' HB3' ' OG ' ' A' ' 176' ' ' SER . 10.8 m -74.1 -29.33 61.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.7 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.557 ' HB3' ' CB ' ' A' ' 153' ' ' SER . 18.8 pt20 -89.1 1.39 55.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.247 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.05 28.59 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.599 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t 65.58 74.43 0.37 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.211 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 177' ' ' THR . . . -104.35 78.43 1.49 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.473 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 p -95.25 25.3 4.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.291 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.4 m 67.41 -49.01 0.5 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.186 0.995 . . . . 0.0 112.557 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.8 t -63.58 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.742 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.0 m -92.94 0.07 57.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 120.96 164.84 12.5 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 170' ' ' THR . . . -139.18 20.77 2.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.01 0.433 . . . . 0.0 110.798 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.47 -84.84 0.34 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.794 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -105.43 -39.2 6.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.396 0.617 . . . . 0.0 109.823 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 2.2 p -83.52 -179.86 7.46 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.079 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -122.2 -83.46 0.67 Allowed Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.037 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 20' ' ' ARG . 10.6 Cg_endo -58.07 -53.32 4.41 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.039 2.493 . . . . 0.0 112.043 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p -148.42 156.63 42.73 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.014 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.08 -58.58 0.2 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.4 -156.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.17 1.913 . . . . 0.0 111.194 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 157' ' ' SER . 9.5 p -77.4 36.96 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.122 0.487 . . . . 0.0 111.487 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 161' ' ' ALA . 9.4 t -100.02 152.42 20.22 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.731 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.07 -139.07 21.53 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.925 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 182' ' ' TYR . 17.1 Cg_exo -70.9 40.55 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.616 2.877 . . . . 0.0 113.533 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 32.9 p -72.54 -46.08 56.22 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.06 -1.91 7.29 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.387 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 179' ' ' PRO . 4.3 m-85 -121.61 90.54 48.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -83.95 125.62 3.69 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 122.098 1.865 . . . . 0.0 112.352 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 122.18 -74.64 0.36 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.874 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.81 5.74 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.268 2.645 . . . . 0.0 114.366 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 98.3 mt 73.43 -28.85 0.19 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.322 0.649 . . . . 0.0 112.745 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.2 -147.77 35.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.307 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -89.47 -37.73 6.91 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.581 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.43 62.66 3.76 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.891 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 186' ' ' LEU . . . -128.32 131.22 23.65 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.491 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 59.4 Cg_endo -73.59 5.18 3.45 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.1 t80 71.71 -41.12 0.5 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.882 0.873 . . . . 0.0 112.572 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -70.34 73.59 0.57 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.622 -0.323 . . . . 0.0 113.663 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -125.14 148.73 48.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 28.8 m -123.99 -12.55 7.47 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.699 0.285 . . . . 0.0 111.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.58 59.93 0.67 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.648 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.96 -172.1 2.49 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 176.52 101.6 0.15 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.009 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.315 0 CA-C-O 118.587 -1.118 . . . . 0.0 111.805 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 120.612 0.244 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.84 176.35 46.36 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.01 165.94 23.62 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.98 2.453 . . . . 0.0 112.427 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.414 ' HG3' HE22 ' A' ' 42' ' ' GLN . 47.5 mt-30 -77.22 90.72 3.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.03 -112.94 4.87 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.597 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 1.07 34.35 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.751 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -65.38 -48.76 71.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.936 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.66 171.65 43.81 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.21 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.29 18.07 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.5 p 52.74 90.91 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.734 0.646 . . . . 0.0 112.465 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.33 161.1 31.11 Favored Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.22 -61.58 6.49 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.627 -0.321 . . . . 0.0 113.452 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.54 86.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.623 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.9 p -63.32 -32.97 74.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.597 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.51 -19.13 65.41 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.3 -38.91 7.02 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.342 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.3 pp -84.69 -22.08 29.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 14' ' ' SER . 11.5 pt -46.96 -50.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -84.77 -19.73 32.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -86.47 -30.81 21.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.3 t -80.96 -101.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.89 35.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.611 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.31 -22.99 66.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.81 81.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.066 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 178' ' ' GLY . 1.8 tt -80.57 -31.77 36.73 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.441 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.85 82.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.212 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 11.2 t-20 61.83 6.03 1.53 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.859 0.864 . . . . 0.0 113.083 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 29' ' ' SER . 0.3 OUTLIER -68.48 177.93 2.21 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.087 0.47 . . . . 0.0 111.292 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.527 ' H ' HG22 ' A' ' 28' ' ' THR . 9.7 m -69.66 -16.03 63.29 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 p -51.62 -50.39 60.33 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.754 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.9 pt? -87.29 -19.98 27.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.326 0.584 . . . . 0.0 110.358 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -74.69 -48.23 27.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.086 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -172.71 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.61 135.52 27.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -54.02 139.19 35.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.346 0.593 . . . . 0.0 111.77 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 3.1 ptm180 -62.71 160.04 15.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.995 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -74.19 111.67 9.59 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.644 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.15 47.13 11.51 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.342 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.6 p -54.99 150.04 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 122.93 0.492 . . . . 0.0 111.364 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 t -81.78 164.36 21.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.1 pt20 -70.06 -12.42 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.763 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.414 HE22 ' HG3' ' A' ' 4' ' ' GLN . 41.6 mm-40 -50.95 -33.05 22.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.113 0.483 . . . . 0.0 110.609 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.717 HG13 ' N ' ' A' ' 44' ' ' ALA . 6.7 pt -83.77 -52.77 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.717 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.47 -66.98 0.83 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m 78.82 -20.5 0.38 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.555 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.5 p -83.1 -82.97 0.14 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.25 -52.53 8.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.594 0.711 . . . . 0.0 110.258 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.33 89.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.461 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 77.9 mt-30 -82.82 -36.93 25.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.777 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 5.7 ttt180 -156.5 5.64 0.17 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.937 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.91 -58.93 0.39 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.162 0.585 . . . . 0.0 110.783 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -62.97 138.54 58.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' SER . 5.0 pm0 -55.54 -18.87 8.28 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.611 -175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -60.02 -71.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.6 tp -87.36 -24.05 24.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.752 0.311 . . . . 0.0 111.604 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.96 -18.91 55.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -53.96 99.97 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.183 0.516 . . . . 0.0 110.886 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -137.68 -36.25 0.63 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.738 HD11 ' ND2' ' A' ' 65' ' ' ASN . 4.1 pp -123.03 11.46 9.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.022 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.04 52.76 1.58 Allowed Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.143 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 65' ' ' ASN . 3.3 t -87.17 114.25 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -156.54 14.29 0.29 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 112.017 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 145.44 -43.71 0.91 Allowed Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.01 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -59.12 -68.45 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.181 0.515 . . . . 0.0 110.598 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.738 ' ND2' HD11 ' A' ' 59' ' ' LEU . 25.8 p-10 -85.92 9.61 16.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 23.9 tp -88.12 -50.67 6.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.993 0.425 . . . . 0.0 110.438 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 133' ' ' SER . . . -81.95 -26.55 33.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -127.08 169.42 13.41 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 69.8 -62.29 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.105 0.562 . . . . 0.0 112.492 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -62.19 2.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.012 0.434 . . . . 0.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 6.7 p -65.04 -33.2 62.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.6 -22.76 66.13 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.937 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.66 -51.08 6.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.102 0.477 . . . . 0.0 110.831 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 61.9 t -71.1 -36.46 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.427 -176.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -83.2 1.37 41.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.856 0.36 . . . . 0.0 111.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -106.37 -21.69 13.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.317 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 4.5 pp -63.71 144.77 97.84 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 111.515 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.73 146.22 88.09 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.777 2.318 . . . . 0.0 111.855 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 18.76 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.24 0.543 . . . . 0.0 111.395 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.85 -23.32 78.16 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.357 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -79.87 -6.07 56.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 t70 73.66 123.85 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 111.168 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -67.74 -37.81 82.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.62 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 m -72.4 -24.99 61.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.422 . . . . 0.0 110.457 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.33 -21.32 65.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.73 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -76.97 -169.41 1.31 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.362 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.97 12.97 0.95 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 1.8 mp0 -67.43 -48.15 68.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.057 0.456 . . . . 0.0 111.109 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -71.73 -30.71 65.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.967 0.413 . . . . 0.0 110.681 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 84.9 m-85 -83.54 8.76 13.12 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.954 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 36' ' ' ARG . 71.9 m -51.8 -43.52 63.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.3 m -61.69 -48.76 79.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.02 -31.05 68.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 41.8 mt -84.17 -19.0 34.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.775 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HB2' HH21 ' A' ' 36' ' ' ARG . 55.6 t80 -87.44 -36.94 17.42 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.096 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.436 ' HA ' HD21 ' A' ' 100' ' ' LEU . 92.6 m-20 55.19 64.86 1.65 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.584 0.707 . . . . 0.0 110.378 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.71 62.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.747 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.83 66.51 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.213 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.9 t -74.72 -24.99 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.319 0.58 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -84.4 150.52 25.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 195' ' ' SER . 40.3 t30 -54.67 107.78 0.32 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.801 0.688 . . . . 0.0 110.986 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -17.49 63.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.936 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.8 m -80.18 -18.04 50.75 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.034 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.482 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -78.62 -29.17 45.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.433 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -64.86 -32.46 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.878 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.8 m -67.94 -61.34 1.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.67 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -129.0 -9.96 4.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.995 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -58.9 -72.04 0.67 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 m -73.95 -12.26 60.59 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.805 0.336 . . . . 0.0 111.365 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.16 -57.83 2.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.28 -53.75 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.56 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.52 -33.39 64.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.182 -178.407 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.2 t 49.49 -103.57 0.12 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.033 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.69 -33.29 60.67 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.115 0.566 . . . . 0.0 112.206 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 120' ' ' VAL . 43.2 tp -57.39 -53.26 60.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 19.2 mt -78.69 -23.72 45.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.724 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.3 -45.44 93.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.1 -29.72 62.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.752 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 116' ' ' LEU . 40.5 t -69.25 -46.11 78.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 122.766 -0.255 . . . . 0.0 111.198 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -58.05 -39.17 77.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.482 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -80.51 -40.19 26.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.876 0.369 . . . . 0.0 111.804 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.2 -70.07 0.6 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.404 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.15 -51.2 18.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -69.95 -35.01 74.17 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.89 0.376 . . . . 0.0 110.508 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.37 -56.66 3.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.141 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.38 -23.53 15.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.57 77.57 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.235 -0.984 . . . . 0.0 111.002 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.49 HG23 ' CB ' ' A' ' 52' ' ' ALA . 36.9 mm -68.47 132.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.65 140.36 48.14 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.76 116.28 46.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.341 0.591 . . . . 0.0 111.333 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.69 43.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 46.0 p -75.49 -4.99 42.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.028 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 -17.85 58.51 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.5 p -107.4 -56.88 2.15 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.06 -62.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -59.02 -40.49 85.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.8 m -60.84 -49.08 78.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.24 -52.29 62.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.819 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 42.7 pt -61.45 -34.87 63.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.459 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 t -67.79 -42.11 82.14 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.97 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 m -77.42 -45.97 24.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.3 m -66.11 -38.73 88.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 p -57.7 -27.55 63.03 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -58.21 -46.87 85.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.991 0.424 . . . . 0.0 110.873 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.84 -35.54 16.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 71.1 mt -82.19 8.62 10.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.755 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.6 m -49.28 -43.07 42.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.479 0.657 . . . . 0.0 109.386 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 179' ' ' PRO . 10.7 m -145.37 -13.66 0.51 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t 64.11 -163.43 0.26 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.48 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.5 p 56.32 -159.78 0.22 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.618 0.767 . . . . 0.0 111.101 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.2 m -99.06 2.9 46.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.853 0.359 . . . . 0.0 110.308 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.9 m -135.62 117.77 15.47 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -127.76 -48.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.857 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.0 p -103.51 7.79 37.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.237 0.541 . . . . 0.0 110.473 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.59 160.11 14.51 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.8 t -67.62 -13.09 61.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.335 0.588 . . . . 0.0 109.801 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -70.54 -22.14 62.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.073 175.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.89 -9.2 58.95 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.046 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.3 m -74.84 -41.99 58.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.856 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.612 ' HA ' ' HB ' ' A' ' 177' ' ' THR . . . -159.05 -67.94 0.08 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.9 t 61.83 24.98 14.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 37.2 t -79.1 -10.6 59.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.7 m -65.39 -30.58 71.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.273 0.559 . . . . 0.0 110.104 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.6 m -89.03 -0.04 57.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . 148.53 153.4 5.97 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.89 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.45 74.42 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.109 0.48 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.28 74.65 2.41 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.65 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 97.2 m-85 74.25 179.98 0.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.768 0.827 . . . . 0.0 110.526 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -146.58 122.18 10.45 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.155 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.92 -148.61 19.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.061 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.99 -6.78 13.52 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.219 2.613 . . . . 0.0 113.503 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.6 p -141.6 27.01 1.89 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -91.71 -138.21 7.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.847 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 169' ' ' TYR . 7.5 Cg_exo -75.03 -171.42 0.98 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.91 2.406 . . . . 0.0 110.747 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 12.2 p -76.85 82.89 3.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.612 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 7.2 t -163.35 139.96 7.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.511 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 25' ' ' LEU . . . 121.01 -66.77 0.44 Allowed Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.499 ' HB2' ' HA ' ' A' ' 149' ' ' THR . 3.4 Cg_exo -82.22 23.55 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.189 2.592 . . . . 0.0 112.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.2 m -45.7 118.52 1.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.0 111.043 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -50.28 -68.95 1.21 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.626 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 60.3 t80 -123.1 -58.69 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.626 ' HD2' ' H ' ' A' ' 182' ' ' TYR . 42.5 Cg_endo -67.91 123.66 10.94 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 121.313 1.342 . . . . 0.0 111.596 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 55.62 74.79 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.707 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -43.1 -50.76 6.13 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.377 2.718 . . . . 0.0 112.166 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.72 88.73 6.81 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.49 58.9 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.897 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.73 -39.93 0.39 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.465 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.28 49.92 4.22 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.774 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.06 152.76 49.22 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.37 -177.73 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.552 2.168 . . . . 0.0 112.242 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -99.35 10.93 40.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -91.34 30.27 6.52 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.524 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.96 123.19 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 2.3 t -74.66 -20.31 59.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.785 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 109.0 36.14 2.22 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.109 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -119.58 -55.82 2.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.019 0.437 . . . . 0.0 109.929 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.69 65.42 2.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.784 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.4 0 CA-C-O 118.486 -1.174 . . . . 0.0 111.525 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.603 0.239 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' HA2' ' HD2' ' A' ' 3' ' ' PRO . . . -106.57 101.52 1.76 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.417 ' HD2' ' HA2' ' A' ' 2' ' ' GLY . 19.2 Cg_endo -59.85 -36.01 92.17 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 122.614 2.209 . . . . 0.0 112.002 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -69.87 -11.02 60.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.302 0.641 . . . . 0.0 111.9 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.19 44.27 2.37 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 115' ' ' ALA . . . 151.93 -30.04 0.91 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 81.41 103.31 0.06 Allowed 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.588 1.555 . . . . 0.0 113.751 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.04 55.69 27.95 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.187 -1.369 . . . . 0.0 114.348 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 113' ' ' LEU . . . -95.98 172.6 7.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.795 0.331 . . . . 0.0 111.381 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.8 p 51.3 84.1 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.234 1.014 . . . . 0.0 112.851 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.13 -167.93 41.07 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.249 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.79 -158.26 51.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.374 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.02 68.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.4 m -63.38 -34.39 77.62 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -19.05 65.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.96 -39.47 6.49 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.778 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.9 pp -84.52 -20.97 30.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' SER . 9.7 pt -41.46 -42.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 8.3 p -78.99 -30.28 44.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -87.28 -23.62 24.61 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 17' ' ' LEU . 17.3 t -80.62 -101.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.13 -53.34 7.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -170.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -63.63 -23.03 67.21 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.369 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.3 -41.48 79.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.95 -19.97 39.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.995 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.63 -40.57 41.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.73 19.42 2.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.663 0.744 . . . . 0.0 111.432 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 5.6 m -74.22 165.88 24.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -60.78 -18.25 53.96 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.054 0.542 . . . . 0.0 111.7 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 36' ' ' ARG . 34.4 p -52.99 -43.2 66.28 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 124.045 0.938 . . . . 0.0 113.085 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.642 HD22 ' HB3' ' A' ' 23' ' ' ASN . 1.6 pt? -96.59 -20.46 18.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.926 0.393 . . . . 0.0 111.19 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -72.07 -50.95 24.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.166 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -168.64 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.13 138.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.6 pt? -56.43 142.04 40.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.301 0.375 . . . . 0.0 110.785 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HA ' HG22 ' A' ' 30' ' ' THR . 31.4 ptt85 -66.84 159.31 28.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.793 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -70.95 111.44 6.34 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.81 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.681 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 85.34 41.26 7.49 Favored Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.642 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 87' ' ' ALA . 10.1 p -47.56 136.3 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.484 0.659 . . . . 0.0 111.831 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -70.23 143.75 52.08 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.538 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 15.4 pm0 -65.57 -12.68 55.21 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -47.09 -44.66 21.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.501 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.79 -40.71 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.83 -75.81 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m 78.86 -19.65 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 111.772 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 p -65.39 -82.04 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.61 -39.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.986 0.422 . . . . 0.0 111.261 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.53 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.5 p -80.31 95.42 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.793 0.806 . . . . 0.0 110.33 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 50.4 mt-30 -79.18 -37.57 38.02 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 8.1 ttm180 -153.66 0.22 0.23 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.08 -48.39 0.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.61 0.364 . . . . 0.0 110.272 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.67 141.08 58.05 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.919 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 57' ' ' SER . 42.4 mm-40 -56.71 -30.66 63.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.479 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.3 m -53.89 -62.2 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' CZ ' ' A' ' 50' ' ' ARG . 4.3 mm? -88.06 -35.82 17.3 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -79.72 -21.46 44.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.7 t -65.25 93.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.622 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.518 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.7 t -139.23 -31.36 0.7 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.917 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.7 mt -118.19 19.14 13.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.39 65.61 1.46 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 96.9 t -89.52 122.48 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.262 0.553 . . . . 0.0 111.368 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -178.2 85.91 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.136 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.88 -54.98 3.46 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.191 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.425 ' HA ' HH21 ' A' ' 68' ' ' ARG . 92.7 m-20 -50.79 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.376 0.67 . . . . 0.0 111.81 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.541 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 27.3 p-10 -86.63 14.57 6.75 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.122 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.2 tp -87.91 -65.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.38 -36.63 58.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.549 0.69 . . . . 0.0 109.749 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 64' ' ' ASN . 60.1 mtm180 -98.95 160.16 14.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.733 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 69.41 -62.27 0.41 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.997 0.519 . . . . 0.0 111.975 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -62.78 -63.14 1.3 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.746 0.307 . . . . 0.0 111.507 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' SER . 59.6 t -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 41.6 mt-30 -60.78 -47.59 85.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.484 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.89 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.8 -38.33 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.929 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 33.2 m -77.31 1.23 19.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.6 mmp_? -111.83 -4.21 14.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.806 0.336 . . . . 0.0 110.169 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.63 123.51 89.1 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.243 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.26 128.64 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.76 2.307 . . . . 0.0 111.46 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.17 94.2 9.47 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.976 0.417 . . . . 0.0 110.154 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.3 -55.28 24.49 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.101 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 m -72.54 -60.44 2.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 178.36 162.81 0.68 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.57 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -67.38 -26.43 66.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.091 0.472 . . . . 0.0 110.778 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -65.63 -17.77 64.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.904 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.23 -21.99 62.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 110.827 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -82.0 -166.37 1.22 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.813 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -76.71 11.6 1.62 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.55 -59.98 2.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.523 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -69.42 -30.91 68.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.042 0.449 . . . . 0.0 110.991 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 96.1 m-85 -82.64 4.03 26.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.307 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -51.25 -39.8 57.48 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.6 m -58.69 -44.88 90.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.11 -30.98 27.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 116' ' ' LEU . 33.5 mt -84.58 -28.94 26.24 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -87.13 -29.67 21.65 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.785 0.326 . . . . 0.0 110.486 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.7 m120 51.15 69.57 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.054 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.77 -8.56 56.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.068 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.47 -6.76 83.24 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.734 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.9 t -80.44 -19.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.492 0.663 . . . . 0.0 109.725 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.47 174.87 9.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.937 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -83.32 143.9 30.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.057 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.27 -18.84 40.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 p -67.75 -30.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.482 0.658 . . . . 0.0 109.827 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 108' ' ' LEU . 19.2 t30 -62.84 -50.44 70.95 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.124 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.526 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.7 mp -72.4 -28.13 27.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.326 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.55 -33.67 66.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.898 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.617 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 86.9 m -85.5 -40.23 16.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.2 pt? -139.94 -27.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.836 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -50.83 -63.98 4.09 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.178 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.5 m -75.57 -17.0 60.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.94 0.4 . . . . 0.0 111.913 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 107' ' ' THR . 66.6 mtt180 -87.2 -58.0 2.75 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.088 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.7 -49.35 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.535 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 9' ' ' ALA . 22.3 mt -70.86 -13.75 62.15 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.111 0.481 . . . . 0.0 110.572 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.0 t 47.74 -104.07 0.11 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 113.657 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . . . -65.86 -33.92 76.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.303 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 94' ' ' LEU . 37.3 tp -53.88 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.463 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 16.6 mt -69.07 -23.56 64.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.33 -46.68 76.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.194 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.6 -27.27 63.51 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.899 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' A' ' 124' ' ' ALA . 25.3 t -68.39 -36.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.795 0.331 . . . . 0.0 110.316 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.0 t -54.47 -41.21 69.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.457 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -83.74 -49.16 9.37 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.53 -58.49 3.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -82.12 -60.27 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -69.18 -35.7 76.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.445 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.28 -69.57 1.39 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.945 -0.645 . . . . 0.0 114.074 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.21 -23.61 24.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.974 0.416 . . . . 0.0 111.269 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 124' ' ' ALA . . . 82.2 91.32 0.6 Allowed Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.025 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 52' ' ' ALA . 63.7 mt -59.64 134.94 24.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -139.56 118.84 12.79 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.245 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.81 156.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.61 163.09 14.35 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.9 m -74.11 84.19 1.81 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.53 -114.94 2.01 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -87.83 -18.73 28.64 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 140' ' ' ILE . 48.9 t -78.72 -62.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.928 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 42.0 tp60 -52.54 -51.67 58.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 p -56.1 -43.97 78.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.88 -40.44 39.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.51 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 136' ' ' VAL . 47.3 pt -67.31 -35.92 75.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.523 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.9 m -57.05 -53.28 59.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.4 m -61.2 -43.59 98.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.496 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 65.0 m -66.09 -39.11 89.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.5 p -77.9 -19.1 55.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.638 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.4 m -84.27 -60.19 2.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.003 0.43 . . . . 0.0 111.19 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -89.71 -59.82 2.1 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.57 -24.25 65.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 53.2 m -52.61 -34.5 51.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.955 0.407 . . . . 0.0 112.085 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -135.08 26.84 3.55 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.5 t -149.4 156.09 41.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.059 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.1 t 62.75 -167.49 0.21 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.5 m 54.52 39.38 31.07 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 110.784 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 158' ' ' GLN . 52.2 p 55.01 19.47 2.73 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.158 0.983 . . . . 0.0 112.895 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 183' ' ' PRO . . . -82.99 19.19 1.44 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.229 0.538 . . . . 0.0 110.565 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.0 p -81.13 4.91 18.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.6 p90 49.57 20.82 0.54 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.213 1.405 . . . . 0.0 114.39 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.8 t -115.31 -0.27 13.25 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 153' ' ' SER . 60.5 mm-40 -120.87 -171.61 2.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.455 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 69.59 -68.44 0.19 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.151 0.58 . . . . 0.0 111.168 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -156.63 -45.29 0.07 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 72.46 -76.97 0.06 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.647 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.4 m -82.38 86.77 6.66 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 120.828 0.347 . . . . 0.0 110.985 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 t -87.53 75.04 9.18 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.296 0.57 . . . . 0.0 109.649 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 m -86.25 -55.64 3.82 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.127 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.4 m -82.56 -55.0 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.191 0.519 . . . . 0.0 109.611 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 173.29 142.19 3.77 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.81 115.32 27.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.956 0.407 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.02 -17.22 63.47 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.796 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.16 22.67 1.4 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.659 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.6 t -71.86 158.17 36.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.54 -139.82 6.02 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.057 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -65.08 -16.55 55.72 Favored 'Trans proline' 0 N--CA 1.48 0.689 0 C-N-CA 123.327 2.685 . . . . 0.0 112.869 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -118.87 -61.46 1.64 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.17 149.84 1.75 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.991 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.479 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 72.5 Cg_endo -87.49 -162.97 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.996 2.464 . . . . 0.0 111.082 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 182' ' ' TYR . 4.3 m -63.15 92.73 0.06 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 186' ' ' LEU . 15.1 t -175.91 28.98 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.09 -149.05 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.527 ' HG3' ' OXT' ' A' ' 199' ' ' GLY . 2.7 Cg_exo -77.94 -150.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.277 2.651 . . . . 0.0 111.863 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 57.7 m 54.47 30.07 12.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 123.111 0.564 . . . . 0.0 111.655 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 96.99 -49.7 1.53 Allowed Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.195 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 4.9 m-85 -165.47 -57.87 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 122.808 0.443 . . . . 0.0 110.11 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 175' ' ' PRO . 43.4 Cg_endo -67.43 122.94 10.23 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.232 1.288 . . . . 0.0 109.189 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.35 147.56 15.52 Favored Glycine 0 N--CA 1.407 -3.243 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.447 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.88 10.69 1.91 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.097 3.198 . . . . 0.0 112.127 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 190' ' ' ALA . 1.2 tt -68.48 -66.19 0.6 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.744 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.87 -124.59 7.06 Favored Glycine 0 C--N 1.32 -0.359 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.648 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -71.8 -47.27 33.63 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.607 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -156.3 39.32 0.58 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 186' ' ' LEU . . . 72.84 159.45 0.16 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 123.487 0.715 . . . . 0.0 110.636 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.84 90.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.3 t80 72.76 -57.21 0.64 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.076 0.951 . . . . 0.0 111.272 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 167.28 177.42 38.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -128.77 174.12 9.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -106.64 16.36 24.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.112 0.482 . . . . 0.0 110.312 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 94.17 93.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.284 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -137.85 -41.39 0.54 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.804 0.335 . . . . 0.0 110.639 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 124.12 -3.79 9.03 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.82 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.527 ' OXT' ' HG3' ' A' ' 179' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.82 0 CA-C-O 118.487 -1.174 . . . . 0.0 111.817 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.513 0.197 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.06 161.91 30.63 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.475 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.0 177.75 8.35 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.895 2.397 . . . . 0.0 111.674 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.529 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 95.5 mt-30 -98.54 -5.09 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.596 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.19 -75.85 2.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.527 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.28 59.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.085 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -99.17 -88.66 0.33 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.826 0.346 . . . . 0.0 110.683 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' H ' ' HB2' ' A' ' 4' ' ' GLN . . . 108.9 -158.67 14.51 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.872 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -163.56 177.0 9.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.9 p 52.07 94.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.859 0.864 . . . . 0.0 113.109 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.27 141.59 30.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.812 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.26 -38.4 95.6 Favored Glycine 0 C--O 1.23 -0.149 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.486 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.44 -37.44 85.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.975 0.417 . . . . 0.0 110.831 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 18' ' ' ILE . 12.6 m -66.97 -31.37 71.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.334 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.68 -25.74 29.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.66 -35.41 8.49 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.149 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.5 pp -85.46 -22.42 28.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 14' ' ' SER . 14.9 pt -46.88 -37.31 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 t -84.63 -20.75 30.85 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.679 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -88.0 -34.9 17.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.55 178.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.73 -32.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 92' ' ' SER . 1.7 t-20 -65.59 -24.01 66.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.352 -0.217 . . . . 0.0 111.393 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.11 86.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.742 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.95 -28.03 57.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.13 0.49 . . . . 0.0 110.392 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -82.92 66.83 8.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.75 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.474 1.51 . . . . 0.0 114.537 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' ALA . 6.6 m -59.8 165.72 2.98 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.053 0.541 . . . . 0.0 110.196 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -59.49 -15.18 16.0 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.764 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -53.16 -29.34 31.03 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.38 1.072 . . . . 0.0 113.595 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -114.98 -19.54 10.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.098 0.475 . . . . 0.0 110.176 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -79.64 -43.35 22.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.773 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -160.79 -49.16 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 m -74.3 157.46 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.199 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.4 pt? -61.34 142.62 56.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.187 0.517 . . . . 0.0 111.188 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 ptm85 -62.68 159.34 16.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.209 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p -76.84 111.86 12.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.118 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 80.03 48.32 6.58 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 14.2 p -51.87 141.99 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.142 0.496 . . . . 0.0 111.63 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -76.34 147.41 38.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -65.31 -13.77 59.23 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.847 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -56.51 -38.22 71.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.94 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.76 -43.69 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.975 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.04 -69.42 0.63 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.497 0.189 . . . . 0.0 111.19 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t 74.73 -29.09 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.721 0.809 . . . . 0.0 112.743 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.5 m -66.43 -67.63 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.75 -35.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -80.72 89.96 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.951 0.405 . . . . 0.0 110.428 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 8.9 mm100 -82.75 -48.25 11.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.68 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HE ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 ttp180 -136.69 -1.11 2.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.832 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 131' ' ' VAL . . . 69.37 -51.01 0.61 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 110.588 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.608 ' HB3' ' HE ' ' A' ' 50' ' ' ARG . . . -69.27 128.47 36.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.095 0.474 . . . . 0.0 110.972 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -49.1 -19.71 0.47 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . 0.569 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 44.0 t -63.21 -62.46 1.68 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 118.803 0.728 . . . . 0.0 110.963 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HD3' ' A' ' 50' ' ' ARG . 15.7 tp -87.52 -25.59 23.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 110.589 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.3 -13.89 60.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.85 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 11.4 p -42.71 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -44.32 -38.45 3.92 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.688 0.795 . . . . 0.0 111.852 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.77 12.9 9.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.664 0.269 . . . . 0.0 111.128 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.33 63.73 3.61 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.212 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 50.7 t -88.08 101.71 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -161.78 100.52 1.14 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.444 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.04 -59.37 4.28 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.646 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -62.57 -76.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.146 0.498 . . . . 0.0 111.031 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 12.3 p-10 -86.69 10.93 14.23 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 132' ' ' ASP . 23.4 tp -88.98 -57.7 2.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.332 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.09 54.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 110.186 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -107.71 170.01 8.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 67.8 -61.53 0.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.84 0.456 . . . . 0.0 111.687 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.45 -58.41 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.535 0.334 . . . . 0.0 111.052 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 91.2 t -60.13 -37.23 72.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -70.17 -34.47 73.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.155 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 -43.93 36.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.71 -40.12 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.836 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.6 t -69.58 -6.68 32.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -79.96 -20.71 44.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.919 0.39 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.71 148.42 98.2 Favored Pre-proline 0 C--O 1.24 0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 126.66 15.5 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.468 2.112 . . . . 0.0 112.9 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.99 30.65 5.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.348 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.1 -53.55 17.95 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.124 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.3 p -78.3 -39.91 38.38 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 84' ' ' SER . 6.6 p-10 -170.61 155.77 5.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -81.57 -18.07 46.16 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.554 0.692 . . . . 0.0 109.333 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.524 ' HA ' ' CB ' ' A' ' 88' ' ' GLN . 28.9 t -58.73 -17.29 21.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.546 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.51 -21.99 29.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.836 0.454 . . . . 0.0 111.25 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -80.33 -164.62 0.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 46.86 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.376 0.608 . . . . 0.0 109.406 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.524 ' CB ' ' HA ' ' A' ' 84' ' ' SER . 7.8 tp-100 -77.57 -59.58 2.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.54 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.28 89.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.725 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.52 17.12 1.85 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.544 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 8.6 t -54.93 -40.96 70.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.763 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 23' ' ' ASN . 6.6 t -72.72 -38.83 67.33 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.4 63.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.4 -20.88 31.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB2' HH12 ' A' ' 36' ' ' ARG . 48.0 t80 -87.88 -50.2 6.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.194 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 56.15 87.02 0.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.973 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.03 -5.12 42.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.555 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.64 -5.39 78.53 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.914 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' ' HA2' ' A' ' 193' ' ' GLY . 18.4 t -94.52 -7.44 10.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -84.71 -177.68 6.66 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.634 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 12.5 p-10 -75.05 125.5 29.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.7 -24.58 61.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.367 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -68.29 -29.74 68.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.671 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.488 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 21.2 t30 -59.86 -51.93 67.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.737 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.1 mp -74.52 -37.85 44.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.442 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.72 -34.56 78.11 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.843 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -89.21 -49.14 6.91 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.33 -15.3 5.18 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.085 -1.046 . . . . 0.0 113.453 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -65.65 -75.74 0.39 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.926 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 114' ' ' SER . 16.3 m -67.77 -16.81 64.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 107' ' ' THR . 60.9 mtp180 -86.76 -46.59 9.85 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -83.81 -52.39 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' HG ' ' HA ' ' A' ' 9' ' ' ALA . 7.0 mp -67.59 -33.59 75.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' SER . 72.3 m 45.64 -99.63 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.48 -35.07 60.17 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.289 0.636 . . . . 0.0 112.306 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.53 -52.66 43.35 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.115 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 12.6 mt -72.43 -26.54 61.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 -57.97 -36.93 73.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 109.836 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.96 -43.19 6.07 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.65 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 117' ' ' LEU . 37.3 t -61.0 -42.23 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.7 t -85.17 -39.85 17.38 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.38 -81.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 129' ' ' ILE . . . -69.08 -44.99 71.42 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 48.2 tt0 -70.5 -38.05 74.26 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.131 0.491 . . . . 0.0 111.183 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.73 -40.97 7.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.455 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.66 -22.48 9.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.36 95.38 0.21 Allowed Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.52 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 37' ' ' THR . 15.8 mm -76.76 132.99 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -115.49 132.01 56.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.782 177.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.466 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.5 t -99.11 120.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' HD21 ' A' ' 66' ' ' LEU . 5.9 m-20 -99.98 35.8 1.97 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.515 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 67.3 p -70.82 -8.06 49.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.077 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.1 -19.75 51.5 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.198 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 p -105.98 -46.96 3.97 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 140' ' ' ILE . 54.2 t -66.28 -62.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.538 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.452 ' HA ' HG12 ' A' ' 140' ' ' ILE . 50.0 tt0 -56.3 -39.23 72.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -62.43 -40.35 96.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.78 -47.12 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.905 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.7 pt -57.4 -38.46 62.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.3 p -56.61 -42.14 78.27 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 111.66 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -84.67 -39.76 18.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 0.0 111.05 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.404 ' HA ' HD13 ' A' ' 147' ' ' LEU . 61.6 m -69.69 -39.58 76.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.0 t -71.37 -23.69 61.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.444 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.3 p -87.83 -49.52 7.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 150' ' ' SER . 83.7 m-85 -86.32 -59.47 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 143' ' ' SER . 10.4 mp -61.27 -8.74 4.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -173.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.7 p -90.68 -67.21 0.86 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.995 0.426 . . . . 0.0 111.672 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.414 HG22 ' CE1' ' A' ' 156' ' ' TYR . 12.6 p -131.24 28.25 4.73 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 146' ' ' PHE . 32.8 t -65.93 158.04 29.12 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 m 59.88 -154.34 0.37 Allowed 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -72.09 -51.83 19.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 156' ' ' TYR . 51.9 m -153.77 86.98 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.092 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.53 -62.06 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.9 m -128.96 22.1 5.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 153' ' ' SER . 33.0 p90 -135.69 141.45 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.441 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.7 m 65.67 -65.89 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.931 0.893 . . . . 0.0 112.846 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -71.54 3.19 4.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.25 -27.71 68.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.296 0.57 . . . . 0.0 109.585 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.0 m -148.11 -41.13 0.17 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.015 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 68.16 -61.26 0.39 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.059 0.943 . . . . 0.0 113.286 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 m -75.33 105.36 6.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.926 0.394 . . . . 0.0 111.981 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 p -83.02 -46.82 12.39 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.9 m -69.18 129.36 39.63 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.0 p 55.88 30.01 15.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.41 0.624 . . . . 0.0 111.237 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -149.03 -97.16 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.673 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -101.86 99.79 10.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.557 0.217 . . . . 0.0 110.695 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.52 -15.63 80.58 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.842 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.48 -45.51 59.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.526 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.427 ' HA ' ' CD ' ' A' ' 175' ' ' PRO . 3.5 m 55.57 89.06 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.537 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.0 -144.76 9.86 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.63 -36.79 96.76 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.424 2.083 . . . . 0.0 111.183 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 p -91.19 10.67 26.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.411 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.68 -141.28 5.79 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.427 ' CD ' ' HA ' ' A' ' 170' ' ' THR . 7.7 Cg_exo -74.54 -8.24 20.35 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.833 2.356 . . . . 0.0 112.993 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.6 m 53.39 48.26 22.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.455 0.645 . . . . 0.0 109.627 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.0 t -85.07 147.52 26.62 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.878 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.37 61.77 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.276 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 156' ' ' TYR . 19.6 Cg_endo -58.4 122.14 11.16 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.494 2.13 . . . . 0.0 112.683 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.0 m -75.97 96.36 3.76 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.08 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.448 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -105.55 118.44 55.55 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.21 135.02 48.38 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.506 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.475 ' HA2' ' CA ' ' A' ' 199' ' ' GLY . . . 141.67 -104.76 0.39 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.926 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.23 -19.4 38.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.414 2.076 . . . . 0.0 111.675 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.8 mt 60.63 -82.31 0.02 OUTLIER 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.549 0.739 . . . . 0.0 111.129 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -150.78 48.08 0.58 Allowed Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.68 36.97 12.48 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 119.46 -86.72 0.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . . . 64.93 143.13 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.819 0.848 . . . . 0.0 112.745 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 190' ' ' ALA . 35.1 Cg_endo -96.37 15.92 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.203 2.602 . . . . 0.0 111.931 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -83.96 -68.83 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.815 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 99' ' ' VAL . . . -113.98 63.47 0.3 Allowed Glycine 0 CA--C 1.486 -1.74 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.789 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.413 ' CD ' ' HA ' ' A' ' 191' ' ' PRO . 6.5 pt20 -115.31 6.57 14.95 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.904 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.9 t -139.75 -57.49 0.57 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.429 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -112.07 51.28 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.975 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.59 -53.72 1.01 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.908 0.385 . . . . 0.0 110.785 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 105.41 86.09 1.88 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.475 ' CA ' ' HA2' ' A' ' 184' ' ' GLY . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.808 -0.996 . . . . 0.0 112.411 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.727 0.298 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.49 166.39 25.46 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.569 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HB3' ' HA2' ' A' ' 8' ' ' GLY . 24.2 Cg_exo -66.02 171.15 10.47 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 123.015 2.477 . . . . 0.0 111.973 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.9 mt-30 -101.97 93.72 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.482 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.94 -109.76 2.91 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.885 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.99 59.73 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.018 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -91.48 87.24 6.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.257 0.551 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 3' ' ' PRO . . . -83.13 55.8 5.05 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.847 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.516 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -66.09 103.9 1.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.659 0.383 . . . . 0.0 111.204 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -145.5 -75.38 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.493 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.5 -40.17 0.12 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.99 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.85 -109.77 2.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.04 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -62.96 -18.03 62.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.788 0.327 . . . . 0.0 111.618 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 18' ' ' ILE . 75.8 m -65.34 -21.83 66.74 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.008 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.78 41.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.931 0.396 . . . . 0.0 111.958 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.78 -41.75 8.07 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.1 pp -87.94 -20.62 25.66 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 14' ' ' SER . 12.0 pt -43.39 -47.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 35.4 t -73.06 -20.19 61.03 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 121.267 -0.173 . . . . 0.0 111.101 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 191' ' ' PRO . 50.4 mtt180 -86.32 -32.24 21.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 17' ' ' LEU . 39.3 t -54.15 169.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.115 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.522 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.73 -32.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 31.7 m-80 -60.79 -24.39 65.76 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.63 -53.05 59.84 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.985 0.421 . . . . 0.0 111.332 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 192' ' ' PHE . 30.3 tp -80.91 -25.77 37.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.333 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -75.72 90.36 2.86 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 32' ' ' ARG . 5.2 m-80 -75.3 17.98 0.23 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.7 m -65.8 148.26 52.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.1 m -58.07 -14.54 6.9 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 p -48.5 -35.72 13.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -108.41 -18.25 13.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.197 0.522 . . . . 0.0 110.679 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 27' ' ' ASN . 17.0 mmt180 -76.73 -49.86 15.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -163.45 -29.76 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.4 t -87.49 144.87 8.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.5 145.58 32.77 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -70.59 153.53 42.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -68.84 120.8 15.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.93 37.14 20.04 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.514 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 7.5 p -51.31 148.37 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.153 0.501 . . . . 0.0 111.29 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -93.0 153.93 18.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -65.41 -12.72 55.01 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.422 -178.994 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -48.96 -38.58 23.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.198 0.523 . . . . 0.0 109.979 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.702 HG13 ' N ' ' A' ' 44' ' ' ALA . 3.9 pt -85.12 -44.47 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.907 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.702 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.14 -67.46 0.79 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.7 m 75.95 -18.57 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.808 0.843 . . . . 0.0 112.627 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.1 t -57.14 -96.2 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.88 0.472 . . . . 0.0 112.153 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.35 -23.21 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.371 0.605 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -79.52 98.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.2 mm-40 -73.41 -47.23 43.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.713 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.4 ttm-85 -149.47 9.02 0.71 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.418 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 -53.31 0.57 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.447 0.699 . . . . 0.0 110.982 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -68.54 142.82 55.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.573 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 57' ' ' SER . 4.8 pm0 -55.03 -19.05 6.12 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -175.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -55.55 -71.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.862 0.363 . . . . 0.0 111.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -25.92 23.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.25 -18.39 57.67 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 19.3 t -52.42 106.04 0.14 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.028 0.442 . . . . 0.0 110.516 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.539 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.4 t -165.39 -40.8 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.69 19.47 11.09 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.36 64.23 1.12 Allowed Glycine 0 C--N 1.316 -0.554 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.795 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.02 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -163.46 13.46 0.06 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.879 0.847 . . . . 0.0 109.461 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.87 -50.74 0.61 Allowed Glycine 0 C--N 1.294 -1.794 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.159 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.34 -55.23 37.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 120.782 0.325 . . . . 0.0 110.551 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.63 -41.79 16.01 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.482 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.58 -58.27 7.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.396 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 -5.74 59.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -128.25 -86.04 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -57.89 -31.91 67.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.48 -52.04 15.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 111.131 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 9.2 p -69.04 -40.77 81.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 75.1 mt-30 -62.91 -39.15 93.66 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.358 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.71 71.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.96 0.41 . . . . 0.0 111.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 77' ' ' LEU . 39.7 t -86.36 -32.37 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.002 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -70.81 -23.27 62.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.164 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 24.7 mmt180 -85.18 1.65 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.776 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 86' ' ' TYR . 77.0 mt -85.52 154.64 59.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.019 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -52.52 160.49 3.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.993 2.462 . . . . 0.0 112.624 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.12 -148.62 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.53 -37.64 1.28 Allowed Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.3 m -56.55 -29.91 62.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.222 0.511 . . . . 0.0 111.804 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.45 -23.43 10.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.289 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -63.21 -41.44 99.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 m -69.31 -23.74 63.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.246 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -22.65 50.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.595 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.54 ' CE2' HD13 ' A' ' 77' ' ' LEU . 18.3 m-30 -85.29 -164.71 1.04 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.359 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -72.55 53.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.237 0.615 . . . . 0.0 111.352 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -90.6 -59.2 2.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.117 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.26 -26.27 30.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.657 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.3 m-85 -83.51 6.68 19.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.528 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.3 m -52.84 -31.44 39.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.425 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 73.6 m -61.22 -47.68 84.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.54 32.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.789 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 84.0 mt -85.15 -32.19 22.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -84.85 -36.52 21.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.769 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.01 86.47 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 112.022 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.04 56.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.755 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.9 -13.63 42.46 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.73 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.546 ' CG1' ' HA2' ' A' ' 193' ' ' GLY . 5.1 t -84.17 -1.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.612 0.72 . . . . 0.0 110.434 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.15 179.32 6.41 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.896 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.78 141.19 30.68 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.529 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.21 -23.64 57.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.814 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m -69.05 -34.78 75.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.469 0.652 . . . . 0.0 110.386 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.59 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 31.5 t30 -60.21 -51.71 68.41 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.487 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.61 -33.9 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.22 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.86 -48.41 76.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.966 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 71.1 m -73.1 -56.54 4.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -174.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.3 pp -102.18 -24.37 13.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.067 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.28 -65.91 2.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.274 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -65.61 -28.18 68.94 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 107' ' ' THR . 11.5 mpt_? -86.57 -55.31 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.54 -48.77 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.13 -42.64 65.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.6 m 48.46 -95.09 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.6 -33.28 54.38 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.206 0.602 . . . . 0.0 112.031 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD22 ' HB1' ' A' ' 9' ' ' ALA . 60.7 tp -62.19 -53.59 53.04 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.503 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 13.7 mt -66.6 -28.34 68.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.777 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -59.49 -43.99 93.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.963 0.411 . . . . 0.0 110.038 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.24 -31.73 41.31 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.98 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 124' ' ' ALA . 69.4 t -68.43 -38.9 79.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 122.863 -0.198 . . . . 0.0 111.269 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 64.9 m -57.55 -41.95 82.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.845 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -83.85 -39.24 20.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.94 -80.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -64.22 -55.61 20.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -175.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 70.0 mt-30 -70.12 -29.23 66.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.197 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.68 -64.73 2.01 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.091 -0.575 . . . . 0.0 114.185 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.7 mt -104.35 -23.78 13.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.859 0.362 . . . . 0.0 111.656 -175.192 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.94 97.72 1.12 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.422 HG23 ' CB ' ' A' ' 52' ' ' ALA . 30.1 mm -75.37 129.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -127.84 131.92 49.46 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.962 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.97 118.31 50.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.471 0.653 . . . . 0.0 111.405 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -97.63 43.97 1.06 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.455 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 21.0 p -78.62 1.14 23.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 120.855 0.36 . . . . 0.0 111.256 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.36 -21.96 29.28 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.567 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.2 t -106.0 -58.67 1.88 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 122.927 -0.16 . . . . 0.0 111.285 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -50.63 -51.97 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 137' ' ' GLN . 8.3 tt0 -61.76 -44.44 96.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -60.69 -46.78 89.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.952 0.406 . . . . 0.0 110.302 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -62.8 -51.1 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.578 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 136' ' ' VAL . 39.4 pt -69.32 -38.09 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -63.05 -52.35 63.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.465 0.174 . . . . 0.0 111.316 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.9 p -62.85 -43.34 99.04 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -65.18 -40.52 94.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.311 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 m -77.53 -19.52 55.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.144 0.497 . . . . 0.0 110.946 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -81.61 -60.49 2.23 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.85 0.357 . . . . 0.0 110.857 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.98 -46.2 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.2 mt -85.7 -4.42 59.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -54.27 -54.19 43.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 111.173 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.5 m -146.31 83.93 1.63 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.127 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.6 t -85.04 121.56 27.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.95 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p 51.39 -95.95 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.904 . . . . 0.0 112.269 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -134.14 -17.93 2.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.354 0.597 . . . . 0.0 109.782 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . 45.1 m -153.21 145.87 24.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.353 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.41 77.39 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.3 m -85.72 -1.76 57.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.0 t80 67.65 -59.5 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.876 0.87 . . . . 0.0 112.791 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.7 m -58.46 -22.07 53.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.908 0.483 . . . . 0.0 111.556 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 153' ' ' SER . 84.0 mt-30 -66.02 -44.61 84.2 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 161' ' ' ALA . . . 40.22 75.73 0.08 Allowed 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.164 0.986 . . . . 0.0 112.258 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.4 p 65.71 -24.12 0.09 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.385 1.474 . . . . 0.0 113.187 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 159' ' ' ALA . . . 57.72 -165.91 0.15 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.163 0.585 . . . . 0.0 110.674 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.4 t -130.82 82.75 2.07 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.146 0.498 . . . . 0.0 109.901 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.5 m -64.85 -14.28 58.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.165 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.0 m -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.444 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.4 t -102.32 -8.16 21.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.354 0.597 . . . . 0.0 109.677 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 117.56 125.25 3.57 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.49 -43.48 66.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 111.733 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.68 -59.25 3.79 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.234 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -63.73 -25.98 68.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.948 0.404 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 m -153.53 113.24 3.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.024 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.48 -54.33 32.67 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.932 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.56 83.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.048 2.499 . . . . 0.0 113.88 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 190' ' ' ALA . 39.3 t 69.91 -13.51 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.92 0.888 . . . . 0.0 113.278 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.43 174.33 14.79 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.147 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.44 83.76 2.16 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.143 2.562 . . . . 0.0 113.137 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 t 58.78 28.77 17.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.468 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 t -78.13 -5.06 50.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.227 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.414 ' HA2' ' HD3' ' A' ' 179' ' ' PRO . . . -92.95 153.41 21.48 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' A' ' 178' ' ' GLY . 4.1 Cg_exo -77.62 123.95 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.406 2.071 . . . . 0.0 112.044 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.2 p -83.96 -75.4 0.34 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.818 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -112.87 63.41 0.29 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -139.26 153.95 71.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.64 128.86 30.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.609 2.206 . . . . 0.0 110.82 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.19 74.44 0.89 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.78 -153.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.238 2.625 . . . . 0.0 112.419 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 186' ' ' LEU . 1.1 pt? -52.56 120.58 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -86.35 41.24 3.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.0 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.02 -25.44 14.12 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.06 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.07 -51.51 44.35 Favored Glycine 0 C--O 1.238 0.382 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.276 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 186' ' ' LEU . . . -67.82 148.17 98.5 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-O 120.435 0.16 . . . . 0.0 110.604 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 194' ' ' GLN . 28.0 Cg_endo -97.19 17.5 0.59 Allowed 'Trans proline' 0 N--CA 1.435 -1.959 0 C-N-CA 123.091 2.527 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 93.5 t80 -69.5 -73.29 0.16 Allowed 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.018 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 99' ' ' VAL . . . -98.09 38.11 3.22 Favored Glycine 0 CA--C 1.5 -0.887 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 191' ' ' PRO . 5.0 pt20 -54.83 -43.46 73.01 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 40.2 m -79.09 1.9 22.57 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.27 34.02 6.93 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.148 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 99' ' ' VAL . 70.4 m-85 -119.79 153.57 35.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.94 -75.87 2.15 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.978 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.445 0 CA-C-O 118.689 -1.062 . . . . 0.0 111.068 179.606 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.62 129.03 7.53 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.945 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.78 144.61 49.08 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.546 2.164 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -92.55 98.36 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.046 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.42 27.9 70.23 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.91 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.59 -10.32 56.07 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.183 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.96 109.06 20.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.759 0.314 . . . . 0.0 110.486 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.85 -161.71 18.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.093 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.83 -172.66 3.37 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.514 0.197 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.1 p 61.2 104.06 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.893 1.277 . . . . 0.0 113.014 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.62 155.38 22.62 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.195 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.0 -45.45 20.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.242 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.84 90.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.976 0.388 . . . . 0.0 111.211 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.7 m -60.22 -28.6 68.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.754 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.11 -21.44 22.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.93 -39.42 7.51 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.407 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.1 pp -85.98 -25.46 26.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' SER . 14.1 pt -45.38 -50.34 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 14.1 m -84.78 -18.74 34.08 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.699 0.285 . . . . 0.0 111.586 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.74 -24.24 28.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -78.71 -106.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -77.97 -50.14 12.74 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' HD22 ' A' ' 31' ' ' LEU . 19.6 m-80 -60.51 -21.42 62.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.13 -40.83 77.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.176 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.14 -37.05 15.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.255 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -79.41 83.02 5.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 18.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.853 0.861 . . . . 0.0 113.069 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 26' ' ' ALA . 2.3 m -62.38 164.85 6.68 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.432 0.634 . . . . 0.0 111.346 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.1 t -65.45 -14.92 62.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.896 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -48.13 -44.03 31.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.742 0.817 . . . . 0.0 112.838 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -99.15 -19.86 16.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.496 0.665 . . . . 0.0 109.8 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -70.64 -53.39 15.99 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.761 -174.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -167.16 -24.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.93 141.39 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 35' ' ' LEU . 1.9 pt? -54.72 150.03 10.23 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 111.91 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.49 163.49 26.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.169 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 131' ' ' VAL . 18.4 p -77.12 147.4 36.61 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.1 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 131' ' ' VAL . . . 73.71 24.38 74.59 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.313 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.8 165.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.76 0.424 . . . . 0.0 110.782 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.9 m -134.95 165.04 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.147 -0.346 . . . . 0.0 111.525 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.4 pp0? -66.77 -12.54 59.18 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' A' ' 116' ' ' LEU . 82.9 mm-40 -53.44 -38.8 63.87 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -86.63 -44.11 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -81.89 -65.25 1.03 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.614 0.245 . . . . 0.0 111.362 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m 81.81 -19.02 0.44 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.911 0.884 . . . . 0.0 112.152 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -70.91 -90.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.005 0.431 . . . . 0.0 111.705 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.61 -19.69 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.404 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.38 81.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.169 0.509 . . . . 0.0 110.105 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 1.8 mp0 -64.41 -48.93 73.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.231 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 46.4 ttm-85 -148.31 4.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.061 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . 67.63 -51.3 0.51 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -175.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -67.46 140.82 57.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.375 0.607 . . . . 0.0 110.857 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.6 mt-30 -59.52 -17.5 32.56 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.415 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -62.35 -74.06 0.1 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.848 0.356 . . . . 0.0 111.747 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.581 HD13 ' HE ' ' A' ' 50' ' ' ARG . 9.0 tt -87.22 -25.03 24.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.653 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.22 -19.51 43.06 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -50.06 108.11 0.2 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -150.02 -41.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.738 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.4 mt -118.22 19.33 13.54 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.338 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.48 56.34 1.27 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.811 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 53' ' ' GLN . 2.9 t -90.23 104.09 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -156.18 15.14 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.08 -37.37 2.16 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.026 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -54.49 -74.0 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.44 0.296 . . . . 0.0 111.458 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.5 p-10 -81.11 -20.83 40.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.013 0.435 . . . . 0.0 110.216 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.5 -55.05 35.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.655 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 133' ' ' SER . . . -82.79 1.66 37.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -126.08 -87.55 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -57.35 -38.43 74.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.47 92.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.958 0.409 . . . . 0.0 110.824 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.35 -46.26 71.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.13 -40.38 81.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.655 0.264 . . . . 0.0 111.584 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.04 88.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.835 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.598 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.2 t -85.31 -17.69 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.005 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -93.35 -19.6 21.18 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 121.946 -0.471 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -118.55 22.46 12.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.491 0.662 . . . . 0.0 110.744 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -73.39 158.21 86.92 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.106 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.94 128.04 11.99 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.874 1.716 . . . . 0.0 111.224 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.75 70.83 10.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.91 -57.32 2.87 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.741 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 p -81.89 -6.18 58.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.431 0.157 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 87.25 149.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.55 1.14 . . . . 0.0 110.487 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.423 HG22 HE22 ' A' ' 88' ' ' GLN . 4.1 m -60.34 -37.58 81.08 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.442 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 79.2 p -71.34 -32.02 68.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.63 -20.13 59.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.113 0.482 . . . . 0.0 111.483 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.509 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 4.2 m-85 -69.45 -165.71 0.08 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.468 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.62 17.62 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 77.7 mt-30 -88.89 -55.45 3.69 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.364 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -72.41 -40.96 66.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.302 0.572 . . . . 0.0 109.592 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.7 m-85 -81.64 16.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.082 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -51.63 -57.2 9.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.2 m -55.12 -36.68 66.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.93 -39.15 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 18.9 mt -81.9 -30.32 31.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.825 0.345 . . . . 0.0 111.68 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -85.06 -28.56 25.58 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.3 t30 52.77 84.28 0.06 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.81 -7.45 57.87 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.128 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.18 -11.93 40.67 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.035 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 t -78.53 -8.54 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.53 -171.42 3.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.487 -177.088 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.07 129.41 42.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.29 61.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.14 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -67.9 -32.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.529 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 11.5 t30 -62.7 -54.01 45.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -69.06 -35.96 71.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.384 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.86 -30.81 67.31 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.709 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.1 m -92.74 -34.55 13.87 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 2.2 pp -137.47 -29.61 0.87 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.812 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -53.17 -68.56 1.56 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.987 -0.625 . . . . 0.0 114.326 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 114' ' ' SER . 8.1 m -60.89 -20.6 62.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.714 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -88.14 -54.59 4.14 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.356 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.59 -45.89 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.812 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.4 mm? -81.5 -29.87 33.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 110' ' ' SER . 35.3 t 44.7 -96.68 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.39 68.31 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.908 0.483 . . . . 0.0 111.8 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 39.5 tp -65.32 -60.12 3.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.69 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.57 -29.26 68.58 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.57 -43.85 93.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.788 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 -37.13 28.66 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.999 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 124' ' ' ALA . 63.1 t -68.65 -41.11 82.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 8.1 t -55.73 -46.52 77.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.076 0.465 . . . . 0.0 111.201 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -74.66 -49.56 20.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.108 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.41 -70.88 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.646 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -73.59 -47.6 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 121' ' ' SER . 32.5 tt0 -68.64 -35.49 77.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.055 0.455 . . . . 0.0 110.428 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.62 -71.32 1.28 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.77 -0.65 . . . . 0.0 114.034 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.43 -24.16 23.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.816 0.341 . . . . 0.0 111.371 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.49 92.92 0.98 Allowed Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.191 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.518 HG23 ' CB ' ' A' ' 52' ' ' ALA . 20.7 mm -78.17 129.6 37.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -108.9 131.14 55.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.486 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 51' ' ' ALA . 7.3 m -98.73 90.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.04 0.924 . . . . 0.0 111.14 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.57 46.01 1.02 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.279 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.3 m -68.37 -6.05 22.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.566 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 -23.42 30.18 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.122 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -105.55 -31.99 8.7 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.548 HG11 ' CG2' ' A' ' 131' ' ' VAL . 40.6 t -67.27 -57.18 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.712 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 40.5 tt0 -50.5 -53.36 30.53 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.46 0.475 . . . . 0.0 111.804 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -54.23 -37.73 64.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.171 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.58 -47.0 10.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.652 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.5 pt -64.99 -39.17 84.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.8 p -61.91 -49.07 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.429 . . . . 0.0 110.67 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.2 m -65.63 -28.95 69.48 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.329 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.1 t -89.06 -20.37 24.44 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.7 p -64.64 -19.18 65.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 p -56.61 -23.99 44.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.098 0.475 . . . . 0.0 111.181 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -72.97 -10.22 59.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.18 -32.4 73.46 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.206 0.527 . . . . 0.0 110.398 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.3 m -70.01 -10.52 58.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.083 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.2 m 78.67 90.79 0.06 Allowed 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.594 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.9 t -96.36 8.58 43.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.225 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 p -85.91 -175.36 5.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.282 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.5 m -71.34 -18.09 62.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.797 0.332 . . . . 0.0 111.533 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 158' ' ' GLN . 18.2 m -59.44 -32.89 70.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.94 71.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.9 p -85.31 41.46 0.89 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.807 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 62.61 14.96 7.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.565 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.5 t -71.45 -24.38 62.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.089 0.471 . . . . 0.0 109.807 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 8.4 pt20 -71.44 -62.22 1.49 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.095 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 158' ' ' GLN . . . 53.94 23.11 3.73 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.211 0.604 . . . . 0.0 111.962 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' HG3' ' A' ' 179' ' ' PRO . 9.2 t 56.57 79.54 0.18 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.253 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.52 134.34 55.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.388 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.9 m -83.42 44.35 0.95 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.0 m -65.57 -21.46 66.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.223 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.1 m -62.97 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.4 m -79.46 -19.41 49.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.016 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 179.75 116.79 0.52 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.711 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.13 150.05 32.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.646 0.26 . . . . 0.0 110.513 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.24 -61.1 1.5 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.456 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.13 107.08 9.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' CD ' ' A' ' 175' ' ' PRO . 14.6 t -110.76 164.06 13.14 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.134 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.82 -162.92 29.89 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.009 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.31 115.82 3.54 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.027 2.485 . . . . 0.0 111.772 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.6 t 69.0 20.53 7.75 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.32 -116.58 0.7 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.569 ' CD ' ' HA ' ' A' ' 170' ' ' THR . 31.9 Cg_exo -63.47 155.26 63.52 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.196 1.931 . . . . 0.0 110.853 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 60.95 2.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.246 0.546 . . . . 0.0 111.241 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.3 t -103.9 149.19 25.32 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.66 70.26 1.25 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.309 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HG3' ' HA ' ' A' ' 160' ' ' SER . 19.3 Cg_exo -67.63 155.65 69.23 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.859 2.373 . . . . 0.0 112.747 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.6 m -76.74 28.48 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.418 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.46 84.84 1.57 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.459 ' O ' ' HD2' ' A' ' 185' ' ' PRO . 95.3 m-85 68.39 91.0 0.08 OUTLIER Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 123.215 0.606 . . . . 0.0 110.875 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.69 124.72 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.059 1.84 . . . . 0.0 111.496 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 154.65 -63.9 0.34 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.412 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 182' ' ' TYR . 38.2 Cg_endo -65.18 173.09 6.55 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.531 2.154 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 190' ' ' ALA . 73.0 mt -83.09 81.41 8.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.95 0.405 . . . . 0.0 111.289 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.44 123.15 11.5 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.022 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 64.89 22.35 68.4 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.169 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.18 -35.48 4.43 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 186' ' ' LEU . . . 67.28 155.36 0.14 Allowed Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 123.766 0.826 . . . . 0.0 111.958 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.26 106.03 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.283 1.989 . . . . 0.0 111.587 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 68.21 -72.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.497 0.719 . . . . 0.0 111.554 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.98 112.16 0.27 Allowed Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.052 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 61.2 mt-30 -65.17 140.26 58.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 73.7 m -83.73 59.83 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.47 44.8 Favored Glycine 0 CA--C 1.502 -0.759 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.631 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -75.39 -38.41 59.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -164.85 25.87 0.18 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.842 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.08 0 CA-C-O 117.949 -1.473 . . . . 0.0 110.938 -179.753 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.653 0.263 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.69 -84.13 0.12 Allowed Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.89 100.09 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.414 2.076 . . . . 0.0 111.088 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.86 153.95 18.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.15 98.0 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.639 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.27 -15.7 20.32 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -139.51 76.46 1.57 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.15 92.4 1.56 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.831 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -174.44 2.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.5 0.19 . . . . 0.0 110.943 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.686 ' H ' HD13 ' A' ' 113' ' ' LEU . 61.7 p 62.48 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.9 1.28 . . . . 0.0 112.901 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.56 153.54 24.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.179 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.77 -50.9 58.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.59 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.91 87.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' ILE . 67.4 m -62.78 -24.62 67.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.67 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.91 -33.03 10.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 3.4 pp -84.48 -19.26 33.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' SER . 18.3 pt -30.77 -56.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.3 m -84.53 -20.04 32.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -86.29 -44.58 12.0 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.679 HG11 ' HB3' ' A' ' 100' ' ' LEU . 15.9 t -59.02 -97.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -171.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.26 -48.62 13.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -65.45 -25.11 67.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -67.85 -39.62 83.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.353 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -71.92 -33.7 68.47 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.922 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.64 69.19 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.892 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 3.1 t-20 64.49 8.58 4.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.736 0.814 . . . . 0.0 112.031 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 29' ' ' SER . 1.9 m -72.43 172.83 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 28' ' ' THR . 33.1 m -63.24 -15.68 57.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -54.5 -22.52 13.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.026 0.93 . . . . 0.0 113.433 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.4 pt? -120.53 -21.86 6.63 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.209 0.528 . . . . 0.0 110.393 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -79.66 -37.69 35.36 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 34' ' ' VAL . 9.9 t -164.58 -26.12 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.444 HG23 HG23 ' A' ' 33' ' ' THR . 87.7 t -99.76 141.23 17.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.72 163.18 5.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.553 ' HG2' ' HB1' ' A' ' 87' ' ' ALA . 4.3 ptm180 -69.42 141.84 53.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.447 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -68.46 124.6 24.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.88 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 85.08 29.78 27.4 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.587 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.78 145.74 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 20.4 t -104.65 166.33 10.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 112.024 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 51.5 tt0 -73.23 -14.93 61.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.189 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.37 -48.79 65.37 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD11 ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -85.72 -47.79 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.12 175.154 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . . . -58.08 -32.02 67.65 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m 72.18 -38.84 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -71.09 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.61 -19.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.671 HG22 ' HB1' ' A' ' 70' ' ' ALA . 46.1 t -62.34 82.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 116.905 -0.134 . . . . 0.0 111.321 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 40' ' ' SER . 47.8 mm-40 -63.58 -43.95 95.49 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.154 0.502 . . . . 0.0 110.35 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.668 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 20.0 ttm180 -157.25 0.47 0.12 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.48 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.98 -53.18 0.46 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.402 0.681 . . . . 0.0 110.756 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.32 133.98 55.85 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.956 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 18.2 mp0 -59.21 -18.17 34.31 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.372 0.669 . . . . 0.0 112.759 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.8 t -55.89 -68.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.668 HD22 ' CZ ' ' A' ' 50' ' ' ARG . 4.0 tp -87.74 -30.1 20.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.243 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -65.61 -18.7 65.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 18.1 t -64.56 83.71 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 59' ' ' LEU . 8.9 t -136.29 -37.24 0.71 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.024 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' THR . 1.2 pp -123.2 13.48 9.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.34 49.08 2.08 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.084 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 39.6 t -89.26 118.56 34.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.513 0.197 . . . . 0.0 110.86 176.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.94 21.64 1.6 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.977 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.42 -31.4 6.0 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.986 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 13.9 p-10 -52.47 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.997 0.919 . . . . 0.0 111.786 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 8.3 p30 -86.97 26.16 1.2 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.971 0.415 . . . . 0.0 110.243 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 5.6 tt -88.02 -78.19 0.33 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.177 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.93 74.71 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.66 160.76 16.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 69.53 -62.62 0.41 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.016 0.527 . . . . 0.0 111.787 -177.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.671 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -62.65 -62.64 1.6 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -63.59 -38.81 83.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.671 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 85.8 mt-30 -63.46 -32.32 73.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.921 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.54 -40.94 22.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.686 0.279 . . . . 0.0 111.614 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.2 -35.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.185 0.516 . . . . 0.0 111.094 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -78.11 -4.89 49.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.282 0.563 . . . . 0.0 110.25 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 47.5 ttp180 -90.0 -6.77 55.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.592 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.88 140.68 89.97 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.859 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -52.34 128.5 27.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.789 2.326 . . . . 0.0 111.616 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.04 84.79 2.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.644 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.68 -55.43 5.44 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -87.17 -53.74 4.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 178.68 174.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.569 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 m -81.2 -47.69 13.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -64.85 -16.44 63.16 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.34 11.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.61 ' HD1' ' N ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -58.61 -46.24 87.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.61 ' N ' ' HD1' ' A' ' 86' ' ' TYR . . . -88.14 -17.87 30.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.894 0.378 . . . . 0.0 111.397 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.58 -45.44 90.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.337 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.45 -62.51 1.63 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.271 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 61.4 m-85 -84.27 32.94 0.49 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.801 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 p -54.82 -61.5 2.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -68.59 -38.37 80.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' O ' HD21 ' A' ' 117' ' ' LEU . . . -64.69 -39.86 94.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 36.5 mt -83.77 -34.33 24.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -76.22 -47.04 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.335 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.517 ' ND2' HG12 ' A' ' 105' ' ' ILE . 37.9 t-20 57.21 92.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.983 0.802 . . . . 0.0 111.119 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.41 -2.15 48.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.6 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.03 -13.47 31.62 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.733 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 196' ' ' GLY . 12.0 t -80.46 -8.95 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.64 0.734 . . . . 0.0 109.921 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -84.4 -179.23 7.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.257 -176.284 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -77.26 113.83 15.43 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.549 179.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.39 64.27 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.717 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -41.32 77.86 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.414 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 2.7 t-20 -62.14 -33.23 74.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.715 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.517 HG12 ' ND2' ' A' ' 96' ' ' ASN . 1.5 mp -78.15 -43.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.541 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.57 -19.02 56.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.459 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -84.31 -55.48 4.15 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.015 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 3.3 pp -123.47 -32.57 3.36 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -50.33 -75.21 0.22 Allowed Glycine 0 C--O 1.223 -0.541 0 C-N-CA 121.596 -0.335 . . . . 0.0 113.772 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.5 m -62.4 -18.37 61.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.796 0.331 . . . . 0.0 111.841 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -81.0 -54.27 5.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.447 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.02 -40.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.994 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.686 HD13 ' H ' ' A' ' 10' ' ' THR . 3.3 mm? -70.08 -16.68 63.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.6 p 45.44 -118.24 0.71 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.918 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.8 69.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 120' ' ' VAL . 11.6 tp -59.38 -62.88 1.55 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.519 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 117' ' ' LEU . 15.8 mt -71.9 -29.99 64.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.564 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -61.19 -40.23 93.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.284 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.92 -32.63 56.6 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.661 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 124' ' ' ALA . 54.2 t -68.51 -35.99 72.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.651 -0.323 . . . . 0.0 110.962 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 59.0 m -53.03 -47.36 68.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.1 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 p -80.85 -43.25 20.25 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.79 -72.51 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.651 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.24 -50.43 32.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' SER . 45.4 tt0 -64.62 -35.87 82.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.054 0.454 . . . . 0.0 110.769 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.21 -53.37 3.14 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.9 -0.667 . . . . 0.0 114.618 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.5 mt -105.48 -24.12 12.68 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.9 94.5 0.73 Allowed Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.879 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.558 HG13 ' HD3' ' A' ' 50' ' ' ARG . 30.1 mm -77.87 141.12 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.253 0.549 . . . . 0.0 112.429 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -123.23 152.13 41.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.73 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 46.3 t -107.88 163.31 5.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 131' ' ' VAL . 35.8 t70 -58.8 160.05 6.19 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.508 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 15.4 m -74.64 29.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.11 -87.17 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -106.23 -48.47 3.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.818 0.342 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 140' ' ' ILE . 45.1 t -52.15 -63.16 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -172.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 36.5 tt0 -62.59 -41.21 98.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -60.1 -44.0 95.17 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.083 0.468 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.87 -51.99 14.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.924 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 136' ' ' VAL . 34.4 pt -62.01 -34.47 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -64.74 -47.8 76.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 0.0 110.752 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -34.93 71.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.362 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.4 t -67.88 -56.59 8.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.875 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.5 p -51.16 -30.3 16.36 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.2 m -62.14 -56.38 19.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -89.0 -40.66 12.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 111.891 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 4.3 mm? -74.0 9.88 1.39 Allowed 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.62 0.768 . . . . 0.0 112.885 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.0 t -46.62 -46.93 20.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.358 0.599 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.493 ' HB ' ' NE2' ' A' ' 158' ' ' GLN . 7.4 m -161.01 81.71 0.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.8 t -84.75 121.94 28.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.115 0.484 . . . . 0.0 111.175 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -172.53 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.007 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.9 p -137.96 -150.59 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -62.15 101.53 0.23 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.66 89.1 0.72 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.659 0.743 . . . . 0.0 111.486 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -173.98 -160.57 0.11 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.61 -1.177 . . . . 0.0 107.945 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -66.15 -19.93 65.99 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 t -56.37 -41.19 75.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.065 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.493 ' NE2' ' HB ' ' A' ' 149' ' ' THR . 12.7 pt20 -96.92 9.26 42.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 111.166 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.38 139.43 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.653 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.4 m 60.29 22.64 12.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.319 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 176' ' ' SER . . . -73.52 111.37 8.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.082 0.468 . . . . 0.0 110.328 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.4 m -110.47 169.63 8.62 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.433 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -74.58 -1.02 19.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.843 0.354 . . . . 0.0 111.379 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.1 m -60.78 -25.1 66.29 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.595 0.758 . . . . 0.0 111.402 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.1 m -72.46 -7.3 49.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.931 0.396 . . . . 0.0 110.852 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.8 60.19 0.66 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.626 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -123.03 105.09 9.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.84 0.352 . . . . 0.0 111.045 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -94.87 -20.07 29.62 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.622 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 53.1 t80 -87.43 95.17 9.92 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.4 p -124.8 172.03 9.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.829 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 142.48 -162.0 27.32 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.64 -19.08 60.01 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.766 2.311 . . . . 0.0 111.377 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.5 p -144.2 84.13 1.75 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.256 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -139.63 -113.76 1.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.622 ' HD3' ' O ' ' A' ' 169' ' ' TYR . 88.0 Cg_endo -81.2 172.69 12.53 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.313 2.009 . . . . 0.0 111.171 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 40.1 p -81.05 86.45 6.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.3 t -119.0 156.94 28.73 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.33 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.497 ' N ' ' HD3' ' A' ' 179' ' ' PRO . . . 63.24 56.73 18.55 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.014 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 178' ' ' GLY . 5.6 Cg_exo -77.9 105.4 2.01 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.556 2.171 . . . . 0.0 112.259 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.6 m -74.89 135.02 41.53 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.901 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 142.4 -23.73 2.36 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.816 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -129.71 162.9 50.47 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 122.605 -0.35 . . . . 0.0 111.082 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.59 125.77 20.11 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.082 2.521 . . . . 0.0 112.464 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.94 61.9 2.94 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.302 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.08 -18.09 56.04 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 111.986 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.36 82.07 5.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.058 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -136.72 149.15 20.07 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.777 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 87.57 -93.29 1.87 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.742 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -138.1 121.74 2.28 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -140.42 158.79 65.5 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.99 146.47 16.91 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.878 2.385 . . . . 0.0 112.349 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -91.02 21.91 3.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.813 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -128.88 59.77 0.68 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -102.75 147.33 26.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -149.95 7.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 99' ' ' VAL . . . -175.33 72.88 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -110.61 143.14 41.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.948 0.404 . . . . 0.0 111.09 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.79 77.98 2.05 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.791 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.201 0 CA-C-O 118.417 -1.213 . . . . 0.0 111.934 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.96 153.77 21.41 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.745 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.02 130.69 9.55 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.541 2.161 . . . . 0.0 110.921 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.91 94.23 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.993 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.28 -75.99 0.63 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.698 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.17 28.18 1.97 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -123.56 105.35 9.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.886 0.374 . . . . 0.0 111.732 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.4 81.53 0.76 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' HG3' ' A' ' 42' ' ' GLN . . . -72.73 93.9 1.71 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.38 138.03 10.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.617 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.59 96.89 2.25 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.896 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.1 -51.45 50.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.824 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB3' HD22 ' A' ' 108' ' ' LEU . . . -72.28 -10.98 60.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.796 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 18' ' ' ILE . 20.3 m -78.55 -22.18 47.63 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.552 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -55.43 -30.44 60.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.15 -38.93 24.8 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.432 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -32.29 22.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' SER . 19.9 pt -47.79 -47.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 11.7 m -70.83 -24.58 62.56 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.68 0.276 . . . . 0.0 111.599 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -87.56 -24.37 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.882 0.372 . . . . 0.0 111.576 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 17' ' ' LEU . 84.3 t -59.92 173.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.51 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -37.45 -33.51 0.07 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.753 1.221 . . . . 0.0 114.189 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.19 -23.0 61.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.58 -38.17 86.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.9 -41.95 12.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.31 69.54 7.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HB3' ' CG ' ' A' ' 146' ' ' PHE . 2.8 t-20 -68.41 19.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.4 1.08 . . . . 0.0 112.39 -175.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 24.2 m -55.98 161.52 2.27 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 123.556 0.743 . . . . 0.0 111.482 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -52.69 -19.51 2.45 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 p -51.79 -44.83 63.6 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.895 . . . . 0.0 113.253 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -100.09 -20.23 16.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.375 0.607 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 1.2 tpt180 -66.72 -56.14 11.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.301 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -163.85 -34.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.859 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.62 146.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.89 139.86 57.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.105 0.478 . . . . 0.0 110.849 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 48.7 ptt85 -63.57 157.37 23.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.166 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.03 112.21 4.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.894 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' H ' HG22 ' A' ' 131' ' ' VAL . . . 90.71 35.72 7.16 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.687 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.9 p -45.12 143.6 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.44 0.696 . . . . 0.0 112.415 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.2 p -82.13 139.81 34.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.077 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.0 pt20 -59.55 -14.12 11.91 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.44 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 9' ' ' ALA . 11.7 mm100 -65.04 -32.02 73.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.746 0.307 . . . . 0.0 111.216 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.01 -34.08 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.413 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . -84.0 -76.94 0.28 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.567 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m 75.21 -18.92 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.838 0.855 . . . . 0.0 111.629 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 44' ' ' ALA . 16.8 p -68.04 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.296 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.56 -32.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.5 p -79.15 89.43 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 121.931 0.872 . . . . 0.0 110.795 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 10.9 mm100 -82.53 -43.49 17.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.021 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -133.88 -4.82 2.81 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.497 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.61 -50.12 0.66 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.305 0.642 . . . . 0.0 112.722 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.42 -90.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 12.1 pt20 -172.74 -45.15 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 179.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -50.31 -62.11 1.78 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 tt -86.06 -23.64 26.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.415 0.626 . . . . 0.0 110.138 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' THR . . . -76.98 -17.92 58.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 p -62.72 65.33 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.528 0.68 . . . . 0.0 112.724 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.496 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.9 t -102.5 -37.32 8.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 58' ' ' THR . 81.2 mt -121.76 19.16 11.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 65.33 1.57 Allowed Glycine 0 C--O 1.217 -0.968 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.24 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.572 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.9 t -90.07 110.17 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.98 0.419 . . . . 0.0 109.979 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -141.77 18.0 2.16 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.41 -34.71 4.3 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.09 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.3 -70.53 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 110.375 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 26.7 p-10 -86.04 18.88 2.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.454 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.7 tt -88.14 -74.41 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.529 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.41 -27.25 66.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -111.71 162.88 14.75 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 66.82 -61.74 0.32 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.85 -61.54 2.11 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.761 0.315 . . . . 0.0 110.73 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.76 -35.77 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -69.88 -21.37 63.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.446 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -42.85 29.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.83 0.348 . . . . 0.0 110.152 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 27.3 t -78.23 -33.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -70.97 -18.11 62.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.275 0.56 . . . . 0.0 110.431 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -116.58 18.95 14.86 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.182 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . 10.7 tp -82.24 140.0 45.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.278 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.21 127.74 22.99 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.427 2.084 . . . . 0.0 111.244 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.23 20.81 6.56 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.271 0.558 . . . . 0.0 111.106 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.87 -22.31 79.17 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.636 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 m -72.3 -15.48 61.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.5 t70 75.69 141.79 0.07 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.898 0.879 . . . . 0.0 111.598 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 p -61.33 -33.72 74.08 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.5 t -70.37 -18.49 63.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.334 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.84 -21.71 26.24 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.98 -174.16 1.17 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.251 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -75.01 12.84 0.78 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 4.1 mp0 -74.55 -59.86 2.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.95 71.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.086 0.47 . . . . 0.0 110.827 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 93.0 m-85 -83.24 12.38 5.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.522 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 47.8 t -51.19 -43.27 61.31 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.524 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.9 m -58.16 -44.64 88.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.69 30.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.781 0.324 . . . . 0.0 111.803 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 68.2 mt -81.59 -32.16 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -84.97 -34.72 22.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.447 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 49.05 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.979 0.8 . . . . 0.0 111.093 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.72 -6.34 51.77 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.598 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.16 -2.85 87.27 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.833 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 32.8 t -92.71 -13.33 8.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.646 0.736 . . . . 0.0 109.818 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.7 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -91.29 -176.08 4.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.597 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 31.9 t30 -84.54 105.17 15.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.76 -16.93 64.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.176 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -81.34 -19.76 42.12 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.476 ' ND2' HD12 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.97 -26.52 64.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.141 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.476 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -69.67 -33.17 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.564 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -77.48 -27.18 51.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.109 0.48 . . . . 0.0 109.959 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 89.9 m -78.54 -46.65 18.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.838 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -133.51 -40.99 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -48.5 -71.88 0.52 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' SER . 10.3 t -67.32 -14.05 62.56 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.097 0.475 . . . . 0.0 111.494 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 107' ' ' THR . 80.4 mtp180 -87.19 -49.51 7.23 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.4 -42.81 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.258 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 116' ' ' LEU . 6.0 mp -80.09 -29.46 39.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 110' ' ' SER . 19.5 m 47.72 -99.09 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.473 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.22 -36.79 63.89 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 113' ' ' LEU . 55.5 tp -62.47 -57.08 12.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.601 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' SER . 25.9 mt -71.47 -23.78 61.88 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.165 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 93.2 m-20 -67.12 -34.11 76.9 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.19 -43.22 6.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.455 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 124' ' ' ALA . 56.0 t -62.42 -28.99 45.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 122.358 0.263 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 9.3 t -57.35 -40.51 78.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.267 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 23.7 m -85.57 -28.83 24.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.0 -83.82 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -70.17 -47.49 61.37 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 42.9 tt0 -75.71 -17.57 59.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.326 0.584 . . . . 0.0 109.793 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 122' ' ' SER . . . -85.13 -64.06 1.55 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.207 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -127.69 -4.93 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.37 119.43 1.32 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.593 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.46 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.967 0.413 . . . . 0.0 111.261 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -101.02 152.19 20.89 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.28 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -116.61 -149.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' H ' HG12 ' A' ' 131' ' ' VAL . 2.8 p-10 -85.44 147.44 26.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.491 0.663 . . . . 0.0 110.871 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 p -80.53 15.38 1.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.301 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.05 -64.43 0.48 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.499 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.6 m -85.25 -49.86 7.84 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' ILE . 99.5 t -72.23 -51.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 52.0 tt0 -54.82 -48.25 73.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 p -58.79 -41.78 87.49 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.831 0.348 . . . . 0.0 111.86 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -50.4 16.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.996 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.3 pt -65.27 -31.73 55.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -61.41 -43.94 97.99 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.2 p -86.52 -40.57 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 22.8 t -78.09 -18.36 55.83 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.6 p -57.32 -18.14 15.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 p -45.87 -30.62 1.78 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 27' ' ' ASN . 94.7 m-85 -62.1 -17.16 56.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.64 -11.71 5.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 111.205 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -63.85 -37.91 89.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.7 p -80.46 -8.81 59.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.889 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -73.77 -6.07 44.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.675 0.75 . . . . 0.0 109.052 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.3 m -148.34 -147.24 0.22 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.2 m -56.34 111.58 1.01 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.239 0.472 . . . . 0.0 110.03 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -38.67 -59.73 0.9 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.413 1.085 . . . . 0.0 113.728 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -167.78 -148.82 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.6 m -51.95 -41.1 61.81 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.237 0.541 . . . . 0.0 110.229 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -92.09 126.02 37.0 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.1 m -74.86 70.06 1.91 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.831 0.348 . . . . 0.0 111.208 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 44.19 26.06 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.91 1.284 . . . . 0.0 114.074 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.09 -10.14 59.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.547 0.689 . . . . 0.0 109.924 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 p -84.38 -8.92 58.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.444 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -124.52 89.06 3.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.187 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.3 t -88.4 94.57 9.89 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.318 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.1 p -79.64 -20.95 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.5 t -70.3 -20.5 63.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.21 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.9 t -95.89 6.93 47.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.875 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.03 103.13 1.72 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.28 -28.47 16.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.93 0.395 . . . . 0.0 110.529 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.29 -64.32 0.69 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.462 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -102.18 -66.0 0.95 Allowed 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.739 -0.271 . . . . 0.0 111.031 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.1 m 72.22 159.56 0.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.625 0.578 . . . . 0.0 110.961 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 72.44 -135.66 22.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.352 -0.451 . . . . 0.0 113.401 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.38 -8.56 22.45 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.276 2.651 . . . . 0.0 112.973 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.4 p -123.13 12.23 9.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.224 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.56 -164.87 10.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.65 174.91 12.07 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.953 2.435 . . . . 0.0 112.301 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.5 p -76.68 86.36 3.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.351 0.596 . . . . 0.0 110.393 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.0 t -140.76 162.16 36.07 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.262 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 186' ' ' LEU . . . 110.22 -114.76 3.92 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.172 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.03 -13.7 41.21 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.671 2.247 . . . . 0.0 112.596 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.4 m -62.57 -31.82 72.69 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.27 146.78 18.33 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.514 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 87.7 m-85 -85.21 -53.33 0.46 Allowed Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 182' ' ' TYR . 16.9 Cg_exo -68.32 123.07 10.14 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.412 1.408 . . . . 0.0 110.299 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.12 2.38 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.78 158.59 37.02 Favored 'Trans proline' 0 CA--C 1.505 -0.973 0 C-N-CA 122.218 1.945 . . . . 0.0 111.261 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 190' ' ' ALA . 88.6 mt 67.46 -140.36 0.12 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.735 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 170.45 -154.98 24.13 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.615 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.35 3.37 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.183 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.44 57.21 5.03 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 186' ' ' LEU . . . -77.54 130.92 72.57 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.56 134.76 59.32 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.707 2.272 . . . . 0.0 111.468 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.89 52.76 1.28 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.421 0.629 . . . . 0.0 110.69 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 101' ' ' ASN . . . -128.4 -118.48 2.11 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.128 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 50.4 89.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 45.4 m -111.16 23.88 13.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 130.36 57.83 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.353 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -147.58 -64.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 0.0 110.162 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -96.1 98.17 2.17 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.375 0 CA-C-O 118.471 -1.183 . . . . 0.0 111.254 -179.71 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 121.059 0.456 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.7 -155.52 16.16 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.17 136.47 64.95 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.309 2.006 . . . . 0.0 111.784 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -89.23 150.97 22.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.3 81.62 0.58 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -28.46 2.48 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -130.82 84.47 2.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.35 87.48 0.91 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.417 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.17 156.19 7.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.127 0.171 . . . . 0.0 110.864 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.438 ' H ' ' HG ' ' A' ' 113' ' ' LEU . 28.5 p 61.9 130.37 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.495 1.118 . . . . 0.0 112.305 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.2 167.65 13.81 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.649 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 -44.38 76.02 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.056 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.59 77.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.3 p -76.21 -27.99 57.04 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.291 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.99 -23.02 52.21 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.01 -41.8 6.17 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.511 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -84.41 -22.64 30.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 5.1 pt -40.22 -55.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 t -85.06 -19.71 31.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.712 0.291 . . . . 0.0 111.632 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -83.14 -27.42 30.13 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 100' ' ' LEU . 23.8 t -71.28 -100.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.99 35.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB3' HD22 ' A' ' 31' ' ' LEU . 4.4 m-80 -70.91 -24.56 62.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -174.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.7 87.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.167 0.508 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 25' ' ' LEU . 6.0 tt -75.91 -40.21 54.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.05 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.73 90.41 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.741 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 53.77 16.97 1.14 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.793 0.837 . . . . 0.0 111.794 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 29' ' ' SER . 19.7 m -75.66 165.59 24.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.27 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 16.3 m -60.08 -17.63 41.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.819 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -53.48 -31.26 44.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.687 0.795 . . . . 0.0 112.73 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -110.08 -20.28 12.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.525 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 15.5 ttm180 -79.87 -38.61 32.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.878 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -174.64 -26.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.08 139.64 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.42 145.37 22.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -63.12 155.25 28.5 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 m -71.22 114.45 9.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.262 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 40.13 9.19 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.762 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.86 151.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.203 0.525 . . . . 0.0 111.605 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -91.31 159.51 15.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.599 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.0 pt20 -67.42 -13.37 61.96 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.285 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' CG ' HD13 ' A' ' 116' ' ' LEU . 83.4 mm-40 -55.62 -47.78 76.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.043 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.94 -29.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.784 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.32 -55.36 4.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.118 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 m 75.53 -18.9 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.866 0.866 . . . . 0.0 111.821 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -68.43 -88.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -145.01 -27.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.947 0.403 . . . . 0.0 111.814 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.62 98.21 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.342 0.591 . . . . 0.0 111.824 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 31.2 mt-30 -82.54 -48.27 11.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.351 177.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.726 ' NH1' ' HA ' ' A' ' 123' ' ' ALA . 54.7 ttt180 -134.31 -3.14 2.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.879 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.07 -58.26 0.54 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.354 0.662 . . . . 0.0 110.306 -174.695 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.43 137.61 57.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.274 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' SER . 4.6 pm0 -50.29 -24.38 2.89 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.296 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -50.93 -74.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.56 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 47.5 tp -87.94 -24.53 23.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.514 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.85 59.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 14.3 t -58.67 84.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 111.65 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.7 t -123.3 -35.99 2.88 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.73 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' THR . 84.0 mt -120.82 18.57 11.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.948 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.43 59.69 2.35 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.391 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.707 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 33.0 t -89.43 103.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 120.929 0.395 . . . . 0.0 110.834 -177.114 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -169.2 96.77 0.34 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.502 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.77 -63.87 4.18 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.21 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.55 -75.52 0.05 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.914 0.486 . . . . 0.0 111.664 -175.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.707 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.5 p-10 -85.8 15.16 5.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.26 -56.1 3.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.442 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.01 46.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.246 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -121.24 161.09 22.54 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 66.95 -63.11 0.28 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.89 -31.24 52.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 110.349 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -68.61 -29.5 68.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.65 65.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.122 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -77.5 -38.92 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.7 t -66.37 -21.92 66.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -113.32 15.44 19.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.9 tp -80.31 119.22 75.77 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.661 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 27.5 Cg_exo -63.27 128.73 23.44 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.56 83.51 7.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.102 0.477 . . . . 0.0 110.377 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.29 -35.9 56.21 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.16 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.3 p -88.56 -62.59 1.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.747 0.308 . . . . 0.0 110.479 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 176.03 159.65 0.29 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -69.5 -30.8 68.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.969 0.414 . . . . 0.0 110.356 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -70.04 -18.42 63.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.042 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -21.49 63.77 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -78.44 -174.44 3.79 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.523 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.81 35.6 0.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.235 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 85.6 mm-40 -74.43 -60.39 2.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.331 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -78.67 -32.67 47.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.409 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.43 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 56.6 m-85 -80.68 9.03 6.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.055 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 p -52.15 -56.53 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 11.7 t -61.53 -36.04 79.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.968 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -74.61 -36.54 62.95 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.39 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.438 HD22 HD21 ' A' ' 116' ' ' LEU . 50.1 mt -83.62 -20.68 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.164 0.507 . . . . 0.0 111.163 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 78.9 t80 -85.13 -25.27 27.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 84.9 m-20 48.57 65.59 1.3 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.972 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.92 64.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.098 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.13 -15.45 61.0 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.113 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.17 -12.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.98 0.895 . . . . 0.0 109.02 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -83.6 175.29 9.85 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 -178.025 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 39.1 t30 -72.17 109.51 5.99 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.833 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.53 -24.43 63.74 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.865 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.1 m -69.46 -26.88 64.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.527 0.68 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -64.62 -46.56 82.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.606 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.68 -36.95 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.019 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.59 -39.06 92.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 176.535 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 93.4 m -74.87 -62.89 1.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' OD1' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -113.21 -33.22 6.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.9 -56.87 14.3 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.188 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.9 t -69.49 -26.44 64.56 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.764 0.316 . . . . 0.0 111.573 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 107' ' ' THR . 3.6 mpt_? -83.09 -47.39 11.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.24 -50.08 15.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 10' ' ' THR . 9.0 mp -67.87 -41.27 83.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.925 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.7 t 46.72 -95.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.761 0.824 . . . . 0.0 113.104 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.8 66.0 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.092 0.557 . . . . 0.0 112.121 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 120' ' ' VAL . 35.2 tp -65.93 -48.22 72.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.524 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 17.0 mt -70.75 -23.49 62.44 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.718 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -58.46 -34.78 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.55 -41.42 6.88 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.555 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 116' ' ' LEU . 76.4 t -61.18 -32.55 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.8 m -54.43 -45.67 73.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -84.33 -23.9 30.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.827 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.726 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.17 -84.96 0.14 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 95' ' ' PHE . . . -76.51 -45.91 28.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.835 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -72.52 -20.38 61.36 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.089 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.73 -70.96 1.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.62 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.69 -9.07 5.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.653 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.63 120.78 3.12 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.895 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 mt -85.27 146.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.051 0.453 . . . . 0.0 111.863 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.52 149.37 42.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.2 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 20.7 t -120.89 161.72 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 131' ' ' VAL . 21.2 t70 -59.72 156.22 14.31 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.261 0.553 . . . . 0.0 111.74 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 14.5 m -78.97 20.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.477 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.84 -77.97 0.35 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.183 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.9 m -107.83 -31.15 8.14 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.8 t -86.58 -64.46 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 37.3 tt0 -67.59 -23.0 65.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.358 . . . . 0.0 111.96 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -68.85 -44.97 72.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.065 0.46 . . . . 0.0 111.084 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.48 -50.23 14.54 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.511 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 137' ' ' GLN . 44.9 pt -58.79 -40.47 79.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -36.95 70.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.755 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.1 t -84.42 -45.53 12.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.0 110.568 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.458 ' HA ' HD23 ' A' ' 147' ' ' LEU . 45.6 t -59.14 -45.41 91.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.905 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.1 m -65.52 -19.93 66.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.5 t -85.72 -49.87 7.62 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -89.09 -60.3 1.99 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 143' ' ' SER . 3.7 mm? -54.98 -29.91 58.06 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -172.092 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.3 m -54.07 -37.24 63.99 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.7 p -129.84 14.82 5.85 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.159 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.7 m -80.83 142.11 34.01 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.76 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.6 t 68.62 -70.12 0.14 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.586 0.754 . . . . 0.0 109.914 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 161' ' ' ALA . 32.8 t -105.12 104.5 14.25 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 158' ' ' GLN . 13.2 m -68.32 165.87 17.7 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.703 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 178' ' ' GLY . . . -80.68 -31.52 36.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.821 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 179' ' ' PRO . 15.0 m -51.53 132.78 30.37 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.17 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -54.28 -40.67 68.07 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 p -73.59 -7.47 52.04 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.999 0.428 . . . . 0.0 111.674 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 153' ' ' SER . 75.9 mt-30 -126.55 13.21 7.54 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.089 0.471 . . . . 0.0 110.124 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.17 168.11 14.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.703 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.2 p 52.07 30.35 7.42 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.435 0.694 . . . . 0.0 111.951 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 152' ' ' SER . . . -72.6 -24.89 61.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.18 0.514 . . . . 0.0 110.873 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 175' ' ' PRO . 47.0 t -111.59 143.08 43.04 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 167' ' ' ALA . 37.7 p 47.24 46.39 16.63 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.871 0.468 . . . . 0.0 112.195 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.5 m -55.88 110.75 0.78 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.181 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.9 p 55.3 18.83 2.69 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.964 0.905 . . . . 0.0 112.174 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -127.45 4.13 7.16 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB2' ' OG ' ' A' ' 163' ' ' SER . . . -78.77 -56.72 4.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.752 0.311 . . . . 0.0 110.635 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.88 -36.86 2.31 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.474 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -89.83 -49.09 6.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.548 0.213 . . . . 0.0 110.842 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.4 m 63.43 95.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.107 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 117.83 -89.13 0.47 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.555 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.18 -32.17 79.06 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.113 2.542 . . . . 0.0 111.499 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m -150.56 70.67 1.02 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.04 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.77 -157.45 17.07 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.147 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.43 ' HB3' ' O ' ' A' ' 162' ' ' SER . 49.8 Cg_endo -99.99 -178.46 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.359 2.706 . . . . 0.0 112.887 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.7 t -93.1 168.36 11.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.413 ' H ' ' H ' ' A' ' 178' ' ' GLY . 14.7 t -177.75 12.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.172 0.511 . . . . 0.0 110.62 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.419 ' O ' ' HB1' ' A' ' 154' ' ' ALA . . . -115.53 85.34 0.39 Allowed Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.563 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 14.8 Cg_endo -57.01 121.2 9.65 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.597 2.198 . . . . 0.0 112.916 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.2 m -88.78 105.27 17.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.327 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 130.28 168.0 12.17 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.36 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 69.78 154.88 0.15 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.796 0.838 . . . . 0.0 112.027 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -58.83 126.87 22.44 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.639 2.226 . . . . 0.0 111.222 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.4 65.21 2.93 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.348 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 179' ' ' PRO . 22.3 Cg_exo -66.05 -52.56 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.856 2.371 . . . . 0.0 112.514 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.81 107.5 15.47 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.797 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -116.99 -149.89 9.14 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.464 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.85 121.18 21.22 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.982 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 130.88 -35.18 2.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.78 94.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.83 124.02 11.76 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.077 1.852 . . . . 0.0 110.877 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.86 62.85 3.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.659 0.742 . . . . 0.0 110.902 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -121.84 29.37 5.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -119.84 161.23 21.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.331 -0.935 . . . . 0.0 109.75 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 m -89.39 11.66 18.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.974 0.416 . . . . 0.0 111.618 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 120.27 -46.34 1.14 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.755 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.6 t80 59.04 51.47 7.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.887 0.851 . . . . 0.0 108.982 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 110.48 -102.93 1.58 Allowed Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.547 0 CA-C-O 118.516 -1.158 . . . . 0.0 112.282 178.773 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.93 -150.59 34.33 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 140.54 52.42 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.204 1.936 . . . . 0.0 111.175 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -103.39 174.56 5.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.13 -64.43 3.26 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.666 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.05 -26.15 42.01 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.603 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -103.22 108.84 20.2 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.93 0.395 . . . . 0.0 110.277 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.77 155.53 48.31 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.359 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.04 142.47 4.16 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p 46.11 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.13 179.57 42.36 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.542 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.32 -166.38 14.45 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.951 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.21 -1.1 24.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.305 0.574 . . . . 0.0 110.437 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 18' ' ' ILE . 27.5 p -76.5 -25.01 53.78 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.27 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.47 43.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.49 -38.93 6.91 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.53 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -83.77 -25.02 30.84 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 9.5 pt -45.44 -42.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.2 m -83.12 -19.83 35.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 62.8 mtt180 -86.71 -23.84 25.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -72.14 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.149 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -51.79 -33.26 34.69 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.439 0.696 . . . . 0.0 112.76 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB3' HD22 ' A' ' 31' ' ' LEU . 10.0 m-80 -65.69 -24.29 66.97 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -70.95 -42.42 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 183' ' ' PRO . 3.5 mm? -81.23 -16.1 53.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.494 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 148' ' ' SER . . . -84.57 -36.99 21.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 3.1 t-20 51.26 18.25 0.59 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.683 1.193 . . . . 0.0 112.228 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 143' ' ' SER . 7.1 m -66.26 164.11 16.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.201 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 54.9 m -63.85 -16.3 61.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.832 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -51.31 -41.04 60.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.762 0.825 . . . . 0.0 112.289 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -99.84 -19.31 16.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.394 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 17.5 ttm180 -74.47 -59.58 2.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.199 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -162.78 -28.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.82 136.06 24.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.6 138.29 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.81 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -64.07 152.46 40.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.669 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -67.65 111.63 4.32 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.418 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 129' ' ' ILE . . . 85.93 38.37 8.68 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.215 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.9 148.29 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.131 0.491 . . . . 0.0 111.105 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -87.86 157.37 19.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.073 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 18.8 pt20 -63.52 -19.39 64.73 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.302 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -51.5 -46.18 63.12 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 111.458 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -84.08 -32.66 8.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -83.67 -48.91 9.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.8 p 67.48 -18.84 0.13 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.292 1.437 . . . . 0.0 113.095 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ALA . 20.8 p -68.38 -75.69 0.1 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.61 -34.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.836 0.351 . . . . 0.0 111.903 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.52 97.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.1 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 72.8 mt-30 -82.84 -51.01 8.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.349 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.59 HH22 ' HB2' ' A' ' 127' ' ' LEU . 41.1 ttt180 -130.69 -5.72 4.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.673 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' O ' HD13 ' A' ' 66' ' ' LEU . . . 71.08 -55.74 0.64 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.599 -172.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 136.07 54.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.901 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -51.01 -29.86 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -173.488 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.3 t -46.84 -69.25 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.106 0.412 . . . . 0.0 112.079 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.448 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 57.4 tp -88.6 -24.19 22.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 111.602 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' THR . . . -79.26 -18.91 51.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.0 t -48.48 98.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.089 0.471 . . . . 0.0 111.662 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ALA . 8.9 t -142.04 -37.72 0.39 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.557 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.92 18.7 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.02 67.63 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 46.7 t -87.35 110.23 20.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.14 0.495 . . . . 0.0 110.998 -175.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -158.94 20.92 0.2 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.991 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 123.48 -37.75 2.65 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.814 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.28 -74.47 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.552 0.176 . . . . 0.0 110.928 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -85.48 9.69 15.07 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 178.557 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 19.5 tp -87.97 -56.6 3.27 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.963 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 -35.52 40.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.508 0.671 . . . . 0.0 109.899 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.81 162.87 12.94 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 68.89 -61.68 0.41 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.65 -62.16 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.817 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -40.34 86.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.125 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.38 -44.6 95.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.722 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.51 74.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.02 -38.18 78.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -74.79 -21.78 59.12 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.979 0.419 . . . . 0.0 110.76 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 4.8 tpm_? -92.06 -8.9 44.59 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.15 0.5 . . . . 0.0 110.11 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.45 142.67 98.44 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.38 128.36 20.17 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.37 2.713 . . . . 0.0 112.997 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.97 20.0 12.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.078 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.51 -40.19 78.8 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 14.9 m -88.52 -6.65 57.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.348 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' SER . 8.8 m-20 72.69 168.9 0.32 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 p -73.86 -19.38 60.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.237 0.541 . . . . 0.0 109.732 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -63.66 -17.58 63.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.081 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.7 -21.35 61.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.352 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -77.6 -162.4 0.31 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 109.769 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.18 41.33 0.37 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.297 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 tp60 -64.81 -61.59 2.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.911 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -80.34 -27.1 38.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.69 10.45 2.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t -52.03 -51.07 59.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.1 m -59.14 -34.96 72.68 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -32.84 31.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.94 -35.38 18.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -78.74 -30.84 46.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 52.07 82.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.85 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.64 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.74 -13.71 60.16 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.135 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.27 -2.07 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.645 0.736 . . . . 0.0 109.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -84.92 173.81 10.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.355 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 18.8 t-20 -68.39 103.74 1.71 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.733 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.36 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.813 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 p -74.84 -16.67 60.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.057 0.456 . . . . 0.0 110.673 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -68.06 -47.32 68.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.406 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.48 -41.93 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.17 -30.72 70.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.147 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.1 m -91.42 -52.46 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -117.48 -27.86 6.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.75 -64.89 3.97 Favored Glycine 0 C--O 1.234 0.103 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.961 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 p -76.71 -11.8 59.9 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -54.73 4.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.33 -54.48 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.164 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 113' ' ' LEU . 6.1 mp -72.96 -57.92 3.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m 67.24 -86.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.1 -36.92 61.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' VAL . 27.6 tp -65.29 -50.97 63.68 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.743 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HA ' HG22 ' A' ' 120' ' ' VAL . 5.4 mp -67.95 -23.22 65.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.05 -42.65 7.01 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.822 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.769 HG22 ' HA ' ' A' ' 117' ' ' LEU . 2.7 m -67.71 -32.46 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.828 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -62.21 -34.18 75.98 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.755 0.312 . . . . 0.0 110.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 t -85.34 -38.5 18.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.471 0.653 . . . . 0.0 110.303 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.22 -79.43 0.21 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 129' ' ' ILE . . . -65.23 -60.93 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.414 -175.078 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -31.86 70.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 109.965 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.94 2.22 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.484 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' LEU . . . . . 0.59 ' HB2' HH22 ' A' ' 50' ' ' ARG . 73.0 mt -115.02 -5.54 12.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.0 105.07 0.07 OUTLIER Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.3 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 124' ' ' ALA . 27.9 mt -77.57 134.88 27.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -128.1 115.74 18.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.082 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 132' ' ' ASP . 16.2 t -82.75 166.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.936 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 131' ' ' VAL . 18.9 t70 -59.35 158.18 9.78 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.104 0.478 . . . . 0.0 111.252 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 33.1 m -79.86 16.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.345 -177.479 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.58 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.934 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.0 p -106.83 -30.14 9.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.39 -63.97 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 34.8 tp60 -59.17 -41.77 89.21 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 m -57.63 -45.7 85.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.877 0.37 . . . . 0.0 111.885 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.71 -52.87 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.459 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.4 pt -55.75 -38.91 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -62.87 -35.26 79.41 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 m -84.82 -38.24 19.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 111.009 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 28' ' ' THR . 50.9 m -72.28 -40.73 67.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.353 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t -72.86 -21.79 60.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -86.93 -53.15 5.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.88 -56.06 3.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 3.2 mm? -79.18 6.33 9.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.313 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 2.5 p -62.68 -66.26 0.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.331 0.586 . . . . 0.0 111.622 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 180' ' ' SER . 3.7 m -144.37 63.2 1.32 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 154' ' ' ALA . 35.2 t -57.21 131.7 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.159 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.3 m -59.28 133.86 56.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.769 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.718 ' O ' ' HB3' ' A' ' 158' ' ' GLN . 48.0 m 71.65 25.15 3.34 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 123.739 0.649 . . . . 0.0 110.443 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 161' ' ' ALA . 14.6 t 70.08 177.4 0.27 Allowed 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.966 0.906 . . . . 0.0 112.945 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 150' ' ' SER . . . -152.46 12.99 0.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.899 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 39.6 t -117.17 137.16 52.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.335 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 t80 52.06 57.51 6.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.827 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 m 60.92 20.92 11.2 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.114 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.718 ' HB3' ' O ' ' A' ' 152' ' ' SER . 51.7 mt-30 69.86 18.08 7.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.098 0.559 . . . . 0.0 111.543 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.57 -44.25 67.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.1 p -82.86 90.09 6.9 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.719 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 153' ' ' SER . . . -133.05 -48.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.7 m -96.42 117.24 30.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.586 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m -89.86 3.71 52.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.7 m -58.61 -32.06 68.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.4 m -72.28 -5.54 36.79 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.388 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.09 77.77 1.38 Allowed Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.411 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.06 -55.8 3.77 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.41 12.53 80.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.197 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -97.02 -71.92 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.793 0.296 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.6 p 53.18 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.261 1.024 . . . . 0.0 112.473 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 104.62 -107.33 2.89 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.435 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.5 117.03 3.71 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.412 2.075 . . . . 0.0 110.946 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p 52.62 30.62 8.9 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.592 0.757 . . . . 0.0 111.253 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.44 165.81 12.79 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.552 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.88 140.32 16.1 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.119 2.546 . . . . 0.0 112.015 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 p -78.57 79.1 5.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.15 0.5 . . . . 0.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 12.9 t -118.61 12.8 13.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.772 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 -166.35 33.47 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.372 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.62 104.94 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.936 2.424 . . . . 0.0 111.483 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.456 ' HA ' HG21 ' A' ' 149' ' ' THR . 13.1 t -54.4 127.03 25.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.014 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.76 -68.53 3.04 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.339 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -130.91 131.46 23.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 O-C-N 122.859 -0.201 . . . . 0.0 111.21 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HG3' HD23 ' A' ' 25' ' ' LEU . 22.2 Cg_exo -65.41 125.24 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.37 2.046 . . . . 0.0 110.827 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.94 -77.58 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.467 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.54 -17.58 57.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.645 2.23 . . . . 0.0 112.122 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.67 19.24 11.61 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.764 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.16 156.11 45.0 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.822 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.77 -119.27 6.4 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.512 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -113.7 95.76 0.77 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.583 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -140.36 161.56 54.4 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 14.4 Cg_exo -67.03 125.29 13.39 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.25 1.966 . . . . 0.0 111.157 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -78.39 77.41 4.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.055 0.455 . . . . 0.0 110.807 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.95 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 64.76 163.64 0.14 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.715 0.806 . . . . 0.0 111.868 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.551 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 29.2 p -84.54 -32.12 24.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.48 0.657 . . . . 0.0 109.761 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 118.69 -11.07 12.29 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.66 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.97 107.14 3.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 90.82 129.21 4.18 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.311 -178.926 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.569 0.223 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.81 74.18 0.42 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.92 144.48 53.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.373 2.048 . . . . 0.0 111.437 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 7' ' ' PHE . 14.8 mm100 -63.45 135.13 56.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.585 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.95 112.14 3.9 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.871 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.01 -6.98 81.68 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.324 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 91.0 m-85 -126.53 20.37 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.884 0.373 . . . . 0.0 110.263 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.33 94.19 0.26 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 120.88 15.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.383 0.611 . . . . 0.0 111.869 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -161.17 136.44 7.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.293 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.21 109.51 3.82 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.684 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.37 -60.69 4.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.712 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.89 74.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.22 0.534 . . . . 0.0 110.682 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.6 m -62.82 -26.78 68.91 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.86 -18.31 4.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.79 -45.9 5.01 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.422 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.2 pp -86.63 -21.63 26.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 4.7 pt -35.49 -58.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.1 t -79.41 -20.23 48.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.685 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 99.5 mtt180 -86.65 -32.96 20.28 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' LEU . 45.7 t -62.0 -94.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -53.39 6.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -65.75 -24.41 66.95 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.16 -35.91 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.725 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD12 ' HG2' ' A' ' 179' ' ' PRO . 3.9 mm? -74.74 -21.6 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.482 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.68 33.74 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 2.8 t-20 55.96 18.09 2.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.714 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 m -81.32 148.38 29.42 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 -17.18 1.01 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.882 1.273 . . . . 0.0 114.101 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -61.2 -21.99 64.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 pp -93.83 -26.99 16.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.217 0.532 . . . . 0.0 110.379 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -82.42 -45.88 14.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 -26.58 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 ' OD1' ' A' ' 139' ' ' ASP . 25.8 t -84.35 161.47 3.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.6 pt? -85.1 159.27 20.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.696 0.284 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -89.39 166.47 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.296 0.569 . . . . 0.0 111.514 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -74.87 124.87 27.66 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.601 177.719 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 73.31 38.26 53.6 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.451 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.93 149.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.042 0.937 . . . . 0.0 112.66 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.3 m -77.83 142.65 38.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.003 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -68.87 -13.09 62.2 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -58.98 -35.43 73.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.93 -42.35 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.795 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.39 -69.15 0.65 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.591 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m 74.9 -21.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.968 0.907 . . . . 0.0 112.347 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 p -70.2 -82.24 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 -22.88 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.58 85.0 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 46.5 mt-30 -83.16 -43.62 15.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.51 -13.22 6.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.436 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.21 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.591 0.756 . . . . 0.0 110.255 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.27 144.34 50.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.528 ' O ' ' HB2' ' A' ' 57' ' ' SER . 5.1 pm0 -55.03 -19.21 6.47 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -175.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -56.28 -81.72 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 50' ' ' ARG . 9.9 tt -86.04 -22.81 27.04 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.903 0.382 . . . . 0.0 111.123 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -73.32 -18.44 61.19 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.9 t -52.22 97.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.105 0.478 . . . . 0.0 110.94 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 t -131.81 -37.37 1.17 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.88 19.65 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.395 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 67.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.855 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 42.6 t -87.88 102.33 12.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -150.62 17.58 0.81 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 110.583 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 127.7 -42.44 1.45 Allowed Glycine 0 C--N 1.288 -2.095 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.521 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . 52.2 m-80 -55.06 -79.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.713 0.302 . . . . 0.0 111.723 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -85.3 12.95 7.13 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.297 177.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 39.3 tp -88.61 -57.34 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.07 -32.63 56.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -109.76 160.61 16.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 68.91 -62.32 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 135' ' ' SER . 9.6 p -72.69 -37.2 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.74 -27.79 65.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.3 -47.45 13.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.425 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.13 -35.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.048 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.7 p -72.41 -21.41 61.27 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.056 0.455 . . . . 0.0 110.545 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -91.11 -14.48 31.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.1 mt -56.48 113.2 5.49 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.83 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 3.1 Cg_exo -77.41 128.73 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.766 2.311 . . . . 0.0 111.154 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.4 111.12 16.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.84 -50.46 18.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.748 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -83.47 -57.52 3.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.023 0.439 . . . . 0.0 110.36 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -169.69 151.26 4.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.522 HG22 HE22 ' A' ' 88' ' ' GLN . 11.4 m -73.44 -20.52 60.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.8 0.334 . . . . 0.0 111.81 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 m -66.18 -17.18 64.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.02 -21.4 61.29 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.725 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 77.8 m-85 -76.17 -168.81 1.0 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.61 25.11 0.2 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.646 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.522 HE22 HG22 ' A' ' 83' ' ' THR . 65.0 mt-30 -87.17 -59.34 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.105 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.596 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -70.28 -48.13 58.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.0 m-85 -79.09 23.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 89' ' ' ALA . 6.9 p -51.01 -60.29 3.25 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.415 0.686 . . . . 0.0 112.696 -177.276 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -65.26 -32.66 74.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.95 56.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.704 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.3 mt -84.35 -28.2 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.617 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.99 -38.2 22.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.065 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.2 m120 53.69 73.0 0.4 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.681 0.613 . . . . 0.0 111.118 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.36 -2.76 33.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.742 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.77 -5.7 68.88 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.127 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.87 21.75 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 109.737 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' CB ' HG11 ' A' ' 21' ' ' VAL . 1.8 pt? -117.4 163.71 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.82 128.15 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.467 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.61 -20.67 62.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.9 t -65.98 -36.63 83.82 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 108' ' ' LEU . 9.2 t30 -61.8 -49.32 76.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.061 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 35.8 mm -68.94 -38.44 78.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.166 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.67 -24.55 61.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -79.79 -55.83 4.71 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.417 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -130.83 -23.49 2.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.472 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.68 -65.5 3.14 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.1 p -78.58 -11.62 59.97 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.442 -0.446 . . . . 0.0 111.924 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -87.54 -52.58 5.27 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -83.75 -44.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.915 0.388 . . . . 0.0 111.259 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.0 mp -78.39 -51.73 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.1 m 53.18 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.78 29.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.76 0.824 . . . . 0.0 112.878 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 120' ' ' VAL . 61.6 tp -63.47 -55.7 22.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.855 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.0 mt -66.06 -28.76 69.08 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.156 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -58.3 -49.83 75.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 109.903 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.82 -36.49 61.46 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.105 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 116' ' ' LEU . 78.2 t -64.48 -38.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.606 0.241 . . . . 0.0 110.708 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -58.12 -46.31 85.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -70.86 -42.72 69.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.3 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -84.35 -80.19 0.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -66.41 -49.51 66.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 25.7 tm0? -71.03 -28.39 64.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.989 0.423 . . . . 0.0 110.87 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.1 -55.87 2.55 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.053 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.7 tp -102.13 -26.13 13.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.905 0.353 . . . . 0.0 111.796 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.8 73.38 1.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.572 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.444 ' H ' ' HA ' ' A' ' 124' ' ' ALA . 1.3 mp -68.18 139.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -130.88 131.8 44.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.46 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.493 ' H ' HG22 ' A' ' 37' ' ' THR . 22.4 t -89.5 120.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.026 0.441 . . . . 0.0 111.306 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -100.82 49.72 0.88 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.979 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -79.77 0.33 31.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.811 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.82 -25.71 20.13 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.904 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 71' ' ' VAL . 6.2 m -105.64 -49.05 3.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 140' ' ' ILE . 84.0 t -52.74 -62.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 17.9 tm0? -57.31 -44.11 83.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.526 -179.058 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.3 m -58.65 -45.57 89.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.855 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASP . . . . . 0.478 ' OD1' HG21 ' A' ' 34' ' ' VAL . 12.0 t70 -69.09 -53.17 21.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.728 0.299 . . . . 0.0 111.496 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 136' ' ' VAL . 44.0 pt -65.08 -42.02 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -66.14 -39.5 89.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 t -72.54 -45.5 59.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.866 0.365 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.3 m -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.704 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -61.02 -22.05 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -64.89 -45.41 86.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.738 0.304 . . . . 0.0 110.657 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -88.99 -42.0 12.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.396 0.617 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 4.3 mm? -75.18 8.87 2.34 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.131 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.5 m -46.79 -47.22 20.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.24 0.543 . . . . 0.0 109.663 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 152' ' ' SER . 11.8 p -154.01 104.31 2.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 p -95.64 -55.36 3.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.1 m -71.87 -15.72 62.13 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 111.592 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.524 ' OG ' ' HA ' ' A' ' 176' ' ' SER . 9.4 m -137.46 160.43 39.13 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 158' ' ' GLN . 23.2 t -105.11 141.64 36.3 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.12 24.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 50.9 m -93.51 14.33 19.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 111.068 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 69.63 -62.38 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.666 0.786 . . . . 0.0 112.881 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.4 t -60.28 -33.79 72.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.479 . . . . 0.0 110.535 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 83.1 mm-40 -92.04 15.94 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.06 24.87 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.696 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 m -153.74 69.18 0.79 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.223 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 111.7 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.161 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 98.0 p 54.28 -165.34 0.1 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 0.0 111.554 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 20.3 m 64.28 2.4 1.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.244 0.617 . . . . 0.0 112.248 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.9 t -80.0 -27.96 39.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.8 m -120.12 23.47 10.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.258 0.551 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . 142.27 134.61 2.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.52 105.18 7.9 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.44 -31.28 54.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.18 127.82 54.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 t -160.0 158.99 31.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.687 0.28 . . . . 0.0 110.376 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.95 -177.12 30.79 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.44 -14.0 42.69 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.875 2.383 . . . . 0.0 111.581 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -149.77 101.98 3.11 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -146.84 -130.5 2.09 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.381 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.17 164.12 35.17 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.675 2.25 . . . . 0.0 111.319 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.524 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 46.6 m -75.41 68.51 2.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.484 0.659 . . . . 0.0 111.274 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -130.33 113.4 14.33 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.33 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.94 -173.14 50.64 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.861 -176.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HG2' HD12 ' A' ' 25' ' ' LEU . 4.6 Cg_exo -80.11 4.9 6.39 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 123.073 2.515 . . . . 0.0 112.663 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.7 m -139.25 -73.9 0.38 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 159.66 56.85 0.01 OUTLIER Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.029 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.22 165.26 35.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.712 ' O ' ' HD3' ' A' ' 185' ' ' PRO . 50.3 Cg_exo -56.79 163.61 7.05 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.257 1.971 . . . . 0.0 110.255 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -107.59 89.05 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.175 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 183' ' ' PRO . 9.5 Cg_endo -90.42 -42.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.605 2.203 . . . . 0.0 110.887 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.476 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 54.5 mt -94.33 -69.32 0.76 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.096 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.62 -135.3 7.17 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.66 75.37 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.697 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 183' ' ' PRO . . . -177.72 127.91 1.24 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.216 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -162.08 154.63 16.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.685 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.0 Cg_endo -69.34 170.75 15.35 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.065 1.843 . . . . 0.0 112.378 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.71 32.8 3.46 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.975 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.15 35.73 2.0 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.437 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -107.44 179.43 4.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 23.8 p -97.26 18.18 15.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.77 79.51 0.89 Allowed Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.434 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -84.04 -20.25 33.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 84.53 -169.93 45.76 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.62 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.317 179.795 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.4 119.5 15.84 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.067 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.18 123.36 12.37 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.4 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.82 107.16 2.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.777 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.4 -110.03 1.24 Allowed Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.259 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.71 18.65 7.59 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -66.37 -61.55 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.368 0.127 . . . . 0.0 110.899 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 72.58 0.61 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.398 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 176.6 6.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.685 0.279 . . . . 0.0 111.196 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.51 ' H ' ' CD2' ' A' ' 113' ' ' LEU . 29.8 p 53.81 92.78 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.153 0.981 . . . . 0.0 113.299 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.85 -160.74 33.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.606 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.33 -163.44 51.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.378 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.34 -16.34 60.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.523 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 18' ' ' ILE . 42.5 m -60.46 -34.77 74.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.14 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.16 -22.83 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.35 -43.18 5.64 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.551 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -85.28 -25.18 27.38 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 3.0 pt -34.3 -63.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 42.5 t -75.07 -19.14 60.12 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.96 -21.51 37.16 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.66 0.384 . . . . 0.0 112.026 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 100' ' ' LEU . 1.8 t -71.68 -142.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -62.02 -23.41 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.9 OUTLIER -66.68 -26.56 67.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.986 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.41 -44.13 92.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.536 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.11 -28.75 38.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.649 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.83 87.73 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.26 17.87 3.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.864 0.866 . . . . 0.0 112.057 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.457 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 2.3 m -76.7 164.57 25.76 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.492 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 29.6 m -62.66 -16.49 57.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.035 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -52.3 -38.73 59.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.664 0.785 . . . . 0.0 112.515 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -104.02 -20.9 13.7 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.409 0.623 . . . . 0.0 110.538 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 13.1 ttm180 -72.81 -40.72 65.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.708 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 34' ' ' VAL . 8.2 t -173.3 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 33' ' ' THR . 47.4 t -87.2 139.89 16.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.2 pt? -54.14 141.68 28.15 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.007 0.432 . . . . 0.0 110.695 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 46.5 ptt85 -67.55 162.72 22.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.506 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.74 129.84 38.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.431 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' HA3' ' HB ' ' A' ' 129' ' ' ILE . . . 72.1 35.49 60.9 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.731 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.4 p -44.99 149.84 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.125 0.97 . . . . 0.0 112.771 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.8 m -88.11 149.43 23.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.289 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 7.7 pm0 -70.64 -12.99 61.91 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.627 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 14.6 mm100 -55.48 -31.94 62.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.759 0.314 . . . . 0.0 110.988 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -85.03 -44.73 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.029 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.57 -71.49 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.703 0.287 . . . . 0.0 111.696 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 t 79.63 -20.49 0.38 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.543 1.137 . . . . 0.0 111.022 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -78.91 -96.59 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.891 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -99.41 -35.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 0.0 111.291 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.71 81.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HA ' ' CB ' ' A' ' 41' ' ' GLN . 42.4 mt-30 -83.01 -47.85 11.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.597 0.713 . . . . 0.0 110.392 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 2.5 tpm_? -125.16 -12.71 6.87 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.514 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 -52.17 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.404 0.681 . . . . 0.0 110.054 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -74.44 155.46 38.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.434 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.665 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.7 mp0 -60.38 -18.82 53.02 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.372 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -58.32 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 19.3 mt -86.08 -22.14 27.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -77.42 -20.25 54.86 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -56.2 101.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.172 0.511 . . . . 0.0 110.594 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.3 t -145.99 -32.46 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 75.4 mt -121.4 18.88 11.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.0 0.429 . . . . 0.0 109.9 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 67.18 1.46 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.088 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 65' ' ' ASN . 61.9 t -97.44 113.6 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.377 0.271 . . . . 0.0 110.756 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -170.92 78.69 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.148 0.499 . . . . 0.0 110.456 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 -46.07 2.07 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.991 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.442 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.5 p-10 -52.04 -74.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.018 0.927 . . . . 0.0 112.796 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.475 HD21 HG22 ' A' ' 61' ' ' VAL . 31.6 p-10 -85.03 -16.71 39.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.181 0.515 . . . . 0.0 109.875 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 132' ' ' ASP . 61.4 tp -63.59 -47.25 82.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.705 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.21 -15.0 60.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 91.0 mtt180 -120.65 -84.44 0.66 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.875 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -52.17 -39.19 59.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.62 -57.12 9.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.655 0.264 . . . . 0.0 111.68 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.29 -38.3 82.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 68' ' ' ARG . 96.8 mt-30 -65.43 -35.11 79.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.99 94.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.0 t -86.23 -41.11 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.568 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -64.46 -28.54 69.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -102.84 5.04 38.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.373 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.23 119.28 75.62 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.355 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.99 128.79 18.31 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.663 2.242 . . . . 0.0 112.032 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.4 133.54 38.65 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.98 -54.51 4.11 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.345 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.4 p -92.26 -60.83 1.75 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.017 0.437 . . . . 0.0 110.336 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -164.46 164.1 22.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.496 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.7 m -67.01 -29.77 69.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 p -67.72 -17.65 64.63 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.345 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.77 66.4 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.526 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 -68.13 -174.43 0.49 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.434 0.635 . . . . 0.0 111.255 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -74.64 22.26 0.1 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.673 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 86' ' ' TYR . 70.7 mt-30 -86.42 -60.29 2.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 120.989 0.424 . . . . 0.0 109.927 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.9 -41.55 82.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.107 0.479 . . . . 0.0 109.957 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.0 m-85 -83.88 15.64 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.67 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . 0.516 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . 47.1 t -56.47 -50.75 70.83 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -60.14 -30.1 69.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.8 -40.65 22.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.748 0.308 . . . . 0.0 111.388 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 37.9 mt -83.25 -29.47 28.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.903 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -79.24 -36.78 39.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.31 90.35 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.56 -16.44 60.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.649 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 -14.01 52.13 Favored Glycine 0 C--O 1.227 -0.322 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.749 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 197' ' ' PHE . 9.0 p -93.61 1.35 9.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.203 1.002 . . . . 0.0 109.527 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -83.94 173.76 10.92 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.129 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -81.27 135.9 35.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.094 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.26 54.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.25 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.1 p -68.36 -30.67 69.68 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 121.217 0.532 . . . . 0.0 110.698 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.562 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.1 t30 -60.24 -53.79 53.45 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.51 -38.02 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.86 -31.7 71.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.839 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 m -91.68 -53.82 4.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -111.76 -35.24 5.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.79 -52.67 40.93 Favored Glycine 0 N--CA 1.46 0.293 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.121 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.625 ' HA ' HD12 ' A' ' 117' ' ' LEU . 33.0 t -66.09 -24.11 66.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.735 0.302 . . . . 0.0 111.551 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -87.13 -40.75 14.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.88 0.371 . . . . 0.0 111.42 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.12 -55.79 6.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.87 0.367 . . . . 0.0 111.376 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 10' ' ' THR . 17.9 mt -72.57 -42.29 64.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 49.53 -94.86 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.432 ' HA ' ' OD1' ' A' ' 118' ' ' ASN . . . -66.74 -19.08 65.68 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.447 HD21 HD22 ' A' ' 94' ' ' LEU . 58.1 tp -73.87 -36.81 64.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.741 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 110' ' ' SER . 33.0 mt -68.06 -43.51 78.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASN . . . . . 0.432 ' OD1' ' HA ' ' A' ' 115' ' ' ALA . 1.9 p-10 -62.68 -24.38 67.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.054 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.77 -30.1 21.89 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.572 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 124' ' ' ALA . 49.5 t -84.7 -34.66 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.4 p -53.38 -49.25 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.13 0.49 . . . . 0.0 111.627 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.2 t -76.26 -28.8 57.23 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB1' ' HD3' ' A' ' 50' ' ' ARG . . . -84.56 -85.3 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.85 -41.57 74.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -76.58 -21.89 55.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.197 0.522 . . . . 0.0 110.201 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.18 -81.04 1.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.375 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.67 -23.87 19.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.24 88.1 0.77 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.64 HG23 ' HB2' ' A' ' 52' ' ' ALA . 48.8 mm -58.06 136.98 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.66 152.32 24.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.167 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 136' ' ' VAL . 5.3 t -116.9 163.49 14.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 23.3 t70 -59.97 152.04 24.68 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.316 0.579 . . . . 0.0 112.073 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 24.0 m -73.71 -11.54 60.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -45.86 -74.54 0.22 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 123.266 0.354 . . . . 0.0 113.275 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.8 t -106.56 -57.24 2.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.309 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.509 HG21 HG11 ' A' ' 131' ' ' VAL . 60.8 t -48.68 -60.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.254 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.544 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 45.9 tp60 -58.16 -48.93 78.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.543 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -61.46 -41.93 97.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.27 -49.73 63.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.566 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.5 pt -68.57 -35.94 72.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -62.96 -50.28 71.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.654 0.264 . . . . 0.0 110.731 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.5 t -59.45 -43.9 93.06 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.213 0.53 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -64.72 -41.77 95.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.059 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.6 t -69.85 -24.39 63.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.931 0.396 . . . . 0.0 110.971 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.0 m -85.86 -58.82 2.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.637 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 150' ' ' SER . 90.1 m-85 -89.82 -56.65 3.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.97 -4.41 28.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -49.92 75.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.836 0.35 . . . . 0.0 111.745 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 m -147.9 -11.99 0.38 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.732 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 40.0 m -77.79 69.45 4.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.405 0.621 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.2 m -152.62 130.58 11.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.323 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.3 m -70.88 1.2 5.83 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -90.64 -78.32 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.1 -27.9 62.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -102.68 7.83 39.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.01 -76.47 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.642 -0.823 . . . . 0.0 113.088 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.9 m -60.06 -33.44 72.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -94.96 2.58 55.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.436 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.1 175.25 6.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.3 m 52.14 45.83 27.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.587 0.708 . . . . 0.0 109.668 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -100.76 136.56 40.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.836 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.9 m -99.78 86.63 3.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 -20.67 60.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -56.24 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.858 0.361 . . . . 0.0 111.599 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.4 m 61.92 20.47 11.54 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.502 0.721 . . . . 0.0 111.735 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 36.28 1.59 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.023 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -158.8 160.58 36.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.602 0.239 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 48.01 3.95 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.246 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 70.52 131.48 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.937 0.895 . . . . 0.0 111.697 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.4 p -67.38 146.36 54.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 101.83 -123.26 7.84 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.78 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.31 115.43 2.65 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.685 2.257 . . . . 0.0 112.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.2 m 67.59 17.88 9.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.64 -167.89 15.24 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.481 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -68.93 154.92 70.06 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.725 2.283 . . . . 0.0 111.909 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.8 m -87.52 87.81 7.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.272 0.558 . . . . 0.0 110.837 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -83.5 -14.21 52.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 186' ' ' LEU . . . -129.08 71.62 0.49 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.188 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 -174.89 2.24 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.32 2.013 . . . . 0.0 111.088 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.9 p -76.05 -75.52 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.884 0.373 . . . . 0.0 111.291 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.09 -106.92 2.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -129.77 146.83 62.88 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.44 125.01 14.3 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.253 2.635 . . . . 0.0 112.649 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 144.22 -99.43 0.22 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -87.16 176.73 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.642 2.228 . . . . 0.0 110.063 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 178' ' ' GLY . 7.1 mp -101.43 81.03 2.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.351 0.596 . . . . 0.0 110.346 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 77.77 -62.58 3.55 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.4 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.66 -40.57 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -112.67 68.57 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.131 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.56 133.72 76.76 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.301 0.096 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.42 138.99 87.47 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.48 2.12 . . . . 0.0 111.417 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -79.02 43.73 0.53 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.24 0.543 . . . . 0.0 111.847 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.11 -5.59 19.56 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -106.5 152.71 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.5 m -83.49 52.84 2.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.097 0.475 . . . . 0.0 111.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.1 -34.33 3.24 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.867 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.424 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 72.2 t80 72.57 -67.42 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.013 0.925 . . . . 0.0 111.068 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -141.95 -164.3 9.99 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 CA-C-O 118.358 -1.245 . . . . 0.0 111.561 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 120.591 0.234 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.46 -117.3 3.16 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.783 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . 90.0 Cg_endo -80.45 177.62 7.94 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.684 2.256 . . . . 0.0 111.862 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -138.67 107.44 5.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.821 0.343 . . . . 0.0 110.171 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.28 -122.48 27.21 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.888 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.57 -3.64 71.32 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.82 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.89 131.28 34.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.809 0.338 . . . . 0.0 110.324 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -97.05 77.74 0.68 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.277 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 3' ' ' PRO . . . -64.98 142.08 58.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 p 52.59 82.64 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.428 0.691 . . . . 0.0 112.323 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.52 174.22 37.18 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.075 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.91 -160.29 36.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.122 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -62.16 -13.05 23.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.017 0.437 . . . . 0.0 111.558 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' ILE . 7.9 m -54.3 -41.02 68.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.636 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.8 59.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.37 -43.9 5.43 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.503 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -83.66 -20.15 34.09 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' SER . 8.5 pt -42.84 -49.82 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 p -84.77 -18.93 33.52 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.586 ' O ' ' HG2' ' A' ' 191' ' ' PRO . 98.4 mtt180 -85.66 -36.15 20.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 100' ' ' LEU . 21.1 t -72.8 -102.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -71.33 -51.83 22.1 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.465 ' HB3' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -61.41 -24.95 66.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.116 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.14 91.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.57 -28.18 28.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.19 89.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.85 17.65 3.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.184 176.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 3.5 m -71.59 169.26 15.9 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.048 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 20.0 m -61.89 -18.28 59.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ARG . 58.4 p -56.44 -40.71 75.24 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -97.15 -20.13 18.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.235 0.541 . . . . 0.0 110.233 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -74.98 -43.95 51.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.573 -174.714 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 t -176.47 -25.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.4 t -91.89 139.41 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.03 145.17 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 123.186 0.303 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HA ' HG22 ' A' ' 30' ' ' THR . 36.5 ptt85 -60.13 152.12 25.15 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.256 0.551 . . . . 0.0 111.302 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -67.28 114.7 6.2 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.608 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 83.67 40.0 9.21 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.474 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -50.62 146.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 14.6 m -92.8 154.96 17.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.232 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 49' ' ' GLN . 8.5 pt20 -67.07 -12.15 59.12 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' A' ' 116' ' ' LEU . 84.7 mm-40 -53.93 -42.58 68.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.31 -31.2 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.748 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.38 -50.39 8.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 m 78.43 -18.69 0.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.413 1.085 . . . . 0.0 111.737 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 p -71.42 -101.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 -22.04 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.14 89.64 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.279 0.561 . . . . 0.0 111.769 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 68.4 mt-30 -77.47 -61.46 1.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.39 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 63.3 ttt180 -118.58 -2.06 11.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.552 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.93 -59.79 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.597 0.759 . . . . 0.0 112.055 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.03 -84.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLN . . . . . . . . . . . . . 7.3 pt20 178.56 -44.57 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -178.026 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -49.19 -69.41 0.12 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.428 0.691 . . . . 0.0 112.362 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.93 -23.07 27.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.225 0.536 . . . . 0.0 110.475 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.13 -19.72 62.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.821 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 p -47.93 107.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.733 0.646 . . . . 0.0 111.614 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -154.37 -42.23 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.088 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -122.59 19.38 10.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.332 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.11 63.96 1.49 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.128 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.8 t -89.7 114.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.457 -177.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -178.46 86.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.19 -58.65 4.73 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.935 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -61.78 -76.2 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 p30 -85.39 18.45 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.223 0.535 . . . . 0.0 110.838 -179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.6 tp -87.23 -56.12 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.888 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -37.23 49.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.143 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -104.04 172.82 6.59 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 63.07 -62.29 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.43 -59.66 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 110.879 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.66 -41.49 92.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.25 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -59.58 -43.21 93.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.613 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.87 -47.52 82.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.61 -41.12 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -66.28 -25.24 66.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.304 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -107.6 9.23 29.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 14.2 tp -84.13 115.0 58.01 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.28 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.53 129.92 23.73 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.619 2.213 . . . . 0.0 111.761 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.14 115.87 15.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.22 47.35 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -92.72 -60.5 1.8 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.011 0.434 . . . . 0.0 110.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -171.68 159.28 5.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.67 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.7 m -64.06 -26.73 68.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.91 0.386 . . . . 0.0 110.657 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -65.61 -18.6 65.45 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.25 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.07 60.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.04 0.448 . . . . 0.0 110.779 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -74.84 -170.27 1.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.871 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.7 46.7 0.68 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.813 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.621 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 mm-40 -91.75 -62.72 1.36 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.563 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -86.32 -33.56 20.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' ILE . 97.7 m-85 -72.72 2.38 6.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -51.79 -49.2 63.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 m -58.79 -39.75 82.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.29 33.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.35 -31.52 24.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -86.47 -31.1 21.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.799 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.1 m120 53.19 68.82 0.78 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.791 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.05 4.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.2 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.51 -13.51 40.69 Favored Glycine 0 C--O 1.225 -0.409 0 C-N-CA 121.314 -0.469 . . . . 0.0 112.855 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 21.6 t -72.04 -19.26 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.21 0.529 . . . . 0.0 110.295 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -85.16 156.0 21.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.286 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 9.5 p-10 -70.36 132.0 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.161 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.79 65.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 p -66.2 -33.49 75.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 28.5 t30 -63.44 -47.73 80.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.104 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.97 -37.9 77.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.307 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -66.66 -33.87 76.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.305 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -85.24 -58.62 2.61 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.8 pp -116.44 -26.78 6.98 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -58.38 -60.05 9.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.955 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -76.93 -11.13 59.77 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.607 -0.349 . . . . 0.0 111.507 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.33 -48.83 7.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 0.0 111.337 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 8' ' ' GLY . 48.4 t -84.51 -57.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 116' ' ' LEU . 6.2 mp -72.01 -42.95 65.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.308 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m 55.57 -101.76 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.35 -34.88 64.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.119 0.568 . . . . 0.0 112.448 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 113' ' ' LEU . 22.2 tp -59.78 -55.24 36.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.18 -29.47 67.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.63 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -60.53 -43.09 97.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.83 -40.34 75.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.466 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 116' ' ' LEU . 89.5 t -62.85 -38.36 81.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 75.6 m -55.88 -33.42 64.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 111.427 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 t -85.09 -35.82 21.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.222 0.534 . . . . 0.0 110.429 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.99 -84.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.24 -49.5 34.68 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.843 0.354 . . . . 0.0 111.712 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 40.8 tt0 -67.72 -28.77 67.94 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.53 -61.57 1.78 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.247 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -118.63 -17.82 9.18 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 117.306 0.553 . . . . 0.0 111.455 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.27 120.04 2.37 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.54 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.444 HG21 ' HA3' ' A' ' 38' ' ' GLY . 18.7 mt -88.32 124.29 41.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.658 0.266 . . . . 0.0 110.813 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -124.32 120.21 31.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.88 157.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.67 174.39 2.33 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.401 0.62 . . . . 0.0 112.155 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 13.1 m -80.49 33.38 0.3 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.879 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.81 -91.16 0.11 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.2 m -107.0 -21.26 13.06 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.06 -64.6 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 46.3 tp60 -61.27 -39.76 91.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -59.94 -44.13 94.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.981 0.42 . . . . 0.0 111.738 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.25 -48.42 34.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.744 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 137' ' ' GLN . 47.2 pt -64.25 -35.36 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.0 p -65.23 -35.72 81.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.405 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -74.89 -40.75 60.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.14 0.495 . . . . 0.0 110.608 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 24.5 t -82.69 -20.39 36.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.525 -176.564 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 77.6 p -64.15 -16.38 61.78 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 p -47.63 -19.65 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 149' ' ' THR . 71.2 m-85 -69.29 -16.51 63.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.959 -0.463 . . . . 0.0 111.327 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.66 -17.82 63.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.9 m -66.9 -45.97 76.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.873 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 146' ' ' PHE . 10.2 t -70.05 -30.33 67.58 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.799 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.9 t -59.98 -25.15 65.0 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.024 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 m -94.84 -48.29 6.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.694 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.2 m -160.51 120.16 2.76 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.083 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 159' ' ' ALA . 20.2 m -68.36 108.74 3.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.863 0.363 . . . . 0.0 110.084 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.38 -52.38 16.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.806 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.8 p -87.27 -1.86 58.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.588 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 t80 70.64 -38.62 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.74 0.816 . . . . 0.0 112.589 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -60.96 -17.51 51.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.176 0.513 . . . . 0.0 111.332 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.38 -18.08 62.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.068 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.413 ' HB2' ' OG ' ' A' ' 153' ' ' SER . . . -113.96 6.09 16.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.973 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 56.6 m -149.46 104.26 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.964 0.412 . . . . 0.0 111.309 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.22 33.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.9 t -77.69 93.68 4.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.305 0.574 . . . . 0.0 111.308 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.9 t -87.73 -14.63 39.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.188 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.8 t -76.75 -9.95 59.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.131 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.2 m -94.42 6.23 49.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.866 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 121.78 103.39 1.8 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.205 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -122.16 -34.42 3.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.949 0.404 . . . . 0.0 110.751 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.18 -74.01 1.48 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.996 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -111.06 -34.69 6.12 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.515 0.198 . . . . 0.0 111.054 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 177' ' ' THR . 23.0 m 64.86 88.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.128 0.49 . . . . 0.0 110.752 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' A' ' 172' ' ' PRO . . . 177.79 -148.76 8.83 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.666 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.447 ' HD2' ' HA3' ' A' ' 171' ' ' GLY . 4.9 Cg_endo -51.03 -40.17 59.38 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.261 2.64 . . . . 0.0 113.22 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.4 m -102.3 27.15 6.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.27 -163.86 11.31 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.843 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.76 168.77 24.07 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.724 2.283 . . . . 0.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 21.7 m -77.92 61.49 2.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.757 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 170' ' ' THR . 88.4 m -97.93 95.93 7.83 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 187' ' ' GLY . . . -179.92 79.04 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.311 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -39.77 104.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.398 2.732 . . . . 0.0 112.538 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.6 m -66.28 106.92 1.82 Allowed 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 162.61 -129.16 2.0 Allowed Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.462 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.662 ' N ' ' HD3' ' A' ' 183' ' ' PRO . 24.9 m-85 -151.41 36.43 0.1 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 182' ' ' TYR . 64.8 Cg_endo -85.4 124.78 2.83 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 C-N-CA 121.439 1.426 . . . . 0.0 112.156 -174.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.29 -106.93 2.02 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.051 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 183' ' ' PRO . 72.9 Cg_endo -88.42 -63.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.936 2.424 . . . . 0.0 112.576 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 198' ' ' GLY . 5.1 tt -145.37 -63.76 0.33 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 178' ' ' GLY . . . 179.1 78.83 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.92 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 74.12 -61.4 2.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.847 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -147.07 -78.53 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 67.4 158.71 0.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.596 . . . . 0.0 111.263 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.586 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 17.3 Cg_exo -70.49 -20.55 31.23 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.476 2.118 . . . . 0.0 111.539 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.7 t80 72.39 -13.17 0.65 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.783 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -77.5 55.67 3.72 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.708 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -110.63 173.55 6.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 13.6 t -93.91 11.6 28.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.985 0.421 . . . . 0.0 110.271 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 88.11 49.14 3.85 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -91.07 -27.68 18.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 186' ' ' LEU . . . -157.66 133.58 3.59 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.281 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.993 179.359 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.52 88.7 0.26 Allowed Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.462 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.21 144.52 69.1 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.602 2.202 . . . . 0.0 110.744 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -93.58 -39.93 10.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.066 0.46 . . . . 0.0 111.32 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.79 -65.52 0.33 Allowed Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.39 -32.35 57.99 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.69 120.17 41.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.0 79.2 0.28 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 140.88 51.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.49 0.186 . . . . 0.0 110.898 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m 69.07 89.69 0.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.803 0.689 . . . . 0.0 111.222 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.84 -153.11 24.09 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.183 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.93 39.74 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.275 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 108' ' ' LEU . . . -71.43 -6.96 44.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' ILE . 11.7 m -54.04 -30.33 47.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.994 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.22 -23.67 15.52 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 -41.47 6.39 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.7 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -22.52 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' SER . 11.7 pt -46.13 -50.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m -67.57 -21.14 65.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.714 0.292 . . . . 0.0 111.374 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HA ' ' HD3' ' A' ' 172' ' ' PRO . 69.1 mtt180 -89.96 -22.43 21.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 46.4 t -61.38 169.34 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.386 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.946 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -45.88 -21.55 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -69.05 -22.69 64.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.75 0.309 . . . . 0.0 111.253 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.88 -55.03 34.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HG ' ' HA3' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -76.13 -16.65 59.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.056 0.455 . . . . 0.0 110.304 -178.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 148' ' ' SER . . . -71.91 -48.51 45.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER 49.65 18.0 0.29 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 175.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 29' ' ' SER . 2.1 m -74.32 173.46 10.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.76 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 4.1 m -46.42 -28.54 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.377 1.071 . . . . 0.0 113.037 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -54.46 -32.53 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -112.57 -18.76 12.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.426 0.631 . . . . 0.0 109.863 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 5.6 tpp180 -67.68 -56.19 10.3 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.819 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -168.77 -36.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.31 136.69 24.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -49.63 139.79 12.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.439 0.638 . . . . 0.0 112.282 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 36' ' ' ARG . 6.9 ptm180 -58.77 164.65 2.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.34 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.2 111.36 9.29 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.549 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 77.91 47.34 8.63 Favored Glycine 0 N--CA 1.426 -2.014 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.068 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG21 HD11 ' A' ' 43' ' ' ILE . 8.2 p -56.41 143.75 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.035 0.445 . . . . 0.0 109.897 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 17.4 m -101.6 157.02 17.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -61.79 -12.83 19.02 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.861 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.85 -46.34 81.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.773 0.321 . . . . 0.0 110.368 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 39' ' ' VAL . 2.3 pp -85.93 -36.01 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.523 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.5 -65.9 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.802 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m 77.29 -18.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.856 0.862 . . . . 0.0 112.188 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -61.21 -73.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.658 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.14 -64.43 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.282 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -41.71 107.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.219 1.008 . . . . 0.0 113.652 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 20.6 mp0 -73.75 -53.66 9.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.628 ' HE ' HG13 ' A' ' 129' ' ' ILE . 26.1 ttt85 -145.36 4.39 1.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.856 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.73 -55.87 0.53 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.143 0.577 . . . . 0.0 110.779 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.41 131.34 46.19 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.62 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 9.3 mp0 -56.21 -18.09 9.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.699 -174.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -56.25 -69.9 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.839 0.352 . . . . 0.0 111.235 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 tp -87.9 -23.82 23.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.911 0.386 . . . . 0.0 111.14 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -76.73 -18.16 58.65 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 32.3 t -54.11 91.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.256 0.551 . . . . 0.0 111.339 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' HG ' ' A' ' 59' ' ' LEU . 1.9 t -151.6 -35.52 0.13 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.469 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 58' ' ' THR . 58.3 mt -115.57 19.79 15.12 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.41 54.55 7.6 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 38.7 t -89.6 107.97 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.801 -0.199 . . . . 0.0 110.666 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.16 82.36 0.22 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.27 -51.14 4.44 Favored Glycine 0 C--N 1.32 -0.319 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.359 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 17.2 p-10 -55.49 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.696 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.0 p-10 -85.73 14.82 5.32 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.278 0.561 . . . . 0.0 110.088 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 71' ' ' VAL . 26.0 tp -87.63 -60.41 1.98 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.52 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.74 64.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.356 0.598 . . . . 0.0 109.513 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.0 mpt_? -93.18 157.4 16.29 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 69.16 -62.66 0.4 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -67.46 -62.36 1.46 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' LEU . 82.0 t -56.24 -41.02 68.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -68.39 -37.14 80.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.24 84.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.99 -35.02 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.204 0.526 . . . . 0.0 110.284 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 t -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.689 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -89.18 -0.59 57.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.736 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 33.7 mt -67.25 134.33 93.39 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 39.5 Cg_exo -57.77 127.92 27.08 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.53 2.153 . . . . 0.0 111.908 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.42 19.19 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.519 0.676 . . . . 0.0 110.034 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.62 -28.99 70.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.181 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 p -80.67 -5.38 56.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.947 0.404 . . . . 0.0 109.973 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.1 t70 77.71 153.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.377 1.071 . . . . 0.0 111.274 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -65.13 -28.29 69.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.761 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.4 t -63.73 -22.74 67.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.19 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.73 -21.31 55.46 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.86 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.502 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 7.9 m-85 -82.85 -166.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.11 36.88 0.24 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.54 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -89.63 -59.7 2.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.05 82.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.107 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.557 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 94.1 m-85 -83.68 10.24 9.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.609 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 t -56.94 -40.79 77.05 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.226 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 69.9 m -57.98 -43.96 86.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.182 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.92 -31.89 64.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.411 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 22.1 mt -84.31 -21.54 30.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.978 0.418 . . . . 0.0 111.291 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' HB2' HH12 ' A' ' 36' ' ' ARG . 67.4 t80 -87.42 -38.52 16.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.139 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . 0.608 ' O ' HD22 ' A' ' 100' ' ' LEU . 17.7 m120 68.47 -74.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.894 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 75.33 -30.89 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.106 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.48 -4.35 64.14 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 13.7 t -101.78 42.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.342 1.068 . . . . 0.0 108.581 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.608 HD22 ' O ' ' A' ' 96' ' ' ASN . 2.6 pt? -137.81 -171.23 2.95 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.396 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.8 115.5 26.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.233 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.54 63.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.266 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 p -64.38 -37.35 87.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.83 -43.17 90.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.655 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.42 -44.95 94.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.09 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.78 -18.38 60.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.587 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 m -88.74 -62.29 1.52 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 13' ' ' ALA . 4.0 pp -116.53 -23.12 8.39 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.0 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' CA ' HD12 ' A' ' 117' ' ' LEU . . . -56.25 -63.52 5.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.997 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.0 m -77.71 -9.62 59.09 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.663 0.268 . . . . 0.0 111.496 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -89.46 -58.77 2.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.57 -58.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.938 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.3 mp -70.0 -45.77 66.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 t 52.65 -94.8 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.46 -1.245 . . . . 0.0 113.39 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.31 -37.23 35.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.1 tp -68.22 -58.7 4.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.214 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CA ' ' A' ' 109' ' ' GLY . 23.6 mt -66.49 -27.42 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -61.63 -37.46 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 109.784 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.44 -32.48 34.29 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 116' ' ' LEU . 96.4 t -63.09 -44.11 99.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.498 0.19 . . . . 0.0 110.735 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 69.2 m -54.62 -39.06 67.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.62 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.8 m -80.98 -41.86 22.1 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.446 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.84 -70.49 0.56 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.77 -41.79 61.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 58.5 tt0 -80.49 -17.53 51.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 109.841 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.53 -70.44 1.33 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.955 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.62 -24.25 14.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.738 0.304 . . . . 0.0 111.199 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.4 100.66 2.17 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.672 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HE ' ' A' ' 50' ' ' ARG . 15.0 mm -80.03 132.07 32.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.154 0.502 . . . . 0.0 111.569 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -148.23 145.97 28.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.271 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.19 142.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.03 -172.08 0.17 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 112.878 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 39.0 m -79.88 29.31 0.27 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.64 -79.09 0.22 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 t -110.25 -59.76 1.89 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.205 0.526 . . . . 0.0 110.822 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 140' ' ' ILE . 96.6 t -47.77 -63.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.365 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.1 tp-100 -56.34 -39.96 73.68 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -174.944 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.5 m -72.9 -26.9 61.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.804 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.52 -40.82 22.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.837 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.4 pt -79.38 -27.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 p -55.97 -62.13 1.91 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -63.94 -37.7 88.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.097 0.475 . . . . 0.0 111.227 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.4 m -66.09 -34.33 77.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.213 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.3 t -69.6 -21.06 63.62 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.051 0.453 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.6 m -70.55 -58.28 3.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.128 0.489 . . . . 0.0 110.303 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -90.78 -56.1 3.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.535 ' HB3' ' NH2' ' A' ' 32' ' ' ARG . 85.0 mt -68.83 -6.21 25.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -170.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 72.0 m -62.11 -54.43 41.43 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.662 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.7 p -113.11 -30.88 6.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.585 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 t 58.56 23.1 10.47 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.7 0.762 . . . . 0.0 110.193 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.2 t -105.95 176.61 5.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.587 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.6 p -73.2 -11.1 60.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.379 0.609 . . . . 0.0 110.101 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 157' ' ' SER . 8.0 m -93.71 -0.16 56.14 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.792 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.83 129.57 42.52 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.18 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.8 m 72.9 117.88 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.794 0.837 . . . . 0.0 112.063 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.19 -51.76 0.71 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.045 0.938 . . . . 0.0 112.936 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' SER . 34.9 t -70.65 -41.22 72.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.982 0.42 . . . . 0.0 111.223 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.11 -16.26 63.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.527 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.23 20.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -76.31 -15.21 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.281 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.98 -176.12 3.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.8 m -77.57 37.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.945 0.402 . . . . 0.0 111.428 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 163' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 167' ' ' ALA . 16.7 t -73.7 -41.85 62.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.7 m -77.71 -8.83 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.121 0.486 . . . . 0.0 110.847 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.9 m -68.87 -21.69 64.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 149.27 -37.14 1.0 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.947 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . -101.13 102.28 13.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.78 -48.03 84.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.972 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -140.15 145.21 37.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 171' ' ' GLY . 1.6 m -125.73 -147.13 0.36 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 170' ' ' THR . . . -69.74 -162.56 3.53 Favored Glycine 0 C--O 1.218 -0.898 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.905 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 20' ' ' ARG . 52.0 Cg_exo -59.94 -16.61 39.62 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.013 2.476 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' SER . . . . . 0.476 ' HB3' ' HA3' ' A' ' 187' ' ' GLY . 48.5 m -105.24 0.99 27.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.837 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' HA3' ' HG ' ' A' ' 25' ' ' LEU . . . 45.58 -156.27 0.41 Allowed Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.77 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.37 76.68 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 122.976 2.451 . . . . 0.0 111.486 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 13.8 t 67.72 31.33 6.0 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.014 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.1 t -108.0 -28.15 9.74 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.364 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.474 ' HA2' ' HA3' ' A' ' 187' ' ' GLY . . . 62.45 -165.82 22.31 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.039 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.01 56.86 5.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.845 2.364 . . . . 0.0 110.78 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.9 t 65.93 25.7 11.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.487 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -173.97 170.59 43.73 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.22 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' N ' ' HD3' ' A' ' 183' ' ' PRO . 3.1 t80 60.91 51.53 2.44 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.042 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 182' ' ' TYR . 53.0 Cg_endo -84.83 157.85 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.139 1.893 . . . . 0.0 111.521 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.94 -69.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.026 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.96 -66.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.088 1.858 . . . . 0.0 111.488 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 199' ' ' GLY . 12.0 tp -158.79 -41.24 0.06 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.483 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 173' ' ' SER . . . 147.28 34.99 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.231 -0.985 . . . . 0.0 113.566 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.29 -85.52 1.23 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.635 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -74.29 -68.43 1.57 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.217 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 64.38 150.47 0.11 Allowed Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.688 0.795 . . . . 0.0 111.456 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -66.77 126.41 15.3 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.09 1.86 . . . . 0.0 111.749 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -71.38 -12.13 61.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 109.874 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -105.95 78.25 0.26 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.871 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -125.28 147.52 49.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.038 0.447 . . . . 0.0 111.413 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 17.2 t -91.51 6.17 46.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.472 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 112.36 2.89 26.05 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.283 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -88.92 100.28 13.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.939 0.4 . . . . 0.0 110.875 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 156.45 164.97 13.99 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.227 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 186' ' ' LEU . . . . . . . . 0 C--O 1.245 0.809 0 CA-C-O 118.727 -1.041 . . . . 0.0 111.46 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.708 0.29 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.97 92.11 0.21 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.1 172.11 16.99 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.573 2.182 . . . . 0.0 111.363 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -82.71 29.62 0.45 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.667 0.27 . . . . 0.0 111.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.96 -111.24 3.78 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.529 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -13.0 62.5 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.302 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.05 23.13 14.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.145 0.498 . . . . 0.0 109.974 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 113' ' ' LEU . . . -78.11 170.41 54.88 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.598 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -79.02 -168.76 1.56 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.9 p 62.42 105.85 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.661 1.184 . . . . 0.0 112.616 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA2' HG11 ' A' ' 112' ' ' VAL . . . -108.76 43.11 1.78 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.972 -176.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.92 -85.1 0.16 Allowed Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.328 0.491 . . . . 0.0 114.328 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.01 72.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.639 0.376 . . . . 0.0 111.615 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' ILE . 9.6 m -58.67 -31.45 68.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.396 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.3 62.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.41 -35.82 8.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.8 pp -85.63 -21.94 28.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' SER . 11.9 pt -37.75 -52.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.0 m -71.61 -24.67 61.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.503 ' NH2' ' HA ' ' A' ' 169' ' ' TYR . 93.9 mtt180 -87.58 -23.13 24.42 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 22' ' ' ALA . 31.6 t -62.34 174.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.425 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.582 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -37.57 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 10.6 m-80 -63.5 -24.56 67.87 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.102 -0.374 . . . . 0.0 111.851 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.89 -35.91 79.74 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.354 0.597 . . . . 0.0 109.437 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 tp -80.23 -35.06 36.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.715 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.99 77.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.021 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 9.6 t-20 59.2 13.25 2.92 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.172 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 29' ' ' SER . 1.5 m -83.56 168.54 16.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.283 0.563 . . . . 0.0 112.066 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.648 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 1.8 m -51.92 -26.22 9.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.62 1.168 . . . . 0.0 112.927 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 p -53.29 -40.82 65.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.872 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -99.63 -19.52 16.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.598 0.713 . . . . 0.0 109.646 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.648 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 16.1 tpp180 -66.22 -64.62 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.605 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 83' ' ' THR . 12.3 t -164.77 -23.74 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.122 -174.255 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.94 137.59 20.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.99 140.43 25.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.063 0.459 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -65.82 164.52 14.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.681 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 131' ' ' VAL . 2.4 p -70.7 111.88 6.5 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.16 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.0 43.23 8.93 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 87' ' ' ALA . 9.2 p -46.07 138.65 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 111.815 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.6 m -70.78 137.99 50.05 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.37 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 48.4 tt0 -62.69 -13.44 32.25 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.165 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -52.62 -42.21 64.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.006 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.62 -39.53 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.539 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.24 -68.0 0.74 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.471 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 5.9 m 71.64 -33.74 0.28 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -66.24 -79.26 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' CG2' HD21 ' A' ' 65' ' ' ASN . 7.5 p -118.74 -30.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.259 0.552 . . . . 0.0 111.526 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.37 92.78 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 74.9 mt-30 -81.11 -40.44 24.05 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.162 0.506 . . . . 0.0 110.126 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.619 ' NH1' HD13 ' A' ' 55' ' ' LEU . 11.2 ttm180 -149.03 -1.4 0.48 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.656 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.23 -55.74 0.6 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.094 0.557 . . . . 0.0 110.259 -175.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.46 131.0 47.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.378 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' SER . 4.8 pm0 -54.9 -17.77 4.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.852 -177.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.619 HD13 ' NH1' ' A' ' 50' ' ' ARG . 2.2 tt -88.59 -24.09 22.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 111.385 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.8 -18.5 62.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.3 t -55.34 96.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.299 0.571 . . . . 0.0 110.729 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.0 t -132.99 -30.06 1.4 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.171 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 94.4 mt -120.26 20.09 12.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.804 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.58 66.85 1.64 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.38 109.73 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.38 87.02 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.6 -53.05 3.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.734 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.1 p-10 -61.45 -73.72 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.386 0.674 . . . . 0.0 112.321 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 66.2 t30 -84.75 11.66 8.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.675 0.75 . . . . 0.0 109.622 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.83 -70.48 0.63 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.279 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 -34.03 39.75 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.42 0.629 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 56.5 mtm180 -99.46 157.72 16.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.622 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 68.03 -57.05 0.48 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.511 0.725 . . . . 0.0 112.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.17 0.91 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.703 0.287 . . . . 0.0 111.355 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.64 -35.5 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -68.08 -25.51 65.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.342 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.71 23.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.382 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.98 -32.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.245 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -69.89 -14.74 62.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.229 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 44.5 ttp180 -87.62 -15.71 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.111 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.66 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 9.4 mp -84.23 108.17 13.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.29 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 76' ' ' ARG . 73.8 Cg_endo -76.81 128.46 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.205 1.937 . . . . 0.0 111.781 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.59 86.32 7.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.97 -50.41 6.4 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -63.8 -61.69 2.13 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 120.628 0.251 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -179.46 159.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.709 ' HB ' ' OE1' ' A' ' 88' ' ' GLN . 12.6 p -77.4 -23.43 50.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.225 0.536 . . . . 0.0 110.674 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 m -63.08 -18.0 62.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.464 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.4 64.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.131 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.66 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 64.3 m-85 -84.94 -171.99 3.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.083 0.468 . . . . 0.0 110.35 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -77.11 25.63 0.16 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.582 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.709 ' OE1' ' HB ' ' A' ' 83' ' ' THR . 76.3 mt-30 -86.18 -56.73 3.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.632 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.73 -29.34 68.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.376 0.607 . . . . 0.0 110.036 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.545 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.0 m-85 -84.31 3.76 34.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -50.71 -35.89 33.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 70.3 m -53.92 -53.41 53.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.73 -24.03 33.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 51.1 mt -84.82 -36.13 21.84 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -85.2 -41.1 15.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.93 90.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.501 0.667 . . . . 0.0 111.648 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.76 -0.97 55.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.823 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.02 -3.14 85.36 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.712 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 197' ' ' PHE . 10.5 t -100.57 -13.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 109.929 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -84.02 167.42 16.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.365 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -77.44 104.4 7.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.674 0.75 . . . . 0.0 110.385 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -13.04 61.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.682 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -69.21 -34.46 74.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -35.78 77.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.74 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.59 -41.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.211 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.83 -18.09 51.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.031 0.443 . . . . 0.0 111.463 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.1 m -81.82 -58.63 2.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.391 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.2 -20.92 4.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 117' ' ' LEU . . . -57.37 -68.41 1.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.158 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' SER . 6.5 p -67.4 -16.82 64.45 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -84.64 -45.54 12.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.666 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG11 ' HA2' ' A' ' 11' ' ' GLY . 48.1 t -84.47 -50.79 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.597 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 6.5 mp -70.59 -34.36 72.08 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.006 0.431 . . . . 0.0 110.317 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' SER . 50.8 m 48.16 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.96 -36.77 50.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 9' ' ' ALA . 57.1 tp -69.3 -60.16 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.991 -178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 109' ' ' GLY . 49.0 mt -64.34 -34.23 77.68 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -69.77 -22.67 63.32 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.109 0.481 . . . . 0.0 110.907 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.13 -32.78 11.65 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.936 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 94' ' ' LEU . 54.2 t -76.24 -29.92 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.996 0.518 . . . . 0.0 111.914 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 15.8 p -52.2 -44.04 64.53 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.306 0.642 . . . . 0.0 112.592 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.1 p -84.47 -26.46 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.923 0.392 . . . . 0.0 111.481 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.83 -78.45 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.449 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.34 -49.16 45.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 37.2 tt0 -72.07 -21.33 61.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.09 -56.13 2.5 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.204 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.6 mt -126.95 -25.01 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.998 0.399 . . . . 0.0 111.786 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.55 107.95 3.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.001 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' THR . 32.6 mt -76.37 126.83 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -120.81 135.57 55.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 132' ' ' ASP . 12.7 t -89.09 172.83 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 131' ' ' VAL . 3.5 p-10 -60.45 162.61 6.07 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.548 0.689 . . . . 0.0 112.018 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.4 t -80.16 6.61 11.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.301 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.27 -78.94 0.61 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.295 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 m -93.73 -39.89 10.52 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.27 -62.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.435 ' HA ' HG12 ' A' ' 140' ' ' ILE . 57.3 tt0 -59.18 -39.79 83.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -59.4 -43.98 92.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.442 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.58 -50.01 19.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 137' ' ' GLN . 42.0 pt -60.67 -38.46 78.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.812 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 t -65.7 -40.03 91.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.3 m -70.8 -42.44 70.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 t -72.42 -42.44 65.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.634 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.67 ' HA ' ' OG ' ' A' ' 148' ' ' SER . 23.5 t -60.33 -41.82 94.36 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 111.445 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.0 m -67.43 -43.94 79.97 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.887 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -89.97 -58.19 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.53 -42.63 34.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -171.574 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 144' ' ' SER . 18.5 m -58.96 -32.02 69.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.44 ' C ' ' HG ' ' A' ' 150' ' ' SER . 39.6 p -130.81 -45.05 1.05 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.251 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 149' ' ' THR . 53.7 p 54.66 -85.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.088 0.955 . . . . 0.0 112.822 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -144.19 105.03 4.18 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t 70.49 -76.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 158' ' ' GLN . 8.6 t -127.23 158.93 35.83 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.8 166.88 20.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.601 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 156' ' ' TYR . 21.9 m -59.98 146.29 43.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 155' ' ' SER . 89.5 t80 76.12 -37.85 0.32 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.432 0.693 . . . . 0.0 111.293 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' SER . . . . . 0.488 ' HA ' ' OG ' ' A' ' 176' ' ' SER . 46.0 t -59.06 -61.77 2.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 11.0 pt20 -69.96 -16.43 63.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.56 -23.72 42.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.676 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -105.53 -89.88 0.42 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.865 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 175' ' ' PRO . . . 53.66 -166.08 0.08 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 122.955 0.502 . . . . 0.0 111.95 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t 61.07 87.59 0.09 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.492 0.717 . . . . 0.0 112.264 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 t -77.14 -5.28 48.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.63 0.729 . . . . 0.0 109.268 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -83.42 -45.66 13.42 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.61 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.9 t -65.47 -32.29 73.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.452 0.644 . . . . 0.0 109.775 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.12 138.48 5.79 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.82 156.05 38.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.953 0.376 . . . . 0.0 110.72 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 137.13 9.56 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' TYR . . . . . 0.503 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 49.9 m-85 74.84 17.55 2.81 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.764 0.826 . . . . 0.0 109.344 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.2 p -51.19 121.58 6.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.516 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 128.55 -121.7 3.74 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.631 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.18 -7.22 11.08 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.967 2.445 . . . . 0.0 113.576 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.5 t -115.46 -2.68 12.51 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.562 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.03 -133.29 1.47 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.64 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 161' ' ' ALA . 3.0 Cg_exo -75.51 106.63 2.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.087 1.858 . . . . 0.0 110.896 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 3.5 m -67.03 93.36 0.28 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.6 t -92.54 18.27 8.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.927 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.73 75.13 0.43 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.883 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -86.63 150.42 8.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.842 2.361 . . . . 0.0 112.905 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.2 m -87.79 2.12 52.14 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.828 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.75 -11.51 85.16 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.241 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.8 152.55 77.26 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.13 124.63 14.26 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 110.817 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.75 92.4 0.13 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.267 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.84 20.26 0.54 Allowed 'Trans proline' 0 N--CA 1.475 0.429 0 C-N-CA 122.916 2.411 . . . . 0.0 112.551 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 75.0 mt -92.86 87.93 6.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.991 0.424 . . . . 0.0 110.18 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.97 71.93 2.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.772 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.65 -99.92 1.05 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -91.74 89.48 1.43 Allowed Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.661 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -99.9 147.73 33.85 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.484 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 88.8 Cg_endo -92.4 1.33 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.281 1.987 . . . . 0.0 112.775 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -63.07 -21.28 66.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.715 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . 136.3 -61.96 0.61 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.832 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 57.35 38.23 28.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.281 0.633 . . . . 0.0 111.586 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 40.6 p -79.08 23.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.652 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 89.16 51.99 2.84 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.49 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.419 ' CD1' HG22 ' A' ' 99' ' ' VAL . 79.6 t80 -75.11 -38.08 61.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.023 0.44 . . . . 0.0 110.737 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 97.44 -126.37 8.84 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.793 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.117 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.56 -179.492 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.573 0.225 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.5 93.24 0.61 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.23 174.93 8.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.68 2.254 . . . . 0.0 111.688 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.19 62.28 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.633 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.85 64.02 4.77 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.005 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.47 -42.78 1.86 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.585 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -81.87 89.78 6.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.989 0.424 . . . . 0.0 109.963 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.31 118.8 5.8 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.521 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . . . -71.07 126.66 30.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.83 154.74 18.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.755 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.24 151.25 19.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.231 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.94 -65.33 0.2 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.998 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.6 71.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.142 0.496 . . . . 0.0 110.732 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.6 m -66.91 -21.58 65.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.83 -18.52 44.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.8 -43.59 5.69 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.334 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -84.21 -21.88 31.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 89' ' ' ALA . 8.9 pt -46.2 -47.31 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m -73.39 -20.0 60.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.749 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 191' ' ' PRO . 32.3 mtm180 -86.03 -33.5 21.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.696 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 100' ' ' LEU . 58.0 t -50.16 168.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.088 0.555 . . . . 0.0 111.406 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.516 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.72 -28.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 m-80 -60.39 -28.9 68.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.729 0.241 . . . . 0.0 111.436 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.21 -44.93 93.91 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.292 0.568 . . . . 0.0 109.85 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.2 -38.21 66.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.156 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.96 80.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 1.6 t-20 54.55 17.84 1.79 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.446 174.042 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 m -77.76 166.33 23.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.496 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.8 m -61.11 -16.98 50.18 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 122.78 0.432 . . . . 0.0 112.105 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -52.23 -34.44 45.79 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -108.14 -21.58 12.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -79.85 -42.78 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t -158.19 -50.5 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.211 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.6 129.97 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 1.5 pt? -50.32 139.9 14.27 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.456 0.472 . . . . 0.0 111.808 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -60.75 159.75 10.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.867 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 1.7 p -77.47 142.71 39.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.064 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.57 71.46 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.538 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 147.81 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.799 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 10.3 m -106.75 161.83 14.32 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.95 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -66.23 -13.75 60.83 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.555 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -54.95 -43.72 73.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -86.62 -36.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.525 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.48 -39.96 19.86 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m 78.32 -18.36 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.108 0.963 . . . . 0.0 111.476 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 m -76.51 -162.24 0.24 Allowed 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 122.212 1.006 . . . . 0.0 110.721 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 59' ' ' LEU . 35.0 m -74.64 -20.55 16.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.516 -176.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.38 84.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.551 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 40' ' ' SER . 74.5 mt-30 -83.62 -43.99 15.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 0.0 111.86 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 51.0 ttt180 -132.19 -10.11 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.63 -36.69 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.294 0.638 . . . . 0.0 110.646 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -80.22 150.95 29.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.795 0.331 . . . . 0.0 110.11 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' SER . 21.2 mp0 -56.28 -34.3 66.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -174.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.9 m -54.48 -70.85 0.09 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -86.18 -25.02 25.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -80.42 -18.82 47.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -65.92 79.82 0.08 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.72 0.772 . . . . 0.0 111.46 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -100.97 -28.51 12.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.038 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 47' ' ' VAL . 89.6 mt -122.37 19.17 10.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.019 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.62 1.41 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.765 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.685 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 65.7 t -88.38 120.07 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.882 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 t70 178.46 90.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.504 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.03 -57.4 3.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.954 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -55.85 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.266 0.626 . . . . 0.0 111.547 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.685 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.3 p-10 -87.38 21.25 2.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.059 0.456 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.15 -72.73 0.54 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.689 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.32 -7.98 50.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.303 0.573 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.32 170.61 13.91 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 66.05 -62.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.59 -64.02 1.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.769 0.318 . . . . 0.0 110.882 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 98.3 mt-30 -63.35 -37.1 85.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.602 0.239 . . . . 0.0 111.49 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.58 -48.6 25.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.089 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.74 -42.15 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.589 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.0 p -74.06 -4.96 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 111.032 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 34.1 ttm180 -98.11 -0.5 44.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.195 0.521 . . . . 0.0 110.535 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.96 144.37 87.71 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.227 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.93 144.03 46.75 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.558 2.172 . . . . 0.0 112.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.51 22.33 13.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.201 0.524 . . . . 0.0 110.938 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.01 63.77 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -76.43 -6.39 51.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.477 -0.362 . . . . 0.0 110.54 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 75.89 157.51 0.19 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.891 0.876 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.434 HG22 ' HG3' ' A' ' 88' ' ' GLN . 9.3 m -66.49 -25.91 66.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.759 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.2 m -65.22 -18.78 65.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.55 -21.06 61.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.02 0.438 . . . . 0.0 110.606 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -77.83 -167.58 1.02 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.4 14.98 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.998 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 35' ' ' LEU . 8.2 mm100 -71.71 -37.54 70.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.001 0.429 . . . . 0.0 111.288 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' O ' HD12 ' A' ' 18' ' ' ILE . . . -67.89 -62.16 1.54 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.84 32.41 0.48 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.142 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.7 m -50.54 -55.7 14.95 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.6 m -63.97 -36.3 83.5 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.97 70.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.538 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 40.0 mt -84.57 -23.49 29.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.505 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -85.56 -47.36 9.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.743 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.36 61.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.241 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.17 1.99 71.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.86 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.35 -15.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.481 0.657 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.51 179.28 7.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.255 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -75.23 125.77 29.64 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 111.662 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.65 61.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.276 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.7 t -65.18 -35.01 79.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.513 ' O ' HD13 ' A' ' 108' ' ' LEU . 11.1 t30 -61.01 -50.42 73.45 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.047 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ILE . . . . . 0.522 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -66.69 -38.09 80.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.827 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -30.41 69.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.875 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -80.1 -62.96 1.52 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -122.22 -15.5 7.68 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.731 -176.764 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -56.11 -72.02 0.64 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.795 -0.716 . . . . 0.0 113.638 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 m -70.82 -10.35 59.37 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 111' ' ' ARG . 6.0 mpt_? -86.68 -53.99 4.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.35 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.27 -54.66 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.017 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mp -63.13 -31.97 73.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.1 p 38.71 -93.14 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.25 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.427 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 120' ' ' VAL . 65.4 tp -68.61 -52.63 29.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.042 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 18.8 mt -61.44 -28.18 69.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -59.13 -36.98 76.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.402 . . . . 0.0 110.208 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.45 -33.58 11.45 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.969 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.1 t -60.99 -31.7 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.3 m -48.65 -52.04 25.26 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.294 0.371 . . . . 0.0 111.936 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 p -83.68 -21.42 32.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 111.09 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 120' ' ' VAL . . . -81.31 -93.76 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.13 29.43 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.01 -29.77 71.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.18 -90.91 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.4 mt -112.56 -8.29 13.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.774 0.321 . . . . 0.0 111.553 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.14 98.85 0.94 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.153 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 37' ' ' THR . 25.1 mm -67.66 139.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 137' ' ' GLN . 18.7 t-20 -90.55 136.06 33.3 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 133' ' ' SER . 30.7 t -75.66 146.07 9.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.906 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.47 -37.31 83.14 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 122.083 0.944 . . . . 0.0 111.068 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 131' ' ' VAL . 38.9 t -58.65 107.59 0.53 Allowed 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.026 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.75 -17.91 29.76 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.199 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.1 m -65.57 -37.44 86.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.993 0.425 . . . . 0.0 110.197 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 140' ' ' ILE . 46.4 t -77.99 -50.69 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.796 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.433 ' HG3' HD21 ' A' ' 130' ' ' ASN . 46.7 tt0 -59.25 -49.62 77.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.708 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -65.75 -28.74 69.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.04 -54.9 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.451 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 136' ' ' VAL . 42.6 pt -58.92 -34.77 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.255 -177.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.6 t -50.59 -49.34 56.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.262 0.351 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -84.84 -42.47 15.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.852 0.358 . . . . 0.0 111.831 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' SER . . . . . 0.441 ' HA ' HD23 ' A' ' 147' ' ' LEU . 62.9 m -57.79 -38.84 76.2 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 148' ' ' SER . 43.8 p -65.78 -20.53 66.29 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -82.44 -55.51 4.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.697 0.284 . . . . 0.0 111.238 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.6 -46.23 17.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 143' ' ' SER . 2.9 mm? -82.03 6.81 15.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' SER . 23.8 t -51.34 -29.37 15.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 153' ' ' SER . 4.0 m -157.7 24.42 0.28 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.526 0.679 . . . . 0.0 109.254 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 p -54.99 -64.31 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.263 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.4 t -84.67 35.31 0.56 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 175' ' ' PRO . 32.4 t -132.96 -87.98 0.43 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.477 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . 0.545 ' H ' HG22 ' A' ' 149' ' ' THR . 33.1 m -156.67 52.1 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.649 0.261 . . . . 0.0 110.71 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.42 65.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.553 0.692 . . . . 0.0 109.548 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.4 t -108.77 144.41 36.63 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -58.71 -33.19 69.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.172 0.511 . . . . 0.0 110.312 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.2 m -69.56 -10.92 60.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.516 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 153' ' ' SER . 97.7 mt-30 -94.86 -9.42 34.39 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 110.403 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.91 -20.9 60.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.33 0.586 . . . . 0.0 109.612 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 t -94.92 36.7 1.18 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.834 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.54 161.45 27.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.351 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 m -70.11 90.81 0.67 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.193 0.521 . . . . 0.0 111.268 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 p -137.29 15.81 2.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.123 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.2 m -63.38 -29.43 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.147 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 p -81.98 1.08 37.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.27 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 99.47 -9.06 60.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 72.59 -50.69 0.7 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.881 . . . . 0.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.5 -69.18 3.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.582 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -73.54 -60.41 2.26 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.336 0.112 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 48.5 m 56.75 82.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.241 0.543 . . . . 0.0 111.913 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 122.24 -79.99 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.812 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.64 -44.21 49.34 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.545 2.83 . . . . 0.0 112.582 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.4 m -146.33 43.45 1.21 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -142.4 -173.85 14.56 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.489 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 152' ' ' SER . 89.4 Cg_endo -83.61 9.9 3.91 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.839 2.36 . . . . 0.0 112.142 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 13.4 m 49.8 42.1 23.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 t -59.87 143.23 51.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.59 0.71 . . . . 0.0 111.962 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.38 68.24 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.79 115.34 2.55 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.139 2.56 . . . . 0.0 113.381 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.5 m -78.76 135.77 37.2 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.699 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.56 30.28 14.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.475 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' TYR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 183' ' ' PRO . 36.8 m-85 -132.1 151.0 77.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 182' ' ' TYR . 2.5 Cg_endo -80.38 141.92 14.54 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.601 2.201 . . . . 0.0 111.72 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.38 67.09 1.55 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.5 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.1 175.41 9.24 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.66 2.24 . . . . 0.0 112.267 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' LEU . . . . . 0.422 HD21 ' O ' ' A' ' 193' ' ' GLY . 3.7 mm? 63.61 18.67 11.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.502 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -111.93 113.69 3.38 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.63 -64.39 4.07 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -102.11 128.32 9.51 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' ALA . . . . . 0.592 ' H ' ' HD2' ' A' ' 191' ' ' PRO . . . -119.36 -50.58 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -174.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.592 ' HD2' ' H ' ' A' ' 190' ' ' ALA . 57.0 Cg_endo -67.02 13.28 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.934 1.756 . . . . 0.0 114.75 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -94.46 -7.03 42.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' HD21 ' A' ' 186' ' ' LEU . . . -163.18 62.98 0.26 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 191' ' ' PRO . 32.6 mt-30 -77.81 -32.34 52.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.002 0.43 . . . . 0.0 111.786 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.4 p -85.1 19.22 2.25 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.119 0.485 . . . . 0.0 110.288 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.57 21.01 75.91 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -176.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -69.28 134.19 48.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.586 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.75 162.07 32.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.63 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.431 -1.205 . . . . 0.0 111.726 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.14 104.41 0.26 Allowed Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.438 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.5 Cg_endo -73.81 179.27 5.83 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.584 2.19 . . . . 0.0 111.713 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 7' ' ' PHE . 6.6 tp-100 -89.15 150.36 22.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.7 98.89 0.17 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.583 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.73 -3.26 52.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.282 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 45.3 m-85 -135.48 87.52 2.33 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.071 0.462 . . . . 0.0 110.145 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.23 129.9 9.91 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.286 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -86.59 -176.64 5.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.719 0.295 . . . . 0.0 111.007 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p 53.14 86.55 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.688 0.795 . . . . 0.0 112.255 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.37 163.87 54.54 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.652 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.22 -40.8 6.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.066 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' HD13 ' A' ' 108' ' ' LEU . . . -67.47 -45.43 75.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.935 0.398 . . . . 0.0 110.997 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 18' ' ' ILE . 16.7 m -68.06 -22.63 64.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.044 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.66 58.61 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.16 -38.84 7.12 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.117 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 pp -84.83 -22.35 29.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 14' ' ' SER . 10.1 pt -44.75 -48.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 t -84.67 -20.14 31.73 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.552 0.215 . . . . 0.0 111.377 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HG2' ' HG3' ' A' ' 172' ' ' PRO . 62.0 mtt180 -86.89 -25.94 24.19 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.103 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.9 t -74.21 -107.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -79.1 -35.81 41.73 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.98 -24.25 66.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.482 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.25 -45.37 88.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.068 0.461 . . . . 0.0 110.316 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.16 -18.95 44.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.787 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HA ' HD23 ' A' ' 147' ' ' LEU . . . -71.56 -38.33 70.97 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.922 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASN . . . . . 0.492 ' HB3' ' CB ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER 57.58 16.98 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 176.934 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -75.82 167.68 21.44 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.7 m -72.23 -14.26 61.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLN . 19.0 p -50.2 -53.3 28.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.753 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -78.71 -19.73 51.73 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.151 0.5 . . . . 0.0 110.985 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -76.74 -52.98 8.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.631 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -169.05 -19.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.84 136.26 23.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -55.91 149.61 14.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 0.0 111.243 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 87' ' ' ALA . 7.7 ptm180 -76.06 164.45 26.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.405 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.01 109.3 9.54 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.984 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 94.49 37.69 5.24 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.841 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG23 HD11 ' A' ' 43' ' ' ILE . 2.3 p -48.38 124.94 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.251 0.548 . . . . 0.0 109.957 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 16.5 m -85.67 167.0 15.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 14.7 pt20 -69.14 -13.15 62.26 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.243 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' OE1' ' HA ' ' A' ' 3' ' ' PRO . 65.8 mm-40 -63.02 -55.0 29.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.305 0.574 . . . . 0.0 109.869 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -85.27 -32.19 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.717 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . . . -78.54 -61.69 1.93 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.499 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 87.0 p 68.82 -31.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.687 1.595 . . . . 0.0 115.291 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.5 m -66.27 -73.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.79 -27.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.838 0.351 . . . . 0.0 111.841 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -80.47 100.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.351 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' SER . 44.6 mt-30 -82.17 -34.85 28.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.082 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . 0.638 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 16.5 ttt85 -158.03 4.34 0.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.731 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' N ' ' HB2' ' A' ' 56' ' ' ALA . . . 67.87 -52.83 0.52 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.067 0.547 . . . . 0.0 110.841 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' CB ' HG13 ' A' ' 129' ' ' ILE . . . -63.51 137.41 58.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.222 177.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLN . . . . . 0.566 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 17.5 mp0 -53.49 -26.89 22.47 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -60.83 -67.57 0.39 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.815 0.34 . . . . 0.0 111.885 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.468 HD23 ' HD2' ' A' ' 50' ' ' ARG . 25.9 tp -87.83 -24.01 23.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -78.57 -19.1 53.55 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 5.8 t -62.39 88.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.406 0.622 . . . . 0.0 111.491 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.607 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 8.2 t -112.23 -32.46 6.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.819 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.486 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.1 mt -121.6 18.83 11.22 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.946 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 67.56 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 HD21 ' A' ' 65' ' ' ASN . 36.9 t -89.89 120.84 39.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.712 0.292 . . . . 0.0 111.158 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -170.85 83.89 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.883 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -47.29 3.55 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ASN . . . . . 0.478 ' HA ' HH21 ' A' ' 68' ' ' ARG . 18.0 p-10 -54.33 -83.19 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.735 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.458 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 29.2 p-10 -87.99 24.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.303 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 tp -87.0 -66.4 0.91 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.067 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.26 62.02 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.479 0.657 . . . . 0.0 110.412 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.478 HH21 ' HA ' ' A' ' 64' ' ' ASN . 29.9 mtm180 -110.39 165.63 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 68.05 -61.91 0.37 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.69 3.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.864 0.364 . . . . 0.0 111.492 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.525 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -65.27 -35.77 82.06 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.644 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.14 -47.71 60.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.857 0.36 . . . . 0.0 111.397 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.67 -34.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.987 0.422 . . . . 0.0 110.932 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.0 p -73.94 -23.06 59.46 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.158 0.504 . . . . 0.0 110.457 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -87.08 -15.03 39.74 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.919 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.1 tp -73.32 123.78 89.83 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.126 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.94 157.46 23.93 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.608 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.54 121.09 38.6 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.0 -60.4 4.21 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.6 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -80.31 -60.3 2.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.857 0.361 . . . . 0.0 111.755 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.99 160.47 42.07 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.9 m -70.25 -35.09 73.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.077 0.465 . . . . 0.0 110.262 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 p -68.7 -17.02 64.0 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.701 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.82 -21.31 56.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.852 0.461 . . . . 0.0 111.399 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -72.14 -161.71 0.08 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.971 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -77.85 18.48 0.47 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 33.9 mt-30 -80.83 -56.63 4.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.144 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.38 -35.88 82.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.085 0.469 . . . . 0.0 110.278 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -82.4 13.37 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.556 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -59.21 -44.3 92.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -62.96 -41.06 99.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.66 69.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.687 0.28 . . . . 0.0 111.48 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 28.3 mt -84.78 -19.54 32.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.022 0.439 . . . . 0.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.88 -36.98 19.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.59 80.84 0.14 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.989 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.03 -12.2 60.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.811 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.62 -11.93 64.8 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.95 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.65 -15.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.325 0.583 . . . . 0.0 109.977 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -84.8 161.39 19.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.801 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASN . . . . . 0.473 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 46.2 t30 -67.82 107.25 2.54 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.526 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.63 -15.84 63.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.951 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -74.52 -27.6 60.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -71.41 -33.99 69.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.166 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 34.8 mm -66.11 -34.23 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.21 -32.37 66.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.196 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.4 m -68.55 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.853 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -121.28 -21.09 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -56.2 -65.21 3.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.944 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -71.91 -11.54 60.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.802 0.334 . . . . 0.0 111.603 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -87.04 -61.07 1.81 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.19 -56.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.548 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 17.0 mt -62.42 -55.23 29.81 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.181 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.7 t 55.42 -87.04 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.107 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.34 66.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 122.947 0.499 . . . . 0.0 111.459 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.3 tp -67.02 -49.88 63.86 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 21.3 mt -66.97 -25.1 66.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.928 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.76 -36.57 81.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 109.666 175.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.13 -17.69 58.82 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.227 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.8 t -85.25 -44.02 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 11.8 p -52.49 -61.82 2.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 t -76.0 -23.84 55.28 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.085 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.499 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -83.57 -80.21 0.19 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ALA . . . . . 0.626 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -72.51 -44.67 61.9 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.662 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 121' ' ' SER . 42.6 tt0 -70.96 -34.76 71.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.281 0.562 . . . . 0.0 110.097 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.43 -63.2 2.54 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.043 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.87 -23.98 11.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.92 97.3 1.22 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ILE . . . . . 0.514 HG13 ' CB ' ' A' ' 52' ' ' ALA . 1.2 mp -81.54 136.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.539 0.685 . . . . 0.0 112.229 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -135.14 137.33 42.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.105 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -80.85 156.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.4 169.15 1.79 Allowed 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 3.0 m -74.31 39.42 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.63 -93.86 0.2 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.9 t -106.44 -43.38 4.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.887 0.375 . . . . 0.0 110.273 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.1 t -51.96 -62.48 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.409 -173.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 41.8 tt0 -59.04 -37.46 77.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.656 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.1 m -65.95 -48.32 71.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.902 0.382 . . . . 0.0 110.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.66 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.584 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.1 pt -76.09 -29.8 19.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -56.47 -45.72 80.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.334 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 p -82.0 -42.78 18.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.356 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.4 m -68.9 -19.99 64.23 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' SER . . . . . 0.744 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.7 p -70.98 -16.55 62.64 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 p -50.87 -23.72 3.02 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PHE . . . . . 0.492 ' CB ' ' HB3' ' A' ' 27' ' ' ASN . 78.8 m-85 -67.98 -9.12 42.97 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 144' ' ' SER . 68.7 mt -60.8 -16.32 39.41 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.382 177.268 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 m -66.44 -33.29 75.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.566 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 152' ' ' SER . 0.2 OUTLIER -74.89 -27.5 60.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.751 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.6 p -62.35 -17.66 59.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.406 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 180' ' ' SER . 3.4 p -112.13 -20.76 11.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 149' ' ' THR . 25.9 t -164.41 148.0 9.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 111.058 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -80.17 69.84 6.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.81 -27.93 68.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.684 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.0 p -65.16 -36.21 83.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.957 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -114.47 14.4 17.81 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 111.006 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.0 m 53.55 33.64 16.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.555 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 47.96 27.16 1.11 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.746 1.218 . . . . 0.0 112.921 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.98 -81.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -140.09 118.85 12.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.795 0.331 . . . . 0.0 110.396 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 175' ' ' PRO . . . -125.96 22.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.068 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.2 p 50.29 34.32 8.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.392 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 p -92.13 123.74 35.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.058 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 49.7 m -147.12 92.74 2.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.8 m 63.09 19.76 11.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.559 0.695 . . . . 0.0 110.065 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 135.42 -168.87 23.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' THR . . . -130.03 160.53 33.4 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.996 0.398 . . . . 0.0 110.755 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.34 -31.37 34.26 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.939 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -77.63 -29.95 52.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.157 0.504 . . . . 0.0 110.491 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 51.7 m -153.28 137.58 16.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -65.16 -92.92 0.03 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PRO . . . . . 0.486 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 44.3 Cg_endo -84.61 16.17 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 123.121 2.547 . . . . 0.0 113.894 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.6 t -162.87 -161.31 0.69 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 100.15 -105.87 3.05 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.19 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' HB2' ' HB1' ' A' ' 161' ' ' ALA . 98.2 Cg_endo -77.69 40.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.884 2.389 . . . . 0.0 112.414 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.3 p 50.45 42.1 25.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.504 0.722 . . . . 0.0 112.238 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 t -82.9 104.72 13.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.366 0.603 . . . . 0.0 111.394 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . 0.567 ' H ' ' HD3' ' A' ' 179' ' ' PRO . . . 97.33 62.91 0.9 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.245 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . 0.567 ' HD3' ' H ' ' A' ' 178' ' ' GLY . 3.0 Cg_exo -78.94 153.27 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.503 2.136 . . . . 0.0 110.943 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 t -107.48 -174.77 2.61 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.807 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.59 -63.14 0.52 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.9 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -78.06 157.41 78.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.79 125.38 15.72 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.973 2.449 . . . . 0.0 111.901 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' N ' ' HD3' ' A' ' 185' ' ' PRO . . . 81.96 61.72 2.0 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.843 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 184' ' ' GLY . 37.1 Cg_exo -63.9 -23.59 68.27 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.913 2.409 . . . . 0.0 111.919 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.25 4.8 47.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.014 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -35.98 91.33 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.28 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.45 -11.93 84.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.275 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 107.04 44.83 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.632 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.06 152.81 39.14 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.632 -0.136 . . . . 0.0 110.632 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.65 147.31 94.93 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.802 2.334 . . . . 0.0 111.426 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.15 22.91 0.5 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.874 0.368 . . . . 0.0 111.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.86 -2.88 87.15 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.873 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -84.76 150.66 24.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 67.1 m -92.59 17.89 9.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.947 0.403 . . . . 0.0 111.162 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 112.54 -68.25 0.23 Allowed Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 69.1 t80 68.64 -67.65 0.2 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.765 0.826 . . . . 0.0 112.296 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.04 75.18 2.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.681 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.992 0 CA-C-O 118.807 -0.996 . . . . 0.0 111.742 178.802 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.353 0 N-CA-C 112.823 -0.111 . . . . 0.0 112.823 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.69 80.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.203 0.525 . . . . 0.0 110.759 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.4 p -68.44 -17.75 64.27 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -18.28 63.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.49 11.74 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.815 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.3 pp -85.99 -22.89 27.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 14' ' ' SER . 17.6 pt -42.46 -55.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 2.4 m -68.69 -21.74 64.4 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.0 111.677 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.553 ' HD2' ' N ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -88.57 -24.46 22.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.961 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 100' ' ' LEU . 85.1 t -57.19 168.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.759 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -39.47 -27.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.0 m-80 -60.27 -24.22 64.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.571 0.224 . . . . 0.0 111.498 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.71 -36.98 82.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.076 0.465 . . . . 0.0 110.306 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.58 -13.36 54.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.448 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.17 -44.11 13.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 14.3 t-20 55.16 13.0 0.74 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.841 0.856 . . . . 0.0 112.263 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -72.41 165.49 24.46 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.931 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 27.8 m -61.67 -15.31 38.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p -56.04 -25.94 46.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.785 0.834 . . . . 0.0 113.143 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.83 -17.62 11.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.157 0.504 . . . . 0.0 110.672 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 11.4 ttm180 -77.51 -48.68 16.45 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.745 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -167.06 -32.14 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -80.65 137.21 21.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -52.91 138.67 29.41 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.999 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 47.3 ptt85 -64.43 155.59 32.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.944 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -70.74 114.85 9.23 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.65 40.18 9.97 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -47.37 145.95 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.585 0.754 . . . . 0.0 112.307 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.525 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.4 m -71.48 140.29 49.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.406 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.569 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.87 -12.81 27.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 116' ' ' LEU . 89.2 mm-40 -57.06 -38.06 72.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.855 0.359 . . . . 0.0 110.757 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 40' ' ' SER . 2.8 pp -84.4 -35.62 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.488 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.97 -73.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.962 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 75.5 -18.92 0.42 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.639 0.776 . . . . 0.0 112.403 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -67.61 -79.88 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.16 0.505 . . . . 0.0 112.024 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -130.93 -27.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.313 0.578 . . . . 0.0 110.848 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.92 94.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.184 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 mm-40 -82.54 -50.23 9.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 0.0 110.256 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 20.7 ttm180 -132.77 -3.93 3.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.941 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.03 -50.49 0.7 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.258 0.623 . . . . 0.0 110.17 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.63 131.45 45.23 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -46.6 -30.78 2.45 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m -49.58 -71.56 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 55' ' ' LEU . 6.6 tt -86.38 -23.84 26.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.43 -20.69 62.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.2 p -48.56 112.74 0.64 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.565 0.541 . . . . 0.0 110.697 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.403 HG23 ' HG ' ' A' ' 59' ' ' LEU . 15.1 t -161.73 -40.41 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 58' ' ' THR . 91.8 mt -121.91 18.83 10.96 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.677 0.275 . . . . 0.0 110.996 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 66.12 1.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.134 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.745 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 37.5 t -89.3 104.97 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.385 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -173.62 76.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.499 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.22 -63.07 1.22 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.981 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -63.04 -69.49 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.745 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 p-10 -82.18 7.2 14.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.462 . . . . 0.0 110.444 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 tp -88.02 -53.17 4.87 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.735 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.8 29.02 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.499 0.666 . . . . 0.0 110.086 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 35.6 mmt180 -107.99 173.13 6.46 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 64.14 -62.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.63 -61.95 2.24 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.717 0.407 . . . . 0.0 111.716 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' SER . 39.1 t -59.66 -42.26 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.586 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 2.6 mp0 -65.78 -36.48 83.65 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.619 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.92 64.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.803 0.335 . . . . 0.0 110.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.46 -34.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.486 0.66 . . . . 0.0 110.239 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 3.7 m -75.5 -19.78 59.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 20.8 mtm180 -86.87 -13.1 45.89 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.543 0.211 . . . . 0.0 110.551 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.6 mt . . . . . 0 C--O 1.238 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.122 178.55 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 88' ' ' GLN . 8.0 m-85 . . . . . 0 N--CA 1.452 -0.357 0 CA-C-O 120.668 0.27 . . . . 0.0 110.538 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.47 41.45 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.01 0.433 . . . . 0.0 111.215 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 91' ' ' SER . 8.1 tp-100 -90.14 -59.03 2.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.919 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.86 94.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.825 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.513 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 74.6 m-85 -80.66 12.04 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.541 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 15.6 t -50.61 -45.12 57.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.659 0.383 . . . . 0.0 111.556 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 55.4 m -61.54 -41.89 98.02 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.55 37.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.0 111.414 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 74.8 mt -84.94 -28.06 26.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -85.18 -36.43 21.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.209 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 50.45 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.98 -22.41 45.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.26 -14.09 63.92 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.82 32.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.968 0.889 . . . . 0.0 108.955 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -116.9 -169.16 1.59 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.053 -178.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 14.6 t30 -78.39 106.69 10.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.37 -29.33 70.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.451 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 p -72.26 -18.15 61.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.226 0.536 . . . . 0.0 110.276 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 6.2 t30 -63.81 -50.75 67.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.654 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.454 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.0 mp -73.43 -35.3 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.855 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.48 -35.09 78.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.401 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.2 m -93.61 -60.6 1.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 1.1 pp -104.53 -35.99 7.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -52.86 -58.49 11.39 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.897 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 114' ' ' SER . 13.7 p -71.19 -21.05 62.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -88.13 -52.76 5.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.28 -50.56 20.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.9 mp -79.3 -29.94 42.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.147 0.499 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 110' ' ' SER . 32.1 t 50.97 -100.28 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.688 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.71 -34.68 73.23 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 120' ' ' VAL . 51.8 tp -61.75 -59.36 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.743 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -29.22 70.46 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.931 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -61.1 -42.83 99.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.078 0.466 . . . . 0.0 110.035 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -29.27 58.82 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.822 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 116' ' ' LEU . 82.3 t -72.69 -30.22 32.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 122.816 -0.226 . . . . 0.0 110.757 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 53.2 m -55.99 -39.45 71.85 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.566 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.1 p -85.68 -25.87 26.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.061 0.458 . . . . 0.0 111.155 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.76 -90.98 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.85 69.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 111.548 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 53.2 tt0 -77.24 -24.59 51.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.82 -65.12 1.63 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.448 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.58 -23.84 8.05 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.799 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.81 104.37 2.2 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.842 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.4 mt -68.75 130.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.959 0.409 . . . . 0.0 111.885 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -120.78 128.35 52.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 132' ' ' ASP . 18.2 t -98.57 167.58 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.317 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 131' ' ' VAL . 27.6 t70 -58.45 151.83 19.27 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.344 0.592 . . . . 0.0 111.747 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.591 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 15.2 m -75.37 -2.25 27.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.083 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.37 -72.07 0.64 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.184 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 m -106.5 -58.21 1.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.42 HG21 HG11 ' A' ' 131' ' ' VAL . 69.3 t -52.32 -55.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.591 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 5.4 tp-100 -60.02 -42.45 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m -58.46 -41.04 84.27 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.086 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.1 -54.61 8.08 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.639 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 136' ' ' VAL . 38.7 pt -61.46 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -64.44 -45.29 88.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.993 0.425 . . . . 0.0 110.72 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.4 m -76.91 -20.74 55.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.294 0.569 . . . . 0.0 111.134 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 43.4 t -86.5 -60.17 2.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.781 -178.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.3 t . . . . . 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.253 -174.431 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.217 0 N-CA-C 113.53 0.172 . . . . 0.0 113.53 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.97 89.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.12 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' ILE . 70.0 m -72.1 -30.6 65.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.717 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.04 -26.75 50.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.98 7.09 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.683 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 pp -83.88 -22.55 31.59 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' SER . 10.6 pt -43.25 -43.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.3 t -74.38 -27.55 60.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -88.0 -23.41 23.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 17' ' ' LEU . 56.4 t -58.52 176.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.832 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.577 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -36.67 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 5.7 m-80 -63.29 -24.77 68.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.244 0.474 . . . . 0.0 111.404 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.04 -28.25 69.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 tp -83.41 -40.98 18.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.06 73.55 8.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.43 19.89 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.911 1.284 . . . . 0.0 114.2 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -63.46 -178.76 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 13.0 m -66.51 -20.48 66.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -51.13 -62.53 1.56 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.8 pt? -80.78 -20.55 42.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.28 0.562 . . . . 0.0 110.148 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 22.4 ttm180 -68.41 -46.45 69.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.474 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -177.34 -35.43 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.17 139.97 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.619 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 88' ' ' GLN . 4.0 pp -51.42 140.43 17.61 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 123.787 0.679 . . . . 0.0 112.6 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 36' ' ' ARG . 15.9 ttt180 -50.76 137.72 19.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.564 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -66.27 111.39 3.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.644 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 93.78 31.63 8.09 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.7 p -51.11 137.13 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 110.72 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 13.0 m -105.17 161.9 13.86 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 3.1 pt20 -60.44 -14.98 22.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.404 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 116' ' ' LEU . 83.2 mm-40 -53.92 -48.72 69.9 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.263 0.554 . . . . 0.0 109.758 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.1 pp -85.99 -39.41 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.241 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.403 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.86 -62.03 1.71 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 74.63 -20.96 0.3 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -71.02 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.761 0.315 . . . . 0.0 111.771 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.91 -22.49 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.194 0.521 . . . . 0.0 110.832 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.6 t -75.72 96.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 76.8 mt-30 -81.97 -47.46 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.139 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 33.8 ttm-85 -144.8 4.13 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.402 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.53 -53.86 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.479 0.712 . . . . 0.0 111.18 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.674 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.26 141.28 57.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.569 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 14.0 mp0 -58.83 -18.46 32.7 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.081 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -63.05 -76.96 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.85 -24.79 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.32 -18.11 61.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 77.6 p -45.7 104.05 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.856 0.722 . . . . 0.0 111.156 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 56' ' ' ALA . 10.5 t -149.97 -40.92 0.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.089 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.27 19.34 13.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.975 0.417 . . . . 0.0 110.235 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.24 67.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.607 HG22 HD21 ' A' ' 65' ' ' ASN . 6.1 t -87.85 109.01 19.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 120.706 0.289 . . . . 0.0 110.653 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -163.37 80.04 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.51 -48.85 2.94 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.73 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 20.9 p-10 -52.64 -80.07 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.829 0.851 . . . . 0.0 112.862 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.607 HD21 HG22 ' A' ' 61' ' ' VAL . 3.9 p-10 -85.81 9.17 17.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.215 0.531 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.1 tp -88.31 -50.85 6.08 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.128 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.14 -49.81 14.39 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.545 0.688 . . . . 0.0 109.31 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -90.87 162.38 14.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 68.32 -61.72 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -64.42 -62.92 1.3 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -36.13 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.81 -43.37 88.82 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.301 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -67.34 -44.93 77.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.509 0.195 . . . . 0.0 111.286 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.9 -43.45 85.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -65.12 -30.17 71.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.039 0.447 . . . . 0.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -98.32 6.28 47.49 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.645 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 14.4 mt . . . . . 0 CA--C 1.51 -0.591 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.081 179.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 . . . . . 0 N--CA 1.45 -0.432 0 CA-C-O 121.306 0.574 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 36' ' ' ARG . . . -65.91 1.59 1.35 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -69.96 -47.15 63.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.33 -40.24 77.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.794 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -83.92 10.54 9.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.419 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.8 m -49.79 -38.48 34.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 72.6 m -56.41 -50.4 71.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.12 31.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.5 mt -80.42 -33.08 37.22 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -84.56 -37.41 21.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 56.0 85.74 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.852 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.58 -2.61 43.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.578 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.54 34.53 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.529 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.93 -13.38 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.464 0.649 . . . . 0.0 110.097 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -179.69 7.14 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.524 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -75.21 118.66 18.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.98 61.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m -74.99 -31.36 61.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.855 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -61.87 -53.28 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.488 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.49 -39.97 87.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.129 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.34 -38.1 85.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.2 m -78.59 -55.22 5.37 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.14 -22.32 6.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.22 -65.29 3.47 Favored Glycine 0 C--N 1.32 -0.336 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.778 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 m -72.96 -9.71 59.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.107 0.479 . . . . 0.0 110.973 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.54 -55.94 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.629 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.96 -57.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.91 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -68.32 -49.8 57.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.923 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.4 t 52.9 -93.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.57 -40.78 60.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.241 0.616 . . . . 0.0 112.428 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 120' ' ' VAL . 59.7 tp -60.87 -47.32 86.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 30.2 mt -71.3 -25.77 62.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.53 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -60.28 -44.36 95.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.42 -31.1 57.45 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.558 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 116' ' ' LEU . 52.1 t -63.82 -41.26 91.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 122.848 -0.207 . . . . 0.0 110.712 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 54.2 m -52.82 -45.75 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.813 0.696 . . . . 0.0 112.352 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 p -83.74 -36.38 23.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.9 -76.1 0.31 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.7 -49.69 50.94 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.707 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 52.6 mt-30 -72.52 -24.6 61.17 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.94 -53.39 3.02 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.732 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.18 -19.27 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.39 79.84 0.86 Allowed Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.065 -1.064 . . . . 0.0 110.488 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 52' ' ' ALA . 35.0 mm -64.6 136.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -134.62 125.9 28.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.8 t -89.48 113.93 26.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.494 0.664 . . . . 0.0 111.669 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.24 42.97 1.08 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.466 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 56.4 p -78.7 2.97 17.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.562 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.25 -27.37 20.66 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.15 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 m -105.95 -42.84 5.01 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 131' ' ' VAL . 20.6 t -70.43 -63.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 137' ' ' GLN . 7.5 tt0 -59.55 -43.5 93.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.954 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.6 m -58.33 -38.01 76.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.947 0.403 . . . . 0.0 111.025 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.62 -56.65 5.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.49 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.444 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 44.2 pt -61.83 -27.63 42.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.526 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -75.43 -35.83 60.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.03 0.443 . . . . 0.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.3 m -79.2 -29.42 42.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.178 0.513 . . . . 0.0 110.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 140' ' ' ILE . 98.9 p -86.73 -21.0 26.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.258 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.921 -179.369 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.096 0 N-CA-C 112.03 -0.428 . . . . 0.0 112.03 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.23 -19.13 62.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.844 0.354 . . . . 0.0 111.885 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.5 m -63.9 -20.38 65.8 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.953 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.95 65.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.987 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.29 -34.88 22.19 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.303 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.4 pp -87.74 -31.78 19.49 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 14' ' ' SER . 16.3 pt -42.23 -57.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.7 m -66.56 -20.36 66.0 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -88.9 -31.23 18.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 17' ' ' LEU . 83.7 t -49.53 158.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 O-C-N 123.597 0.561 . . . . 0.0 111.384 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.458 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -40.31 -25.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.408 ' HB3' ' OG ' ' A' ' 92' ' ' SER . 20.4 t-20 -61.73 -28.67 69.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 0.0 109.938 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -58.97 -46.19 88.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.511 0.672 . . . . 0.0 109.934 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 61.9 tp -68.06 -28.66 67.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.297 -178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.99 87.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 0.0 110.133 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 59.4 2.99 0.35 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.899 0.88 . . . . 0.0 112.535 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 5.5 m -68.53 163.44 23.5 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.266 0.555 . . . . 0.0 111.289 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 m -58.94 -15.34 12.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.8 p -54.59 -30.43 54.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.644 0.777 . . . . 0.0 112.992 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.1 pt? -106.57 -18.6 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.214 0.53 . . . . 0.0 110.507 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -76.2 -60.17 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.067 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -155.25 -31.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.425 ' C ' HE22 ' A' ' 88' ' ' GLN . 96.0 t -75.57 137.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 74' ' ' VAL . 2.6 pt? -55.79 145.66 23.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.224 0.535 . . . . 0.0 112.016 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -52.84 130.21 32.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.556 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.445 HG23 HG21 ' A' ' 136' ' ' VAL . 3.3 m -66.02 111.84 3.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.437 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.88 31.46 9.98 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.182 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 4.3 p -59.58 163.15 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.386 0.674 . . . . 0.0 112.265 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -109.52 161.39 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.781 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.7 pt20 -64.78 -15.22 61.36 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HG3' HD13 ' A' ' 116' ' ' LEU . 81.3 mm-40 -53.14 -46.41 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.024 0.44 . . . . 0.0 111.106 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' HB ' ' CD2' ' A' ' 86' ' ' TYR . 2.4 pp -84.35 -35.98 11.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.989 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.89 -60.68 2.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.574 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 t 70.83 -21.06 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.631 0.772 . . . . 0.0 112.87 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -69.33 -79.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.38 -37.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.265 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.503 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.4 p -71.11 99.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.459 0.647 . . . . 0.0 110.714 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 40.6 mt-30 -82.99 -38.01 23.22 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HE ' HD13 ' A' ' 55' ' ' LEU . 23.8 ttm-85 -148.23 -1.61 0.55 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.784 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.0 -46.63 0.64 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.247 0.619 . . . . 0.0 111.128 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.31 142.05 58.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.2 mm-40 -64.5 -16.46 62.57 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.104 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 p -63.08 -76.74 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.141 0.496 . . . . 0.0 112.26 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.576 HD13 ' HE ' ' A' ' 50' ' ' ARG . 7.1 tt -85.36 -23.65 27.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.741 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.17 -21.05 39.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.5 t -62.94 94.92 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.756 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 9.6 t -119.99 -34.73 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 58' ' ' THR . 96.2 mt -118.07 19.5 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.25 67.69 1.46 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.487 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.7 t -88.49 126.31 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.81 0.338 . . . . 0.0 110.28 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 177.01 89.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.574 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.07 -60.12 4.48 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.125 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -50.14 -79.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 0.0 112.131 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 21.5 p-10 -85.77 14.0 6.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.998 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 tp -88.07 -58.41 2.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.746 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.62 48.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.456 0.646 . . . . 0.0 109.785 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -99.08 162.85 12.83 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.918 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 70.14 -61.92 0.44 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.415 0.447 . . . . 0.0 111.715 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.59 -62.7 1.42 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.335 0.254 . . . . 0.0 111.586 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.69 -41.94 90.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.86 -37.33 76.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.69 63.08 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.55 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.4 t -85.42 -16.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.4 p -90.74 -23.88 20.55 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.243 0.544 . . . . 0.0 110.176 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 76' ' ' ARG . 34.6 ttp180 -117.93 22.34 12.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.167 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.829 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.247 -178.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.424 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 3.1 m-85 . . . . . 0 N--CA 1.449 -0.517 0 CA-C-O 121.402 0.62 . . . . 0.0 111.089 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.98 31.19 0.11 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.114 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.425 HE22 ' C ' ' A' ' 34' ' ' VAL . 87.8 mm-40 -89.65 -60.12 2.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.145 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.69 -37.1 56.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.277 0.56 . . . . 0.0 110.155 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.82 5.38 25.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.571 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 t -52.17 -39.42 60.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.03 0.443 . . . . 0.0 110.794 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 3.3 m -58.37 -53.19 61.15 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.437 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.88 -22.6 53.21 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.873 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.599 ' O ' HG11 ' A' ' 120' ' ' VAL . 78.1 mt -82.77 -45.86 13.84 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -70.79 -43.45 68.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.49 88.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.394 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.74 46.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.787 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.34 -13.81 31.84 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.458 ' HB ' ' CB ' ' A' ' 22' ' ' ALA . 3.5 t -101.07 28.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.461 0.648 . . . . 0.0 109.982 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.7 pt? -122.95 172.56 8.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.235 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 37.0 t30 -73.84 99.61 3.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -17.76 64.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -70.89 -30.56 66.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.423 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.96 -35.37 76.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.722 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.82 -35.46 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.753 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.53 -24.09 45.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.63 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.7 m -75.18 -60.72 2.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.276 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 104' ' ' ASN . 1.7 pt? -121.4 -21.17 6.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.772 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -53.07 -61.07 7.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.769 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -82.58 -15.0 53.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -87.95 -60.06 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.9 t -78.02 -58.21 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.334 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.536 HD23 ' HA2' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -69.34 -26.77 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.011 0.434 . . . . 0.0 110.03 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.7 t 45.34 -105.0 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.471 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.96 -36.27 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.67 0.788 . . . . 0.0 112.635 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 120' ' ' VAL . 25.7 tp -59.27 -62.37 1.93 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.278 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' CA ' ' A' ' 109' ' ' GLY . 45.8 mt -79.99 -22.89 41.99 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -62.96 -44.2 96.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 109.957 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.79 -34.65 72.24 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.318 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 94' ' ' LEU . 53.0 t -69.28 -39.76 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.748 0.308 . . . . 0.0 111.204 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 34.0 t -57.04 -35.91 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 m -83.72 -39.33 20.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.97 -72.91 0.44 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 129' ' ' ILE . . . -70.54 -47.87 58.21 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.925 0.393 . . . . 0.0 111.847 -176.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' SER . 27.0 tt0 -71.01 -24.53 62.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.11 -66.34 1.4 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.768 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.2 mt -109.34 -24.58 10.99 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 122.621 -0.341 . . . . 0.0 111.898 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.86 104.08 1.74 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.612 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 124' ' ' ALA . 13.8 mt -79.58 136.38 23.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.591 0.234 . . . . 0.0 111.483 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -121.63 129.12 52.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.902 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.488 ' HB ' HG11 ' A' ' 136' ' ' VAL . 24.5 t -82.2 168.74 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.466 ' N ' HG12 ' A' ' 131' ' ' VAL . 24.1 t70 -59.38 137.19 58.08 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.305 0.574 . . . . 0.0 111.238 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.6 m -58.33 -23.07 55.49 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.824 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.28 -41.08 99.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.733 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 p -106.49 -45.55 4.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 140' ' ' ILE . 10.8 p -78.76 -55.4 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . 8.7 tt0 -59.62 -44.26 93.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 p -56.22 -41.87 76.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.996 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.83 -49.8 8.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.7 pt -62.05 -33.37 58.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -60.71 -29.59 69.43 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 m -83.94 -32.99 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 0.0 110.94 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -87.84 -27.78 22.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 34.7 t . . . . . 0 C--N 1.319 -0.756 0 C-N-CA 123.339 0.656 . . . . 0.0 111.727 -178.469 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.568 0 CA-C-O 120.214 -0.214 . . . . 0.0 113.153 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -60.1 -35.73 75.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 111.247 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' ILE . 24.9 t -74.84 -22.08 58.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.113 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.99 -22.51 66.96 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.9 12.67 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.062 -1.065 . . . . 0.0 112.164 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.37 -32.73 24.05 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' SER . 10.0 pt -44.16 -51.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.9 m -67.81 -20.61 65.2 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 79.0 mtt180 -89.24 -24.51 22.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -176.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -72.33 -162.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.13 -37.42 6.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.84 -24.95 67.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.44 -53.46 56.23 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 109.66 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.07 -33.82 76.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.28 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.562 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 53.31 17.94 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.355 0.662 . . . . 0.0 111.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -76.31 157.61 32.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -62.22 -16.87 56.12 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.338 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -54.06 -34.54 60.35 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.6 pt? -112.28 -18.29 12.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -79.0 -43.76 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.147 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 34' ' ' VAL . 7.6 t -164.44 -37.75 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 33' ' ' THR . 98.1 t -88.38 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -54.39 140.12 34.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 111.489 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 94' ' ' LEU . 2.0 ptm180 -58.88 154.1 15.83 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -70.07 124.13 23.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.237 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.8 40.77 64.21 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 36' ' ' ARG . 8.4 p -47.4 149.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.704 0.802 . . . . 0.0 112.523 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' ILE . 8.6 m -69.86 127.63 33.57 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.244 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.1 pt20 -61.53 -14.03 26.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.025 0.44 . . . . 0.0 111.115 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.86 -32.0 73.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 40' ' ' SER . 2.5 pp -83.76 -35.52 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.71 -72.49 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.446 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m 76.01 -19.62 0.4 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.969 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.0 p -68.18 -88.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.236 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 65' ' ' ASN . 30.0 m -126.62 -32.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.793 0.33 . . . . 0.0 111.634 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.7 p -79.31 91.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.726 0.774 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.6 mt-30 -83.04 -68.58 0.69 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.732 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.519 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 26.0 ttp180 -108.46 -3.06 18.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.425 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.13 -55.76 0.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.109 0.564 . . . . 0.0 109.85 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -67.29 142.31 56.9 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.265 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 22.3 mp0 -46.89 -51.16 17.42 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -46.54 -62.88 1.17 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 50' ' ' ARG . 28.8 tp -86.65 -27.6 23.7 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.036 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.56 -20.58 39.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 6.2 t -62.91 89.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.602 0.715 . . . . 0.0 111.466 -176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.7 t -113.18 -36.43 5.05 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.785 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.88 18.57 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.095 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.06 68.05 1.13 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.95 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.45 103.2 13.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -151.3 14.04 0.68 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.065 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.497 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 134.85 -47.95 0.96 Allowed Glycine 0 C--N 1.28 -2.583 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 92.8 m-20 -62.7 -65.34 0.7 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.489 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 47' ' ' VAL . 66.2 t30 -84.71 4.23 33.62 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 52.9 tp -88.88 -67.14 0.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.945 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.56 58.21 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.544 0.688 . . . . 0.0 110.137 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 94.5 mtt180 -100.91 162.2 13.07 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.815 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 67.77 -62.28 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -61.48 -62.43 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 122.664 0.386 . . . . 0.0 111.356 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.0 -39.23 84.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 85.1 mm-40 -60.94 -47.3 87.06 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.548 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.21 -39.81 70.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -86.41 -34.27 7.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.959 0.409 . . . . 0.0 111.306 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -71.97 -26.5 62.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 17.6 mmt180 -101.02 9.25 42.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.456 0.646 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.45 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 9.9 tt . . . . . 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.91 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 . . . . . 0 N--CA 1.443 -0.781 0 N-CA-C 110.004 -0.369 . . . . 0.0 110.004 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.415 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -77.74 44.54 0.46 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 8.2 tp-100 -89.62 -61.46 1.69 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.765 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.18 -26.79 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 m-85 -78.13 3.83 14.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.678 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -50.45 -40.28 50.19 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.355 0.409 . . . . 0.0 111.638 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 15.2 m -57.29 -49.46 76.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.74 -23.82 36.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.693 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 83.3 mt -84.63 -29.97 25.3 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -81.14 -38.49 27.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.605 0.241 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 m120 63.99 91.89 0.07 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.03 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.31 -10.84 45.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.375 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 4.38 71.41 Favored Glycine 0 N--CA 1.459 0.227 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.525 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.39 -14.05 8.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.639 0.733 . . . . 0.0 109.076 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.537 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.7 pp -81.64 -179.26 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.057 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 44.1 t30 -68.45 110.73 4.29 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.072 -176.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -26.4 65.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.752 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -73.99 -27.66 61.09 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.055 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -62.52 -46.74 87.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.101 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.08 -31.5 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.59 -43.09 70.1 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.021 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.2 m -71.27 -56.04 6.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 13' ' ' ALA . 4.4 pp -115.55 -13.31 11.55 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.823 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.61 -65.2 3.0 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.254 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.5 p -73.79 -19.5 60.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.802 0.335 . . . . 0.0 111.641 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -87.42 -58.23 2.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.2 t -81.2 -54.8 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.254 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.6 mp -67.35 -45.2 77.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 t 46.03 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.096 1.359 . . . . 0.0 113.686 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.27 73.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.533 0.333 . . . . 0.0 111.57 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.4 tp -61.96 -50.23 72.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.492 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' SER . 17.4 mt -68.95 -24.16 64.23 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -66.18 -36.79 84.01 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.554 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.33 -39.44 7.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 83.1 t -70.16 -22.99 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.619 0.247 . . . . 0.0 111.322 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 28.9 t -55.16 -44.03 74.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -84.39 -23.2 30.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.119 0.485 . . . . 0.0 110.608 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 50' ' ' ARG . . . -83.43 -97.48 0.05 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.892 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.03 67.85 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.762 0.315 . . . . 0.0 111.769 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 34.2 tt0 -65.13 -42.45 93.86 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.767 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.62 -48.24 4.81 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.436 0.618 . . . . 0.0 112.246 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.65 99.05 0.5 Allowed Glycine 0 C--N 1.312 -0.78 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 52' ' ' ALA . 34.6 mm -86.63 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.025 0.44 . . . . 0.0 112.176 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -116.59 135.43 53.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 132' ' ' ASP . 18.5 t -86.2 173.06 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 131' ' ' VAL . 30.4 t70 -58.97 145.5 41.41 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.174 0.512 . . . . 0.0 111.384 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 47.8 m -64.04 -22.19 66.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.57 -69.07 1.05 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 123.37 0.419 . . . . 0.0 114.133 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -99.42 -34.91 10.09 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 140' ' ' ILE . 86.5 t -83.18 -62.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 8.8 tp-100 -56.82 -45.97 81.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.7 m -54.62 -38.92 67.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.36 -48.33 10.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 137' ' ' GLN . 43.9 pt -65.7 -27.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 p -67.45 -48.59 66.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.1 m -84.27 -20.22 32.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 42.1 t -85.54 -20.16 30.04 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.6 p . . . . . 0 C--N 1.32 -0.716 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -174.312 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.339 0 CA-C-O 120.331 -0.149 . . . . 0.0 113.452 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.54 86.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.623 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.9 p -63.32 -32.97 74.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.597 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.51 -19.13 65.41 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.3 -38.91 7.02 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.342 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.3 pp -84.69 -22.08 29.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 14' ' ' SER . 11.5 pt -46.96 -50.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -84.77 -19.73 32.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -86.47 -30.81 21.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.3 t -80.96 -101.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.89 35.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.611 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.31 -22.99 66.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.81 81.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.066 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 1.8 tt -80.57 -31.77 36.73 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.441 178.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.85 82.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.212 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 61.83 6.03 1.53 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.859 0.864 . . . . 0.0 113.083 176.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 29' ' ' SER . 0.3 OUTLIER -68.48 177.93 2.21 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.087 0.47 . . . . 0.0 111.292 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.527 ' H ' HG22 ' A' ' 28' ' ' THR . 9.7 m -69.66 -16.03 63.29 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 p -51.62 -50.39 60.33 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.754 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.9 pt? -87.29 -19.98 27.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.326 0.584 . . . . 0.0 110.358 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -74.69 -48.23 27.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.086 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -172.71 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.61 135.52 27.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -54.02 139.19 35.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.346 0.593 . . . . 0.0 111.77 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 3.1 ptm180 -62.71 160.04 15.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.995 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -74.19 111.67 9.59 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.644 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.15 47.13 11.51 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.342 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.6 p -54.99 150.04 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 122.93 0.492 . . . . 0.0 111.364 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 t -81.78 164.36 21.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.1 pt20 -70.06 -12.42 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.763 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 41.6 mm-40 -50.95 -33.05 22.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.113 0.483 . . . . 0.0 110.609 -179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.717 HG13 ' N ' ' A' ' 44' ' ' ALA . 6.7 pt -83.77 -52.77 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.717 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.47 -66.98 0.83 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m 78.82 -20.5 0.38 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.555 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.5 p -83.1 -82.97 0.14 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.25 -52.53 8.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.594 0.711 . . . . 0.0 110.258 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.33 89.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.461 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 77.9 mt-30 -82.82 -36.93 25.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.777 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 5.7 ttt180 -156.5 5.64 0.17 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.937 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.91 -58.93 0.39 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.162 0.585 . . . . 0.0 110.783 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -62.97 138.54 58.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.54 -18.87 8.28 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.611 -175.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -60.02 -71.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.6 tp -87.36 -24.05 24.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.752 0.311 . . . . 0.0 111.604 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.96 -18.91 55.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -53.96 99.97 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.183 0.516 . . . . 0.0 110.886 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -137.68 -36.25 0.63 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.738 HD11 ' ND2' ' A' ' 65' ' ' ASN . 4.1 pp -123.03 11.46 9.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.022 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.04 52.76 1.58 Allowed Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.143 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 65' ' ' ASN . 3.3 t -87.17 114.25 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -156.54 14.29 0.29 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 112.017 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 145.44 -43.71 0.91 Allowed Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.01 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -59.12 -68.45 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.181 0.515 . . . . 0.0 110.598 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.738 ' ND2' HD11 ' A' ' 59' ' ' LEU . 25.8 p-10 -85.92 9.61 16.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 23.9 tp -88.12 -50.67 6.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.993 0.425 . . . . 0.0 110.438 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 133' ' ' SER . . . -81.95 -26.55 33.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -127.08 169.42 13.41 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 69.8 -62.29 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.105 0.562 . . . . 0.0 112.492 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -62.19 2.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.012 0.434 . . . . 0.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 6.7 p -65.04 -33.2 62.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.6 -22.76 66.13 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.937 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.66 -51.08 6.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.102 0.477 . . . . 0.0 110.831 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 61.9 t -71.1 -36.46 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.427 -176.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -83.2 1.37 41.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.856 0.36 . . . . 0.0 111.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -106.37 -21.69 13.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.317 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 4.5 pp . . . . . 0 C--O 1.236 0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 111.515 -177.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 . . . . . 0 N--CA 1.44 -0.97 0 CA-C-O 120.97 0.414 . . . . 0.0 110.362 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.97 12.97 0.95 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 1.8 mp0 -67.43 -48.15 68.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.057 0.456 . . . . 0.0 111.109 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.542 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -71.73 -30.71 65.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.967 0.413 . . . . 0.0 110.681 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 84.9 m-85 -83.54 8.76 13.12 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.954 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 36' ' ' ARG . 71.9 m -51.8 -43.52 63.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.3 m -61.69 -48.76 79.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.02 -31.05 68.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 41.8 mt -84.17 -19.0 34.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.775 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HB2' HH21 ' A' ' 36' ' ' ARG . 55.6 t80 -87.44 -36.94 17.42 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.096 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.436 ' HA ' HD21 ' A' ' 100' ' ' LEU . 14.5 m120 55.19 64.86 1.65 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.584 0.707 . . . . 0.0 110.378 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.71 62.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.747 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.83 66.51 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.213 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.9 t -74.72 -24.99 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.319 0.58 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -84.4 150.52 25.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 40.3 t30 -54.67 107.78 0.32 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.801 0.688 . . . . 0.0 110.986 -177.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -17.49 63.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.936 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.8 m -80.18 -18.04 50.75 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.034 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.482 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -78.62 -29.17 45.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.433 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -64.86 -32.46 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.878 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.8 m -67.94 -61.34 1.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.67 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -129.0 -9.96 4.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.995 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -58.9 -72.04 0.67 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 m -73.95 -12.26 60.59 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.805 0.336 . . . . 0.0 111.365 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.16 -57.83 2.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.28 -53.75 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.56 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.52 -33.39 64.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.182 -178.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.2 t 49.49 -103.57 0.12 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.033 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.69 -33.29 60.67 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.115 0.566 . . . . 0.0 112.206 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 120' ' ' VAL . 43.2 tp -57.39 -53.26 60.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 19.2 mt -78.69 -23.72 45.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.724 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.3 -45.44 93.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.1 -29.72 62.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.752 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 116' ' ' LEU . 40.5 t -69.25 -46.11 78.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 122.766 -0.255 . . . . 0.0 111.198 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -58.05 -39.17 77.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.482 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -80.51 -40.19 26.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.876 0.369 . . . . 0.0 111.804 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.2 -70.07 0.6 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.404 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.15 -51.2 18.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -69.95 -35.01 74.17 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.89 0.376 . . . . 0.0 110.508 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.37 -56.66 3.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.141 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.38 -23.53 15.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.57 77.57 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.235 -0.984 . . . . 0.0 111.002 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.49 HG23 ' CB ' ' A' ' 52' ' ' ALA . 36.9 mm -68.47 132.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.65 140.36 48.14 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.76 116.28 46.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.341 0.591 . . . . 0.0 111.333 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.69 43.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 46.0 p -75.49 -4.99 42.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.028 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 -17.85 58.51 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.5 p -107.4 -56.88 2.15 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.06 -62.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.02 -40.49 85.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.8 m -60.84 -49.08 78.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.24 -52.29 62.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.819 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 42.7 pt -61.45 -34.87 63.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.459 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 t -67.79 -42.11 82.14 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.97 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 m -77.42 -45.97 24.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.3 m -66.11 -38.73 88.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 p . . . . . 0 N--CA 1.47 0.558 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.394 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.879 0 N-CA-C 112.374 -0.29 . . . . 0.0 112.374 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.02 68.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.4 m -63.38 -34.39 77.62 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -19.05 65.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.96 -39.47 6.49 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.778 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.9 pp -84.52 -20.97 30.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' SER . 9.7 pt -41.46 -42.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 8.3 p -78.99 -30.28 44.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -87.28 -23.62 24.61 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 17' ' ' LEU . 17.3 t -80.62 -101.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.13 -53.34 7.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -170.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -63.63 -23.03 67.21 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.3 -41.48 79.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.95 -19.97 39.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.995 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.63 -40.57 41.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.73 19.42 2.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.663 0.744 . . . . 0.0 111.432 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 5.6 m -74.22 165.88 24.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -60.78 -18.25 53.96 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.054 0.542 . . . . 0.0 111.7 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 36' ' ' ARG . 34.4 p -52.99 -43.2 66.28 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 124.045 0.938 . . . . 0.0 113.085 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.642 HD22 ' HB3' ' A' ' 23' ' ' ASN . 1.6 pt? -96.59 -20.46 18.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.926 0.393 . . . . 0.0 111.19 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -72.07 -50.95 24.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.166 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -168.64 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.13 138.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.6 pt? -56.43 142.04 40.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.301 0.375 . . . . 0.0 110.785 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HA ' HG22 ' A' ' 30' ' ' THR . 31.4 ptt85 -66.84 159.31 28.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.793 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -70.95 111.44 6.34 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.81 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.681 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 85.34 41.26 7.49 Favored Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.642 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 87' ' ' ALA . 10.1 p -47.56 136.3 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.484 0.659 . . . . 0.0 111.831 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -70.23 143.75 52.08 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.538 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 15.4 pm0 -65.57 -12.68 55.21 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -47.09 -44.66 21.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.501 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.79 -40.71 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.482 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.83 -75.81 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m 78.86 -19.65 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 111.772 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 p -65.39 -82.04 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.61 -39.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.986 0.422 . . . . 0.0 111.261 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.53 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.5 p -80.31 95.42 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.793 0.806 . . . . 0.0 110.33 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 50.4 mt-30 -79.18 -37.57 38.02 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 8.1 ttm180 -153.66 0.22 0.23 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.08 -48.39 0.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.61 0.364 . . . . 0.0 110.272 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.67 141.08 58.05 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.919 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 57' ' ' SER . 42.4 mm-40 -56.71 -30.66 63.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.479 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.3 m -53.89 -62.2 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' CZ ' ' A' ' 50' ' ' ARG . 4.3 mm? -88.06 -35.82 17.3 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -79.72 -21.46 44.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.7 t -65.25 93.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.622 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.518 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.7 t -139.23 -31.36 0.7 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.917 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.7 mt -118.19 19.14 13.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.39 65.61 1.46 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 96.9 t -89.52 122.48 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.262 0.553 . . . . 0.0 111.368 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -178.2 85.91 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.136 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.88 -54.98 3.46 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.191 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.425 ' HA ' HH21 ' A' ' 68' ' ' ARG . 92.7 m-20 -50.79 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.376 0.67 . . . . 0.0 111.81 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.541 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 27.3 p-10 -86.63 14.57 6.75 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.122 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.2 tp -87.91 -65.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.38 -36.63 58.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.549 0.69 . . . . 0.0 109.749 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 64' ' ' ASN . 60.1 mtm180 -98.95 160.16 14.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.733 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 69.41 -62.27 0.41 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.997 0.519 . . . . 0.0 111.975 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -62.78 -63.14 1.3 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.746 0.307 . . . . 0.0 111.507 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' SER . 59.6 t -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 41.6 mt-30 -60.78 -47.59 85.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.484 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.89 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.8 -38.33 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.929 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 33.2 m -77.31 1.23 19.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.6 mmp_? -111.83 -4.21 14.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.806 0.336 . . . . 0.0 110.169 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 mt . . . . . 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.243 -179.632 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 . . . . . 0 N--CA 1.442 -0.849 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -76.71 11.6 1.62 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.55 -59.98 2.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.523 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -69.42 -30.91 68.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.042 0.449 . . . . 0.0 110.991 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 96.1 m-85 -82.64 4.03 26.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.307 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -51.25 -39.8 57.48 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.6 m -58.69 -44.88 90.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.11 -30.98 27.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 116' ' ' LEU . 33.5 mt -84.58 -28.94 26.24 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -87.13 -29.67 21.65 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.785 0.326 . . . . 0.0 110.486 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.7 m120 51.15 69.57 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.054 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.77 -8.56 56.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.068 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.47 -6.76 83.24 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.734 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.9 t -80.44 -19.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.492 0.663 . . . . 0.0 109.725 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.47 174.87 9.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.937 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -83.32 143.9 30.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.057 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.27 -18.84 40.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 p -67.75 -30.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.482 0.658 . . . . 0.0 109.827 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 108' ' ' LEU . 19.2 t30 -62.84 -50.44 70.95 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.124 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.526 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.7 mp -72.4 -28.13 27.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.326 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.55 -33.67 66.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.898 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.617 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 86.9 m -85.5 -40.23 16.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.2 pt? -139.94 -27.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.836 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -50.83 -63.98 4.09 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.178 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.5 m -75.57 -17.0 60.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.94 0.4 . . . . 0.0 111.913 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 107' ' ' THR . 66.6 mtt180 -87.2 -58.0 2.75 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.088 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.7 -49.35 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.535 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 22.3 mt -70.86 -13.75 62.15 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.111 0.481 . . . . 0.0 110.572 -177.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.0 t 47.74 -104.07 0.11 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 113.657 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -65.86 -33.92 76.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 94' ' ' LEU . 37.3 tp -53.88 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.463 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 16.6 mt -69.07 -23.56 64.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.33 -46.68 76.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.194 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.6 -27.27 63.51 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.899 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' A' ' 124' ' ' ALA . 25.3 t -68.39 -36.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.795 0.331 . . . . 0.0 110.316 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.0 t -54.47 -41.21 69.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.457 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -83.74 -49.16 9.37 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.53 -58.49 3.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -82.12 -60.27 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -69.18 -35.7 76.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.445 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.28 -69.57 1.39 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.945 -0.645 . . . . 0.0 114.074 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.21 -23.61 24.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.974 0.416 . . . . 0.0 111.269 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 124' ' ' ALA . . . 82.2 91.32 0.6 Allowed Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.025 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 52' ' ' ALA . 63.7 mt -59.64 134.94 24.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -139.56 118.84 12.79 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.245 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.81 156.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.61 163.09 14.35 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.9 m -74.11 84.19 1.81 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.53 -114.94 2.01 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -87.83 -18.73 28.64 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 140' ' ' ILE . 48.9 t -78.72 -62.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.928 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -52.54 -51.67 58.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 p -56.1 -43.97 78.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.88 -40.44 39.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.51 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 136' ' ' VAL . 47.3 pt -67.31 -35.92 75.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.523 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.9 m -57.05 -53.28 59.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.4 m -61.2 -43.59 98.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.496 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 65.0 m -66.09 -39.11 89.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.5 p . . . . . 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.638 -178.496 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 -0.149 0 N-CA-C 112.486 -0.246 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.44 -37.44 85.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.975 0.417 . . . . 0.0 110.831 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 18' ' ' ILE . 12.6 m -66.97 -31.37 71.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.334 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.68 -25.74 29.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.66 -35.41 8.49 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.149 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.5 pp -85.46 -22.42 28.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 14' ' ' SER . 14.9 pt -46.88 -37.31 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 t -84.63 -20.75 30.85 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.679 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -88.0 -34.9 17.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.55 178.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.73 -32.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 92' ' ' SER . 1.7 t-20 -65.59 -24.01 66.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.352 -0.217 . . . . 0.0 111.393 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.11 86.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.742 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.95 -28.03 57.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.13 0.49 . . . . 0.0 110.392 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -82.92 66.83 8.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.75 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.474 1.51 . . . . 0.0 114.537 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' ALA . 6.6 m -59.8 165.72 2.98 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.053 0.541 . . . . 0.0 110.196 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -59.49 -15.18 16.0 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.764 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -53.16 -29.34 31.03 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.38 1.072 . . . . 0.0 113.595 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -114.98 -19.54 10.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.098 0.475 . . . . 0.0 110.176 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -79.64 -43.35 22.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.773 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -160.79 -49.16 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 m -74.3 157.46 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.199 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.4 pt? -61.34 142.62 56.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.187 0.517 . . . . 0.0 111.188 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 ptm85 -62.68 159.34 16.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.209 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p -76.84 111.86 12.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.118 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.466 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 80.03 48.32 6.58 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 14.2 p -51.87 141.99 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.142 0.496 . . . . 0.0 111.63 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -76.34 147.41 38.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -65.31 -13.77 59.23 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.847 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -56.51 -38.22 71.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.94 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.76 -43.69 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.975 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.04 -69.42 0.63 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.497 0.189 . . . . 0.0 111.19 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t 74.73 -29.09 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.721 0.809 . . . . 0.0 112.743 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.5 m -66.43 -67.63 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.75 -35.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -80.72 89.96 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.951 0.405 . . . . 0.0 110.428 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 8.9 mm100 -82.75 -48.25 11.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.68 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HE ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 ttp180 -136.69 -1.11 2.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.832 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 131' ' ' VAL . . . 69.37 -51.01 0.61 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 110.588 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.608 ' HB3' ' HE ' ' A' ' 50' ' ' ARG . . . -69.27 128.47 36.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.095 0.474 . . . . 0.0 110.972 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -49.1 -19.71 0.47 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . 0.569 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 44.0 t -63.21 -62.46 1.68 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 118.803 0.728 . . . . 0.0 110.963 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HD3' ' A' ' 50' ' ' ARG . 15.7 tp -87.52 -25.59 23.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 110.589 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.3 -13.89 60.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.85 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 11.4 p -42.71 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -44.32 -38.45 3.92 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.688 0.795 . . . . 0.0 111.852 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.77 12.9 9.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.664 0.269 . . . . 0.0 111.128 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.33 63.73 3.61 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.212 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 50.7 t -88.08 101.71 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -161.78 100.52 1.14 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.444 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.04 -59.37 4.28 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.646 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -62.57 -76.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.146 0.498 . . . . 0.0 111.031 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 12.3 p-10 -86.69 10.93 14.23 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 132' ' ' ASP . 23.4 tp -88.98 -57.7 2.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.332 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.09 54.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 110.186 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -107.71 170.01 8.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 67.8 -61.53 0.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.84 0.456 . . . . 0.0 111.687 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.45 -58.41 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.535 0.334 . . . . 0.0 111.052 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 91.2 t -60.13 -37.23 72.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -70.17 -34.47 73.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.155 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 -43.93 36.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.71 -40.12 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.836 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.6 t -69.58 -6.68 32.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -79.96 -20.71 44.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.919 0.39 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mp . . . . . 0 C--O 1.24 0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.506 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 . . . . . 0 N--CA 1.453 -0.301 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 46.86 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.376 0.608 . . . . 0.0 109.406 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.49 ' O ' ' HB2' ' A' ' 91' ' ' SER . 7.8 tp-100 -77.57 -59.58 2.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.54 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.28 89.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.725 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.52 17.12 1.85 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.544 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 8.6 t -54.93 -40.96 70.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.763 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 23' ' ' ASN . 6.6 t -72.72 -38.83 67.33 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.4 63.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.4 -20.88 31.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB2' HH12 ' A' ' 36' ' ' ARG . 48.0 t80 -87.88 -50.2 6.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.194 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 56.15 87.02 0.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.973 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.03 -5.12 42.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.555 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.64 -5.39 78.53 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.914 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 18.4 t -94.52 -7.44 10.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -178.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -84.71 -177.68 6.66 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.634 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 12.5 p-10 -75.05 125.5 29.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.7 -24.58 61.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.367 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -68.29 -29.74 68.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.671 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.488 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 21.2 t30 -59.86 -51.93 67.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.737 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.1 mp -74.52 -37.85 44.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.442 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.72 -34.56 78.11 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.843 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -89.21 -49.14 6.91 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.33 -15.3 5.18 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.085 -1.046 . . . . 0.0 113.453 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -65.65 -75.74 0.39 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.926 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 114' ' ' SER . 16.3 m -67.77 -16.81 64.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 107' ' ' THR . 60.9 mtp180 -86.76 -46.59 9.85 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -83.81 -52.39 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.409 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.0 mp -67.59 -33.59 75.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' SER . 72.3 m 45.64 -99.63 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.48 -35.07 60.17 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.289 0.636 . . . . 0.0 112.306 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.53 -52.66 43.35 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.115 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 12.6 mt -72.43 -26.54 61.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.97 -36.93 73.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 109.836 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.96 -43.19 6.07 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.65 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 117' ' ' LEU . 37.3 t -61.0 -42.23 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.7 t -85.17 -39.85 17.38 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.38 -81.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 129' ' ' ILE . . . -69.08 -44.99 71.42 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 48.2 tt0 -70.5 -38.05 74.26 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.131 0.491 . . . . 0.0 111.183 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.73 -40.97 7.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.455 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.66 -22.48 9.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.36 95.38 0.21 Allowed Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.52 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 37' ' ' THR . 15.8 mm -76.76 132.99 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.514 HD21 ' NE2' ' A' ' 137' ' ' GLN . 10.8 t30 -115.49 132.01 56.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.782 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.466 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.5 t -99.11 120.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' HD21 ' A' ' 66' ' ' LEU . 5.9 m-20 -99.98 35.8 1.97 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.515 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 67.3 p -70.82 -8.06 49.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.077 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.1 -19.75 51.5 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.198 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 p -105.98 -46.96 3.97 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 140' ' ' ILE . 54.2 t -66.28 -62.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.538 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.514 ' NE2' HD21 ' A' ' 130' ' ' ASN . 8.1 tt0 -56.3 -39.23 72.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -62.43 -40.35 96.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.78 -47.12 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.905 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.7 pt -57.4 -38.46 62.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.3 p -56.61 -42.14 78.27 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 111.66 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -84.67 -39.76 18.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 0.0 111.05 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 61.6 m -69.69 -39.58 76.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.0 t . . . . . 0 C--N 1.326 -0.415 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.444 -178.062 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.346 0 CA-C-O 120.499 -0.056 . . . . 0.0 113.04 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -62.96 -18.03 62.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.788 0.327 . . . . 0.0 111.618 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 18' ' ' ILE . 75.8 m -65.34 -21.83 66.74 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.008 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.78 41.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.931 0.396 . . . . 0.0 111.958 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.78 -41.75 8.07 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.1 pp -87.94 -20.62 25.66 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 14' ' ' SER . 12.0 pt -43.39 -47.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 35.4 t -73.06 -20.19 61.03 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 121.267 -0.173 . . . . 0.0 111.101 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 50.4 mtt180 -86.32 -32.24 21.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 17' ' ' LEU . 39.3 t -54.15 169.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.115 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.522 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.73 -32.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 31.7 m-80 -60.79 -24.39 65.76 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.63 -53.05 59.84 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.985 0.421 . . . . 0.0 111.332 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 30.3 tp -80.91 -25.77 37.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.333 -178.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -75.72 90.36 2.86 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 32' ' ' ARG . 5.2 m-80 -75.3 17.98 0.23 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.7 m -65.8 148.26 52.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.1 m -58.07 -14.54 6.9 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 p -48.5 -35.72 13.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -108.41 -18.25 13.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.197 0.522 . . . . 0.0 110.679 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 27' ' ' ASN . 17.0 mmt180 -76.73 -49.86 15.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -163.45 -29.76 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.4 t -87.49 144.87 8.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.5 145.58 32.77 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -70.59 153.53 42.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -68.84 120.8 15.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.93 37.14 20.04 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.514 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 7.5 p -51.31 148.37 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.153 0.501 . . . . 0.0 111.29 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -93.0 153.93 18.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -65.41 -12.72 55.01 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.422 -178.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -48.96 -38.58 23.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.198 0.523 . . . . 0.0 109.979 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.702 HG13 ' N ' ' A' ' 44' ' ' ALA . 3.9 pt -85.12 -44.47 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.907 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.702 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.14 -67.46 0.79 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.7 m 75.95 -18.57 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.808 0.843 . . . . 0.0 112.627 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.1 t -57.14 -96.2 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.88 0.472 . . . . 0.0 112.153 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.35 -23.21 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.371 0.605 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -79.52 98.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.2 mm-40 -73.41 -47.23 43.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.713 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.4 ttm-85 -149.47 9.02 0.71 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.418 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 -53.31 0.57 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.447 0.699 . . . . 0.0 110.982 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -68.54 142.82 55.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.573 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.03 -19.05 6.12 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -55.55 -71.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.862 0.363 . . . . 0.0 111.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -25.92 23.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.25 -18.39 57.67 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 19.3 t -52.42 106.04 0.14 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.028 0.442 . . . . 0.0 110.516 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.539 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.4 t -165.39 -40.8 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.69 19.47 11.09 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.36 64.23 1.12 Allowed Glycine 0 C--N 1.316 -0.554 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.795 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.02 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -163.46 13.46 0.06 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.879 0.847 . . . . 0.0 109.461 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.87 -50.74 0.61 Allowed Glycine 0 C--N 1.294 -1.794 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.159 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.34 -55.23 37.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 120.782 0.325 . . . . 0.0 110.551 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.63 -41.79 16.01 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.482 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.58 -58.27 7.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.396 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 -5.74 59.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -128.25 -86.04 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -57.89 -31.91 67.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.48 -52.04 15.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 111.131 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 9.2 p -69.04 -40.77 81.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 75.1 mt-30 -62.91 -39.15 93.66 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.358 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.71 71.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.96 0.41 . . . . 0.0 111.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 77' ' ' LEU . 39.7 t -86.36 -32.37 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.002 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -70.81 -23.27 62.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.164 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 24.7 mmt180 -85.18 1.65 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.776 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 86' ' ' TYR . 77.0 mt . . . . . 0 C--N 1.321 -0.667 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.019 179.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.54 ' CE2' HD13 ' A' ' 77' ' ' LEU . 18.3 m-30 . . . . . 0 N--CA 1.44 -0.946 0 CA-C-O 120.901 0.381 . . . . 0.0 111.359 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.422 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -72.55 53.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.237 0.615 . . . . 0.0 111.352 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -90.6 -59.2 2.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.117 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.26 -26.27 30.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.657 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.3 m-85 -83.51 6.68 19.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.528 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.3 m -52.84 -31.44 39.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.425 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 73.6 m -61.22 -47.68 84.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.54 32.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.789 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 84.0 mt -85.15 -32.19 22.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -84.85 -36.52 21.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.769 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.01 86.47 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 112.022 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.04 56.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.755 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.9 -13.63 42.46 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.73 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.1 t -84.17 -1.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.612 0.72 . . . . 0.0 110.434 -178.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.15 179.32 6.41 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.896 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.78 141.19 30.68 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.529 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.21 -23.64 57.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.814 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m -69.05 -34.78 75.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.469 0.652 . . . . 0.0 110.386 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.59 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 31.5 t30 -60.21 -51.71 68.41 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.487 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.61 -33.9 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.22 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.86 -48.41 76.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.966 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 71.1 m -73.1 -56.54 4.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -174.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.3 pp -102.18 -24.37 13.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.067 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.28 -65.91 2.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.274 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -65.61 -28.18 68.94 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 107' ' ' THR . 11.5 mpt_? -86.57 -55.31 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.54 -48.77 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.13 -42.64 65.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.6 m 48.46 -95.09 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.6 -33.28 54.38 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.206 0.602 . . . . 0.0 112.031 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.489 ' O ' HG23 ' A' ' 120' ' ' VAL . 60.7 tp -62.19 -53.59 53.04 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.503 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 13.7 mt -66.6 -28.34 68.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.777 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -59.49 -43.99 93.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.963 0.411 . . . . 0.0 110.038 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.24 -31.73 41.31 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.98 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 124' ' ' ALA . 69.4 t -68.43 -38.9 79.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 122.863 -0.198 . . . . 0.0 111.269 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 64.9 m -57.55 -41.95 82.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.845 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -83.85 -39.24 20.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.94 -80.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -64.22 -55.61 20.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 70.0 mt-30 -70.12 -29.23 66.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.197 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.68 -64.73 2.01 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.091 -0.575 . . . . 0.0 114.185 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.7 mt -104.35 -23.78 13.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.859 0.362 . . . . 0.0 111.656 -175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.94 97.72 1.12 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.422 HG23 ' CB ' ' A' ' 52' ' ' ALA . 30.1 mm -75.37 129.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -127.84 131.92 49.46 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.962 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.97 118.31 50.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.471 0.653 . . . . 0.0 111.405 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -97.63 43.97 1.06 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.455 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 21.0 p -78.62 1.14 23.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 120.855 0.36 . . . . 0.0 111.256 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.36 -21.96 29.28 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.567 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.2 t -106.0 -58.67 1.88 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 122.927 -0.16 . . . . 0.0 111.285 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -50.63 -51.97 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 137' ' ' GLN . 8.3 tt0 -61.76 -44.44 96.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -60.69 -46.78 89.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.952 0.406 . . . . 0.0 110.302 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -62.8 -51.1 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.578 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 136' ' ' VAL . 39.4 pt -69.32 -38.09 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -63.05 -52.35 63.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.465 0.174 . . . . 0.0 111.316 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.9 p -62.85 -43.34 99.04 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -65.18 -40.52 94.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.311 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 m . . . . . 0 C--N 1.321 -0.662 0 CA-C-O 121.144 0.497 . . . . 0.0 110.946 179.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.38 0 CA-C-O 120.401 -0.11 . . . . 0.0 113.242 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.84 90.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.976 0.388 . . . . 0.0 111.211 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.7 m -60.22 -28.6 68.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.754 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.11 -21.44 22.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.93 -39.42 7.51 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.407 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.1 pp -85.98 -25.46 26.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' SER . 14.1 pt -45.38 -50.34 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 14.1 m -84.78 -18.74 34.08 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.699 0.285 . . . . 0.0 111.586 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.74 -24.24 28.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -78.71 -106.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.446 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -77.97 -50.14 12.74 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' HD22 ' A' ' 31' ' ' LEU . 19.6 m-80 -60.51 -21.42 62.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.13 -40.83 77.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.176 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.14 -37.05 15.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.255 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -79.41 83.02 5.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 18.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.853 0.861 . . . . 0.0 113.069 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 26' ' ' ALA . 2.3 m -62.38 164.85 6.68 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.432 0.634 . . . . 0.0 111.346 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.1 t -65.45 -14.92 62.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.896 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -48.13 -44.03 31.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.742 0.817 . . . . 0.0 112.838 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -99.15 -19.86 16.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.496 0.665 . . . . 0.0 109.8 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -70.64 -53.39 15.99 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.761 -174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -167.16 -24.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.93 141.39 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 35' ' ' LEU . 1.9 pt? -54.72 150.03 10.23 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 111.91 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.49 163.49 26.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.169 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 131' ' ' VAL . 18.4 p -77.12 147.4 36.61 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.1 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 131' ' ' VAL . . . 73.71 24.38 74.59 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.313 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.8 165.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.76 0.424 . . . . 0.0 110.782 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.9 m -134.95 165.04 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.147 -0.346 . . . . 0.0 111.525 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.4 pp0? -66.77 -12.54 59.18 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' A' ' 116' ' ' LEU . 82.9 mm-40 -53.44 -38.8 63.87 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -86.63 -44.11 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -81.89 -65.25 1.03 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.614 0.245 . . . . 0.0 111.362 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m 81.81 -19.02 0.44 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.911 0.884 . . . . 0.0 112.152 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -70.91 -90.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.005 0.431 . . . . 0.0 111.705 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.61 -19.69 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.404 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.38 81.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.169 0.509 . . . . 0.0 110.105 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 1.8 mp0 -64.41 -48.93 73.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.231 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 46.4 ttm-85 -148.31 4.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.061 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . 67.63 -51.3 0.51 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -67.46 140.82 57.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.375 0.607 . . . . 0.0 110.857 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.6 mt-30 -59.52 -17.5 32.56 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.415 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -62.35 -74.06 0.1 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.848 0.356 . . . . 0.0 111.747 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.581 HD13 ' HE ' ' A' ' 50' ' ' ARG . 9.0 tt -87.22 -25.03 24.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.653 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.22 -19.51 43.06 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -50.06 108.11 0.2 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -150.02 -41.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.738 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.4 mt -118.22 19.33 13.54 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.338 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.48 56.34 1.27 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.811 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 53' ' ' GLN . 2.9 t -90.23 104.09 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -156.18 15.14 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.08 -37.37 2.16 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.026 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -54.49 -74.0 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.44 0.296 . . . . 0.0 111.458 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.5 p-10 -81.11 -20.83 40.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.013 0.435 . . . . 0.0 110.216 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.5 -55.05 35.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.655 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 133' ' ' SER . . . -82.79 1.66 37.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -126.08 -87.55 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -57.35 -38.43 74.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.47 92.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.958 0.409 . . . . 0.0 110.824 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.35 -46.26 71.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.13 -40.38 81.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.655 0.264 . . . . 0.0 111.584 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.04 88.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.835 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.598 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.2 t -85.31 -17.69 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -93.35 -19.6 21.18 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 121.946 -0.471 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -118.55 22.46 12.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.491 0.662 . . . . 0.0 110.744 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.311 -1.095 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.106 -178.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.509 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 4.2 m-85 . . . . . 0 N--CA 1.444 -0.752 0 CA-C-O 121.272 0.558 . . . . 0.0 111.468 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.62 17.62 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 77.7 mt-30 -88.89 -55.45 3.69 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.364 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -72.41 -40.96 66.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.302 0.572 . . . . 0.0 109.592 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.7 m-85 -81.64 16.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.082 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -51.63 -57.2 9.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.2 m -55.12 -36.68 66.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.93 -39.15 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 18.9 mt -81.9 -30.32 31.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.825 0.345 . . . . 0.0 111.68 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -85.06 -28.56 25.58 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 52.77 84.28 0.06 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.81 -7.45 57.87 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.128 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.18 -11.93 40.67 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.035 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 t -78.53 -8.54 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.53 -171.42 3.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.487 -177.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.07 129.41 42.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.29 61.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.14 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -67.9 -32.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.529 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 11.5 t30 -62.7 -54.01 45.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -69.06 -35.96 71.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.384 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.86 -30.81 67.31 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.709 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.1 m -92.74 -34.55 13.87 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 2.2 pp -137.47 -29.61 0.87 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.812 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -53.17 -68.56 1.56 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.987 -0.625 . . . . 0.0 114.326 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 114' ' ' SER . 8.1 m -60.89 -20.6 62.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.714 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -88.14 -54.59 4.14 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.356 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.59 -45.89 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.812 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.4 mm? -81.5 -29.87 33.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 110' ' ' SER . 35.3 t 44.7 -96.68 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.39 68.31 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.908 0.483 . . . . 0.0 111.8 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 39.5 tp -65.32 -60.12 3.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.69 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.57 -29.26 68.58 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.57 -43.85 93.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.788 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 -37.13 28.66 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.999 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 124' ' ' ALA . 63.1 t -68.65 -41.11 82.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 8.1 t -55.73 -46.52 77.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.076 0.465 . . . . 0.0 111.201 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -74.66 -49.56 20.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.108 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.41 -70.88 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.646 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -73.59 -47.6 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 121' ' ' SER . 32.5 tt0 -68.64 -35.49 77.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.055 0.455 . . . . 0.0 110.428 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.62 -71.32 1.28 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.77 -0.65 . . . . 0.0 114.034 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.43 -24.16 23.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.816 0.341 . . . . 0.0 111.371 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.49 92.92 0.98 Allowed Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.191 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.518 HG23 ' CB ' ' A' ' 52' ' ' ALA . 20.7 mm -78.17 129.6 37.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -108.9 131.14 55.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.486 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 51' ' ' ALA . 7.3 m -98.73 90.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.04 0.924 . . . . 0.0 111.14 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.57 46.01 1.02 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.279 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.3 m -68.37 -6.05 22.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.566 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 -23.42 30.18 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.122 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -105.55 -31.99 8.7 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.548 HG11 ' CG2' ' A' ' 131' ' ' VAL . 40.6 t -67.27 -57.18 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.712 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.5 -53.36 30.53 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.46 0.475 . . . . 0.0 111.804 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -54.23 -37.73 64.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.171 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.58 -47.0 10.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.652 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.5 pt -64.99 -39.17 84.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.8 p -61.91 -49.07 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.429 . . . . 0.0 110.67 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.2 m -65.63 -28.95 69.48 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.329 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.1 t -89.06 -20.37 24.44 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.7 p . . . . . 0 C--N 1.326 -0.423 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.178 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.519 0.342 0 N-CA-C 113.59 0.196 . . . . 0.0 113.59 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.91 87.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' ILE . 67.4 m -62.78 -24.62 67.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.67 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.91 -33.03 10.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.506 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 3.4 pp -84.48 -19.26 33.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' SER . 18.3 pt -30.77 -56.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.3 m -84.53 -20.04 32.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -86.29 -44.58 12.0 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.679 HG11 ' HB3' ' A' ' 100' ' ' LEU . 15.9 t -59.02 -97.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -171.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.26 -48.62 13.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -65.45 -25.11 67.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -67.85 -39.62 83.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.353 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -71.92 -33.7 68.47 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.922 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.64 69.19 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.892 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 64.49 8.58 4.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.736 0.814 . . . . 0.0 112.031 177.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 29' ' ' SER . 1.9 m -72.43 172.83 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 28' ' ' THR . 33.1 m -63.24 -15.68 57.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -54.5 -22.52 13.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.026 0.93 . . . . 0.0 113.433 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.4 pt? -120.53 -21.86 6.63 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.209 0.528 . . . . 0.0 110.393 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -79.66 -37.69 35.36 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 34' ' ' VAL . 9.9 t -164.58 -26.12 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.444 HG23 HG23 ' A' ' 33' ' ' THR . 87.7 t -99.76 141.23 17.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.72 163.18 5.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.553 ' HG2' ' HB1' ' A' ' 87' ' ' ALA . 4.3 ptm180 -69.42 141.84 53.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.447 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -68.46 124.6 24.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.88 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 85.08 29.78 27.4 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.587 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.78 145.74 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 20.4 t -104.65 166.33 10.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 112.024 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 51.5 tt0 -73.23 -14.93 61.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.189 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.37 -48.79 65.37 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.584 HD11 ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -85.72 -47.79 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.12 175.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . . . -58.08 -32.02 67.65 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m 72.18 -38.84 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -71.09 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.61 -19.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.671 HG22 ' HB1' ' A' ' 70' ' ' ALA . 46.1 t -62.34 82.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 116.905 -0.134 . . . . 0.0 111.321 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 40' ' ' SER . 47.8 mm-40 -63.58 -43.95 95.49 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.154 0.502 . . . . 0.0 110.35 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.668 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 20.0 ttm180 -157.25 0.47 0.12 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.48 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.98 -53.18 0.46 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.402 0.681 . . . . 0.0 110.756 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.32 133.98 55.85 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.956 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.504 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 18.2 mp0 -59.21 -18.17 34.31 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.372 0.669 . . . . 0.0 112.759 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.8 t -55.89 -68.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.668 HD22 ' CZ ' ' A' ' 50' ' ' ARG . 4.0 tp -87.74 -30.1 20.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.243 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -65.61 -18.7 65.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 18.1 t -64.56 83.71 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 59' ' ' LEU . 8.9 t -136.29 -37.24 0.71 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.024 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' THR . 1.2 pp -123.2 13.48 9.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.34 49.08 2.08 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.084 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.431 HG22 HD21 ' A' ' 65' ' ' ASN . 39.6 t -89.26 118.56 34.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.513 0.197 . . . . 0.0 110.86 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.94 21.64 1.6 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.977 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.42 -31.4 6.0 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.986 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 13.9 p-10 -52.47 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.997 0.919 . . . . 0.0 111.786 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.482 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 2.9 p-10 -86.97 26.16 1.2 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.971 0.415 . . . . 0.0 110.243 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 5.6 tt -88.02 -78.19 0.33 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.177 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.93 74.71 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.66 160.76 16.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . 0.488 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 98.1 m-85 69.53 -62.62 0.41 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.016 0.527 . . . . 0.0 111.787 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.671 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -62.65 -62.64 1.6 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -63.59 -38.81 83.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.671 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 21.1 mt-30 -63.46 -32.32 73.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.921 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.54 -40.94 22.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.686 0.279 . . . . 0.0 111.614 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.2 -35.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.185 0.516 . . . . 0.0 111.094 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -78.11 -4.89 49.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.282 0.563 . . . . 0.0 110.25 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 47.5 ttp180 -90.0 -6.77 55.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.592 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp . . . . . 0 C--O 1.24 0.574 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.859 179.351 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.61 ' HD1' ' N ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER . . . . . 0 CA--C 1.543 0.696 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.61 ' N ' ' HD1' ' A' ' 86' ' ' TYR . . . -88.14 -17.87 30.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.894 0.378 . . . . 0.0 111.397 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.58 -45.44 90.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.337 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.45 -62.51 1.63 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.271 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.585 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 61.4 m-85 -84.27 32.94 0.49 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.801 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 p -54.82 -61.5 2.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -68.59 -38.37 80.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.436 ' O ' HD21 ' A' ' 117' ' ' LEU . . . -64.69 -39.86 94.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 36.5 mt -83.77 -34.33 24.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -76.22 -47.04 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.335 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.517 ' ND2' HG12 ' A' ' 105' ' ' ILE . 37.9 t-20 57.21 92.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.983 0.802 . . . . 0.0 111.119 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.41 -2.15 48.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.6 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.03 -13.47 31.62 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.733 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.0 t -80.46 -8.95 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.64 0.734 . . . . 0.0 109.921 179.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -84.4 -179.23 7.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.257 -176.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -77.26 113.83 15.43 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.549 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.39 64.27 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.717 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -41.32 77.86 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.494 ' HB3' ' ND2' ' A' ' 101' ' ' ASN . 2.1 t30 -62.14 -33.23 74.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.715 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.517 HG12 ' ND2' ' A' ' 96' ' ' ASN . 1.5 mp -78.15 -43.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.541 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.57 -19.02 56.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.459 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -84.31 -55.48 4.15 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.015 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 3.3 pp -123.47 -32.57 3.36 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -50.33 -75.21 0.22 Allowed Glycine 0 C--O 1.223 -0.541 0 C-N-CA 121.596 -0.335 . . . . 0.0 113.772 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.5 m -62.4 -18.37 61.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.796 0.331 . . . . 0.0 111.841 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -81.0 -54.27 5.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.447 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.02 -40.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.994 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.509 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 3.3 mm? -70.08 -16.68 63.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.6 p 45.44 -118.24 0.71 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.918 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.8 69.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 120' ' ' VAL . 11.6 tp -59.38 -62.88 1.55 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.519 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 117' ' ' LEU . 15.8 mt -71.9 -29.99 64.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.564 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -61.19 -40.23 93.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.284 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.92 -32.63 56.6 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.661 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 124' ' ' ALA . 54.2 t -68.51 -35.99 72.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.651 -0.323 . . . . 0.0 110.962 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 59.0 m -53.03 -47.36 68.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.1 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 p -80.85 -43.25 20.25 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.79 -72.51 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.651 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.24 -50.43 32.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' SER . 45.4 tt0 -64.62 -35.87 82.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.054 0.454 . . . . 0.0 110.769 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.21 -53.37 3.14 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.9 -0.667 . . . . 0.0 114.618 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.5 mt -105.48 -24.12 12.68 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.9 94.5 0.73 Allowed Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.879 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.558 HG13 ' HD3' ' A' ' 50' ' ' ARG . 30.1 mm -77.87 141.12 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.253 0.549 . . . . 0.0 112.429 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -123.23 152.13 41.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.73 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 46.3 t -107.88 163.31 5.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 131' ' ' VAL . 35.8 t70 -58.8 160.05 6.19 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.508 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 15.4 m -74.64 29.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.11 -87.17 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -106.23 -48.47 3.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.818 0.342 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 140' ' ' ILE . 45.1 t -52.15 -63.16 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -172.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.6 tt0 -62.59 -41.21 98.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -60.1 -44.0 95.17 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.083 0.468 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.87 -51.99 14.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.924 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 136' ' ' VAL . 34.4 pt -62.01 -34.47 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -64.74 -47.8 76.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 0.0 110.752 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -34.93 71.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.362 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.4 t -67.88 -56.59 8.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.875 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.5 p . . . . . 0 N--CA 1.474 0.74 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.94 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.314 0 N-CA-C 111.824 -0.511 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB3' HD22 ' A' ' 108' ' ' LEU . . . -72.28 -10.98 60.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.796 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 18' ' ' ILE . 20.3 m -78.55 -22.18 47.63 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.552 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -55.43 -30.44 60.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.15 -38.93 24.8 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.432 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -32.29 22.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' SER . 19.9 pt -47.79 -47.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 11.7 m -70.83 -24.58 62.56 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.68 0.276 . . . . 0.0 111.599 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -87.56 -24.37 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.882 0.372 . . . . 0.0 111.576 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 17' ' ' LEU . 84.3 t -59.92 173.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.51 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -37.45 -33.51 0.07 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.753 1.221 . . . . 0.0 114.189 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.19 -23.0 61.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.58 -38.17 86.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.9 -41.95 12.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.31 69.54 7.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -68.41 19.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.4 1.08 . . . . 0.0 112.39 -175.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 24.2 m -55.98 161.52 2.27 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 123.556 0.743 . . . . 0.0 111.482 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -52.69 -19.51 2.45 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 p -51.79 -44.83 63.6 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.895 . . . . 0.0 113.253 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -100.09 -20.23 16.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.375 0.607 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 1.2 tpt180 -66.72 -56.14 11.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.301 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -163.85 -34.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.859 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.62 146.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.89 139.86 57.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.105 0.478 . . . . 0.0 110.849 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 48.7 ptt85 -63.57 157.37 23.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.166 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.03 112.21 4.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.894 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.5 ' H ' HG22 ' A' ' 131' ' ' VAL . . . 90.71 35.72 7.16 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.687 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.9 p -45.12 143.6 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.44 0.696 . . . . 0.0 112.415 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.2 p -82.13 139.81 34.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.077 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.0 pt20 -59.55 -14.12 11.91 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.44 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.441 ' HG3' HD22 ' A' ' 116' ' ' LEU . 72.7 mm-40 -65.04 -32.02 73.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.746 0.307 . . . . 0.0 111.216 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.01 -34.08 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.413 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . -84.0 -76.94 0.28 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.567 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m 75.21 -18.92 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.838 0.855 . . . . 0.0 111.629 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 44' ' ' ALA . 16.8 p -68.04 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.296 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.56 -32.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.5 p -79.15 89.43 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 121.931 0.872 . . . . 0.0 110.795 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 10.9 mm100 -82.53 -43.49 17.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.021 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -133.88 -4.82 2.81 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.497 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.61 -50.12 0.66 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.305 0.642 . . . . 0.0 112.722 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.42 -90.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.429 ' HB3' HE21 ' A' ' 53' ' ' GLN . 2.6 pt20 -172.74 -45.15 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -50.31 -62.11 1.78 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 tt -86.06 -23.64 26.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.415 0.626 . . . . 0.0 110.138 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' THR . . . -76.98 -17.92 58.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 p -62.72 65.33 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.528 0.68 . . . . 0.0 112.724 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.496 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.9 t -102.5 -37.32 8.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 58' ' ' THR . 81.2 mt -121.76 19.16 11.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 65.33 1.57 Allowed Glycine 0 C--O 1.217 -0.968 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.24 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.572 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.9 t -90.07 110.17 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.98 0.419 . . . . 0.0 109.979 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -141.77 18.0 2.16 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.41 -34.71 4.3 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.09 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.3 -70.53 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 110.375 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 26.7 p-10 -86.04 18.88 2.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.454 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.7 tt -88.14 -74.41 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.529 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.41 -27.25 66.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -111.71 162.88 14.75 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 66.82 -61.74 0.32 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.85 -61.54 2.11 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.761 0.315 . . . . 0.0 110.73 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.76 -35.77 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -69.88 -21.37 63.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.446 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -42.85 29.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.83 0.348 . . . . 0.0 110.152 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 27.3 t -78.23 -33.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -70.97 -18.11 62.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.275 0.56 . . . . 0.0 110.431 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -116.58 18.95 14.86 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.182 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . 10.7 tp . . . . . 0 C--N 1.309 -1.19 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.278 -177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 . . . . . 0 N--CA 1.443 -0.814 0 CA-C-O 121.085 0.469 . . . . 0.0 110.251 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -75.01 12.84 0.78 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 4.1 mp0 -74.55 -59.86 2.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.95 71.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.086 0.47 . . . . 0.0 110.827 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 93.0 m-85 -83.24 12.38 5.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.522 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 47.8 t -51.19 -43.27 61.31 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.524 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.9 m -58.16 -44.64 88.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.69 30.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.781 0.324 . . . . 0.0 111.803 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 68.2 mt -81.59 -32.16 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -84.97 -34.72 22.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.447 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 49.05 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.979 0.8 . . . . 0.0 111.093 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.72 -6.34 51.77 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.598 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.16 -2.85 87.27 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.833 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 32.8 t -92.71 -13.33 8.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.646 0.736 . . . . 0.0 109.818 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.7 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -91.29 -176.08 4.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 31.9 t30 -84.54 105.17 15.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.76 -16.93 64.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.176 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -81.34 -19.76 42.12 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.476 ' ND2' HD12 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.97 -26.52 64.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.476 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -69.67 -33.17 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.564 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -77.48 -27.18 51.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.109 0.48 . . . . 0.0 109.959 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 89.9 m -78.54 -46.65 18.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.838 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -133.51 -40.99 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -48.5 -71.88 0.52 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' SER . 10.3 t -67.32 -14.05 62.56 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.097 0.475 . . . . 0.0 111.494 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 107' ' ' THR . 80.4 mtp180 -87.19 -49.51 7.23 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.4 -42.81 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.258 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 116' ' ' LEU . 6.0 mp -80.09 -29.46 39.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 110' ' ' SER . 19.5 m 47.72 -99.09 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.473 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.22 -36.79 63.89 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 113' ' ' LEU . 55.5 tp -62.47 -57.08 12.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.601 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' SER . 25.9 mt -71.47 -23.78 61.88 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.165 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.12 -34.11 76.9 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.19 -43.22 6.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.455 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 124' ' ' ALA . 56.0 t -62.42 -28.99 45.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 122.358 0.263 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 9.3 t -57.35 -40.51 78.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.267 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 23.7 m -85.57 -28.83 24.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.0 -83.82 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -70.17 -47.49 61.37 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 42.9 tt0 -75.71 -17.57 59.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.326 0.584 . . . . 0.0 109.793 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 122' ' ' SER . . . -85.13 -64.06 1.55 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.207 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -127.69 -4.93 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.37 119.43 1.32 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.593 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.46 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.967 0.413 . . . . 0.0 111.261 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -101.02 152.19 20.89 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.28 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -116.61 -149.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.444 ' H ' HG12 ' A' ' 131' ' ' VAL . 2.8 p-10 -85.44 147.44 26.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.491 0.663 . . . . 0.0 110.871 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 p -80.53 15.38 1.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.301 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.05 -64.43 0.48 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.499 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.6 m -85.25 -49.86 7.84 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' ILE . 99.5 t -72.23 -51.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.82 -48.25 73.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 p -58.79 -41.78 87.49 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.831 0.348 . . . . 0.0 111.86 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -50.4 16.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.996 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.3 pt -65.27 -31.73 55.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -61.41 -43.94 97.99 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.2 p -86.52 -40.57 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 22.8 t -78.09 -18.36 55.83 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.6 p . . . . . 0 N--CA 1.474 0.729 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.773 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.24 0 CA-C-O 120.369 -0.128 . . . . 0.0 113.056 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.59 77.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.3 p -76.21 -27.99 57.04 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.291 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.99 -23.02 52.21 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.01 -41.8 6.17 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.511 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -84.41 -22.64 30.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 5.1 pt -40.22 -55.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 t -85.06 -19.71 31.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.712 0.291 . . . . 0.0 111.632 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -83.14 -27.42 30.13 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 100' ' ' LEU . 23.8 t -71.28 -100.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.99 35.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB3' HD22 ' A' ' 31' ' ' LEU . 4.4 m-80 -70.91 -24.56 62.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.7 87.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.167 0.508 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 25' ' ' LEU . 6.0 tt -75.91 -40.21 54.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.05 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.73 90.41 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.741 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 53.77 16.97 1.14 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.793 0.837 . . . . 0.0 111.794 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 29' ' ' SER . 19.7 m -75.66 165.59 24.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.27 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 16.3 m -60.08 -17.63 41.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.819 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -53.48 -31.26 44.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.687 0.795 . . . . 0.0 112.73 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -110.08 -20.28 12.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.525 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 15.5 ttm180 -79.87 -38.61 32.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.878 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -174.64 -26.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.08 139.64 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.42 145.37 22.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -63.12 155.25 28.5 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 m -71.22 114.45 9.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.262 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 40.13 9.19 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.762 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.86 151.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.203 0.525 . . . . 0.0 111.605 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -91.31 159.51 15.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.599 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.0 pt20 -67.42 -13.37 61.96 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.285 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.415 ' CG ' HD13 ' A' ' 116' ' ' LEU . 83.4 mm-40 -55.62 -47.78 76.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.043 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.94 -29.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.784 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.32 -55.36 4.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.118 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 m 75.53 -18.9 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.866 0.866 . . . . 0.0 111.821 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -68.43 -88.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -145.01 -27.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.947 0.403 . . . . 0.0 111.814 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.62 98.21 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.342 0.591 . . . . 0.0 111.824 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 31.2 mt-30 -82.54 -48.27 11.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.351 177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.726 ' NH1' ' HA ' ' A' ' 123' ' ' ALA . 54.7 ttt180 -134.31 -3.14 2.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.879 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.07 -58.26 0.54 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.354 0.662 . . . . 0.0 110.306 -174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.43 137.61 57.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.274 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -50.29 -24.38 2.89 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -50.93 -74.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.56 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 47.5 tp -87.94 -24.53 23.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.514 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.85 59.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 14.3 t -58.67 84.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 111.65 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.7 t -123.3 -35.99 2.88 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.73 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' THR . 84.0 mt -120.82 18.57 11.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.948 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.43 59.69 2.35 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.391 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.707 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 33.0 t -89.43 103.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 120.929 0.395 . . . . 0.0 110.834 -177.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -169.2 96.77 0.34 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.502 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.77 -63.87 4.18 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.21 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.55 -75.52 0.05 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.914 0.486 . . . . 0.0 111.664 -175.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.707 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.5 p-10 -85.8 15.16 5.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.26 -56.1 3.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.442 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.01 46.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.246 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -121.24 161.09 22.54 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 66.95 -63.11 0.28 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.89 -31.24 52.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 110.349 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -68.61 -29.5 68.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.65 65.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.122 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -77.5 -38.92 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.7 t -66.37 -21.92 66.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -113.32 15.44 19.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 77' ' ' LEU . 11.9 tp . . . . . 0 C--N 1.317 -0.825 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.661 -177.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 . . . . . 0 N--CA 1.444 -0.748 0 CA-C-O 120.967 0.413 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.81 35.6 0.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.235 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 85.6 mm-40 -74.43 -60.39 2.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.331 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -78.67 -32.67 47.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.409 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.43 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 56.6 m-85 -80.68 9.03 6.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.055 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 p -52.15 -56.53 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 11.7 t -61.53 -36.04 79.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -74.61 -36.54 62.95 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.39 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.438 HD22 HD21 ' A' ' 116' ' ' LEU . 50.1 mt -83.62 -20.68 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.164 0.507 . . . . 0.0 111.163 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.53 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 78.9 t80 -85.13 -25.27 27.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m120 48.57 65.59 1.3 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.972 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.92 64.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.098 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.13 -15.45 61.0 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.113 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.17 -12.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.98 0.895 . . . . 0.0 109.02 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -83.6 175.29 9.85 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 -178.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 39.1 t30 -72.17 109.51 5.99 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.833 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.53 -24.43 63.74 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.865 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.1 m -69.46 -26.88 64.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.527 0.68 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -64.62 -46.56 82.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.606 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.68 -36.95 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.019 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.59 -39.06 92.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 93.4 m -74.87 -62.89 1.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' OD1' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -113.21 -33.22 6.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.9 -56.87 14.3 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.188 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.9 t -69.49 -26.44 64.56 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.764 0.316 . . . . 0.0 111.573 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 107' ' ' THR . 3.6 mpt_? -83.09 -47.39 11.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.24 -50.08 15.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 9.0 mp -67.87 -41.27 83.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.925 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.7 t 46.72 -95.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.761 0.824 . . . . 0.0 113.104 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.8 66.0 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.092 0.557 . . . . 0.0 112.121 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 120' ' ' VAL . 35.2 tp -65.93 -48.22 72.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.524 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 17.0 mt -70.75 -23.49 62.44 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.718 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -58.46 -34.78 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.55 -41.42 6.88 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.555 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 116' ' ' LEU . 76.4 t -61.18 -32.55 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.8 m -54.43 -45.67 73.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -84.33 -23.9 30.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.827 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.726 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.17 -84.96 0.14 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 95' ' ' PHE . . . -76.51 -45.91 28.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.835 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -72.52 -20.38 61.36 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.089 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.73 -70.96 1.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.62 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.69 -9.07 5.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.653 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.63 120.78 3.12 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.895 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 mt -85.27 146.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.051 0.453 . . . . 0.0 111.863 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.52 149.37 42.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.2 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 20.7 t -120.89 161.72 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 131' ' ' VAL . 21.2 t70 -59.72 156.22 14.31 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.261 0.553 . . . . 0.0 111.74 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 14.5 m -78.97 20.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.477 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.84 -77.97 0.35 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.183 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.9 m -107.83 -31.15 8.14 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.8 t -86.58 -64.46 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.2 tt0 -67.59 -23.0 65.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.358 . . . . 0.0 111.96 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -68.85 -44.97 72.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.065 0.46 . . . . 0.0 111.084 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.48 -50.23 14.54 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.511 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 137' ' ' GLN . 44.9 pt -58.79 -40.47 79.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -36.95 70.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.755 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.1 t -84.42 -45.53 12.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.0 110.568 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 45.6 t -59.14 -45.41 91.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.905 -177.798 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.1 m . . . . . 0 N--CA 1.467 0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 -179.023 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.847 0 N-CA-C 111.951 -0.459 . . . . 0.0 111.951 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.21 -1.1 24.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.305 0.574 . . . . 0.0 110.437 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 18' ' ' ILE . 27.5 p -76.5 -25.01 53.78 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.27 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.47 43.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.49 -38.93 6.91 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.53 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -83.77 -25.02 30.84 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 9.5 pt -45.44 -42.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.2 m -83.12 -19.83 35.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.8 mtt180 -86.71 -23.84 25.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -72.14 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.471 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -51.79 -33.26 34.69 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.439 0.696 . . . . 0.0 112.76 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB3' HD22 ' A' ' 31' ' ' LEU . 10.0 m-80 -65.69 -24.29 66.97 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -70.95 -42.42 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -81.23 -16.1 53.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.494 179.568 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -84.57 -36.99 21.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 51.26 18.25 0.59 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.683 1.193 . . . . 0.0 112.228 176.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 143' ' ' SER . 7.1 m -66.26 164.11 16.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.201 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 54.9 m -63.85 -16.3 61.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.832 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -51.31 -41.04 60.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.762 0.825 . . . . 0.0 112.289 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -99.84 -19.31 16.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.394 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 17.5 ttm180 -74.47 -59.58 2.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.199 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -162.78 -28.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.82 136.06 24.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.6 138.29 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.81 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -64.07 152.46 40.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.669 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -67.65 111.63 4.32 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.418 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 129' ' ' ILE . . . 85.93 38.37 8.68 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.215 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.9 148.29 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.131 0.491 . . . . 0.0 111.105 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -87.86 157.37 19.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.073 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 18.8 pt20 -63.52 -19.39 64.73 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.302 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -51.5 -46.18 63.12 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 111.458 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -84.08 -32.66 8.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -83.67 -48.91 9.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.8 p 67.48 -18.84 0.13 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.292 1.437 . . . . 0.0 113.095 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ALA . 20.8 p -68.38 -75.69 0.1 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.61 -34.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.836 0.351 . . . . 0.0 111.903 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.52 97.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.1 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 72.8 mt-30 -82.84 -51.01 8.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.349 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.59 HH22 ' HB2' ' A' ' 127' ' ' LEU . 41.1 ttt180 -130.69 -5.72 4.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.673 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.426 ' O ' HD13 ' A' ' 66' ' ' LEU . . . 71.08 -55.74 0.64 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.599 -172.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 136.07 54.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.901 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -51.01 -29.86 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -173.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.3 t -46.84 -69.25 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.106 0.412 . . . . 0.0 112.079 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.448 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 57.4 tp -88.6 -24.19 22.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 111.602 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' THR . . . -79.26 -18.91 51.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.0 t -48.48 98.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.089 0.471 . . . . 0.0 111.662 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ALA . 8.9 t -142.04 -37.72 0.39 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.557 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.92 18.7 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.02 67.63 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.446 HG22 HD21 ' A' ' 65' ' ' ASN . 46.7 t -87.35 110.23 20.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.14 0.495 . . . . 0.0 110.998 -175.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -158.94 20.92 0.2 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.991 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 123.48 -37.75 2.65 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.814 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.28 -74.47 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.552 0.176 . . . . 0.0 110.928 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.446 HD21 HG22 ' A' ' 61' ' ' VAL . 2.5 p-10 -85.48 9.69 15.07 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 19.5 tp -87.97 -56.6 3.27 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.963 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 -35.52 40.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.508 0.671 . . . . 0.0 109.899 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.81 162.87 12.94 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 68.89 -61.68 0.41 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.65 -62.16 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.817 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -40.34 86.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.125 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.38 -44.6 95.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.722 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.51 74.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.02 -38.18 78.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -74.79 -21.78 59.12 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.979 0.419 . . . . 0.0 110.76 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 4.8 tpm_? -92.06 -8.9 44.59 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.15 0.5 . . . . 0.0 110.11 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 tp . . . . . 0 C--N 1.32 -0.714 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.276 -179.705 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 . . . . . 0 N--CA 1.446 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 109.769 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.18 41.33 0.37 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.297 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 tp60 -64.81 -61.59 2.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.911 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -80.34 -27.1 38.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.69 10.45 2.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t -52.03 -51.07 59.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.1 m -59.14 -34.96 72.68 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -32.84 31.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.94 -35.38 18.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -78.74 -30.84 46.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.0 m120 52.07 82.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.85 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.64 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.74 -13.71 60.16 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.135 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.27 -2.07 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.645 0.736 . . . . 0.0 109.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -84.92 173.81 10.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.355 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 16.1 t30 -68.39 103.74 1.71 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.733 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.36 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.813 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 p -74.84 -16.67 60.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.057 0.456 . . . . 0.0 110.673 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -68.06 -47.32 68.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.406 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.48 -41.93 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.17 -30.72 70.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.147 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.1 m -91.42 -52.46 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -117.48 -27.86 6.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.75 -64.89 3.97 Favored Glycine 0 C--O 1.234 0.103 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.961 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 p -76.71 -11.8 59.9 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -54.73 4.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.33 -54.48 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.164 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 113' ' ' LEU . 6.1 mp -72.96 -57.92 3.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m 67.24 -86.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.1 -36.92 61.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' VAL . 27.6 tp -65.29 -50.97 63.68 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.743 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HA ' HG22 ' A' ' 120' ' ' VAL . 5.4 mp -67.95 -23.22 65.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.05 -42.65 7.01 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.822 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.769 HG22 ' HA ' ' A' ' 117' ' ' LEU . 2.7 m -67.71 -32.46 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.828 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -62.21 -34.18 75.98 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.755 0.312 . . . . 0.0 110.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 t -85.34 -38.5 18.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.471 0.653 . . . . 0.0 110.303 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.22 -79.43 0.21 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 129' ' ' ILE . . . -65.23 -60.93 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.414 -175.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -31.86 70.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 109.965 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.94 2.22 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.484 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . 0.59 ' HB2' HH22 ' A' ' 50' ' ' ARG . 73.0 mt -115.02 -5.54 12.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.0 105.07 0.07 OUTLIER Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.3 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 124' ' ' ALA . 27.9 mt -77.57 134.88 27.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -128.1 115.74 18.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.082 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 132' ' ' ASP . 16.2 t -82.75 166.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.936 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 131' ' ' VAL . 18.9 t70 -59.35 158.18 9.78 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.104 0.478 . . . . 0.0 111.252 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 33.1 m -79.86 16.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.345 -177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.58 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.934 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.0 p -106.83 -30.14 9.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.39 -63.97 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tp-100 -59.17 -41.77 89.21 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 m -57.63 -45.7 85.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.877 0.37 . . . . 0.0 111.885 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.71 -52.87 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.459 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.4 pt -55.75 -38.91 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -62.87 -35.26 79.41 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 m -84.82 -38.24 19.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 111.009 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 28' ' ' THR . 50.9 m -72.28 -40.73 67.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.353 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t . . . . . 0 C--N 1.325 -0.487 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.024 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 0.47 0 N-CA-C 112.712 -0.155 . . . . 0.0 112.712 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.89 74.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.22 0.534 . . . . 0.0 110.682 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.6 m -62.82 -26.78 68.91 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.86 -18.31 4.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.79 -45.9 5.01 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.422 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.2 pp -86.63 -21.63 26.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 4.7 pt -35.49 -58.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.1 t -79.41 -20.23 48.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -86.65 -32.96 20.28 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' LEU . 45.7 t -62.0 -94.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -53.39 6.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -65.75 -24.41 66.95 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.16 -35.91 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.725 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -74.74 -21.6 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.482 178.477 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.68 33.74 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 55.96 18.09 2.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.714 176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 m -81.32 148.38 29.42 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 -17.18 1.01 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.882 1.273 . . . . 0.0 114.101 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -61.2 -21.99 64.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 pp -93.83 -26.99 16.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.217 0.532 . . . . 0.0 110.379 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -82.42 -45.88 14.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 -26.58 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 ' OD1' ' A' ' 139' ' ' ASP . 25.8 t -84.35 161.47 3.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.6 pt? -85.1 159.27 20.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.696 0.284 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -89.39 166.47 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.296 0.569 . . . . 0.0 111.514 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -74.87 124.87 27.66 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.601 177.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 73.31 38.26 53.6 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.451 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.93 149.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.042 0.937 . . . . 0.0 112.66 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.3 m -77.83 142.65 38.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.003 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -68.87 -13.09 62.2 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -58.98 -35.43 73.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.93 -42.35 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.795 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.39 -69.15 0.65 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.591 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m 74.9 -21.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.968 0.907 . . . . 0.0 112.347 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 p -70.2 -82.24 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 -22.88 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.58 85.0 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 46.5 mt-30 -83.16 -43.62 15.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.51 -13.22 6.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.436 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.21 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.591 0.756 . . . . 0.0 110.255 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.27 144.34 50.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -55.03 -19.21 6.47 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -175.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -56.28 -81.72 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 50' ' ' ARG . 9.9 tt -86.04 -22.81 27.04 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.903 0.382 . . . . 0.0 111.123 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.486 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -73.32 -18.44 61.19 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.9 t -52.22 97.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.105 0.478 . . . . 0.0 110.94 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 t -131.81 -37.37 1.17 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.88 19.65 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.395 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 67.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.855 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 65' ' ' ASN . 42.6 t -87.88 102.33 12.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -150.62 17.58 0.81 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 110.583 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 127.7 -42.44 1.45 Allowed Glycine 0 C--N 1.288 -2.095 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.521 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . 52.2 m-80 -55.06 -79.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.713 0.302 . . . . 0.0 111.723 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.505 HD21 HG22 ' A' ' 61' ' ' VAL . 3.2 p-10 -85.3 12.95 7.13 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.297 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 39.3 tp -88.61 -57.34 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.07 -32.63 56.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -109.76 160.61 16.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 68.91 -62.32 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 135' ' ' SER . 9.6 p -72.69 -37.2 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.74 -27.79 65.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.3 -47.45 13.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.425 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.13 -35.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.048 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.7 p -72.41 -21.41 61.27 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.056 0.455 . . . . 0.0 110.545 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -91.11 -14.48 31.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.458 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 34.1 mt . . . . . 0 C--O 1.235 0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.83 -179.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 77.8 m-85 . . . . . 0 N--CA 1.446 -0.634 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.61 25.11 0.2 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.646 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.483 ' HA ' ' O ' ' A' ' 30' ' ' THR . 65.0 mt-30 -87.17 -59.34 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.105 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.596 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -70.28 -48.13 58.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.0 m-85 -79.09 23.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 89' ' ' ALA . 6.9 p -51.01 -60.29 3.25 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.415 0.686 . . . . 0.0 112.696 -177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -65.26 -32.66 74.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.95 56.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.704 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.3 mt -84.35 -28.2 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.617 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.99 -38.2 22.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.065 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.2 m120 53.69 73.0 0.4 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.681 0.613 . . . . 0.0 111.118 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.36 -2.76 33.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.742 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.77 -5.7 68.88 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.127 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.87 21.75 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 109.737 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.515 ' CB ' HG11 ' A' ' 21' ' ' VAL . 1.8 pt? -117.4 163.71 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.82 128.15 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.467 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.61 -20.67 62.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.9 t -65.98 -36.63 83.82 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 108' ' ' LEU . 9.2 t30 -61.8 -49.32 76.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.061 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 35.8 mm -68.94 -38.44 78.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.166 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.67 -24.55 61.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -79.79 -55.83 4.71 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.417 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -130.83 -23.49 2.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.68 -65.5 3.14 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.1 p -78.58 -11.62 59.97 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.442 -0.446 . . . . 0.0 111.924 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -87.54 -52.58 5.27 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -83.75 -44.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.915 0.388 . . . . 0.0 111.259 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.0 mp -78.39 -51.73 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.1 m 53.18 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.78 29.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.76 0.824 . . . . 0.0 112.878 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 120' ' ' VAL . 61.6 tp -63.47 -55.7 22.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.855 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.0 mt -66.06 -28.76 69.08 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.156 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.3 -49.83 75.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 109.903 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.82 -36.49 61.46 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.105 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 116' ' ' LEU . 78.2 t -64.48 -38.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.606 0.241 . . . . 0.0 110.708 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -58.12 -46.31 85.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -70.86 -42.72 69.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.3 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.427 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -84.35 -80.19 0.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -66.41 -49.51 66.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 25.7 tm0? -71.03 -28.39 64.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.989 0.423 . . . . 0.0 110.87 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.1 -55.87 2.55 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.053 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.7 tp -102.13 -26.13 13.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.905 0.353 . . . . 0.0 111.796 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.8 73.38 1.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.572 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.444 ' H ' ' HA ' ' A' ' 124' ' ' ALA . 1.3 mp -68.18 139.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -130.88 131.8 44.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.46 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.493 ' H ' HG22 ' A' ' 37' ' ' THR . 22.4 t -89.5 120.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.026 0.441 . . . . 0.0 111.306 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -100.82 49.72 0.88 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.979 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -79.77 0.33 31.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.811 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.82 -25.71 20.13 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.904 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 71' ' ' VAL . 6.2 m -105.64 -49.05 3.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 140' ' ' ILE . 84.0 t -52.74 -62.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 137' ' ' GLN . 1.0 OUTLIER -57.31 -44.11 83.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.526 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.3 m -58.65 -45.57 89.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.855 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . 0.478 ' OD1' HG21 ' A' ' 34' ' ' VAL . 12.0 t70 -69.09 -53.17 21.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.728 0.299 . . . . 0.0 111.496 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 136' ' ' VAL . 44.0 pt -65.08 -42.02 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -66.14 -39.5 89.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 t -72.54 -45.5 59.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.866 0.365 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.3 m -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.704 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p . . . . . 0 CA--C 1.532 0.285 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.186 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.576 0 N-CA-C 112.378 -0.289 . . . . 0.0 112.378 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.34 -16.34 60.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.523 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 18' ' ' ILE . 42.5 m -60.46 -34.77 74.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.14 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.16 -22.83 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.35 -43.18 5.64 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.551 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -85.28 -25.18 27.38 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 3.0 pt -34.3 -63.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 42.5 t -75.07 -19.14 60.12 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.96 -21.51 37.16 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.66 0.384 . . . . 0.0 112.026 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 100' ' ' LEU . 1.8 t -71.68 -142.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -62.02 -23.41 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.9 OUTLIER -66.68 -26.56 67.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.986 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.41 -44.13 92.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.536 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.11 -28.75 38.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.649 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.83 87.73 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.26 17.87 3.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.864 0.866 . . . . 0.0 112.057 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.457 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 2.3 m -76.7 164.57 25.76 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.492 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 29.6 m -62.66 -16.49 57.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.035 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -52.3 -38.73 59.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.664 0.785 . . . . 0.0 112.515 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -104.02 -20.9 13.7 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.409 0.623 . . . . 0.0 110.538 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 13.1 ttm180 -72.81 -40.72 65.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.708 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 34' ' ' VAL . 8.2 t -173.3 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 33' ' ' THR . 47.4 t -87.2 139.89 16.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.2 pt? -54.14 141.68 28.15 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.007 0.432 . . . . 0.0 110.695 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 46.5 ptt85 -67.55 162.72 22.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.506 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.74 129.84 38.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.431 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.473 ' HA3' ' HB ' ' A' ' 129' ' ' ILE . . . 72.1 35.49 60.9 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.731 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.4 p -44.99 149.84 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.125 0.97 . . . . 0.0 112.771 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.8 m -88.11 149.43 23.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.289 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 7.7 pm0 -70.64 -12.99 61.91 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.627 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -55.48 -31.94 62.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.759 0.314 . . . . 0.0 110.988 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -85.03 -44.73 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.029 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.57 -71.49 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.703 0.287 . . . . 0.0 111.696 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 t 79.63 -20.49 0.38 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.543 1.137 . . . . 0.0 111.022 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -78.91 -96.59 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.891 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -99.41 -35.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 0.0 111.291 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.71 81.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HA ' ' CB ' ' A' ' 41' ' ' GLN . 42.4 mt-30 -83.01 -47.85 11.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.597 0.713 . . . . 0.0 110.392 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 2.5 tpm_? -125.16 -12.71 6.87 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.514 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 -52.17 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.404 0.681 . . . . 0.0 110.054 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -74.44 155.46 38.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.434 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.665 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.7 mp0 -60.38 -18.82 53.02 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.372 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -58.32 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 19.3 mt -86.08 -22.14 27.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -77.42 -20.25 54.86 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -56.2 101.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.172 0.511 . . . . 0.0 110.594 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.3 t -145.99 -32.46 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 75.4 mt -121.4 18.88 11.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.0 0.429 . . . . 0.0 109.9 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 67.18 1.46 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.088 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 65' ' ' ASN . 61.9 t -97.44 113.6 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.377 0.271 . . . . 0.0 110.756 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -170.92 78.69 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.148 0.499 . . . . 0.0 110.456 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 -46.07 2.07 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.991 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.442 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.5 p-10 -52.04 -74.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.018 0.927 . . . . 0.0 112.796 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.475 HD21 HG22 ' A' ' 61' ' ' VAL . 31.6 p-10 -85.03 -16.71 39.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.181 0.515 . . . . 0.0 109.875 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 132' ' ' ASP . 61.4 tp -63.59 -47.25 82.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.705 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.21 -15.0 60.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 91.0 mtt180 -120.65 -84.44 0.66 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.875 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -52.17 -39.19 59.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.62 -57.12 9.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.655 0.264 . . . . 0.0 111.68 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.29 -38.3 82.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 68' ' ' ARG . 24.5 mt-30 -65.43 -35.11 79.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.99 94.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.0 t -86.23 -41.11 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.568 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -64.46 -28.54 69.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -102.84 5.04 38.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.373 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp . . . . . 0 C--N 1.315 -0.903 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.355 -177.497 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 . . . . . 0 N--CA 1.446 -0.673 0 CA-C-O 121.434 0.635 . . . . 0.0 111.255 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -74.64 22.26 0.1 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.673 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 86' ' ' TYR . 70.7 mt-30 -86.42 -60.29 2.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 120.989 0.424 . . . . 0.0 109.927 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.9 -41.55 82.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.107 0.479 . . . . 0.0 109.957 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.0 m-85 -83.88 15.64 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.67 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . 0.516 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . 47.1 t -56.47 -50.75 70.83 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -60.14 -30.1 69.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.8 -40.65 22.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.748 0.308 . . . . 0.0 111.388 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 37.9 mt -83.25 -29.47 28.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.903 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -79.24 -36.78 39.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.31 90.35 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.56 -16.44 60.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.649 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 -14.01 52.13 Favored Glycine 0 C--O 1.227 -0.322 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.749 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 9.0 p -93.61 1.35 9.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.203 1.002 . . . . 0.0 109.527 178.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -83.94 173.76 10.92 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.129 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -81.27 135.9 35.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.094 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.26 54.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.25 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.1 p -68.36 -30.67 69.68 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 121.217 0.532 . . . . 0.0 110.698 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.562 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.1 t30 -60.24 -53.79 53.45 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.51 -38.02 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.86 -31.7 71.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.839 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 m -91.68 -53.82 4.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -111.76 -35.24 5.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.79 -52.67 40.93 Favored Glycine 0 N--CA 1.46 0.293 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.121 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.625 ' HA ' HD12 ' A' ' 117' ' ' LEU . 33.0 t -66.09 -24.11 66.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.735 0.302 . . . . 0.0 111.551 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -87.13 -40.75 14.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.88 0.371 . . . . 0.0 111.42 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.12 -55.79 6.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.87 0.367 . . . . 0.0 111.376 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 17.9 mt -72.57 -42.29 64.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -177.561 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 49.53 -94.86 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.582 ' HA ' ' ND2' ' A' ' 118' ' ' ASN . . . -66.74 -19.08 65.68 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.447 HD21 HD22 ' A' ' 94' ' ' LEU . 58.1 tp -73.87 -36.81 64.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.741 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 110' ' ' SER . 33.0 mt -68.06 -43.51 78.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . 0.582 ' ND2' ' HA ' ' A' ' 115' ' ' ALA . 11.8 p30 -62.68 -24.38 67.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.054 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.77 -30.1 21.89 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.572 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 124' ' ' ALA . 49.5 t -84.7 -34.66 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.4 p -53.38 -49.25 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.13 0.49 . . . . 0.0 111.627 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.2 t -76.26 -28.8 57.23 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB1' ' HD3' ' A' ' 50' ' ' ARG . . . -84.56 -85.3 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.85 -41.57 74.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -76.58 -21.89 55.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.197 0.522 . . . . 0.0 110.201 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.18 -81.04 1.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.375 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.67 -23.87 19.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.24 88.1 0.77 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.64 HG23 ' HB2' ' A' ' 52' ' ' ALA . 48.8 mm -58.06 136.98 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.66 152.32 24.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.167 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 136' ' ' VAL . 5.3 t -116.9 163.49 14.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 23.3 t70 -59.97 152.04 24.68 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.316 0.579 . . . . 0.0 112.073 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 24.0 m -73.71 -11.54 60.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -45.86 -74.54 0.22 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 123.266 0.354 . . . . 0.0 113.275 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.8 t -106.56 -57.24 2.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.309 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.509 HG21 HG11 ' A' ' 131' ' ' VAL . 60.8 t -48.68 -60.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.544 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -58.16 -48.93 78.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.543 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -61.46 -41.93 97.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.27 -49.73 63.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.566 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.5 pt -68.57 -35.94 72.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -62.96 -50.28 71.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.654 0.264 . . . . 0.0 110.731 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.5 t -59.45 -43.9 93.06 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.213 0.53 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -64.72 -41.77 95.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.059 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.6 t . . . . . 0 C--N 1.32 -0.68 0 CA-C-O 120.931 0.396 . . . . 0.0 110.971 -178.846 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.122 -0.391 . . . . 0.0 112.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -62.16 -13.05 23.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.017 0.437 . . . . 0.0 111.558 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' ILE . 7.9 m -54.3 -41.02 68.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.636 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.8 59.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.37 -43.9 5.43 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.503 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -83.66 -20.15 34.09 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' SER . 8.5 pt -42.84 -49.82 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 p -84.77 -18.93 33.52 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -85.66 -36.15 20.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 100' ' ' LEU . 21.1 t -72.8 -102.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -71.33 -51.83 22.1 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.465 ' HB3' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -61.41 -24.95 66.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.14 91.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.57 -28.18 28.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.19 89.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.85 17.65 3.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.184 176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 3.5 m -71.59 169.26 15.9 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.048 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 20.0 m -61.89 -18.28 59.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ARG . 58.4 p -56.44 -40.71 75.24 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -97.15 -20.13 18.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.235 0.541 . . . . 0.0 110.233 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -74.98 -43.95 51.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.573 -174.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 t -176.47 -25.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.4 t -91.89 139.41 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.03 145.17 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 123.186 0.303 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HA ' HG22 ' A' ' 30' ' ' THR . 36.5 ptt85 -60.13 152.12 25.15 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.256 0.551 . . . . 0.0 111.302 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -67.28 114.7 6.2 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.608 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 83.67 40.0 9.21 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.474 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -50.62 146.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 14.6 m -92.8 154.96 17.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.232 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 49' ' ' GLN . 8.5 pt20 -67.07 -12.15 59.12 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' A' ' 116' ' ' LEU . 84.7 mm-40 -53.93 -42.58 68.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.31 -31.2 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.748 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.38 -50.39 8.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 m 78.43 -18.69 0.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.413 1.085 . . . . 0.0 111.737 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 p -71.42 -101.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 -22.04 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.14 89.64 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.279 0.561 . . . . 0.0 111.769 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 68.4 mt-30 -77.47 -61.46 1.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.39 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 63.3 ttt180 -118.58 -2.06 11.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.552 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.93 -59.79 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.597 0.759 . . . . 0.0 112.055 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.03 -84.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER 178.56 -44.57 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -178.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -49.19 -69.41 0.12 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.428 0.691 . . . . 0.0 112.362 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.93 -23.07 27.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.225 0.536 . . . . 0.0 110.475 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.13 -19.72 62.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.821 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 p -47.93 107.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.733 0.646 . . . . 0.0 111.614 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -154.37 -42.23 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.088 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -122.59 19.38 10.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.332 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.11 63.96 1.49 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.128 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.524 HG22 HD21 ' A' ' 65' ' ' ASN . 10.8 t -89.7 114.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.457 -177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -178.46 86.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.19 -58.65 4.73 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.935 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -61.78 -76.2 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.524 HD21 HG22 ' A' ' 61' ' ' VAL . 3.2 p-10 -85.39 18.45 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.223 0.535 . . . . 0.0 110.838 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.6 tp -87.23 -56.12 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.888 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -37.23 49.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.143 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -104.04 172.82 6.59 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 63.07 -62.29 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.43 -59.66 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 110.879 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.66 -41.49 92.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.25 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -59.58 -43.21 93.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.613 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.87 -47.52 82.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.61 -41.12 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -66.28 -25.24 66.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.304 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -107.6 9.23 29.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 14.2 tp . . . . . 0 C--N 1.319 -0.752 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.28 -178.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 . . . . . 0 N--CA 1.453 -0.313 0 CA-C-O 121.098 0.475 . . . . 0.0 110.871 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.7 46.7 0.68 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.813 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.621 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 mm-40 -91.75 -62.72 1.36 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.563 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.627 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -86.32 -33.56 20.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' ILE . 97.7 m-85 -72.72 2.38 6.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -51.79 -49.2 63.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 m -58.79 -39.75 82.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.29 33.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.35 -31.52 24.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -86.47 -31.1 21.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.799 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.1 m120 53.19 68.82 0.78 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.791 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.05 4.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.2 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.51 -13.51 40.69 Favored Glycine 0 C--O 1.225 -0.409 0 C-N-CA 121.314 -0.469 . . . . 0.0 112.855 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 21.6 t -72.04 -19.26 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.21 0.529 . . . . 0.0 110.295 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -85.16 156.0 21.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.286 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 9.5 p-10 -70.36 132.0 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.161 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.79 65.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 p -66.2 -33.49 75.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 28.5 t30 -63.44 -47.73 80.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.104 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.97 -37.9 77.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.307 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -66.66 -33.87 76.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.305 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -85.24 -58.62 2.61 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.8 pp -116.44 -26.78 6.98 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -58.38 -60.05 9.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.955 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -76.93 -11.13 59.77 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.607 -0.349 . . . . 0.0 111.507 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.33 -48.83 7.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 0.0 111.337 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -84.51 -57.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 -179.585 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 116' ' ' LEU . 6.2 mp -72.01 -42.95 65.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.308 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m 55.57 -101.76 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.35 -34.88 64.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.119 0.568 . . . . 0.0 112.448 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 113' ' ' LEU . 22.2 tp -59.78 -55.24 36.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.18 -29.47 67.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.63 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.53 -43.09 97.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.83 -40.34 75.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.466 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 116' ' ' LEU . 89.5 t -62.85 -38.36 81.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 75.6 m -55.88 -33.42 64.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 111.427 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 t -85.09 -35.82 21.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.222 0.534 . . . . 0.0 110.429 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.99 -84.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.24 -49.5 34.68 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.843 0.354 . . . . 0.0 111.712 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 40.8 tt0 -67.72 -28.77 67.94 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.53 -61.57 1.78 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.247 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -118.63 -17.82 9.18 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 117.306 0.553 . . . . 0.0 111.455 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.27 120.04 2.37 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.54 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.444 HG21 ' HA3' ' A' ' 38' ' ' GLY . 18.7 mt -88.32 124.29 41.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.658 0.266 . . . . 0.0 110.813 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -124.32 120.21 31.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.88 157.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.67 174.39 2.33 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.401 0.62 . . . . 0.0 112.155 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 13.1 m -80.49 33.38 0.3 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.879 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.81 -91.16 0.11 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.2 m -107.0 -21.26 13.06 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.06 -64.6 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -61.27 -39.76 91.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -59.94 -44.13 94.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.981 0.42 . . . . 0.0 111.738 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.25 -48.42 34.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.744 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 137' ' ' GLN . 47.2 pt -64.25 -35.36 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.0 p -65.23 -35.72 81.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.405 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -74.89 -40.75 60.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.14 0.495 . . . . 0.0 110.608 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 24.5 t -82.69 -20.39 36.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.525 -176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 77.6 p . . . . . 0 C--O 1.22 -0.476 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.84 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.704 0 N-CA-C 112.275 -0.33 . . . . 0.0 112.275 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 108' ' ' LEU . . . -71.43 -6.96 44.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' ILE . 11.7 m -54.04 -30.33 47.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.994 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.22 -23.67 15.52 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 -41.47 6.39 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.7 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -22.52 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' SER . 11.7 pt -46.13 -50.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m -67.57 -21.14 65.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.714 0.292 . . . . 0.0 111.374 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 69.1 mtt180 -89.96 -22.43 21.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 46.4 t -61.38 169.34 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.386 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.946 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -45.88 -21.55 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.2 m-80 -69.05 -22.69 64.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.75 0.309 . . . . 0.0 111.253 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.88 -55.03 34.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.13 -16.65 59.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.056 0.455 . . . . 0.0 110.304 -178.421 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.91 -48.51 45.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.576 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.65 18.0 0.29 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 175.619 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 29' ' ' SER . 2.1 m -74.32 173.46 10.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.76 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 4.1 m -46.42 -28.54 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.377 1.071 . . . . 0.0 113.037 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -54.46 -32.53 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -112.57 -18.76 12.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.426 0.631 . . . . 0.0 109.863 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 5.6 tpp180 -67.68 -56.19 10.3 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.819 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -168.77 -36.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.31 136.69 24.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -49.63 139.79 12.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.439 0.638 . . . . 0.0 112.282 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 36' ' ' ARG . 6.9 ptm180 -58.77 164.65 2.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.34 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.2 111.36 9.29 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.549 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 77.91 47.34 8.63 Favored Glycine 0 N--CA 1.426 -2.014 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.068 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.401 HG21 HD11 ' A' ' 43' ' ' ILE . 8.2 p -56.41 143.75 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.035 0.445 . . . . 0.0 109.897 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 17.4 m -101.6 157.02 17.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -61.79 -12.83 19.02 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.861 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.85 -46.34 81.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.773 0.321 . . . . 0.0 110.368 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 39' ' ' VAL . 2.3 pp -85.93 -36.01 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.523 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.5 -65.9 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.802 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m 77.29 -18.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.856 0.862 . . . . 0.0 112.188 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -61.21 -73.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.658 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.14 -64.43 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.282 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -41.71 107.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.219 1.008 . . . . 0.0 113.652 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 20.6 mp0 -73.75 -53.66 9.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.628 ' HE ' HG13 ' A' ' 129' ' ' ILE . 26.1 ttt85 -145.36 4.39 1.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.856 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.73 -55.87 0.53 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.143 0.577 . . . . 0.0 110.779 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.41 131.34 46.19 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.62 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 9.3 mp0 -56.21 -18.09 9.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.699 -174.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -56.25 -69.9 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.839 0.352 . . . . 0.0 111.235 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 tp -87.9 -23.82 23.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.911 0.386 . . . . 0.0 111.14 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -76.73 -18.16 58.65 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 32.3 t -54.11 91.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.256 0.551 . . . . 0.0 111.339 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' HG ' ' A' ' 59' ' ' LEU . 1.9 t -151.6 -35.52 0.13 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.469 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 58' ' ' THR . 58.3 mt -115.57 19.79 15.12 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.41 54.55 7.6 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.602 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 38.7 t -89.6 107.97 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.801 -0.199 . . . . 0.0 110.666 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.16 82.36 0.22 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.27 -51.14 4.44 Favored Glycine 0 C--N 1.32 -0.319 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.359 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 17.2 p-10 -55.49 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.696 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.0 p-10 -85.73 14.82 5.32 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.278 0.561 . . . . 0.0 110.088 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 71' ' ' VAL . 26.0 tp -87.63 -60.41 1.98 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.52 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.74 64.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.356 0.598 . . . . 0.0 109.513 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.0 mpt_? -93.18 157.4 16.29 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 69.16 -62.66 0.4 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -67.46 -62.36 1.46 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' LEU . 82.0 t -56.24 -41.02 68.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -68.39 -37.14 80.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.24 84.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.99 -35.02 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.204 0.526 . . . . 0.0 110.284 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 t -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.689 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -89.18 -0.59 57.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.736 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 33.7 mt . . . . . 0 C--N 1.323 -0.582 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.502 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 7.9 m-85 . . . . . 0 N--CA 1.449 -0.513 0 CA-C-O 120.874 0.368 . . . . 0.0 110.27 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.11 36.88 0.24 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.54 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -89.63 -59.7 2.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.05 82.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.107 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.557 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 94.1 m-85 -83.68 10.24 9.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.609 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 t -56.94 -40.79 77.05 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.226 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 69.9 m -57.98 -43.96 86.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.182 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.92 -31.89 64.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.411 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 22.1 mt -84.31 -21.54 30.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.978 0.418 . . . . 0.0 111.291 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . 0.422 ' HB2' HH12 ' A' ' 36' ' ' ARG . 67.4 t80 -87.42 -38.52 16.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.139 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . 0.608 ' O ' HD22 ' A' ' 100' ' ' LEU . 17.7 m120 68.47 -74.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.894 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 75.33 -30.89 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.106 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.48 -4.35 64.14 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 13.7 t -101.78 42.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.342 1.068 . . . . 0.0 108.581 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.608 HD22 ' O ' ' A' ' 96' ' ' ASN . 2.6 pt? -137.81 -171.23 2.95 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.396 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.8 115.5 26.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.233 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.54 63.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.266 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 p -64.38 -37.35 87.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.83 -43.17 90.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.655 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.42 -44.95 94.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.09 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.78 -18.38 60.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.587 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 m -88.74 -62.29 1.52 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 13' ' ' ALA . 4.0 pp -116.53 -23.12 8.39 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.0 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.507 ' CA ' HD12 ' A' ' 117' ' ' LEU . . . -56.25 -63.52 5.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.997 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.0 m -77.71 -9.62 59.09 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.663 0.268 . . . . 0.0 111.496 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -89.46 -58.77 2.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.57 -58.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.938 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.3 mp -70.0 -45.77 66.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 t 52.65 -94.8 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.46 -1.245 . . . . 0.0 113.39 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.31 -37.23 35.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.1 tp -68.22 -58.7 4.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.214 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CA ' ' A' ' 109' ' ' GLY . 23.6 mt -66.49 -27.42 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.63 -37.46 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 109.784 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.44 -32.48 34.29 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 116' ' ' LEU . 96.4 t -63.09 -44.11 99.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.498 0.19 . . . . 0.0 110.735 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 69.2 m -54.62 -39.06 67.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.62 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.8 m -80.98 -41.86 22.1 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.446 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.84 -70.49 0.56 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.77 -41.79 61.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 58.5 tt0 -80.49 -17.53 51.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 109.841 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.53 -70.44 1.33 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.955 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.62 -24.25 14.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.738 0.304 . . . . 0.0 111.199 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.4 100.66 2.17 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.672 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HE ' ' A' ' 50' ' ' ARG . 15.0 mm -80.03 132.07 32.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.154 0.502 . . . . 0.0 111.569 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -148.23 145.97 28.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.271 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.19 142.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.03 -172.08 0.17 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 112.878 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 39.0 m -79.88 29.31 0.27 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.64 -79.09 0.22 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 t -110.25 -59.76 1.89 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.205 0.526 . . . . 0.0 110.822 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 140' ' ' ILE . 96.6 t -47.77 -63.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.1 tp-100 -56.34 -39.96 73.68 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.5 m -72.9 -26.9 61.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.804 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.52 -40.82 22.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.837 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.4 pt -79.38 -27.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 p -55.97 -62.13 1.91 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -63.94 -37.7 88.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.097 0.475 . . . . 0.0 111.227 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.4 m -66.09 -34.33 77.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.213 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.3 t . . . . . 0 C--N 1.318 -0.794 0 CA-C-O 121.051 0.453 . . . . 0.0 110.88 -179.45 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 0.362 0 N-CA-C 114.328 0.491 . . . . 0.0 114.328 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.01 72.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.639 0.376 . . . . 0.0 111.615 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' ILE . 9.6 m -58.67 -31.45 68.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.396 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.3 62.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.41 -35.82 8.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.8 pp -85.63 -21.94 28.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' SER . 11.9 pt -37.75 -52.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.0 m -71.61 -24.67 61.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 93.9 mtt180 -87.58 -23.13 24.42 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 22' ' ' ALA . 31.6 t -62.34 174.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.425 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.582 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -37.57 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.421 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 10.6 m-80 -63.5 -24.56 67.87 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.102 -0.374 . . . . 0.0 111.851 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.89 -35.91 79.74 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.354 0.597 . . . . 0.0 109.437 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 tp -80.23 -35.06 36.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.715 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.99 77.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.021 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 59.2 13.25 2.92 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.172 174.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 29' ' ' SER . 1.5 m -83.56 168.54 16.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.283 0.563 . . . . 0.0 112.066 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . 0.648 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 1.8 m -51.92 -26.22 9.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.62 1.168 . . . . 0.0 112.927 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 p -53.29 -40.82 65.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.872 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -99.63 -19.52 16.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.598 0.713 . . . . 0.0 109.646 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.648 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 16.1 tpp180 -66.22 -64.62 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.605 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.3 t -164.77 -23.74 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.122 -174.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.94 137.59 20.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.99 140.43 25.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.063 0.459 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -65.82 164.52 14.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.681 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 131' ' ' VAL . 2.4 p -70.7 111.88 6.5 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.16 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.0 43.23 8.93 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 87' ' ' ALA . 9.2 p -46.07 138.65 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 111.815 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.6 m -70.78 137.99 50.05 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.37 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.471 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 48.4 tt0 -62.69 -13.44 32.25 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.165 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -52.62 -42.21 64.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.006 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.62 -39.53 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.539 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.24 -68.0 0.74 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.471 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 5.9 m 71.64 -33.74 0.28 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -66.24 -79.26 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.403 ' CG2' HD21 ' A' ' 65' ' ' ASN . 7.5 p -118.74 -30.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.259 0.552 . . . . 0.0 111.526 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.37 92.78 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 74.9 mt-30 -81.11 -40.44 24.05 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.162 0.506 . . . . 0.0 110.126 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.619 ' NH1' HD13 ' A' ' 55' ' ' LEU . 11.2 ttm180 -149.03 -1.4 0.48 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.656 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.23 -55.74 0.6 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.094 0.557 . . . . 0.0 110.259 -175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.46 131.0 47.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.378 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -54.9 -17.77 4.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.852 -177.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.619 HD13 ' NH1' ' A' ' 50' ' ' ARG . 2.2 tt -88.59 -24.09 22.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 111.385 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.8 -18.5 62.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.3 t -55.34 96.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.299 0.571 . . . . 0.0 110.729 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.0 t -132.99 -30.06 1.4 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.171 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 94.4 mt -120.26 20.09 12.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.804 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.58 66.85 1.64 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.38 109.73 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.38 87.02 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.6 -53.05 3.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.734 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.1 p-10 -61.45 -73.72 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.386 0.674 . . . . 0.0 112.321 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 66.2 t30 -84.75 11.66 8.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.675 0.75 . . . . 0.0 109.622 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.83 -70.48 0.63 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.279 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 -34.03 39.75 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.42 0.629 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 56.5 mtm180 -99.46 157.72 16.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.622 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 68.03 -57.05 0.48 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.511 0.725 . . . . 0.0 112.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.17 0.91 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.703 0.287 . . . . 0.0 111.355 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.64 -35.5 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -68.08 -25.51 65.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.342 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.71 23.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.382 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.98 -32.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.245 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -69.89 -14.74 62.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.229 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 76' ' ' ARG . 44.5 ttp180 -87.62 -15.71 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.111 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.66 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 9.4 mp . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.29 179.019 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.66 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 64.3 m-85 . . . . . 0 N--CA 1.444 -0.744 0 CA-C-O 121.083 0.468 . . . . 0.0 110.35 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -77.11 25.63 0.16 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.582 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.472 ' H ' ' C ' ' A' ' 86' ' ' TYR . 76.3 mt-30 -86.18 -56.73 3.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.632 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.73 -29.34 68.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.376 0.607 . . . . 0.0 110.036 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.545 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.0 m-85 -84.31 3.76 34.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -50.71 -35.89 33.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 70.3 m -53.92 -53.41 53.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.73 -24.03 33.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 51.1 mt -84.82 -36.13 21.84 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -85.2 -41.1 15.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.93 90.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.501 0.667 . . . . 0.0 111.648 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.76 -0.97 55.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.823 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.02 -3.14 85.36 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.712 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 10.5 t -100.57 -13.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 109.929 -179.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -84.02 167.42 16.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.365 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -77.44 104.4 7.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.674 0.75 . . . . 0.0 110.385 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -13.04 61.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.682 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -69.21 -34.46 74.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -35.78 77.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.74 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.59 -41.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.211 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.83 -18.09 51.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.031 0.443 . . . . 0.0 111.463 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.1 m -81.82 -58.63 2.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.391 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.2 -20.92 4.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 117' ' ' LEU . . . -57.37 -68.41 1.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.158 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' SER . 6.5 p -67.4 -16.82 64.45 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -84.64 -45.54 12.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.666 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.1 t -84.47 -50.79 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.597 -179.795 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 6.5 mp -70.59 -34.36 72.08 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.006 0.431 . . . . 0.0 110.317 -179.291 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' SER . 50.8 m 48.16 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.96 -36.77 50.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 57.1 tp -69.3 -60.16 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.991 -178.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 109' ' ' GLY . 49.0 mt -64.34 -34.23 77.68 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -69.77 -22.67 63.32 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.109 0.481 . . . . 0.0 110.907 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.13 -32.78 11.65 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.936 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 94' ' ' LEU . 54.2 t -76.24 -29.92 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.996 0.518 . . . . 0.0 111.914 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 15.8 p -52.2 -44.04 64.53 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.306 0.642 . . . . 0.0 112.592 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.1 p -84.47 -26.46 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.923 0.392 . . . . 0.0 111.481 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.83 -78.45 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.449 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.34 -49.16 45.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 37.2 tt0 -72.07 -21.33 61.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.09 -56.13 2.5 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.204 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.6 mt -126.95 -25.01 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.998 0.399 . . . . 0.0 111.786 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.55 107.95 3.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.001 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' THR . 32.6 mt -76.37 126.83 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -120.81 135.57 55.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 132' ' ' ASP . 12.7 t -89.09 172.83 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 131' ' ' VAL . 3.5 p-10 -60.45 162.61 6.07 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.548 0.689 . . . . 0.0 112.018 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.4 t -80.16 6.61 11.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.301 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.27 -78.94 0.61 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.295 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 m -93.73 -39.89 10.52 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.27 -62.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.435 ' HA ' HG12 ' A' ' 140' ' ' ILE . 9.4 tt0 -59.18 -39.79 83.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -59.4 -43.98 92.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.442 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.58 -50.01 19.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 137' ' ' GLN . 42.0 pt -60.67 -38.46 78.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.812 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 t -65.7 -40.03 91.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.3 m -70.8 -42.44 70.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 t -72.42 -42.44 65.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.634 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 23.5 t . . . . . 0 C--O 1.235 0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 111.445 -177.869 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.548 0 N-CA-C 111.998 -0.441 . . . . 0.0 111.998 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.6 71.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.142 0.496 . . . . 0.0 110.732 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.6 m -66.91 -21.58 65.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.83 -18.52 44.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.8 -43.59 5.69 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.334 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -84.21 -21.88 31.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 89' ' ' ALA . 8.9 pt -46.2 -47.31 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m -73.39 -20.0 60.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.749 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 32.3 mtm180 -86.03 -33.5 21.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.696 179.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 100' ' ' LEU . 58.0 t -50.16 168.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.088 0.555 . . . . 0.0 111.406 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.516 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.72 -28.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 m-80 -60.39 -28.9 68.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.729 0.241 . . . . 0.0 111.436 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.21 -44.93 93.91 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.292 0.568 . . . . 0.0 109.85 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.2 -38.21 66.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.156 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.96 80.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 54.55 17.84 1.79 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.446 174.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 m -77.76 166.33 23.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.496 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.8 m -61.11 -16.98 50.18 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 122.78 0.432 . . . . 0.0 112.105 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -52.23 -34.44 45.79 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -108.14 -21.58 12.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -79.85 -42.78 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t -158.19 -50.5 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.211 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.6 129.97 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 1.5 pt? -50.32 139.9 14.27 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.456 0.472 . . . . 0.0 111.808 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -60.75 159.75 10.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.867 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 1.7 p -77.47 142.71 39.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.064 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.57 71.46 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.538 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 147.81 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.799 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 10.3 m -106.75 161.83 14.32 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.95 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -66.23 -13.75 60.83 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.555 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -54.95 -43.72 73.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -86.62 -36.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.525 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.48 -39.96 19.86 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m 78.32 -18.36 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.108 0.963 . . . . 0.0 111.476 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 m -76.51 -162.24 0.24 Allowed 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 122.212 1.006 . . . . 0.0 110.721 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 59' ' ' LEU . 35.0 m -74.64 -20.55 16.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.516 -176.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.38 84.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.551 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 40' ' ' SER . 74.5 mt-30 -83.62 -43.99 15.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 0.0 111.86 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.474 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 51.0 ttt180 -132.19 -10.11 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.63 -36.69 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.294 0.638 . . . . 0.0 110.646 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -80.22 150.95 29.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.795 0.331 . . . . 0.0 110.11 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' SER . 21.2 mp0 -56.28 -34.3 66.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.9 m -54.48 -70.85 0.09 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -86.18 -25.02 25.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -80.42 -18.82 47.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -65.92 79.82 0.08 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.72 0.772 . . . . 0.0 111.46 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -100.97 -28.51 12.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.038 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 47' ' ' VAL . 89.6 mt -122.37 19.17 10.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.019 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.62 1.41 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.765 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.685 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 65.7 t -88.38 120.07 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.882 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 t70 178.46 90.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.504 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.03 -57.4 3.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.954 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -55.85 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.266 0.626 . . . . 0.0 111.547 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.685 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.3 p-10 -87.38 21.25 2.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.059 0.456 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.15 -72.73 0.54 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.689 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.32 -7.98 50.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.303 0.573 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.32 170.61 13.91 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 66.05 -62.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.59 -64.02 1.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.769 0.318 . . . . 0.0 110.882 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 98.3 mt-30 -63.35 -37.1 85.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.602 0.239 . . . . 0.0 111.49 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.58 -48.6 25.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.089 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.74 -42.15 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.589 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.0 p -74.06 -4.96 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 111.032 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 34.1 ttm180 -98.11 -0.5 44.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.195 0.521 . . . . 0.0 110.535 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--O 1.237 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.227 177.538 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 121.107 0.48 . . . . 0.0 111.339 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.4 14.98 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.998 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 35' ' ' LEU . 8.2 mm100 -71.71 -37.54 70.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.001 0.429 . . . . 0.0 111.288 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.548 ' O ' HD12 ' A' ' 18' ' ' ILE . . . -67.89 -62.16 1.54 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.482 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.84 32.41 0.48 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.142 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.7 m -50.54 -55.7 14.95 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.6 m -63.97 -36.3 83.5 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.97 70.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.538 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 40.0 mt -84.57 -23.49 29.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.505 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -85.56 -47.36 9.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.743 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.36 61.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.241 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.17 1.99 71.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.86 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.35 -15.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.481 0.657 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.51 179.28 7.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.255 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -75.23 125.77 29.64 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 111.662 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.65 61.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.276 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.7 t -65.18 -35.01 79.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.513 ' O ' HD13 ' A' ' 108' ' ' LEU . 11.1 t30 -61.01 -50.42 73.45 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.047 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . 0.522 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -66.69 -38.09 80.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.827 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -30.41 69.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.875 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -80.1 -62.96 1.52 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -122.22 -15.5 7.68 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.731 -176.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -56.11 -72.02 0.64 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.795 -0.716 . . . . 0.0 113.638 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 m -70.82 -10.35 59.37 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 111' ' ' ARG . 6.0 mpt_? -86.68 -53.99 4.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.35 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.27 -54.66 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.017 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.424 HD13 ' HA2' ' A' ' 109' ' ' GLY . 6.4 mp -63.13 -31.97 73.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.1 p 38.71 -93.14 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.25 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.427 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 120' ' ' VAL . 65.4 tp -68.61 -52.63 29.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.042 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 18.8 mt -61.44 -28.18 69.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -59.13 -36.98 76.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.402 . . . . 0.0 110.208 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.45 -33.58 11.45 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.969 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.1 t -60.99 -31.7 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.3 m -48.65 -52.04 25.26 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.294 0.371 . . . . 0.0 111.936 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 p -83.68 -21.42 32.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 111.09 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 120' ' ' VAL . . . -81.31 -93.76 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.13 29.43 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.01 -29.77 71.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.18 -90.91 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.4 mt -112.56 -8.29 13.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.774 0.321 . . . . 0.0 111.553 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.14 98.85 0.94 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.153 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 37' ' ' THR . 25.1 mm -67.66 139.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 137' ' ' GLN . 18.7 t-20 -90.55 136.06 33.3 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 133' ' ' SER . 30.7 t -75.66 146.07 9.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.906 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.47 -37.31 83.14 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 122.083 0.944 . . . . 0.0 111.068 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 131' ' ' VAL . 38.9 t -58.65 107.59 0.53 Allowed 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.026 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.75 -17.91 29.76 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.199 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.1 m -65.57 -37.44 86.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.993 0.425 . . . . 0.0 110.197 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 140' ' ' ILE . 46.4 t -77.99 -50.69 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.796 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.433 ' HG3' HD21 ' A' ' 130' ' ' ASN . 7.8 tt0 -59.25 -49.62 77.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.708 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -65.75 -28.74 69.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.04 -54.9 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.451 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 136' ' ' VAL . 42.6 pt -58.92 -34.77 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.255 -177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.6 t -50.59 -49.34 56.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.262 0.351 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -84.84 -42.47 15.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.852 0.358 . . . . 0.0 111.831 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 62.9 m -57.79 -38.84 76.2 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.302 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 43.8 p . . . . . 0 C--N 1.326 -0.441 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.777 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.614 0 CA-C-O 120.281 -0.177 . . . . 0.0 113.066 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' HD13 ' A' ' 108' ' ' LEU . . . -67.47 -45.43 75.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.935 0.398 . . . . 0.0 110.997 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 18' ' ' ILE . 16.7 m -68.06 -22.63 64.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.044 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.66 58.61 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.16 -38.84 7.12 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.117 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 pp -84.83 -22.35 29.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 14' ' ' SER . 10.1 pt -44.75 -48.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 t -84.67 -20.14 31.73 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.552 0.215 . . . . 0.0 111.377 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.0 mtt180 -86.89 -25.94 24.19 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.9 t -74.21 -107.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -79.1 -35.81 41.73 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.98 -24.25 66.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.25 -45.37 88.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.068 0.461 . . . . 0.0 110.316 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.16 -18.95 44.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.787 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -71.56 -38.33 70.97 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.922 177.49 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 57.58 16.98 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 176.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -75.82 167.68 21.44 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.7 m -72.23 -14.26 61.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLN . 19.0 p -50.2 -53.3 28.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.753 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -78.71 -19.73 51.73 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.151 0.5 . . . . 0.0 110.985 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -76.74 -52.98 8.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.631 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -169.05 -19.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.84 136.26 23.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -55.91 149.61 14.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 0.0 111.243 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 87' ' ' ALA . 7.7 ptm180 -76.06 164.45 26.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.405 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.01 109.3 9.54 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.984 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 94.49 37.69 5.24 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.841 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . 0.573 HG23 HD11 ' A' ' 43' ' ' ILE . 2.3 p -48.38 124.94 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.251 0.548 . . . . 0.0 109.957 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 16.5 m -85.67 167.0 15.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 14.7 pt20 -69.14 -13.15 62.26 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.243 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 65.8 mm-40 -63.02 -55.0 29.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.305 0.574 . . . . 0.0 109.869 179.064 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -85.27 -32.19 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.717 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . . . -78.54 -61.69 1.93 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.499 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 87.0 p 68.82 -31.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.687 1.595 . . . . 0.0 115.291 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.5 m -66.27 -73.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.79 -27.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.838 0.351 . . . . 0.0 111.841 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -80.47 100.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.351 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' SER . 44.6 mt-30 -82.17 -34.85 28.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.082 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . 0.638 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 16.5 ttt85 -158.03 4.34 0.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.731 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ALA . . . . . 0.494 ' N ' ' HB2' ' A' ' 56' ' ' ALA . . . 67.87 -52.83 0.52 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.067 0.547 . . . . 0.0 110.841 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.514 ' CB ' HG13 ' A' ' 129' ' ' ILE . . . -63.51 137.41 58.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.222 177.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLN . . . . . 0.566 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 17.5 mp0 -53.49 -26.89 22.47 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -60.83 -67.57 0.39 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.815 0.34 . . . . 0.0 111.885 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.468 HD23 ' HD2' ' A' ' 50' ' ' ARG . 25.9 tp -87.83 -24.01 23.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -78.57 -19.1 53.55 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 5.8 t -62.39 88.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.406 0.622 . . . . 0.0 111.491 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.607 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 8.2 t -112.23 -32.46 6.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.819 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.486 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.1 mt -121.6 18.83 11.22 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.946 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 67.56 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 HD21 ' A' ' 65' ' ' ASN . 36.9 t -89.89 120.84 39.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.712 0.292 . . . . 0.0 111.158 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -170.85 83.89 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.883 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -47.29 3.55 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ASN . . . . . 0.478 ' HA ' HH21 ' A' ' 68' ' ' ARG . 18.0 p-10 -54.33 -83.19 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.735 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.458 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 29.2 p-10 -87.99 24.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.303 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 tp -87.0 -66.4 0.91 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.067 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.26 62.02 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.479 0.657 . . . . 0.0 110.412 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.478 HH21 ' HA ' ' A' ' 64' ' ' ASN . 29.9 mtm180 -110.39 165.63 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 68.05 -61.91 0.37 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.69 3.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.864 0.364 . . . . 0.0 111.492 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.525 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -65.27 -35.77 82.06 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.644 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.14 -47.71 60.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.857 0.36 . . . . 0.0 111.397 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.67 -34.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.987 0.422 . . . . 0.0 110.932 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.0 p -73.94 -23.06 59.46 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.158 0.504 . . . . 0.0 110.457 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -87.08 -15.03 39.74 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.919 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.1 tp . . . . . 0 C--N 1.316 -0.882 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.126 -179.583 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 121.376 0.607 . . . . 0.0 109.971 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -77.85 18.48 0.47 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 33.9 mt-30 -80.83 -56.63 4.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.144 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.38 -35.88 82.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.085 0.469 . . . . 0.0 110.278 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.487 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -82.4 13.37 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.556 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -59.21 -44.3 92.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -62.96 -41.06 99.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.66 69.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.687 0.28 . . . . 0.0 111.48 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 28.3 mt -84.78 -19.54 32.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.022 0.439 . . . . 0.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.88 -36.98 19.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.59 80.84 0.14 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.989 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.03 -12.2 60.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.811 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.62 -11.93 64.8 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.95 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.65 -15.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.325 0.583 . . . . 0.0 109.977 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -84.8 161.39 19.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.801 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 46.2 t30 -67.82 107.25 2.54 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.526 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.63 -15.84 63.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.951 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -74.52 -27.6 60.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -71.41 -33.99 69.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 34.8 mm -66.11 -34.23 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.21 -32.37 66.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.196 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.4 m -68.55 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.853 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -121.28 -21.09 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -56.2 -65.21 3.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.944 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -71.91 -11.54 60.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.802 0.334 . . . . 0.0 111.603 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -87.04 -61.07 1.81 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.19 -56.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.548 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 17.0 mt -62.42 -55.23 29.81 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.181 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.7 t 55.42 -87.04 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.107 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.34 66.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 122.947 0.499 . . . . 0.0 111.459 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.3 tp -67.02 -49.88 63.86 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 21.3 mt -66.97 -25.1 66.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.928 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.76 -36.57 81.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 109.666 175.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.13 -17.69 58.82 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.227 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.8 t -85.25 -44.02 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 11.8 p -52.49 -61.82 2.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 t -76.0 -23.84 55.28 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.085 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.499 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -83.57 -80.21 0.19 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ALA . . . . . 0.626 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -72.51 -44.67 61.9 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 121' ' ' SER . 42.6 tt0 -70.96 -34.76 71.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.281 0.562 . . . . 0.0 110.097 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.43 -63.2 2.54 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.043 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.87 -23.98 11.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.92 97.3 1.22 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ILE . . . . . 0.514 HG13 ' CB ' ' A' ' 52' ' ' ALA . 1.2 mp -81.54 136.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.539 0.685 . . . . 0.0 112.229 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -135.14 137.33 42.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.105 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -80.85 156.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.4 169.15 1.79 Allowed 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 3.0 m -74.31 39.42 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.63 -93.86 0.2 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.9 t -106.44 -43.38 4.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.887 0.375 . . . . 0.0 110.273 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.1 t -51.96 -62.48 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.409 -173.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.7 tt0 -59.04 -37.46 77.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.656 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.1 m -65.95 -48.32 71.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.902 0.382 . . . . 0.0 110.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.66 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.584 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.1 pt -76.09 -29.8 19.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -56.47 -45.72 80.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.334 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 p -82.0 -42.78 18.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.356 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.4 m -68.9 -19.99 64.23 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 24.7 p . . . . . 0 C--N 1.321 -0.668 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.778 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.696 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -135.13 123.96 3.25 Favored Glycine 0 N--CA 1.445 -0.758 0 C-N-CA 120.61 -0.805 . . . . 0.0 112.428 -179.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -72.71 119.6 6.19 Favored 'Trans proline' 0 CA--C 1.531 0.362 0 C-N-CA 122.575 2.183 . . . . 0.0 111.897 179.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.448 ' H ' ' CD ' ' A' ' 4' ' ' GLN . 22.9 mp0 -58.44 101.96 0.1 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.706 -0.679 . . . . 0.0 111.287 -178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.31 22.36 60.92 Favored Glycine 0 CA--C 1.518 0.271 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.766 178.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 89.5 9.49 66.69 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.756 -0.735 . . . . 0.0 112.993 -179.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.425 ' HD2' ' O ' ' A' ' 4' ' ' GLN . 1.6 m-85 -55.28 -57.61 11.1 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 116.67 0.235 . . . . 0.0 111.457 178.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.26 75.41 0.28 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.873 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . . . -85.47 98.97 10.9 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.52 0.676 . . . . 0.0 111.418 -177.564 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 11.0 m -162.67 143.45 9.86 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.7 -178.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -128.2 125.42 5.08 Favored Glycine 0 C--N 1.33 0.218 0 C-N-CA 120.282 -0.961 . . . . 0.0 112.681 -179.136 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.04 -26.34 45.17 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 121.168 -0.539 . . . . 0.0 112.823 -179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -68.43 -37.69 80.5 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.203 0.525 . . . . 0.0 110.759 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.605 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.4 p -68.44 -17.75 64.27 Favored 'General case' 0 N--CA 1.439 -1.009 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.49 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.21 -18.28 63.34 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 120.987 0.422 . . . . 0.0 111.534 -179.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -81.89 -39.49 11.74 Favored Glycine 0 N--CA 1.439 -1.149 0 C-N-CA 120.059 -1.067 . . . . 0.0 111.815 177.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.54 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.3 pp -85.99 -22.89 27.08 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 113.7 1.0 . . . . 0.0 113.7 -177.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.605 HG23 ' O ' ' A' ' 14' ' ' SER . 17.6 pt -42.46 -55.02 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 N-CA-C 114.815 1.413 . . . . 0.0 114.815 -175.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.497 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 2.4 m -68.69 -21.74 64.4 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 120.864 0.364 . . . . 0.0 111.677 -174.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.642 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 0.1 OUTLIER -88.57 -24.46 22.86 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.961 -177.687 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.639 HG13 ' HB3' ' A' ' 100' ' ' LEU . 85.1 t -57.19 168.71 0.32 Allowed 'Isoleucine or valine' 0 CA--C 1.55 0.978 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.759 179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.507 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -39.47 -27.63 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 -178.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.41 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.0 m-80 -60.27 -24.22 64.76 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-O 120.571 0.224 . . . . 0.0 111.498 178.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.497 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.71 -36.98 82.52 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 121.076 0.465 . . . . 0.0 110.306 177.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -83.58 -13.36 54.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.448 -179.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -85.17 -44.11 13.23 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.705 178.24 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.598 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 14.3 t-20 55.16 13.0 0.74 Allowed 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 123.841 0.856 . . . . 0.0 112.263 177.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 22.2 m -72.41 165.49 24.46 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.397 -0.819 . . . . 0.0 110.931 -178.259 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.425 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 27.8 m -61.67 -15.31 38.87 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.1 p -56.04 -25.94 46.95 Favored 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 123.785 0.834 . . . . 0.0 113.143 -178.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -114.83 -17.62 11.52 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 121.157 0.504 . . . . 0.0 110.672 178.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.425 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 11.4 ttm180 -77.51 -48.68 16.45 Favored 'General case' 0 CA--C 1.541 0.63 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.745 -176.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 12.0 t -167.06 -32.14 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 112.542 0.571 . . . . 0.0 112.542 -177.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.3 t -80.65 137.21 21.81 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.231 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -52.91 138.67 29.41 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 120.956 0.408 . . . . 0.0 110.999 -178.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.446 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 47.3 ptt85 -64.43 155.59 32.13 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.944 -178.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.3 m -70.74 114.85 9.23 Favored 'General case' 0 N--CA 1.439 -1.0 0 CA-C-N 115.987 -0.551 . . . . 0.0 109.657 -179.278 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.65 40.18 9.97 Favored Glycine 0 N--CA 1.437 -1.293 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 -177.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.7 p -47.37 145.95 0.7 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.557 0 C-N-CA 123.585 0.754 . . . . 0.0 112.307 -179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.525 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.4 m -71.48 140.29 49.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.406 -177.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.569 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -62.87 -12.81 27.45 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 179.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.42 ' HG3' HD22 ' A' ' 116' ' ' LEU . 89.2 mm-40 -57.06 -38.06 72.72 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-O 120.855 0.359 . . . . 0.0 110.757 178.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.525 HG13 ' O ' ' A' ' 40' ' ' SER . 2.8 pp -84.4 -35.62 10.83 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 N-CA-C 112.103 0.408 . . . . 0.0 112.103 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.488 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.97 -73.55 0.4 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.962 -179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 75.5 -18.92 0.42 Allowed 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.639 0.776 . . . . 0.0 112.403 176.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 14.9 p -67.61 -79.88 0.05 OUTLIER 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.16 0.505 . . . . 0.0 112.024 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.9 p -130.93 -27.59 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 CA-C-O 121.313 0.578 . . . . 0.0 110.848 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.8 t -73.92 94.17 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.819 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.184 -178.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 81.6 mm-40 -82.54 -50.23 9.03 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.259 0.552 . . . . 0.0 110.256 176.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.609 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 20.7 ttm180 -132.77 -3.93 3.24 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.875 -0.602 . . . . 0.0 109.941 177.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 72.03 -50.49 0.7 Allowed 'General case' 0 N--CA 1.477 0.916 0 C-N-CA 123.258 0.623 . . . . 0.0 110.17 -173.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -68.63 131.45 45.23 Favored 'General case' 0 C--O 1.24 0.593 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 175.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.506 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -46.6 -30.78 2.45 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.231 1.197 . . . . 0.0 114.231 -174.101 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.5 m -49.58 -71.56 0.06 Allowed 'General case' 0 CA--C 1.545 0.765 0 N-CA-C 112.111 0.411 . . . . 0.0 112.111 -178.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.513 HD23 ' O ' ' A' ' 55' ' ' LEU . 6.6 tt -86.38 -23.84 26.0 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.801 0.334 . . . . 0.0 110.454 -179.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.573 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -70.43 -20.69 62.89 Favored 'General case' 0 CA--C 1.51 -0.563 0 N-CA-C 111.836 0.31 . . . . 0.0 111.836 -179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 59.2 p -48.56 112.74 0.64 Allowed 'General case' 0 CA--C 1.535 0.383 0 O-C-N 123.565 0.541 . . . . 0.0 110.697 179.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.403 HG23 ' HG ' ' A' ' 59' ' ' LEU . 15.1 t -161.73 -40.41 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.79 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.298 -177.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.403 ' HG ' HG23 ' A' ' 58' ' ' THR . 91.8 mt -121.91 18.83 10.96 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-O 120.677 0.275 . . . . 0.0 110.996 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.74 66.12 1.23 Allowed Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.548 -0.834 . . . . 0.0 111.134 -177.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.745 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 37.5 t -89.3 104.97 15.5 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 120.937 0.399 . . . . 0.0 111.385 -177.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -173.62 76.49 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.499 178.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 96.22 -63.07 1.22 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.981 177.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 21.6 t30 -63.04 -69.49 0.26 Allowed 'General case' 0 CA--C 1.52 -0.196 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -173.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.745 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.6 p-10 -82.18 7.2 14.24 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.069 0.462 . . . . 0.0 110.444 -178.714 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.5 tp -88.02 -53.17 4.87 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.62 -0.718 . . . . 0.0 109.735 176.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.83 -35.8 29.02 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.499 0.666 . . . . 0.0 110.086 178.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.586 ' HA ' ' NE2' ' A' ' 72' ' ' GLN . 35.6 mmt180 -107.99 173.13 6.46 Favored 'General case' 0 C--O 1.212 -0.902 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 177.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 64.14 -62.1 0.17 Allowed 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.63 -61.95 2.24 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 122.717 0.407 . . . . 0.0 111.716 -177.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 75' ' ' SER . 39.1 t -59.66 -42.26 87.91 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.99 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.474 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.586 ' NE2' ' HA ' ' A' ' 68' ' ' ARG . 2.6 mp0 -65.78 -36.48 83.65 Favored 'General case' 0 C--O 1.207 -1.151 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.619 -178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.25 -51.92 64.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 120.803 0.335 . . . . 0.0 110.772 178.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.2 t -67.46 -34.01 65.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.486 0.66 . . . . 0.0 110.239 179.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 3.7 m -75.5 -19.78 59.17 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-N 115.485 -0.78 . . . . 0.0 112.177 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.507 ' HG3' ' O ' ' A' ' 72' ' ' GLN . 20.8 mtm180 -86.87 -13.1 45.89 Favored 'General case' 0 N--CA 1.468 0.466 0 CA-C-O 120.543 0.211 . . . . 0.0 110.551 177.159 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.6 mt -60.81 142.09 92.39 Favored Pre-proline 0 C--O 1.238 0.482 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.122 178.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -60.34 127.74 23.92 Favored 'Trans proline' 0 N--CA 1.456 -0.69 0 C-N-CA 122.176 1.917 . . . . 0.0 111.142 178.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -104.7 17.62 23.79 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.62 0.724 . . . . 0.0 110.579 -179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -67.06 -25.31 73.36 Favored Glycine 0 C--N 1.313 -0.712 0 CA-C-N 114.783 -1.099 . . . . 0.0 111.617 178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.1 m -79.72 -6.73 57.82 Favored 'General case' 0 C--N 1.324 -0.543 0 C-N-CA 122.28 0.232 . . . . 0.0 110.637 178.432 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 76.92 154.95 0.16 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 123.937 0.895 . . . . 0.0 110.557 -177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.9 p -65.33 -28.07 69.04 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.402 0.519 . . . . 0.0 112.402 -178.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 38.0 p -67.3 -25.58 66.1 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.736 -178.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.62 -23.72 60.97 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.988 0.423 . . . . 0.0 110.725 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.407 ' C ' ' H ' ' A' ' 88' ' ' GLN . 8.0 m-85 -76.67 -164.36 0.41 Allowed 'General case' 0 N--CA 1.452 -0.357 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.538 178.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -73.47 41.45 0.11 Allowed 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 121.01 0.433 . . . . 0.0 111.215 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.451 ' O ' ' HB2' ' A' ' 91' ' ' SER . 8.1 tp-100 -90.14 -59.03 2.3 Favored 'General case' 0 N--CA 1.436 -1.146 0 CA-C-N 115.556 -0.747 . . . . 0.0 110.919 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -65.0 -41.86 94.98 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.224 0.535 . . . . 0.0 110.825 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.513 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 74.6 m-85 -80.66 12.04 3.4 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.541 -178.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.451 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 15.6 t -50.61 -45.12 57.34 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 122.659 0.383 . . . . 0.0 111.556 -178.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.41 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 55.4 m -61.54 -41.89 98.02 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 -178.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -80.6 -26.55 37.76 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.963 0.411 . . . . 0.0 111.414 -177.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 74.8 mt -84.94 -28.06 26.12 Favored 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.597 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -85.18 -36.43 21.03 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.209 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 70.8 m-20 50.45 87.2 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 113.115 0.783 . . . . 0.0 113.115 179.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.98 -22.41 45.64 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.997 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 97.26 -14.09 63.92 Favored Glycine 0 C--O 1.223 -0.565 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.18 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 3.4 t -95.82 32.59 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-O 121.968 0.889 . . . . 0.0 108.955 179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.639 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.9 OUTLIER -116.9 -169.16 1.59 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 114.891 -1.05 . . . . 0.0 111.053 -178.425 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.593 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 14.6 t30 -78.39 106.69 10.5 Favored 'General case' 0 N--CA 1.443 -0.823 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 -179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.37 -29.33 70.03 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.905 -0.589 . . . . 0.0 112.451 -175.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 8.3 p -72.26 -18.15 61.84 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 121.226 0.536 . . . . 0.0 110.276 -178.557 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.593 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 6.2 t30 -63.81 -50.75 67.73 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.654 177.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.454 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.0 mp -73.43 -35.3 45.33 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.855 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.3 t70 -67.48 -35.09 78.49 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.401 179.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 98.2 m -93.61 -60.6 1.73 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.052 0.76 . . . . 0.0 113.052 -176.169 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.49 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 1.1 pp -104.53 -35.99 7.68 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.568 0.581 . . . . 0.0 112.568 -173.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.454 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -52.86 -58.49 11.39 Favored Glycine 0 CA--C 1.52 0.377 0 C-N-CA 120.966 -0.635 . . . . 0.0 113.897 -176.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.543 ' O ' ' HA ' ' A' ' 114' ' ' SER . 13.7 p -71.19 -21.05 62.2 Favored 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -177.495 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.4 mpt_? -88.13 -52.76 5.07 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.6 t -77.28 -50.56 20.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.521 -176.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.427 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.9 mp -79.3 -29.94 42.66 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.147 0.499 . . . . 0.0 109.926 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HA ' ' O ' ' A' ' 110' ' ' SER . 32.1 t 50.97 -100.28 0.08 Allowed 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 115.003 -0.999 . . . . 0.0 113.688 175.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.71 -34.68 73.23 Favored 'General case' 0 C--N 1.332 -0.187 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 -174.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 120' ' ' VAL . 51.8 tp -61.75 -59.36 5.28 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.925 -0.31 . . . . 0.0 111.743 -177.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 25.1 mt -63.75 -29.22 70.46 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.684 -0.407 . . . . 0.0 111.931 -177.237 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.0 m-80 -61.1 -42.83 99.24 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.078 0.466 . . . . 0.0 110.035 176.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -76.18 -29.27 58.82 Favored Glycine 0 N--CA 1.448 -0.514 0 C-N-CA 120.94 -0.648 . . . . 0.0 111.822 178.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 116' ' ' LEU . 82.3 t -72.69 -30.22 32.78 Favored 'Isoleucine or valine' 0 C--O 1.238 0.499 0 O-C-N 122.816 -0.226 . . . . 0.0 110.757 178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 53.2 m -55.99 -39.45 71.85 Favored 'General case' 0 C--O 1.224 -0.269 0 CA-C-N 116.38 -0.373 . . . . 0.0 111.566 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 7.1 p -85.68 -25.87 26.29 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 121.061 0.458 . . . . 0.0 111.155 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.76 -90.98 0.08 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 113.421 0.896 . . . . 0.0 113.421 -176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -71.36 -41.85 69.22 Favored 'General case' 0 CA--C 1.509 -0.61 0 CA-C-O 121.012 0.434 . . . . 0.0 111.548 -175.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 53.2 tt0 -77.24 -24.59 51.17 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.33 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -82.82 -65.12 1.63 Allowed Glycine 0 N--CA 1.443 -0.888 0 CA-C-N 115.687 -0.688 . . . . 0.0 113.448 -177.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.2 mt -116.58 -23.84 8.05 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 120.923 -0.311 . . . . 0.0 111.799 -176.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.81 104.37 2.2 Favored Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 120.341 -0.933 . . . . 0.0 110.842 -177.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 39.4 mt -68.75 130.31 33.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 CA-C-O 120.959 0.409 . . . . 0.0 111.885 -177.399 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -120.78 128.35 52.8 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 176.502 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 132' ' ' ASP . 18.2 t -98.57 167.58 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 CA-C-N 116.507 -0.315 . . . . 0.0 110.317 -178.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.47 ' N ' HG12 ' A' ' 131' ' ' VAL . 27.6 t70 -58.45 151.83 19.27 Favored 'General case' 0 C--O 1.244 0.801 0 CA-C-O 121.344 0.592 . . . . 0.0 111.747 -177.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.591 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 15.2 m -75.37 -2.25 27.6 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.357 -0.838 . . . . 0.0 113.083 -175.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.37 -72.07 0.64 Allowed Glycine 0 CA--C 1.523 0.542 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.184 179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.3 m -106.5 -58.21 1.95 Allowed 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.414 0.524 . . . . 0.0 112.414 -177.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.42 HG21 HG11 ' A' ' 131' ' ' VAL . 69.3 t -52.32 -55.02 12.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.509 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.591 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 5.4 tp-100 -60.02 -42.45 94.39 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.729 0.299 . . . . 0.0 111.075 -178.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.7 m -58.46 -41.04 84.27 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.086 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -73.1 -54.61 8.08 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.639 -179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.401 HG12 ' O ' ' A' ' 136' ' ' VAL . 38.7 pt -61.46 -39.09 81.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -176.164 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 20.4 t -64.44 -45.29 88.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-O 120.993 0.425 . . . . 0.0 110.72 -179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.4 m -76.91 -20.74 55.85 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.294 0.569 . . . . 0.0 111.134 -178.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.511 ' OG ' HD12 ' A' ' 147' ' ' LEU . 43.4 t -86.5 -60.17 2.07 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.781 -178.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 9.3 t -57.84 -30.46 65.8 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.12 -0.491 . . . . 0.0 112.253 -174.431 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 3.4 p -62.69 -52.01 64.96 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -85.22 -35.85 21.34 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.114 0.483 . . . . 0.0 111.362 -178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.598 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 76.7 mt -82.29 8.01 12.37 Favored 'General case' 0 C--N 1.314 -0.949 0 N-CA-C 112.856 0.688 . . . . 0.0 112.856 -175.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 60.3 m -46.8 -48.57 20.72 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-O 121.068 0.461 . . . . 0.0 111.205 -178.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.5 m -141.46 32.63 1.67 Allowed 'General case' 0 C--N 1.314 -0.975 0 CA-C-O 121.806 0.812 . . . . 0.0 109.047 178.627 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.434 ' HB3' ' HA ' ' A' ' 147' ' ' LEU . 9.6 t -86.16 27.7 0.89 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.428 -176.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.53 ' HB2' ' OE1' ' A' ' 158' ' ' GLN . 15.0 m -62.38 -36.08 81.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.18 0.514 . . . . 0.0 110.185 178.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.8 m -151.75 -52.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.199 177.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 19.1 m -135.3 98.7 4.04 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.577 -179.759 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -76.11 -34.6 59.49 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.965 -179.226 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 50.7 m -59.04 -40.11 84.06 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.418 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 77.6 m-85 -97.55 0.82 48.11 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 120.893 0.378 . . . . 0.0 110.364 179.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 30.4 m 55.81 23.87 6.84 Favored 'General case' 0 CA--C 1.534 0.361 0 CA-C-N 115.505 -0.771 . . . . 0.0 111.59 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.53 ' OE1' ' HB2' ' A' ' 151' ' ' SER . 10.9 pt20 43.65 30.03 0.33 Allowed 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.46 1.104 . . . . 0.0 112.878 -178.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.7 -28.12 61.56 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.79 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.2 m -72.99 -27.2 61.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.36 -0.836 . . . . 0.0 110.385 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.541 ' HA ' ' O ' ' A' ' 176' ' ' SER . . . 67.26 150.75 0.06 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.809 0.844 . . . . 0.0 112.503 179.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 26.4 p -93.03 27.89 2.3 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.805 -0.634 . . . . 0.0 111.332 -178.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 13.5 m -73.63 -14.21 61.14 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.567 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 6.5 m -61.2 -33.52 73.6 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 115.899 -0.592 . . . . 0.0 111.158 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.2 m -91.33 11.15 24.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.389 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 64.82 49.49 63.24 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.998 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -68.9 -36.84 78.52 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.591 0.234 . . . . 0.0 111.208 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.77 -73.18 1.7 Allowed Glycine 0 C--N 1.332 0.31 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 -178.163 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.476 ' HA ' ' HA2' ' A' ' 174' ' ' GLY . 46.1 p90 -153.31 133.38 13.33 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 109.67 -0.492 . . . . 0.0 109.67 176.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.677 ' OG1' ' HA ' ' A' ' 175' ' ' PRO . 62.9 m -105.46 -47.77 3.85 Favored 'General case' 0 N--CA 1.434 -1.252 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.2 -177.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -160.76 -85.37 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.579 -0.819 . . . . 0.0 112.027 179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.609 ' HA ' ' HG3' ' A' ' 20' ' ' ARG . 21.1 Cg_exo -70.71 94.48 0.61 Allowed 'Trans proline' 0 N--CA 1.458 -0.593 0 C-N-CA 122.557 2.171 . . . . 0.0 111.97 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.9 m 72.21 -52.08 0.7 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 123.684 0.794 . . . . 0.0 112.256 179.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.476 ' HA2' ' HA ' ' A' ' 169' ' ' TYR . . . -153.53 -145.57 4.18 Favored Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.059 -179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.677 ' HA ' ' OG1' ' A' ' 170' ' ' THR . 15.1 Cg_exo -70.02 -162.19 0.09 OUTLIER 'Trans proline' 0 C--N 1.343 0.263 0 C-N-CA 123.558 2.839 . . . . 0.0 112.791 -178.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.541 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 15.7 m -71.8 91.82 1.18 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 177.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.423 HG22 ' O ' ' A' ' 175' ' ' PRO . 9.4 t -147.88 -173.83 4.4 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.307 -176.77 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 76.9 80.98 0.61 Allowed Glycine 0 N--CA 1.446 -0.659 0 N-CA-C 110.807 -0.917 . . . . 0.0 110.807 -176.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.417 ' O ' ' HB3' ' A' ' 185' ' ' PRO . 2.8 Cg_exo -76.42 139.47 20.77 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.519 2.146 . . . . 0.0 111.751 -179.08 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.2 m -76.23 -7.47 54.94 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.226 0.536 . . . . 0.0 110.268 178.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.404 ' O ' ' HB2' ' A' ' 182' ' ' TYR . . . -127.03 -171.55 13.08 Favored Glycine 0 N--CA 1.442 -0.901 0 N-CA-C 110.734 -0.947 . . . . 0.0 110.734 178.583 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.404 ' HB2' ' O ' ' A' ' 181' ' ' GLY . 79.3 m-85 71.94 150.38 0.13 Allowed Pre-proline 0 N--CA 1.474 0.728 0 C-N-CA 123.241 0.616 . . . . 0.0 111.403 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -64.33 125.39 14.99 Favored 'Trans proline' 0 N--CA 1.455 -0.736 0 C-N-CA 121.981 1.787 . . . . 0.0 110.93 177.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 79.37 67.3 1.6 Allowed Glycine 0 CA--C 1.526 0.721 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.636 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.417 ' HB3' ' O ' ' A' ' 179' ' ' PRO . 29.7 Cg_exo -64.89 -11.27 28.69 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.958 2.439 . . . . 0.0 111.827 177.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 63.0 mt -77.02 -1.97 31.56 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.136 -179.142 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.11 102.14 0.69 Allowed Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.403 179.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 85.76 -60.0 4.7 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 121.03 -0.605 . . . . 0.0 112.588 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -85.13 63.3 4.39 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 121.04 -0.6 . . . . 0.0 113.076 -178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . . . -124.93 133.41 24.79 Favored Pre-proline 0 C--N 1.311 -1.073 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.642 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 22.7 Cg_exo -63.42 155.47 62.1 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.808 2.339 . . . . 0.0 112.332 179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.9 m-85 -76.94 -19.13 57.75 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -123.51 86.4 0.38 Allowed Glycine 0 N--CA 1.442 -0.951 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 59.8 tt0 -135.42 129.08 32.72 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-O 120.85 0.357 . . . . 0.0 110.855 -176.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.1 t -128.76 144.64 51.22 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 177.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 81.34 18.06 69.89 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.64 -0.791 . . . . 0.0 111.367 -178.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 44.3 p90 -71.38 142.57 50.34 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.898 0.38 . . . . 0.0 110.966 -179.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 121.73 174.26 14.68 Favored Glycine 0 N--CA 1.44 -1.08 0 C-N-CA 120.522 -0.846 . . . . 0.0 112.056 179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.319 0 CA-C-O 118.318 -1.268 . . . . 0.0 111.06 -179.674 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.642 0 CA-C-O 120.797 0.332 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -129.84 124.98 4.58 Favored Glycine 0 N--CA 1.438 -1.217 0 C-N-CA 120.428 -0.891 . . . . 0.0 112.637 179.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 95.3 Cg_endo -80.01 -161.81 0.16 Allowed 'Trans proline' 0 CA--C 1.533 0.445 0 C-N-CA 122.856 2.37 . . . . 0.0 110.789 176.591 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.62 ' HB2' ' HB2' ' A' ' 7' ' ' PHE . 94.3 mt-30 -123.34 158.29 31.37 Favored 'General case' 0 C--N 1.314 -0.936 0 CA-C-O 120.596 0.236 . . . . 0.0 110.457 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.43 106.53 1.71 Allowed Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.237 -179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 87.22 2.88 82.78 Favored Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.839 -0.696 . . . . 0.0 111.938 -178.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.62 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 92.3 m-85 -135.77 102.91 5.23 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 121.108 0.48 . . . . 0.0 110.806 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -122.41 123.76 5.5 Favored Glycine 0 N--CA 1.44 -1.076 0 N-CA-C 111.067 -0.813 . . . . 0.0 111.067 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.406 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -75.67 -171.28 1.51 Allowed 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -178.05 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 71.8 p 61.71 103.66 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.132 0 C-N-CA 124.501 1.121 . . . . 0.0 113.378 178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.03 149.84 19.91 Favored Glycine 0 C--N 1.332 0.341 0 CA-C-N 115.69 -0.686 . . . . 0.0 111.94 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.45 -46.99 53.57 Favored Glycine 0 N--CA 1.453 -0.217 0 C-N-CA 121.445 -0.407 . . . . 0.0 113.53 -177.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.98 -37.97 89.41 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.073 0.463 . . . . 0.0 111.12 -178.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.6 ' O ' HG23 ' A' ' 18' ' ' ILE . 70.0 m -72.1 -30.6 65.24 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.717 179.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.04 -26.75 50.38 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 113.092 0.775 . . . . 0.0 113.092 -176.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.09 -38.98 7.09 Favored Glycine 0 N--CA 1.447 -0.625 0 C-N-CA 120.185 -1.007 . . . . 0.0 113.039 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.683 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.2 pp -83.88 -22.55 31.59 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -175.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' SER . 10.6 pt -43.25 -43.1 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 114.205 1.187 . . . . 0.0 114.205 -175.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.466 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 23.3 t -74.38 -27.55 60.71 Favored 'General case' 0 C--N 1.315 -0.911 0 N-CA-C 112.31 0.485 . . . . 0.0 112.31 -176.18 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.493 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 98.6 mtt180 -88.0 -23.41 23.82 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 111.802 0.297 . . . . 0.0 111.802 -177.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 17' ' ' LEU . 56.4 t -58.52 176.89 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.568 1.65 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.832 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.577 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -36.67 -31.49 0.03 OUTLIER 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 -177.048 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.469 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 5.7 m-80 -63.29 -24.77 68.01 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 118.244 0.474 . . . . 0.0 111.404 179.28 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.466 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.04 -28.25 69.66 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.954 0.407 . . . . 0.0 110.151 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 32.4 tp -83.41 -40.98 18.66 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.4 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.06 73.55 8.1 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.928 -0.767 . . . . 0.0 108.928 176.312 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -63.43 19.89 0.01 OUTLIER 'General case' 0 CA--C 1.565 1.556 0 C-N-CA 124.911 1.284 . . . . 0.0 114.2 -173.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.4 ' H ' ' C ' ' A' ' 26' ' ' ALA . 0.3 OUTLIER -63.46 -178.76 0.29 Allowed 'General case' 0 CA--C 1.553 1.082 0 CA-C-O 121.595 0.712 . . . . 0.0 112.171 -179.614 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.449 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 13.0 m -66.51 -20.48 66.04 Favored 'General case' 0 CA--C 1.541 0.597 0 N-CA-C 113.583 0.957 . . . . 0.0 113.583 -176.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.5 p -51.13 -62.53 1.56 Allowed 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 113.266 0.839 . . . . 0.0 113.266 -175.577 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.731 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.8 pt? -80.78 -20.55 42.35 Favored 'General case' 0 C--N 1.311 -1.094 0 CA-C-O 121.28 0.562 . . . . 0.0 110.148 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 22.4 ttm180 -68.41 -46.45 69.89 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.398 -0.819 . . . . 0.0 112.474 -176.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 9.9 t -177.34 -35.43 0.01 OUTLIER 'General case' 0 C--O 1.236 0.392 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -177.92 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 97.6 t -74.17 139.97 18.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.663 -0.244 . . . . 0.0 110.619 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.545 ' HA ' ' CD ' ' A' ' 88' ' ' GLN . 4.0 pp -51.42 140.43 17.61 Favored 'General case' 0 C--O 1.237 0.44 0 O-C-N 123.787 0.679 . . . . 0.0 112.6 -176.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.441 HH11 ' HD3' ' A' ' 36' ' ' ARG . 15.9 ttt180 -50.76 137.72 19.77 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.595 -1.184 . . . . 0.0 112.564 -179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.1 p -66.27 111.39 3.45 Favored 'General case' 0 N--CA 1.437 -1.079 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.644 175.461 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 93.78 31.63 8.09 Favored Glycine 0 N--CA 1.433 -1.523 0 N-CA-C 110.991 -0.844 . . . . 0.0 110.991 -177.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.7 p -51.11 137.13 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.459 0.647 . . . . 0.0 110.72 179.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 13.0 m -105.17 161.9 13.86 Favored 'General case' 0 C--N 1.303 -1.417 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -173.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.496 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 3.1 pt20 -60.44 -14.98 22.21 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.203 -0.908 . . . . 0.0 112.404 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.413 ' HG3' HD22 ' A' ' 116' ' ' LEU . 83.2 mm-40 -53.92 -48.72 69.9 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.263 0.554 . . . . 0.0 109.758 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.1 pp -85.99 -39.41 13.6 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-N 116.006 -0.543 . . . . 0.0 112.241 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.403 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -82.86 -62.03 1.71 Allowed 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.859 0.318 . . . . 0.0 111.859 -176.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.0 m 74.63 -20.96 0.3 Allowed 'General case' 0 N--CA 1.474 0.748 0 N-CA-C 113.484 0.92 . . . . 0.0 113.484 177.045 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.2 t -71.02 -95.94 0.01 OUTLIER 'General case' 0 CA--C 1.545 0.759 0 CA-C-O 120.761 0.315 . . . . 0.0 111.771 -178.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 17.0 m -112.91 -22.49 4.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.54 0 CA-C-O 121.194 0.521 . . . . 0.0 110.832 179.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 36.6 t -75.72 96.94 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.744 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.885 -179.331 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.566 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 76.8 mt-30 -81.97 -47.46 12.67 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.139 177.005 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.475 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 33.8 ttm-85 -144.8 4.13 1.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.402 175.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 67.53 -53.86 0.49 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.479 0.712 . . . . 0.0 111.18 -176.307 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.674 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.26 141.28 57.65 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.321 178.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.569 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 14.0 mp0 -58.83 -18.46 32.7 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.043 -0.981 . . . . 0.0 112.081 -175.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.8 t -63.05 -76.96 0.06 Allowed 'General case' 0 CA--C 1.537 0.461 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -178.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.3 tt -86.85 -24.79 24.82 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 111.761 0.282 . . . . 0.0 111.761 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.566 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -72.32 -18.11 61.8 Favored 'General case' 0 CA--C 1.509 -0.601 0 N-CA-C 111.895 0.331 . . . . 0.0 111.895 -178.38 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 77.6 p -45.7 104.05 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 O-C-N 123.856 0.722 . . . . 0.0 111.156 179.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.408 HG22 ' O ' ' A' ' 56' ' ' ALA . 10.5 t -149.97 -40.92 0.14 Allowed 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.185 -0.462 . . . . 0.0 111.089 -179.226 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.7 mt -118.27 19.34 13.51 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.975 0.417 . . . . 0.0 110.235 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.24 67.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.13 0 N-CA-C 110.593 -1.003 . . . . 0.0 110.593 -177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.607 HG22 HD21 ' A' ' 65' ' ' ASN . 6.1 t -87.85 109.01 19.08 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.971 0 CA-C-O 120.706 0.289 . . . . 0.0 110.653 -174.12 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -163.37 80.04 0.45 Allowed 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.808 178.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 77.51 -48.85 2.94 Favored Glycine 0 CA--C 1.523 0.537 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.73 -179.239 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.514 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 20.9 p-10 -52.64 -80.07 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 123.829 0.851 . . . . 0.0 112.862 -177.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.607 HD21 HG22 ' A' ' 61' ' ' VAL . 3.9 p-10 -85.81 9.17 17.37 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.215 0.531 . . . . 0.0 109.933 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.499 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 59.1 tp -88.31 -50.85 6.08 Favored 'General case' 0 N--CA 1.439 -0.98 0 CA-C-N 115.406 -0.816 . . . . 0.0 110.128 176.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.14 -49.81 14.39 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 121.545 0.688 . . . . 0.0 109.31 178.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 63.6 mtt180 -90.87 162.38 14.82 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 176.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 68.32 -61.72 0.39 Allowed 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 112.293 0.479 . . . . 0.0 112.293 179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.499 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -64.42 -62.92 1.3 Allowed 'General case' 0 C--O 1.236 0.345 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -178.523 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 87.5 t -61.85 -36.13 72.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-O 120.794 0.331 . . . . 0.0 110.402 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -65.81 -43.37 88.82 Favored 'General case' 0 C--N 1.314 -0.958 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.301 -179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.484 ' O ' ' HG ' ' A' ' 77' ' ' LEU . . . -67.34 -44.93 77.87 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.509 0.195 . . . . 0.0 111.286 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 71.1 t -67.9 -43.45 85.88 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.812 0.339 . . . . 0.0 111.268 -178.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 28.1 t -65.12 -30.17 71.09 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-O 121.039 0.447 . . . . 0.0 110.72 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 93.8 mtt180 -98.32 6.28 47.49 Favored 'General case' 0 C--O 1.237 0.395 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.645 -178.402 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 73' ' ' ALA . 14.4 mt -62.08 125.61 85.7 Favored Pre-proline 0 CA--C 1.51 -0.591 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.081 179.052 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -63.73 127.55 19.93 Favored 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 122.08 1.853 . . . . 0.0 109.608 176.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -79.8 95.12 5.93 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-O 121.133 0.492 . . . . 0.0 111.552 -176.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.99 -50.62 5.78 Favored Glycine 0 N--CA 1.439 -1.102 0 N-CA-C 111.06 -0.816 . . . . 0.0 111.06 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 15.9 m -90.43 -61.7 1.62 Allowed 'General case' 0 C--N 1.319 -0.731 0 N-CA-C 110.161 -0.311 . . . . 0.0 110.161 178.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.458 ' HB2' ' O ' ' A' ' 81' ' ' SER . 21.4 t70 168.97 161.57 0.05 OUTLIER 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.562 0.745 . . . . 0.0 109.172 179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 22.7 m -67.09 -39.1 86.71 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.775 0.321 . . . . 0.0 110.988 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 74.9 p -79.69 -18.5 51.15 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.995 0.426 . . . . 0.0 110.858 -179.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.79 -19.74 65.12 Favored 'General case' 0 CA--C 1.518 -0.251 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.86 179.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 5.1 m-30 -64.15 -168.96 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.225 178.295 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.411 ' HB1' ' HD3' ' A' ' 36' ' ' ARG . . . -65.91 1.59 1.35 Allowed 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -176.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.545 ' CD ' ' HA ' ' A' ' 35' ' ' LEU . 1.0 OUTLIER -69.96 -47.15 63.43 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.78 0.289 . . . . 0.0 111.78 -178.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -69.33 -40.24 77.72 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 121.255 0.55 . . . . 0.0 110.794 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.507 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -83.92 10.54 9.52 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.856 -0.611 . . . . 0.0 112.419 -177.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 75.8 m -49.79 -38.48 34.6 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.134 0.42 . . . . 0.0 112.134 -179.313 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 72.6 m -56.41 -50.4 71.74 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.13 -30.12 31.29 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 111.773 0.286 . . . . 0.0 111.773 -177.199 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.507 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.5 mt -80.42 -33.08 37.22 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 112.307 0.484 . . . . 0.0 112.307 -176.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 55.0 t80 -84.56 -37.41 21.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 56.0 85.74 0.07 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 114.87 -1.059 . . . . 0.0 111.852 178.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -79.58 -2.61 43.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.578 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.55 -13.54 34.53 Favored Glycine 0 C--O 1.225 -0.463 0 C-N-CA 121.297 -0.478 . . . . 0.0 112.529 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 20.5 t -77.93 -13.38 13.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 121.464 0.649 . . . . 0.0 110.097 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -84.83 -179.69 7.14 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.524 -177.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -75.21 118.66 18.37 Favored 'General case' 0 CA--C 1.508 -0.653 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.325 -178.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -71.77 -21.98 61.66 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 177.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.4 m -74.99 -31.36 61.41 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-N 115.745 -0.661 . . . . 0.0 109.855 -179.411 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 19.2 t30 -61.87 -53.28 57.96 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.69 -0.687 . . . . 0.0 109.488 177.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -64.49 -39.97 87.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.129 178.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -61.34 -38.1 85.71 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 120.858 0.361 . . . . 0.0 110.754 178.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 90.2 m -78.59 -55.22 5.37 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -176.236 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.2 pp -121.14 -22.32 6.13 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -174.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -60.22 -65.29 3.47 Favored Glycine 0 C--N 1.32 -0.336 0 C-N-CA 120.472 -0.87 . . . . 0.0 112.778 -178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 19.4 m -72.96 -9.71 59.02 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.107 0.479 . . . . 0.0 110.973 -179.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -86.54 -55.94 3.65 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.629 179.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 47.3 t -80.96 -57.95 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.91 -178.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.435 HD12 ' N ' ' A' ' 113' ' ' LEU . 5.3 mp -68.32 -49.8 57.82 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.187 -0.461 . . . . 0.0 109.923 -178.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 31.4 t 52.9 -93.4 0.03 OUTLIER 'General case' 0 CA--C 1.545 0.775 0 N-CA-C 113.46 0.911 . . . . 0.0 113.46 176.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.57 -40.78 60.39 Favored 'General case' 0 N--CA 1.469 0.51 0 C-N-CA 123.241 0.616 . . . . 0.0 112.428 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.564 ' O ' HG23 ' A' ' 120' ' ' VAL . 59.7 tp -60.87 -47.32 86.92 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.621 -179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.485 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 30.2 mt -71.3 -25.77 62.57 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.53 -178.756 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.7 m120 -60.28 -44.36 95.42 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 176.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.42 -31.1 57.45 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.667 -0.778 . . . . 0.0 111.558 177.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 116' ' ' LEU . 52.1 t -63.82 -41.26 91.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.202 0 O-C-N 122.848 -0.207 . . . . 0.0 110.712 178.21 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.472 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 54.2 m -52.82 -45.75 67.42 Favored 'General case' 0 C--N 1.325 -0.481 0 O-C-N 123.813 0.696 . . . . 0.0 112.352 -177.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.3 p -83.74 -36.38 23.69 Favored 'General case' 0 C--N 1.315 -0.924 0 CA-C-O 120.95 0.405 . . . . 0.0 112.065 -177.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.9 -76.1 0.31 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 113.007 0.743 . . . . 0.0 113.007 -176.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.517 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.7 -49.69 50.94 Favored 'General case' 0 C--O 1.222 -0.367 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.707 -175.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.472 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 52.6 mt-30 -72.52 -24.6 61.17 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.058 -179.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.94 -53.39 3.02 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 120.857 -0.687 . . . . 0.0 113.732 -177.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.18 -19.27 12.32 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 112.536 0.569 . . . . 0.0 112.536 -175.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.39 79.84 0.86 Allowed Glycine 0 C--N 1.316 -0.529 0 C-N-CA 120.065 -1.064 . . . . 0.0 110.488 -176.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.674 HG23 ' HB2' ' A' ' 52' ' ' ALA . 35.0 mm -64.6 136.33 26.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 N-CA-C 113.415 0.895 . . . . 0.0 113.415 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 48.0 t-20 -134.62 125.9 28.12 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 107.968 -1.123 . . . . 0.0 107.968 176.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.8 t -89.48 113.93 26.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-O 121.494 0.664 . . . . 0.0 111.669 -177.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.7 p-10 -100.24 42.97 1.08 Allowed 'General case' 0 C--N 1.298 -1.654 0 CA-C-N 115.029 -0.987 . . . . 0.0 110.914 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.466 ' HA ' ' HG ' ' A' ' 66' ' ' LEU . 56.4 p -78.7 2.97 17.79 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.562 -178.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 102.25 -27.37 20.66 Favored Glycine 0 N--CA 1.436 -1.31 0 C-N-CA 120.465 -0.874 . . . . 0.0 112.15 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 20.4 m -105.95 -42.84 5.01 Favored 'General case' 0 C--N 1.314 -0.948 0 N-CA-C 112.762 0.653 . . . . 0.0 112.762 -175.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.446 ' HB ' ' O ' ' A' ' 131' ' ' VAL . 20.6 t -70.43 -63.2 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -173.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.437 HE21 ' HB2' ' A' ' 137' ' ' GLN . 7.5 tt0 -59.55 -43.5 93.52 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.954 -176.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.6 m -58.33 -38.01 76.29 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 120.947 0.403 . . . . 0.0 111.025 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -72.62 -56.65 5.01 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.49 -179.083 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.444 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 44.2 pt -61.83 -27.63 42.66 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.871 0 CA-C-N 115.877 -0.602 . . . . 0.0 112.526 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 50.7 m -75.43 -35.83 60.88 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 121.03 0.443 . . . . 0.0 110.721 -179.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.3 m -79.2 -29.42 42.84 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.178 0.513 . . . . 0.0 110.302 179.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.444 ' OG ' ' HA ' ' A' ' 140' ' ' ILE . 98.9 p -86.73 -21.0 26.87 Favored 'General case' 0 N--CA 1.445 -0.678 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.258 -178.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.538 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 40.5 t -63.13 -19.57 64.57 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.921 -179.369 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 55.5 p -61.65 -19.72 62.61 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.202 0.525 . . . . 0.0 110.982 178.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 -88.21 -6.37 57.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.731 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.538 ' HG ' ' HA ' ' A' ' 144' ' ' SER . 23.2 mt -64.84 -3.98 3.95 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 114.011 1.115 . . . . 0.0 114.011 -175.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 29.1 t -55.23 -62.77 1.45 Allowed 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.134 -1.061 . . . . 0.0 108.134 176.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -172.69 82.77 0.05 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.763 174.206 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 35.6 t -92.11 -16.06 26.86 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.424 0.631 . . . . 0.0 110.173 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 5.5 m -90.66 -57.57 2.78 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.764 -179.254 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.6 m -122.92 -154.97 0.63 Allowed 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.668 -176.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.447 ' CB ' ' HB2' ' A' ' 158' ' ' GLN . 78.4 p -115.78 178.1 4.43 Favored 'General case' 0 N--CA 1.442 -0.854 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 177.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -158.86 25.05 0.22 Allowed 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.942 -0.303 . . . . 0.0 111.545 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 27.6 t -134.78 -78.1 0.45 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.706 -179.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.6 t80 -156.43 -176.48 5.99 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 70.2 p 58.41 -72.01 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 124.981 1.313 . . . . 0.0 113.341 177.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.447 ' HB2' ' CB ' ' A' ' 153' ' ' SER . 78.9 mt-30 -64.85 -27.64 69.01 Favored 'General case' 0 C--N 1.315 -0.911 0 CA-C-O 121.204 0.526 . . . . 0.0 110.285 178.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -81.08 2.87 25.37 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.268 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 30.6 m -84.89 6.72 23.66 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.181 0.515 . . . . 0.0 110.729 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -99.79 139.7 35.07 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.021 178.154 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 t -115.23 150.06 36.75 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-O 121.17 0.51 . . . . 0.0 111.408 -178.283 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 47.4 m -102.64 -46.87 4.61 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.697 175.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.5 t -63.39 -39.13 93.69 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.934 -178.394 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 12.0 p -124.53 29.09 6.39 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.257 0.551 . . . . 0.0 110.286 179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -133.56 -109.06 1.09 Allowed Glycine 0 N--CA 1.442 -0.901 0 C-N-CA 120.22 -0.991 . . . . 0.0 113.381 -178.189 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -88.03 5.78 39.27 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.274 0.472 . . . . 0.0 112.274 -176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 78.26 -69.49 2.74 Favored Glycine 0 CA--C 1.509 -0.307 0 N-CA-C 111.364 -0.694 . . . . 0.0 111.364 -178.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 55.3 p90 -173.05 150.21 1.95 Allowed 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 177.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 19.5 m -134.96 74.71 1.53 Allowed 'General case' 0 C--N 1.307 -1.275 0 CA-C-O 121.5 0.667 . . . . 0.0 110.562 -178.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 66.6 -156.93 50.76 Favored Glycine 0 N--CA 1.443 -0.871 0 CA-C-N 115.467 -0.788 . . . . 0.0 112.633 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.493 ' O ' ' HA3' ' A' ' 188' ' ' GLY . 3.4 Cg_exo -81.61 -2.96 11.74 Favored 'Trans proline' 0 C--O 1.224 -0.191 0 C-N-CA 123.496 2.797 . . . . 0.0 112.298 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 6.1 p -105.14 -42.71 5.22 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 120.985 0.422 . . . . 0.0 111.305 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 83.21 171.59 47.67 Favored Glycine 0 N--CA 1.438 -1.216 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.816 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -73.79 47.97 1.56 Allowed 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.861 2.374 . . . . 0.0 112.252 178.584 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.5 m 68.17 19.3 9.19 Favored 'General case' 0 N--CA 1.467 0.392 0 C-N-CA 123.515 0.726 . . . . 0.0 111.417 179.699 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.3 t -109.98 150.87 27.87 Favored 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.149 -178.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 117.63 87.22 1.21 Allowed Glycine 0 N--CA 1.444 -0.813 0 N-CA-C 111.318 -0.713 . . . . 0.0 111.318 -177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_exo -66.78 151.16 82.99 Favored 'Trans proline' 0 C--O 1.234 0.322 0 C-N-CA 122.75 2.3 . . . . 0.0 112.318 -178.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 33.5 t -97.33 -1.42 44.61 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.719 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 182' ' ' TYR . . . -72.56 147.76 40.92 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.682 -0.771 . . . . 0.0 111.509 179.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.454 ' HB2' ' O ' ' A' ' 181' ' ' GLY . 26.5 m-85 75.43 122.23 0.03 OUTLIER Pre-proline 0 N--CA 1.474 0.738 0 C-N-CA 123.335 0.654 . . . . 0.0 110.589 -178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -54.83 124.09 15.38 Favored 'Trans proline' 0 C--O 1.237 0.461 0 C-N-CA 122.254 1.969 . . . . 0.0 111.383 179.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 60.23 71.03 0.85 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.345 -177.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_endo -84.36 -74.45 0.0 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.531 2.154 . . . . 0.0 112.074 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 89.5 mt -145.92 -63.75 0.32 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.756 -178.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 137.04 -161.08 25.12 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.606 -0.807 . . . . 0.0 111.757 -179.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 172' ' ' PRO . . . -74.91 101.22 1.29 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.957 -0.639 . . . . 0.0 112.41 -178.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 77.88 5.01 86.43 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.089 -179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 64.36 82.93 0.21 Allowed Pre-proline 0 N--CA 1.462 0.138 0 C-N-CA 123.837 0.855 . . . . 0.0 112.196 -179.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.493 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 27.8 Cg_endo -67.46 139.75 50.26 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.988 1.792 . . . . 0.0 111.384 177.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 92.7 m-85 -85.39 32.45 0.56 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.706 0.765 . . . . 0.0 110.712 -179.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -146.85 46.96 0.71 Allowed Glycine 0 N--CA 1.438 -1.171 0 N-CA-C 109.82 -1.312 . . . . 0.0 109.82 177.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 46.7 tp60 -127.72 166.2 18.6 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.589 -0.523 . . . . 0.0 109.589 -177.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 11.3 t -98.32 -176.76 3.49 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 178.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -93.64 -36.37 5.87 Favored Glycine 0 N--CA 1.445 -0.714 0 C-N-CA 121.051 -0.595 . . . . 0.0 111.627 179.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 78.5 t80 67.69 -72.83 0.09 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 123.685 0.794 . . . . 0.0 112.164 178.693 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 177.87 -116.71 0.55 Allowed Glycine 0 N--CA 1.442 -0.955 0 C-N-CA 120.716 -0.754 . . . . 0.0 112.483 -178.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.443 -0.898 0 CA-C-O 119.035 -0.869 . . . . 0.0 111.433 -179.571 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 121.04 0.447 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 111.77 -147.69 18.05 Favored Glycine 0 N--CA 1.437 -1.262 0 N-CA-C 111.351 -0.7 . . . . 0.0 111.351 -179.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -78.54 147.72 22.65 Favored 'Trans proline' 0 N--CA 1.459 -0.535 0 C-N-CA 122.247 1.965 . . . . 0.0 112.425 -179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 82.4 mm-40 -86.53 137.3 32.63 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.7 100.77 0.52 Allowed Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 121.175 -0.536 . . . . 0.0 111.916 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 124.0 -9.85 8.43 Favored Glycine 0 N--CA 1.442 -0.933 0 N-CA-C 111.612 -0.595 . . . . 0.0 111.612 -178.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 77.2 m-85 -120.23 -45.39 2.45 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 120.737 0.303 . . . . 0.0 111.256 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 70.75 41.77 62.99 Favored Glycine 0 N--CA 1.449 -0.472 0 C-N-CA 120.233 -0.984 . . . . 0.0 111.041 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.51 ' HA ' HD12 ' A' ' 113' ' ' LEU . . . -61.39 147.46 44.84 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -177.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.1 m 66.49 92.58 0.08 Allowed 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.69 179.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.445 ' HA2' ' CE1' ' A' ' 90' ' ' PHE . . . 143.1 -172.7 24.5 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.766 -0.73 . . . . 0.0 111.938 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 109.31 -162.9 12.62 Favored Glycine 0 N--CA 1.44 -1.096 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.03 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.23 -19.13 62.85 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.844 0.354 . . . . 0.0 111.885 -179.142 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.559 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.5 m -63.9 -20.38 65.8 Favored 'General case' 0 N--CA 1.445 -0.724 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.953 179.464 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -62.02 -21.95 65.31 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 120.917 0.389 . . . . 0.0 111.987 -179.076 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -82.29 -34.88 22.19 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.303 178.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.543 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.4 pp -87.74 -31.78 19.49 Favored 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -178.707 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.559 HG23 ' O ' ' A' ' 14' ' ' SER . 16.3 pt -42.23 -57.47 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 N-CA-C 115.429 1.64 . . . . 0.0 115.429 -173.253 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.526 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 12.7 m -66.56 -20.36 66.0 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.305 0.484 . . . . 0.0 112.305 -174.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.436 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 57.0 mtt180 -88.9 -31.23 18.33 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 111.936 0.347 . . . . 0.0 111.936 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.543 HG23 ' O ' ' A' ' 17' ' ' LEU . 83.7 t -49.53 158.83 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.212 -0.916 0 O-C-N 123.597 0.561 . . . . 0.0 111.384 -177.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.458 ' CB ' ' HB ' ' A' ' 99' ' ' VAL . . . -40.31 -25.46 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 114.304 1.224 . . . . 0.0 114.304 -178.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.408 ' HB3' ' OG ' ' A' ' 92' ' ' SER . 20.4 t-20 -61.73 -28.67 69.59 Favored 'General case' 0 CA--C 1.543 0.706 0 CA-C-O 120.998 0.428 . . . . 0.0 109.938 178.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.526 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -58.97 -46.19 88.69 Favored 'General case' 0 CA--C 1.517 -0.306 0 CA-C-O 121.511 0.672 . . . . 0.0 109.934 176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.453 HD13 ' HD2' ' A' ' 179' ' ' PRO . 61.9 tp -68.06 -28.66 67.56 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 114.786 -1.097 . . . . 0.0 111.297 -178.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -59.94 -39.99 87.45 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.869 0.366 . . . . 0.0 110.133 178.871 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 9.9 t-20 59.4 2.99 0.35 Allowed 'General case' 0 CA--C 1.546 0.795 0 C-N-CA 123.899 0.88 . . . . 0.0 112.535 177.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.616 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 5.5 m -68.53 163.44 23.5 Favored 'General case' 0 N--CA 1.443 -0.812 0 CA-C-O 121.266 0.555 . . . . 0.0 111.289 -178.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.5 m -58.94 -15.34 12.43 Favored 'General case' 0 C--N 1.318 -0.799 0 N-CA-C 112.756 0.65 . . . . 0.0 112.756 -178.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 24.8 p -54.59 -30.43 54.52 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.644 0.777 . . . . 0.0 112.992 -178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.415 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.1 pt? -106.57 -18.6 13.92 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.214 0.53 . . . . 0.0 110.507 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 31.8 ttm180 -76.2 -60.17 2.45 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.067 -176.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 8.9 t -155.25 -31.4 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.275 0.472 . . . . 0.0 112.275 -175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.425 ' C ' HE22 ' A' ' 88' ' ' GLN . 96.0 t -75.57 137.48 22.76 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.5 HD13 HG11 ' A' ' 74' ' ' VAL . 2.6 pt? -55.79 145.66 23.76 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.224 0.535 . . . . 0.0 112.016 -177.35 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.9 ttt180 -52.84 130.21 32.39 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.068 -0.969 . . . . 0.0 111.556 178.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.445 HG23 HG21 ' A' ' 136' ' ' VAL . 3.3 m -66.02 111.84 3.56 Favored 'General case' 0 N--CA 1.439 -0.99 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 176.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.437 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 90.88 31.46 9.98 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.58 -0.819 . . . . 0.0 111.182 -177.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.536 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 4.3 p -59.58 163.15 0.92 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.721 0 C-N-CA 123.386 0.674 . . . . 0.0 112.265 -177.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 58.5 m -109.52 161.39 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.781 179.659 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.573 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 11.7 pt20 -64.78 -15.22 61.36 Favored 'General case' 0 N--CA 1.47 0.534 0 N-CA-C 112.429 0.529 . . . . 0.0 112.429 -177.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.41 ' HG3' HD13 ' A' ' 116' ' ' LEU . 81.3 mm-40 -53.14 -46.41 68.82 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.024 0.44 . . . . 0.0 111.106 -178.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' HB ' ' CD2' ' A' ' 86' ' ' TYR . 2.4 pp -84.35 -35.98 11.29 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.903 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.989 -178.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -77.89 -60.68 2.27 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.552 -0.294 . . . . 0.0 111.574 -176.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.7 t 70.83 -21.06 0.2 Allowed 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.631 0.772 . . . . 0.0 112.87 177.416 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -69.33 -79.6 0.06 Allowed 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 -178.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -144.38 -37.02 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 120.968 0.413 . . . . 0.0 111.265 -177.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.503 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.4 p -71.11 99.28 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-O 121.459 0.647 . . . . 0.0 110.714 178.608 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.573 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 40.6 mt-30 -82.99 -38.01 23.22 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.976 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.576 ' HE ' HD13 ' A' ' 55' ' ' LEU . 23.8 ttm-85 -148.23 -1.61 0.55 Allowed 'General case' 0 N--CA 1.437 -1.113 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.784 -179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.0 -46.63 0.64 Allowed 'General case' 0 N--CA 1.478 0.959 0 C-N-CA 123.247 0.619 . . . . 0.0 111.128 -176.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.504 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.31 142.05 58.38 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 176.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.538 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.2 mm-40 -64.5 -16.46 62.57 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 115.743 -0.662 . . . . 0.0 112.104 -174.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.3 p -63.08 -76.74 0.06 Allowed 'General case' 0 C--N 1.313 -0.987 0 CA-C-O 121.141 0.496 . . . . 0.0 112.26 -178.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.576 HD13 ' HE ' ' A' ' 50' ' ' ARG . 7.1 tt -85.36 -23.65 27.91 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.741 -175.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.565 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -81.17 -21.05 39.99 Favored 'General case' 0 CA--C 1.514 -0.433 0 N-CA-C 113.59 0.959 . . . . 0.0 113.59 -177.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.538 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.5 t -62.94 94.92 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 120.337 -0.545 . . . . 0.0 110.756 -179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.48 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 9.6 t -119.99 -34.73 3.64 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.637 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.464 ' HG ' HG23 ' A' ' 58' ' ' THR . 96.2 mt -118.07 19.5 13.57 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.158 -0.474 . . . . 0.0 109.972 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.25 67.69 1.46 Allowed Glycine 0 N--CA 1.441 -0.979 0 N-CA-C 110.409 -1.076 . . . . 0.0 110.409 -176.144 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.487 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.7 t -88.49 126.31 41.73 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 120.81 0.338 . . . . 0.0 110.28 -176.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 35.1 t70 177.01 89.16 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.574 179.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.07 -60.12 4.48 Favored Glycine 0 CA--C 1.521 0.441 0 C-N-CA 121.14 -0.552 . . . . 0.0 113.125 178.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -50.14 -79.52 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.269 0.628 . . . . 0.0 112.131 -176.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.487 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 21.5 p-10 -85.77 14.0 6.49 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.998 -179.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 64.7 tp -88.07 -58.41 2.58 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.746 176.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.86 -42.62 48.95 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-O 121.456 0.646 . . . . 0.0 109.785 179.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 95.9 mtt180 -99.08 162.85 12.83 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.427 -0.806 . . . . 0.0 108.918 178.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 70.14 -61.92 0.44 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 123.415 0.447 . . . . 0.0 111.715 -179.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.503 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.59 -62.7 1.42 Allowed 'General case' 0 C--O 1.236 0.35 0 C-N-CA 122.335 0.254 . . . . 0.0 111.586 -178.217 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.3 t -60.69 -41.94 90.11 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.573 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.879 -179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -58.86 -37.33 76.26 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -73.38 -41.69 63.08 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -179.04 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.55 ' O ' HD12 ' A' ' 77' ' ' LEU . 15.4 t -85.42 -16.78 9.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.235 0.457 . . . . 0.0 112.235 -176.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 88.4 p -90.74 -23.88 20.55 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-O 121.243 0.544 . . . . 0.0 110.176 178.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 76' ' ' ARG . 34.6 ttp180 -117.93 22.34 12.32 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.167 -178.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.55 HD12 ' O ' ' A' ' 74' ' ' VAL . 0.0 OUTLIER -64.25 145.1 98.35 Favored Pre-proline 0 C--N 1.317 -0.829 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.247 -178.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -61.3 127.97 23.61 Favored 'Trans proline' 0 C--O 1.237 0.465 0 C-N-CA 122.438 2.092 . . . . 0.0 111.632 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -78.48 6.13 9.23 Favored 'General case' 0 CA--C 1.51 -0.567 0 CA-C-O 121.396 0.617 . . . . 0.0 111.881 -177.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.73 -15.44 80.75 Favored Glycine 0 C--N 1.297 -1.598 0 CA-C-N 115.036 -0.984 . . . . 0.0 110.903 178.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.9 m -86.37 -7.91 58.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 109.493 -0.558 . . . . 0.0 109.493 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 11.8 m-20 70.13 122.91 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 124.141 0.977 . . . . 0.0 112.614 178.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 5.5 p -66.77 -36.07 81.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.447 178.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 19.6 m -67.06 -19.5 65.68 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.746 178.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -85.72 -21.64 28.18 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.72 177.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.424 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 3.1 m-85 -78.41 -169.41 1.66 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.089 178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.98 31.19 0.11 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.114 -178.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.425 HE22 ' C ' ' A' ' 34' ' ' VAL . 87.8 mm-40 -89.65 -60.12 2.03 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.162 0.506 . . . . 0.0 110.145 178.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -76.69 -37.1 56.74 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.277 0.56 . . . . 0.0 110.155 179.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.82 5.38 25.31 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.705 -0.68 . . . . 0.0 111.571 -179.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.4 t -52.17 -39.42 60.02 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-O 121.03 0.443 . . . . 0.0 110.794 -178.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.497 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 3.3 m -58.37 -53.19 61.15 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.437 -178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.88 -22.6 53.21 Favored 'General case' 0 CA--C 1.513 -0.465 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.873 -176.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.599 ' O ' HG11 ' A' ' 120' ' ' VAL . 78.1 mt -82.77 -45.86 13.84 Favored 'General case' 0 C--N 1.315 -0.934 0 C-N-CA 120.885 -0.326 . . . . 0.0 111.346 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -70.79 -43.45 68.67 Favored 'General case' 0 C--N 1.321 -0.661 0 N-CA-C 112.138 0.421 . . . . 0.0 112.138 -176.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 65.49 88.4 0.11 Allowed 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 121.235 0.54 . . . . 0.0 110.394 -175.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.77 0.74 46.06 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.787 179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.34 -13.81 31.84 Favored Glycine 0 C--O 1.227 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.999 -179.123 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.5 HG12 HE22 ' A' ' 194' ' ' GLN . 3.5 t -101.07 28.85 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.317 -0.839 0 CA-C-O 121.461 0.648 . . . . 0.0 109.982 -178.224 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.421 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.7 pt? -122.95 172.56 8.4 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.235 -179.505 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.408 ' HB2' ' O ' ' A' ' 193' ' ' GLY . 37.0 t30 -73.84 99.61 3.25 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 109.702 -0.481 . . . . 0.0 109.702 178.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.74 -17.76 64.11 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 47.1 t -70.89 -30.56 66.95 Favored 'General case' 0 N--CA 1.436 -1.172 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.423 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -68.96 -35.37 76.68 Favored 'General case' 0 N--CA 1.449 -0.509 0 CA-C-N 115.898 -0.592 . . . . 0.0 109.722 178.65 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 43.1 mm -67.82 -35.46 72.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.753 176.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -78.53 -24.09 45.89 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.63 178.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 94.7 m -75.18 -60.72 2.17 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.643 -0.253 . . . . 0.0 111.276 -179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.423 HD23 ' O ' ' A' ' 104' ' ' ASN . 1.7 pt? -121.4 -21.17 6.38 Favored 'General case' 0 C--N 1.327 -0.384 0 C-N-CA 120.268 -0.573 . . . . 0.0 111.772 -179.135 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.536 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -53.07 -61.07 7.26 Favored Glycine 0 CA--C 1.52 0.399 0 C-N-CA 121.097 -0.573 . . . . 0.0 113.769 -176.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 5.0 p -82.58 -15.0 53.85 Favored 'General case' 0 C--N 1.308 -1.231 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.0 mpt_? -87.95 -60.06 2.07 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.156 0.428 . . . . 0.0 112.156 -179.148 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 68.9 t -78.02 -58.21 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.706 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.334 -176.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.536 HD23 ' HA2' ' A' ' 109' ' ' GLY . 0.7 OUTLIER -69.34 -26.77 64.86 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.011 0.434 . . . . 0.0 110.03 -179.15 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 34.7 t 45.34 -105.0 0.09 Allowed 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 114.925 -1.034 . . . . 0.0 113.471 175.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -47.96 -36.27 12.23 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.67 0.788 . . . . 0.0 112.635 -176.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 120' ' ' VAL . 25.7 tp -59.27 -62.37 1.93 Allowed 'General case' 0 N--CA 1.441 -0.898 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.278 -179.018 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.531 HD12 ' CA ' ' A' ' 109' ' ' GLY . 45.8 mt -79.99 -22.89 41.99 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.406 0.521 . . . . 0.0 112.406 -176.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 8.5 m-80 -62.96 -44.2 96.71 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.006 0.432 . . . . 0.0 109.957 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.79 -34.65 72.24 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.473 -0.87 . . . . 0.0 111.318 177.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.599 HG11 ' O ' ' A' ' 94' ' ' LEU . 53.0 t -69.28 -39.76 79.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.748 0.308 . . . . 0.0 111.204 179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.445 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 34.0 t -57.04 -35.91 69.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.837 -179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 9.3 m -83.72 -39.33 20.26 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.96 179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.97 -72.91 0.44 Allowed 'General case' 0 CA--C 1.545 0.756 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -176.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.514 ' HB2' HD12 ' A' ' 129' ' ' ILE . . . -70.54 -47.87 58.21 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 120.925 0.393 . . . . 0.0 111.847 -176.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.445 ' HB3' ' O ' ' A' ' 121' ' ' SER . 27.0 tt0 -71.01 -24.53 62.39 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 115.785 -0.643 . . . . 0.0 109.793 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.11 -66.34 1.4 Allowed Glycine 0 N--CA 1.444 -0.825 0 CA-C-N 115.779 -0.646 . . . . 0.0 113.768 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 53.2 mt -109.34 -24.58 10.99 Favored 'General case' 0 C--N 1.331 -0.209 0 O-C-N 122.621 -0.341 . . . . 0.0 111.898 -174.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.86 104.08 1.74 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.612 -178.564 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.514 HD12 ' HB2' ' A' ' 124' ' ' ALA . 13.8 mt -79.58 136.38 23.71 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.865 0 CA-C-O 120.591 0.234 . . . . 0.0 111.483 -178.725 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 83.9 m-20 -121.63 129.12 52.59 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.902 175.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.488 ' HB ' HG11 ' A' ' 136' ' ' VAL . 24.5 t -82.2 168.74 1.74 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 179.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.466 ' N ' HG12 ' A' ' 131' ' ' VAL . 24.1 t70 -59.38 137.19 58.08 Favored 'General case' 0 C--O 1.241 0.657 0 CA-C-O 121.305 0.574 . . . . 0.0 111.238 -178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 13.6 m -58.33 -23.07 55.49 Favored 'General case' 0 C--O 1.238 0.468 0 CA-C-N 115.11 -0.95 . . . . 0.0 112.824 -176.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.28 -41.08 99.74 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.733 -177.261 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.2 p -106.49 -45.55 4.23 Favored 'General case' 0 C--N 1.317 -0.832 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -176.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.565 ' O ' HG12 ' A' ' 140' ' ' ILE . 10.8 p -78.76 -55.4 9.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 N-CA-C 112.791 0.663 . . . . 0.0 112.791 -173.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.456 ' N ' HG13 ' A' ' 136' ' ' VAL . 8.7 tt0 -59.62 -44.26 93.51 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.116 0.413 . . . . 0.0 112.116 -175.524 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.5 p -56.22 -41.87 76.34 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.996 -178.364 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -84.83 -49.8 8.1 Favored 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -177.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.565 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.7 pt -62.05 -33.37 58.02 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.884 0 N-CA-C 112.812 0.671 . . . . 0.0 112.812 -175.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 49.9 m -60.71 -29.59 69.43 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.033 0.383 . . . . 0.0 112.033 -178.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.6 m -83.94 -32.99 24.76 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-O 121.118 0.485 . . . . 0.0 110.94 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.616 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -87.84 -27.78 22.03 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.991 -0.55 . . . . 0.0 112.201 -176.689 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.767 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 34.7 t -62.5 -17.47 59.76 Favored 'General case' 0 C--N 1.319 -0.756 0 C-N-CA 123.339 0.656 . . . . 0.0 111.727 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.3 m -47.4 -19.7 0.18 Allowed 'General case' 0 CA--C 1.55 0.974 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -65.37 -10.15 30.91 Favored 'General case' 0 CA--C 1.534 0.331 0 CA-C-O 120.58 0.229 . . . . 0.0 111.472 179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.767 ' HG ' ' O ' ' A' ' 144' ' ' SER . 77.8 mt -59.18 -30.06 67.91 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.04 0.447 . . . . 0.0 110.026 177.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 24.3 m -66.7 -39.4 88.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-N 115.899 -0.591 . . . . 0.0 109.844 177.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 3.6 m -66.1 -33.0 74.8 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 121.567 0.698 . . . . 0.0 109.168 177.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.8 t -68.17 -14.37 62.93 Favored 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.18 178.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.2 m -104.01 -46.29 4.5 Favored 'General case' 0 CA--C 1.535 0.404 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.523 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 35.1 t -153.37 148.71 27.04 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 44.4 m -81.68 39.23 0.54 Allowed 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 121.247 0.546 . . . . 0.0 110.967 -179.16 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -74.83 -18.98 60.37 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.286 179.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 21.1 m -57.87 113.41 1.85 Allowed 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.758 179.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 71.2 m-85 61.21 23.18 13.42 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.285 179.725 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 38.0 m 56.81 69.12 0.77 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.254 -179.066 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 53.1 15.09 0.55 Allowed 'General case' 0 N--CA 1.486 1.334 0 C-N-CA 125.404 1.482 . . . . 0.0 113.852 178.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -99.8 10.95 40.45 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.572 0.701 . . . . 0.0 109.667 177.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 2.4 p -69.58 -33.03 72.13 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.008 -0.996 . . . . 0.0 111.523 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.42 ' HA ' ' O ' ' A' ' 175' ' ' PRO . . . -82.58 7.26 15.09 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.844 -178.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 47.2 m -89.11 156.27 18.93 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 72.0 m -70.82 82.43 0.64 Allowed 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.097 0.475 . . . . 0.0 111.899 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 25.8 m -58.78 124.43 19.76 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.301 176.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 50.0 m 68.58 4.86 4.53 Favored 'General case' 0 CA--C 1.537 0.472 0 O-C-N 123.641 0.588 . . . . 0.0 111.369 -178.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 87.53 41.95 6.3 Favored Glycine 0 N--CA 1.438 -1.192 0 C-N-CA 120.458 -0.877 . . . . 0.0 111.894 179.48 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -56.51 -60.55 3.37 Favored 'General case' 0 C--O 1.234 0.28 0 CA-C-O 120.772 0.32 . . . . 0.0 110.991 179.079 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 79.35 -64.85 3.72 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.024 179.7 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 35.0 p90 -114.38 137.91 51.22 Favored 'General case' 0 N--CA 1.438 -1.07 0 CA-C-O 120.98 0.419 . . . . 0.0 110.518 -179.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 20.1 m -154.38 76.39 1.03 Allowed 'General case' 0 C--N 1.307 -1.28 0 N-CA-C 108.483 -0.932 . . . . 0.0 108.483 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 69.63 -171.95 40.13 Favored Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 111.08 -0.808 . . . . 0.0 111.08 -176.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_exo -70.11 -17.52 35.95 Favored 'Trans proline' 0 C--N 1.33 -0.403 0 C-N-CA 122.484 2.122 . . . . 0.0 111.252 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.51 ' HA ' ' HA3' ' A' ' 189' ' ' GLY . 46.6 t -75.48 -65.49 0.89 Allowed 'General case' 0 N--CA 1.444 -0.746 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.214 -178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 135.69 174.08 13.26 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.806 -0.711 . . . . 0.0 111.43 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.42 ' O ' ' HA ' ' A' ' 161' ' ' ALA . 73.5 Cg_exo -55.45 99.92 0.07 OUTLIER 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.094 2.529 . . . . 0.0 113.621 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 18.5 m 41.82 71.61 0.2 Allowed 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 113.565 0.95 . . . . 0.0 113.565 175.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 15.1 t -135.4 168.55 19.0 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 178.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 175.35 -165.28 36.14 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.6 -0.81 . . . . 0.0 112.473 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.453 ' HD2' HD13 ' A' ' 25' ' ' LEU . 53.6 Cg_endo -70.68 -26.86 22.79 Favored 'Trans proline' 0 CA--C 1.528 0.199 0 C-N-CA 122.918 2.412 . . . . 0.0 113.559 -178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 27.0 t 54.96 74.57 0.35 Allowed 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.048 0.451 . . . . 0.0 110.526 -178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 144.13 -89.17 0.17 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 121.031 -0.604 . . . . 0.0 111.897 -178.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 183' ' ' PRO . 75.6 m-85 -117.16 118.09 36.21 Favored Pre-proline 0 C--N 1.318 -0.8 0 O-C-N 122.874 -0.192 . . . . 0.0 110.895 179.543 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 182' ' ' TYR . 14.2 Cg_exo -70.72 124.79 11.01 Favored 'Trans proline' 0 N--CA 1.459 -0.507 0 C-N-CA 122.31 2.007 . . . . 0.0 111.223 176.788 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.419 ' C ' ' H ' ' A' ' 186' ' ' LEU . . . 137.14 -62.08 0.59 Allowed Glycine 0 N--CA 1.447 -0.585 0 C-N-CA 120.141 -1.028 . . . . 0.0 113.386 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.7 34.93 0.13 Allowed 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 123.51 2.806 . . . . 0.0 114.069 -179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.419 ' H ' ' C ' ' A' ' 184' ' ' GLY . 91.9 mt 68.92 135.42 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.949 0.88 . . . . 0.0 112.789 178.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.575 ' H ' ' HB2' ' A' ' 190' ' ' ALA . . . -152.67 -171.77 20.47 Favored Glycine 0 N--CA 1.429 -1.771 0 N-CA-C 109.982 -1.247 . . . . 0.0 109.982 177.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -57.07 109.35 1.63 Allowed Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.102 178.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.51 ' HA3' ' HA ' ' A' ' 173' ' ' SER . . . 72.48 32.77 61.74 Favored Glycine 0 N--CA 1.441 -1.003 0 C-N-CA 121.023 -0.608 . . . . 0.0 113.108 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.575 ' HB2' ' H ' ' A' ' 187' ' ' GLY . . . -75.46 156.14 85.37 Favored Pre-proline 0 C--O 1.238 0.5 0 CA-C-N 116.645 0.223 . . . . 0.0 110.505 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.436 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 6.2 Cg_exo -76.69 152.08 32.75 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 122.485 2.123 . . . . 0.0 111.896 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 66.8 m-85 -82.55 -21.12 35.45 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 101' ' ' ASN . . . -103.05 45.3 1.35 Allowed Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.866 -0.893 . . . . 0.0 110.866 177.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.5 HE22 HG12 ' A' ' 99' ' ' VAL . 56.4 tp60 -81.16 144.96 31.27 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 120.854 0.359 . . . . 0.0 111.008 -178.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 34.3 t -99.9 154.51 18.3 Favored 'General case' 0 C--O 1.243 0.763 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.436 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -74.41 94.48 0.83 Allowed Glycine 0 N--CA 1.437 -1.246 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.037 -178.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 77.8 t80 -98.93 -48.21 4.98 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-O 121.021 0.439 . . . . 0.0 110.08 179.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -85.1 -21.61 54.69 Favored Glycine 0 N--CA 1.445 -0.754 0 C-N-CA 120.728 -0.748 . . . . 0.0 111.291 178.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.519 -1.156 . . . . 0.0 111.117 179.435 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.511 -0.542 0 CA-C-O 120.65 0.262 . . . . 0.0 110.389 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -148.19 137.29 6.38 Favored Glycine 0 N--CA 1.439 -1.122 0 C-N-CA 120.489 -0.862 . . . . 0.0 111.883 178.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -66.13 120.68 7.86 Favored 'Trans proline' 0 N--CA 1.456 -0.706 0 C-N-CA 122.163 1.909 . . . . 0.0 111.088 178.669 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -63.58 118.77 8.67 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.349 -179.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 50.68 -135.33 29.5 Favored Glycine 0 C--N 1.334 0.468 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.821 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -105.77 15.66 44.62 Favored Glycine 0 N--CA 1.438 -1.206 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 177.567 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -69.91 -52.95 20.33 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.325 -0.437 . . . . 0.0 110.117 179.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 63.2 70.22 1.11 Allowed Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.363 -178.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -63.21 -171.68 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 -176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.7 p 54.31 88.04 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.742 0.817 . . . . 0.0 111.531 -175.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.16 148.12 40.49 Favored Glycine 0 C--N 1.336 0.572 0 CA-C-N 115.423 -0.808 . . . . 0.0 113.391 -176.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.51 -40.95 86.12 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 121.62 -0.324 . . . . 0.0 113.153 -178.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.433 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -60.1 -35.73 75.88 Favored 'General case' 0 N--CA 1.467 0.414 0 CA-C-O 120.998 0.428 . . . . 0.0 111.247 -179.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.515 ' O ' HG23 ' A' ' 18' ' ' ILE . 24.9 t -74.84 -22.08 58.9 Favored 'General case' 0 N--CA 1.442 -0.854 0 CA-C-N 116.231 -0.441 . . . . 0.0 111.113 -178.62 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -63.99 -22.51 66.96 Favored 'General case' 0 N--CA 1.465 0.294 0 N-CA-C 112.127 0.417 . . . . 0.0 112.127 -178.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.9 12.67 Favored Glycine 0 N--CA 1.443 -0.88 0 C-N-CA 120.062 -1.065 . . . . 0.0 112.164 178.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 4.1 pp -84.37 -32.73 24.05 Favored 'General case' 0 C--O 1.219 -0.533 0 N-CA-C 112.698 0.629 . . . . 0.0 112.698 -177.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.515 HG23 ' O ' ' A' ' 14' ' ' SER . 10.0 pt -44.16 -51.91 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 -175.012 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.617 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 3.9 m -67.81 -20.61 65.2 Favored 'General case' 0 C--N 1.307 -1.243 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -176.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.529 ' HA ' ' HG3' ' A' ' 172' ' ' PRO . 79.0 mtt180 -89.24 -24.51 22.08 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 113.44 0.904 . . . . 0.0 113.44 -176.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.537 HG11 ' HB3' ' A' ' 100' ' ' LEU . 0.1 OUTLIER -72.33 -162.47 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 N-CA-C 113.011 0.745 . . . . 0.0 113.011 -173.063 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -46.13 -37.42 6.91 Favored 'General case' 0 N--CA 1.472 0.637 0 N-CA-C 113.754 1.02 . . . . 0.0 113.754 -176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.566 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 0.7 OUTLIER -64.84 -24.95 67.7 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.582 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.617 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.44 -53.46 56.23 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.169 0.509 . . . . 0.0 109.66 177.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 31.6 tp -66.07 -33.82 76.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.28 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.46 -34.72 71.18 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 115.846 -0.616 . . . . 0.0 110.562 179.083 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 53.31 17.94 1.16 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.355 0.662 . . . . 0.0 111.904 178.477 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 7.5 m -76.31 157.61 32.31 Favored 'General case' 0 N--CA 1.435 -1.21 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.294 -176.145 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 16.0 m -62.22 -16.87 56.12 Favored 'General case' 0 C--O 1.216 -0.694 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.338 -178.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.3 p -54.06 -34.54 60.35 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.944 0.72 . . . . 0.0 112.944 -177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.523 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.6 pt? -112.28 -18.29 12.55 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.318 0.58 . . . . 0.0 110.126 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.2 tpt85 -79.0 -43.76 23.67 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.147 -174.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.465 HG23 HG23 ' A' ' 34' ' ' VAL . 7.6 t -164.44 -37.75 0.03 OUTLIER 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 112.953 0.723 . . . . 0.0 112.953 -175.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.465 HG23 HG23 ' A' ' 33' ' ' THR . 98.1 t -88.38 143.42 11.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 -178.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.462 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.1 pt? -54.39 140.12 34.82 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.114 0.483 . . . . 0.0 111.489 -179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.457 ' NH1' ' HB3' ' A' ' 94' ' ' LEU . 2.0 ptm180 -58.88 154.1 15.83 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-N 115.42 -0.809 . . . . 0.0 111.794 -179.337 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.502 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 0.8 OUTLIER -70.07 124.13 23.31 Favored 'General case' 0 N--CA 1.434 -1.239 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.237 177.895 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.8 40.77 64.21 Favored Glycine 0 N--CA 1.442 -0.95 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 -176.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.402 ' HA ' ' HG3' ' A' ' 36' ' ' ARG . 8.4 p -47.4 149.64 0.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.43 0 C-N-CA 123.704 0.802 . . . . 0.0 112.523 -178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.616 ' O ' HG13 ' A' ' 43' ' ' ILE . 8.6 m -69.86 127.63 33.57 Favored 'General case' 0 N--CA 1.436 -1.158 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.244 -179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.438 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.1 pt20 -61.53 -14.03 26.22 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.025 0.44 . . . . 0.0 111.115 179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 94.1 mt-30 -63.86 -32.0 73.37 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.972 179.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.616 HG13 ' O ' ' A' ' 40' ' ' SER . 2.5 pp -83.76 -35.52 11.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-O 120.913 0.387 . . . . 0.0 110.869 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.71 -72.49 0.46 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.446 -179.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.3 m 76.01 -19.62 0.4 Allowed 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.155 0.982 . . . . 0.0 111.969 178.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 20.0 p -68.18 -88.35 0.01 OUTLIER 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 116.051 -0.522 . . . . 0.0 112.236 -178.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.426 ' HB ' HD21 ' A' ' 65' ' ' ASN . 30.0 m -126.62 -32.44 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 120.793 0.33 . . . . 0.0 111.634 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.609 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.7 p -79.31 91.01 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.722 0 CA-C-O 121.726 0.774 . . . . 0.0 111.271 -178.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.496 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.6 mt-30 -83.04 -68.58 0.69 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.335 -0.848 . . . . 0.0 110.732 178.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.519 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 26.0 ttp180 -108.46 -3.06 18.5 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.425 178.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.13 -55.76 0.6 Allowed 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 123.109 0.564 . . . . 0.0 109.85 -173.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.533 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -67.29 142.31 56.9 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.265 176.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.526 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 22.3 mp0 -46.89 -51.16 17.42 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 115.124 1.527 . . . . 0.0 115.124 -171.088 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.9 m -46.54 -62.88 1.17 Allowed 'General case' 0 N--CA 1.476 0.863 0 N-CA-C 113.687 0.995 . . . . 0.0 113.687 -172.409 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.514 ' HB3' ' HD3' ' A' ' 50' ' ' ARG . 28.8 tp -86.65 -27.6 23.7 Favored 'General case' 0 C--N 1.315 -0.9 0 C-N-CA 120.736 -0.386 . . . . 0.0 112.036 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.519 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.56 -20.58 39.62 Favored 'General case' 0 CA--C 1.513 -0.447 0 N-CA-C 113.744 1.016 . . . . 0.0 113.744 -175.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.435 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 6.2 t -62.91 89.04 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.602 0.715 . . . . 0.0 111.466 -176.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.402 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.7 t -113.18 -36.43 5.05 Favored 'General case' 0 N--CA 1.435 -1.207 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.785 178.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.402 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.88 18.57 10.99 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.095 178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.06 68.05 1.13 Allowed Glycine 0 N--CA 1.44 -1.074 0 C-N-CA 120.144 -1.027 . . . . 0.0 111.95 -177.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 58.6 t -89.45 103.2 13.85 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.899 0 N-CA-C 109.334 -0.617 . . . . 0.0 109.334 178.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -151.3 14.04 0.68 Allowed 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.454 -0.793 . . . . 0.0 110.065 -177.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.497 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 134.85 -47.95 0.96 Allowed Glycine 0 C--N 1.28 -2.583 0 N-CA-C 110.309 -1.116 . . . . 0.0 110.309 -175.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.469 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 92.8 m-20 -62.7 -65.34 0.7 Allowed 'General case' 0 C--O 1.219 -0.539 0 CA-C-N 115.498 -0.351 . . . . 0.0 110.489 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.426 HD21 ' HB ' ' A' ' 47' ' ' VAL . 66.2 t30 -84.71 4.23 33.62 Favored 'General case' 0 C--O 1.219 -0.533 0 CA-C-O 121.473 0.654 . . . . 0.0 109.951 178.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.497 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 52.9 tp -88.88 -67.14 0.86 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.945 178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.77 -38.56 58.21 Favored 'General case' 0 CA--C 1.509 -0.613 0 CA-C-O 121.544 0.688 . . . . 0.0 110.137 -179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 94.5 mtt180 -100.91 162.2 13.07 Favored 'General case' 0 N--CA 1.433 -1.292 0 CA-C-N 115.298 -0.864 . . . . 0.0 108.815 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 67.77 -62.28 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 O-C-N 123.664 0.602 . . . . 0.0 111.819 -178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.609 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -61.48 -62.43 1.82 Allowed 'General case' 0 C--O 1.235 0.342 0 C-N-CA 122.664 0.386 . . . . 0.0 111.356 -179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.4 t -63.0 -39.23 84.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.427 179.623 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.465 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 85.1 mm-40 -60.94 -47.3 87.06 Favored 'General case' 0 C--O 1.216 -0.701 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.548 -179.096 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.45 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -55.21 -39.81 70.09 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 32.3 t -86.41 -34.27 7.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 CA-C-O 120.959 0.409 . . . . 0.0 111.306 -179.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 13.9 t -71.97 -26.5 62.28 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.028 0.442 . . . . 0.0 110.592 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.465 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 17.6 mmt180 -101.02 9.25 42.41 Favored 'General case' 0 CA--C 1.513 -0.472 0 CA-C-O 121.456 0.646 . . . . 0.0 109.747 179.501 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.481 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 9.9 tt -82.02 124.61 78.78 Favored Pre-proline 0 C--N 1.305 -1.336 0 CA-C-N 115.089 -0.96 . . . . 0.0 109.91 -179.081 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 13.0 Cg_exo -71.62 128.02 13.85 Favored 'Trans proline' 0 C--O 1.236 0.39 0 C-N-CA 122.593 2.195 . . . . 0.0 111.265 179.231 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.34 63.84 3.63 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.043 0.449 . . . . 0.0 111.383 -178.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.62 -28.62 68.99 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.724 -0.751 . . . . 0.0 111.349 178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 24.1 m -92.25 -5.4 52.49 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 177.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.6 t70 76.71 157.04 0.18 Allowed 'General case' 0 N--CA 1.472 0.649 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.517 -177.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 17.0 p -62.02 -32.64 73.15 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.513 -179.031 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 11.0 m -59.08 -27.16 65.29 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.191 -0.459 . . . . 0.0 111.913 -178.437 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -78.14 -22.27 49.03 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-O 121.034 0.445 . . . . 0.0 110.932 -179.87 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -85.38 -170.03 2.93 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.897 -0.592 . . . . 0.0 110.004 177.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.415 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -77.74 44.54 0.46 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 120.853 0.359 . . . . 0.0 110.813 -179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.408 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 8.2 tp-100 -89.62 -61.46 1.69 Allowed 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.765 -177.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -74.18 -26.79 60.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.963 -178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.493 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.2 m-85 -78.13 3.83 14.06 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.678 -178.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 46.1 t -50.45 -40.28 50.19 Favored 'General case' 0 CA--C 1.536 0.439 0 O-C-N 123.355 0.409 . . . . 0.0 111.638 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.566 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 15.2 m -57.29 -49.46 76.02 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.74 -23.82 36.45 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.693 -176.769 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.493 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 83.3 mt -84.63 -29.97 25.3 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 112.301 0.482 . . . . 0.0 112.301 -178.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -81.14 -38.49 27.1 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.605 0.241 . . . . 0.0 110.496 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 13.0 m120 63.99 91.89 0.07 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.03 179.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -89.31 -10.84 45.27 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.375 178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 74.88 4.38 71.41 Favored Glycine 0 N--CA 1.459 0.227 0 CA-C-N 115.773 -0.649 . . . . 0.0 113.525 178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 p -100.39 -14.05 8.01 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.262 0 CA-C-O 121.639 0.733 . . . . 0.0 109.076 177.285 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.537 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.7 pp -81.64 -179.26 7.31 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 114.549 -1.205 . . . . 0.0 112.057 -174.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.42 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 44.1 t30 -68.45 110.73 4.29 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.072 -176.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.95 -26.4 65.04 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.752 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 87.8 p -73.99 -27.66 61.09 Favored 'General case' 0 C--O 1.217 -0.636 0 C-N-CA 120.386 -0.526 . . . . 0.0 110.055 -178.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 10.5 t30 -62.52 -46.74 87.05 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.101 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.8 mp -72.08 -31.5 40.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.093 -179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -70.59 -43.09 70.1 Favored 'General case' 0 C--N 1.304 -1.377 0 C-N-CA 119.928 -0.709 . . . . 0.0 110.021 176.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 93.2 m -71.27 -56.04 6.83 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 112.581 0.585 . . . . 0.0 112.581 -175.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.433 ' CD2' ' HB3' ' A' ' 13' ' ' ALA . 4.4 pp -115.55 -13.31 11.55 Favored 'General case' 0 C--N 1.317 -0.826 0 C-N-CA 119.732 -0.787 . . . . 0.0 112.823 -176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.552 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -65.61 -65.2 3.0 Favored Glycine 0 C--N 1.308 -0.974 0 C-N-CA 120.085 -1.055 . . . . 0.0 112.254 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 14.5 p -73.79 -19.5 60.74 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.802 0.335 . . . . 0.0 111.641 -178.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mpt_? -87.42 -58.23 2.66 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 74.2 t -81.2 -54.8 9.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.254 -175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.552 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 7.6 mp -67.35 -45.2 77.07 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 177.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 3.0 t 46.03 -89.69 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.096 1.359 . . . . 0.0 113.686 174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.47 -35.27 73.76 Favored 'General case' 0 C--O 1.233 0.223 0 C-N-CA 122.533 0.333 . . . . 0.0 111.57 -177.486 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 68.4 tp -61.96 -50.23 72.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.492 179.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.496 ' O ' ' HB2' ' A' ' 121' ' ' SER . 17.4 mt -68.95 -24.16 64.23 Favored 'General case' 0 C--O 1.214 -0.801 0 N-CA-C 112.291 0.478 . . . . 0.0 112.291 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.5 m-80 -66.18 -36.79 84.01 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.554 177.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.33 -39.44 7.83 Favored Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.695 -0.764 . . . . 0.0 111.808 178.011 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.478 ' HA ' ' HB3' ' A' ' 123' ' ' ALA . 83.1 t -70.16 -22.99 24.65 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 120.619 0.247 . . . . 0.0 111.322 -179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 117' ' ' LEU . 28.9 t -55.16 -44.03 74.81 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.064 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.1 p -84.39 -23.2 30.18 Favored 'General case' 0 N--CA 1.444 -0.763 0 CA-C-O 121.119 0.485 . . . . 0.0 110.608 179.456 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.509 ' CB ' ' HD2' ' A' ' 50' ' ' ARG . . . -83.43 -97.48 0.05 Allowed 'General case' 0 N--CA 1.447 -0.581 0 CA-C-N 115.588 -0.733 . . . . 0.0 112.892 -176.332 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.07 -41.03 67.85 Favored 'General case' 0 CA--C 1.511 -0.548 0 CA-C-O 120.762 0.315 . . . . 0.0 111.769 -175.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.48 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 34.2 tt0 -65.13 -42.45 93.86 Favored 'General case' 0 C--N 1.31 -1.133 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.767 -178.535 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.62 -48.24 4.81 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 114.847 0.699 . . . . 0.0 114.847 -175.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -112.67 -24.72 9.48 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 117.436 0.618 . . . . 0.0 112.246 -175.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.65 99.05 0.5 Allowed Glycine 0 C--N 1.312 -0.78 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -176.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.533 HG23 ' HB2' ' A' ' 52' ' ' ALA . 34.6 mm -86.63 139.5 17.26 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.052 0 CA-C-O 121.025 0.44 . . . . 0.0 112.176 -176.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 58.5 t30 -116.59 135.43 53.81 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.743 178.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 132' ' ' ASP . 18.5 t -86.2 173.06 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 177.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.506 ' H ' HG12 ' A' ' 131' ' ' VAL . 30.4 t70 -58.97 145.5 41.41 Favored 'General case' 0 C--O 1.244 0.803 0 CA-C-O 121.174 0.512 . . . . 0.0 111.384 -179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.561 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 47.8 m -64.04 -22.19 66.83 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.342 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -48.57 -69.07 1.05 Allowed Glycine 0 CA--C 1.52 0.392 0 O-C-N 123.37 0.419 . . . . 0.0 114.133 -177.214 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.3 m -99.42 -34.91 10.09 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 112.755 0.65 . . . . 0.0 112.755 -176.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.431 ' O ' HG12 ' A' ' 140' ' ' ILE . 86.5 t -83.18 -62.61 1.41 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -173.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.561 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 8.8 tp-100 -56.82 -45.97 81.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.353 0.501 . . . . 0.0 112.353 -175.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 53.7 m -54.62 -38.92 67.39 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 112.101 0.408 . . . . 0.0 112.101 -178.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -83.36 -48.33 10.5 Favored 'General case' 0 C--N 1.319 -0.754 0 N-CA-C 112.062 0.393 . . . . 0.0 112.062 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' A' ' 137' ' ' GLN . 43.9 pt -65.7 -27.63 41.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.4 p -67.45 -48.59 66.78 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -178.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 17.1 m -84.27 -20.22 32.55 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 112.329 0.492 . . . . 0.0 112.329 -177.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.496 ' HA ' HD13 ' A' ' 147' ' ' LEU . 42.1 t -85.54 -20.16 30.04 Favored 'General case' 0 C--N 1.318 -0.803 0 N-CA-C 112.749 0.648 . . . . 0.0 112.749 -176.818 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 11.6 p -72.2 -65.4 0.78 Allowed 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 113.775 1.028 . . . . 0.0 113.775 -174.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 32.1 t -86.05 -34.59 20.68 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 113.318 0.858 . . . . 0.0 113.318 -173.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 44.0 t80 -66.01 -27.03 67.82 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -174.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.496 HD13 ' HA ' ' A' ' 143' ' ' SER . 11.0 mp -78.22 -62.67 1.61 Allowed 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -177.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 22.8 t -91.52 -66.41 0.93 Allowed 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 52.6 p -87.0 54.47 3.19 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -174.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 25.7 p -101.49 171.02 7.82 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.042 0.449 . . . . 0.0 111.223 179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 19.3 m -84.8 11.0 9.98 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.393 -178.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 21.9 t -139.44 174.7 10.24 Favored 'General case' 0 C--N 1.317 -0.839 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.557 ' CB ' ' HB3' ' A' ' 158' ' ' GLN . 50.5 m -95.73 128.85 42.95 Favored 'General case' 0 C--N 1.31 -1.149 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 179.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -96.26 -96.76 0.19 Allowed 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -176.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 11.4 p -98.13 101.7 13.24 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 -176.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 2.9 t80 56.9 19.55 4.62 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.021 177.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.502 ' HB3' ' OG ' ' A' ' 176' ' ' SER . 10.8 m -74.1 -29.33 61.8 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.7 -176.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.557 ' HB3' ' CB ' ' A' ' 153' ' ' SER . 18.8 pt20 -89.1 1.39 55.66 Favored 'General case' 0 C--N 1.313 -1.006 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.247 -177.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -103.05 28.59 6.13 Favored 'General case' 0 C--N 1.317 -0.806 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.599 179.229 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 8.7 t 65.58 74.43 0.37 Allowed 'General case' 0 C--O 1.237 0.414 0 CA-C-N 114.889 -1.051 . . . . 0.0 110.211 -179.081 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.465 ' O ' ' HB ' ' A' ' 177' ' ' THR . . . -104.35 78.43 1.49 Allowed 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 115.258 -0.883 . . . . 0.0 110.473 -178.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 11.3 p -95.25 25.3 4.4 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.291 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 66.4 m 67.41 -49.01 0.5 Allowed 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.186 0.995 . . . . 0.0 112.557 -179.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 9.8 t -63.58 -32.41 73.87 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.938 0.399 . . . . 0.0 110.742 179.391 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.0 m -92.94 0.07 57.33 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.169 0.509 . . . . 0.0 110.063 178.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 120.96 164.84 12.5 Favored Glycine 0 N--CA 1.439 -1.12 0 N-CA-C 111.132 -0.787 . . . . 0.0 111.132 -177.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 170' ' ' THR . . . -139.18 20.77 2.6 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.01 0.433 . . . . 0.0 110.798 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 70.47 -84.84 0.34 Allowed Glycine 0 N--CA 1.449 -0.454 0 CA-C-N 115.655 -0.702 . . . . 0.0 112.794 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -105.43 -39.2 6.22 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.396 0.617 . . . . 0.0 109.823 -177.697 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.462 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 2.2 p -83.52 -179.86 7.46 Favored 'General case' 0 N--CA 1.435 -1.209 0 CA-C-N 115.084 -0.962 . . . . 0.0 111.079 -179.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -122.2 -83.46 0.67 Allowed Glycine 0 C--N 1.316 -0.58 0 C-N-CA 120.657 -0.782 . . . . 0.0 112.037 179.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.529 ' HG3' ' HA ' ' A' ' 20' ' ' ARG . 10.6 Cg_endo -58.07 -53.32 4.41 Favored 'Trans proline' 0 CA--C 1.53 0.284 0 C-N-CA 123.039 2.493 . . . . 0.0 112.043 179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 5.3 p -148.42 156.63 42.73 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.014 178.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 169.08 -58.58 0.2 Allowed Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 111.461 -0.656 . . . . 0.0 111.461 -177.019 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.4 -156.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.17 1.913 . . . . 0.0 111.194 175.039 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.502 ' OG ' ' HB3' ' A' ' 157' ' ' SER . 9.5 p -77.4 36.96 0.2 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 121.122 0.487 . . . . 0.0 111.487 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.465 ' HB ' ' O ' ' A' ' 161' ' ' ALA . 9.4 t -100.02 152.42 20.22 Favored 'General case' 0 C--N 1.315 -0.904 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.731 -177.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 79.07 -139.07 21.53 Favored Glycine 0 N--CA 1.443 -0.852 0 C-N-CA 120.823 -0.703 . . . . 0.0 112.925 177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 182' ' ' TYR . 17.1 Cg_exo -70.9 40.55 0.36 Allowed 'Trans proline' 0 CA--C 1.535 0.526 0 C-N-CA 123.616 2.877 . . . . 0.0 113.533 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 32.9 p -72.54 -46.08 56.22 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -126.06 -1.91 7.29 Favored Glycine 0 N--CA 1.442 -0.965 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.387 177.068 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.448 ' O ' ' HA ' ' A' ' 179' ' ' PRO . 4.3 m-85 -121.61 90.54 48.13 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.934 -0.395 . . . . 0.0 109.934 -179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -83.95 125.62 3.69 Favored 'Trans proline' 0 N--CA 1.448 -1.171 0 C-N-CA 122.098 1.865 . . . . 0.0 112.352 -179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 122.18 -74.64 0.36 Allowed Glycine 0 CA--C 1.526 0.75 0 C-N-CA 120.204 -0.998 . . . . 0.0 113.874 178.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -68.81 5.74 1.25 Allowed 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 123.268 2.645 . . . . 0.0 114.366 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.511 ' HB3' ' HB2' ' A' ' 190' ' ' ALA . 98.3 mt 73.43 -28.85 0.19 Allowed 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.322 0.649 . . . . 0.0 112.745 178.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 76.2 -147.77 35.08 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.659 -0.782 . . . . 0.0 112.307 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -89.47 -37.73 6.91 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.581 -179.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -78.43 62.66 3.76 Favored Glycine 0 CA--C 1.517 0.2 0 C-N-CA 121.338 -0.458 . . . . 0.0 112.891 -178.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.511 ' HB2' ' HB3' ' A' ' 186' ' ' LEU . . . -128.32 131.22 23.65 Favored Pre-proline 0 N--CA 1.44 -0.947 0 N-CA-C 110.259 -0.275 . . . . 0.0 110.259 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.491 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 59.4 Cg_endo -73.59 5.18 3.45 Favored 'Trans proline' 0 C--N 1.348 0.504 0 C-N-CA 122.602 2.201 . . . . 0.0 112.675 179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.1 t80 71.71 -41.12 0.5 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.882 0.873 . . . . 0.0 112.572 178.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -70.34 73.59 0.57 Allowed Glycine 0 CA--C 1.522 0.498 0 C-N-CA 121.622 -0.323 . . . . 0.0 113.663 -178.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.475 HE21 ' HG2' ' A' ' 191' ' ' PRO . 78.2 mm-40 -125.14 148.73 48.45 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.42 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 28.8 m -123.99 -12.55 7.47 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-O 120.699 0.285 . . . . 0.0 111.327 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -133.58 59.93 0.67 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.003 -1.094 . . . . 0.0 112.648 -177.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -95.96 -172.1 2.49 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 110.398 -0.223 . . . . 0.0 110.398 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 176.52 101.6 0.15 Allowed Glycine 0 N--CA 1.446 -0.662 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.009 179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.253 1.315 0 CA-C-O 118.587 -1.118 . . . . 0.0 111.805 -179.649 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.652 0 CA-C-O 120.612 0.244 . . . . 0.0 110.737 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -173.84 176.35 46.36 Favored Glycine 0 N--CA 1.439 -1.119 0 C-N-CA 120.253 -0.975 . . . . 0.0 112.295 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -79.01 165.94 23.62 Favored 'Trans proline' 0 C--O 1.239 0.534 0 C-N-CA 122.98 2.453 . . . . 0.0 112.427 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.414 ' HG3' HE22 ' A' ' 42' ' ' GLN . 47.5 mt-30 -77.22 90.72 3.71 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.781 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 60.03 -112.94 4.87 Favored Glycine 0 N--CA 1.448 -0.517 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.597 178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -107.61 1.07 34.35 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.917 -0.659 . . . . 0.0 112.751 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -65.38 -48.76 71.79 Favored 'General case' 0 CA--C 1.51 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.936 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 90.66 171.65 43.81 Favored Glycine 0 N--CA 1.435 -1.389 0 C-N-CA 120.617 -0.801 . . . . 0.0 112.21 179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -161.79 171.29 18.07 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 68.5 p 52.74 90.91 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 O-C-N 123.734 0.646 . . . . 0.0 112.465 179.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.33 161.1 31.11 Favored Glycine 0 C--O 1.236 0.276 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.372 -178.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -62.22 -61.58 6.49 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 121.627 -0.321 . . . . 0.0 113.452 -178.043 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -58.67 -41.54 86.4 Favored 'General case' 0 N--CA 1.466 0.345 0 CA-C-O 120.93 0.395 . . . . 0.0 111.306 -178.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.623 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.9 p -63.32 -32.97 74.53 Favored 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.597 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.51 -19.13 65.41 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 -177.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.3 -38.91 7.02 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.365 -0.921 . . . . 0.0 112.342 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.58 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.3 pp -84.69 -22.08 29.92 Favored 'General case' 0 CA--C 1.541 0.609 0 N-CA-C 113.251 0.834 . . . . 0.0 113.251 -176.695 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.623 HG23 ' O ' ' A' ' 14' ' ' SER . 11.5 pt -46.96 -50.02 6.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.089 0 N-CA-C 113.984 1.105 . . . . 0.0 113.984 -176.356 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 34.6 m -84.77 -19.73 32.13 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 112.142 0.423 . . . . 0.0 112.142 -177.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -86.47 -30.81 21.74 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 113.769 1.026 . . . . 0.0 113.769 -175.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.58 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.3 t -80.96 -101.9 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.026 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -70.21 -50.89 35.38 Favored 'General case' 0 CA--C 1.517 -0.322 0 N-CA-C 113.323 0.86 . . . . 0.0 113.323 -170.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.611 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.31 -22.99 66.3 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 113.085 0.772 . . . . 0.0 113.085 -176.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -62.82 -35.81 81.13 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.919 0.39 . . . . 0.0 110.066 177.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 178' ' ' GLY . 1.8 tt -80.57 -31.77 36.73 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.441 178.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.79 -43.85 82.81 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.212 178.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.472 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 11.2 t-20 61.83 6.03 1.53 Allowed 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 123.859 0.864 . . . . 0.0 113.083 176.628 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.527 HG22 ' H ' ' A' ' 29' ' ' SER . 0.3 OUTLIER -68.48 177.93 2.21 Favored 'General case' 0 CA--C 1.553 1.08 0 CA-C-O 121.087 0.47 . . . . 0.0 111.292 -178.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.527 ' H ' HG22 ' A' ' 28' ' ' THR . 9.7 m -69.66 -16.03 63.29 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 112.804 0.668 . . . . 0.0 112.804 -178.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.3 p -51.62 -50.39 60.33 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.784 0.661 . . . . 0.0 112.784 -177.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.754 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.9 pt? -87.29 -19.98 27.49 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.326 0.584 . . . . 0.0 110.358 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 22.7 ttm-85 -74.69 -48.23 27.18 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.323 -0.853 . . . . 0.0 112.086 -175.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -172.71 -37.03 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 N-CA-C 112.246 0.461 . . . . 0.0 112.246 -178.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.5 t -73.61 135.52 27.4 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.423 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -54.02 139.19 35.35 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.346 0.593 . . . . 0.0 111.77 -177.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB3' ' OG ' ' A' ' 91' ' ' SER . 3.1 ptm180 -62.71 160.04 15.05 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 114.925 -1.034 . . . . 0.0 111.995 -178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.2 p -74.19 111.67 9.59 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.644 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.15 47.13 11.51 Favored Glycine 0 N--CA 1.432 -1.588 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.342 -179.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.653 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 12.6 p -54.99 150.04 2.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 C-N-CA 122.93 0.492 . . . . 0.0 111.364 178.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 21.6 t -81.78 164.36 21.74 Favored 'General case' 0 N--CA 1.446 -0.673 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.1 pt20 -70.06 -12.42 61.6 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.763 -178.305 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.414 HE22 ' HG3' ' A' ' 4' ' ' GLN . 41.6 mm-40 -50.95 -33.05 22.87 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 121.113 0.483 . . . . 0.0 110.609 -179.57 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.717 HG13 ' N ' ' A' ' 44' ' ' ALA . 6.7 pt -83.77 -52.77 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 N-CA-C 112.421 0.526 . . . . 0.0 112.421 -178.705 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.717 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.47 -66.98 0.83 Allowed 'General case' 0 CA--C 1.513 -0.448 0 CA-C-O 120.719 0.295 . . . . 0.0 111.171 -177.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.6 m 78.82 -20.5 0.38 Allowed 'General case' 0 N--CA 1.474 0.746 0 CA-C-N 115.049 -0.978 . . . . 0.0 111.555 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.5 p -83.1 -82.97 0.14 Allowed 'General case' 0 N--CA 1.435 -1.224 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.501 -178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 43.0 t -103.25 -52.53 8.02 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.594 0.711 . . . . 0.0 110.258 -178.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 61.5 t -70.33 89.86 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.461 -178.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.545 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 77.9 mt-30 -82.82 -36.93 25.1 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.777 175.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.653 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 5.7 ttt180 -156.5 5.64 0.17 Allowed 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.937 173.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.91 -58.93 0.39 Allowed 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 123.162 0.585 . . . . 0.0 110.783 -175.044 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.49 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -62.97 138.54 58.59 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 120.983 0.421 . . . . 0.0 111.055 178.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.69 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.54 -18.87 8.28 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 114.916 -1.038 . . . . 0.0 113.611 -175.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 24.9 t -60.02 -71.31 0.13 Allowed 'General case' 0 CA--C 1.54 0.584 0 CA-C-O 120.847 0.356 . . . . 0.0 111.326 -179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 41.6 tp -87.36 -24.05 24.38 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.752 0.311 . . . . 0.0 111.604 -178.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.545 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.96 -18.91 55.45 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.862 0.69 . . . . 0.0 112.862 -176.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.69 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -53.96 99.97 0.03 OUTLIER 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.183 0.516 . . . . 0.0 110.886 -179.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 11.2 t -137.68 -36.25 0.63 Allowed 'General case' 0 N--CA 1.439 -0.988 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.605 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.738 HD11 ' ND2' ' A' ' 65' ' ' ASN . 4.1 pp -123.03 11.46 9.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.254 -0.43 . . . . 0.0 112.022 -178.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.04 52.76 1.58 Allowed Glycine 0 N--CA 1.438 -1.206 0 C-N-CA 119.851 -1.166 . . . . 0.0 111.143 -175.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.664 HG22 HD21 ' A' ' 65' ' ' ASN . 3.3 t -87.17 114.25 25.96 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -156.54 14.29 0.29 Allowed 'General case' 0 CA--C 1.514 -0.44 0 CA-C-O 120.965 0.412 . . . . 0.0 112.017 -177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.404 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 145.44 -43.71 0.91 Allowed Glycine 0 C--N 1.29 -2.005 0 C-N-CA 119.719 -1.229 . . . . 0.0 113.01 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -59.12 -68.45 0.27 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.181 0.515 . . . . 0.0 110.598 -178.003 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.738 ' ND2' HD11 ' A' ' 59' ' ' LEU . 25.8 p-10 -85.92 9.61 16.35 Favored 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.753 178.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 23.9 tp -88.12 -50.67 6.24 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-O 120.993 0.425 . . . . 0.0 110.438 178.371 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.407 ' HA ' ' HA ' ' A' ' 133' ' ' SER . . . -81.95 -26.55 33.89 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.941 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -127.08 169.42 13.41 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.722 -179.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 69.8 -62.29 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.105 0.562 . . . . 0.0 112.492 179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.07 -62.19 2.07 Favored 'General case' 0 N--CA 1.467 0.395 0 CA-C-O 121.012 0.434 . . . . 0.0 111.131 -179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 6.7 p -65.04 -33.2 62.07 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.815 179.784 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 76.7 mt-30 -66.6 -22.76 66.13 Favored 'General case' 0 C--O 1.218 -0.553 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.937 -178.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -85.66 -51.08 6.7 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-O 121.102 0.477 . . . . 0.0 110.831 178.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.557 ' O ' ' HG ' ' A' ' 77' ' ' LEU . 61.9 t -71.1 -36.46 62.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.427 -176.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 23.3 t -83.2 1.37 41.03 Favored 'General case' 0 C--N 1.317 -0.819 0 CA-C-O 120.856 0.36 . . . . 0.0 111.174 -178.828 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 43.1 ttm180 -106.37 -21.69 13.02 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.317 -179.137 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 74' ' ' VAL . 4.5 pp -63.71 144.77 97.84 Favored Pre-proline 0 C--O 1.236 0.384 0 CA-C-O 120.968 0.413 . . . . 0.0 111.515 -177.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -64.73 146.22 88.09 Favored 'Trans proline' 0 C--O 1.239 0.558 0 C-N-CA 122.777 2.318 . . . . 0.0 111.855 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -81.0 18.76 0.97 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.24 0.543 . . . . 0.0 111.395 -178.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.85 -23.32 78.16 Favored Glycine 0 C--N 1.311 -0.855 0 CA-C-N 115.364 -0.835 . . . . 0.0 111.357 178.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 14.2 m -79.87 -6.07 56.71 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 177.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 14.4 t70 73.66 123.85 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 124.564 1.146 . . . . 0.0 111.168 -179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 10.4 m -67.74 -37.81 82.65 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.62 -177.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 9.2 m -72.4 -24.99 61.33 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.985 0.422 . . . . 0.0 110.457 -179.272 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -67.33 -21.32 65.66 Favored 'General case' 0 CA--C 1.514 -0.413 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.73 178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -76.97 -169.41 1.31 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.362 177.235 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -75.97 12.97 0.95 Allowed 'General case' 0 C--N 1.312 -1.032 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 -177.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.523 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 1.8 mp0 -67.43 -48.15 68.12 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.057 0.456 . . . . 0.0 111.109 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.542 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -71.73 -30.71 65.92 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 120.967 0.413 . . . . 0.0 110.681 179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.502 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 84.9 m-85 -83.54 8.76 13.12 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 115.773 -0.649 . . . . 0.0 111.954 -177.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.535 ' OG ' ' HB3' ' A' ' 36' ' ' ARG . 71.9 m -51.8 -43.52 63.11 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 -176.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 48.3 m -61.69 -48.76 79.31 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -177.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -70.02 -31.05 68.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.889 0.376 . . . . 0.0 111.185 -177.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.502 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 41.8 mt -84.17 -19.0 34.84 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.775 -179.438 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.401 ' HB2' HH21 ' A' ' 36' ' ' ARG . 55.6 t80 -87.44 -36.94 17.42 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 116.646 -0.252 . . . . 0.0 111.096 178.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.436 ' HA ' HD21 ' A' ' 100' ' ' LEU . 14.5 m120 55.19 64.86 1.65 Allowed 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.584 0.707 . . . . 0.0 110.378 -176.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.69 -15.71 62.73 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 115.159 -0.928 . . . . 0.0 111.747 -178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 92.72 -13.83 66.51 Favored Glycine 0 CA--C 1.507 -0.454 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.213 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 36.9 t -74.72 -24.99 18.6 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.319 0.58 . . . . 0.0 109.863 179.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 1.6 pt? -84.4 150.52 25.28 Favored 'General case' 0 CA--C 1.5 -0.957 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.982 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.448 ' HA ' ' CB ' ' A' ' 195' ' ' SER . 40.3 t30 -54.67 107.78 0.32 Allowed 'General case' 0 N--CA 1.449 -0.524 0 O-C-N 123.801 0.688 . . . . 0.0 110.986 -177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.83 -17.49 63.18 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.936 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.8 m -80.18 -18.04 50.75 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.034 179.674 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.482 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -78.62 -29.17 45.82 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 179.356 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.433 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -64.86 -32.46 58.23 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.178 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 173.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -74.88 -33.19 62.03 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 115.346 -0.843 . . . . 0.0 109.878 175.747 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.8 m -67.94 -61.34 1.91 Allowed 'General case' 0 C--N 1.318 -0.771 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.67 -178.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -129.0 -9.96 4.83 Favored 'General case' 0 C--N 1.32 -0.696 0 C-N-CA 120.108 -0.637 . . . . 0.0 111.995 -177.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.497 ' HA2' HD23 ' A' ' 113' ' ' LEU . . . -58.9 -72.04 0.67 Allowed Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.746 -0.74 . . . . 0.0 113.135 -177.797 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 8.3 m -73.95 -12.26 60.59 Favored 'General case' 0 C--N 1.311 -1.067 0 CA-C-O 120.805 0.336 . . . . 0.0 111.365 -178.746 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -87.16 -57.83 2.81 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.303 0.483 . . . . 0.0 112.303 -179.487 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 58.6 t -83.28 -53.75 10.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.56 -176.679 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.523 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.0 OUTLIER -73.52 -33.39 64.72 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.182 -178.407 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 22.2 t 49.49 -103.57 0.12 Allowed 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 115.245 -0.889 . . . . 0.0 113.033 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.69 -33.29 60.67 Favored 'General case' 0 C--O 1.238 0.495 0 C-N-CA 123.115 0.566 . . . . 0.0 112.206 -176.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.535 ' O ' HG23 ' A' ' 120' ' ' VAL . 43.2 tp -57.39 -53.26 60.2 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.2 179.382 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.452 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 19.2 mt -78.69 -23.72 45.47 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.724 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -60.3 -45.44 93.36 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 176.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.1 -29.72 62.15 Favored Glycine 0 N--CA 1.445 -0.724 0 CA-C-N 115.496 -0.775 . . . . 0.0 111.752 178.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 116' ' ' LEU . 40.5 t -69.25 -46.11 78.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 O-C-N 122.766 -0.255 . . . . 0.0 111.198 178.512 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 32.9 t -58.05 -39.17 77.79 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.482 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.4 p -80.51 -40.19 26.5 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 120.876 0.369 . . . . 0.0 111.804 -178.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.2 -70.07 0.6 Allowed 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -177.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.404 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.15 -51.2 18.76 Favored 'General case' 0 C--N 1.324 -0.501 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -174.412 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 23.5 tm0? -69.95 -35.01 74.17 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-O 120.89 0.376 . . . . 0.0 110.508 -177.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.37 -56.66 3.14 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.782 -0.723 . . . . 0.0 114.141 -177.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 76.1 mt -99.38 -23.53 15.11 Favored 'General case' 0 C--N 1.323 -0.581 0 N-CA-C 112.299 0.481 . . . . 0.0 112.299 -174.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.57 77.57 0.97 Allowed Glycine 0 N--CA 1.444 -0.827 0 C-N-CA 120.235 -0.984 . . . . 0.0 111.002 -177.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.49 HG23 ' CB ' ' A' ' 52' ' ' ALA . 36.9 mm -68.47 132.95 32.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -176.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 38.7 t-20 -132.65 140.36 48.14 Favored 'General case' 0 C--N 1.316 -0.857 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 176.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 21.9 t -102.76 116.28 46.19 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.837 0 CA-C-O 121.341 0.591 . . . . 0.0 111.333 -177.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -97.69 43.38 1.07 Allowed 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.374 -179.754 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.411 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 46.0 p -75.49 -4.99 42.85 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.028 -179.105 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 95.14 -17.85 58.51 Favored Glycine 0 N--CA 1.437 -1.289 0 N-CA-C 111.057 -0.817 . . . . 0.0 111.057 -178.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 25.5 p -107.4 -56.88 2.15 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.254 0.465 . . . . 0.0 112.254 -178.592 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 48.4 t -56.06 -62.93 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 N-CA-C 112.468 0.544 . . . . 0.0 112.468 -174.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 9.6 tt0 -59.02 -40.49 85.13 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.346 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 18.8 m -60.84 -49.08 78.91 Favored 'General case' 0 C--N 1.318 -0.799 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.992 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -63.24 -52.29 62.76 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.819 -178.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 42.7 pt -61.45 -34.87 63.27 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.472 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.459 -178.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 18.7 t -67.79 -42.11 82.14 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 120.847 0.356 . . . . 0.0 110.97 179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.2 m -77.42 -45.97 24.14 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-O 120.938 0.399 . . . . 0.0 111.493 -179.546 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 49.3 m -66.11 -38.73 88.92 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.729 0.64 . . . . 0.0 112.729 -176.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 42.0 p -57.7 -27.55 63.03 Favored 'General case' 0 N--CA 1.47 0.558 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 37.7 t -58.21 -46.87 85.09 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 120.991 0.424 . . . . 0.0 110.873 179.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 62.9 m-85 -88.84 -35.54 16.52 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.208 0.528 . . . . 0.0 110.489 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.472 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 71.1 mt -82.19 8.62 10.51 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.755 -176.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 36.6 m -49.28 -43.07 42.86 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.479 0.657 . . . . 0.0 109.386 177.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.499 ' HA ' ' HB2' ' A' ' 179' ' ' PRO . 10.7 m -145.37 -13.66 0.51 Allowed 'General case' 0 N--CA 1.44 -0.948 0 CA-C-N 114.982 -1.008 . . . . 0.0 108.905 174.508 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 23.0 t 64.11 -163.43 0.26 Allowed 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.48 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 63.5 p 56.32 -159.78 0.22 Allowed 'General case' 0 C--O 1.241 0.624 0 C-N-CA 123.618 0.767 . . . . 0.0 111.101 -178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 10.2 m -99.06 2.9 46.57 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.853 0.359 . . . . 0.0 110.308 178.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 35.9 m -135.62 117.77 15.47 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 120.978 0.418 . . . . 0.0 111.292 -178.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -127.76 -48.28 1.38 Allowed 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.857 179.547 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 13.0 p -103.51 7.79 37.8 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 121.237 0.541 . . . . 0.0 110.473 178.422 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -97.59 160.11 14.51 Favored 'General case' 0 CA--C 1.508 -0.656 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.906 -179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 8.8 t -67.62 -13.09 61.78 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.335 0.588 . . . . 0.0 109.801 178.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 21.7 mt-30 -70.54 -22.14 62.64 Favored 'General case' 0 N--CA 1.451 -0.406 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.073 175.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -77.89 -9.2 58.95 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.046 178.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 32.3 m -74.84 -41.99 58.81 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.856 176.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.612 ' HA ' ' HB ' ' A' ' 177' ' ' THR . . . -159.05 -67.94 0.08 Allowed 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 111.866 0.321 . . . . 0.0 111.866 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 37.9 t 61.83 24.98 14.96 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.355 0.598 . . . . 0.0 110.756 -177.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.457 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 37.2 t -79.1 -10.6 59.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.777 -0.647 . . . . 0.0 110.577 -178.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 17.7 m -65.39 -30.58 71.41 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.273 0.559 . . . . 0.0 110.104 177.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 13.6 m -89.03 -0.04 57.08 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.731 -179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . 148.53 153.4 5.97 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.993 -0.622 . . . . 0.0 111.89 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.45 74.42 1.32 Allowed 'General case' 0 C--N 1.317 -0.82 0 CA-C-O 121.109 0.48 . . . . 0.0 110.981 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.28 74.65 2.41 Favored Glycine 0 N--CA 1.441 -0.968 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 177.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.65 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 97.2 m-85 74.25 179.98 0.2 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 123.768 0.827 . . . . 0.0 110.526 -178.437 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 2.8 p -146.58 122.18 10.45 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.155 178.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 137.92 -148.61 19.98 Favored Glycine 0 N--CA 1.442 -0.915 0 C-N-CA 120.459 -0.877 . . . . 0.0 112.061 179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 37.2 Cg_endo -64.99 -6.78 13.52 Favored 'Trans proline' 0 C--N 1.352 0.712 0 C-N-CA 123.219 2.613 . . . . 0.0 113.503 -177.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 25.6 p -141.6 27.01 1.89 Allowed 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 121.083 0.468 . . . . 0.0 110.819 178.659 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -91.71 -138.21 7.96 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.748 -0.739 . . . . 0.0 111.847 179.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.65 ' HD3' ' O ' ' A' ' 169' ' ' TYR . 7.5 Cg_exo -75.03 -171.42 0.98 Allowed 'Trans proline' 0 C--O 1.24 0.582 0 C-N-CA 122.91 2.406 . . . . 0.0 110.747 178.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 12.2 p -76.85 82.89 3.42 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 176.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.612 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 7.2 t -163.35 139.96 7.15 Favored 'General case' 0 N--CA 1.441 -0.884 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.511 -177.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.491 ' O ' ' HG ' ' A' ' 25' ' ' LEU . . . 121.01 -66.77 0.44 Allowed Glycine 0 C--O 1.217 -0.95 0 C-N-CA 120.471 -0.871 . . . . 0.0 112.138 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.499 ' HB2' ' HA ' ' A' ' 149' ' ' THR . 3.4 Cg_exo -82.22 23.55 0.78 Allowed 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 123.189 2.592 . . . . 0.0 112.348 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.2 m -45.7 118.52 1.83 Allowed 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.703 0.801 . . . . 0.0 111.043 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -50.28 -68.95 1.21 Allowed Glycine 0 C--N 1.336 0.578 0 N-CA-C 115.183 0.833 . . . . 0.0 115.183 -175.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.626 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 60.3 t80 -123.1 -58.69 0.03 OUTLIER Pre-proline 0 C--N 1.319 -0.745 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -176.805 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.626 ' HD2' ' H ' ' A' ' 182' ' ' TYR . 42.5 Cg_endo -67.91 123.66 10.94 Favored 'Trans proline' 0 C--N 1.365 1.438 0 C-N-CA 121.313 1.342 . . . . 0.0 111.596 -179.052 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 55.62 74.79 0.28 Allowed Glycine 0 CA--C 1.521 0.425 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.707 -178.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_exo -43.1 -50.76 6.13 Favored 'Trans proline' 0 C--N 1.363 1.338 0 C-N-CA 123.377 2.718 . . . . 0.0 112.166 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 92.4 mt -91.72 88.73 6.81 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 109.072 -0.714 . . . . 0.0 109.072 176.149 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -54.03 -49.49 58.9 Favored Glycine 0 C--N 1.333 0.38 0 C-N-CA 121.01 -0.614 . . . . 0.0 112.897 -178.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 161.73 -39.93 0.39 Allowed Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.781 -0.723 . . . . 0.0 111.465 -179.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -82.28 49.92 4.22 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.995 -0.622 . . . . 0.0 111.774 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -117.06 152.76 49.22 Favored Pre-proline 0 C--N 1.315 -0.901 0 N-CA-C 109.716 -0.476 . . . . 0.0 109.716 -179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.37 -177.73 3.74 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.552 2.168 . . . . 0.0 112.242 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -99.35 10.93 40.47 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.398 -179.51 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -91.34 30.27 6.52 Favored Glycine 0 C--O 1.226 -0.373 0 C-N-CA 121.037 -0.601 . . . . 0.0 112.524 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -91.96 123.19 35.14 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 2.3 t -74.66 -20.31 59.93 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.785 -175.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 109.0 36.14 2.22 Favored Glycine 0 N--CA 1.443 -0.882 0 C-N-CA 120.479 -0.867 . . . . 0.0 111.109 -177.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 74.5 t80 -119.58 -55.82 2.09 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.019 0.437 . . . . 0.0 109.929 -179.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -91.69 65.42 2.38 Favored Glycine 0 N--CA 1.445 -0.759 0 C-N-CA 120.853 -0.689 . . . . 0.0 111.784 -179.717 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.435 -1.4 0 CA-C-O 118.486 -1.174 . . . . 0.0 111.525 -179.859 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.651 0 CA-C-O 120.603 0.239 . . . . 0.0 110.462 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.417 ' HA2' ' HD2' ' A' ' 3' ' ' PRO . . . -106.57 101.52 1.76 Allowed Glycine 0 N--CA 1.443 -0.841 0 C-N-CA 120.677 -0.773 . . . . 0.0 111.977 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.417 ' HD2' ' HA2' ' A' ' 2' ' ' GLY . 19.2 Cg_endo -59.85 -36.01 92.17 Favored 'Trans proline' 0 C--O 1.21 -0.912 0 C-N-CA 122.614 2.209 . . . . 0.0 112.002 -178.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.9 tt0 -69.87 -11.02 60.55 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 123.302 0.641 . . . . 0.0 111.9 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -78.19 44.27 2.37 Favored Glycine 0 N--CA 1.471 1.0 0 N-CA-C 111.011 -0.836 . . . . 0.0 111.011 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 115' ' ' ALA . . . 151.93 -30.04 0.91 Allowed Glycine 0 N--CA 1.438 -1.202 0 N-CA-C 107.85 -2.1 . . . . 0.0 107.85 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 90.3 t80 81.41 103.31 0.06 Allowed 'General case' 0 C--O 1.22 -0.459 0 C-N-CA 125.588 1.555 . . . . 0.0 113.751 174.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 56.04 55.69 27.95 Favored Glycine 0 C--N 1.338 0.673 0 CA-C-N 114.187 -1.369 . . . . 0.0 114.348 177.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.417 ' HA ' ' CD2' ' A' ' 113' ' ' LEU . . . -95.98 172.6 7.9 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-O 120.795 0.331 . . . . 0.0 111.381 179.891 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 48.8 p 51.3 84.1 0.05 OUTLIER 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 124.234 1.014 . . . . 0.0 112.851 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.13 -167.93 41.07 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.249 179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 74.79 -158.26 51.18 Favored Glycine 0 N--CA 1.443 -0.879 0 C-N-CA 121.254 -0.498 . . . . 0.0 112.374 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.34 -28.02 68.92 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.05 0.452 . . . . 0.0 111.261 179.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.646 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.4 m -63.38 -34.39 77.62 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.988 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -64.89 -19.05 65.7 Favored 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 112.296 0.48 . . . . 0.0 112.296 -177.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.96 -39.47 6.49 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.281 -0.962 . . . . 0.0 112.778 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.579 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.9 pp -84.52 -20.97 30.74 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -175.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 HG23 ' O ' ' A' ' 14' ' ' SER . 9.7 pt -41.46 -42.13 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 N-CA-C 114.733 1.382 . . . . 0.0 114.733 -175.884 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.478 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 8.3 p -78.99 -30.28 44.26 Favored 'General case' 0 C--N 1.306 -1.314 0 N-CA-C 113.002 0.741 . . . . 0.0 113.002 -176.235 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 62.6 mtt180 -87.28 -23.62 24.61 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 114.056 1.132 . . . . 0.0 114.056 -175.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.579 HG23 ' O ' ' A' ' 17' ' ' LEU . 17.3 t -80.62 -101.17 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.934 0 N-CA-C 114.91 1.448 . . . . 0.0 114.91 -171.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.13 -53.34 7.48 Favored 'General case' 0 CA--C 1.517 -0.304 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -170.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -63.63 -23.03 67.21 Favored 'General case' 0 C--N 1.316 -0.849 0 N-CA-C 113.034 0.753 . . . . 0.0 113.034 -176.369 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.3 -41.48 79.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.843 0.354 . . . . 0.0 110.956 178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -81.95 -19.97 39.58 Favored 'General case' 0 CA--C 1.52 -0.196 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.995 179.34 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -77.63 -40.57 41.45 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.344 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 54.73 19.42 2.51 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 121.663 0.744 . . . . 0.0 111.432 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.422 ' HA ' ' HB3' ' A' ' 143' ' ' SER . 5.6 m -74.22 165.88 24.41 Favored 'General case' 0 N--CA 1.436 -1.167 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.922 -178.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.0 m -60.78 -18.25 53.96 Favored 'General case' 0 C--N 1.317 -0.835 0 C-N-CA 123.054 0.542 . . . . 0.0 111.7 -179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.456 HG22 ' HA ' ' A' ' 36' ' ' ARG . 34.4 p -52.99 -43.2 66.28 Favored 'General case' 0 C--O 1.22 -0.471 0 C-N-CA 124.045 0.938 . . . . 0.0 113.085 -176.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.642 HD22 ' HB3' ' A' ' 23' ' ' ASN . 1.6 pt? -96.59 -20.46 18.31 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.926 0.393 . . . . 0.0 111.19 -178.606 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 45.8 ttm180 -72.07 -50.95 24.05 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.958 -0.565 . . . . 0.0 112.166 -176.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.7 t -168.64 -40.19 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.019 0.377 . . . . 0.0 112.019 -177.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 79.7 t -71.13 138.58 21.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.466 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.404 ' H ' HD23 ' A' ' 35' ' ' LEU . 2.6 pt? -56.43 142.04 40.07 Favored 'General case' 0 C--O 1.235 0.336 0 O-C-N 123.301 0.375 . . . . 0.0 110.785 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.456 ' HA ' HG22 ' A' ' 30' ' ' THR . 31.4 ptt85 -66.84 159.31 28.43 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.888 -0.596 . . . . 0.0 111.793 -177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.2 p -70.95 111.44 6.34 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.81 178.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.681 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 85.34 41.26 7.49 Favored Glycine 0 N--CA 1.428 -1.864 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.642 -178.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.486 HG23 ' HB3' ' A' ' 87' ' ' ALA . 10.1 p -47.56 136.3 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.484 0.659 . . . . 0.0 111.831 179.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 11.1 m -70.23 143.75 52.08 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.202 -0.908 . . . . 0.0 110.538 -178.805 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 15.4 pm0 -65.57 -12.68 55.21 Favored 'General case' 0 C--O 1.222 -0.374 0 CA-C-N 116.403 -0.362 . . . . 0.0 111.02 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.1 mm-40 -47.09 -44.66 21.43 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.501 177.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.482 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.79 -40.71 16.03 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.599 0 CA-C-N 116.174 -0.466 . . . . 0.0 112.097 -179.142 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.482 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.83 -75.81 0.34 Allowed 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 112.347 0.499 . . . . 0.0 112.347 -178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.5 m 78.86 -19.65 0.43 Allowed 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.232 1.013 . . . . 0.0 111.772 179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 17.0 p -65.39 -82.04 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.576 0 N-CA-C 113.228 0.825 . . . . 0.0 113.228 -177.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.3 m -124.61 -39.72 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-O 120.986 0.422 . . . . 0.0 111.261 -179.46 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.53 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 3.5 p -80.31 95.42 2.39 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 CA-C-O 121.793 0.806 . . . . 0.0 110.33 179.457 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 50.4 mt-30 -79.18 -37.57 38.02 Favored 'General case' 0 C--N 1.314 -0.951 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.016 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.555 ' CZ ' ' HG ' ' A' ' 55' ' ' LEU . 8.1 ttm180 -153.66 0.22 0.23 Allowed 'General case' 0 N--CA 1.432 -1.338 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.08 -48.39 0.59 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 122.61 0.364 . . . . 0.0 110.272 -173.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.838 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -61.67 141.08 58.05 Favored 'General case' 0 CA--C 1.503 -0.83 0 CA-C-N 116.28 -0.418 . . . . 0.0 109.919 176.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.461 ' O ' ' HB2' ' A' ' 57' ' ' SER . 42.4 mm-40 -56.71 -30.66 63.72 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.606 -0.724 . . . . 0.0 111.479 -176.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 60.3 m -53.89 -62.2 1.81 Allowed 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.102 0.408 . . . . 0.0 112.102 -178.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' HG ' ' CZ ' ' A' ' 50' ' ' ARG . 4.3 mm? -88.06 -35.82 17.3 Favored 'General case' 0 C--N 1.309 -1.188 0 N-CA-C 112.931 0.715 . . . . 0.0 112.931 -178.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.435 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -79.72 -21.46 44.53 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 114.047 1.129 . . . . 0.0 114.047 -173.299 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.461 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.7 t -65.25 93.2 0.13 Allowed 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.622 179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.518 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.7 t -139.23 -31.36 0.7 Allowed 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.917 -177.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.518 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.7 mt -118.19 19.14 13.63 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 85.39 65.61 1.46 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.602 -0.999 . . . . 0.0 110.602 -176.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.541 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 96.9 t -89.52 122.48 40.91 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-O 121.262 0.553 . . . . 0.0 111.368 -176.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.9 t70 -178.2 85.91 0.02 OUTLIER 'General case' 0 C--N 1.315 -0.92 0 CA-C-N 114.648 -1.16 . . . . 0.0 110.136 178.745 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.88 -54.98 3.46 Favored Glycine 0 CA--C 1.521 0.456 0 CA-C-N 115.894 -0.594 . . . . 0.0 113.191 178.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.425 ' HA ' HH21 ' A' ' 68' ' ' ARG . 92.7 m-20 -50.79 -79.77 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 123.376 0.67 . . . . 0.0 111.81 -177.824 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.541 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 27.3 p-10 -86.63 14.57 6.75 Favored 'General case' 0 C--N 1.316 -0.885 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.122 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 53.2 tp -87.91 -65.47 1.01 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.651 178.099 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.38 -36.63 58.02 Favored 'General case' 0 CA--C 1.516 -0.339 0 CA-C-O 121.549 0.69 . . . . 0.0 109.749 179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.425 HH21 ' HA ' ' A' ' 64' ' ' ASN . 60.1 mtm180 -98.95 160.16 14.45 Favored 'General case' 0 C--N 1.313 -0.985 0 CA-C-N 115.068 -0.969 . . . . 0.0 108.733 178.325 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 69.41 -62.27 0.41 Allowed 'General case' 0 N--CA 1.476 0.875 0 C-N-CA 122.997 0.519 . . . . 0.0 111.975 -178.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.53 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -62.78 -63.14 1.3 Allowed 'General case' 0 C--O 1.237 0.395 0 CA-C-O 120.746 0.307 . . . . 0.0 111.507 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.436 ' O ' ' HB2' ' A' ' 75' ' ' SER . 59.6 t -64.82 -39.15 84.68 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.587 179.6 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 41.6 mt-30 -60.78 -47.59 85.63 Favored 'General case' 0 C--N 1.315 -0.905 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.484 -178.754 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.48 -52.89 63.28 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 111.733 0.272 . . . . 0.0 111.733 -178.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -65.8 -38.33 81.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 121.11 0.481 . . . . 0.0 110.929 -178.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 71' ' ' VAL . 33.2 m -77.31 1.23 19.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.769 179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.469 ' NE ' ' HA ' ' A' ' 76' ' ' ARG . 4.6 mmp_? -111.83 -4.21 14.68 Favored 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.806 0.336 . . . . 0.0 110.169 175.202 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 65.0 mt -74.63 123.51 89.1 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.243 -179.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -74.26 128.64 12.27 Favored 'Trans proline' 0 N--CA 1.458 -0.6 0 C-N-CA 122.76 2.307 . . . . 0.0 111.46 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -91.17 94.2 9.47 Favored 'General case' 0 C--N 1.312 -1.049 0 CA-C-O 120.976 0.417 . . . . 0.0 110.154 178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -64.3 -55.28 24.49 Favored Glycine 0 N--CA 1.448 -0.535 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.101 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 8.0 m -72.54 -60.44 2.23 Favored 'General case' 0 C--N 1.318 -0.761 0 N-CA-C 109.646 -0.502 . . . . 0.0 109.646 178.584 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 178.36 162.81 0.68 Allowed 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.57 179.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 2.1 p -67.38 -26.43 66.45 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.091 0.472 . . . . 0.0 110.778 178.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 13.7 m -65.63 -17.77 64.83 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.904 178.626 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -70.23 -21.99 62.95 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-O 121.075 0.464 . . . . 0.0 110.827 178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 37.6 m-85 -82.0 -166.37 1.22 Allowed 'General case' 0 N--CA 1.442 -0.849 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.813 177.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -76.71 11.6 1.62 Allowed 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -67.55 -59.98 2.93 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.523 -177.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.519 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -69.42 -30.91 68.96 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-O 121.042 0.449 . . . . 0.0 110.991 -178.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.486 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 96.1 m-85 -82.64 4.03 26.51 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 115.951 -0.568 . . . . 0.0 112.307 -177.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.1 m -51.25 -39.8 57.48 Favored 'General case' 0 C--O 1.217 -0.646 0 N-CA-C 113.139 0.792 . . . . 0.0 113.139 -177.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 70.6 m -58.69 -44.88 90.39 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.221 0.452 . . . . 0.0 112.221 -179.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.11 -30.98 27.51 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.72 -177.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.49 HD22 HD21 ' A' ' 116' ' ' LEU . 33.5 mt -84.58 -28.94 26.24 Favored 'General case' 0 C--O 1.222 -0.361 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -176.795 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 66.3 t80 -87.13 -29.67 21.65 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 120.785 0.326 . . . . 0.0 110.486 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 22.7 m120 51.15 69.57 0.63 Allowed 'General case' 0 N--CA 1.469 0.5 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.054 -177.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.77 -8.56 56.03 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.524 -0.762 . . . . 0.0 112.068 -178.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 88.47 -6.76 83.24 Favored Glycine 0 C--O 1.229 -0.176 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.734 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 17.9 t -80.44 -19.32 11.97 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-O 121.492 0.663 . . . . 0.0 109.725 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.78 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.47 174.87 9.18 Favored 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.937 -177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.7 p-10 -83.32 143.9 30.05 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.057 -179.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -82.27 -18.84 40.99 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.96 -0.564 . . . . 0.0 110.815 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.8 p -67.75 -30.28 69.71 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.482 0.658 . . . . 0.0 109.827 -178.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.531 ' O ' HD23 ' A' ' 108' ' ' LEU . 19.2 t30 -62.84 -50.44 70.95 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.061 -0.972 . . . . 0.0 110.124 178.31 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.526 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.7 mp -72.4 -28.13 27.83 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.125 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.326 -179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -72.55 -33.67 66.97 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.898 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.617 ' O ' ' HD2' ' A' ' 111' ' ' ARG . 86.9 m -85.5 -40.23 16.58 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -176.085 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.531 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.2 pt? -139.94 -27.42 0.76 Allowed 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 119.368 -0.933 . . . . 0.0 112.836 -179.169 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.526 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -50.83 -63.98 4.09 Favored Glycine 0 CA--C 1.522 0.52 0 C-N-CA 120.96 -0.638 . . . . 0.0 114.178 -177.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 53.5 m -75.57 -17.0 60.18 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 120.94 0.4 . . . . 0.0 111.913 -177.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.617 ' HD2' ' O ' ' A' ' 107' ' ' THR . 66.6 mtt180 -87.2 -58.0 2.75 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 116.27 -0.423 . . . . 0.0 112.088 -176.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 44.2 t -79.7 -49.35 19.55 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.73 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.535 -175.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.417 ' CD2' ' HA ' ' A' ' 9' ' ' ALA . 22.3 mt -70.86 -13.75 62.15 Favored 'General case' 0 C--O 1.237 0.433 0 CA-C-O 121.111 0.481 . . . . 0.0 110.572 -177.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 35.0 t 47.74 -104.07 0.11 Allowed 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 124.345 1.058 . . . . 0.0 113.657 175.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.53 ' HB3' ' HA2' ' A' ' 6' ' ' GLY . . . -65.86 -33.92 76.94 Favored 'General case' 0 C--N 1.325 -0.465 0 N-CA-C 112.853 0.686 . . . . 0.0 112.853 -174.303 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.49 HD21 HD22 ' A' ' 94' ' ' LEU . 37.3 tp -53.88 -62.7 1.48 Allowed 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.505 0.557 . . . . 0.0 112.505 -174.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.463 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 16.6 mt -69.07 -23.56 64.04 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 113.069 0.766 . . . . 0.0 113.069 -176.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 22.3 m-80 -66.33 -46.68 76.01 Favored 'General case' 0 C--N 1.32 -0.675 0 C-N-CA 120.379 -0.528 . . . . 0.0 110.194 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -75.6 -27.27 63.51 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.424 -0.893 . . . . 0.0 111.899 178.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.589 HG13 ' HB3' ' A' ' 124' ' ' ALA . 25.3 t -68.39 -36.55 75.38 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 120.795 0.331 . . . . 0.0 110.316 177.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.0 t -54.47 -41.21 69.26 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.789 -0.642 . . . . 0.0 111.457 -179.302 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.7 p -83.74 -49.16 9.37 Favored 'General case' 0 C--N 1.318 -0.791 0 CA-C-O 120.955 0.407 . . . . 0.0 111.744 -179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -71.53 -58.49 3.46 Favored 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -176.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.589 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -82.12 -60.27 2.28 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -175.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 24.9 tm0? -69.18 -35.7 76.56 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.445 -176.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -81.28 -69.57 1.39 Allowed Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.945 -0.645 . . . . 0.0 114.074 -177.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 92.3 mt -87.21 -23.61 24.7 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 120.974 0.416 . . . . 0.0 111.269 -175.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 124' ' ' ALA . . . 82.2 91.32 0.6 Allowed Glycine 0 N--CA 1.433 -1.549 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.025 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.838 HG23 ' HB2' ' A' ' 52' ' ' ALA . 63.7 mt -59.64 134.94 24.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.828 0.347 . . . . 0.0 110.912 178.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 51.0 t30 -139.56 118.84 12.79 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.245 178.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.6 t -72.81 156.94 6.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.936 179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 t70 -64.61 163.09 14.35 Favored 'General case' 0 C--O 1.244 0.783 0 N-CA-C 109.987 -0.375 . . . . 0.0 109.987 -179.482 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 19.9 m -74.11 84.19 1.81 Allowed 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.238 0.542 . . . . 0.0 111.508 -178.247 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -125.53 -114.94 2.01 Favored Glycine 0 N--CA 1.437 -1.283 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 177.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 4.6 m -87.83 -18.73 28.64 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.045 0.45 . . . . 0.0 110.524 178.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.403 ' O ' HG12 ' A' ' 140' ' ' ILE . 48.9 t -78.72 -62.78 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 CA-C-N 115.722 -0.672 . . . . 0.0 111.928 -176.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -52.54 -51.67 58.51 Favored 'General case' 0 C--O 1.22 -0.46 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -174.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.9 p -56.1 -43.97 78.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 112.571 0.582 . . . . 0.0 112.571 -177.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.88 -40.44 39.94 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.51 -177.037 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.403 HG12 ' O ' ' A' ' 136' ' ' VAL . 47.3 pt -67.31 -35.92 75.17 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.115 0 C-N-CA 120.732 -0.387 . . . . 0.0 111.523 -179.02 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 69.9 m -57.05 -53.28 59.86 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 120.693 0.282 . . . . 0.0 110.95 179.337 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.4 m -61.2 -43.59 98.63 Favored 'General case' 0 C--O 1.238 0.461 0 CA-C-N 116.414 -0.357 . . . . 0.0 111.496 -179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.422 ' HB3' ' HA ' ' A' ' 28' ' ' THR . 65.0 m -66.09 -39.11 89.75 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.175 0.435 . . . . 0.0 112.175 -178.657 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.5 p -77.9 -19.1 55.32 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.912 0.387 . . . . 0.0 111.638 -178.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.4 m -84.27 -60.19 2.16 Favored 'General case' 0 C--N 1.316 -0.889 0 CA-C-O 121.003 0.43 . . . . 0.0 111.19 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -89.71 -59.82 2.1 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -175.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 84.0 mt -60.57 -24.25 65.29 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 -171.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 53.2 m -52.61 -34.5 51.22 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 120.955 0.407 . . . . 0.0 112.085 -179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 34.5 p -135.08 26.84 3.55 Favored 'General case' 0 N--CA 1.437 -1.115 0 CA-C-O 121.005 0.431 . . . . 0.0 110.751 -179.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 22.5 t -149.4 156.09 41.49 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.059 -178.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 15.1 t 62.75 -167.49 0.21 Allowed 'General case' 0 CA--C 1.538 0.501 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 -177.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 14.5 m 54.52 39.38 31.07 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 120.703 0.287 . . . . 0.0 110.784 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.47 ' HB2' ' HB2' ' A' ' 158' ' ' GLN . 52.2 p 55.01 19.47 2.73 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 124.158 0.983 . . . . 0.0 112.895 -176.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.474 ' O ' ' HG3' ' A' ' 183' ' ' PRO . . . -82.99 19.19 1.44 Allowed 'General case' 0 C--O 1.224 -0.273 0 CA-C-O 121.229 0.538 . . . . 0.0 110.565 178.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.0 p -81.13 4.91 18.4 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.861 -0.609 . . . . 0.0 109.39 176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 21.6 p90 49.57 20.82 0.54 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 125.213 1.405 . . . . 0.0 114.39 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 19.8 t -115.31 -0.27 13.25 Favored 'General case' 0 C--N 1.295 -1.772 0 N-CA-C 107.896 -1.149 . . . . 0.0 107.896 175.282 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.47 ' HB2' ' HB2' ' A' ' 153' ' ' SER . 60.5 mm-40 -120.87 -171.61 2.22 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 114.566 -1.197 . . . . 0.0 108.455 178.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . 69.59 -68.44 0.19 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.151 0.58 . . . . 0.0 111.168 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 18.2 m -156.63 -45.29 0.07 Allowed 'General case' 0 C--N 1.317 -0.841 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 178.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 72.46 -76.97 0.06 Allowed 'General case' 0 C--N 1.346 0.453 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.647 177.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.4 m -82.38 86.77 6.66 Favored 'General case' 0 N--CA 1.438 -1.032 0 CA-C-O 120.828 0.347 . . . . 0.0 110.985 -178.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 36.3 t -87.53 75.04 9.18 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-O 121.296 0.57 . . . . 0.0 109.649 178.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.1 m -86.25 -55.64 3.82 Favored 'General case' 0 N--CA 1.44 -0.963 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.127 -179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 26.4 m -82.56 -55.0 4.73 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.191 0.519 . . . . 0.0 109.611 177.664 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 173.29 142.19 3.77 Favored Glycine 0 N--CA 1.439 -1.109 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -95.81 115.32 27.25 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 120.956 0.407 . . . . 0.0 111.006 -178.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -85.02 -17.22 63.47 Favored Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.867 -0.682 . . . . 0.0 111.796 178.822 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -85.16 22.67 1.4 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.793 0.33 . . . . 0.0 111.659 -179.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.6 t -71.86 158.17 36.55 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 178.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 165.54 -139.82 6.02 Favored Glycine 0 N--CA 1.431 -1.635 0 C-N-CA 120.395 -0.907 . . . . 0.0 112.057 -178.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -65.08 -16.55 55.72 Favored 'Trans proline' 0 N--CA 1.48 0.689 0 C-N-CA 123.327 2.685 . . . . 0.0 112.869 179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 48.8 m -118.87 -61.46 1.64 Allowed 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.532 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 74.17 149.84 1.75 Allowed Glycine 0 CA--C 1.529 0.931 0 C-N-CA 120.902 -0.666 . . . . 0.0 113.991 178.407 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.479 ' O ' ' HA ' ' A' ' 183' ' ' PRO . 72.5 Cg_endo -87.49 -162.97 0.15 Allowed 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 122.996 2.464 . . . . 0.0 111.082 176.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 182' ' ' TYR . 4.3 m -63.15 92.73 0.06 Allowed 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 177.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.42 ' O ' ' HB3' ' A' ' 186' ' ' LEU . 15.1 t -175.91 28.98 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.613 -177.09 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -164.09 -149.05 5.63 Favored Glycine 0 CA--C 1.524 0.65 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.164 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.527 ' HG3' ' OXT' ' A' ' 199' ' ' GLY . 2.7 Cg_exo -77.94 -150.14 0.04 OUTLIER 'Trans proline' 0 C--N 1.349 0.598 0 C-N-CA 123.277 2.651 . . . . 0.0 111.863 178.609 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 57.7 m 54.47 30.07 12.27 Favored 'General case' 0 C--N 1.347 0.497 0 C-N-CA 123.111 0.564 . . . . 0.0 111.655 179.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 96.99 -49.7 1.53 Allowed Glycine 0 N--CA 1.436 -1.341 0 C-N-CA 120.958 -0.639 . . . . 0.0 112.195 179.782 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.434 ' H ' ' HD2' ' A' ' 183' ' ' PRO . 4.9 m-85 -165.47 -57.87 0.01 OUTLIER Pre-proline 0 C--N 1.326 -0.453 0 C-N-CA 122.808 0.443 . . . . 0.0 110.11 -175.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.479 ' HA ' ' O ' ' A' ' 175' ' ' PRO . 43.4 Cg_endo -67.43 122.94 10.23 Favored 'Trans proline' 0 C--N 1.365 1.404 0 C-N-CA 121.232 1.288 . . . . 0.0 109.189 177.084 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -158.35 147.56 15.52 Favored Glycine 0 N--CA 1.407 -3.243 0 C-N-CA 119.159 -1.496 . . . . 0.0 113.447 -175.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -75.88 10.69 1.91 Allowed 'Trans proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.097 3.198 . . . . 0.0 112.127 179.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.588 ' HA ' ' HA ' ' A' ' 190' ' ' ALA . 1.2 tt -68.48 -66.19 0.6 Allowed 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.744 -177.769 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 86.87 -124.59 7.06 Favored Glycine 0 C--N 1.32 -0.359 0 C-N-CA 120.603 -0.808 . . . . 0.0 112.648 178.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -71.8 -47.27 33.63 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.054 -0.593 . . . . 0.0 112.607 -178.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -156.3 39.32 0.58 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.695 179.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.588 ' HA ' ' HA ' ' A' ' 186' ' ' LEU . . . 72.84 159.45 0.16 Allowed Pre-proline 0 N--CA 1.473 0.685 0 C-N-CA 123.487 0.715 . . . . 0.0 110.636 -179.061 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -62.84 90.08 0.13 Allowed 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.158 1.905 . . . . 0.0 111.912 176.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 36.3 t80 72.76 -57.21 0.64 Allowed 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.076 0.951 . . . . 0.0 111.272 -179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 167.28 177.42 38.86 Favored Glycine 0 N--CA 1.438 -1.2 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.939 -179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -128.77 174.12 9.74 Favored 'General case' 0 C--N 1.316 -0.864 0 N-CA-C 109.281 -0.637 . . . . 0.0 109.281 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 32.4 t -106.64 16.36 24.63 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.112 0.482 . . . . 0.0 110.312 178.097 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 94.17 93.56 1.61 Allowed Glycine 0 N--CA 1.439 -1.146 0 C-N-CA 120.578 -0.82 . . . . 0.0 111.284 -179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -137.85 -41.39 0.54 Allowed 'General case' 0 C--N 1.313 -0.994 0 CA-C-O 120.804 0.335 . . . . 0.0 110.639 -179.521 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 124.12 -3.79 9.03 Favored Glycine 0 N--CA 1.448 -0.526 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.82 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.527 ' OXT' ' HG3' ' A' ' 179' ' ' PRO . . . . . . . . 0 N--CA 1.444 -0.82 0 CA-C-O 118.487 -1.174 . . . . 0.0 111.817 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.564 0 CA-C-O 120.513 0.197 . . . . 0.0 110.88 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -155.06 161.91 30.63 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.098 -1.048 . . . . 0.0 112.475 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -76.0 177.75 8.35 Favored 'Trans proline' 0 C--N 1.346 0.426 0 C-N-CA 122.895 2.397 . . . . 0.0 111.674 179.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.529 ' HB2' ' H ' ' A' ' 8' ' ' GLY . 95.5 mt-30 -98.54 -5.09 32.79 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.596 -178.659 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 79.19 -75.85 2.02 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.967 -0.635 . . . . 0.0 112.527 178.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -70.83 -43.28 59.18 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.919 -0.658 . . . . 0.0 112.085 179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 40.2 m-85 -99.17 -88.66 0.33 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.826 0.346 . . . . 0.0 110.683 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.529 ' H ' ' HB2' ' A' ' 4' ' ' GLN . . . 108.9 -158.67 14.51 Favored Glycine 0 N--CA 1.44 -1.084 0 C-N-CA 120.705 -0.759 . . . . 0.0 111.872 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.475 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -163.56 177.0 9.15 Favored 'General case' 0 C--N 1.316 -0.879 0 N-CA-C 110.261 -0.274 . . . . 0.0 110.261 -179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 45.9 p 52.07 94.0 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.653 0 C-N-CA 123.859 0.864 . . . . 0.0 113.109 178.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -73.27 141.59 30.24 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.598 -0.811 . . . . 0.0 111.812 179.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.26 -38.4 95.6 Favored Glycine 0 C--O 1.23 -0.149 0 C-N-CA 121.317 -0.468 . . . . 0.0 112.486 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.44 -37.44 85.17 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.975 0.417 . . . . 0.0 110.831 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.595 ' O ' HG23 ' A' ' 18' ' ' ILE . 12.6 m -66.97 -31.37 71.89 Favored 'General case' 0 N--CA 1.449 -0.498 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.334 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.68 -25.74 29.12 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 112.948 0.721 . . . . 0.0 112.948 -176.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.66 -35.41 8.49 Favored Glycine 0 N--CA 1.447 -0.629 0 C-N-CA 120.129 -1.034 . . . . 0.0 113.149 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.635 ' O ' HG22 ' A' ' 21' ' ' VAL . 4.5 pp -85.46 -22.42 28.26 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 113.217 0.821 . . . . 0.0 113.217 -177.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 14' ' ' SER . 14.9 pt -46.88 -37.31 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 -175.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 20.0 t -84.63 -20.75 30.85 Favored 'General case' 0 C--N 1.312 -1.051 0 C-N-CA 120.52 -0.472 . . . . 0.0 111.679 -177.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 85.0 mtt180 -88.0 -34.9 17.88 Favored 'General case' 0 C--N 1.322 -0.587 0 N-CA-C 112.617 0.599 . . . . 0.0 112.617 -178.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 17' ' ' LEU . 0.0 OUTLIER -56.55 178.62 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -37.73 -32.62 0.06 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.512 ' HB2' ' CB ' ' A' ' 92' ' ' SER . 1.7 t-20 -65.59 -24.01 66.98 Favored 'General case' 0 C--N 1.324 -0.541 0 O-C-N 122.352 -0.217 . . . . 0.0 111.393 -178.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.11 86.94 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.742 -179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 44.1 tp -75.95 -28.03 57.79 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.13 0.49 . . . . 0.0 110.392 -179.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.466 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -82.92 66.83 8.73 Favored 'General case' 0 N--CA 1.445 -0.719 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 175.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 4.4 t-20 -61.75 20.55 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 125.474 1.51 . . . . 0.0 114.537 -173.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.466 ' H ' ' C ' ' A' ' 26' ' ' ALA . 6.6 m -59.8 165.72 2.98 Favored 'General case' 0 C--N 1.309 -1.188 0 C-N-CA 123.053 0.541 . . . . 0.0 110.196 177.159 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 12.6 m -59.49 -15.18 16.0 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.764 178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -53.16 -29.34 31.03 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 124.38 1.072 . . . . 0.0 113.595 -177.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -114.98 -19.54 10.89 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 121.098 0.475 . . . . 0.0 110.176 178.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 27.3 ttm180 -79.64 -43.35 22.99 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.773 -176.162 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -160.79 -49.16 0.05 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 N-CA-C 114.17 1.174 . . . . 0.0 114.17 -175.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.0 m -74.3 157.46 6.17 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.648 0 C-N-CA 120.101 -0.64 . . . . 0.0 111.199 -177.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.527 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.4 pt? -61.34 142.62 56.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.187 0.517 . . . . 0.0 111.188 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.542 ' HE ' ' HA ' ' A' ' 39' ' ' VAL . 5.1 ptm85 -62.68 159.34 16.38 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.284 -0.871 . . . . 0.0 112.209 -179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 3.3 p -76.84 111.86 12.82 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.118 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.466 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 80.03 48.32 6.58 Favored Glycine 0 N--CA 1.427 -1.916 0 N-CA-C 110.733 -0.947 . . . . 0.0 110.733 -177.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.542 ' HA ' ' HE ' ' A' ' 36' ' ' ARG . 14.2 p -51.87 141.99 4.89 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-O 121.142 0.496 . . . . 0.0 111.63 178.458 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.6 m -76.34 147.41 38.14 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.599 -0.728 . . . . 0.0 111.644 -178.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.554 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -65.31 -13.77 59.23 Favored 'General case' 0 C--O 1.217 -0.607 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.847 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.0 mm-40 -56.51 -38.22 71.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 120.921 0.391 . . . . 0.0 110.94 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.475 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -83.76 -43.69 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.975 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.475 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.04 -69.42 0.63 Allowed 'General case' 0 C--N 1.333 -0.121 0 CA-C-O 120.497 0.189 . . . . 0.0 111.19 -178.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.7 t 74.73 -29.09 0.19 Allowed 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.721 0.809 . . . . 0.0 112.743 175.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.5 m -66.43 -67.63 0.43 Allowed 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.046 0.387 . . . . 0.0 112.046 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.7 m -133.75 -35.95 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.312 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -177.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 35.9 t -80.72 89.96 1.7 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 120.951 0.405 . . . . 0.0 110.428 -178.91 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.554 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 8.9 mm100 -82.75 -48.25 11.05 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.68 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.608 ' HE ' ' HB3' ' A' ' 52' ' ' ALA . 8.2 ttp180 -136.69 -1.11 2.29 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.832 176.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.401 ' HB1' HG13 ' A' ' 131' ' ' VAL . . . 69.37 -51.01 0.61 Allowed 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 123.47 0.708 . . . . 0.0 110.588 -174.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.608 ' HB3' ' HE ' ' A' ' 50' ' ' ARG . . . -69.27 128.47 36.71 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.095 0.474 . . . . 0.0 110.972 178.178 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.706 ' HB3' ' O ' ' A' ' 61' ' ' VAL . 0.0 OUTLIER -49.1 -19.71 0.47 Allowed 'General case' 0 C--N 1.313 -1.017 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -175.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . 0.569 ' HB3' ' NH2' ' A' ' 50' ' ' ARG . 44.0 t -63.21 -62.46 1.68 Allowed 'General case' 0 C--N 1.315 -0.9 0 CA-C-N 118.803 0.728 . . . . 0.0 110.963 179.405 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.496 ' CB ' ' HD3' ' A' ' 50' ' ' ARG . 15.7 tp -87.52 -25.59 23.59 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.322 0.582 . . . . 0.0 110.589 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -76.3 -13.89 60.13 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.85 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.434 ' HB3' ' O ' ' A' ' 53' ' ' GLN . 11.4 p -42.71 -13.18 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 114.229 1.196 . . . . 0.0 114.229 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.6 t -44.32 -38.45 3.92 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 123.688 0.795 . . . . 0.0 111.852 178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 76.7 mt -122.77 12.9 9.89 Favored 'General case' 0 CA--C 1.521 -0.141 0 CA-C-O 120.664 0.269 . . . . 0.0 111.128 177.864 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 67.33 63.73 3.61 Favored Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.212 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.706 ' O ' ' HB3' ' A' ' 53' ' ' GLN . 50.7 t -88.08 101.71 11.88 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.002 0 CA-C-O 120.865 0.364 . . . . 0.0 110.414 -177.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -161.78 100.52 1.14 Allowed 'General case' 0 C--N 1.307 -1.269 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.444 179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 79.04 -59.37 4.28 Favored Glycine 0 N--CA 1.443 -0.889 0 CA-C-N 115.456 -0.793 . . . . 0.0 112.646 179.212 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.3 m-20 -62.57 -76.93 0.05 Allowed 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.146 0.498 . . . . 0.0 111.031 -176.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.598 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 12.3 p-10 -86.69 10.93 14.23 Favored 'General case' 0 C--N 1.317 -0.848 0 CA-C-N 115.802 -0.635 . . . . 0.0 111.135 179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.45 HD21 ' HB2' ' A' ' 132' ' ' ASP . 23.4 tp -88.98 -57.7 2.81 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.332 176.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.97 -40.09 54.64 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-O 121.329 0.585 . . . . 0.0 110.186 179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 65.8 mtt180 -107.71 170.01 8.25 Favored 'General case' 0 C--N 1.311 -1.069 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 178.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 67.8 -61.53 0.37 Allowed 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 122.84 0.456 . . . . 0.0 111.687 -178.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.45 -58.41 8.13 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 122.535 0.334 . . . . 0.0 111.052 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.531 ' CG2' ' HB2' ' A' ' 133' ' ' SER . 91.2 t -60.13 -37.23 72.34 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.273 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.869 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -70.17 -34.47 73.03 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.378 -0.374 . . . . 0.0 111.155 -178.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -76.59 -43.93 36.63 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.921 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 91.0 t -67.71 -40.12 83.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.836 -179.883 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 29.6 t -69.58 -6.68 32.67 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.126 -179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 38.2 ttt85 -79.96 -20.71 44.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-O 120.919 0.39 . . . . 0.0 110.329 179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.9 mp -65.71 148.42 98.2 Favored Pre-proline 0 C--O 1.24 0.574 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 177.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -67.07 126.66 15.5 Favored 'Trans proline' 0 CA--C 1.53 0.312 0 C-N-CA 122.468 2.112 . . . . 0.0 112.9 -177.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -127.99 30.65 5.22 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.348 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.1 -53.55 17.95 Favored Glycine 0 N--CA 1.446 -0.698 0 CA-C-N 115.251 -0.886 . . . . 0.0 113.124 -176.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 72.3 p -78.3 -39.91 38.38 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-O 120.947 0.403 . . . . 0.0 111.099 -178.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.453 ' OD2' ' HB3' ' A' ' 84' ' ' SER . 6.6 p-10 -170.61 155.77 5.06 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.193 -176.214 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.1 m -81.57 -18.07 46.16 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-O 121.554 0.692 . . . . 0.0 109.333 177.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.524 ' HA ' ' CB ' ' A' ' 88' ' ' GLN . 28.9 t -58.73 -17.29 21.73 Favored 'General case' 0 CA--C 1.536 0.429 0 CA-C-N 115.001 -1.0 . . . . 0.0 111.546 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -56.51 -21.99 29.8 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 122.836 0.454 . . . . 0.0 111.25 177.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -80.33 -164.62 0.72 Allowed 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 175.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.46 46.86 0.99 Allowed 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.376 0.608 . . . . 0.0 109.406 175.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.524 ' CB ' ' HA ' ' A' ' 84' ' ' SER . 7.8 tp-100 -77.57 -59.58 2.72 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.54 -175.493 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -62.47 -38.28 89.2 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.944 -0.571 . . . . 0.0 111.725 -177.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 -82.52 17.12 1.85 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.544 -178.32 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 88' ' ' GLN . 8.6 t -54.93 -40.96 70.45 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.763 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.512 ' CB ' ' HB2' ' A' ' 23' ' ' ASN . 6.6 t -72.72 -38.83 67.33 Favored 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -177.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -73.44 -31.4 63.79 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.945 0.402 . . . . 0.0 111.172 -177.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.4 -20.88 31.15 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.046 179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.449 ' HB2' HH12 ' A' ' 36' ' ' ARG . 48.0 t80 -87.88 -50.2 6.59 Favored 'General case' 0 C--N 1.322 -0.597 0 C-N-CA 120.908 -0.317 . . . . 0.0 110.194 177.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 83.1 m-20 56.15 87.02 0.06 Allowed 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.235 -0.893 . . . . 0.0 111.973 -177.138 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -75.03 -5.12 42.37 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.296 -0.866 . . . . 0.0 111.555 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.64 -5.39 78.53 Favored Glycine 0 C--O 1.225 -0.417 0 C-N-CA 121.184 -0.531 . . . . 0.0 112.914 178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.446 ' CG1' ' HA2' ' A' ' 193' ' ' GLY . 18.4 t -94.52 -7.44 10.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.827 0 CA-C-O 121.364 0.602 . . . . 0.0 110.643 -178.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.69 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.1 pt? -84.71 -177.68 6.66 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.634 -176.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.488 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 12.5 p-10 -75.05 125.5 29.06 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.359 0.599 . . . . 0.0 111.433 -176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.7 -24.58 61.02 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.473 -0.785 . . . . 0.0 111.367 -177.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 20.6 m -68.29 -29.74 68.59 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.307 0.575 . . . . 0.0 109.671 -178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.488 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 21.2 t30 -59.86 -51.93 67.61 Favored 'General case' 0 C--N 1.315 -0.929 0 CA-C-N 115.158 -0.928 . . . . 0.0 109.737 177.565 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.59 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 2.1 mp -74.52 -37.85 44.87 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.995 0 CA-C-N 115.74 -0.663 . . . . 0.0 111.442 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.4 t70 -66.72 -34.56 78.11 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.843 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.461 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 98.2 m -89.21 -49.14 6.91 Favored 'General case' 0 C--O 1.22 -0.454 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -176.505 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 109' ' ' GLY . 0.0 OUTLIER -127.33 -15.3 5.18 Favored 'General case' 0 C--N 1.319 -0.757 0 C-N-CA 119.085 -1.046 . . . . 0.0 113.453 -177.282 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.59 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -65.65 -75.74 0.39 Allowed Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 119.747 -1.216 . . . . 0.0 112.926 -178.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.479 ' O ' ' HA ' ' A' ' 114' ' ' SER . 16.3 m -67.77 -16.81 64.3 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.857 0.36 . . . . 0.0 111.542 -178.095 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.461 ' HD3' ' O ' ' A' ' 107' ' ' THR . 60.9 mtp180 -86.76 -46.59 9.85 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 112.287 0.476 . . . . 0.0 112.287 -177.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 86.1 t -83.81 -52.39 12.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 C-N-CA 120.829 -0.348 . . . . 0.0 110.756 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.475 ' HG ' ' HA ' ' A' ' 9' ' ' ALA . 7.0 mp -67.59 -33.59 75.31 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.144 179.907 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 110' ' ' SER . 72.3 m 45.64 -99.63 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 177.694 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.48 -35.07 60.17 Favored 'General case' 0 CA--C 1.518 -0.269 0 C-N-CA 123.289 0.636 . . . . 0.0 112.306 -175.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 52.3 tp -66.53 -52.66 43.35 Favored 'General case' 0 N--CA 1.443 -0.805 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.115 -179.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.53 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 12.6 mt -72.43 -26.54 61.88 Favored 'General case' 0 CA--C 1.51 -0.593 0 N-CA-C 112.498 0.555 . . . . 0.0 112.498 -177.845 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -57.97 -36.93 73.29 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 121.177 0.513 . . . . 0.0 109.836 178.356 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.96 -43.19 6.07 Favored Glycine 0 N--CA 1.437 -1.248 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.65 176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.53 ' HB ' ' HA ' ' A' ' 117' ' ' LEU . 37.3 t -61.0 -42.23 92.2 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.43 0 N-CA-C 112.554 0.576 . . . . 0.0 112.554 -178.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -59.06 -32.3 69.65 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.984 0.421 . . . . 0.0 111.285 -179.084 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 18.7 t -85.17 -39.85 17.38 Favored 'General case' 0 N--CA 1.438 -1.029 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.322 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.38 -81.5 0.11 Allowed 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 113.138 0.792 . . . . 0.0 113.138 -176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.468 ' HA ' HG12 ' A' ' 129' ' ' ILE . . . -69.08 -44.99 71.42 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 112.268 0.47 . . . . 0.0 112.268 -174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.45 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 48.2 tt0 -70.5 -38.05 74.26 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 121.131 0.491 . . . . 0.0 111.183 -177.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.73 -40.97 7.43 Favored Glycine 0 N--CA 1.443 -0.893 0 C-N-CA 120.753 -0.737 . . . . 0.0 114.455 -176.064 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 79.8 mt -114.66 -22.48 9.71 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 -174.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 77.36 95.38 0.21 Allowed Glycine 0 C--N 1.317 -0.473 0 C-N-CA 120.056 -1.069 . . . . 0.0 110.52 -176.335 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.501 ' O ' ' HB ' ' A' ' 37' ' ' THR . 15.8 mm -76.76 132.99 31.88 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 N-CA-C 112.943 0.72 . . . . 0.0 112.943 -175.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.514 HD21 ' NE2' ' A' ' 137' ' ' GLN . 10.8 t30 -115.49 132.01 56.75 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.782 177.637 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.466 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 21.5 t -99.11 120.94 49.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.07 0 CA-C-O 121.153 0.501 . . . . 0.0 110.408 178.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' HD21 ' A' ' 66' ' ' LEU . 5.9 m-20 -99.98 35.8 1.97 Allowed 'General case' 0 C--N 1.305 -1.333 0 CA-C-N 115.567 -0.742 . . . . 0.0 109.515 -179.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.531 ' HB2' ' CG2' ' A' ' 71' ' ' VAL . 67.3 p -70.82 -8.06 49.77 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.077 -176.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 94.1 -19.75 51.5 Favored Glycine 0 N--CA 1.437 -1.286 0 C-N-CA 120.086 -1.054 . . . . 0.0 111.198 -177.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 7.4 p -105.98 -46.96 3.97 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 112.352 0.501 . . . . 0.0 112.352 -177.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.458 ' O ' HG12 ' A' ' 140' ' ' ILE . 54.2 t -66.28 -62.5 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.887 0.375 . . . . 0.0 111.538 -177.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.514 ' NE2' HD21 ' A' ' 130' ' ' ASN . 8.1 tt0 -56.3 -39.23 72.38 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -175.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.3 p -62.43 -40.35 96.29 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.071 0.397 . . . . 0.0 112.071 -177.35 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -84.78 -47.12 10.71 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 120.255 -0.578 . . . . 0.0 111.905 -179.433 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.458 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.7 pt -57.4 -38.46 62.95 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.484 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -176.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 10.3 p -56.61 -42.14 78.27 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 120.87 0.367 . . . . 0.0 111.66 -179.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.0 t -84.67 -39.76 18.21 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.005 0.431 . . . . 0.0 111.05 -179.565 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.404 ' HA ' HD13 ' A' ' 147' ' ' LEU . 61.6 m -69.69 -39.58 76.87 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.452 0.538 . . . . 0.0 112.452 -178.089 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 27.0 t -71.37 -23.69 61.94 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 121.14 -0.224 . . . . 0.0 111.444 -178.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 10.3 p -87.83 -49.52 7.05 Favored 'General case' 0 N--CA 1.441 -0.924 0 N-CA-C 111.966 0.358 . . . . 0.0 111.966 179.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.449 ' HA ' ' HB2' ' A' ' 150' ' ' SER . 83.7 m-85 -86.32 -59.47 2.28 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 113.273 0.842 . . . . 0.0 113.273 -176.616 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.404 HD13 ' HA ' ' A' ' 143' ' ' SER . 10.4 mp -61.27 -8.74 4.04 Favored 'General case' 0 N--CA 1.476 0.835 0 N-CA-C 113.456 0.909 . . . . 0.0 113.456 -173.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 40.7 p -90.68 -67.21 0.86 Allowed 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 120.995 0.426 . . . . 0.0 111.672 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.414 HG22 ' CE1' ' A' ' 156' ' ' TYR . 12.6 p -131.24 28.25 4.73 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 113.888 1.07 . . . . 0.0 113.888 -173.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.449 ' HB2' ' HA ' ' A' ' 146' ' ' PHE . 32.8 t -65.93 158.04 29.12 Favored 'General case' 0 C--O 1.243 0.74 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 176.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 33.9 m 59.88 -154.34 0.37 Allowed 'General case' 0 C--O 1.24 0.573 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 16.6 m -72.09 -51.83 19.68 Favored 'General case' 0 N--CA 1.44 -0.934 0 N-CA-C 109.392 -0.595 . . . . 0.0 109.392 176.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.49 ' HA ' ' CE1' ' A' ' 156' ' ' TYR . 51.9 m -153.77 86.98 1.2 Allowed 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.092 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.53 -62.06 2.16 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -177.359 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.9 m -128.96 22.1 5.78 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 -175.181 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.49 ' CE1' ' HA ' ' A' ' 153' ' ' SER . 33.0 p90 -135.69 141.45 44.95 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 120.327 -0.549 . . . . 0.0 111.441 -178.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 64.7 m 65.67 -65.89 0.16 Allowed 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.931 0.893 . . . . 0.0 112.846 178.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -71.54 3.19 4.12 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.051 0.389 . . . . 0.0 112.051 -176.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.25 -27.71 68.17 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.296 0.57 . . . . 0.0 109.585 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.0 m -148.11 -41.13 0.17 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.659 -0.7 . . . . 0.0 110.015 176.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . 68.16 -61.26 0.39 Allowed 'General case' 0 N--CA 1.474 0.741 0 C-N-CA 124.059 0.943 . . . . 0.0 113.286 177.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 57.9 m -75.33 105.36 6.31 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.926 0.394 . . . . 0.0 111.981 -177.103 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.7 p -83.02 -46.82 12.39 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 174.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 15.9 m -69.18 129.36 39.63 Favored 'General case' 0 N--CA 1.437 -1.089 0 N-CA-C 107.988 -1.116 . . . . 0.0 107.988 174.216 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 67.0 p 55.88 30.01 15.14 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.41 0.624 . . . . 0.0 111.237 -176.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -149.03 -97.16 0.18 Allowed Glycine 0 N--CA 1.44 -1.071 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.673 178.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -101.86 99.79 10.03 Favored 'General case' 0 C--N 1.316 -0.869 0 CA-C-O 120.557 0.217 . . . . 0.0 110.695 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -78.52 -15.63 80.58 Favored Glycine 0 CA--C 1.519 0.327 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.842 -179.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 94.8 m-85 -72.48 -45.51 59.16 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.792 0.329 . . . . 0.0 110.526 179.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.427 ' HA ' ' CD ' ' A' ' 175' ' ' PRO . 3.5 m 55.57 89.06 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.629 0 CA-C-N 115.392 -0.822 . . . . 0.0 112.537 -179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 163.0 -144.76 9.86 Favored Glycine 0 N--CA 1.444 -0.789 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -58.63 -36.79 96.76 Favored 'Trans proline' 0 C--N 1.344 0.324 0 C-N-CA 122.424 2.083 . . . . 0.0 111.183 176.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.0 p -91.19 10.67 26.14 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.411 178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -123.68 -141.28 5.79 Favored Glycine 0 N--CA 1.44 -1.035 0 CA-C-N 115.64 -0.709 . . . . 0.0 111.849 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.427 ' CD ' ' HA ' ' A' ' 170' ' ' THR . 7.7 Cg_exo -74.54 -8.24 20.35 Favored 'Trans proline' 0 C--N 1.346 0.436 0 C-N-CA 122.833 2.356 . . . . 0.0 112.993 -178.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 16.6 m 53.39 48.26 22.32 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-O 121.455 0.645 . . . . 0.0 109.627 -178.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.0 t -85.07 147.52 26.62 Favored 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.412 -0.813 . . . . 0.0 111.878 -176.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 160.37 61.77 0.01 OUTLIER Glycine 0 N--CA 1.442 -0.939 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.276 179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.415 ' HA ' ' CE2' ' A' ' 156' ' ' TYR . 19.6 Cg_endo -58.4 122.14 11.16 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.494 2.13 . . . . 0.0 112.683 -177.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 9.0 m -75.97 96.36 3.76 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.831 179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -157.08 -77.25 0.02 OUTLIER Glycine 0 N--CA 1.439 -1.158 0 C-N-CA 120.556 -0.83 . . . . 0.0 112.448 -179.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -105.55 118.44 55.55 Favored Pre-proline 0 C--N 1.321 -0.668 0 CA-C-O 120.743 0.306 . . . . 0.0 111.288 -177.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_exo -63.21 135.02 48.38 Favored 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.733 2.289 . . . . 0.0 111.506 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.475 ' HA2' ' CA ' ' A' ' 199' ' ' GLY . . . 141.67 -104.76 0.39 Allowed Glycine 0 N--CA 1.441 -0.975 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.926 -179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -69.23 -19.4 38.72 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.414 2.076 . . . . 0.0 111.675 179.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 97.8 mt 60.63 -82.31 0.02 OUTLIER 'General case' 0 C--N 1.348 0.528 0 C-N-CA 123.549 0.739 . . . . 0.0 111.129 -179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -150.78 48.08 0.58 Allowed Glycine 0 N--CA 1.44 -1.064 0 N-CA-C 110.221 -1.151 . . . . 0.0 110.221 178.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 83.68 36.97 12.48 Favored Glycine 0 N--CA 1.444 -0.799 0 N-CA-C 110.909 -0.877 . . . . 0.0 110.909 -177.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 119.46 -86.72 0.4 Allowed Glycine 0 N--CA 1.438 -1.197 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 -177.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.447 ' HA ' ' HD3' ' A' ' 191' ' ' PRO . . . 64.93 143.13 0.07 OUTLIER Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 123.819 0.848 . . . . 0.0 112.745 179.258 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 190' ' ' ALA . 35.1 Cg_endo -96.37 15.92 0.82 Allowed 'Trans proline' 0 N--CA 1.449 -1.114 0 C-N-CA 123.203 2.602 . . . . 0.0 111.931 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 82.7 t80 -83.96 -68.83 0.68 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.815 -178.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.446 ' HA2' ' CG1' ' A' ' 99' ' ' VAL . . . -113.98 63.47 0.3 Allowed Glycine 0 CA--C 1.486 -1.74 0 C-N-CA 121.033 -0.603 . . . . 0.0 111.789 -174.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.413 ' CD ' ' HA ' ' A' ' 191' ' ' PRO . 2.7 pt20 -115.31 6.57 14.95 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.413 -0.394 . . . . 0.0 111.904 -176.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 47.9 t -139.75 -57.49 0.57 Allowed 'General case' 0 C--N 1.319 -0.755 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.429 -178.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . -112.07 51.28 0.71 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.193 -1.003 . . . . 0.0 111.975 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 22.0 t80 -131.59 -53.72 1.01 Allowed 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.908 0.385 . . . . 0.0 110.785 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 105.41 86.09 1.88 Allowed Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.742 179.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.475 ' CA ' ' HA2' ' A' ' 184' ' ' GLY . . . . . . . . 0 C--O 1.248 1.011 0 CA-C-O 118.808 -0.996 . . . . 0.0 112.411 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.486 0 CA-C-O 120.727 0.298 . . . . 0.0 110.343 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 166.49 166.39 25.46 Favored Glycine 0 N--CA 1.438 -1.23 0 C-N-CA 119.937 -1.125 . . . . 0.0 112.569 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.54 ' HB3' ' HA2' ' A' ' 8' ' ' GLY . 24.2 Cg_exo -66.02 171.15 10.47 Favored 'Trans proline' 0 C--O 1.241 0.652 0 C-N-CA 123.015 2.477 . . . . 0.0 111.973 179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -101.97 93.72 5.41 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.482 -178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.94 -109.76 2.91 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.812 -0.708 . . . . 0.0 111.885 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -98.23 2.99 59.73 Favored Glycine 0 N--CA 1.443 -0.85 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.018 179.419 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -91.48 87.24 6.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.257 0.551 . . . . 0.0 111.217 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.54 ' HA2' ' HB3' ' A' ' 3' ' ' PRO . . . -83.13 55.8 5.05 Favored Glycine 0 N--CA 1.452 -0.248 0 CA-C-N 115.505 -0.77 . . . . 0.0 111.847 177.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.516 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -66.09 103.9 1.05 Allowed 'General case' 0 C--N 1.32 -0.687 0 C-N-CA 122.659 0.383 . . . . 0.0 111.204 -178.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.8 p -145.5 -75.38 0.22 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.911 -0.586 . . . . 0.0 111.493 -178.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 174.5 -40.17 0.12 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 121.041 -0.599 . . . . 0.0 111.99 -179.374 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 58.85 -109.77 2.24 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.04 177.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.466 ' HB3' ' CD2' ' A' ' 108' ' ' LEU . . . -62.96 -18.03 62.69 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 120.788 0.327 . . . . 0.0 111.618 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.566 ' O ' HG23 ' A' ' 18' ' ' ILE . 75.8 m -65.34 -21.83 66.74 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.008 176.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.45 -23.78 41.13 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-O 120.931 0.396 . . . . 0.0 111.958 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -83.78 -41.75 8.07 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.476 -0.869 . . . . 0.0 112.597 179.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.55 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.1 pp -87.94 -20.62 25.66 Favored 'General case' 0 CA--C 1.549 0.923 0 N-CA-C 114.788 1.403 . . . . 0.0 114.788 -178.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.566 HG23 ' O ' ' A' ' 14' ' ' SER . 12.0 pt -43.39 -47.67 1.57 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 N-CA-C 114.877 1.436 . . . . 0.0 114.877 -174.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.531 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 35.4 t -73.06 -20.19 61.03 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 121.267 -0.173 . . . . 0.0 111.101 -177.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.445 ' O ' ' HB2' ' A' ' 191' ' ' PRO . 50.4 mtt180 -86.32 -32.24 21.13 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 179.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.55 HG23 ' O ' ' A' ' 17' ' ' LEU . 39.3 t -54.15 169.95 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.009 0 CA-C-N 116.471 -0.331 . . . . 0.0 111.115 -178.653 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.522 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.73 -32.5 0.04 OUTLIER 'General case' 0 N--CA 1.48 1.033 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 -177.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.439 ' HA ' ' HB3' ' A' ' 26' ' ' ALA . 31.7 m-80 -60.79 -24.39 65.76 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.098 0.407 . . . . 0.0 112.098 179.703 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.531 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.63 -53.05 59.84 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-O 120.985 0.421 . . . . 0.0 111.332 179.104 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' HB3' ' CD1' ' A' ' 192' ' ' PHE . 30.3 tp -80.91 -25.77 37.27 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.333 -178.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -75.72 90.36 2.86 Favored 'General case' 0 N--CA 1.444 -0.738 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 176.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.532 ' HA ' ' NH2' ' A' ' 32' ' ' ARG . 5.2 m-80 -75.3 17.98 0.23 Allowed 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 113.358 0.873 . . . . 0.0 113.358 -175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 36.7 m -65.8 148.26 52.05 Favored 'General case' 0 N--CA 1.431 -1.407 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 175.139 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 53.1 m -58.07 -14.54 6.9 Favored 'General case' 0 C--N 1.319 -0.735 0 N-CA-C 113.881 1.067 . . . . 0.0 113.881 -176.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 19.2 p -48.5 -35.72 13.71 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 113.696 0.999 . . . . 0.0 113.696 -177.604 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.465 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -108.41 -18.25 13.79 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-O 121.197 0.522 . . . . 0.0 110.679 179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.532 ' NH2' ' HA ' ' A' ' 27' ' ' ASN . 17.0 mmt180 -76.73 -49.86 15.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.674 -175.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 11.7 t -163.45 -29.76 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.917 0 N-CA-C 113.397 0.888 . . . . 0.0 113.397 -176.58 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 96.4 t -87.49 144.87 8.36 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.871 0 N-CA-C 110.424 -0.213 . . . . 0.0 110.424 -179.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -57.5 145.58 32.77 Favored 'General case' 0 C--O 1.236 0.354 0 CA-C-O 120.784 0.326 . . . . 0.0 110.728 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.2 ptt85 -70.59 153.53 42.78 Favored 'General case' 0 N--CA 1.446 -0.666 0 CA-C-O 121.04 0.448 . . . . 0.0 110.899 -179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.3 m -68.84 120.8 15.34 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.599 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.93 37.14 20.04 Favored Glycine 0 N--CA 1.44 -1.081 0 C-N-CA 120.676 -0.773 . . . . 0.0 112.514 178.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.457 ' O ' ' HA ' ' A' ' 50' ' ' ARG . 7.5 p -51.31 148.37 1.19 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 CA-C-O 121.153 0.501 . . . . 0.0 111.29 178.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 15.3 m -93.0 153.93 18.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.061 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.586 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 1.0 OUTLIER -65.41 -12.72 55.01 Favored 'General case' 0 C--O 1.222 -0.394 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.422 -178.994 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 72.7 mm-40 -48.96 -38.58 23.49 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.198 0.523 . . . . 0.0 109.979 178.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.702 HG13 ' N ' ' A' ' 44' ' ' ALA . 3.9 pt -85.12 -44.47 17.29 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.76 -0.655 . . . . 0.0 111.907 178.142 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.702 ' N ' HG13 ' A' ' 43' ' ' ILE . . . -84.14 -67.46 0.79 Allowed 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -175.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 33.7 m 75.95 -18.57 0.46 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 123.808 0.843 . . . . 0.0 112.627 178.738 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.1 t -57.14 -96.2 0.0 OUTLIER 'General case' 0 CA--C 1.549 0.928 0 C-N-CA 122.88 0.472 . . . . 0.0 112.153 -179.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 22.3 m -124.35 -23.21 2.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.371 0.605 . . . . 0.0 110.582 179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.4 p -79.52 98.69 3.17 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.192 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.44 179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.597 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 79.2 mm-40 -73.41 -47.23 43.51 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.713 177.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.457 ' HA ' ' O ' ' A' ' 39' ' ' VAL . 27.4 ttm-85 -149.47 9.02 0.71 Allowed 'General case' 0 N--CA 1.436 -1.166 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.418 178.492 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.87 -53.31 0.57 Allowed 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 123.447 0.699 . . . . 0.0 110.982 -175.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.422 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -68.54 142.82 55.13 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.573 177.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.601 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -55.03 -19.05 6.12 Favored 'General case' 0 C--O 1.215 -0.738 0 N-CA-C 113.168 0.803 . . . . 0.0 113.168 -175.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 32.9 t -55.55 -71.4 0.09 Allowed 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 120.862 0.363 . . . . 0.0 111.138 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.7 -25.92 23.23 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-O 120.932 0.396 . . . . 0.0 111.231 -179.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -77.25 -18.39 57.67 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 113.361 0.874 . . . . 0.0 113.361 -176.107 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.601 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 19.3 t -52.42 106.04 0.14 Allowed 'General case' 0 C--O 1.238 0.484 0 CA-C-O 121.028 0.442 . . . . 0.0 110.516 -179.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.539 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.4 t -165.39 -40.8 0.03 OUTLIER 'General case' 0 N--CA 1.441 -0.912 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.306 -177.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.539 ' HG ' HG23 ' A' ' 58' ' ' THR . 93.0 mt -121.69 19.47 11.09 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 -178.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 92.36 64.23 1.12 Allowed Glycine 0 C--N 1.316 -0.554 0 C-N-CA 120.201 -1.0 . . . . 0.0 111.795 -178.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 48.6 t -100.02 101.89 12.7 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-O 121.057 0.456 . . . . 0.0 110.612 -179.444 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.4 p-10 -163.46 13.46 0.06 Allowed 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.879 0.847 . . . . 0.0 109.461 178.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 145.87 -50.74 0.61 Allowed Glycine 0 C--N 1.294 -1.794 0 CA-C-N 114.392 -1.276 . . . . 0.0 111.159 -176.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 9.0 t30 -58.34 -55.23 37.64 Favored 'General case' 0 C--O 1.226 -0.184 0 CA-C-O 120.782 0.325 . . . . 0.0 110.551 179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -84.63 -41.79 16.01 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.482 175.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 62.5 tp -53.58 -58.27 7.78 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.396 -176.08 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.09 -5.74 59.22 Favored 'General case' 0 C--N 1.315 -0.915 0 N-CA-C 112.632 0.604 . . . . 0.0 112.632 -176.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 51.5 mtt180 -128.25 -86.04 0.57 Allowed 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 -176.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -57.89 -31.91 67.21 Favored 'General case' 0 N--CA 1.473 0.72 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -172.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -73.48 -52.04 15.02 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.701 0.286 . . . . 0.0 111.131 -178.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.545 ' HB ' ' HB2' ' A' ' 133' ' ' SER . 9.2 p -69.04 -40.77 81.22 Favored 'Isoleucine or valine' 0 C--O 1.218 -0.591 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.276 -179.305 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.503 ' O ' ' HG2' ' A' ' 76' ' ' ARG . 75.1 mt-30 -62.91 -39.15 93.66 Favored 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 121.348 -0.141 . . . . 0.0 111.358 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.26 -43.71 71.21 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.96 0.41 . . . . 0.0 111.127 179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.518 ' HA ' HD12 ' A' ' 77' ' ' LEU . 39.7 t -86.36 -32.37 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.58 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.002 -179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 22.4 t -70.81 -23.27 62.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.164 -179.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.503 ' HG2' ' O ' ' A' ' 72' ' ' GLN . 24.7 mmt180 -85.18 1.65 47.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.484 -0.325 . . . . 0.0 110.776 178.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.54 HD13 ' CE2' ' A' ' 86' ' ' TYR . 77.0 mt -85.52 154.64 59.39 Favored Pre-proline 0 C--N 1.321 -0.667 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.019 179.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_endo -52.52 160.49 3.63 Favored 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 122.993 2.462 . . . . 0.0 112.624 178.066 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -73.12 -148.62 0.02 OUTLIER 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -40.53 -37.64 1.28 Allowed Glycine 0 N--CA 1.472 1.063 0 N-CA-C 115.55 0.98 . . . . 0.0 115.55 -175.11 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 65.3 m -56.55 -29.91 62.51 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 117.222 0.511 . . . . 0.0 111.804 -179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -111.45 -23.43 10.75 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.289 179.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 27.5 m -63.21 -41.44 99.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 177.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 20.3 m -69.31 -23.74 63.85 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.246 178.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -77.6 -22.65 50.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.595 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.54 ' CE2' HD13 ' A' ' 77' ' ' LEU . 18.3 m-30 -85.29 -164.71 1.04 Allowed 'General case' 0 C--N 1.313 -0.984 0 CA-C-N 115.445 -0.798 . . . . 0.0 111.359 -179.56 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.422 ' H ' HG21 ' A' ' 43' ' ' ILE . . . -72.55 53.27 0.31 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 123.237 0.615 . . . . 0.0 111.352 -179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 8.1 tp-100 -90.6 -59.2 2.24 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.035 -0.53 . . . . 0.0 111.117 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -83.26 -26.27 30.85 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.657 -177.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.407 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.3 m-85 -83.51 6.68 19.55 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.407 -0.361 . . . . 0.0 111.528 -178.078 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 67.3 m -52.84 -31.44 39.13 Favored 'General case' 0 C--O 1.223 -0.291 0 N-CA-C 112.277 0.473 . . . . 0.0 112.277 -179.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.425 ' HA ' ' ND2' ' A' ' 23' ' ' ASN . 73.6 m -61.22 -47.68 84.99 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -83.04 -25.54 32.03 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.789 -178.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 84.0 mt -85.15 -32.19 22.87 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 113.147 0.795 . . . . 0.0 113.147 -177.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 76.9 t80 -84.85 -36.52 21.53 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 121.125 -0.23 . . . . 0.0 110.769 -178.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.5 m120 62.01 86.47 0.11 Allowed 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 121.509 0.671 . . . . 0.0 112.022 179.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.04 56.65 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.755 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.9 -13.63 42.46 Favored Glycine 0 C--O 1.225 -0.418 0 CA-C-N 115.953 -0.567 . . . . 0.0 112.73 179.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.546 ' CG1' ' HA2' ' A' ' 193' ' ' GLY . 5.1 t -84.17 -1.05 6.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.612 0.72 . . . . 0.0 110.434 -178.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HB3' HG13 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.15 179.32 6.41 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.298 -0.865 . . . . 0.0 110.896 -179.653 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.3 p30 -84.78 141.19 30.68 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 120.227 -0.589 . . . . 0.0 110.529 -179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -75.21 -23.64 57.64 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-N 115.66 -0.7 . . . . 0.0 112.814 -175.415 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 45.6 m -69.05 -34.78 75.74 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.469 0.652 . . . . 0.0 110.386 -176.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.59 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 31.5 t30 -60.21 -51.71 68.41 Favored 'General case' 0 C--N 1.303 -1.456 0 CA-C-N 115.172 -0.922 . . . . 0.0 110.487 178.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -77.61 -33.9 19.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-N 115.993 -0.549 . . . . 0.0 112.22 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -63.86 -48.41 76.83 Favored 'General case' 0 C--N 1.301 -1.519 0 C-N-CA 119.934 -0.706 . . . . 0.0 109.966 176.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.54 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 71.1 m -73.1 -56.54 4.97 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 -174.145 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.59 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.3 pp -102.18 -24.37 13.93 Favored 'General case' 0 C--N 1.315 -0.909 0 C-N-CA 119.39 -0.924 . . . . 0.0 112.067 -176.429 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -65.28 -65.91 2.7 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.176 -1.011 . . . . 0.0 112.274 -179.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.2 m -65.61 -28.18 68.94 Favored 'General case' 0 C--N 1.312 -1.052 0 N-CA-C 111.93 0.344 . . . . 0.0 111.93 -178.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.54 ' HD3' ' O ' ' A' ' 107' ' ' THR . 11.5 mpt_? -86.57 -55.31 3.94 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 -177.789 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 61.5 t -83.54 -48.77 17.1 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 N-CA-C 112.038 0.384 . . . . 0.0 112.038 -174.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 15.4 mt -72.13 -42.64 65.79 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 110.098 -0.334 . . . . 0.0 110.098 -178.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 64.6 m 48.46 -95.09 0.03 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 176.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.6 -33.28 54.38 Favored 'General case' 0 N--CA 1.465 0.281 0 C-N-CA 123.206 0.602 . . . . 0.0 112.031 -177.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.516 HD22 ' HB1' ' A' ' 9' ' ' ALA . 60.7 tp -62.19 -53.59 53.04 Favored 'General case' 0 N--CA 1.446 -0.625 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.503 179.329 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.41 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 13.7 mt -66.6 -28.34 68.42 Favored 'General case' 0 N--CA 1.447 -0.599 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.777 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.1 m120 -59.49 -43.99 93.19 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 120.963 0.411 . . . . 0.0 110.038 177.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -79.24 -31.73 41.31 Favored Glycine 0 N--CA 1.447 -0.574 0 C-N-CA 120.73 -0.748 . . . . 0.0 111.98 178.568 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.592 HG13 ' HB3' ' A' ' 124' ' ' ALA . 69.4 t -68.43 -38.9 79.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 O-C-N 122.863 -0.198 . . . . 0.0 111.269 179.198 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.427 ' HA ' ' HB2' ' A' ' 125' ' ' GLN . 64.9 m -57.55 -41.95 82.0 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.845 -178.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 6.4 p -83.85 -39.24 20.16 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 111.983 0.364 . . . . 0.0 111.983 -179.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.94 -80.48 0.19 Allowed 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 113.099 0.777 . . . . 0.0 113.099 -176.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.592 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -64.22 -55.61 20.4 Favored 'General case' 0 N--CA 1.467 0.404 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -175.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.427 ' HB2' ' HA ' ' A' ' 121' ' ' SER . 70.0 mt-30 -70.12 -29.23 66.12 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.197 -179.334 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -77.68 -64.73 2.01 Favored Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 121.091 -0.575 . . . . 0.0 114.185 -175.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 63.7 mt -104.35 -23.78 13.16 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-O 120.859 0.362 . . . . 0.0 111.656 -175.192 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 89.94 97.72 1.12 Allowed Glycine 0 N--CA 1.441 -0.983 0 N-CA-C 110.066 -1.214 . . . . 0.0 110.066 -176.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.422 HG23 ' CB ' ' A' ' 52' ' ' ALA . 30.1 mm -75.37 129.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.083 0 N-CA-C 113.156 0.799 . . . . 0.0 113.156 -175.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 33.6 t30 -127.84 131.92 49.46 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 114.423 -1.262 . . . . 0.0 107.962 175.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -103.97 118.31 50.91 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-O 121.471 0.653 . . . . 0.0 111.405 -177.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -97.63 43.97 1.06 Allowed 'General case' 0 C--N 1.306 -1.319 0 CA-C-N 115.088 -0.96 . . . . 0.0 110.455 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.545 ' HB2' ' HB ' ' A' ' 71' ' ' VAL . 21.0 p -78.62 1.14 23.71 Favored 'General case' 0 C--N 1.313 -1.022 0 CA-C-O 120.855 0.36 . . . . 0.0 111.256 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 90.36 -21.96 29.28 Favored Glycine 0 N--CA 1.44 -1.054 0 C-N-CA 120.924 -0.655 . . . . 0.0 111.567 -178.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 26.2 t -106.0 -58.67 1.88 Allowed 'General case' 0 C--N 1.317 -0.84 0 O-C-N 122.927 -0.16 . . . . 0.0 111.285 -178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.489 ' O ' HG12 ' A' ' 140' ' ' ILE . 63.3 t -50.63 -51.97 17.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 CA-C-N 116.325 -0.398 . . . . 0.0 112.003 -174.194 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.413 HE21 ' HB2' ' A' ' 137' ' ' GLN . 8.3 tt0 -61.76 -44.44 96.88 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.237 -179.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.4 m -60.69 -46.78 89.08 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.952 0.406 . . . . 0.0 110.302 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -62.8 -51.1 68.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.651 -0.704 . . . . 0.0 111.578 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.489 HG12 ' O ' ' A' ' 136' ' ' VAL . 39.4 pt -69.32 -38.09 76.85 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 N-CA-C 112.21 0.448 . . . . 0.0 112.21 -177.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.1 t -63.05 -52.35 63.13 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.465 0.174 . . . . 0.0 111.316 -178.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 23.9 p -62.85 -43.34 99.04 Favored 'General case' 0 C--O 1.239 0.511 0 CA-C-O 121.04 0.448 . . . . 0.0 110.985 -179.097 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 23.5 t -65.18 -40.52 94.36 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.311 -179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 16.1 m -77.53 -19.52 55.65 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.144 0.497 . . . . 0.0 110.946 179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 33.2 t -81.61 -60.49 2.23 Favored 'General case' 0 C--N 1.313 -0.982 0 CA-C-O 120.85 0.357 . . . . 0.0 110.857 178.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -88.98 -46.2 9.06 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 -175.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 62.2 mt -85.7 -4.42 59.16 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -173.403 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 2.5 p -54.27 -54.19 43.46 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-O 121.403 0.621 . . . . 0.0 111.173 -178.64 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.5 m -146.31 83.93 1.63 Allowed 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.127 176.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 43.6 t -85.04 121.56 27.99 Favored 'General case' 0 N--CA 1.439 -0.977 0 CA-C-N 115.057 -0.974 . . . . 0.0 109.95 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 80.3 p 51.39 -95.95 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.959 0.904 . . . . 0.0 112.269 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 32.1 t -134.14 -17.93 2.07 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 121.354 0.597 . . . . 0.0 109.782 179.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.426 ' HB3' ' OE1' ' A' ' 158' ' ' GLN . 45.1 m -153.21 145.87 24.26 Favored 'General case' 0 N--CA 1.446 -0.659 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.353 -179.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -56.71 -41.41 77.39 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 112.528 0.566 . . . . 0.0 112.528 -177.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 16.3 m -85.72 -1.76 57.52 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.361 0.504 . . . . 0.0 112.361 -177.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 48.0 t80 67.65 -59.5 0.41 Allowed 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.876 0.87 . . . . 0.0 112.791 178.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 20.7 m -58.46 -22.07 53.38 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 122.908 0.483 . . . . 0.0 111.556 -178.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.426 ' OE1' ' HB3' ' A' ' 153' ' ' SER . 84.0 mt-30 -66.02 -44.61 84.2 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 176.537 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.446 ' C ' ' H ' ' A' ' 161' ' ' ALA . . . 40.22 75.73 0.08 Allowed 'General case' 0 C--N 1.344 0.355 0 C-N-CA 124.164 0.986 . . . . 0.0 112.258 179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 92.4 p 65.71 -24.12 0.09 Allowed 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 125.385 1.474 . . . . 0.0 113.187 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.446 ' H ' ' C ' ' A' ' 159' ' ' ALA . . . 57.72 -165.91 0.15 Allowed 'General case' 0 C--O 1.238 0.453 0 C-N-CA 123.163 0.585 . . . . 0.0 110.674 -179.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 18.4 t -130.82 82.75 2.07 Favored 'General case' 0 C--N 1.308 -1.215 0 CA-C-O 121.146 0.498 . . . . 0.0 109.901 177.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 16.5 m -64.85 -14.28 58.92 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.165 -179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.0 m -63.91 -39.95 95.35 Favored 'General case' 0 N--CA 1.447 -0.608 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.444 178.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 21.4 t -102.32 -8.16 21.45 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.354 0.597 . . . . 0.0 109.677 178.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 117.56 125.25 3.57 Favored Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 110.997 -0.841 . . . . 0.0 110.997 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -71.49 -43.48 66.48 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.675 0.274 . . . . 0.0 111.733 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 77.68 -59.25 3.79 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 121.016 -0.612 . . . . 0.0 112.234 -179.526 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 74.1 m-85 -63.73 -25.98 68.44 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.948 0.404 . . . . 0.0 111.165 -179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 71.2 m -153.53 113.24 3.86 Favored 'General case' 0 C--N 1.318 -0.78 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.024 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -63.48 -54.33 32.67 Favored Glycine 0 CA--C 1.522 0.507 0 CA-C-O 119.335 -0.703 . . . . 0.0 113.932 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -56.56 83.91 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.292 0 C-N-CA 123.048 2.499 . . . . 0.0 113.88 -178.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.431 ' HB2' ' HA ' ' A' ' 190' ' ' ALA . 39.3 t 69.91 -13.51 0.41 Allowed 'General case' 0 N--CA 1.471 0.584 0 C-N-CA 123.92 0.888 . . . . 0.0 113.278 176.29 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 121.43 174.33 14.79 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.205 -0.998 . . . . 0.0 112.147 -177.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -80.44 83.76 2.16 Favored 'Trans proline' 0 N--CA 1.459 -0.557 0 C-N-CA 123.143 2.562 . . . . 0.0 113.137 -176.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 15.9 t 58.78 28.77 17.82 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 115.879 -0.601 . . . . 0.0 111.468 177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.7 t -78.13 -5.06 50.46 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.227 -179.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.414 ' HA2' ' HD3' ' A' ' 179' ' ' PRO . . . -92.95 153.41 21.48 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 111.224 -0.751 . . . . 0.0 111.224 178.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' A' ' 178' ' ' GLY . 4.1 Cg_exo -77.62 123.95 6.7 Favored 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.406 2.071 . . . . 0.0 112.044 -179.719 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 10.2 p -83.96 -75.4 0.34 Allowed 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.818 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -112.87 63.41 0.29 Allowed Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 179.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 78.3 m-85 -139.26 153.95 71.56 Favored Pre-proline 0 C--N 1.321 -0.649 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 -178.722 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -57.64 128.86 30.89 Favored 'Trans proline' 0 C--N 1.349 0.583 0 C-N-CA 122.609 2.206 . . . . 0.0 110.82 176.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 75.19 74.44 0.89 Allowed Glycine 0 N--CA 1.445 -0.724 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -175.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_exo -70.78 -153.61 0.04 OUTLIER 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 123.238 2.625 . . . . 0.0 112.419 -178.876 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.523 HD23 ' H ' ' A' ' 186' ' ' LEU . 1.1 pt? -52.56 120.58 5.8 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.367 -179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -86.35 41.24 3.08 Favored Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.0 178.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 91.02 -25.44 14.12 Favored Glycine 0 CA--C 1.521 0.428 0 C-N-CA 121.145 -0.55 . . . . 0.0 113.06 179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -66.07 -51.51 44.35 Favored Glycine 0 C--O 1.238 0.382 0 C-N-CA 121.019 -0.61 . . . . 0.0 112.276 -178.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.481 ' HB3' ' CB ' ' A' ' 186' ' ' LEU . . . -67.82 148.17 98.5 Favored Pre-proline 0 N--CA 1.448 -0.558 0 CA-C-O 120.435 0.16 . . . . 0.0 110.604 179.171 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.509 ' HA ' ' HB3' ' A' ' 194' ' ' GLN . 28.0 Cg_endo -97.19 17.5 0.59 Allowed 'Trans proline' 0 N--CA 1.435 -1.959 0 C-N-CA 123.091 2.527 . . . . 0.0 111.385 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . 0.413 ' CD1' ' HB3' ' A' ' 25' ' ' LEU . 93.5 t80 -69.5 -73.29 0.16 Allowed 'General case' 0 C--O 1.219 -0.514 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.018 179.193 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.546 ' HA2' ' CG1' ' A' ' 99' ' ' VAL . . . -98.09 38.11 3.22 Favored Glycine 0 CA--C 1.5 -0.887 0 N-CA-C 110.334 -1.106 . . . . 0.0 110.334 179.158 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.509 ' HB3' ' HA ' ' A' ' 191' ' ' PRO . 5.0 pt20 -54.83 -43.46 73.01 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 113.734 1.013 . . . . 0.0 113.734 -174.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 40.2 m -79.09 1.9 22.57 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.145 0.424 . . . . 0.0 112.145 -176.739 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 93.27 34.02 6.93 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.601 -0.809 . . . . 0.0 112.148 179.636 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.544 ' HB2' HG13 ' A' ' 99' ' ' VAL . 70.4 m-85 -119.79 153.57 35.52 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 120.746 0.308 . . . . 0.0 110.835 -178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 86.94 -75.87 2.15 Favored Glycine 0 N--CA 1.446 -0.697 0 C-N-CA 121.081 -0.58 . . . . 0.0 111.978 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.434 -1.445 0 CA-C-O 118.689 -1.062 . . . . 0.0 111.068 179.606 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.522 -0.11 0 CA-C-O 120.729 0.299 . . . . 0.0 110.712 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -121.62 129.03 7.53 Favored Glycine 0 N--CA 1.441 -1.005 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.945 179.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.78 144.61 49.08 Favored 'Trans proline' 0 C--O 1.235 0.339 0 C-N-CA 122.546 2.164 . . . . 0.0 111.745 179.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 83.7 mm-40 -92.55 98.36 11.4 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.046 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 62.42 27.9 70.23 Favored Glycine 0 C--O 1.23 -0.152 0 C-N-CA 121.256 -0.497 . . . . 0.0 112.91 178.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 102.59 -10.32 56.07 Favored Glycine 0 N--CA 1.448 -0.562 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.183 -179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -90.96 109.06 20.29 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-O 120.759 0.314 . . . . 0.0 110.486 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -109.85 -161.71 18.92 Favored Glycine 0 N--CA 1.445 -0.731 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.093 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -138.83 -172.66 3.37 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 120.514 0.197 . . . . 0.0 111.122 -178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 75.1 p 61.2 104.06 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 124.893 1.277 . . . . 0.0 113.014 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -92.62 155.38 22.62 Favored Glycine 0 N--CA 1.45 -0.369 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.195 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -75.0 -45.45 20.44 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 121.168 -0.539 . . . . 0.0 113.242 -177.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -45.84 90.68 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.976 0.388 . . . . 0.0 111.211 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 18.7 m -60.22 -28.6 68.13 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.754 179.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.11 -21.44 22.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 112.766 0.654 . . . . 0.0 112.766 -177.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -86.93 -39.42 7.51 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.407 178.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.625 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.1 pp -85.98 -25.46 26.0 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 113.335 0.865 . . . . 0.0 113.335 -177.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.58 HG23 ' O ' ' A' ' 14' ' ' SER . 14.1 pt -45.38 -50.34 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.269 0 N-CA-C 114.002 1.112 . . . . 0.0 114.002 -175.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.413 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 14.1 m -84.78 -18.74 34.08 Favored 'General case' 0 C--N 1.31 -1.14 0 CA-C-O 120.699 0.285 . . . . 0.0 111.586 -177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.74 -24.24 28.93 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 113.096 0.776 . . . . 0.0 113.096 -176.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.625 HG23 ' O ' ' A' ' 17' ' ' LEU . 23.2 t -78.71 -106.15 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.173 0 N-CA-C 113.957 1.095 . . . . 0.0 113.957 -174.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.446 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -77.97 -50.14 12.74 Favored 'General case' 0 CA--C 1.512 -0.49 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -172.651 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.488 ' HB3' HD22 ' A' ' 31' ' ' LEU . 19.6 m-80 -60.51 -21.42 62.44 Favored 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 112.72 0.637 . . . . 0.0 112.72 -177.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.413 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -57.13 -40.83 77.9 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 120.933 0.397 . . . . 0.0 110.176 175.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -89.14 -37.05 15.35 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.255 178.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.433 ' HB3' ' HA ' ' A' ' 23' ' ' ASN . . . -79.41 83.02 5.47 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.252 -0.648 . . . . 0.0 109.252 177.309 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -68.04 18.57 0.03 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.853 0.861 . . . . 0.0 113.069 -175.075 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.422 ' H ' ' C ' ' A' ' 26' ' ' ALA . 2.3 m -62.38 164.85 6.68 Favored 'General case' 0 CA--C 1.547 0.828 0 CA-C-O 121.432 0.634 . . . . 0.0 111.346 -179.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 9.1 t -65.45 -14.92 62.02 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.896 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.9 p -48.13 -44.03 31.74 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 123.742 0.817 . . . . 0.0 112.838 -178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.616 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.5 pt? -99.15 -19.86 16.95 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.496 0.665 . . . . 0.0 109.8 178.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -70.64 -53.39 15.99 Favored 'General case' 0 N--CA 1.445 -0.716 0 CA-C-N 115.011 -0.995 . . . . 0.0 112.761 -174.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.8 t -167.16 -24.55 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -176.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 73.0 t -96.93 141.39 15.7 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 N-CA-C 110.431 -0.211 . . . . 0.0 110.431 178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.466 HD23 ' H ' ' A' ' 35' ' ' LEU . 1.9 pt? -54.72 150.03 10.23 Favored 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.393 0.616 . . . . 0.0 111.91 -178.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 19.5 ptt85 -76.49 163.49 26.88 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.286 -0.87 . . . . 0.0 111.169 -179.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.468 HG22 HG22 ' A' ' 131' ' ' VAL . 18.4 p -77.12 147.4 36.61 Favored 'General case' 0 N--CA 1.433 -1.298 0 CA-C-N 115.507 -0.77 . . . . 0.0 109.1 175.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.513 ' H ' HG13 ' A' ' 131' ' ' VAL . . . 73.71 24.38 74.59 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.561 -0.828 . . . . 0.0 112.313 -179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.5 p -59.8 165.63 0.69 Allowed 'Isoleucine or valine' 0 CA--C 1.551 1.004 0 C-N-CA 122.76 0.424 . . . . 0.0 110.782 -179.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.576 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.9 m -134.95 165.04 26.24 Favored 'General case' 0 C--N 1.325 -0.486 0 O-C-N 122.147 -0.346 . . . . 0.0 111.525 -177.144 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.578 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.4 pp0? -66.77 -12.54 59.18 Favored 'General case' 0 C--O 1.216 -0.678 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.433 ' HG3' ' HB2' ' A' ' 116' ' ' LEU . 82.9 mm-40 -53.44 -38.8 63.87 Favored 'General case' 0 C--N 1.315 -0.899 0 N-CA-C 109.825 -0.435 . . . . 0.0 109.825 176.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.576 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -86.63 -44.11 16.33 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.7 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.224 177.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.427 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -81.89 -65.25 1.03 Allowed 'General case' 0 N--CA 1.471 0.589 0 CA-C-O 120.614 0.245 . . . . 0.0 111.362 -177.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.4 m 81.81 -19.02 0.44 Allowed 'General case' 0 N--CA 1.475 0.816 0 C-N-CA 123.911 0.884 . . . . 0.0 112.152 176.376 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 21.9 p -70.91 -90.05 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-O 121.005 0.431 . . . . 0.0 111.705 -179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 13.1 m -125.61 -19.69 2.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.116 0.484 . . . . 0.0 111.404 -179.62 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 46.0 t -73.38 81.25 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-O 121.169 0.509 . . . . 0.0 110.105 177.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.578 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 1.8 mp0 -64.41 -48.93 73.53 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.231 177.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.621 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 46.4 ttm-85 -148.31 4.36 0.7 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.061 174.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.642 ' HB3' HG12 ' A' ' 131' ' ' VAL . . . 67.63 -51.3 0.51 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.564 0.746 . . . . 0.0 111.161 -175.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.518 ' CB ' HG23 ' A' ' 129' ' ' ILE . . . -67.46 140.82 57.1 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-O 121.375 0.607 . . . . 0.0 110.857 178.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.689 ' O ' ' HB2' ' A' ' 57' ' ' SER . 22.6 mt-30 -59.52 -17.5 32.56 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-N 114.573 -1.194 . . . . 0.0 113.415 -175.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.9 m -62.35 -74.06 0.1 Allowed 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.848 0.356 . . . . 0.0 111.747 -178.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.581 HD13 ' HE ' ' A' ' 50' ' ' ARG . 9.0 tt -87.22 -25.03 24.22 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.653 -177.703 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.621 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -81.22 -19.51 43.06 Favored 'General case' 0 C--O 1.222 -0.353 0 N-CA-C 114.015 1.117 . . . . 0.0 114.015 -175.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.689 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -50.06 108.11 0.2 Allowed 'General case' 0 CA--C 1.539 0.544 0 CA-C-O 120.846 0.355 . . . . 0.0 110.898 -177.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 9.0 t -150.02 -41.76 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.738 -177.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.4 mt -118.22 19.33 13.54 Favored 'General case' 0 N--CA 1.465 0.289 0 CA-C-O 120.9 0.381 . . . . 0.0 111.338 -177.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.48 56.34 1.27 Allowed Glycine 0 N--CA 1.442 -0.94 0 C-N-CA 120.568 -0.825 . . . . 0.0 111.811 -179.139 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.633 ' O ' ' HG2' ' A' ' 53' ' ' GLN . 2.9 t -90.23 104.09 14.89 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.074 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.2 p-10 -156.18 15.14 0.33 Allowed 'General case' 0 C--N 1.313 -1.007 0 CA-C-O 121.551 0.691 . . . . 0.0 109.897 177.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 130.08 -37.37 2.16 Favored Glycine 0 C--N 1.298 -1.556 0 CA-C-N 114.864 -1.062 . . . . 0.0 112.026 -177.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 43.1 t-20 -54.49 -74.0 0.04 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 C-N-CA 122.44 0.296 . . . . 0.0 111.458 -179.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.429 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.5 p-10 -81.11 -20.83 40.61 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.013 0.435 . . . . 0.0 110.216 179.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 35.1 tp -61.5 -55.05 35.38 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.655 -178.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . 0.557 ' HA ' ' O ' ' A' ' 133' ' ' SER . . . -82.79 1.66 37.91 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 94.8 mtt180 -126.08 -87.55 0.6 Allowed 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -176.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 80.8 m-85 -57.35 -38.43 74.14 Favored 'General case' 0 C--N 1.328 -0.369 0 N-CA-C 112.877 0.695 . . . . 0.0 112.877 -175.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -62.77 -45.47 92.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.958 0.409 . . . . 0.0 110.824 -178.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 61.1 t -70.35 -46.26 71.86 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.688 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 88.5 mm-40 -58.13 -40.38 81.14 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.655 0.264 . . . . 0.0 111.584 -178.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -65.48 -44.04 88.34 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.835 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.598 ' O ' HD22 ' A' ' 77' ' ' LEU . 33.2 t -85.31 -17.69 9.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 N-CA-C 112.155 0.428 . . . . 0.0 112.155 -177.005 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -93.35 -19.6 21.18 Favored 'General case' 0 C--N 1.314 -0.966 0 O-C-N 121.946 -0.471 . . . . 0.0 111.37 -179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.3 ttt180 -118.55 22.46 12.05 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.491 0.662 . . . . 0.0 110.744 -178.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.598 HD22 ' O ' ' A' ' 74' ' ' VAL . 0.8 OUTLIER -73.39 158.21 86.92 Favored Pre-proline 0 C--N 1.311 -1.095 0 CA-C-N 115.563 -0.744 . . . . 0.0 111.106 -178.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.94 128.04 11.99 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 121.874 1.716 . . . . 0.0 111.224 176.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.75 70.83 10.42 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-O 120.965 0.412 . . . . 0.0 111.033 -179.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -80.91 -57.32 2.87 Favored Glycine 0 N--CA 1.445 -0.748 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.741 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 33.0 p -81.89 -6.18 58.88 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.431 0.157 . . . . 0.0 110.861 179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 17.8 t70 87.25 149.23 0.05 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 124.55 1.14 . . . . 0.0 110.487 -177.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.423 HG22 HE22 ' A' ' 88' ' ' GLN . 4.1 m -60.34 -37.58 81.08 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.442 -177.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 79.2 p -71.34 -32.02 68.06 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.07 0.396 . . . . 0.0 112.07 -176.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.63 -20.13 59.92 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-O 121.113 0.482 . . . . 0.0 111.483 -179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.509 ' CD2' ' HB ' ' A' ' 43' ' ' ILE . 4.2 m-85 -69.45 -165.71 0.08 Allowed 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.675 -0.693 . . . . 0.0 111.468 178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -70.62 17.62 0.06 Allowed 'General case' 0 CA--C 1.538 0.482 0 N-CA-C 112.464 0.542 . . . . 0.0 112.464 -178.306 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 77.7 mt-30 -88.89 -55.45 3.69 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.364 179.291 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.492 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -72.41 -40.96 66.75 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.302 0.572 . . . . 0.0 109.592 177.175 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.58 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.7 m-85 -81.64 16.63 1.69 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.57 -0.741 . . . . 0.0 111.082 -179.854 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 6.9 p -51.63 -57.2 9.82 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 37.2 m -55.12 -36.68 66.0 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 -177.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.93 -39.15 24.18 Favored 'General case' 0 C--N 1.322 -0.629 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -176.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.58 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 18.9 mt -81.9 -30.32 31.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.825 0.345 . . . . 0.0 111.68 -176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -85.06 -28.56 25.58 Favored 'General case' 0 C--N 1.316 -0.862 0 N-CA-C 109.921 -0.4 . . . . 0.0 109.921 179.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 52.77 84.28 0.06 Allowed 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.033 -0.985 . . . . 0.0 111.005 -178.231 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -78.81 -7.45 57.87 Favored 'General case' 0 C--N 1.312 -1.047 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.128 -179.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.18 -11.93 40.67 Favored Glycine 0 C--N 1.333 0.367 0 C-N-CA 121.206 -0.521 . . . . 0.0 112.035 -179.006 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.3 t -78.53 -8.54 11.62 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-O 121.352 0.596 . . . . 0.0 110.229 -179.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.604 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -88.53 -171.42 3.33 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.789 -0.642 . . . . 0.0 112.487 -177.088 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -95.07 129.41 42.18 Favored 'General case' 0 N--CA 1.443 -0.783 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.393 178.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.62 -19.29 61.49 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.14 -178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 32.5 t -67.9 -32.26 72.61 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 109.508 -0.552 . . . . 0.0 109.508 -178.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.529 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 11.5 t30 -62.7 -54.01 45.71 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.484 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.564 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -69.06 -35.96 71.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.384 -178.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.9 t70 -70.86 -30.81 67.31 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.709 -179.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 96.1 m -92.74 -34.55 13.87 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.686 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 2.2 pp -137.47 -29.61 0.87 Allowed 'General case' 0 C--N 1.319 -0.759 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.812 -176.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.564 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -53.17 -68.56 1.56 Allowed Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.987 -0.625 . . . . 0.0 114.326 -176.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.5 ' O ' ' HA ' ' A' ' 114' ' ' SER . 8.1 m -60.89 -20.6 62.23 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-O 120.987 0.422 . . . . 0.0 111.714 -177.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -88.14 -54.59 4.14 Favored 'General case' 0 C--N 1.312 -1.06 0 CA-C-N 116.038 -0.528 . . . . 0.0 112.356 -177.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 80.1 t -72.59 -45.89 56.76 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.812 -177.037 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 1.4 mm? -81.5 -29.87 33.46 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.949 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 110' ' ' SER . 35.3 t 44.7 -96.68 0.02 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 N-CA-C 114.147 1.166 . . . . 0.0 114.147 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -59.9 -29.39 68.31 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 122.908 0.483 . . . . 0.0 111.8 -176.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 113' ' ' LEU . 39.5 tp -65.32 -60.12 3.32 Favored 'General case' 0 N--CA 1.441 -0.876 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.69 179.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 35.2 mt -67.57 -29.26 68.58 Favored 'General case' 0 C--O 1.214 -0.81 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -177.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 7.2 m-80 -59.57 -43.85 93.48 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 120.396 -0.522 . . . . 0.0 110.788 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -78.36 -37.13 28.66 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.527 -0.844 . . . . 0.0 111.999 178.304 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.646 HG13 ' HB3' ' A' ' 124' ' ' ALA . 63.1 t -68.65 -41.11 82.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 111.793 0.294 . . . . 0.0 111.793 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.503 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 8.1 t -55.73 -46.52 77.76 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.076 0.465 . . . . 0.0 111.201 -177.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 16.5 m -74.66 -49.56 20.95 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.108 -179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -76.41 -70.88 0.42 Allowed 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -175.676 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.646 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -73.59 -47.6 39.16 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -173.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.503 ' HB3' ' O ' ' A' ' 121' ' ' SER . 32.5 tt0 -68.64 -35.49 77.34 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.055 0.455 . . . . 0.0 110.428 -178.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -80.62 -71.32 1.28 Allowed Glycine 0 N--CA 1.447 -0.584 0 CA-C-N 115.77 -0.65 . . . . 0.0 114.034 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -88.43 -24.16 23.1 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.816 0.341 . . . . 0.0 111.371 -174.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.49 92.92 0.98 Allowed Glycine 0 N--CA 1.433 -1.521 0 C-N-CA 120.122 -1.037 . . . . 0.0 111.191 -178.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.518 HG23 ' CB ' ' A' ' 52' ' ' ALA . 20.7 mm -78.17 129.6 37.28 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-O 121.14 0.495 . . . . 0.0 111.648 -178.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -108.9 131.14 55.31 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.39 -0.823 . . . . 0.0 109.486 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.642 HG12 ' HB3' ' A' ' 51' ' ' ALA . 7.3 m -98.73 90.02 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.287 0 CA-C-O 122.04 0.924 . . . . 0.0 111.14 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -82.57 46.01 1.02 Allowed 'General case' 0 C--N 1.302 -1.466 0 CA-C-N 114.954 -1.021 . . . . 0.0 111.279 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.557 ' O ' ' HA ' ' A' ' 67' ' ' ALA . 9.3 m -68.37 -6.05 22.31 Favored 'General case' 0 C--N 1.311 -1.106 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.566 179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.42 -23.42 30.18 Favored Glycine 0 N--CA 1.441 -0.976 0 C-N-CA 120.814 -0.708 . . . . 0.0 112.122 179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 31.1 m -105.55 -31.99 8.7 Favored 'General case' 0 C--N 1.309 -1.161 0 N-CA-C 111.791 0.293 . . . . 0.0 111.791 -178.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.548 HG11 ' CG2' ' A' ' 131' ' ' VAL . 40.6 t -67.27 -57.18 10.74 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.712 -177.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -50.5 -53.36 30.53 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 123.46 0.475 . . . . 0.0 111.804 -178.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.8 m -54.23 -37.73 64.95 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.141 -0.481 . . . . 0.0 112.171 -177.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -84.58 -47.0 10.99 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 116.587 -0.279 . . . . 0.0 111.652 -176.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.493 HG12 ' O ' ' A' ' 136' ' ' VAL . 49.5 pt -64.99 -39.17 84.8 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.435 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -177.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.8 p -61.91 -49.07 77.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.002 0.429 . . . . 0.0 110.67 -179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.2 m -65.63 -28.95 69.48 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.329 -179.569 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 29.1 t -89.06 -20.37 24.44 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 112.374 0.509 . . . . 0.0 112.374 -178.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 85.7 p -64.64 -19.18 65.55 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 35.3 p -56.61 -23.99 44.78 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.098 0.475 . . . . 0.0 111.181 179.004 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 83.2 m-85 -72.97 -10.22 59.57 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 112.395 0.517 . . . . 0.0 112.395 -179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.9 mp -67.18 -32.4 73.46 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-O 121.206 0.527 . . . . 0.0 110.398 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 8.3 m -70.01 -10.52 58.93 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.083 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.2 m 78.67 90.79 0.06 Allowed 'General case' 0 N--CA 1.434 -1.249 0 CA-C-N 114.05 -1.432 . . . . 0.0 109.594 -177.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 12.9 t -96.36 8.58 43.62 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 114.985 -1.007 . . . . 0.0 110.225 -177.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 22.2 p -85.91 -175.36 5.55 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.282 179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 20.5 m -71.34 -18.09 62.4 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 120.797 0.332 . . . . 0.0 111.533 -179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.521 ' O ' ' HG2' ' A' ' 158' ' ' GLN . 18.2 m -59.44 -32.89 70.63 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.602 -179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -60.34 -32.94 71.73 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.646 0.609 . . . . 0.0 112.646 -176.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 1.9 p -85.31 41.46 0.89 Allowed 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.038 0.447 . . . . 0.0 111.807 -179.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 92.0 m-85 62.61 14.96 7.56 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.783 -0.644 . . . . 0.0 112.565 177.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 44.5 t -71.45 -24.38 62.01 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.089 0.471 . . . . 0.0 109.807 178.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.523 ' HG3' ' H ' ' A' ' 159' ' ' ALA . 8.4 pt20 -71.44 -62.22 1.49 Allowed 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.623 -0.717 . . . . 0.0 111.095 179.13 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.523 ' H ' ' HG3' ' A' ' 158' ' ' GLN . . . 53.94 23.11 3.73 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.211 0.604 . . . . 0.0 111.962 179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . 0.407 ' HA ' ' HG3' ' A' ' 179' ' ' PRO . 9.2 t 56.57 79.54 0.18 Allowed 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.893 -0.594 . . . . 0.0 110.253 -177.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -63.52 134.34 55.4 Favored 'General case' 0 N--CA 1.451 -0.425 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.388 -178.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 21.9 m -83.42 44.35 0.95 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.437 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 51.0 m -65.57 -21.46 66.6 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.223 -179.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.1 m -62.97 -30.24 71.44 Favored 'General case' 0 CA--C 1.541 0.609 0 CA-C-O 120.969 0.414 . . . . 0.0 110.513 178.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 14.4 m -79.46 -19.41 49.91 Favored 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.016 -179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 179.75 116.79 0.52 Allowed Glycine 0 N--CA 1.444 -0.788 0 C-N-CA 120.869 -0.681 . . . . 0.0 111.711 -179.101 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -149.13 150.05 32.05 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-O 120.646 0.26 . . . . 0.0 110.513 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -88.24 -61.1 1.5 Allowed Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.74 -0.743 . . . . 0.0 111.456 178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 79.7 m-85 -129.13 107.08 9.29 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.569 ' HA ' ' CD ' ' A' ' 175' ' ' PRO . 14.6 t -110.76 164.06 13.14 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.134 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 151.82 -162.92 29.89 Favored Glycine 0 N--CA 1.43 -1.733 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.009 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_exo -65.31 115.82 3.54 Favored 'Trans proline' 0 C--O 1.235 0.341 0 C-N-CA 123.027 2.485 . . . . 0.0 111.772 -179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 16.6 t 69.0 20.53 7.75 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.966 179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -84.32 -116.58 0.7 Allowed Glycine 0 C--N 1.334 0.458 0 N-CA-C 111.208 -0.757 . . . . 0.0 111.208 178.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.569 ' CD ' ' HA ' ' A' ' 170' ' ' THR . 31.9 Cg_exo -63.47 155.26 63.52 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.196 1.931 . . . . 0.0 110.853 176.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 20.9 t -78.81 60.95 2.94 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.246 0.546 . . . . 0.0 111.241 -178.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.3 t -103.9 149.19 25.32 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 178.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 72.66 70.26 1.25 Allowed Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.315 -0.945 . . . . 0.0 111.309 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.407 ' HG3' ' HA ' ' A' ' 160' ' ' SER . 19.3 Cg_exo -67.63 155.65 69.23 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 122.859 2.373 . . . . 0.0 112.747 -177.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.6 m -76.74 28.48 0.13 Allowed 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.828 -0.623 . . . . 0.0 111.418 179.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.46 84.84 1.57 Allowed Glycine 0 N--CA 1.441 -1.019 0 N-CA-C 110.669 -0.973 . . . . 0.0 110.669 178.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.459 ' O ' ' HD2' ' A' ' 185' ' ' PRO . 95.3 m-85 68.39 91.0 0.08 OUTLIER Pre-proline 0 N--CA 1.464 0.269 0 C-N-CA 123.215 0.606 . . . . 0.0 110.875 -176.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -64.69 124.72 13.63 Favored 'Trans proline' 0 N--CA 1.462 -0.375 0 C-N-CA 122.059 1.84 . . . . 0.0 111.496 179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 154.65 -63.9 0.34 Allowed Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.567 -0.825 . . . . 0.0 112.412 -178.064 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.459 ' HD2' ' O ' ' A' ' 182' ' ' TYR . 38.2 Cg_endo -65.18 173.09 6.55 Favored 'Trans proline' 0 C--O 1.236 0.424 0 C-N-CA 122.531 2.154 . . . . 0.0 111.887 177.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 190' ' ' ALA . 73.0 mt -83.09 81.41 8.7 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 120.95 0.405 . . . . 0.0 111.289 -177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -70.44 123.15 11.5 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.895 -0.593 . . . . 0.0 112.022 179.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 64.89 22.35 68.4 Favored Glycine 0 CA--C 1.516 0.12 0 C-N-CA 121.224 -0.512 . . . . 0.0 112.169 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 97.18 -35.48 4.43 Favored Glycine 0 N--CA 1.443 -0.841 0 N-CA-C 111.501 -0.64 . . . . 0.0 111.501 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 186' ' ' LEU . . . 67.28 155.36 0.14 Allowed Pre-proline 0 N--CA 1.469 0.524 0 C-N-CA 123.766 0.826 . . . . 0.0 111.958 179.464 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -68.26 106.03 1.32 Allowed 'Trans proline' 0 C--N 1.347 0.469 0 C-N-CA 122.283 1.989 . . . . 0.0 111.587 178.9 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 68.21 -72.67 0.09 Allowed 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.497 0.719 . . . . 0.0 111.554 -179.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 163.98 112.16 0.27 Allowed Glycine 0 N--CA 1.437 -1.257 0 C-N-CA 120.828 -0.701 . . . . 0.0 112.052 -179.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 16.8 mt-30 -65.17 140.26 58.75 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 178.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 73.7 m -83.73 59.83 5.4 Favored 'General case' 0 C--N 1.316 -0.887 0 N-CA-C 112.933 0.716 . . . . 0.0 112.933 -177.31 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 66.04 51.47 44.8 Favored Glycine 0 CA--C 1.502 -0.759 0 CA-C-N 115.61 -0.723 . . . . 0.0 113.631 173.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 76.7 t80 -75.39 -38.41 59.97 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 121.048 0.451 . . . . 0.0 109.822 177.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -164.85 25.87 0.18 Allowed Glycine 0 N--CA 1.448 -0.537 0 C-N-CA 120.842 -0.694 . . . . 0.0 111.842 179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.44 -1.08 0 CA-C-O 117.949 -1.473 . . . . 0.0 110.938 -179.753 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.481 0 CA-C-O 120.653 0.263 . . . . 0.0 110.334 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 160.69 -84.13 0.12 Allowed Glycine 0 N--CA 1.439 -1.129 0 N-CA-C 110.766 -0.934 . . . . 0.0 110.766 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_exo -74.89 100.09 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.894 0 C-N-CA 122.414 2.076 . . . . 0.0 111.088 176.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -99.86 153.95 18.74 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 109.417 -0.586 . . . . 0.0 109.417 -179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -65.15 98.0 0.29 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.73 -0.747 . . . . 0.0 111.639 178.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 114.27 -15.7 20.32 Favored Glycine 0 N--CA 1.443 -0.858 0 N-CA-C 111.257 -0.737 . . . . 0.0 111.257 -178.019 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 81.1 m-85 -139.51 76.46 1.57 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -94.15 92.4 1.56 Allowed Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.831 -177.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.63 -174.44 2.11 Favored 'General case' 0 CA--C 1.537 0.448 0 CA-C-O 120.5 0.19 . . . . 0.0 110.943 178.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.686 ' H ' HD13 ' A' ' 113' ' ' LEU . 61.7 p 62.48 113.45 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.24 0 C-N-CA 124.9 1.28 . . . . 0.0 112.901 -179.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.56 153.54 24.18 Favored Glycine 0 C--N 1.334 0.421 0 CA-C-N 115.868 -0.606 . . . . 0.0 112.179 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.77 -50.9 58.08 Favored Glycine 0 CA--C 1.519 0.342 0 C-N-CA 121.456 -0.402 . . . . 0.0 113.59 -177.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.91 87.37 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 111.947 0.351 . . . . 0.0 111.947 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' O ' HG23 ' A' ' 18' ' ' ILE . 67.4 m -62.78 -24.62 67.81 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -178.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -66.09 -19.67 65.92 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.82 0.304 . . . . 0.0 111.82 -179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.91 -33.03 10.11 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.291 -0.957 . . . . 0.0 113.246 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.506 ' HB2' ' CG2' ' A' ' 21' ' ' VAL . 3.4 pp -84.48 -19.26 33.62 Favored 'General case' 0 C--N 1.312 -1.035 0 N-CA-C 113.118 0.785 . . . . 0.0 113.118 -176.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.502 HG23 ' O ' ' A' ' 14' ' ' SER . 18.3 pt -30.77 -56.37 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 115.662 1.726 . . . . 0.0 115.662 -176.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.3 m -84.53 -20.04 32.23 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 113.058 0.762 . . . . 0.0 113.058 -173.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 86.3 mtt180 -86.29 -44.58 12.0 Favored 'General case' 0 C--O 1.209 -1.035 0 N-CA-C 113.31 0.856 . . . . 0.0 113.31 -174.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.679 HG11 ' HB3' ' A' ' 100' ' ' LEU . 15.9 t -59.02 -97.54 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.081 0 N-CA-C 115.113 1.523 . . . . 0.0 115.113 -171.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -79.26 -48.62 13.83 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 113.377 0.88 . . . . 0.0 113.377 -173.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -65.45 -25.11 67.36 Favored 'General case' 0 C--N 1.316 -0.874 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 -174.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.442 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -67.85 -39.62 83.78 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.171 -0.611 . . . . 0.0 110.353 177.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 62.9 tp -71.92 -33.7 68.47 Favored 'General case' 0 C--N 1.334 -0.103 0 CA-C-N 115.857 -0.611 . . . . 0.0 109.922 178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -65.1 -49.64 69.19 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.747 -0.661 . . . . 0.0 109.892 177.679 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 3.1 t-20 64.49 8.58 4.41 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 123.736 0.814 . . . . 0.0 112.031 177.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.477 HG22 ' H ' ' A' ' 29' ' ' SER . 1.9 m -72.43 172.83 9.72 Favored 'General case' 0 CA--C 1.549 0.935 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.649 -179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.477 ' H ' HG22 ' A' ' 28' ' ' THR . 33.1 m -63.24 -15.68 57.86 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 112.149 0.426 . . . . 0.0 112.149 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 23.0 p -54.5 -22.52 13.14 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 124.026 0.93 . . . . 0.0 113.433 -177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.408 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.4 pt? -120.53 -21.86 6.63 Favored 'General case' 0 C--N 1.313 -0.984 0 CA-C-O 121.209 0.528 . . . . 0.0 110.393 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 17.7 ttm180 -79.66 -37.69 35.36 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 113.21 0.818 . . . . 0.0 113.21 -175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.444 HG23 HG23 ' A' ' 34' ' ' VAL . 9.9 t -164.58 -26.12 0.03 OUTLIER 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.444 HG23 HG23 ' A' ' 33' ' ' THR . 87.7 t -99.76 141.23 17.32 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.117 0 N-CA-C 109.774 -0.454 . . . . 0.0 109.774 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.72 163.18 5.8 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.605 0.594 . . . . 0.0 112.605 -178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.553 ' HG2' ' HB1' ' A' ' 87' ' ' ALA . 4.3 ptm180 -69.42 141.84 53.99 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.447 -178.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 4.1 m -68.46 124.6 24.0 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 115.594 -0.73 . . . . 0.0 109.88 178.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.458 ' H ' ' CG2' ' A' ' 131' ' ' VAL . . . 85.08 29.78 27.4 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.927 -0.654 . . . . 0.0 112.587 178.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 p -54.78 145.74 4.57 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.711 0 CA-C-O 120.931 0.396 . . . . 0.0 110.46 177.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 20.4 t -104.65 166.33 10.47 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-O 121.047 0.451 . . . . 0.0 112.024 -174.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.645 ' HA ' ' HB3' ' A' ' 44' ' ' ALA . 51.5 tt0 -73.23 -14.93 61.43 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 115.756 -0.656 . . . . 0.0 111.189 -178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 86.5 mm-40 -52.37 -48.79 65.37 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 175.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.584 HD11 ' CD1' ' A' ' 86' ' ' TYR . 0.0 OUTLIER -85.72 -47.79 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.12 175.154 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.645 ' HB3' ' HA ' ' A' ' 41' ' ' GLN . . . -58.08 -32.02 67.65 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.07 0.767 . . . . 0.0 113.07 -174.399 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.0 m 72.18 -38.84 0.43 Allowed 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 113.507 0.929 . . . . 0.0 113.507 175.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 43.2 t -71.09 -91.61 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 113.161 0.8 . . . . 0.0 113.161 -175.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 6.1 m -140.61 -19.99 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 112.555 0.576 . . . . 0.0 112.555 -175.838 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.671 HG22 ' HB1' ' A' ' 70' ' ' ALA . 46.1 t -62.34 82.61 0.03 OUTLIER 'Isoleucine or valine' 0 C--O 1.219 -0.548 0 CA-C-N 116.905 -0.134 . . . . 0.0 111.321 -179.422 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.53 ' O ' ' HA ' ' A' ' 40' ' ' SER . 47.8 mm-40 -63.58 -43.95 95.49 Favored 'General case' 0 CA--C 1.507 -0.696 0 CA-C-O 121.154 0.502 . . . . 0.0 110.35 177.046 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.668 ' CZ ' HD22 ' A' ' 55' ' ' LEU . 20.0 ttm180 -157.25 0.47 0.12 Allowed 'General case' 0 N--CA 1.433 -1.296 0 CA-C-N 115.392 -0.822 . . . . 0.0 111.48 179.352 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 66.98 -53.18 0.46 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 123.402 0.681 . . . . 0.0 110.756 -174.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.32 133.98 55.85 Favored 'General case' 0 C--O 1.241 0.651 0 CA-C-N 116.199 -0.455 . . . . 0.0 109.956 176.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.504 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 18.2 mp0 -59.21 -18.17 34.31 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.372 0.669 . . . . 0.0 112.759 -173.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 18.8 t -55.89 -68.46 0.2 Allowed 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.692 0.282 . . . . 0.0 110.769 179.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.668 HD22 ' CZ ' ' A' ' 50' ' ' ARG . 4.0 tp -87.74 -30.1 20.57 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.587 -0.445 . . . . 0.0 111.243 -179.83 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.527 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -65.61 -18.7 65.51 Favored 'General case' 0 CA--C 1.51 -0.58 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -177.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 18.1 t -64.56 83.71 0.04 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 176.669 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.415 HG23 ' HG ' ' A' ' 59' ' ' LEU . 8.9 t -136.29 -37.24 0.71 Allowed 'General case' 0 N--CA 1.433 -1.315 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.024 -178.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HG ' HG23 ' A' ' 58' ' ' THR . 1.2 pp -123.2 13.48 9.65 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 112.481 0.549 . . . . 0.0 112.481 179.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 96.34 49.08 2.08 Favored Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.438 -0.887 . . . . 0.0 113.084 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.431 HG22 HD21 ' A' ' 65' ' ' ASN . 39.6 t -89.26 118.56 34.79 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 120.513 0.197 . . . . 0.0 110.86 176.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.0 p-10 -144.94 21.64 1.6 Allowed 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.732 0.777 . . . . 0.0 109.977 175.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 116.42 -31.4 6.0 Favored Glycine 0 C--N 1.309 -0.947 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.986 -178.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.482 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 13.9 p-10 -52.47 -81.0 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 123.997 0.919 . . . . 0.0 111.786 179.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.482 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 2.9 p-10 -86.97 26.16 1.2 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-O 120.971 0.415 . . . . 0.0 110.243 177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.523 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 5.6 tt -88.02 -78.19 0.33 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.177 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -61.56 -33.93 74.71 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.319 -0.855 . . . . 0.0 110.424 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 54.9 mtm180 -109.66 160.76 16.02 Favored 'General case' 0 C--N 1.306 -1.298 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . 0.488 ' H ' ' NE2' ' A' ' 72' ' ' GLN . 98.1 m-85 69.53 -62.62 0.41 Allowed 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.016 0.527 . . . . 0.0 111.787 -177.508 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.671 ' HB1' HG22 ' A' ' 48' ' ' VAL . . . -62.65 -62.64 1.6 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-O 120.823 0.344 . . . . 0.0 111.006 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 64.1 t -63.59 -38.81 83.22 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.459 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.671 179.023 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.504 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 21.1 mt-30 -63.46 -32.32 73.73 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.405 -0.362 . . . . 0.0 111.921 -177.585 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.54 -40.94 22.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.686 0.279 . . . . 0.0 111.614 -179.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 45.6 t -73.2 -35.5 47.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 121.185 0.516 . . . . 0.0 111.094 -179.127 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 92.4 p -78.11 -4.89 49.7 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.282 0.563 . . . . 0.0 110.25 179.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.504 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 47.5 ttp180 -90.0 -6.77 55.25 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.592 -178.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 8.5 mp -59.88 140.68 89.97 Favored Pre-proline 0 C--O 1.24 0.574 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.859 179.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 69.1 Cg_exo -52.34 128.5 27.84 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.789 2.326 . . . . 0.0 111.616 178.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -105.04 84.79 2.17 Favored 'General case' 0 N--CA 1.44 -0.951 0 CA-C-N 116.176 -0.465 . . . . 0.0 111.644 -178.523 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -74.68 -55.43 5.44 Favored Glycine 0 N--CA 1.445 -0.754 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 176.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 32.1 t -87.17 -53.74 4.69 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 178.68 174.76 0.63 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.68 -1.145 . . . . 0.0 108.569 178.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 28.2 m -81.2 -47.69 13.09 Favored 'General case' 0 C--N 1.31 -1.111 0 N-CA-C 111.757 0.28 . . . . 0.0 111.757 -177.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.8 m -64.85 -16.44 63.16 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 112.945 0.72 . . . . 0.0 112.945 -176.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -47.16 -38.34 11.64 Favored 'General case' 0 CA--C 1.513 -0.444 0 N-CA-C 113.177 0.806 . . . . 0.0 113.177 -175.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.61 ' HD1' ' N ' ' A' ' 87' ' ' ALA . 0.2 OUTLIER -58.61 -46.24 87.44 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 112.477 0.547 . . . . 0.0 112.477 -178.558 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.61 ' N ' ' HD1' ' A' ' 86' ' ' TYR . . . -88.14 -17.87 30.01 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-O 120.894 0.378 . . . . 0.0 111.397 -179.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.2 tp60 -63.58 -45.44 90.42 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.578 -0.737 . . . . 0.0 112.337 -174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -63.45 -62.51 1.63 Allowed 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.271 -177.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.585 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 61.4 m-85 -84.27 32.94 0.49 Allowed 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.801 -176.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 7.0 p -54.82 -61.5 2.27 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -177.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 47.6 m -68.59 -38.37 80.6 Favored 'General case' 0 N--CA 1.469 0.5 0 N-CA-C 112.507 0.558 . . . . 0.0 112.507 -179.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.436 ' O ' HD21 ' A' ' 117' ' ' LEU . . . -64.69 -39.86 94.38 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 111.941 0.349 . . . . 0.0 111.941 -176.072 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.585 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 36.5 mt -83.77 -34.33 24.82 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -178.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 87.0 t80 -76.22 -47.04 25.44 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.681 -0.236 . . . . 0.0 111.335 -177.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.517 ' ND2' HG12 ' A' ' 105' ' ' ILE . 37.9 t-20 57.21 92.05 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.214 0 O-C-N 123.983 0.802 . . . . 0.0 111.119 -177.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -81.41 -2.15 48.36 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.6 -178.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.03 -13.47 31.62 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.295 -0.479 . . . . 0.0 112.733 -179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.479 ' HA ' ' O ' ' A' ' 196' ' ' GLY . 12.0 t -80.46 -8.95 11.82 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.64 0.734 . . . . 0.0 109.921 179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.679 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -84.4 -179.23 7.13 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.152 -0.931 . . . . 0.0 112.257 -176.284 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.494 ' ND2' ' HB3' ' A' ' 104' ' ' ASN . 0.2 OUTLIER -77.26 113.83 15.43 Favored 'General case' 0 N--CA 1.438 -1.065 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.549 179.162 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.94 -24.39 64.27 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.717 -177.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 50.1 m -69.03 -41.32 77.86 Favored 'General case' 0 CA--C 1.501 -0.927 0 N-CA-C 109.32 -0.622 . . . . 0.0 109.32 -179.155 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.494 ' HB3' ' ND2' ' A' ' 101' ' ' ASN . 2.1 t30 -62.14 -33.23 74.09 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.52 -0.764 . . . . 0.0 110.715 178.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.517 HG12 ' ND2' ' A' ' 96' ' ' ASN . 1.5 mp -78.15 -43.75 27.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.541 179.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -77.57 -19.02 56.32 Favored 'General case' 0 C--N 1.319 -0.749 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.459 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 95.8 m -84.31 -55.48 4.15 Favored 'General case' 0 C--N 1.315 -0.899 0 C-N-CA 120.714 -0.394 . . . . 0.0 111.015 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.414 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 3.3 pp -123.47 -32.57 3.36 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.624 0.601 . . . . 0.0 112.624 -176.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -50.33 -75.21 0.22 Allowed Glycine 0 C--O 1.223 -0.541 0 C-N-CA 121.596 -0.335 . . . . 0.0 113.772 -177.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 13.5 m -62.4 -18.37 61.45 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 120.796 0.331 . . . . 0.0 111.841 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 11.1 mpt_? -81.0 -54.27 5.71 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.552 -0.295 . . . . 0.0 111.447 -179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 41.6 t -78.02 -40.3 26.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-O 121.026 0.441 . . . . 0.0 110.994 -178.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.686 HD13 ' H ' ' A' ' 10' ' ' THR . 3.3 mm? -70.08 -16.68 63.17 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.6 p 45.44 -118.24 0.71 Allowed 'General case' 0 C--O 1.241 0.618 0 CA-C-N 115.037 -0.983 . . . . 0.0 112.918 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -58.97 -32.8 69.98 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.203 0.445 . . . . 0.0 112.203 -176.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.556 ' O ' HG23 ' A' ' 120' ' ' VAL . 11.6 tp -59.38 -62.88 1.55 Allowed 'General case' 0 N--CA 1.45 -0.453 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.519 -177.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.448 ' HA ' HD23 ' A' ' 117' ' ' LEU . 15.8 mt -71.9 -29.99 64.9 Favored 'General case' 0 CA--C 1.508 -0.646 0 C-N-CA 120.077 -0.649 . . . . 0.0 112.564 -178.718 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -61.19 -40.23 93.13 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 120.259 -0.576 . . . . 0.0 110.284 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -74.92 -32.63 56.6 Favored Glycine 0 N--CA 1.439 -1.15 0 C-N-CA 120.278 -0.963 . . . . 0.0 111.661 177.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.651 HG13 ' HB3' ' A' ' 124' ' ' ALA . 54.2 t -68.51 -35.99 72.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 O-C-N 122.651 -0.323 . . . . 0.0 110.962 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.483 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 59.0 m -53.03 -47.36 68.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.733 -0.667 . . . . 0.0 112.1 -178.596 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 8.5 p -80.85 -43.25 20.25 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 111.982 0.364 . . . . 0.0 111.982 -178.204 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -78.79 -72.51 0.38 Allowed 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 -175.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.651 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.24 -50.43 32.92 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -174.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.483 ' HB3' ' O ' ' A' ' 121' ' ' SER . 45.4 tt0 -64.62 -35.87 82.41 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.054 0.454 . . . . 0.0 110.769 -178.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.21 -53.37 3.14 Favored Glycine 0 N--CA 1.444 -0.789 0 C-N-CA 120.9 -0.667 . . . . 0.0 114.618 -176.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 69.5 mt -105.48 -24.12 12.68 Favored 'General case' 0 N--CA 1.467 0.389 0 N-CA-C 112.691 0.626 . . . . 0.0 112.691 -173.698 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.9 94.5 0.73 Allowed Glycine 0 C--N 1.312 -0.762 0 C-N-CA 120.159 -1.02 . . . . 0.0 110.879 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.558 HG13 ' HD3' ' A' ' 50' ' ' ARG . 30.1 mm -77.87 141.12 15.95 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.974 0 CA-C-O 121.253 0.549 . . . . 0.0 112.429 -176.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -123.23 152.13 41.6 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 115.138 -0.937 . . . . 0.0 109.73 179.496 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.458 ' CG2' ' H ' ' A' ' 38' ' ' GLY . 46.3 t -107.88 163.31 5.66 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.764 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.441 ' N ' HG12 ' A' ' 131' ' ' VAL . 35.8 t70 -58.8 160.05 6.19 Favored 'General case' 0 C--O 1.243 0.748 0 CA-C-O 120.894 0.378 . . . . 0.0 111.244 -179.421 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.508 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 15.4 m -74.64 29.8 0.09 Allowed 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -176.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.11 -87.17 0.16 Allowed Glycine 0 N--CA 1.439 -1.114 0 N-CA-C 110.716 -0.954 . . . . 0.0 110.716 176.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 8.7 t -106.23 -48.47 3.57 Favored 'General case' 0 C--N 1.312 -1.059 0 CA-C-O 120.818 0.342 . . . . 0.0 110.607 177.799 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 140' ' ' ILE . 45.1 t -52.15 -63.16 0.49 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.38 0 N-CA-C 112.928 0.714 . . . . 0.0 112.928 -172.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.508 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.6 tt0 -62.59 -41.21 98.82 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.338 -176.121 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.1 m -60.1 -44.0 95.17 Favored 'General case' 0 C--O 1.242 0.682 0 CA-C-O 121.083 0.468 . . . . 0.0 110.786 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -73.87 -51.99 14.44 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.924 -179.38 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.481 HG12 ' O ' ' A' ' 136' ' ' VAL . 34.4 pt -62.01 -34.47 63.33 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 N-CA-C 112.042 0.386 . . . . 0.0 112.042 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 46.6 t -64.74 -47.8 76.91 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.976 0.417 . . . . 0.0 110.752 179.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 15.4 m -70.98 -34.93 71.88 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-O 121.33 0.586 . . . . 0.0 110.362 179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 32.4 t -67.88 -56.59 8.53 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.875 -178.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 30.5 p -51.16 -30.3 16.36 Favored 'General case' 0 N--CA 1.474 0.74 0 N-CA-C 113.049 0.759 . . . . 0.0 113.049 -174.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.2 m -62.14 -56.38 19.38 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 120.852 0.358 . . . . 0.0 111.048 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 55.4 m-85 -89.0 -40.66 12.85 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.185 0.517 . . . . 0.0 111.891 -176.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 4.3 mm? -74.0 9.88 1.39 Allowed 'General case' 0 C--N 1.316 -0.869 0 C-N-CA 123.62 0.768 . . . . 0.0 112.885 -176.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 26.0 t -46.62 -46.93 20.05 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.358 0.599 . . . . 0.0 109.744 178.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.493 ' HB ' ' NE2' ' A' ' 158' ' ' GLN . 7.4 m -161.01 81.71 0.64 Allowed 'General case' 0 C--N 1.317 -0.808 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 14.8 t -84.75 121.94 28.41 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-O 121.115 0.484 . . . . 0.0 111.175 -176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 42.4 t -172.53 -54.18 0.02 OUTLIER 'General case' 0 C--N 1.319 -0.748 0 CA-C-N 115.436 -0.802 . . . . 0.0 109.007 179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 49.9 p -137.96 -150.59 0.35 Allowed 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 6.0 m -62.15 101.53 0.23 Allowed 'General case' 0 C--O 1.237 0.429 0 N-CA-C 110.39 -0.226 . . . . 0.0 110.39 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.66 89.1 0.72 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.659 0.743 . . . . 0.0 111.486 -177.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.7 t -173.98 -160.57 0.11 Allowed 'General case' 0 N--CA 1.429 -1.489 0 CA-C-N 114.61 -1.177 . . . . 0.0 107.945 -179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -66.15 -19.93 65.99 Favored 'General case' 0 C--N 1.312 -1.025 0 CA-C-O 121.15 0.5 . . . . 0.0 110.103 179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 33.2 t -56.37 -41.19 75.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.065 177.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.493 ' NE2' ' HB ' ' A' ' 149' ' ' THR . 12.7 pt20 -96.92 9.26 42.45 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.939 0.399 . . . . 0.0 111.166 -178.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.38 139.43 45.95 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.653 -179.666 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 22.4 m 60.29 22.64 12.08 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 115.793 -0.64 . . . . 0.0 112.319 179.195 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 176' ' ' SER . . . -73.52 111.37 8.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 CA-C-O 121.082 0.468 . . . . 0.0 110.328 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 13.4 m -110.47 169.63 8.62 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.433 -178.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 4.6 p -74.58 -1.02 19.69 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.843 0.354 . . . . 0.0 111.379 -179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 2.1 m -60.78 -25.1 66.29 Favored 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 123.595 0.758 . . . . 0.0 111.402 179.504 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 19.1 m -72.46 -7.3 49.19 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.931 0.396 . . . . 0.0 110.852 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 104.8 60.19 0.66 Allowed Glycine 0 N--CA 1.44 -1.046 0 C-N-CA 120.955 -0.64 . . . . 0.0 111.626 -179.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -123.03 105.09 9.65 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 120.84 0.352 . . . . 0.0 111.045 -179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -94.87 -20.07 29.62 Favored Glycine 0 N--CA 1.444 -0.821 0 N-CA-C 110.786 -0.926 . . . . 0.0 110.786 177.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.622 ' O ' ' HD3' ' A' ' 175' ' ' PRO . 53.1 t80 -87.43 95.17 9.92 Favored 'General case' 0 N--CA 1.445 -0.704 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 13.4 p -124.8 172.03 9.66 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.829 -179.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 142.48 -162.0 27.32 Favored Glycine 0 N--CA 1.446 -0.681 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_exo -65.64 -19.08 60.01 Favored 'Trans proline' 0 C--N 1.349 0.568 0 C-N-CA 122.766 2.311 . . . . 0.0 111.377 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 15.5 p -144.2 84.13 1.75 Allowed 'General case' 0 N--CA 1.44 -0.971 0 CA-C-N 115.409 -0.814 . . . . 0.0 110.256 178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -139.63 -113.76 1.12 Allowed Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 111.173 -0.771 . . . . 0.0 111.173 179.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.622 ' HD3' ' O ' ' A' ' 169' ' ' TYR . 88.0 Cg_endo -81.2 172.69 12.53 Favored 'Trans proline' 0 C--O 1.238 0.514 0 C-N-CA 122.313 2.009 . . . . 0.0 111.171 177.37 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.535 ' O ' ' HB3' ' A' ' 161' ' ' ALA . 40.1 p -81.05 86.45 6.14 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-O 121.117 0.484 . . . . 0.0 110.517 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 6.3 t -119.0 156.94 28.73 Favored 'General case' 0 C--N 1.307 -1.266 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.33 -179.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.497 ' N ' ' HD3' ' A' ' 179' ' ' PRO . . . 63.24 56.73 18.55 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 121.043 -0.599 . . . . 0.0 112.014 -177.125 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.497 ' HD3' ' N ' ' A' ' 178' ' ' GLY . 5.6 Cg_exo -77.9 105.4 2.01 Favored 'Trans proline' 0 N--CA 1.45 -1.058 0 C-N-CA 122.556 2.171 . . . . 0.0 112.259 -176.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 19.6 m -74.89 135.02 41.53 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.901 178.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 142.4 -23.73 2.36 Favored Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.816 -179.871 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 29.3 p90 -129.71 162.9 50.47 Favored Pre-proline 0 CA--C 1.536 0.422 0 O-C-N 122.605 -0.35 . . . . 0.0 111.082 -179.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_exo -54.59 125.77 20.11 Favored 'Trans proline' 0 C--N 1.361 1.203 0 C-N-CA 123.082 2.521 . . . . 0.0 112.464 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 74.94 61.9 2.94 Favored Glycine 0 N--CA 1.444 -0.768 0 C-N-CA 121.042 -0.599 . . . . 0.0 112.302 -177.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -66.08 -18.09 56.04 Favored 'Trans proline' 0 C--N 1.359 1.096 0 C-N-CA 122.473 2.116 . . . . 0.0 111.986 -179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -79.36 82.07 5.54 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.058 178.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -136.72 149.15 20.07 Favored Glycine 0 N--CA 1.438 -1.181 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.777 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 87.57 -93.29 1.87 Allowed Glycine 0 N--CA 1.441 -1.004 0 C-N-CA 120.827 -0.701 . . . . 0.0 111.742 -179.408 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -138.1 121.74 2.28 Favored Glycine 0 N--CA 1.444 -0.826 0 N-CA-C 111.806 -0.518 . . . . 0.0 111.806 179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -140.42 158.79 65.5 Favored Pre-proline 0 C--N 1.314 -0.972 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 -179.484 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -49.99 146.47 16.91 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 122.878 2.385 . . . . 0.0 112.349 178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -91.02 21.91 3.97 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.813 -177.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -128.88 59.77 0.68 Allowed Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.648 179.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 57.1 mt-30 -102.75 147.33 26.98 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 -179.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 49.1 m -149.95 7.17 0.62 Allowed 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 177.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.479 ' O ' ' HA ' ' A' ' 99' ' ' VAL . . . -175.33 72.88 0.08 OUTLIER Glycine 0 CA--C 1.506 -0.514 0 C-N-CA 120.423 -0.894 . . . . 0.0 112.099 -179.388 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 43.5 p90 -110.61 143.14 41.48 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-O 120.948 0.404 . . . . 0.0 111.09 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.79 77.98 2.05 Favored Glycine 0 N--CA 1.441 -1.032 0 C-N-CA 120.989 -0.624 . . . . 0.0 111.791 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.201 0 CA-C-O 118.417 -1.213 . . . . 0.0 111.934 179.783 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.733 0 N-CA-C 110.325 -0.25 . . . . 0.0 110.325 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -170.96 153.77 21.41 Favored Glycine 0 N--CA 1.444 -0.782 0 C-N-CA 120.066 -1.064 . . . . 0.0 112.745 178.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -79.02 130.69 9.55 Favored 'Trans proline' 0 N--CA 1.456 -0.724 0 C-N-CA 122.541 2.161 . . . . 0.0 110.921 176.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -79.91 94.23 5.82 Favored 'General case' 0 C--N 1.317 -0.833 0 C-N-CA 120.937 -0.305 . . . . 0.0 110.993 -177.926 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 71.28 -75.99 0.63 Allowed Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.857 -0.61 . . . . 0.0 111.698 -178.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -144.17 28.18 1.97 Allowed Glycine 0 N--CA 1.436 -1.339 0 N-CA-C 110.718 -0.953 . . . . 0.0 110.718 178.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 96.3 m-85 -123.56 105.35 9.68 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.886 0.374 . . . . 0.0 111.732 -178.568 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -96.4 81.53 0.76 Allowed Glycine 0 N--CA 1.448 -0.531 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.493 ' HB3' ' HG3' ' A' ' 42' ' ' GLN . . . -72.73 93.9 1.71 Allowed 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 113.412 0.893 . . . . 0.0 113.412 -172.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -159.38 138.03 10.8 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.766 -1.107 . . . . 0.0 109.617 178.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -88.59 96.89 2.25 Favored Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.431 -0.89 . . . . 0.0 112.896 -177.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -65.1 -51.45 50.44 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.824 178.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.455 ' HB3' HD22 ' A' ' 108' ' ' LEU . . . -72.28 -10.98 60.5 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-O 121.093 0.473 . . . . 0.0 110.796 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.49 ' O ' HG23 ' A' ' 18' ' ' ILE . 20.3 m -78.55 -22.18 47.63 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.552 177.466 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.419 ' HA ' ' CD1' ' A' ' 18' ' ' ILE . . . -55.43 -30.44 60.48 Favored 'General case' 0 N--CA 1.469 0.522 0 N-CA-C 112.391 0.515 . . . . 0.0 112.391 -177.222 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -78.15 -38.93 24.8 Favored Glycine 0 N--CA 1.441 -1.002 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.432 178.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.632 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -32.29 22.98 Favored 'General case' 0 C--N 1.322 -0.619 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -177.166 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.49 HG23 ' O ' ' A' ' 14' ' ' SER . 19.9 pt -47.79 -47.49 11.75 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.268 0 N-CA-C 113.72 1.007 . . . . 0.0 113.72 -175.216 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.598 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 11.7 m -70.83 -24.58 62.56 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-O 120.68 0.276 . . . . 0.0 111.599 -177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 81.7 mtt180 -87.56 -24.37 24.04 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.882 0.372 . . . . 0.0 111.576 -178.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 17' ' ' LEU . 84.3 t -59.92 173.18 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.199 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.51 179.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.556 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -37.45 -33.51 0.07 Allowed 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 124.753 1.221 . . . . 0.0 114.189 -178.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.6 m-80 -59.19 -23.0 61.87 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.598 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.58 -38.17 86.56 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.119 0.485 . . . . 0.0 110.206 176.32 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -88.9 -41.95 12.13 Favored 'General case' 0 N--CA 1.451 -0.384 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 178.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.462 ' C ' ' H ' ' A' ' 28' ' ' THR . . . -81.31 69.54 7.96 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.706 -0.849 . . . . 0.0 108.706 176.193 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.436 ' HB3' ' CG ' ' A' ' 146' ' ' PHE . 2.8 t-20 -68.41 19.92 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 124.4 1.08 . . . . 0.0 112.39 -175.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.501 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 24.2 m -55.98 161.52 2.27 Favored 'General case' 0 CA--C 1.56 1.356 0 C-N-CA 123.556 0.743 . . . . 0.0 111.482 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 20.2 m -52.69 -19.51 2.45 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 113.363 0.875 . . . . 0.0 113.363 -177.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 13.9 p -51.79 -44.83 63.6 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 123.936 0.895 . . . . 0.0 113.253 -177.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.486 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -100.09 -20.23 16.11 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.375 0.607 . . . . 0.0 110.166 -179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 32' ' ' ARG . 1.2 tpt180 -66.72 -56.14 11.9 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.246 -0.888 . . . . 0.0 112.301 -175.192 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 10.2 t -163.85 -34.7 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.57 -0.452 . . . . 0.0 111.859 -178.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.3 t -77.62 146.85 7.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.183 -0.673 . . . . 0.0 109.183 178.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.89 139.86 57.87 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-O 121.105 0.478 . . . . 0.0 110.849 -179.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 48.7 ptt85 -63.57 157.37 23.88 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.541 -0.754 . . . . 0.0 112.166 -176.778 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -68.03 112.21 4.88 Favored 'General case' 0 N--CA 1.436 -1.163 0 CA-C-N 115.414 -0.812 . . . . 0.0 108.894 177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.5 ' H ' HG22 ' A' ' 131' ' ' VAL . . . 90.71 35.72 7.16 Favored Glycine 0 N--CA 1.433 -1.551 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.687 -179.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.9 p -45.12 143.6 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.667 0 C-N-CA 123.44 0.696 . . . . 0.0 112.415 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.532 ' O ' HG13 ' A' ' 43' ' ' ILE . 2.2 p -82.13 139.81 34.15 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 115.693 -0.685 . . . . 0.0 112.077 -176.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 4.0 pt20 -59.55 -14.12 11.91 Favored 'General case' 0 C--O 1.22 -0.498 0 CA-C-N 115.453 -0.794 . . . . 0.0 112.44 179.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.493 ' HG3' ' HB3' ' A' ' 9' ' ' ALA . 72.7 mm-40 -65.04 -32.02 73.52 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 120.746 0.307 . . . . 0.0 111.216 -177.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.532 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.01 -34.08 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 CA-C-O 120.993 0.425 . . . . 0.0 110.347 179.541 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.413 ' CB ' HG13 ' A' ' 48' ' ' VAL . . . -84.0 -76.94 0.28 Allowed 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.78 -0.645 . . . . 0.0 111.567 -179.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.6 m 75.21 -18.92 0.42 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.838 0.855 . . . . 0.0 111.629 178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.408 ' H ' ' C ' ' A' ' 44' ' ' ALA . 16.8 p -68.04 -81.45 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.899 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.296 -178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 24.6 m -133.56 -32.37 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.943 0.401 . . . . 0.0 111.495 -178.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.606 ' HB ' ' HB1' ' A' ' 70' ' ' ALA . 2.5 p -79.15 89.43 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.857 0 CA-C-O 121.931 0.872 . . . . 0.0 110.795 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 10.9 mm100 -82.53 -43.49 17.07 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.021 -179.644 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 70.4 ttt180 -133.88 -4.82 2.81 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.497 177.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.61 -50.12 0.66 Allowed 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.305 0.642 . . . . 0.0 112.722 -179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -57.42 -90.74 0.0 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 N-CA-C 112.559 0.577 . . . . 0.0 112.559 -178.912 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.429 ' HB3' HE21 ' A' ' 53' ' ' GLN . 2.6 pt20 -172.74 -45.15 0.02 OUTLIER 'General case' 0 C--O 1.207 -1.162 0 N-CA-C 113.62 0.971 . . . . 0.0 113.62 179.157 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.4 m -50.31 -62.11 1.78 Allowed 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.484 0.55 . . . . 0.0 112.484 -176.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 9.9 tt -86.06 -23.64 26.65 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.415 0.626 . . . . 0.0 110.138 178.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' O ' ' N ' ' A' ' 58' ' ' THR . . . -76.98 -17.92 58.55 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 113.024 0.75 . . . . 0.0 113.024 -176.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 36.7 p -62.72 65.33 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.528 0.68 . . . . 0.0 112.724 -177.432 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.496 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.9 t -102.5 -37.32 8.04 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.749 178.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HG ' HG23 ' A' ' 58' ' ' THR . 81.2 mt -121.76 19.16 11.07 Favored 'General case' 0 CA--C 1.528 0.132 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.442 178.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.59 65.33 1.57 Allowed Glycine 0 C--O 1.217 -0.968 0 C-N-CA 120.637 -0.792 . . . . 0.0 112.24 -178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.572 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 45.9 t -90.07 110.17 21.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-O 120.98 0.419 . . . . 0.0 109.979 -179.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 45.0 p-10 -141.77 18.0 2.16 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 115.712 -0.676 . . . . 0.0 111.02 -177.405 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 118.41 -34.71 4.3 Favored Glycine 0 C--N 1.292 -1.875 0 CA-C-N 115.416 -0.811 . . . . 0.0 112.09 -178.053 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -61.3 -70.53 0.18 Allowed 'General case' 0 N--CA 1.467 0.415 0 CA-C-O 121.242 0.544 . . . . 0.0 110.375 179.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.572 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 26.7 p-10 -86.04 18.88 2.82 Favored 'General case' 0 C--N 1.317 -0.84 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.454 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.432 ' O ' ' HB3' ' A' ' 70' ' ' ALA . 6.7 tt -88.14 -74.41 0.45 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.529 178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -68.41 -27.25 66.04 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.415 -0.811 . . . . 0.0 110.778 179.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -111.71 162.88 14.75 Favored 'General case' 0 C--N 1.316 -0.889 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 177.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 66.82 -61.74 0.32 Allowed 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 112.295 0.48 . . . . 0.0 112.295 -178.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.606 ' HB1' ' HB ' ' A' ' 48' ' ' VAL . . . -64.85 -61.54 2.11 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-O 120.761 0.315 . . . . 0.0 110.73 179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 56.9 t -60.76 -35.77 66.51 Favored 'Isoleucine or valine' 0 C--O 1.213 -0.854 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.188 177.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 64.0 mm-40 -69.88 -21.37 63.33 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.446 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -78.29 -42.85 29.67 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.83 0.348 . . . . 0.0 110.152 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.483 ' HA ' ' HB2' ' A' ' 77' ' ' LEU . 27.3 t -78.23 -33.34 17.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.843 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 60.6 p -70.97 -18.11 62.63 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.275 0.56 . . . . 0.0 110.431 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -116.58 18.95 14.86 Favored 'General case' 0 C--O 1.236 0.37 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.182 178.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.483 ' HB2' ' HA ' ' A' ' 74' ' ' VAL . 10.7 tp -82.24 140.0 45.49 Favored Pre-proline 0 C--N 1.309 -1.19 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.278 -177.119 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_exo -51.21 127.74 22.99 Favored 'Trans proline' 0 C--N 1.348 0.537 0 C-N-CA 122.427 2.084 . . . . 0.0 111.244 177.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -93.23 20.81 6.56 Favored 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.271 0.558 . . . . 0.0 111.106 -178.101 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.87 -22.31 79.17 Favored Glycine 0 C--N 1.309 -0.928 0 CA-C-N 115.197 -0.911 . . . . 0.0 111.636 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 15.2 m -72.3 -15.48 61.9 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 177.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 33.5 t70 75.69 141.79 0.07 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 123.898 0.879 . . . . 0.0 111.598 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.9 p -61.33 -33.72 74.08 Favored 'General case' 0 C--N 1.316 -0.876 0 N-CA-C 112.964 0.727 . . . . 0.0 112.964 -177.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 34.5 t -70.37 -18.49 63.05 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.679 -0.237 . . . . 0.0 111.334 -178.452 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -86.84 -21.71 26.24 Favored 'General case' 0 CA--C 1.511 -0.532 0 CA-C-O 120.94 0.4 . . . . 0.0 110.954 179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 46.5 m-85 -71.98 -174.16 1.17 Allowed 'General case' 0 N--CA 1.443 -0.814 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.251 177.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.495 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -75.01 12.84 0.78 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 4.1 mp0 -74.55 -59.86 2.54 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.789 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -71.04 -39.95 71.98 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-O 121.086 0.47 . . . . 0.0 110.827 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.457 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 93.0 m-85 -83.24 12.38 5.37 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.522 -178.505 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.471 ' HA ' ' HD3' ' A' ' 36' ' ' ARG . 47.8 t -51.19 -43.27 61.31 Favored 'General case' 0 C--O 1.225 -0.21 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.524 -179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 74.9 m -58.16 -44.64 88.03 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 113.149 0.796 . . . . 0.0 113.149 -177.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.96 -32.69 30.63 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-O 120.781 0.324 . . . . 0.0 111.803 -176.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.457 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 68.2 mt -81.59 -32.16 32.2 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.117 0.414 . . . . 0.0 112.117 -176.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -84.97 -34.72 22.35 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 116.592 -0.276 . . . . 0.0 110.447 179.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 51.8 t-20 49.05 83.52 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 O-C-N 123.979 0.8 . . . . 0.0 111.093 -178.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.72 -6.34 51.77 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-N 115.488 -0.778 . . . . 0.0 111.598 -178.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 84.16 -2.85 87.27 Favored Glycine 0 C--O 1.228 -0.221 0 C-N-CA 120.92 -0.657 . . . . 0.0 111.833 -177.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.423 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 32.8 t -92.71 -13.33 8.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-O 121.646 0.736 . . . . 0.0 109.818 -178.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.7 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -91.29 -176.08 4.46 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.282 -0.872 . . . . 0.0 109.827 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.597 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 31.9 t30 -84.54 105.17 15.15 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 179.18 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.76 -16.93 64.25 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.176 -178.636 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 69.2 m -81.34 -19.76 42.12 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.543 -178.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.476 ' ND2' HD12 ' A' ' 105' ' ' ILE . 0.1 OUTLIER -69.97 -26.52 64.14 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 178.141 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.476 HD12 ' ND2' ' A' ' 104' ' ' ASN . 1.8 mp -69.67 -33.17 55.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.648 -0.705 . . . . 0.0 109.564 174.318 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -77.48 -27.18 51.86 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.109 0.48 . . . . 0.0 109.959 177.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.61 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 89.9 m -78.54 -46.65 18.99 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.737 -0.665 . . . . 0.0 111.838 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.459 HD11 ' OG ' ' A' ' 14' ' ' SER . 1.0 OUTLIER -133.51 -40.99 0.87 Allowed 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 112.388 0.514 . . . . 0.0 112.388 -176.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.44 ' N ' ' HG ' ' A' ' 108' ' ' LEU . . . -48.5 -71.88 0.52 Allowed Glycine 0 CA--C 1.526 0.743 0 N-CA-C 115.081 0.792 . . . . 0.0 115.081 -174.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.426 ' O ' ' HA ' ' A' ' 114' ' ' SER . 10.3 t -67.32 -14.05 62.56 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-O 121.097 0.475 . . . . 0.0 111.494 -175.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.61 ' HD3' ' O ' ' A' ' 107' ' ' THR . 80.4 mtp180 -87.19 -49.51 7.23 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.704 -178.219 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.4 t -83.4 -42.81 17.88 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.258 -178.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 116' ' ' LEU . 6.0 mp -80.09 -29.46 39.08 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 120.94 0.4 . . . . 0.0 110.421 -178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.426 ' HA ' ' O ' ' A' ' 110' ' ' SER . 19.5 m 47.72 -99.09 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.076 -0.965 . . . . 0.0 113.473 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -54.22 -36.79 63.89 Favored 'General case' 0 C--O 1.233 0.228 0 N-CA-C 113.1 0.778 . . . . 0.0 113.1 -175.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.529 HD23 HD23 ' A' ' 113' ' ' LEU . 55.5 tp -62.47 -57.08 12.49 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 120.337 -0.545 . . . . 0.0 111.601 -178.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' A' ' 121' ' ' SER . 25.9 mt -71.47 -23.78 61.88 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 120.516 -0.474 . . . . 0.0 112.165 -176.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -67.12 -34.11 76.9 Favored 'General case' 0 C--N 1.323 -0.576 0 C-N-CA 120.457 -0.497 . . . . 0.0 109.815 176.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.19 -43.22 6.72 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.78 -0.724 . . . . 0.0 111.455 177.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 124' ' ' ALA . 56.0 t -62.42 -28.99 45.74 Favored 'Isoleucine or valine' 0 C--O 1.235 0.333 0 C-N-CA 122.358 0.263 . . . . 0.0 111.11 179.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.489 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 9.3 t -57.35 -40.51 78.21 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 116.416 -0.357 . . . . 0.0 110.267 179.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . 0.464 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 23.7 m -85.57 -28.83 24.62 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.096 178.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.0 -83.82 0.13 Allowed 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -177.437 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.458 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -70.17 -47.49 61.37 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-O 120.928 0.394 . . . . 0.0 111.371 -176.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.489 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 42.9 tt0 -75.71 -17.57 59.89 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-O 121.326 0.584 . . . . 0.0 109.793 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.464 ' HA3' ' O ' ' A' ' 122' ' ' SER . . . -85.13 -64.06 1.55 Allowed Glycine 0 N--CA 1.439 -1.14 0 CA-C-N 115.62 -0.718 . . . . 0.0 113.207 -178.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.2 mt -127.69 -4.93 5.83 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.917 0.389 . . . . 0.0 111.11 -176.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 87.37 119.43 1.32 Allowed Glycine 0 N--CA 1.439 -1.133 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.593 -178.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 70.9 mt -81.46 130.91 35.04 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.984 0 CA-C-O 120.967 0.413 . . . . 0.0 111.261 178.635 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 53.9 t30 -101.02 152.19 20.89 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.28 176.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.5 HG22 ' H ' ' A' ' 38' ' ' GLY . 0.8 OUTLIER -116.61 -149.84 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 179.957 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.444 ' H ' HG12 ' A' ' 131' ' ' VAL . 2.8 p-10 -85.44 147.44 26.48 Favored 'General case' 0 N--CA 1.437 -1.106 0 CA-C-O 121.491 0.663 . . . . 0.0 110.871 -176.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 2.9 p -80.53 15.38 1.69 Allowed 'General case' 0 C--N 1.31 -1.14 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.301 179.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -112.05 -64.43 0.48 Allowed Glycine 0 N--CA 1.439 -1.11 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.499 -177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 5.6 m -85.25 -49.86 7.84 Favored 'General case' 0 C--N 1.314 -0.951 0 N-CA-C 112.494 0.553 . . . . 0.0 112.494 -175.129 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.454 ' O ' HG12 ' A' ' 140' ' ' ILE . 99.5 t -72.23 -51.71 28.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 N-CA-C 112.32 0.489 . . . . 0.0 112.32 -176.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . . . . . . . . . 8.6 tt0 -54.82 -48.25 73.06 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.0 p -58.79 -41.78 87.49 Favored 'General case' 0 C--O 1.243 0.719 0 CA-C-O 120.831 0.348 . . . . 0.0 111.86 -178.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -75.08 -50.4 16.53 Favored 'General case' 0 CA--C 1.51 -0.572 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.996 -178.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.454 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.3 pt -65.27 -31.73 55.15 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.668 0 C-N-CA 120.505 -0.478 . . . . 0.0 111.39 -178.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 37.5 t -61.41 -43.94 97.99 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 120.723 0.297 . . . . 0.0 111.264 179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 7.2 p -86.52 -40.57 15.13 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 112.949 0.722 . . . . 0.0 112.949 -177.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.501 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 22.8 t -78.09 -18.36 55.83 Favored 'General case' 0 CA--C 1.551 0.988 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 14.6 p -57.32 -18.14 15.56 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 113.326 0.861 . . . . 0.0 113.326 -178.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 20.4 p -45.87 -30.62 1.78 Allowed 'General case' 0 CA--C 1.549 0.93 0 N-CA-C 112.986 0.735 . . . . 0.0 112.986 -179.205 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.436 ' CG ' ' HB3' ' A' ' 27' ' ' ASN . 94.7 m-85 -62.1 -17.16 56.8 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.262 0.468 . . . . 0.0 112.262 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 10.1 mp -59.64 -11.71 5.43 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-O 120.762 0.315 . . . . 0.0 111.205 178.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.8 t -63.85 -37.91 89.15 Favored 'General case' 0 N--CA 1.442 -0.859 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 175.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 70.7 p -80.46 -8.81 59.69 Favored 'General case' 0 N--CA 1.447 -0.577 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.889 -179.09 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 27.7 t -73.77 -6.07 44.67 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 121.675 0.75 . . . . 0.0 109.052 178.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.3 m -148.34 -147.24 0.22 Allowed 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 177.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 69.2 m -56.34 111.58 1.01 Allowed 'General case' 0 C--O 1.24 0.554 0 CA-C-N 118.239 0.472 . . . . 0.0 110.03 176.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 42.9 m -38.67 -59.73 0.9 Allowed 'General case' 0 N--CA 1.47 0.552 0 C-N-CA 124.413 1.085 . . . . 0.0 113.728 -174.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -167.78 -148.82 0.09 Allowed 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 110.114 -0.328 . . . . 0.0 110.114 -177.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 7.6 m -51.95 -41.1 61.81 Favored 'General case' 0 C--N 1.339 0.126 0 CA-C-O 121.237 0.541 . . . . 0.0 110.229 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 91.4 m-85 -92.09 126.02 37.0 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.857 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.1 m -74.86 70.06 1.91 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 120.831 0.348 . . . . 0.0 111.208 -178.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 1.6 pm0 44.19 26.06 0.14 Allowed 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 124.91 1.284 . . . . 0.0 114.074 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.09 -10.14 59.18 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.547 0.689 . . . . 0.0 109.924 178.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 3.9 p -84.38 -8.92 58.83 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-N 115.277 -0.874 . . . . 0.0 110.444 178.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -124.52 89.06 3.01 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.187 179.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 23.3 t -88.4 94.57 9.89 Favored 'General case' 0 C--N 1.314 -0.967 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.318 -179.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 25.1 p -79.64 -20.95 45.49 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.246 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 14.5 t -70.3 -20.5 63.01 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.21 178.326 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.9 t -95.89 6.93 47.71 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.875 178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 94.03 103.13 1.72 Allowed Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.869 -0.682 . . . . 0.0 112.251 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -92.28 -28.47 16.96 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 120.93 0.395 . . . . 0.0 110.529 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 99.29 -64.32 0.69 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.462 179.429 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 86.1 m-85 -102.18 -66.0 0.95 Allowed 'General case' 0 C--N 1.319 -0.739 0 O-C-N 122.739 -0.271 . . . . 0.0 111.031 -179.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 22.1 m 72.22 159.56 0.21 Allowed 'General case' 0 CA--C 1.554 1.133 0 O-C-N 123.625 0.578 . . . . 0.0 110.961 -178.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 72.44 -135.66 22.51 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.352 -0.451 . . . . 0.0 113.401 176.601 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -67.38 -8.56 22.45 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 123.276 2.651 . . . . 0.0 112.973 -178.196 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.4 p -123.13 12.23 9.56 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.224 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -135.56 -164.87 10.51 Favored Glycine 0 N--CA 1.443 -0.883 0 C-N-CA 120.131 -1.033 . . . . 0.0 112.807 -177.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -76.65 174.91 12.07 Favored 'Trans proline' 0 C--O 1.239 0.566 0 C-N-CA 122.953 2.435 . . . . 0.0 112.301 -179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 23.5 p -76.68 86.36 3.32 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-O 121.351 0.596 . . . . 0.0 110.393 179.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.0 t -140.76 162.16 36.07 Favored 'General case' 0 N--CA 1.437 -1.103 0 CA-C-N 115.358 -0.837 . . . . 0.0 109.262 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.407 ' HA2' ' O ' ' A' ' 186' ' ' LEU . . . 110.22 -114.76 3.92 Favored Glycine 0 N--CA 1.433 -1.512 0 C-N-CA 120.151 -1.023 . . . . 0.0 112.172 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -65.03 -13.7 41.21 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.671 2.247 . . . . 0.0 112.596 -179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 7.4 m -62.57 -31.82 72.69 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.097 177.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -98.27 146.78 18.33 Favored Glycine 0 C--N 1.333 0.388 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.592 -178.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.514 ' HB2' ' HD3' ' A' ' 183' ' ' PRO . 87.7 m-85 -85.21 -53.33 0.46 Allowed Pre-proline 0 CA--C 1.544 0.72 0 N-CA-C 112.921 0.712 . . . . 0.0 112.921 -179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.514 ' HD3' ' HB2' ' A' ' 182' ' ' TYR . 16.9 Cg_exo -68.32 123.07 10.14 Favored 'Trans proline' 0 C--N 1.371 1.75 0 C-N-CA 121.412 1.408 . . . . 0.0 110.299 178.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 56.79 67.12 2.38 Favored Glycine 0 CA--C 1.506 -0.49 0 N-CA-C 110.456 -1.058 . . . . 0.0 110.456 -174.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -61.78 158.59 37.02 Favored 'Trans proline' 0 CA--C 1.505 -0.973 0 C-N-CA 122.218 1.945 . . . . 0.0 111.261 -176.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.428 ' HB3' ' CB ' ' A' ' 190' ' ' ALA . 88.6 mt 67.46 -140.36 0.12 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.735 -177.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 170.45 -154.98 24.13 Favored Glycine 0 C--N 1.311 -0.836 0 C-N-CA 120.844 -0.693 . . . . 0.0 111.615 -178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -60.91 -65.35 3.37 Favored Glycine 0 C--N 1.329 0.153 0 C-N-CA 121.191 -0.528 . . . . 0.0 112.183 179.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -84.44 57.21 5.03 Favored Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 111.357 -0.697 . . . . 0.0 111.357 178.2 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.428 ' CB ' ' HB3' ' A' ' 186' ' ' LEU . . . -77.54 130.92 72.57 Favored Pre-proline 0 C--N 1.32 -0.708 0 CA-C-O 120.655 0.264 . . . . 0.0 111.617 -177.583 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -53.56 134.76 59.32 Favored 'Trans proline' 0 C--O 1.238 0.478 0 C-N-CA 122.707 2.272 . . . . 0.0 111.468 175.315 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -78.89 52.76 1.28 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.421 0.629 . . . . 0.0 110.69 179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.549 ' HA2' ' HB2' ' A' ' 101' ' ' ASN . . . -128.4 -118.48 2.11 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.128 179.332 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 65.0 mm-40 50.4 89.52 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 178.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.597 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 45.4 m -111.16 23.88 13.55 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.51 178.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 130.36 57.83 0.1 OUTLIER Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.103 -1.046 . . . . 0.0 113.353 178.148 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 75.7 t80 -147.58 -64.01 0.27 Allowed 'General case' 0 C--N 1.319 -0.743 0 CA-C-O 120.951 0.405 . . . . 0.0 110.162 178.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -96.1 98.17 2.17 Favored Glycine 0 N--CA 1.439 -1.161 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.254 1.375 0 CA-C-O 118.471 -1.183 . . . . 0.0 111.254 -179.71 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.637 0 CA-C-O 121.059 0.456 . . . . 0.0 110.511 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.7 -155.52 16.16 Favored Glycine 0 N--CA 1.444 -0.825 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 -179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -61.17 136.47 64.95 Favored 'Trans proline' 0 C--O 1.235 0.348 0 C-N-CA 122.309 2.006 . . . . 0.0 111.784 178.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 59.2 tt0 -89.23 150.97 22.4 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.652 -177.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -72.3 81.62 0.58 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 111.695 -0.562 . . . . 0.0 111.695 177.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 140.18 -28.46 2.48 Favored Glycine 0 N--CA 1.442 -0.934 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -177.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -130.82 84.47 2.19 Favored 'General case' 0 C--N 1.319 -0.758 0 N-CA-C 109.082 -0.71 . . . . 0.0 109.082 176.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -76.35 87.48 0.91 Allowed Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.417 -178.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -57.17 156.19 7.63 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.127 0.171 . . . . 0.0 110.864 178.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.438 ' H ' ' HG ' ' A' ' 113' ' ' LEU . 28.5 p 61.9 130.37 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.495 1.118 . . . . 0.0 112.305 -176.475 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -107.2 167.65 13.81 Favored Glycine 0 C--O 1.239 0.431 0 C-N-CA 120.418 -0.896 . . . . 0.0 112.649 -178.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -68.22 -44.38 76.02 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 121.244 -0.503 . . . . 0.0 113.056 -178.492 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.87 -34.59 77.7 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.007 0.432 . . . . 0.0 111.097 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.58 ' O ' HG23 ' A' ' 18' ' ' ILE . 15.3 p -76.21 -27.99 57.04 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.291 178.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.99 -23.02 52.21 Favored 'General case' 0 N--CA 1.474 0.746 0 N-CA-C 112.835 0.68 . . . . 0.0 112.835 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.01 -41.8 6.17 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.062 -1.066 . . . . 0.0 112.511 178.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.615 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -84.41 -22.64 30.35 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 -175.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.646 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 5.1 pt -40.22 -55.88 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 N-CA-C 114.146 1.165 . . . . 0.0 114.146 -175.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 9.1 t -85.06 -19.71 31.51 Favored 'General case' 0 C--N 1.306 -1.306 0 CA-C-O 120.712 0.291 . . . . 0.0 111.632 -176.381 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 68.1 mtt180 -83.14 -27.42 30.13 Favored 'General case' 0 C--O 1.224 -0.271 0 N-CA-C 113.553 0.946 . . . . 0.0 113.553 -174.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.715 HG11 ' HB3' ' A' ' 100' ' ' LEU . 23.8 t -71.28 -100.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.55 0.945 0 N-CA-C 113.394 0.887 . . . . 0.0 113.394 -174.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -78.99 -38.99 35.39 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -176.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.428 ' HB3' HD22 ' A' ' 31' ' ' LEU . 4.4 m-80 -70.91 -24.56 62.49 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 113.511 0.93 . . . . 0.0 113.511 -174.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.57 -37.7 87.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.167 0.508 . . . . 0.0 110.038 176.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.425 HD23 ' O ' ' A' ' 25' ' ' LEU . 6.0 tt -75.91 -40.21 54.77 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 115.42 -0.809 . . . . 0.0 109.05 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.9 -39.73 90.41 Favored 'General case' 0 C--O 1.226 -0.173 0 CA-C-N 115.78 -0.646 . . . . 0.0 110.741 178.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 53.77 16.97 1.14 Allowed 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 123.793 0.837 . . . . 0.0 111.794 176.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.421 HG22 ' N ' ' A' ' 29' ' ' SER . 19.7 m -75.66 165.59 24.84 Favored 'General case' 0 N--CA 1.436 -1.129 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.27 -176.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.428 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 16.3 m -60.08 -17.63 41.1 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.819 178.532 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.9 p -53.48 -31.26 44.97 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 123.687 0.795 . . . . 0.0 112.73 -178.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.514 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -110.08 -20.28 12.75 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.525 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.428 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 15.5 ttm180 -79.87 -38.61 32.32 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.878 -175.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.7 t -174.64 -26.0 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.902 0.704 . . . . 0.0 112.902 -176.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 71.0 t -92.08 139.64 17.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 N-CA-C 109.859 -0.422 . . . . 0.0 109.859 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -55.42 145.37 22.67 Favored 'General case' 0 C--O 1.235 0.336 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.883 -179.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 36.4 ptt85 -63.12 155.25 28.5 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-O 121.014 0.435 . . . . 0.0 110.52 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 2.1 m -71.22 114.45 9.29 Favored 'General case' 0 C--N 1.309 -1.153 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.262 -178.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.58 40.13 9.19 Favored Glycine 0 N--CA 1.437 -1.249 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.762 -179.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.5 p -55.86 151.86 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.764 0 CA-C-O 121.203 0.525 . . . . 0.0 111.605 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.6 m -91.31 159.51 15.97 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.599 -177.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.505 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.0 pt20 -67.42 -13.37 61.96 Favored 'General case' 0 C--O 1.217 -0.61 0 CA-C-N 115.91 -0.586 . . . . 0.0 112.285 -178.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.415 ' CG ' HD13 ' A' ' 116' ' ' LEU . 83.4 mm-40 -55.62 -47.78 76.0 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.851 0.357 . . . . 0.0 111.043 -179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -83.94 -29.21 7.37 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.784 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.32 -55.36 4.56 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.221 -0.445 . . . . 0.0 112.118 -176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 36.8 m 75.53 -18.9 0.43 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 123.866 0.866 . . . . 0.0 111.821 179.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 28.4 p -68.43 -88.5 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 113.101 0.778 . . . . 0.0 113.101 -177.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.8 p -145.01 -27.57 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-O 120.947 0.403 . . . . 0.0 111.814 -176.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -67.62 98.21 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 CA-C-O 121.342 0.591 . . . . 0.0 111.824 -179.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.505 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 31.2 mt-30 -82.54 -48.27 11.19 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.351 177.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.726 ' NH1' ' HA ' ' A' ' 123' ' ' ALA . 54.7 ttt180 -134.31 -3.14 2.74 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.331 -0.849 . . . . 0.0 109.879 178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.07 -58.26 0.54 Allowed 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 123.354 0.662 . . . . 0.0 110.306 -174.695 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -65.43 137.61 57.57 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.274 177.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.617 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -50.29 -24.38 2.89 Favored 'General case' 0 C--O 1.213 -0.849 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 -175.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 22.6 t -50.93 -74.17 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.847 0 N-CA-C 112.225 0.454 . . . . 0.0 112.225 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.56 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 47.5 tp -87.94 -24.53 23.56 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.902 0.382 . . . . 0.0 111.514 -179.697 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . . . . . . . . . . . -75.64 -17.85 59.86 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 -175.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.617 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 14.3 t -58.67 84.01 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 121.229 0.538 . . . . 0.0 111.65 -178.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.432 HG23 ' HG ' ' A' ' 59' ' ' LEU . 12.7 t -123.3 -35.99 2.88 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-N 115.691 -0.686 . . . . 0.0 109.73 177.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.432 ' HG ' HG23 ' A' ' 58' ' ' THR . 84.0 mt -120.82 18.57 11.84 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.948 178.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 81.43 59.69 2.35 Favored Glycine 0 C--O 1.225 -0.454 0 C-N-CA 120.631 -0.795 . . . . 0.0 111.391 -177.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.707 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 33.0 t -89.43 103.67 14.29 Favored 'Isoleucine or valine' 0 CA--C 1.51 -0.563 0 CA-C-O 120.929 0.395 . . . . 0.0 110.834 -177.114 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -169.2 96.77 0.34 Allowed 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.502 179.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 80.77 -63.87 4.18 Favored Glycine 0 N--CA 1.444 -0.793 0 CA-C-N 115.645 -0.707 . . . . 0.0 113.21 178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -58.55 -75.52 0.05 Allowed 'General case' 0 C--N 1.333 -0.148 0 C-N-CA 122.914 0.486 . . . . 0.0 111.664 -175.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.707 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.5 p-10 -85.8 15.16 5.04 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.148 0.499 . . . . 0.0 110.501 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 43.8 tp -88.26 -56.1 3.46 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.442 175.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.44 -18.01 46.83 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.246 179.351 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 85.9 mtt180 -121.24 161.09 22.54 Favored 'General case' 0 C--O 1.209 -1.044 0 N-CA-C 108.765 -0.828 . . . . 0.0 108.765 178.324 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.2 m-85 66.95 -63.11 0.28 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 177.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -70.94 -63.41 1.1 Allowed 'General case' 0 N--CA 1.468 0.47 0 N-CA-C 112.695 0.628 . . . . 0.0 112.695 -175.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 14.5 p -66.89 -31.24 52.6 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.418 0 CA-C-O 120.872 0.368 . . . . 0.0 110.349 -179.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.7 mm-40 -68.61 -29.5 68.03 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.006 -179.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.79 -46.65 65.25 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.122 179.429 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -77.5 -38.92 26.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.115 -178.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 21.7 t -66.37 -21.92 66.24 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.873 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 53.2 mtm180 -113.32 15.44 19.24 Favored 'General case' 0 CA--C 1.512 -0.485 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.892 179.627 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.459 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 11.9 tp -80.31 119.22 75.77 Favored Pre-proline 0 C--N 1.317 -0.825 0 C-N-CA 120.801 -0.36 . . . . 0.0 110.661 -177.122 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 27.5 Cg_exo -63.27 128.73 23.44 Favored 'Trans proline' 0 N--CA 1.463 -0.275 0 C-N-CA 122.764 2.309 . . . . 0.0 112.116 -179.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -83.56 83.51 7.87 Favored 'General case' 0 C--N 1.317 -0.828 0 CA-C-O 121.102 0.477 . . . . 0.0 110.377 179.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -73.29 -35.9 56.21 Favored Glycine 0 N--CA 1.444 -0.779 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.16 -179.677 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 7.3 p -88.56 -62.59 1.45 Allowed 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 120.747 0.308 . . . . 0.0 110.479 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 16.4 t70 176.03 159.65 0.29 Allowed 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 109.227 -0.657 . . . . 0.0 109.227 178.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.2 m -69.5 -30.8 68.73 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-O 120.969 0.414 . . . . 0.0 110.356 178.647 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 3.3 m -70.04 -18.42 63.3 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.042 -178.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -69.39 -21.49 63.77 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.857 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 74.9 m-85 -78.44 -174.44 3.79 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.523 178.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.81 35.6 0.31 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.235 -178.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.514 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 85.6 mm-40 -74.43 -60.39 2.29 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.331 -179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.646 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -78.67 -32.67 47.22 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.409 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.43 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 56.6 m-85 -80.68 9.03 6.73 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.055 -178.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.9 p -52.15 -56.53 13.95 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -177.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 18' ' ' ILE . 11.7 t -61.53 -36.04 79.44 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.902 0.705 . . . . 0.0 112.902 -175.968 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . 0.413 ' HB2' HG22 ' A' ' 18' ' ' ILE . . . -74.61 -36.54 62.95 Favored 'General case' 0 C--N 1.32 -0.704 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.39 -177.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.438 HD22 HD21 ' A' ' 116' ' ' LEU . 50.1 mt -83.62 -20.68 33.23 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.164 0.507 . . . . 0.0 111.163 -179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.53 ' O ' ' HB1' ' A' ' 124' ' ' ALA . 78.9 t80 -85.13 -25.27 27.59 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.375 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 10.0 m120 48.57 65.59 1.3 Allowed 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.972 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -58.64 -26.92 64.24 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.408 -0.815 . . . . 0.0 112.098 -178.214 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.13 -15.45 61.0 Favored Glycine 0 N--CA 1.463 0.489 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.113 179.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 12.5 p -84.17 -12.64 11.69 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-O 121.98 0.895 . . . . 0.0 109.02 177.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.715 ' HB3' HG11 ' A' ' 21' ' ' VAL . 1.0 OUTLIER -83.6 175.29 9.85 Favored 'General case' 0 C--N 1.311 -1.107 0 CA-C-N 114.473 -1.239 . . . . 0.0 111.309 -178.025 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.508 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 39.1 t30 -72.17 109.51 5.99 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.833 -179.795 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.53 -24.43 63.74 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.991 -0.549 . . . . 0.0 110.865 178.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 16.1 m -69.46 -26.88 64.8 Favored 'General case' 0 C--O 1.224 -0.27 0 CA-C-O 121.527 0.68 . . . . 0.0 109.494 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.508 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -64.62 -46.56 82.09 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.131 -0.94 . . . . 0.0 109.606 177.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -69.68 -36.95 72.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.502 -0.772 . . . . 0.0 110.019 179.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.59 -39.06 92.53 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.697 176.535 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.409 ' O ' ' HD3' ' A' ' 111' ' ' ARG . 93.4 m -74.87 -62.89 1.39 Allowed 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.589 0.588 . . . . 0.0 112.589 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.482 HD21 ' OD1' ' A' ' 104' ' ' ASN . 0.9 OUTLIER -113.21 -33.22 6.05 Favored 'General case' 0 C--N 1.32 -0.675 0 N-CA-C 112.569 0.581 . . . . 0.0 112.569 -175.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.435 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.9 -56.87 14.3 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 120.789 -0.719 . . . . 0.0 113.188 -176.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 15.9 t -69.49 -26.44 64.56 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-O 120.764 0.316 . . . . 0.0 111.573 -177.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.409 ' HD3' ' O ' ' A' ' 107' ' ' THR . 3.6 mpt_? -83.09 -47.39 11.71 Favored 'General case' 0 C--N 1.323 -0.571 0 N-CA-C 112.415 0.524 . . . . 0.0 112.415 -177.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 39.3 t -83.24 -50.08 15.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 N-CA-C 112.212 0.449 . . . . 0.0 112.212 -175.402 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.438 ' HG ' ' H ' ' A' ' 10' ' ' THR . 9.0 mp -67.87 -41.27 83.11 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.594 -0.276 . . . . 0.0 110.925 -177.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 32.7 t 46.72 -95.76 0.03 OUTLIER 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 123.761 0.824 . . . . 0.0 113.104 176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.95 -34.8 66.0 Favored 'General case' 0 C--N 1.343 0.297 0 C-N-CA 123.092 0.557 . . . . 0.0 112.121 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 120' ' ' VAL . 35.2 tp -65.93 -48.22 72.11 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.524 179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.417 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 17.0 mt -70.75 -23.49 62.44 Favored 'General case' 0 CA--C 1.507 -0.675 0 C-N-CA 120.548 -0.461 . . . . 0.0 111.718 -179.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.7 m120 -58.46 -34.78 71.24 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 176.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.55 -41.42 6.88 Favored Glycine 0 N--CA 1.44 -1.075 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.555 176.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.505 HG23 ' O ' ' A' ' 116' ' ' LEU . 76.4 t -61.18 -32.55 53.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.589 0 N-CA-C 111.943 0.349 . . . . 0.0 111.943 -179.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 70.8 m -54.43 -45.67 73.08 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 120.963 0.411 . . . . 0.0 111.128 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 15.2 m -84.33 -23.9 30.03 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.827 -179.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.726 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.17 -84.96 0.14 Allowed 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.218 0.822 . . . . 0.0 113.218 -176.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 95' ' ' PHE . . . -76.51 -45.91 28.88 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.835 -174.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 40.0 tt0 -72.52 -20.38 61.36 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.089 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.73 -70.96 1.21 Allowed Glycine 0 N--CA 1.441 -1.017 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.62 -177.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 86.7 mt -128.69 -9.07 5.04 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 120.655 -0.418 . . . . 0.0 111.653 -175.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 93.63 120.78 3.12 Favored Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.152 -1.023 . . . . 0.0 110.895 -176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . . . . . . . . . 12.5 mt -85.27 146.81 6.08 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.168 0 CA-C-O 121.051 0.453 . . . . 0.0 111.863 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 59.9 t30 -140.52 149.37 42.38 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.2 175.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.42 HG12 ' N ' ' A' ' 132' ' ' ASP . 20.7 t -120.89 161.72 20.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 109.693 -0.484 . . . . 0.0 109.693 179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.42 ' N ' HG12 ' A' ' 131' ' ' VAL . 21.2 t70 -59.72 156.22 14.31 Favored 'General case' 0 C--O 1.245 0.859 0 CA-C-O 121.261 0.553 . . . . 0.0 111.74 -178.53 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 14.5 m -78.97 20.78 0.46 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.722 -0.672 . . . . 0.0 112.477 -177.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -68.84 -77.97 0.35 Allowed Glycine 0 N--CA 1.438 -1.199 0 C-N-CA 120.552 -0.832 . . . . 0.0 111.183 176.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 37.9 m -107.83 -31.15 8.14 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 179.008 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.407 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.8 t -86.58 -64.46 1.07 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.18 0 N-CA-C 113.684 0.994 . . . . 0.0 113.684 -172.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.2 tt0 -67.59 -23.0 65.34 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.853 0.358 . . . . 0.0 111.96 -174.401 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.0 p -68.85 -44.97 72.29 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.065 0.46 . . . . 0.0 111.084 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -76.48 -50.23 14.54 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.511 -177.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.479 HG12 ' HA ' ' A' ' 137' ' ' GLN . 44.9 pt -58.79 -40.47 79.92 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.311 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -176.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 12.8 p -56.85 -36.95 70.61 Favored 'General case' 0 CA--C 1.536 0.417 0 CA-C-O 120.832 0.349 . . . . 0.0 111.755 -178.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 40.1 t -84.42 -45.53 12.61 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 121.038 0.447 . . . . 0.0 110.568 179.118 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.458 ' HA ' HD23 ' A' ' 147' ' ' LEU . 45.6 t -59.14 -45.41 91.02 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.905 -177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 29.1 m -65.52 -19.93 66.13 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.803 -179.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.5 t -85.72 -49.87 7.62 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -178.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -89.09 -60.3 1.99 Allowed 'General case' 0 C--N 1.324 -0.5 0 N-CA-C 114.157 1.169 . . . . 0.0 114.157 -173.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.458 HD23 ' HA ' ' A' ' 143' ' ' SER . 3.7 mm? -54.98 -29.91 58.06 Favored 'General case' 0 N--CA 1.481 1.09 0 N-CA-C 113.708 1.003 . . . . 0.0 113.708 -172.092 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 4.3 m -54.07 -37.24 63.99 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 112.73 0.641 . . . . 0.0 112.73 -177.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.7 p -129.84 14.82 5.85 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 120.485 -0.486 . . . . 0.0 112.159 -176.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 72.7 m -80.83 142.11 34.01 Favored 'General case' 0 C--O 1.241 0.649 0 CA-C-N 116.748 -0.205 . . . . 0.0 110.76 179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 37.6 t 68.62 -70.12 0.14 Allowed 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.586 0.754 . . . . 0.0 109.914 -177.66 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.45 ' HA ' ' HB3' ' A' ' 161' ' ' ALA . 32.8 t -105.12 104.5 14.25 Favored 'General case' 0 N--CA 1.427 -1.594 0 N-CA-C 108.264 -1.014 . . . . 0.0 108.264 176.306 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.509 ' HB2' ' HB2' ' A' ' 158' ' ' GLN . 13.2 m -68.32 165.87 17.7 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.703 -178.765 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.419 ' HB1' ' O ' ' A' ' 178' ' ' GLY . . . -80.68 -31.52 36.25 Favored 'General case' 0 N--CA 1.44 -0.961 0 CA-C-N 115.969 -0.559 . . . . 0.0 109.821 178.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.479 ' HA ' ' HB3' ' A' ' 179' ' ' PRO . 15.0 m -51.53 132.78 30.37 Favored 'General case' 0 C--O 1.221 -0.409 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.17 178.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -54.28 -40.67 68.07 Favored 'General case' 0 N--CA 1.468 0.434 0 N-CA-C 112.85 0.685 . . . . 0.0 112.85 -174.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 7.5 p -73.59 -7.47 52.04 Favored 'General case' 0 C--N 1.318 -0.793 0 CA-C-O 120.999 0.428 . . . . 0.0 111.674 -178.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.509 ' HB2' ' HB2' ' A' ' 153' ' ' SER . 75.9 mt-30 -126.55 13.21 7.54 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.089 0.471 . . . . 0.0 110.124 -178.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.17 168.11 14.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.703 -178.76 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 80.2 p 52.07 30.35 7.42 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.435 0.694 . . . . 0.0 111.951 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' HB3' ' HA ' ' A' ' 152' ' ' SER . . . -72.6 -24.89 61.15 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.18 0.514 . . . . 0.0 110.873 -179.034 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.43 ' O ' ' HB3' ' A' ' 175' ' ' PRO . 47.0 t -111.59 143.08 43.04 Favored 'General case' 0 C--N 1.312 -1.05 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 178.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.431 ' OG ' ' HB2' ' A' ' 167' ' ' ALA . 37.7 p 47.24 46.39 16.63 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 122.871 0.468 . . . . 0.0 112.195 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 12.5 m -55.88 110.75 0.78 Allowed 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.181 -178.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 36.9 p 55.3 18.83 2.69 Favored 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.964 0.905 . . . . 0.0 112.174 -178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -127.45 4.13 7.16 Favored Glycine 0 N--CA 1.442 -0.966 0 N-CA-C 111.338 -0.705 . . . . 0.0 111.338 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.431 ' HB2' ' OG ' ' A' ' 163' ' ' SER . . . -78.77 -56.72 4.19 Favored 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 120.752 0.311 . . . . 0.0 110.635 -179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 80.88 -36.86 2.31 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.064 -0.588 . . . . 0.0 112.474 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -89.83 -49.09 6.83 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.548 0.213 . . . . 0.0 110.842 -179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 28.4 m 63.43 95.73 0.04 OUTLIER 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.107 -179.178 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 117.83 -89.13 0.47 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.831 -0.699 . . . . 0.0 111.555 -178.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 11.1 Cg_endo -55.18 -32.17 79.06 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 123.113 2.542 . . . . 0.0 111.499 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 50.6 m -150.56 70.67 1.02 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.04 176.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -175.77 -157.45 17.07 Favored Glycine 0 N--CA 1.436 -1.358 0 C-N-CA 120.738 -0.744 . . . . 0.0 112.147 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.43 ' HB3' ' O ' ' A' ' 162' ' ' SER . 49.8 Cg_endo -99.99 -178.46 0.21 Allowed 'Trans proline' 0 N--CA 1.448 -1.156 0 C-N-CA 123.359 2.706 . . . . 0.0 112.887 -179.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 11.7 t -93.1 168.36 11.17 Favored 'General case' 0 N--CA 1.434 -1.237 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.413 ' H ' ' H ' ' A' ' 178' ' ' GLY . 14.7 t -177.75 12.09 0.0 OUTLIER 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.172 0.511 . . . . 0.0 110.62 -176.043 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.419 ' O ' ' HB1' ' A' ' 154' ' ' ALA . . . -115.53 85.34 0.39 Allowed Glycine 0 N--CA 1.434 -1.456 0 N-CA-C 110.177 -1.169 . . . . 0.0 110.177 178.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.563 ' HG2' ' O ' ' A' ' 185' ' ' PRO . 14.8 Cg_endo -57.01 121.2 9.65 Favored 'Trans proline' 0 C--N 1.347 0.47 0 C-N-CA 122.597 2.198 . . . . 0.0 112.916 -174.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 50.2 m -88.78 105.27 17.61 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.327 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 130.28 168.0 12.17 Favored Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 120.733 -0.746 . . . . 0.0 112.36 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 69.78 154.88 0.15 Allowed Pre-proline 0 N--CA 1.475 0.781 0 C-N-CA 123.796 0.838 . . . . 0.0 112.027 179.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_exo -58.83 126.87 22.44 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.639 2.226 . . . . 0.0 111.222 177.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 66.4 65.21 2.93 Favored Glycine 0 CA--C 1.52 0.353 0 C-N-CA 120.783 -0.722 . . . . 0.0 111.348 -176.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.563 ' O ' ' HG2' ' A' ' 179' ' ' PRO . 22.3 Cg_exo -66.05 -52.56 0.87 Allowed 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 122.856 2.371 . . . . 0.0 112.514 -176.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 62.8 mt -82.81 107.5 15.47 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.797 -177.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -116.99 -149.89 9.14 Favored Glycine 0 N--CA 1.443 -0.88 0 CA-C-N 115.592 -0.731 . . . . 0.0 112.464 -179.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -64.85 121.18 21.22 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 121.347 -0.454 . . . . 0.0 112.982 -178.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 130.88 -35.18 2.5 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 -179.278 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -71.18 148.78 94.18 Favored Pre-proline 0 C--N 1.323 -0.558 0 N-CA-C 110.167 -0.309 . . . . 0.0 110.167 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -66.83 124.02 11.76 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.077 1.852 . . . . 0.0 110.877 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -78.86 62.85 3.44 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.659 0.742 . . . . 0.0 110.902 -177.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -121.84 29.37 5.62 Favored Glycine 0 N--CA 1.441 -1.014 0 N-CA-C 109.267 -1.533 . . . . 0.0 109.267 176.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 77.2 mt-30 -119.84 161.23 21.16 Favored 'General case' 0 N--CA 1.442 -0.866 0 CA-C-N 114.331 -0.935 . . . . 0.0 109.75 -177.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 8.8 m -89.39 11.66 18.56 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.974 0.416 . . . . 0.0 111.618 178.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 120.27 -46.34 1.14 Allowed Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.409 -0.901 . . . . 0.0 113.755 176.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 33.6 t80 59.04 51.47 7.13 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 121.887 0.851 . . . . 0.0 108.982 -176.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 110.48 -102.93 1.58 Allowed Glycine 0 N--CA 1.434 -1.492 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -176.093 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.257 1.547 0 CA-C-O 118.516 -1.158 . . . . 0.0 112.282 178.773 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 78.93 -150.59 34.33 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 111.429 -0.669 . . . . 0.0 111.429 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -67.55 140.54 52.42 Favored 'Trans proline' 0 N--CA 1.463 -0.31 0 C-N-CA 122.204 1.936 . . . . 0.0 111.175 178.062 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 64.8 mt-30 -103.39 174.56 5.81 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 -178.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -67.13 -64.43 3.26 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.666 -179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -84.05 -26.15 42.01 Favored Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.603 -179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 88.1 m-85 -103.22 108.84 20.2 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-O 120.93 0.395 . . . . 0.0 110.277 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -74.77 155.53 48.31 Favored Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.359 -179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -167.04 142.47 4.16 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 27.4 p 46.11 91.06 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.875 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 171.13 179.57 42.36 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.372 -0.918 . . . . 0.0 112.542 179.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 105.32 -166.38 14.45 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 121.265 -0.493 . . . . 0.0 111.951 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -76.21 -1.1 24.73 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.305 0.574 . . . . 0.0 110.437 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.532 ' O ' HG23 ' A' ' 18' ' ' ILE . 27.5 p -76.5 -25.01 53.78 Favored 'General case' 0 N--CA 1.433 -1.314 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.27 178.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -56.82 -23.47 43.92 Favored 'General case' 0 N--CA 1.465 0.29 0 N-CA-C 112.792 0.664 . . . . 0.0 112.792 -177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.49 -38.93 6.91 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.53 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.5 pp -83.77 -25.02 30.84 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -175.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.609 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 9.5 pt -45.44 -42.56 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.127 0 N-CA-C 113.734 1.012 . . . . 0.0 113.734 -176.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.542 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 46.2 m -83.12 -19.83 35.97 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 111.905 0.335 . . . . 0.0 111.905 -178.558 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.425 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 62.8 mtt180 -86.71 -23.84 25.39 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 113.887 1.069 . . . . 0.0 113.887 -177.227 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.576 HG11 ' CB ' ' A' ' 100' ' ' LEU . 0.7 OUTLIER -72.14 -147.46 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 112.278 0.473 . . . . 0.0 112.278 -176.149 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.471 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -51.79 -33.26 34.69 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.439 0.696 . . . . 0.0 112.76 -175.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.485 ' HB3' HD22 ' A' ' 31' ' ' LEU . 10.0 m-80 -65.69 -24.29 66.97 Favored 'General case' 0 C--O 1.219 -0.52 0 N-CA-C 112.107 0.41 . . . . 0.0 112.107 -179.418 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.542 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -70.95 -42.42 69.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.023 0.44 . . . . 0.0 110.182 178.326 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.426 HD23 ' HG3' ' A' ' 183' ' ' PRO . 3.5 mm? -81.23 -16.1 53.69 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.735 -0.666 . . . . 0.0 110.494 179.568 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.62 ' O ' ' HA ' ' A' ' 148' ' ' SER . . . -84.57 -36.99 21.73 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 175.633 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.487 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 3.1 t-20 51.26 18.25 0.59 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 124.683 1.193 . . . . 0.0 112.228 176.344 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.464 HG23 ' HB2' ' A' ' 143' ' ' SER . 7.1 m -66.26 164.11 16.56 Favored 'General case' 0 N--CA 1.438 -1.051 0 CA-C-N 115.245 -0.889 . . . . 0.0 111.201 -177.61 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.417 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 54.9 m -63.85 -16.3 61.02 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.832 179.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.6 p -51.31 -41.04 60.25 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.762 0.825 . . . . 0.0 112.289 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.575 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -99.84 -19.31 16.73 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.394 179.803 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 17.5 ttm180 -74.47 -59.58 2.66 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 115.776 -0.647 . . . . 0.0 112.199 -176.287 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 14.3 t -162.78 -28.42 0.04 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.377 0.51 . . . . 0.0 112.377 -177.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 81.4 t -79.82 136.06 24.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.965 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 177.527 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -50.6 138.29 18.11 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.839 0.352 . . . . 0.0 110.81 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.4 ptt85 -64.07 152.46 40.29 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.669 -178.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 1.1 m -67.65 111.63 4.32 Favored 'General case' 0 N--CA 1.435 -1.178 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.418 -178.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.406 ' CA ' HG21 ' A' ' 129' ' ' ILE . . . 85.93 38.37 8.68 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.215 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 8.0 p -56.9 148.29 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.131 0.491 . . . . 0.0 111.105 178.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 13.2 m -87.86 157.37 19.0 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.88 -0.6 . . . . 0.0 112.073 -175.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 18.8 pt20 -63.52 -19.39 64.73 Favored 'General case' 0 C--O 1.214 -0.781 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.302 -179.425 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.0 mm-40 -51.5 -46.18 63.12 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 120.845 0.355 . . . . 0.0 111.458 -178.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -84.08 -32.66 8.56 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.881 0 N-CA-C 112.363 0.505 . . . . 0.0 112.363 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.44 ' C ' ' H ' ' A' ' 46' ' ' SER . . . -83.67 -48.91 9.67 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 113.06 0.763 . . . . 0.0 113.06 -175.587 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 90.8 p 67.48 -18.84 0.13 Allowed 'General case' 0 N--CA 1.49 1.529 0 C-N-CA 125.292 1.437 . . . . 0.0 113.095 179.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.44 ' H ' ' C ' ' A' ' 44' ' ' ALA . 20.8 p -68.38 -75.69 0.1 Allowed 'General case' 0 C--N 1.313 -1.007 0 N-CA-C 113.254 0.835 . . . . 0.0 113.254 -176.594 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 7.6 p -152.61 -34.22 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.836 0.351 . . . . 0.0 111.903 -175.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.7 p -68.52 97.43 0.4 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.652 0 CA-C-O 121.44 0.638 . . . . 0.0 112.1 -178.647 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 72.8 mt-30 -82.84 -51.01 8.03 Favored 'General case' 0 CA--C 1.513 -0.454 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.349 177.421 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.59 HH22 ' HB2' ' A' ' 127' ' ' LEU . 41.1 ttt180 -130.69 -5.72 4.1 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.673 178.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.426 ' O ' HD13 ' A' ' 66' ' ' LEU . . . 71.08 -55.74 0.64 Allowed 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.767 -0.651 . . . . 0.0 109.599 -172.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.93 136.07 54.79 Favored 'General case' 0 N--CA 1.443 -0.78 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.901 176.555 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.581 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.4 OUTLIER -51.01 -29.86 13.58 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 -173.488 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 38.3 t -46.84 -69.25 0.13 Allowed 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 118.106 0.412 . . . . 0.0 112.079 -177.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.448 ' H ' ' HD3' ' A' ' 50' ' ' ARG . 57.4 tp -88.6 -24.19 22.89 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-O 120.868 0.366 . . . . 0.0 111.602 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.405 ' O ' HG22 ' A' ' 58' ' ' THR . . . -79.26 -18.91 51.83 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 113.465 0.913 . . . . 0.0 113.465 -175.376 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.581 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.0 t -48.48 98.47 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.089 0.471 . . . . 0.0 111.662 -178.35 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.405 HG22 ' O ' ' A' ' 56' ' ' ALA . 8.9 t -142.04 -37.72 0.39 Allowed 'General case' 0 N--CA 1.448 -0.54 0 CA-C-N 115.694 -0.685 . . . . 0.0 110.557 -179.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 68.1 mt -121.92 18.7 10.95 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.4 -0.364 . . . . 0.0 111.21 -179.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.02 67.63 1.37 Allowed Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.199 -1.0 . . . . 0.0 111.439 -177.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.446 HG22 HD21 ' A' ' 65' ' ' ASN . 46.7 t -87.35 110.23 20.31 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-O 121.14 0.495 . . . . 0.0 110.998 -175.231 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.0 p-10 -158.94 20.92 0.2 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.991 178.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.448 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 123.48 -37.75 2.65 Favored Glycine 0 C--N 1.297 -1.601 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.814 -177.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -60.28 -74.47 0.07 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.552 0.176 . . . . 0.0 110.928 -178.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.446 HD21 HG22 ' A' ' 61' ' ' VAL . 2.5 p-10 -85.48 9.69 15.07 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.301 0.572 . . . . 0.0 110.181 178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.448 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 19.5 tp -87.97 -56.6 3.27 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.319 -0.855 . . . . 0.0 109.963 176.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.44 -35.52 40.33 Favored 'General case' 0 CA--C 1.517 -0.314 0 CA-C-O 121.508 0.671 . . . . 0.0 109.899 178.554 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -104.81 162.87 12.94 Favored 'General case' 0 C--N 1.315 -0.903 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 178.124 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 68.89 -61.68 0.41 Allowed 'General case' 0 N--CA 1.475 0.814 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -178.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -60.65 -62.16 2.06 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 120.843 0.354 . . . . 0.0 110.817 -179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 47.4 t -62.02 -40.34 86.99 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.518 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.125 178.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -60.38 -44.6 95.48 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.722 -179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -67.86 -45.51 74.34 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 111.687 0.254 . . . . 0.0 111.687 -179.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.5 t -69.02 -38.18 78.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.831 0.348 . . . . 0.0 111.403 -178.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.8 p -74.79 -21.78 59.12 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-O 120.979 0.419 . . . . 0.0 110.76 179.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.409 ' HA ' ' NE ' ' A' ' 76' ' ' ARG . 4.8 tpm_? -92.06 -8.9 44.59 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 121.15 0.5 . . . . 0.0 110.11 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 7.1 tp -64.45 142.67 98.44 Favored Pre-proline 0 C--N 1.32 -0.714 0 CA-C-N 115.756 -0.656 . . . . 0.0 109.276 -179.705 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -49.38 128.36 20.17 Favored 'Trans proline' 0 C--N 1.352 0.758 0 C-N-CA 123.37 2.713 . . . . 0.0 112.997 -177.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -97.97 20.0 12.96 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.078 -178.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -69.51 -40.19 78.8 Favored Glycine 0 C--N 1.307 -1.068 0 N-CA-C 110.777 -0.929 . . . . 0.0 110.777 178.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 82' ' ' ASP . 14.9 m -88.52 -6.65 57.46 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-N 115.474 -0.363 . . . . 0.0 110.348 178.501 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 81' ' ' SER . 8.8 m-20 72.69 168.9 0.32 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.987 0.915 . . . . 0.0 111.716 -178.621 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 56.1 p -73.86 -19.38 60.74 Favored 'General case' 0 N--CA 1.446 -0.629 0 CA-C-O 121.237 0.541 . . . . 0.0 109.732 177.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.3 t -63.66 -17.58 63.07 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.23 -0.895 . . . . 0.0 110.081 177.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -71.7 -21.35 61.79 Favored 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.352 177.223 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -77.6 -162.4 0.31 Allowed 'General case' 0 N--CA 1.446 -0.632 0 CA-C-O 121.457 0.646 . . . . 0.0 109.769 178.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.18 41.33 0.37 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.297 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.575 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 5.2 tp60 -64.81 -61.59 2.09 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.911 -176.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.609 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -80.34 -27.1 38.41 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.617 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 97.2 m-85 -77.69 10.45 2.7 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.646 -177.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 44.1 t -52.03 -51.07 59.88 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.986 -0.552 . . . . 0.0 111.722 -179.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 61.1 m -59.14 -34.96 72.68 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 113.155 0.798 . . . . 0.0 113.155 -177.773 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.57 -32.84 31.96 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 111.971 0.36 . . . . 0.0 111.971 -176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 13.1 mt -86.94 -35.38 18.93 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.17 0.433 . . . . 0.0 112.17 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.2 t80 -78.74 -30.84 46.0 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.853 -178.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 15.0 m120 52.07 82.83 0.06 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.783 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -72.86 -10.85 60.26 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.64 -179.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.74 -13.71 60.16 Favored Glycine 0 C--O 1.225 -0.408 0 C-N-CA 121.222 -0.513 . . . . 0.0 112.135 -179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 5.4 t -98.27 -2.07 10.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-O 121.645 0.736 . . . . 0.0 109.71 -178.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -84.92 173.81 10.28 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.589 -0.732 . . . . 0.0 111.355 -176.818 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.573 ' O ' ' HB3' ' A' ' 104' ' ' ASN . 16.1 t30 -68.39 103.74 1.71 Allowed 'General case' 0 N--CA 1.439 -0.995 0 CA-C-N 116.026 -0.534 . . . . 0.0 109.733 -178.047 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.75 -28.36 69.83 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.723 -0.672 . . . . 0.0 111.813 -176.163 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.4 p -74.84 -16.67 60.68 Favored 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.057 0.456 . . . . 0.0 110.673 -178.679 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.573 ' HB3' ' O ' ' A' ' 101' ' ' ASN . 9.5 t30 -68.06 -47.32 68.65 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.791 -0.641 . . . . 0.0 109.406 177.522 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -71.48 -41.93 72.79 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.741 0 CA-C-N 115.529 -0.759 . . . . 0.0 111.008 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -67.17 -30.72 70.77 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.154 -0.475 . . . . 0.0 112.147 -179.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 85.1 m -91.42 -52.46 4.78 Favored 'General case' 0 C--N 1.322 -0.63 0 N-CA-C 113.014 0.746 . . . . 0.0 113.014 -175.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.503 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -117.48 -27.86 6.24 Favored 'General case' 0 C--N 1.32 -0.697 0 N-CA-C 112.644 0.609 . . . . 0.0 112.644 -174.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -55.75 -64.89 3.97 Favored Glycine 0 C--O 1.234 0.103 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.961 -177.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 4.3 p -76.71 -11.8 59.9 Favored 'General case' 0 C--N 1.309 -1.177 0 N-CA-C 111.855 0.316 . . . . 0.0 111.855 -178.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.96 -54.73 4.18 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.933 0.345 . . . . 0.0 111.933 -179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 48.0 t -83.33 -54.48 9.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 116.469 -0.332 . . . . 0.0 111.164 -177.185 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.41 HD12 ' N ' ' A' ' 113' ' ' LEU . 6.1 mp -72.96 -57.92 3.7 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 -179.456 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.8 m 67.24 -86.71 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.664 0 N-CA-C 113.343 0.868 . . . . 0.0 113.343 175.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -53.1 -36.92 61.26 Favored 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -173.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.466 ' O ' HG13 ' A' ' 120' ' ' VAL . 27.6 tp -65.29 -50.97 63.68 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.743 -178.768 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.769 ' HA ' HG22 ' A' ' 120' ' ' VAL . 5.4 mp -67.95 -23.22 65.04 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 112.815 0.672 . . . . 0.0 112.815 -179.406 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -61.6 -31.45 71.52 Favored 'General case' 0 C--N 1.325 -0.494 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.547 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -85.05 -42.65 7.01 Favored Glycine 0 N--CA 1.429 -1.782 0 CA-C-N 115.211 -0.904 . . . . 0.0 111.822 177.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.769 HG22 ' HA ' ' A' ' 117' ' ' LEU . 2.7 m -67.71 -32.46 56.84 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.828 -177.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 19.2 t -62.21 -34.18 75.98 Favored 'General case' 0 C--O 1.219 -0.508 0 CA-C-O 120.755 0.312 . . . . 0.0 110.51 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 34.3 t -85.34 -38.5 18.71 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 121.471 0.653 . . . . 0.0 110.303 177.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.469 ' HA ' ' NH1' ' A' ' 50' ' ' ARG . . . -84.22 -79.43 0.21 Allowed 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 113.088 0.773 . . . . 0.0 113.088 -176.542 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.439 ' HA ' HG13 ' A' ' 129' ' ' ILE . . . -65.23 -60.93 2.47 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.414 -175.078 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -69.25 -31.86 70.69 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-O 121.343 0.592 . . . . 0.0 109.965 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -74.93 -64.94 2.22 Favored Glycine 0 N--CA 1.441 -0.972 0 CA-C-N 115.55 -0.75 . . . . 0.0 114.484 -176.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . 0.59 ' HB2' HH22 ' A' ' 50' ' ' ARG . 73.0 mt -115.02 -5.54 12.5 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -172.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.0 105.07 0.07 OUTLIER Glycine 0 C--O 1.226 -0.364 0 C-N-CA 120.197 -1.001 . . . . 0.0 111.3 -178.083 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.439 HG13 ' HA ' ' A' ' 124' ' ' ALA . 27.9 mt -77.57 134.88 27.54 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.176 0 N-CA-C 112.736 0.643 . . . . 0.0 112.736 -176.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 29.6 m-80 -128.1 115.74 18.9 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.082 175.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.472 HG12 ' N ' ' A' ' 132' ' ' ASP . 16.2 t -82.75 166.53 2.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 116.331 -0.395 . . . . 0.0 109.936 179.702 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.472 ' N ' HG12 ' A' ' 131' ' ' VAL . 18.9 t70 -59.35 158.18 9.78 Favored 'General case' 0 C--O 1.243 0.758 0 CA-C-O 121.104 0.478 . . . . 0.0 111.252 -179.104 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.458 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 33.1 m -79.86 16.9 1.04 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.85 -0.614 . . . . 0.0 112.345 -177.479 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -62.58 -88.43 0.03 OUTLIER Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.934 176.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.0 p -106.83 -30.14 9.08 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 112.58 0.585 . . . . 0.0 112.58 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 43.5 t -73.39 -63.97 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 N-CA-C 113.468 0.914 . . . . 0.0 113.468 -174.254 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 5.7 tp-100 -59.17 -41.77 89.21 Favored 'General case' 0 N--CA 1.463 0.193 0 N-CA-C 112.166 0.432 . . . . 0.0 112.166 -174.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 12.9 m -57.63 -45.7 85.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 120.877 0.37 . . . . 0.0 111.885 -178.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -74.71 -52.87 10.42 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.459 -178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 48.4 pt -55.75 -38.91 53.1 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.325 0 N-CA-C 112.181 0.438 . . . . 0.0 112.181 -176.271 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 41.4 m -62.87 -35.26 79.41 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-O 120.881 0.372 . . . . 0.0 111.091 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 14.9 m -84.82 -38.24 19.77 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.267 0.556 . . . . 0.0 111.009 -178.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.464 ' HB2' HG23 ' A' ' 28' ' ' THR . 50.9 m -72.28 -40.73 67.38 Favored 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.938 -0.574 . . . . 0.0 112.353 -177.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 36.4 t -72.86 -21.79 60.88 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 111.856 0.317 . . . . 0.0 111.856 -178.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 8.7 p -86.93 -53.15 5.05 Favored 'General case' 0 C--N 1.315 -0.917 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 -179.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 97.6 m-85 -88.88 -56.06 3.44 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 112.828 0.677 . . . . 0.0 112.828 -176.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.487 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 3.2 mm? -79.18 6.33 9.96 Favored 'General case' 0 C--N 1.32 -0.693 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 -174.313 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.62 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 2.5 p -62.68 -66.26 0.57 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.331 0.586 . . . . 0.0 111.622 -178.164 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.456 HG21 ' HA ' ' A' ' 180' ' ' SER . 3.7 m -144.37 63.2 1.32 Allowed 'General case' 0 C--N 1.3 -1.556 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 177.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.485 ' HB3' ' HB2' ' A' ' 154' ' ' ALA . 35.2 t -57.21 131.7 50.76 Favored 'General case' 0 N--CA 1.442 -0.825 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.159 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 16.3 m -59.28 133.86 56.47 Favored 'General case' 0 N--CA 1.444 -0.754 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.769 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.718 ' O ' ' HB3' ' A' ' 158' ' ' GLN . 48.0 m 71.65 25.15 3.34 Favored 'General case' 0 C--O 1.225 -0.23 0 O-C-N 123.739 0.649 . . . . 0.0 110.443 -177.262 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.436 ' HB2' ' HB2' ' A' ' 161' ' ' ALA . 14.6 t 70.08 177.4 0.27 Allowed 'General case' 0 C--O 1.237 0.433 0 C-N-CA 123.966 0.906 . . . . 0.0 112.945 177.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . 0.485 ' HB2' ' HB3' ' A' ' 150' ' ' SER . . . -152.46 12.99 0.55 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.643 -1.162 . . . . 0.0 108.899 177.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 39.6 t -117.17 137.16 52.51 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.542 -0.753 . . . . 0.0 110.335 -178.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 42.9 t80 52.06 57.51 6.41 Favored 'General case' 0 N--CA 1.463 0.207 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.827 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 46.5 m 60.92 20.92 11.2 Favored 'General case' 0 C--O 1.235 0.326 0 CA-C-N 115.462 -0.79 . . . . 0.0 112.114 179.275 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.718 ' HB3' ' O ' ' A' ' 152' ' ' SER . 12.8 mt-30 69.86 18.08 7.42 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 123.098 0.559 . . . . 0.0 111.543 177.442 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.57 -44.25 67.77 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 120.866 0.365 . . . . 0.0 110.542 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 5.1 p -82.86 90.09 6.9 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.719 179.304 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.436 ' HB2' ' HB2' ' A' ' 153' ' ' SER . . . -133.05 -48.67 0.86 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.384 -178.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 6.7 m -96.42 117.24 30.46 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.586 -178.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 17.0 m -89.86 3.71 52.13 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-O 120.904 0.383 . . . . 0.0 111.112 -179.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.7 m -58.61 -32.06 68.66 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.977 -0.556 . . . . 0.0 111.596 -179.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.4 m -72.28 -5.54 36.79 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.388 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 95.09 77.77 1.38 Allowed Glycine 0 N--CA 1.44 -1.04 0 C-N-CA 120.811 -0.709 . . . . 0.0 111.411 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -86.06 -55.8 3.77 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 120.975 0.417 . . . . 0.0 110.672 -179.23 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 73.41 12.53 80.09 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 121.135 -0.555 . . . . 0.0 113.197 179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -97.02 -71.92 0.66 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.793 0.296 . . . . 0.0 110.723 -179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 82.6 p 53.18 100.7 0.01 OUTLIER 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 124.261 1.024 . . . . 0.0 112.473 -177.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 104.62 -107.33 2.89 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.773 -0.727 . . . . 0.0 111.435 -178.808 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -59.5 117.03 3.71 Favored 'Trans proline' 0 C--N 1.352 0.744 0 C-N-CA 122.412 2.075 . . . . 0.0 110.946 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 85.0 p 52.62 30.62 8.9 Favored 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.592 0.757 . . . . 0.0 111.253 -178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -108.44 165.81 12.79 Favored Glycine 0 N--CA 1.437 -1.26 0 C-N-CA 120.88 -0.676 . . . . 0.0 112.552 -178.492 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -78.88 140.32 16.1 Favored 'Trans proline' 0 C--O 1.239 0.528 0 C-N-CA 123.119 2.546 . . . . 0.0 112.015 -179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 14.8 p -78.57 79.1 5.01 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 121.15 0.5 . . . . 0.0 110.599 178.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 12.9 t -118.61 12.8 13.24 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.844 -0.617 . . . . 0.0 110.772 -178.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -96.61 -166.35 33.47 Favored Glycine 0 N--CA 1.439 -1.143 0 C-N-CA 120.154 -1.022 . . . . 0.0 112.372 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_exo -63.62 104.94 0.48 Allowed 'Trans proline' 0 C--N 1.342 0.197 0 C-N-CA 122.936 2.424 . . . . 0.0 111.483 179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.456 ' HA ' HG21 ' A' ' 149' ' ' THR . 13.1 t -54.4 127.03 25.66 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.014 -177.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 87.76 -68.53 3.04 Favored Glycine 0 N--CA 1.444 -0.82 0 CA-C-N 115.734 -0.667 . . . . 0.0 113.339 177.535 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -130.91 131.46 23.26 Favored Pre-proline 0 C--N 1.321 -0.666 0 O-C-N 122.859 -0.201 . . . . 0.0 111.21 -176.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.426 ' HG3' HD23 ' A' ' 25' ' ' LEU . 22.2 Cg_exo -65.41 125.24 14.11 Favored 'Trans proline' 0 N--CA 1.46 -0.465 0 C-N-CA 122.37 2.046 . . . . 0.0 110.827 176.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -145.94 -77.58 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.241 -0.981 . . . . 0.0 112.467 -179.496 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.54 -17.58 57.53 Favored 'Trans proline' 0 C--N 1.349 0.589 0 C-N-CA 122.645 2.23 . . . . 0.0 112.122 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 94.2 mt 63.67 19.24 11.61 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.764 179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -77.16 156.11 45.0 Favored Glycine 0 N--CA 1.445 -0.763 0 C-N-CA 120.833 -0.699 . . . . 0.0 111.822 179.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.77 -119.27 6.4 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.605 -0.807 . . . . 0.0 111.512 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -113.7 95.76 0.77 Allowed Glycine 0 N--CA 1.446 -0.675 0 C-N-CA 120.961 -0.638 . . . . 0.0 111.583 179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -140.36 161.56 54.4 Favored Pre-proline 0 C--N 1.317 -0.816 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 -178.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.425 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 14.4 Cg_exo -67.03 125.29 13.39 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.25 1.966 . . . . 0.0 111.157 178.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -78.39 77.41 4.88 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.055 0.455 . . . . 0.0 110.807 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -175.95 -86.32 0.06 OUTLIER Glycine 0 N--CA 1.442 -0.917 0 N-CA-C 111.222 -0.751 . . . . 0.0 111.222 178.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 23.1 tt0 64.76 163.64 0.14 Allowed 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 123.715 0.806 . . . . 0.0 111.868 178.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.551 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 29.2 p -84.54 -32.12 24.04 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.48 0.657 . . . . 0.0 109.761 176.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 118.69 -11.07 12.29 Favored Glycine 0 N--CA 1.434 -1.49 0 CA-C-N 114.921 -1.036 . . . . 0.0 110.66 -176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -68.97 107.14 3.0 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 110.065 -0.346 . . . . 0.0 110.065 179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 90.82 129.21 4.18 Favored Glycine 0 N--CA 1.441 -0.982 0 N-CA-C 111.451 -0.66 . . . . 0.0 111.451 -178.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.236 0 CA-C-O 118.265 -1.297 . . . . 0.0 111.311 -178.926 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 0.898 0 CA-C-O 120.569 0.223 . . . . 0.0 111.026 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -136.81 74.18 0.42 Allowed Glycine 0 N--CA 1.446 -0.696 0 C-N-CA 120.433 -0.889 . . . . 0.0 112.275 179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_endo -69.92 144.48 53.29 Favored 'Trans proline' 0 N--CA 1.46 -0.487 0 C-N-CA 122.373 2.048 . . . . 0.0 111.437 179.433 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.506 ' HB2' ' HB2' ' A' ' 7' ' ' PHE . 14.8 mm100 -63.45 135.13 56.7 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.585 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -58.95 112.14 3.9 Favored Glycine 0 C--N 1.323 -0.154 0 CA-C-N 116.205 -0.452 . . . . 0.0 112.871 -178.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 91.01 -6.98 81.68 Favored Glycine 0 N--CA 1.449 -0.463 0 C-N-CA 120.971 -0.633 . . . . 0.0 112.324 179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.506 ' HB2' ' HB2' ' A' ' 4' ' ' GLN . 91.0 m-85 -126.53 20.37 7.28 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 120.884 0.373 . . . . 0.0 110.263 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -67.33 94.19 0.26 Allowed Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 177.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -68.64 120.88 15.35 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-O 121.383 0.611 . . . . 0.0 111.869 -176.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 7.8 m -161.17 136.44 7.68 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.293 -178.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -98.21 109.51 3.82 Favored Glycine 0 CA--C 1.519 0.339 0 C-N-CA 120.394 -0.908 . . . . 0.0 112.684 -179.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.37 -60.69 4.94 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 121.143 -0.551 . . . . 0.0 112.712 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.95 -32.89 74.43 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.22 0.534 . . . . 0.0 110.682 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.587 ' O ' HG23 ' A' ' 18' ' ' ILE . 2.6 m -62.82 -26.78 68.91 Favored 'General case' 0 N--CA 1.435 -1.205 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.85 179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.86 -18.31 4.71 Favored 'General case' 0 N--CA 1.472 0.629 0 N-CA-C 112.922 0.712 . . . . 0.0 112.922 -177.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.79 -45.9 5.01 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.175 -1.012 . . . . 0.0 112.422 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.554 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.2 pp -86.63 -21.63 26.65 Favored 'General case' 0 CA--C 1.548 0.874 0 N-CA-C 114.082 1.142 . . . . 0.0 114.082 -177.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.596 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 4.7 pt -35.49 -58.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 N-CA-C 115.89 1.811 . . . . 0.0 115.89 -173.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.1 t -79.41 -20.23 48.07 Favored 'General case' 0 C--N 1.307 -1.273 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -174.686 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.685 ' O ' ' HG3' ' A' ' 191' ' ' PRO . 99.5 mtt180 -86.65 -32.96 20.28 Favored 'General case' 0 C--O 1.217 -0.635 0 N-CA-C 113.413 0.894 . . . . 0.0 113.413 -174.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 17' ' ' LEU . 45.7 t -62.0 -94.14 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.549 0.916 0 N-CA-C 114.221 1.193 . . . . 0.0 114.221 -173.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . . . . . . . . . . . -81.12 -53.39 6.44 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -174.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . . . . . . . . . 31.0 m-80 -65.75 -24.41 66.95 Favored 'General case' 0 C--N 1.316 -0.854 0 N-CA-C 114.143 1.164 . . . . 0.0 114.143 -173.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.16 -35.91 81.86 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 120.512 -0.475 . . . . 0.0 110.725 178.826 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.459 HD12 ' HG2' ' A' ' 179' ' ' PRO . 3.9 mm? -74.74 -21.6 59.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.482 178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -81.23 -31.68 33.74 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 176.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.581 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 2.8 t-20 55.96 18.09 2.91 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.9 -1.046 . . . . 0.0 111.714 176.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 17.8 m -81.32 148.38 29.42 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.74 -176.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 15.0 m -52.21 -17.18 1.01 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.882 1.273 . . . . 0.0 114.101 -177.332 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -61.2 -21.99 64.34 Favored 'General case' 0 C--N 1.323 -0.545 0 N-CA-C 112.438 0.533 . . . . 0.0 112.438 -179.752 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 4.5 pp -93.83 -26.99 16.69 Favored 'General case' 0 C--N 1.305 -1.33 0 CA-C-O 121.217 0.532 . . . . 0.0 110.379 177.269 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 34.3 ttm180 -82.42 -45.88 14.22 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -176.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.2 t -158.94 -26.58 0.07 Allowed 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.478 HG21 ' OD1' ' A' ' 139' ' ' ASP . 25.8 t -84.35 161.47 3.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.627 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.6 pt? -85.1 159.27 20.21 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 120.696 0.284 . . . . 0.0 110.523 -179.783 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 47.7 ptt85 -89.39 166.47 13.7 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 121.296 0.569 . . . . 0.0 111.514 -177.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.493 HG22 ' H ' ' A' ' 131' ' ' VAL . 0.4 OUTLIER -74.87 124.87 27.66 Favored 'General case' 0 N--CA 1.431 -1.402 0 CA-C-N 115.396 -0.82 . . . . 0.0 110.601 177.719 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 73.31 38.26 53.6 Favored Glycine 0 N--CA 1.437 -1.284 0 C-N-CA 120.632 -0.794 . . . . 0.0 111.451 -179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -43.93 149.98 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.791 0 C-N-CA 124.042 0.937 . . . . 0.0 112.66 -178.456 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 43' ' ' ILE . 16.3 m -77.83 142.65 38.42 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.003 -178.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.518 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 12.7 pt20 -68.87 -13.09 62.2 Favored 'General case' 0 C--O 1.219 -0.541 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.113 179.739 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 84.4 mm-40 -58.98 -35.43 73.19 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.687 178.947 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.552 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.93 -42.35 17.15 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.795 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.448 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.39 -69.15 0.65 Allowed 'General case' 0 C--O 1.225 -0.218 0 CA-C-O 120.693 0.282 . . . . 0.0 111.591 -178.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.2 m 74.9 -21.52 0.29 Allowed 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.968 0.907 . . . . 0.0 112.347 176.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 25.6 p -70.2 -82.24 0.04 OUTLIER 'General case' 0 N--CA 1.439 -1.003 0 CA-C-O 121.062 0.458 . . . . 0.0 111.556 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 32.9 m -129.41 -22.88 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.131 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.9 t -80.58 85.0 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.87 -179.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.518 ' HA ' ' HB3' ' A' ' 41' ' ' GLN . 46.5 mt-30 -83.16 -43.62 15.98 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.131 178.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.526 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 0.1 OUTLIER -126.51 -13.22 6.04 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.457 -0.792 . . . . 0.0 110.436 -179.664 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 71.21 -50.35 0.69 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.591 0.756 . . . . 0.0 110.255 -174.223 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -71.27 144.34 50.05 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 175.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.563 ' NE2' ' H ' ' A' ' 53' ' ' GLN . 0.0 OUTLIER -55.03 -19.21 6.47 Favored 'General case' 0 N--CA 1.474 0.766 0 N-CA-C 113.376 0.88 . . . . 0.0 113.376 -175.493 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 46.3 t -56.28 -81.72 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.859 0.689 . . . . 0.0 112.859 -178.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.526 ' HB3' ' HB2' ' A' ' 50' ' ' ARG . 9.9 tt -86.04 -22.81 27.04 Favored 'General case' 0 C--N 1.316 -0.875 0 CA-C-O 120.903 0.382 . . . . 0.0 111.123 -176.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.486 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -73.32 -18.44 61.19 Favored 'General case' 0 CA--C 1.511 -0.522 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.528 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.9 t -52.22 97.81 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 121.105 0.478 . . . . 0.0 110.94 -178.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 6.9 t -131.81 -37.37 1.17 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.747 -179.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.5 mt -120.88 19.65 11.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.395 179.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 89.77 67.16 1.23 Allowed Glycine 0 N--CA 1.44 -1.087 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.855 -178.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.505 HG22 HD21 ' A' ' 65' ' ' ASN . 42.6 t -87.88 102.33 12.44 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 109.163 -0.681 . . . . 0.0 109.163 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -150.62 17.58 0.81 Allowed 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 121.642 0.734 . . . . 0.0 110.583 -178.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.457 ' CA ' ' HB3' ' A' ' 66' ' ' LEU . . . 127.7 -42.44 1.45 Allowed Glycine 0 C--N 1.288 -2.095 0 CA-C-N 115.135 -0.938 . . . . 0.0 111.521 -177.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.58 ' HA ' ' NH2' ' A' ' 68' ' ' ARG . 52.2 m-80 -55.06 -79.12 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 O-C-N 123.713 0.302 . . . . 0.0 111.723 -179.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.505 HD21 HG22 ' A' ' 61' ' ' VAL . 3.2 p-10 -85.3 12.95 7.13 Favored 'General case' 0 C--N 1.324 -0.519 0 C-N-CA 120.551 -0.46 . . . . 0.0 110.297 177.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.457 ' HB3' ' CA ' ' A' ' 63' ' ' GLY . 39.3 tp -88.61 -57.34 2.95 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.407 176.451 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.07 -32.63 56.9 Favored 'General case' 0 CA--C 1.519 -0.232 0 CA-C-O 121.394 0.616 . . . . 0.0 110.182 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.58 ' NH2' ' HA ' ' A' ' 64' ' ' ASN . 0.4 OUTLIER -109.76 160.61 16.18 Favored 'General case' 0 C--N 1.314 -0.936 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 177.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 73.1 m-85 68.91 -62.32 0.4 Allowed 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 178.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -56.44 -63.76 1.09 Allowed 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 112.435 0.531 . . . . 0.0 112.435 -176.06 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.449 HG21 ' HB2' ' A' ' 135' ' ' SER . 9.6 p -72.69 -37.2 55.2 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.301 -178.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -69.74 -27.79 65.25 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -175.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -81.3 -47.45 13.31 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.787 -0.365 . . . . 0.0 110.425 178.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.0 t -65.13 -35.54 75.66 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.048 -179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 80.7 p -72.41 -21.41 61.27 Favored 'General case' 0 N--CA 1.443 -0.781 0 CA-C-O 121.056 0.455 . . . . 0.0 110.545 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 19.1 ttm180 -91.11 -14.48 31.13 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.934 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.486 ' HA ' ' HD3' ' A' ' 78' ' ' PRO . 34.1 mt -56.48 113.2 5.49 Favored Pre-proline 0 C--O 1.235 0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.83 -179.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 3.1 Cg_exo -77.41 128.73 9.79 Favored 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.766 2.311 . . . . 0.0 111.154 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -80.4 111.12 16.49 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 116.396 -0.366 . . . . 0.0 110.618 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.84 -50.46 18.86 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.975 -0.631 . . . . 0.0 112.748 -178.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.4 m -83.47 -57.52 3.21 Favored 'General case' 0 C--N 1.316 -0.854 0 CA-C-O 121.023 0.439 . . . . 0.0 110.36 -179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 25.2 t70 -169.69 151.26 4.22 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 179.278 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.522 HG22 HE22 ' A' ' 88' ' ' GLN . 11.4 m -73.44 -20.52 60.69 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-O 120.8 0.334 . . . . 0.0 111.81 -176.415 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 14.6 m -66.18 -17.18 64.57 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-O 120.743 0.306 . . . . 0.0 110.922 178.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -60.02 -21.4 61.29 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.725 179.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.458 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 77.8 m-85 -76.17 -168.81 1.0 Allowed 'General case' 0 N--CA 1.446 -0.634 0 CA-C-O 121.089 0.471 . . . . 0.0 110.743 178.511 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.61 25.11 0.2 Allowed 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.646 -179.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.522 HE22 HG22 ' A' ' 83' ' ' THR . 65.0 mt-30 -87.17 -59.34 2.28 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.105 -179.66 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.596 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -70.28 -48.13 58.13 Favored 'General case' 0 N--CA 1.444 -0.763 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 178.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.483 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 97.0 m-85 -79.09 23.52 0.36 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.196 -179.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 89' ' ' ALA . 6.9 p -51.01 -60.29 3.25 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 123.415 0.686 . . . . 0.0 112.696 -177.276 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 15.2 m -65.26 -32.66 74.44 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -175.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -76.76 -36.95 56.71 Favored 'General case' 0 C--N 1.318 -0.766 0 C-N-CA 120.919 -0.313 . . . . 0.0 111.704 -177.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.483 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 56.3 mt -84.35 -28.2 27.19 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.461 -0.336 . . . . 0.0 111.617 -179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -82.99 -38.2 22.98 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.065 -177.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 18.2 m120 53.69 73.0 0.4 Allowed 'General case' 0 N--CA 1.465 0.275 0 O-C-N 123.681 0.613 . . . . 0.0 111.118 -178.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.36 -2.76 33.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.742 -178.602 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 81.77 -5.7 68.88 Favored Glycine 0 C--O 1.228 -0.24 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.127 -178.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 4.0 t -97.87 21.75 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-O 121.496 0.665 . . . . 0.0 109.737 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.515 ' CB ' HG11 ' A' ' 21' ' ' VAL . 1.8 pt? -117.4 163.71 15.96 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.389 -178.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.9 p-10 -70.82 128.15 35.05 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.626 -0.715 . . . . 0.0 111.467 -178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -70.61 -20.67 62.73 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.154 -178.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 37.9 t -65.98 -36.63 83.82 Favored 'General case' 0 CA--C 1.51 -0.56 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.468 ' O ' HD23 ' A' ' 108' ' ' LEU . 9.2 t30 -61.8 -49.32 76.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.061 178.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.431 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 35.8 mm -68.94 -38.44 78.58 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.166 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.67 -24.55 61.04 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 120.938 0.399 . . . . 0.0 111.491 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -79.79 -55.83 4.71 Favored 'General case' 0 C--N 1.317 -0.821 0 C-N-CA 120.741 -0.383 . . . . 0.0 111.417 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.468 HD23 ' O ' ' A' ' 104' ' ' ASN . 2.4 pt? -130.83 -23.49 2.52 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.665 0.617 . . . . 0.0 112.665 -176.472 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -51.68 -65.5 3.14 Favored Glycine 0 CA--C 1.521 0.438 0 C-N-CA 121.064 -0.589 . . . . 0.0 113.519 -177.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 6.1 p -78.58 -11.62 59.97 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 122.442 -0.446 . . . . 0.0 111.924 -177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.3 mpt_? -87.54 -52.58 5.27 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 112.197 0.443 . . . . 0.0 112.197 -178.54 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 49.1 t -83.75 -44.22 18.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 120.915 0.388 . . . . 0.0 111.259 -178.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.551 ' HB2' ' O ' ' A' ' 109' ' ' GLY . 6.0 mp -78.39 -51.73 9.63 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.567 -179.243 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 47.1 m 53.18 -94.75 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 113.086 0.773 . . . . 0.0 113.086 178.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -48.72 -40.78 29.72 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 123.76 0.824 . . . . 0.0 112.878 -175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.497 ' O ' HG23 ' A' ' 120' ' ' VAL . 61.6 tp -63.47 -55.7 22.07 Favored 'General case' 0 N--CA 1.447 -0.579 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.855 -179.122 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 27.0 mt -66.06 -28.76 69.08 Favored 'General case' 0 C--O 1.217 -0.64 0 CA-C-N 116.207 -0.451 . . . . 0.0 112.156 -177.316 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.6 m120 -58.3 -49.83 75.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.007 0.432 . . . . 0.0 109.903 177.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -71.82 -36.49 61.46 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.105 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 116' ' ' LEU . 78.2 t -64.48 -38.58 82.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.326 0 CA-C-O 120.606 0.241 . . . . 0.0 110.708 179.02 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.482 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 70.9 m -58.12 -46.31 85.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.076 179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 17.6 m -70.86 -42.72 69.72 Favored 'General case' 0 N--CA 1.439 -1.014 0 CA-C-N 115.796 -0.638 . . . . 0.0 111.3 -178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.427 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -84.35 -80.19 0.2 Allowed 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 113.243 0.831 . . . . 0.0 113.243 -176.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.444 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -66.41 -49.51 66.53 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.083 0.771 . . . . 0.0 113.083 -173.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.482 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 25.7 tm0? -71.03 -28.39 64.36 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.989 0.423 . . . . 0.0 110.87 -178.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.1 -55.87 2.55 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.784 -0.722 . . . . 0.0 114.053 -177.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 25.7 tp -102.13 -26.13 13.47 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.905 0.353 . . . . 0.0 111.796 -175.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.8 73.38 1.27 Allowed Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 119.984 -1.103 . . . . 0.0 110.572 -177.406 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.444 ' H ' ' HA ' ' A' ' 124' ' ' ALA . 1.3 mp -68.18 139.72 20.27 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 CA-C-O 121.744 0.783 . . . . 0.0 112.411 -176.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 43.7 m-80 -130.88 131.8 44.76 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 114.506 -1.224 . . . . 0.0 108.46 176.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.493 ' H ' HG22 ' A' ' 37' ' ' THR . 22.4 t -89.5 120.55 38.42 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.846 0 CA-C-O 121.026 0.441 . . . . 0.0 111.306 -177.55 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.7 m-20 -100.82 49.72 0.88 Allowed 'General case' 0 C--N 1.305 -1.352 0 CA-C-N 115.475 -0.784 . . . . 0.0 110.979 179.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 30.8 p -79.77 0.33 31.18 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.811 177.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . 93.82 -25.71 20.13 Favored Glycine 0 N--CA 1.434 -1.483 0 CA-C-N 115.539 -0.755 . . . . 0.0 111.904 -179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . 0.449 ' HB2' HG21 ' A' ' 71' ' ' VAL . 6.2 m -105.64 -49.05 3.5 Favored 'General case' 0 C--N 1.316 -0.851 0 N-CA-C 112.244 0.461 . . . . 0.0 112.244 -176.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.515 ' O ' HG12 ' A' ' 140' ' ' ILE . 84.0 t -52.74 -62.8 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.801 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 -176.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.4 HE21 ' HB3' ' A' ' 137' ' ' GLN . 1.0 OUTLIER -57.31 -44.11 83.83 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.769 -0.196 . . . . 0.0 111.526 -179.058 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 42.3 m -58.65 -45.57 89.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 116.465 -0.334 . . . . 0.0 111.855 -178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . 0.478 ' OD1' HG21 ' A' ' 34' ' ' VAL . 12.0 t70 -69.09 -53.17 21.74 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.728 0.299 . . . . 0.0 111.496 -177.565 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.515 HG12 ' O ' ' A' ' 136' ' ' VAL . 44.0 pt -65.08 -42.02 93.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 N-CA-C 112.466 0.543 . . . . 0.0 112.466 -176.479 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 22.8 t -66.14 -39.5 89.89 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-O 120.854 0.359 . . . . 0.0 111.281 -178.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.7 t -72.54 -45.5 59.01 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 120.866 0.365 . . . . 0.0 110.182 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 69.3 m -60.51 -49.16 78.67 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.704 -179.625 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 19.1 p -61.02 -22.05 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -178.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -64.89 -45.41 86.06 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.738 0.304 . . . . 0.0 110.657 178.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -88.99 -42.0 12.04 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 121.396 0.617 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.581 ' O ' ' HB3' ' A' ' 27' ' ' ASN . 4.3 mm? -75.18 8.87 2.34 Favored 'General case' 0 C--O 1.213 -0.839 0 CA-C-N 115.163 -0.926 . . . . 0.0 113.131 -177.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 68.5 m -46.79 -47.22 20.96 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.24 0.543 . . . . 0.0 109.663 177.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.427 ' HB ' ' O ' ' A' ' 152' ' ' SER . 11.8 p -154.01 104.31 2.64 Favored 'General case' 0 C--N 1.317 -0.805 0 N-CA-C 107.692 -1.225 . . . . 0.0 107.692 174.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 38.0 p -95.64 -55.36 3.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.509 0.559 . . . . 0.0 112.509 -175.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 34.1 m -71.87 -15.72 62.13 Favored 'General case' 0 C--O 1.237 0.414 0 CA-C-O 121.038 0.446 . . . . 0.0 111.592 -179.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.524 ' OG ' ' HA ' ' A' ' 176' ' ' SER . 9.4 m -137.46 160.43 39.13 Favored 'General case' 0 C--N 1.316 -0.871 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.566 ' HB3' ' HB2' ' A' ' 158' ' ' GLN . 23.2 t -105.11 141.64 36.3 Favored 'General case' 0 C--N 1.31 -1.119 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 178.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -75.12 24.43 0.1 Allowed 'General case' 0 CA--C 1.543 0.677 0 N-CA-C 112.44 0.534 . . . . 0.0 112.44 -177.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 50.9 m -93.51 14.33 19.06 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.76 0.314 . . . . 0.0 111.068 179.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 95.0 m-85 69.63 -62.38 0.42 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.666 0.786 . . . . 0.0 112.881 178.258 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 16.4 t -60.28 -33.79 72.84 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.107 0.479 . . . . 0.0 110.535 -179.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 153' ' ' SER . 83.1 mm-40 -92.04 15.94 12.28 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.443 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -131.06 24.87 4.94 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.696 179.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 49.1 m -153.74 69.18 0.79 Allowed 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.803 -0.635 . . . . 0.0 110.223 179.024 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 111.7 17.91 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.161 179.251 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 98.0 p 54.28 -165.34 0.1 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 123.972 0.909 . . . . 0.0 111.554 -178.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.487 ' HA ' ' O ' ' A' ' 166' ' ' GLY . 20.3 m 64.28 2.4 1.5 Allowed 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 123.244 0.617 . . . . 0.0 112.248 178.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 8.9 t -80.0 -27.96 39.52 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 121.066 0.46 . . . . 0.0 110.954 -178.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.8 m -120.12 23.47 10.96 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-O 121.258 0.551 . . . . 0.0 110.104 -179.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.487 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . 142.27 134.61 2.98 Favored Glycine 0 N--CA 1.445 -0.758 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 -179.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -129.52 105.18 7.9 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 120.977 0.418 . . . . 0.0 111.894 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -76.44 -31.28 54.96 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 110.12 -1.192 . . . . 0.0 110.12 175.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 98.3 m-85 -109.18 127.82 54.53 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 176.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 11.9 t -160.0 158.99 31.56 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-O 120.687 0.28 . . . . 0.0 110.376 -179.326 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 152.95 -177.12 30.79 Favored Glycine 0 N--CA 1.431 -1.64 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 179.328 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_exo -65.44 -14.0 42.69 Favored 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 122.875 2.383 . . . . 0.0 111.581 178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 28.8 t -149.77 101.98 3.11 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 177.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -146.84 -130.5 2.09 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.247 -0.977 . . . . 0.0 112.381 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -69.17 164.12 35.17 Favored 'Trans proline' 0 C--O 1.237 0.469 0 C-N-CA 122.675 2.25 . . . . 0.0 111.319 178.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.524 ' HA ' ' OG ' ' A' ' 152' ' ' SER . 46.6 m -75.41 68.51 2.1 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.484 0.659 . . . . 0.0 111.274 179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 9.8 t -130.33 113.4 14.33 Favored 'General case' 0 N--CA 1.435 -1.19 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.33 178.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 73.94 -173.14 50.64 Favored Glycine 0 N--CA 1.426 -1.973 0 C-N-CA 120.343 -0.932 . . . . 0.0 110.861 -176.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.459 ' HG2' HD12 ' A' ' 25' ' ' LEU . 4.6 Cg_exo -80.11 4.9 6.39 Favored 'Trans proline' 0 C--N 1.313 -1.292 0 C-N-CA 123.073 2.515 . . . . 0.0 112.663 179.465 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 6.7 m -139.25 -73.9 0.38 Allowed 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.817 0.341 . . . . 0.0 111.558 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 159.66 56.85 0.01 OUTLIER Glycine 0 C--O 1.239 0.449 0 C-N-CA 120.905 -0.664 . . . . 0.0 112.029 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -137.22 165.26 35.98 Favored Pre-proline 0 C--N 1.324 -0.542 0 N-CA-C 109.36 -0.608 . . . . 0.0 109.36 -178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.712 ' O ' ' HD3' ' A' ' 185' ' ' PRO . 50.3 Cg_exo -56.79 163.61 7.05 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 122.257 1.971 . . . . 0.0 110.255 174.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . -107.59 89.05 0.56 Allowed Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.682 -1.247 . . . . 0.0 115.175 -174.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.712 ' HD3' ' O ' ' A' ' 183' ' ' PRO . 9.5 Cg_endo -90.42 -42.2 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.047 0 C-N-CA 122.605 2.203 . . . . 0.0 110.887 174.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.476 ' H ' ' HD2' ' A' ' 185' ' ' PRO . 54.5 mt -94.33 -69.32 0.76 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.096 -179.267 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -109.62 -135.3 7.17 Favored Glycine 0 N--CA 1.434 -1.445 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 177.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -70.99 -25.66 75.37 Favored Glycine 0 N--CA 1.443 -0.896 0 C-N-CA 120.234 -0.984 . . . . 0.0 111.697 177.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 183' ' ' PRO . . . -177.72 127.91 1.24 Allowed Glycine 0 N--CA 1.445 -0.718 0 C-N-CA 120.995 -0.621 . . . . 0.0 112.216 -178.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -162.08 154.63 16.67 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.685 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 43.0 Cg_endo -69.34 170.75 15.35 Favored 'Trans proline' 0 C--N 1.351 0.707 0 C-N-CA 122.065 1.843 . . . . 0.0 112.378 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -102.71 32.8 3.46 Favored 'General case' 0 C--N 1.317 -0.835 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.975 -176.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -138.15 35.73 2.0 Allowed Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.594 -0.813 . . . . 0.0 112.437 -179.562 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 41.6 mt-30 -107.44 179.43 4.25 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.772 0.32 . . . . 0.0 110.804 -179.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 100' ' ' LEU . 23.8 p -97.26 18.18 15.66 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.53 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 80.77 79.51 0.89 Allowed Glycine 0 N--CA 1.441 -0.977 0 C-N-CA 120.49 -0.862 . . . . 0.0 111.434 -178.021 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 85.7 t80 -84.04 -20.25 33.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.0 110.694 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 84.53 -169.93 45.76 Favored Glycine 0 N--CA 1.443 -0.845 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.62 -177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.438 -1.232 0 CA-C-O 118.311 -1.272 . . . . 0.0 111.317 179.795 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.64 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -64.4 119.5 15.84 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.067 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_exo -62.18 123.36 12.37 Favored 'Trans proline' 0 C--N 1.348 0.545 0 C-N-CA 122.462 2.108 . . . . 0.0 111.4 179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 67.9 mt-30 -68.82 107.16 2.94 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.777 -178.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 53.4 -110.03 1.24 Allowed Glycine 0 C--N 1.332 0.336 0 CA-C-N 115.996 -0.547 . . . . 0.0 112.259 179.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.71 18.65 7.59 Favored Glycine 0 N--CA 1.437 -1.234 0 N-CA-C 111.445 -0.662 . . . . 0.0 111.445 178.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -66.37 -61.55 1.95 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.368 0.127 . . . . 0.0 110.899 179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 60.96 72.58 0.61 Allowed Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.398 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -74.72 176.6 6.84 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 120.685 0.279 . . . . 0.0 111.196 -179.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.51 ' H ' ' CD2' ' A' ' 113' ' ' LEU . 29.8 p 53.81 92.78 0.02 OUTLIER 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.153 0.981 . . . . 0.0 113.299 -179.407 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 170.85 -160.74 33.37 Favored Glycine 0 N--CA 1.445 -0.739 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.606 179.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 77.33 -163.44 51.85 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.378 179.451 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -63.34 -16.34 60.1 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.816 0.341 . . . . 0.0 111.523 -179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.554 ' O ' HG23 ' A' ' 18' ' ' ILE . 42.5 m -60.46 -34.77 74.48 Favored 'General case' 0 N--CA 1.44 -0.956 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.14 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -58.16 -22.83 53.0 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.104 0.409 . . . . 0.0 112.104 -178.373 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.35 -43.18 5.64 Favored Glycine 0 N--CA 1.441 -1.011 0 C-N-CA 120.301 -0.952 . . . . 0.0 112.551 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.455 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -85.28 -25.18 27.38 Favored 'General case' 0 C--O 1.213 -0.863 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 -176.155 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.59 ' HB ' ' O ' ' A' ' 89' ' ' ALA . 3.0 pt -34.3 -63.01 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 N-CA-C 115.33 1.604 . . . . 0.0 115.33 -174.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 42.5 t -75.07 -19.14 60.12 Favored 'General case' 0 C--N 1.312 -1.065 0 N-CA-C 111.891 0.33 . . . . 0.0 111.891 -176.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 99.4 mtt180 -81.96 -21.51 37.16 Favored 'General case' 0 C--N 1.319 -0.736 0 C-N-CA 122.66 0.384 . . . . 0.0 112.026 -177.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.5 HG11 ' HB3' ' A' ' 100' ' ' LEU . 1.8 t -71.68 -142.37 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.287 0 CA-C-O 120.741 0.305 . . . . 0.0 110.521 179.946 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.447 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -62.02 -23.41 66.42 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 112.02 0.378 . . . . 0.0 112.02 -176.299 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.516 ' OD1' ' HB3' ' A' ' 91' ' ' SER . 0.9 OUTLIER -66.68 -26.56 67.09 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.986 -179.02 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -64.41 -44.13 92.21 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.947 0.403 . . . . 0.0 110.536 179.273 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 28.2 tp -80.11 -28.75 38.97 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.649 -179.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.87 -46.83 87.73 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 109.676 -0.49 . . . . 0.0 109.676 177.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 57.26 17.87 3.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.864 0.866 . . . . 0.0 112.057 176.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.457 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 2.3 m -76.7 164.57 25.76 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.492 -177.328 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.496 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 29.6 m -62.66 -16.49 57.22 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 116.068 -0.515 . . . . 0.0 112.035 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -52.3 -38.73 59.21 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 123.664 0.785 . . . . 0.0 112.515 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.8 OUTLIER -104.02 -20.9 13.7 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.409 0.623 . . . . 0.0 110.538 179.144 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 13.1 ttm180 -72.81 -40.72 65.62 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.27 -0.877 . . . . 0.0 112.708 -175.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.405 HG23 HG23 ' A' ' 34' ' ' VAL . 8.2 t -173.3 -32.91 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 112.489 0.551 . . . . 0.0 112.489 -177.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.405 HG23 HG23 ' A' ' 33' ' ' THR . 47.4 t -87.2 139.89 16.64 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.067 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.458 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.2 pt? -54.14 141.68 28.15 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 121.007 0.432 . . . . 0.0 110.695 178.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.489 ' HD3' ' HA ' ' A' ' 91' ' ' SER . 46.5 ptt85 -67.55 162.72 22.75 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-N 115.664 -0.698 . . . . 0.0 111.506 -177.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.74 129.84 38.76 Favored 'General case' 0 N--CA 1.43 -1.437 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.431 177.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.473 ' HA3' ' HB ' ' A' ' 129' ' ' ILE . . . 72.1 35.49 60.9 Favored Glycine 0 N--CA 1.434 -1.471 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.731 -178.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG23 ' HB3' ' A' ' 87' ' ' ALA . 12.4 p -44.99 149.84 0.25 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.817 0 C-N-CA 124.125 0.97 . . . . 0.0 112.771 -178.455 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.477 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.8 m -88.11 149.43 23.93 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.289 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' CB ' ' HA ' ' A' ' 49' ' ' GLN . 7.7 pm0 -70.64 -12.99 61.91 Favored 'General case' 0 C--O 1.217 -0.643 0 CA-C-N 116.487 -0.324 . . . . 0.0 111.627 -178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 82.9 mm-40 -55.48 -31.94 62.41 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.759 0.314 . . . . 0.0 110.988 179.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.477 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -85.03 -44.73 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 116.344 -0.389 . . . . 0.0 112.029 178.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.451 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -84.57 -71.49 0.51 Allowed 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.703 0.287 . . . . 0.0 111.696 -179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.9 t 79.63 -20.49 0.38 Allowed 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 124.543 1.137 . . . . 0.0 111.022 178.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.2 p -78.91 -96.59 0.03 OUTLIER 'General case' 0 N--CA 1.436 -1.127 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.891 -178.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 30.7 m -99.41 -35.24 4.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-O 120.996 0.427 . . . . 0.0 111.291 -178.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.5 t -81.71 81.05 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.907 -179.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.492 ' HA ' ' CB ' ' A' ' 41' ' ' GLN . 42.4 mt-30 -83.01 -47.85 11.27 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 121.597 0.713 . . . . 0.0 110.392 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.578 ' HB2' ' HB2' ' A' ' 55' ' ' LEU . 2.5 tpm_? -125.16 -12.71 6.87 Favored 'General case' 0 C--N 1.314 -0.945 0 CA-C-N 115.136 -0.938 . . . . 0.0 111.514 -178.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 74.07 -52.17 0.69 Allowed 'General case' 0 N--CA 1.473 0.694 0 C-N-CA 123.404 0.681 . . . . 0.0 110.054 -173.5 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.64 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -74.44 155.46 38.02 Favored 'General case' 0 CA--C 1.515 -0.386 0 CA-C-O 120.816 0.341 . . . . 0.0 110.434 176.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.665 ' O ' ' HB2' ' A' ' 57' ' ' SER . 18.7 mp0 -60.38 -18.82 53.02 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 115.549 -0.75 . . . . 0.0 112.372 -176.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 34.6 t -58.32 -79.43 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.729 0 N-CA-C 112.342 0.497 . . . . 0.0 112.342 -178.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.578 ' HB2' ' HB2' ' A' ' 50' ' ' ARG . 19.3 mt -86.08 -22.14 27.31 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -177.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.523 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -77.42 -20.25 54.86 Favored 'General case' 0 CA--C 1.514 -0.429 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -177.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.665 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 8.7 t -56.2 101.04 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.172 0.511 . . . . 0.0 110.594 -178.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 9.3 t -145.99 -32.46 0.35 Allowed 'General case' 0 N--CA 1.438 -1.054 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.8 -179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 75.4 mt -121.4 18.88 11.38 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.0 0.429 . . . . 0.0 109.9 176.94 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.67 67.18 1.46 Allowed Glycine 0 N--CA 1.447 -0.624 0 C-N-CA 120.519 -0.848 . . . . 0.0 111.088 -176.825 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.475 HG22 HD21 ' A' ' 65' ' ' ASN . 61.9 t -97.44 113.6 32.34 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 C-N-CA 122.377 0.271 . . . . 0.0 110.756 -177.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -170.92 78.69 0.08 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.148 0.499 . . . . 0.0 110.456 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 76.06 -46.07 2.07 Favored Glycine 0 CA--C 1.521 0.413 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.991 179.737 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.442 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.5 p-10 -52.04 -74.16 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.675 0 C-N-CA 124.018 0.927 . . . . 0.0 112.796 -177.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.475 HD21 HG22 ' A' ' 61' ' ' VAL . 31.6 p-10 -85.03 -16.71 39.83 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.181 0.515 . . . . 0.0 109.875 179.768 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.45 ' HG ' ' HB2' ' A' ' 132' ' ' ASP . 61.4 tp -63.59 -47.25 82.21 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.705 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -75.21 -15.0 60.58 Favored 'General case' 0 C--N 1.32 -0.701 0 N-CA-C 111.958 0.355 . . . . 0.0 111.958 -177.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.443 ' O ' ' HG3' ' A' ' 72' ' ' GLN . 91.0 mtt180 -120.65 -84.44 0.66 Allowed 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.627 -0.429 . . . . 0.0 111.875 -177.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.2 m-85 -52.17 -39.19 59.7 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.389 0.885 . . . . 0.0 113.389 -175.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -64.62 -57.12 9.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.655 0.264 . . . . 0.0 111.68 -178.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 13.9 p -64.29 -38.3 82.18 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.487 0 CA-C-N 116.593 -0.276 . . . . 0.0 111.277 -179.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.443 ' HG3' ' O ' ' A' ' 68' ' ' ARG . 24.5 mt-30 -65.43 -35.11 79.94 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-O 120.864 0.364 . . . . 0.0 111.032 179.638 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.43 -39.99 94.9 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.488 -179.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 65.0 t -86.23 -41.11 14.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.568 -178.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 83.6 p -64.46 -28.54 69.74 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-O 121.058 0.456 . . . . 0.0 111.006 -177.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 72.5 mtp180 -102.84 5.04 38.41 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.373 179.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 13.6 tp -74.23 119.28 75.62 Favored Pre-proline 0 C--N 1.315 -0.903 0 CA-C-N 116.646 -0.252 . . . . 0.0 110.355 -177.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -67.99 128.79 18.31 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.663 2.242 . . . . 0.0 112.032 -179.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -77.4 133.54 38.65 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.886 -179.753 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -78.98 -54.51 4.11 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.585 -0.817 . . . . 0.0 111.345 179.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 12.4 p -92.26 -60.83 1.75 Allowed 'General case' 0 C--N 1.314 -0.973 0 CA-C-O 121.017 0.437 . . . . 0.0 110.336 178.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -164.46 164.1 22.02 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.964 -0.562 . . . . 0.0 109.496 179.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 25.7 m -67.01 -29.77 69.69 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.836 0.35 . . . . 0.0 111.005 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 41.7 p -67.72 -17.65 64.63 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.345 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -65.74 -20.77 66.4 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.526 179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.445 ' C ' ' H ' ' A' ' 88' ' ' GLN . 46.5 m-85 -68.13 -174.43 0.49 Allowed 'General case' 0 N--CA 1.446 -0.673 0 CA-C-O 121.434 0.635 . . . . 0.0 111.255 178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.401 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -74.64 22.26 0.1 Allowed 'General case' 0 C--N 1.316 -0.857 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.673 -178.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.445 ' H ' ' C ' ' A' ' 86' ' ' TYR . 70.7 mt-30 -86.42 -60.29 2.04 Favored 'General case' 0 N--CA 1.442 -0.833 0 CA-C-O 120.989 0.424 . . . . 0.0 109.927 -179.925 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.59 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.9 -41.55 82.55 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 121.107 0.479 . . . . 0.0 109.957 179.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.529 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 98.0 m-85 -83.88 15.64 3.22 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.67 -179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . 0.516 ' HB3' ' OD1' ' A' ' 23' ' ' ASN . 47.1 t -56.47 -50.75 70.83 Favored 'General case' 0 C--O 1.22 -0.45 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.0 t -60.14 -30.1 69.08 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 -177.071 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.8 -40.65 22.25 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 120.748 0.308 . . . . 0.0 111.388 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.529 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 37.9 mt -83.25 -29.47 28.41 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.903 -176.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -79.24 -36.78 39.4 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 109.445 -0.576 . . . . 0.0 109.445 179.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 9.0 t-20 55.31 90.35 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 114.891 -1.049 . . . . 0.0 111.475 179.547 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.56 -16.44 60.81 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.515 -0.766 . . . . 0.0 111.649 -178.7 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 85.25 -14.01 52.13 Favored Glycine 0 C--O 1.227 -0.322 0 C-N-CA 121.088 -0.577 . . . . 0.0 112.749 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.424 ' CG2' ' HA ' ' A' ' 197' ' ' PHE . 9.0 p -93.61 1.35 9.63 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.805 0 CA-C-O 122.203 1.002 . . . . 0.0 109.527 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.5 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.8 OUTLIER -83.94 173.76 10.92 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 114.514 -1.221 . . . . 0.0 110.129 179.187 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 7.1 p30 -81.27 135.9 35.75 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 120.236 -0.586 . . . . 0.0 110.094 -178.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -76.13 -23.26 54.86 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-N 115.761 -0.654 . . . . 0.0 112.25 -175.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.1 p -68.36 -30.67 69.68 Favored 'General case' 0 C--O 1.22 -0.5 0 CA-C-O 121.217 0.532 . . . . 0.0 110.698 -176.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.562 ' O ' ' HG ' ' A' ' 108' ' ' LEU . 18.1 t30 -60.24 -53.79 53.45 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.43 178.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 2.0 mp -74.51 -38.02 45.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.253 -179.076 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -67.86 -31.7 71.7 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.839 -178.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 77.2 m -91.68 -53.82 4.14 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 112.6 0.593 . . . . 0.0 112.6 -176.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.562 ' HG ' ' O ' ' A' ' 104' ' ' ASN . 4.1 pp -111.76 -35.24 5.79 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 112.556 0.576 . . . . 0.0 112.556 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -53.79 -52.67 40.93 Favored Glycine 0 N--CA 1.46 0.293 0 C-N-CA 120.938 -0.648 . . . . 0.0 113.121 -178.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.625 ' HA ' HD12 ' A' ' 117' ' ' LEU . 33.0 t -66.09 -24.11 66.64 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.735 0.302 . . . . 0.0 111.551 -178.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.0 mpt_? -87.13 -40.75 14.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.88 0.371 . . . . 0.0 111.42 -177.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 60.7 t -83.12 -55.79 6.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.902 0 CA-C-O 120.87 0.367 . . . . 0.0 111.376 -178.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' CD2' ' H ' ' A' ' 10' ' ' THR . 17.9 mt -72.57 -42.29 64.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.554 -177.561 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 50.4 m 49.53 -94.86 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 113.942 1.09 . . . . 0.0 113.942 176.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.582 ' HA ' ' ND2' ' A' ' 118' ' ' ASN . . . -66.74 -19.08 65.68 Favored 'General case' 0 N--CA 1.463 0.207 0 N-CA-C 112.33 0.493 . . . . 0.0 112.33 -175.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.447 HD21 HD22 ' A' ' 94' ' ' LEU . 58.1 tp -73.87 -36.81 64.87 Favored 'General case' 0 C--N 1.308 -1.235 0 CA-C-O 120.754 0.311 . . . . 0.0 110.741 179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 110' ' ' SER . 33.0 mt -68.06 -43.51 78.49 Favored 'General case' 0 C--O 1.209 -1.063 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 -175.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . 0.582 ' ND2' ' HA ' ' A' ' 115' ' ' ALA . 11.8 p30 -62.68 -24.38 67.61 Favored 'General case' 0 C--N 1.325 -0.485 0 C-N-CA 120.281 -0.568 . . . . 0.0 111.054 -179.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -86.77 -30.1 21.89 Favored Glycine 0 N--CA 1.44 -1.039 0 C-N-CA 120.576 -0.821 . . . . 0.0 111.572 177.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.428 HG13 ' HB3' ' A' ' 124' ' ' ALA . 49.5 t -84.7 -34.66 9.48 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 N-CA-C 112.222 0.453 . . . . 0.0 112.222 -179.474 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 18.4 p -53.38 -49.25 67.61 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-O 121.13 0.49 . . . . 0.0 111.627 -177.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 33.2 t -76.26 -28.8 57.23 Favored 'General case' 0 C--N 1.307 -1.281 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.75 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.408 ' HB1' ' HD3' ' A' ' 50' ' ' ARG . . . -84.56 -85.3 0.14 Allowed 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 113.404 0.89 . . . . 0.0 113.404 -176.489 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.428 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -69.85 -41.57 74.71 Favored 'General case' 0 CA--C 1.514 -0.416 0 N-CA-C 112.055 0.391 . . . . 0.0 112.055 -175.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 36.7 tt0 -76.58 -21.89 55.01 Favored 'General case' 0 C--N 1.315 -0.901 0 CA-C-O 121.197 0.522 . . . . 0.0 110.201 -179.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -86.18 -81.04 1.15 Allowed Glycine 0 N--CA 1.443 -0.898 0 CA-C-N 115.739 -0.664 . . . . 0.0 113.375 -179.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -91.67 -23.87 19.68 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.928 0.394 . . . . 0.0 110.955 -176.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 83.24 88.1 0.77 Allowed Glycine 0 N--CA 1.433 -1.526 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 -176.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.64 HG23 ' HB2' ' A' ' 52' ' ' ALA . 48.8 mm -58.06 136.98 20.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.869 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -176.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -107.66 152.32 24.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.167 179.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.509 HG11 HG21 ' A' ' 136' ' ' VAL . 5.3 t -116.9 163.49 14.02 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.998 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 175.786 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.45 ' HB2' ' HG ' ' A' ' 66' ' ' LEU . 23.3 t70 -59.97 152.04 24.68 Favored 'General case' 0 C--O 1.242 0.683 0 CA-C-O 121.316 0.579 . . . . 0.0 112.073 -177.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.544 ' HA ' ' CB ' ' A' ' 137' ' ' GLN . 24.0 m -73.71 -11.54 60.43 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 113.446 0.906 . . . . 0.0 113.446 -176.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -45.86 -74.54 0.22 Allowed Glycine 0 C--N 1.341 0.806 0 O-C-N 123.266 0.354 . . . . 0.0 113.275 -178.272 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 22.8 t -106.56 -57.24 2.08 Favored 'General case' 0 C--N 1.314 -0.937 0 C-N-CA 120.514 -0.474 . . . . 0.0 111.309 179.009 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.509 HG21 HG11 ' A' ' 131' ' ' VAL . 60.8 t -48.68 -60.57 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.207 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -173.254 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.544 ' CB ' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -58.16 -48.93 78.77 Favored 'General case' 0 C--O 1.224 -0.274 0 C-N-CA 121.044 -0.262 . . . . 0.0 111.543 -177.413 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.4 m -61.46 -41.93 97.99 Favored 'General case' 0 C--N 1.319 -0.734 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.426 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.27 -49.73 63.18 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.566 179.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.472 HG12 ' O ' ' A' ' 136' ' ' VAL . 40.5 pt -68.57 -35.94 72.42 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.307 0 N-CA-C 111.868 0.322 . . . . 0.0 111.868 -178.149 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 21.1 t -62.96 -50.28 71.4 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 120.654 0.264 . . . . 0.0 110.731 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 24.5 t -59.45 -43.9 93.06 Favored 'General case' 0 C--O 1.239 0.544 0 CA-C-O 121.213 0.53 . . . . 0.0 110.05 179.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.457 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 47.7 t -64.72 -41.77 95.73 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.059 179.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 33.6 t -69.85 -24.39 63.43 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 120.931 0.396 . . . . 0.0 110.971 -178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 60.0 m -85.86 -58.82 2.5 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 116.616 -0.265 . . . . 0.0 111.637 179.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.41 ' O ' ' HB2' ' A' ' 150' ' ' SER . 90.1 m-85 -89.82 -56.65 3.15 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 113.104 0.779 . . . . 0.0 113.104 -176.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 7.7 mp -71.97 -4.41 28.31 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 -171.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -60.61 -49.92 75.6 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 120.836 0.35 . . . . 0.0 111.745 -179.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 1.3 m -147.9 -11.99 0.38 Allowed 'General case' 0 C--N 1.319 -0.735 0 C-N-CA 120.829 -0.348 . . . . 0.0 111.732 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.41 ' HB2' ' O ' ' A' ' 146' ' ' PHE . 40.0 m -77.79 69.45 4.03 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.405 0.621 . . . . 0.0 111.006 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.2 m -152.62 130.58 11.78 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.323 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 47.3 m -70.88 1.2 5.83 Favored 'General case' 0 C--N 1.324 -0.529 0 N-CA-C 112.183 0.438 . . . . 0.0 112.183 -178.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 11.4 p -90.64 -78.32 0.38 Allowed 'General case' 0 N--CA 1.426 -1.663 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 178.423 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -57.1 -27.9 62.19 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -177.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 22.8 t -102.68 7.83 39.71 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 112.463 0.542 . . . . 0.0 112.463 -176.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 41.6 t80 -160.01 -76.47 0.06 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 119.642 -0.823 . . . . 0.0 113.088 -178.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 12.9 m -60.06 -33.44 72.05 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 112.041 0.386 . . . . 0.0 112.041 -176.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 75.7 mm-40 -94.96 2.58 55.39 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.436 -179.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -98.1 175.25 6.17 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 177.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 15.3 m 52.14 45.83 27.68 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-O 121.587 0.708 . . . . 0.0 109.668 -178.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -100.76 136.56 40.43 Favored 'General case' 0 N--CA 1.44 -0.969 0 CA-C-N 115.191 -0.913 . . . . 0.0 112.836 -173.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.9 m -99.78 86.63 3.34 Favored 'General case' 0 N--CA 1.441 -0.884 0 N-CA-C 108.023 -1.103 . . . . 0.0 108.023 174.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 20.2 m -74.12 -20.67 60.17 Favored 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 113.113 0.783 . . . . 0.0 113.113 -173.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 27.8 m -56.24 97.95 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.481 0 CA-C-O 120.858 0.361 . . . . 0.0 111.599 -178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 20.4 m 61.92 20.47 11.54 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 123.502 0.721 . . . . 0.0 111.735 179.351 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -143.23 36.28 1.59 Allowed Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.278 -0.963 . . . . 0.0 113.023 -178.455 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -158.8 160.58 36.42 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.602 0.239 . . . . 0.0 110.717 179.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -83.43 48.01 3.95 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.246 179.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 27.2 m-85 70.52 131.48 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.513 0 C-N-CA 123.937 0.895 . . . . 0.0 111.697 179.334 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 6.4 p -67.38 146.36 54.13 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 112.956 0.725 . . . . 0.0 112.956 -176.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 101.83 -123.26 7.84 Favored Glycine 0 N--CA 1.44 -1.077 0 CA-C-N 115.599 -0.728 . . . . 0.0 112.78 177.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.31 115.43 2.65 Favored 'Trans proline' 0 C--O 1.236 0.409 0 C-N-CA 122.685 2.257 . . . . 0.0 112.416 -178.357 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 23.2 m 67.59 17.88 9.93 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-N 115.516 -0.765 . . . . 0.0 111.404 179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -115.64 -167.89 15.24 Favored Glycine 0 N--CA 1.437 -1.282 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.481 178.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -68.93 154.92 70.06 Favored 'Trans proline' 0 C--O 1.242 0.725 0 C-N-CA 122.725 2.283 . . . . 0.0 111.909 178.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 19.8 m -87.52 87.81 7.5 Favored 'General case' 0 N--CA 1.44 -0.945 0 CA-C-O 121.272 0.558 . . . . 0.0 110.837 -179.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 10.2 t -83.5 -14.21 52.89 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.578 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.422 ' HA2' ' O ' ' A' ' 186' ' ' LEU . . . -129.08 71.62 0.49 Allowed Glycine 0 N--CA 1.442 -0.966 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.188 -178.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -76.04 -174.89 2.24 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.32 2.013 . . . . 0.0 111.088 176.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 11.9 p -76.05 -75.52 0.18 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 120.884 0.373 . . . . 0.0 111.291 -179.312 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.09 -106.92 2.08 Favored Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.966 -0.635 . . . . 0.0 111.958 -179.389 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -129.77 146.83 62.88 Favored Pre-proline 0 C--N 1.319 -0.76 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 10.2 Cg_endo -50.44 125.01 14.3 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 123.253 2.635 . . . . 0.0 112.649 -178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 144.22 -99.43 0.22 Allowed Glycine 0 N--CA 1.438 -1.21 0 N-CA-C 110.505 -1.038 . . . . 0.0 110.505 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -87.16 176.73 4.22 Favored 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.642 2.228 . . . . 0.0 110.063 175.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.422 ' O ' ' HA2' ' A' ' 178' ' ' GLY . 7.1 mp -101.43 81.03 2.14 Favored 'General case' 0 C--N 1.308 -1.228 0 CA-C-O 121.351 0.596 . . . . 0.0 110.346 177.728 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . 77.77 -62.58 3.55 Favored Glycine 0 N--CA 1.443 -0.838 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.4 179.655 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -178.66 -40.57 0.07 OUTLIER Glycine 0 N--CA 1.442 -0.907 0 N-CA-C 111.864 -0.494 . . . . 0.0 111.864 -179.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -112.67 68.57 0.23 Allowed Glycine 0 N--CA 1.448 -0.559 0 C-N-CA 120.83 -0.7 . . . . 0.0 112.131 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -74.56 133.72 76.76 Favored Pre-proline 0 C--N 1.321 -0.642 0 CA-C-O 120.301 0.096 . . . . 0.0 110.912 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -59.42 138.99 87.47 Favored 'Trans proline' 0 C--O 1.238 0.515 0 C-N-CA 122.48 2.12 . . . . 0.0 111.417 177.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -79.02 43.73 0.53 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.24 0.543 . . . . 0.0 111.847 -177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -115.11 -5.59 19.56 Favored Glycine 0 N--CA 1.442 -0.905 0 N-CA-C 110.829 -0.909 . . . . 0.0 110.829 177.107 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 63.7 mt-30 -106.5 152.71 23.31 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 74.5 m -83.49 52.84 2.33 Favored 'General case' 0 C--N 1.317 -0.838 0 CA-C-O 121.097 0.475 . . . . 0.0 111.167 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 85.1 -34.33 3.24 Favored Glycine 0 C--O 1.235 0.207 0 C-N-CA 121.22 -0.514 . . . . 0.0 112.867 178.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.424 ' HA ' ' CG2' ' A' ' 99' ' ' VAL . 72.2 t80 72.57 -67.42 0.26 Allowed 'General case' 0 N--CA 1.47 0.54 0 C-N-CA 124.013 0.925 . . . . 0.0 111.068 -179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -141.95 -164.3 9.99 Favored Glycine 0 N--CA 1.441 -0.978 0 N-CA-C 111.049 -0.82 . . . . 0.0 111.049 178.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.986 0 CA-C-O 118.358 -1.245 . . . . 0.0 111.561 -179.951 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.648 0 CA-C-O 120.591 0.234 . . . . 0.0 110.64 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 123.46 -117.3 3.16 Favored Glycine 0 N--CA 1.444 -0.784 0 C-N-CA 121.012 -0.613 . . . . 0.0 111.783 178.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 9' ' ' ALA . 90.0 Cg_endo -80.45 177.62 7.94 Favored 'Trans proline' 0 N--CA 1.459 -0.537 0 C-N-CA 122.684 2.256 . . . . 0.0 111.862 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 56.9 tp60 -138.67 107.44 5.94 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.821 0.343 . . . . 0.0 110.171 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 63.28 -122.48 27.21 Favored Glycine 0 N--CA 1.444 -0.807 0 C-N-CA 121.015 -0.612 . . . . 0.0 111.888 -179.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -90.57 -3.64 71.32 Favored Glycine 0 N--CA 1.443 -0.873 0 C-N-CA 121.002 -0.618 . . . . 0.0 111.82 179.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.9 m-85 -85.89 131.28 34.33 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 120.809 0.338 . . . . 0.0 110.324 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.442 ' O ' HG12 ' A' ' 112' ' ' VAL . . . -97.05 77.74 0.68 Allowed Glycine 0 N--CA 1.438 -1.212 0 CA-C-N 115.82 -0.627 . . . . 0.0 112.277 -178.214 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 3' ' ' PRO . . . -64.98 142.08 58.56 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 177.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 39.2 p 52.59 82.64 0.07 Allowed 'General case' 0 N--CA 1.47 0.562 0 C-N-CA 123.428 0.691 . . . . 0.0 112.323 -178.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -160.52 174.22 37.18 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.806 -0.712 . . . . 0.0 112.075 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 83.91 -160.29 36.96 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 121.125 -0.56 . . . . 0.0 112.122 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.435 ' HB3' HD21 ' A' ' 108' ' ' LEU . . . -62.16 -13.05 23.35 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.017 0.437 . . . . 0.0 111.558 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.638 ' O ' HG23 ' A' ' 18' ' ' ILE . 7.9 m -54.3 -41.02 68.47 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.636 178.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -57.1 -25.8 59.39 Favored 'General case' 0 N--CA 1.466 0.371 0 N-CA-C 112.637 0.606 . . . . 0.0 112.637 -176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.37 -43.9 5.43 Favored Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.101 -1.047 . . . . 0.0 112.503 179.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.492 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -83.66 -20.15 34.09 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.638 HG23 ' O ' ' A' ' 14' ' ' SER . 8.5 pt -42.84 -49.82 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 -178.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.9 p -84.77 -18.93 33.52 Favored 'General case' 0 C--N 1.309 -1.183 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -178.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.586 ' O ' ' HG2' ' A' ' 191' ' ' PRO . 98.4 mtt180 -85.66 -36.15 20.47 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 113.766 1.024 . . . . 0.0 113.766 -174.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.539 HG11 ' HB3' ' A' ' 100' ' ' LEU . 21.1 t -72.8 -102.65 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.053 0 N-CA-C 114.389 1.255 . . . . 0.0 114.389 -172.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.401 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -71.33 -51.83 22.1 Favored 'General case' 0 CA--C 1.516 -0.339 0 N-CA-C 113.198 0.814 . . . . 0.0 113.198 -173.491 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.465 ' HB3' HD22 ' A' ' 31' ' ' LEU . 1.0 OUTLIER -61.41 -24.95 66.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -175.116 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -60.74 -46.14 91.59 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.831 0.348 . . . . 0.0 111.222 179.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 46.2 tp -83.57 -28.18 28.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.617 -179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -66.21 -42.19 89.11 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.556 179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 56.85 17.65 3.38 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 115.55 -0.75 . . . . 0.0 112.184 176.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.466 ' HA ' ' OG ' ' A' ' 143' ' ' SER . 3.5 m -71.59 169.26 15.9 Favored 'General case' 0 CA--C 1.555 1.151 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.048 -178.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.447 ' H ' HG22 ' A' ' 28' ' ' THR . 20.0 m -61.89 -18.28 59.62 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.424 HG22 ' HA ' ' A' ' 36' ' ' ARG . 58.4 p -56.44 -40.71 75.24 Favored 'General case' 0 N--CA 1.468 0.455 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -177.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.621 ' HA ' ' O ' ' A' ' 88' ' ' GLN . 1.3 pt? -97.15 -20.13 18.17 Favored 'General case' 0 C--N 1.316 -0.863 0 CA-C-O 121.235 0.541 . . . . 0.0 110.233 179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 21.9 ttm180 -74.98 -43.95 51.05 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.411 -0.813 . . . . 0.0 112.573 -174.714 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.8 t -176.47 -25.01 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.604 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -177.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.401 ' O ' ' HA ' ' A' ' 30' ' ' THR . 57.4 t -91.89 139.41 17.89 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.15 0 N-CA-C 109.812 -0.44 . . . . 0.0 109.812 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -56.03 145.17 26.34 Favored 'General case' 0 C--O 1.238 0.451 0 O-C-N 123.186 0.303 . . . . 0.0 110.691 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HA ' HG22 ' A' ' 30' ' ' THR . 36.5 ptt85 -60.13 152.12 25.15 Favored 'General case' 0 C--O 1.24 0.603 0 CA-C-O 121.256 0.551 . . . . 0.0 111.302 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 3.4 m -67.28 114.7 6.2 Favored 'General case' 0 N--CA 1.435 -1.195 0 CA-C-N 115.489 -0.778 . . . . 0.0 110.608 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.444 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 83.67 40.0 9.21 Favored Glycine 0 N--CA 1.436 -1.355 0 C-N-CA 120.58 -0.819 . . . . 0.0 112.474 178.86 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 9.4 p -50.62 146.19 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 CA-C-O 121.28 0.562 . . . . 0.0 111.54 178.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 14.6 m -92.8 154.96 17.95 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.232 -177.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.451 ' OE1' ' HG2' ' A' ' 49' ' ' GLN . 8.5 pt20 -67.07 -12.15 59.12 Favored 'General case' 0 C--O 1.208 -1.115 0 N-CA-C 112.805 0.668 . . . . 0.0 112.805 -178.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.452 ' HG3' HD13 ' A' ' 116' ' ' LEU . 84.7 mm-40 -53.93 -42.58 68.95 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-O 121.019 0.438 . . . . 0.0 110.98 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.7 pp -84.31 -31.2 7.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.748 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -83.38 -50.39 8.38 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 112.4 0.519 . . . . 0.0 112.4 -176.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 39.2 m 78.43 -18.69 0.49 Allowed 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.413 1.085 . . . . 0.0 111.737 -179.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 50.9 p -71.42 -101.15 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.94 0 N-CA-C 113.326 0.862 . . . . 0.0 113.326 -176.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 20.8 m -131.69 -22.04 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.69 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -175.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.8 p -71.14 89.64 0.36 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 CA-C-O 121.279 0.561 . . . . 0.0 111.769 -178.705 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.48 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 68.4 mt-30 -77.47 -61.46 1.98 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.39 178.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.479 ' HG2' ' O ' ' A' ' 50' ' ' ARG . 63.3 ttt180 -118.58 -2.06 11.06 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.552 178.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 69.93 -59.79 0.5 Allowed 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.597 0.759 . . . . 0.0 112.055 -178.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -43.03 -84.3 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 113.78 1.029 . . . . 0.0 113.78 -176.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.415 HE21 ' HB3' ' A' ' 53' ' ' GLN . 0.7 OUTLIER 178.56 -44.57 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.772 0 N-CA-C 111.518 0.192 . . . . 0.0 111.518 -178.026 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.8 m -49.19 -69.41 0.12 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 123.428 0.691 . . . . 0.0 112.362 -177.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.3 tp -85.93 -23.07 27.11 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.225 0.536 . . . . 0.0 110.475 179.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.48 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.13 -19.72 62.4 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.821 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 68.5 p -47.93 107.69 0.13 Allowed 'General case' 0 C--N 1.327 -0.39 0 O-C-N 123.733 0.646 . . . . 0.0 111.614 -178.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.1 t -154.37 -42.23 0.09 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.088 -178.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.0 mt -122.59 19.38 10.38 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.332 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 86.11 63.96 1.49 Allowed Glycine 0 C--O 1.225 -0.451 0 C-N-CA 120.512 -0.852 . . . . 0.0 111.128 -177.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.524 HG22 HD21 ' A' ' 65' ' ' ASN . 10.8 t -89.7 114.07 27.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-O 120.739 0.304 . . . . 0.0 110.457 -177.405 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -178.46 86.15 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.601 -0.727 . . . . 0.0 109.887 -179.879 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 86.19 -58.65 4.73 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 121.091 -0.576 . . . . 0.0 113.935 177.133 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 60.2 m-20 -61.78 -76.2 0.06 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 120.853 0.359 . . . . 0.0 111.689 -174.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.524 HD21 HG22 ' A' ' 61' ' ' VAL . 3.2 p-10 -85.39 18.45 2.7 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.223 0.535 . . . . 0.0 110.838 -179.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 23.6 tp -87.23 -56.12 3.51 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.415 -0.811 . . . . 0.0 108.888 175.086 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -77.79 -37.23 49.25 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.143 178.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 27.2 mmt180 -104.04 172.82 6.59 Favored 'General case' 0 CA--C 1.503 -0.863 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 179.438 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 98.4 m-85 63.07 -62.29 0.13 Allowed 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 179.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -61.43 -59.66 4.9 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 0.0 110.879 -179.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 57.6 t -64.66 -41.49 92.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.25 178.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 80.8 mm-40 -59.58 -43.21 93.72 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.613 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.503 ' O ' ' HB2' ' A' ' 77' ' ' LEU . . . -57.87 -47.52 82.52 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.581 -179.599 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 46.0 t -77.61 -41.12 28.78 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.705 -177.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.7 t -66.28 -25.24 66.78 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.304 -178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 18.1 mtp180 -107.6 9.23 29.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.193 -179.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 73' ' ' ALA . 14.2 tp -84.13 115.0 58.01 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.28 -178.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -65.53 129.92 23.73 Favored 'Trans proline' 0 C--O 1.236 0.399 0 C-N-CA 122.619 2.213 . . . . 0.0 111.761 -179.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -75.14 115.87 15.25 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.872 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -65.96 -51.22 47.35 Favored Glycine 0 N--CA 1.446 -0.642 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.525 179.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 18.3 m -92.72 -60.5 1.8 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-O 121.011 0.434 . . . . 0.0 110.118 178.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -171.68 159.28 5.31 Favored 'General case' 0 CA--C 1.518 -0.287 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.67 -179.526 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 20.7 m -64.06 -26.73 68.69 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.91 0.386 . . . . 0.0 110.657 179.517 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 8.1 m -65.61 -18.6 65.45 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.25 179.791 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -73.92 -21.07 60.19 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.04 0.448 . . . . 0.0 110.779 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 45.3 m-85 -74.84 -170.27 1.05 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.873 -0.603 . . . . 0.0 110.871 178.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.7 46.7 0.68 Allowed 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.813 -179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.621 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 78.3 mm-40 -91.75 -62.72 1.36 Allowed 'General case' 0 N--CA 1.444 -0.739 0 CA-C-O 121.564 0.697 . . . . 0.0 109.563 177.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.627 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -86.32 -33.56 20.56 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.564 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.428 ' HA ' ' CG2' ' A' ' 18' ' ' ILE . 97.7 m-85 -72.72 2.38 6.71 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.777 -0.647 . . . . 0.0 112.161 -177.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 50.5 m -51.79 -49.2 63.18 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 112.851 0.685 . . . . 0.0 112.851 -177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 36.2 m -58.79 -39.75 82.01 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 112.719 0.637 . . . . 0.0 112.719 -177.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -81.56 -29.29 33.49 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 111.827 0.306 . . . . 0.0 111.827 -176.759 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 92.6 mt -84.35 -31.52 24.75 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.917 0.389 . . . . 0.0 111.656 -179.551 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -86.47 -31.1 21.53 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.799 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 21.1 m120 53.19 68.82 0.78 Allowed 'General case' 0 N--CA 1.465 0.289 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.791 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 1.05 4.78 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.53 -0.759 . . . . 0.0 112.2 -178.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 82.51 -13.51 40.69 Favored Glycine 0 C--O 1.225 -0.409 0 C-N-CA 121.314 -0.469 . . . . 0.0 112.855 178.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 21.6 t -72.04 -19.26 19.78 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-O 121.21 0.529 . . . . 0.0 110.295 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.539 ' HB3' HG11 ' A' ' 21' ' ' VAL . 0.5 OUTLIER -85.16 156.0 21.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 111.286 -179.832 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.407 ' ND2' ' HB2' ' A' ' 104' ' ' ASN . 9.5 p-10 -70.36 132.0 44.97 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 115.717 -0.674 . . . . 0.0 111.161 -179.586 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -67.32 -23.79 65.67 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 17.9 p -66.2 -33.49 75.87 Favored 'General case' 0 N--CA 1.445 -0.682 0 CA-C-O 121.446 0.641 . . . . 0.0 109.589 -178.817 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.407 ' HB2' ' ND2' ' A' ' 101' ' ' ASN . 28.5 t30 -63.44 -47.73 80.66 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 115.004 -0.998 . . . . 0.0 110.104 179.115 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 1.7 mp -68.97 -37.9 77.83 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.307 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -66.66 -33.87 76.62 Favored 'General case' 0 C--N 1.316 -0.851 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.305 177.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 89.4 m -85.24 -58.62 2.61 Favored 'General case' 0 C--N 1.317 -0.806 0 N-CA-C 112.904 0.705 . . . . 0.0 112.904 -175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.435 HD21 ' HB3' ' A' ' 13' ' ' ALA . 3.8 pp -116.44 -26.78 6.98 Favored 'General case' 0 C--N 1.313 -1.0 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 -175.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.414 ' O ' ' HB2' ' A' ' 113' ' ' LEU . . . -58.38 -60.05 9.67 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.591 -0.814 . . . . 0.0 112.955 -178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 t -76.93 -11.13 59.77 Favored 'General case' 0 C--N 1.315 -0.92 0 O-C-N 122.607 -0.349 . . . . 0.0 111.507 -178.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 mpt_? -87.33 -48.83 7.67 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.877 0.37 . . . . 0.0 111.337 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.442 HG12 ' O ' ' A' ' 8' ' ' GLY . 48.4 t -84.51 -57.44 4.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.075 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 116' ' ' LEU . 6.2 mp -72.01 -42.95 65.81 Favored 'General case' 0 C--O 1.235 0.31 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.308 -178.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 56.5 m 55.57 -101.76 0.14 Allowed 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 113.65 0.982 . . . . 0.0 113.65 176.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -55.35 -34.88 64.63 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.119 0.568 . . . . 0.0 112.448 -174.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.473 HD23 HD23 ' A' ' 113' ' ' LEU . 22.2 tp -59.78 -55.24 36.69 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.097 -179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . . . . . . . . . 34.6 mt -69.18 -29.47 67.47 Favored 'General case' 0 CA--C 1.511 -0.544 0 C-N-CA 120.665 -0.414 . . . . 0.0 111.63 -178.671 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 13.2 m120 -60.53 -43.09 97.54 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 177.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.83 -40.34 75.21 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.747 -0.739 . . . . 0.0 111.466 177.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 116' ' ' LEU . 89.5 t -62.85 -38.36 81.63 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 N-CA-C 111.42 0.155 . . . . 0.0 111.42 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.559 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 75.6 m -55.88 -33.42 64.58 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-O 120.847 0.356 . . . . 0.0 111.427 179.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 19.9 t -85.09 -35.82 21.57 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.222 0.534 . . . . 0.0 110.429 178.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -79.99 -84.6 0.09 Allowed 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 113.34 0.867 . . . . 0.0 113.34 -175.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -72.24 -49.5 34.68 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.843 0.354 . . . . 0.0 111.712 -175.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.559 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 40.8 tt0 -67.72 -28.77 67.94 Favored 'General case' 0 C--N 1.311 -1.082 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.267 -179.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -84.53 -61.57 1.78 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.808 -0.633 . . . . 0.0 114.247 -176.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 75.9 mt -118.63 -17.82 9.18 Favored 'General case' 0 CA--C 1.514 -0.436 0 CA-C-N 117.306 0.553 . . . . 0.0 111.455 -174.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 91.27 120.04 2.37 Favored Glycine 0 N--CA 1.435 -1.411 0 C-N-CA 120.492 -0.861 . . . . 0.0 111.54 -178.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.444 HG21 ' HA3' ' A' ' 38' ' ' GLY . 18.7 mt -88.32 124.29 41.26 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 CA-C-O 120.658 0.266 . . . . 0.0 110.813 177.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 -124.32 120.21 31.51 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.563 178.782 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 23.1 t -96.88 157.36 3.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.156 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.67 174.39 2.33 Favored 'General case' 0 C--O 1.245 0.83 0 CA-C-O 121.401 0.62 . . . . 0.0 112.155 -177.116 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.55 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 13.1 m -80.49 33.38 0.3 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.879 -179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -72.81 -91.16 0.11 Allowed Glycine 0 N--CA 1.434 -1.483 0 N-CA-C 110.356 -1.097 . . . . 0.0 110.356 175.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 14.2 m -107.0 -21.26 13.06 Favored 'General case' 0 C--N 1.308 -1.202 0 CA-C-O 120.832 0.349 . . . . 0.0 110.862 176.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 49.8 t -87.06 -64.6 1.06 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 -172.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.4 tp-100 -61.27 -39.76 91.59 Favored 'General case' 0 C--O 1.224 -0.275 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -172.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.7 m -59.94 -44.13 94.57 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-O 120.981 0.42 . . . . 0.0 111.738 -178.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -73.25 -48.42 34.95 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.744 -179.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.445 HG12 ' HA ' ' A' ' 137' ' ' GLN . 47.2 pt -64.25 -35.36 73.75 Favored 'Isoleucine or valine' 0 C--O 1.212 -0.912 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -177.258 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.0 p -65.23 -35.72 81.92 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.989 0.423 . . . . 0.0 111.405 -179.157 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.9 m -74.89 -40.75 60.74 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-O 121.14 0.495 . . . . 0.0 110.608 179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.466 ' OG ' ' HA ' ' A' ' 28' ' ' THR . 24.5 t -82.69 -20.39 36.22 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.525 -176.564 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 77.6 p -64.15 -16.38 61.78 Favored 'General case' 0 C--O 1.22 -0.476 0 N-CA-C 111.628 0.233 . . . . 0.0 111.628 -179.84 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 5.0 p -47.63 -19.65 0.21 Allowed 'General case' 0 CA--C 1.552 1.055 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.456 ' O ' HG22 ' A' ' 149' ' ' THR . 71.2 m-85 -69.29 -16.51 63.58 Favored 'General case' 0 C--O 1.224 -0.256 0 O-C-N 121.959 -0.463 . . . . 0.0 111.327 176.675 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 82.0 mt -69.66 -17.82 63.53 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 177.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 20.9 m -66.9 -45.97 76.32 Favored 'General case' 0 N--CA 1.444 -0.755 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.873 176.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.456 HG22 ' O ' ' A' ' 146' ' ' PHE . 10.2 t -70.05 -30.33 67.58 Favored 'General case' 0 C--N 1.345 0.377 0 C-N-CA 120.562 -0.455 . . . . 0.0 109.799 177.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 37.9 t -59.98 -25.15 65.0 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.024 177.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 18.1 m -94.84 -48.29 6.09 Favored 'General case' 0 N--CA 1.441 -0.89 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.694 176.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 46.2 m -160.51 120.16 2.76 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.083 178.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.413 ' OG ' ' HB2' ' A' ' 159' ' ' ALA . 20.2 m -68.36 108.74 3.34 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 120.863 0.363 . . . . 0.0 110.084 177.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -72.38 -52.38 16.31 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.806 -176.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 5.8 p -87.27 -1.86 58.21 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.6 -0.273 . . . . 0.0 111.588 -178.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 83.5 t80 70.64 -38.62 0.42 Allowed 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 123.74 0.816 . . . . 0.0 112.589 178.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 2.1 p -60.96 -17.51 51.95 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 121.176 0.513 . . . . 0.0 111.332 179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -71.38 -18.08 62.38 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.068 177.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.413 ' HB2' ' OG ' ' A' ' 153' ' ' SER . . . -113.96 6.09 16.4 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.973 -178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 56.6 m -149.46 104.26 3.35 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-O 120.964 0.412 . . . . 0.0 111.309 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -119.08 154.22 33.52 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 177.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 12.9 t -77.69 93.68 4.3 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.305 0.574 . . . . 0.0 111.308 -177.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 34.9 t -87.73 -14.63 39.26 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.188 178.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 13.8 t -76.75 -9.95 59.03 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.32 -0.854 . . . . 0.0 111.131 -179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 24.2 m -94.42 6.23 49.36 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.866 179.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 121.78 103.39 1.8 Allowed Glycine 0 N--CA 1.441 -0.984 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.205 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -122.16 -34.42 3.32 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-O 120.949 0.404 . . . . 0.0 110.751 179.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 75.18 -74.01 1.48 Allowed Glycine 0 N--CA 1.444 -0.785 0 CA-C-N 115.74 -0.663 . . . . 0.0 112.996 178.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 67.6 t80 -111.06 -34.69 6.12 Favored 'General case' 0 C--N 1.316 -0.884 0 CA-C-O 120.515 0.198 . . . . 0.0 111.054 -177.937 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.427 HG23 ' HB ' ' A' ' 177' ' ' THR . 23.0 m 64.86 88.29 0.11 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 121.128 0.49 . . . . 0.0 110.752 -178.095 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.447 ' HA3' ' HD2' ' A' ' 172' ' ' PRO . . . 177.79 -148.76 8.83 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.874 -0.679 . . . . 0.0 111.666 -178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.447 ' HD2' ' HA3' ' A' ' 171' ' ' GLY . 4.9 Cg_endo -51.03 -40.17 59.38 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 123.261 2.64 . . . . 0.0 113.22 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 19.4 m -102.3 27.15 6.98 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.085 0.469 . . . . 0.0 110.727 -178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -129.27 -163.86 11.31 Favored Glycine 0 N--CA 1.443 -0.894 0 C-N-CA 120.881 -0.676 . . . . 0.0 111.843 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -74.76 168.77 24.07 Favored 'Trans proline' 0 C--O 1.235 0.369 0 C-N-CA 122.724 2.283 . . . . 0.0 111.55 178.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 21.7 m -77.92 61.49 2.54 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.404 0.621 . . . . 0.0 110.757 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . 0.427 ' HB ' HG23 ' A' ' 170' ' ' THR . 88.4 m -97.93 95.93 7.83 Favored 'General case' 0 N--CA 1.436 -1.15 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.572 -179.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.457 ' HA2' ' O ' ' A' ' 187' ' ' GLY . . . -179.92 79.04 0.06 OUTLIER Glycine 0 N--CA 1.433 -1.539 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.311 179.249 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -39.77 104.77 0.04 OUTLIER 'Trans proline' 0 C--N 1.363 1.321 0 C-N-CA 123.398 2.732 . . . . 0.0 112.538 178.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 4.6 m -66.28 106.92 1.82 Allowed 'General case' 0 N--CA 1.432 -1.352 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.518 -179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 162.61 -129.16 2.0 Allowed Glycine 0 N--CA 1.432 -1.611 0 C-N-CA 120.837 -0.697 . . . . 0.0 111.462 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.662 ' N ' ' HD3' ' A' ' 183' ' ' PRO . 24.9 m-85 -151.41 36.43 0.1 Allowed Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 -178.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.662 ' HD3' ' N ' ' A' ' 182' ' ' TYR . 64.8 Cg_endo -85.4 124.78 2.83 Favored 'Trans proline' 0 N--CA 1.436 -1.904 0 C-N-CA 121.439 1.426 . . . . 0.0 112.156 -174.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 71.29 -106.93 2.02 Favored Glycine 0 CA--C 1.525 0.716 0 C-N-CA 121.171 -0.537 . . . . 0.0 113.051 178.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.52 ' HD2' ' O ' ' A' ' 183' ' ' PRO . 72.9 Cg_endo -88.42 -63.9 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.05 0 C-N-CA 122.936 2.424 . . . . 0.0 112.576 -177.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.497 ' HG ' ' O ' ' A' ' 198' ' ' GLY . 5.1 tt -145.37 -63.76 0.33 Allowed 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 108.74 -0.837 . . . . 0.0 108.74 179.722 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.457 ' O ' ' HA2' ' A' ' 178' ' ' GLY . . . 179.1 78.83 0.06 OUTLIER Glycine 0 N--CA 1.44 -1.098 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.92 179.248 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 74.12 -61.4 2.2 Favored Glycine 0 C--N 1.33 0.249 0 C-N-CA 121.429 -0.415 . . . . 0.0 112.847 179.212 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -147.07 -78.53 0.03 OUTLIER Glycine 0 N--CA 1.43 -1.753 0 N-CA-C 111.104 -0.798 . . . . 0.0 111.104 179.159 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 67.4 158.71 0.14 Allowed Pre-proline 0 CA--C 1.54 0.564 0 C-N-CA 123.191 0.596 . . . . 0.0 111.263 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.586 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 17.3 Cg_exo -70.49 -20.55 31.23 Favored 'Trans proline' 0 C--N 1.343 0.262 0 C-N-CA 122.476 2.118 . . . . 0.0 111.539 178.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 63.7 t80 72.39 -13.17 0.65 Allowed 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.396 -0.82 . . . . 0.0 111.783 179.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -77.5 55.67 3.72 Favored Glycine 0 CA--C 1.52 0.37 0 C-N-CA 121.342 -0.456 . . . . 0.0 112.708 179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 69.8 mt-30 -110.63 173.55 6.28 Favored 'General case' 0 C--N 1.318 -0.787 0 N-CA-C 110.19 -0.3 . . . . 0.0 110.19 179.294 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.519 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 13.6 t -93.91 11.6 28.96 Favored 'General case' 0 C--N 1.316 -0.877 0 CA-C-O 120.985 0.421 . . . . 0.0 110.271 178.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 88.11 49.14 3.85 Favored Glycine 0 N--CA 1.44 -1.081 0 N-CA-C 110.438 -1.065 . . . . 0.0 110.438 -176.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 73.9 t80 -91.07 -27.68 18.43 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 121.293 0.568 . . . . 0.0 109.88 -178.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . 0.497 ' O ' ' HG ' ' A' ' 186' ' ' LEU . . . -157.66 133.58 3.59 Favored Glycine 0 N--CA 1.437 -1.234 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.281 179.112 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.437 -1.285 0 CA-C-O 118.832 -0.982 . . . . 0.0 111.993 179.359 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.61 0 N-CA-C 110.248 -0.279 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -133.52 88.7 0.26 Allowed Glycine 0 N--CA 1.441 -0.986 0 C-N-CA 120.509 -0.853 . . . . 0.0 112.462 179.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_exo -67.21 144.52 69.1 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 122.602 2.202 . . . . 0.0 110.744 177.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 55.1 tp60 -93.58 -39.93 10.57 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.066 0.46 . . . . 0.0 111.32 -178.052 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 116.79 -65.52 0.33 Allowed Glycine 0 CA--C 1.498 -0.995 0 N-CA-C 109.358 -1.497 . . . . 0.0 109.358 -175.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -74.39 -32.35 57.99 Favored Glycine 0 N--CA 1.44 -1.037 0 N-CA-C 109.618 -1.393 . . . . 0.0 109.618 173.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -110.69 120.17 41.52 Favored 'General case' 0 N--CA 1.443 -0.815 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 175.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -115.0 79.2 0.28 Allowed Glycine 0 C--N 1.306 -1.127 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -70.86 140.88 51.23 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-O 120.49 0.186 . . . . 0.0 110.898 -178.896 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 21.2 m 69.07 89.69 0.1 Allowed 'General case' 0 CA--C 1.537 0.448 0 O-C-N 123.803 0.689 . . . . 0.0 111.222 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 159.84 -153.11 24.09 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.747 -0.739 . . . . 0.0 112.183 179.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 85.29 -165.93 39.74 Favored Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 121.176 -0.535 . . . . 0.0 112.275 179.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.414 ' H ' HD22 ' A' ' 108' ' ' LEU . . . -71.43 -6.96 44.24 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.152 0.501 . . . . 0.0 110.521 178.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.545 ' O ' HG23 ' A' ' 18' ' ' ILE . 11.7 m -54.04 -30.33 47.42 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.994 179.041 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -54.22 -23.67 15.52 Favored 'General case' 0 N--CA 1.466 0.373 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 -178.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.7 -41.47 6.39 Favored Glycine 0 N--CA 1.443 -0.889 0 C-N-CA 120.001 -1.095 . . . . 0.0 112.7 179.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.548 ' O ' HG23 ' A' ' 21' ' ' VAL . 3.9 pp -85.03 -22.52 28.99 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 -176.629 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.545 HG23 ' O ' ' A' ' 14' ' ' SER . 11.7 pt -46.13 -50.87 4.24 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 N-CA-C 113.755 1.02 . . . . 0.0 113.755 -176.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.535 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 6.4 m -67.57 -21.14 65.45 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-O 120.714 0.292 . . . . 0.0 111.374 -177.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.506 ' HA ' ' HD3' ' A' ' 172' ' ' PRO . 69.1 mtt180 -89.96 -22.43 21.95 Favored 'General case' 0 N--CA 1.438 -1.061 0 N-CA-C 112.658 0.614 . . . . 0.0 112.658 -179.152 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' A' ' 92' ' ' SER . 46.4 t -61.38 169.34 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.561 1.386 0 CA-C-N 116.938 -0.119 . . . . 0.0 110.946 -178.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.527 ' HB2' ' HB ' ' A' ' 99' ' ' VAL . . . -45.88 -21.55 0.14 Allowed 'General case' 0 N--CA 1.485 1.303 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.413 ' ND2' ' HA ' ' A' ' 92' ' ' SER . 21.2 m-80 -69.05 -22.69 64.01 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-O 120.75 0.309 . . . . 0.0 111.253 178.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.535 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -54.88 -55.03 34.95 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 112.711 0.634 . . . . 0.0 112.711 -179.116 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.409 ' HG ' ' HA3' ' A' ' 174' ' ' GLY . 0.2 OUTLIER -76.13 -16.65 59.84 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.056 0.455 . . . . 0.0 110.304 -178.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.535 ' O ' ' HA ' ' A' ' 148' ' ' SER . . . -71.91 -48.51 45.0 Favored 'General case' 0 N--CA 1.445 -0.69 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 175.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.444 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 0.6 OUTLIER 49.65 18.0 0.29 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.522 1.129 . . . . 0.0 113.316 175.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.542 HG22 ' H ' ' A' ' 29' ' ' SER . 2.1 m -74.32 173.46 10.2 Favored 'General case' 0 N--CA 1.433 -1.28 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.76 -177.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.642 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 4.1 m -46.42 -28.54 1.39 Allowed 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 124.377 1.071 . . . . 0.0 113.037 179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.7 p -54.46 -32.53 57.86 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 113.458 0.91 . . . . 0.0 113.458 -177.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.412 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.2 pt? -112.57 -18.76 12.32 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.426 0.631 . . . . 0.0 109.863 176.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.642 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 5.6 tpp180 -67.68 -56.19 10.3 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.088 -0.96 . . . . 0.0 111.819 -178.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.1 t -168.77 -36.63 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 112.495 0.554 . . . . 0.0 112.495 -177.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.5 t -74.31 136.69 24.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -49.63 139.79 12.05 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-O 121.439 0.638 . . . . 0.0 112.282 -176.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.443 HH11 ' HD2' ' A' ' 36' ' ' ARG . 6.9 ptm180 -58.77 164.65 2.67 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.34 -178.644 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -74.2 111.36 9.29 Favored 'General case' 0 N--CA 1.433 -1.286 0 CA-C-N 115.261 -0.881 . . . . 0.0 110.549 179.061 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.436 ' HA3' HG21 ' A' ' 129' ' ' ILE . . . 77.91 47.34 8.63 Favored Glycine 0 N--CA 1.426 -2.014 0 C-N-CA 120.375 -0.917 . . . . 0.0 112.068 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.401 HG21 HD11 ' A' ' 43' ' ' ILE . 8.2 p -56.41 143.75 9.55 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 CA-C-O 121.035 0.445 . . . . 0.0 109.897 176.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 17.4 m -101.6 157.02 17.13 Favored 'General case' 0 C--N 1.308 -1.217 0 N-CA-C 112.337 0.495 . . . . 0.0 112.337 -175.13 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.439 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 13.6 pt20 -61.79 -12.83 19.02 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.466 -0.788 . . . . 0.0 111.861 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.9 mm-40 -56.85 -46.34 81.81 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.773 0.321 . . . . 0.0 110.368 178.725 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.401 HD11 HG21 ' A' ' 39' ' ' VAL . 2.3 pp -85.93 -36.01 10.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.523 178.304 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.5 -65.9 0.95 Allowed 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.802 -177.099 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.5 m 77.29 -18.56 0.48 Allowed 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.856 0.862 . . . . 0.0 112.188 177.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 13.4 p -61.21 -73.5 0.09 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.658 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 59.3 t -137.14 -64.43 0.36 Allowed 'Isoleucine or valine' 0 C--O 1.218 -0.581 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.282 179.118 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 p -41.71 107.36 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.811 0 C-N-CA 124.219 1.008 . . . . 0.0 113.652 -177.096 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.579 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 20.6 mp0 -73.75 -53.66 9.83 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 176.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.628 ' HE ' HG13 ' A' ' 129' ' ' ILE . 26.1 ttt85 -145.36 4.39 1.05 Allowed 'General case' 0 N--CA 1.451 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 110.856 177.319 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 68.73 -55.87 0.53 Allowed 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.143 0.577 . . . . 0.0 110.779 -176.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.496 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -65.41 131.34 46.19 Favored 'General case' 0 N--CA 1.436 -1.145 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 177.119 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.62 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 9.3 mp0 -56.21 -18.09 9.28 Favored 'General case' 0 C--N 1.309 -1.161 0 CA-C-N 114.91 -1.041 . . . . 0.0 112.699 -174.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.4 m -56.25 -69.9 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 120.839 0.352 . . . . 0.0 111.235 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.6 tp -87.9 -23.82 23.82 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 120.911 0.386 . . . . 0.0 111.14 -179.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.579 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -76.73 -18.16 58.65 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 113.137 0.792 . . . . 0.0 113.137 -176.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.569 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 32.3 t -54.11 91.17 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.465 0 CA-C-O 121.256 0.551 . . . . 0.0 111.339 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.582 HG23 ' HG ' ' A' ' 59' ' ' LEU . 1.9 t -151.6 -35.52 0.13 Allowed 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.469 -178.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.582 ' HG ' HG23 ' A' ' 58' ' ' THR . 58.3 mt -115.57 19.79 15.12 Favored 'General case' 0 CA--C 1.514 -0.42 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.232 179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 72.41 54.55 7.6 Favored Glycine 0 N--CA 1.441 -0.99 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.602 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 38.7 t -89.6 107.97 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.867 0 CA-C-N 115.801 -0.199 . . . . 0.0 110.666 -176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -167.16 82.36 0.22 Allowed 'General case' 0 C--N 1.316 -0.865 0 CA-C-O 121.097 0.475 . . . . 0.0 110.304 177.859 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 82.27 -51.14 4.44 Favored Glycine 0 C--N 1.32 -0.319 0 CA-C-N 115.762 -0.653 . . . . 0.0 112.359 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.497 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 17.2 p-10 -55.49 -82.65 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.699 0 C-N-CA 123.685 0.794 . . . . 0.0 112.696 -178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.602 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 30.0 p-10 -85.73 14.82 5.32 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-O 121.278 0.561 . . . . 0.0 110.088 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.538 ' O ' HG23 ' A' ' 71' ' ' VAL . 26.0 tp -87.63 -60.41 1.98 Allowed 'General case' 0 N--CA 1.437 -1.107 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.52 176.158 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -72.81 -41.74 64.59 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-O 121.356 0.598 . . . . 0.0 109.513 178.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.469 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 4.0 mpt_? -93.18 157.4 16.29 Favored 'General case' 0 C--O 1.211 -0.965 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 176.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 88.6 m-85 69.16 -62.66 0.4 Allowed 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 112.842 0.682 . . . . 0.0 112.842 178.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.424 ' HB3' ' O ' ' A' ' 66' ' ' LEU . . . -67.46 -62.36 1.46 Allowed 'General case' 0 C--O 1.235 0.339 0 N-CA-C 111.754 0.279 . . . . 0.0 111.754 -176.653 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.538 HG23 ' O ' ' A' ' 66' ' ' LEU . 82.0 t -56.24 -41.02 68.93 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.482 0 CA-C-N 116.499 -0.319 . . . . 0.0 110.763 179.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 62.2 mm-40 -68.39 -37.14 80.1 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 111.715 0.265 . . . . 0.0 111.715 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.24 84.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.85 0.357 . . . . 0.0 110.997 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.9 t -79.99 -35.02 15.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.204 0.526 . . . . 0.0 110.284 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 15.1 t -68.44 -27.08 65.86 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-N 115.726 -0.67 . . . . 0.0 110.689 179.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 31.3 mmt180 -89.18 -0.59 57.57 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.736 179.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.502 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 33.7 mt -67.25 134.33 93.39 Favored Pre-proline 0 C--N 1.323 -0.582 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 176.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 77' ' ' LEU . 39.5 Cg_exo -57.77 127.92 27.08 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 122.53 2.153 . . . . 0.0 111.908 -178.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -95.42 19.19 11.24 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.519 0.676 . . . . 0.0 110.034 179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -70.62 -28.99 70.13 Favored Glycine 0 N--CA 1.445 -0.747 0 CA-C-N 114.812 -1.085 . . . . 0.0 111.181 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 17.3 p -80.67 -5.38 56.89 Favored 'General case' 0 N--CA 1.443 -0.776 0 CA-C-O 120.947 0.404 . . . . 0.0 109.973 177.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 19.1 t70 77.71 153.18 0.14 Allowed 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 124.377 1.071 . . . . 0.0 111.274 179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 6.0 p -65.13 -28.29 69.33 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 115.939 -0.573 . . . . 0.0 111.761 -178.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 35.4 t -63.73 -22.74 67.06 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.19 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -76.73 -21.31 55.46 Favored 'General case' 0 C--O 1.238 0.483 0 CA-C-O 121.14 0.495 . . . . 0.0 110.86 179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.502 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 7.9 m-85 -82.85 -166.37 1.31 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.27 179.639 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.11 36.88 0.24 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.54 -178.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 32.0 mm-40 -89.63 -59.7 2.14 Favored 'General case' 0 CA--C 1.512 -0.505 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.758 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . . . . . . . . . . . -66.11 -45.05 82.53 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.107 179.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.557 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 94.1 m-85 -83.68 10.24 9.77 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.609 -179.062 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.7 t -56.94 -40.79 77.05 Favored 'General case' 0 C--O 1.224 -0.283 0 CA-C-O 120.853 0.359 . . . . 0.0 110.226 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.556 ' HB3' ' HB ' ' A' ' 21' ' ' VAL . 69.9 m -57.98 -43.96 86.86 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 116.008 -0.542 . . . . 0.0 112.182 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -72.92 -31.89 64.94 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.411 -177.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.557 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 22.1 mt -84.31 -21.54 30.97 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.978 0.418 . . . . 0.0 111.291 -179.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . 0.422 ' HB2' HH12 ' A' ' 36' ' ' ARG . 67.4 t80 -87.42 -38.52 16.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.139 178.29 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . 0.608 ' O ' HD22 ' A' ' 100' ' ' LEU . 17.7 m120 68.47 -74.1 0.08 Allowed 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 115.17 -0.923 . . . . 0.0 111.894 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . 75.33 -30.89 0.2 Allowed 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 123.93 0.892 . . . . 0.0 112.106 -178.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 96.48 -4.35 64.14 Favored Glycine 0 C--O 1.223 -0.541 0 N-CA-C 111.439 -0.664 . . . . 0.0 111.439 -178.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 22' ' ' ALA . 13.7 t -101.78 42.86 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.791 0 CA-C-O 122.342 1.068 . . . . 0.0 108.581 -178.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.608 HD22 ' O ' ' A' ' 96' ' ' ASN . 2.6 pt? -137.81 -171.23 2.95 Favored 'General case' 0 C--N 1.293 -1.875 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.396 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 20.1 p-10 -88.8 115.5 26.39 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.259 0.552 . . . . 0.0 110.233 177.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -69.79 -18.54 63.48 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.266 -178.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 14.9 p -64.38 -37.35 87.19 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -58.83 -43.17 90.63 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.655 178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 36.8 mm -65.42 -44.95 94.29 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 CA-C-N 115.826 -0.625 . . . . 0.0 111.09 -178.33 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -73.78 -18.38 60.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 116.433 -0.348 . . . . 0.0 111.587 179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 73.1 m -88.74 -62.29 1.52 Allowed 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 111.869 0.322 . . . . 0.0 111.869 -179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.414 HD22 ' H ' ' A' ' 13' ' ' ALA . 4.0 pp -116.53 -23.12 8.39 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 120.377 -0.529 . . . . 0.0 112.0 -176.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.507 ' CA ' HD12 ' A' ' 117' ' ' LEU . . . -56.25 -63.52 5.24 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.907 -0.663 . . . . 0.0 112.997 -178.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 17.0 m -77.71 -9.62 59.09 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-O 120.663 0.268 . . . . 0.0 111.496 -179.337 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 mpt_? -89.46 -58.77 2.41 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.433 0.531 . . . . 0.0 112.433 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 42.6 t -79.57 -58.95 3.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.472 -0.331 . . . . 0.0 110.938 -177.054 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.407 ' N ' HD12 ' A' ' 113' ' ' LEU . 6.3 mp -70.0 -45.77 66.55 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 5.8 t 52.65 -94.8 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 114.46 -1.245 . . . . 0.0 113.39 175.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -50.31 -37.23 35.41 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -175.441 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.582 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.1 tp -68.22 -58.7 4.02 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.214 -179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.507 HD12 ' CA ' ' A' ' 109' ' ' GLY . 23.6 mt -66.49 -27.42 67.77 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 112.484 0.549 . . . . 0.0 112.484 -176.459 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 12.2 m120 -61.63 -37.46 84.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.092 0.472 . . . . 0.0 109.784 177.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -80.44 -32.48 34.29 Favored Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 111.383 -0.687 . . . . 0.0 111.383 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.582 HG23 ' O ' ' A' ' 116' ' ' LEU . 96.4 t -63.09 -44.11 99.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 CA-C-O 120.498 0.19 . . . . 0.0 110.735 178.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.538 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 69.2 m -54.62 -39.06 67.55 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.62 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 32.8 m -80.98 -41.86 22.1 Favored 'General case' 0 N--CA 1.439 -1.013 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.446 -179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -83.84 -70.49 0.56 Allowed 'General case' 0 CA--C 1.538 0.494 0 N-CA-C 113.14 0.793 . . . . 0.0 113.14 -176.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.425 ' HA ' ' H ' ' A' ' 129' ' ' ILE . . . -73.77 -41.79 61.94 Favored 'General case' 0 CA--C 1.514 -0.42 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -174.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.538 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 58.5 tt0 -80.49 -17.53 51.33 Favored 'General case' 0 C--N 1.31 -1.122 0 CA-C-O 121.299 0.571 . . . . 0.0 109.841 -179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.53 -70.44 1.33 Allowed Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.955 179.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 98.0 mt -101.62 -24.25 14.14 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-O 120.738 0.304 . . . . 0.0 111.199 -176.833 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 98.4 100.66 2.17 Favored Glycine 0 N--CA 1.439 -1.134 0 C-N-CA 120.325 -0.941 . . . . 0.0 111.672 -178.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.628 HG13 ' HE ' ' A' ' 50' ' ' ARG . 15.0 mm -80.03 132.07 32.7 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.122 0 CA-C-O 121.154 0.502 . . . . 0.0 111.569 -178.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 14.7 t-20 -148.23 145.97 28.46 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-N 115.27 -0.877 . . . . 0.0 109.271 -179.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 45.9 t -103.19 142.22 17.51 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 178.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -67.03 -172.08 0.17 Allowed 'General case' 0 C--O 1.242 0.675 0 CA-C-O 121.719 0.771 . . . . 0.0 112.878 -177.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.587 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 39.0 m -79.88 29.31 0.27 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 113.545 0.943 . . . . 0.0 113.545 -175.574 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -66.64 -79.09 0.22 Allowed Glycine 0 N--CA 1.429 -1.805 0 N-CA-C 108.562 -1.815 . . . . 0.0 108.562 171.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.4 t -110.25 -59.76 1.89 Allowed 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.205 0.526 . . . . 0.0 110.822 174.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 140' ' ' ILE . 96.6 t -47.77 -63.4 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 114.801 1.408 . . . . 0.0 114.801 -172.365 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.587 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 6.1 tp-100 -56.34 -39.96 73.68 Favored 'General case' 0 C--O 1.223 -0.341 0 N-CA-C 111.663 0.246 . . . . 0.0 111.663 -174.944 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 20.5 m -72.9 -26.9 61.59 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.804 -178.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -81.52 -40.82 22.59 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.858 0.361 . . . . 0.0 110.837 178.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.449 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.4 pt -79.38 -27.49 13.01 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -177.106 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 38.7 p -55.97 -62.13 1.91 Allowed 'General case' 0 C--O 1.238 0.479 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -177.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.0 m -63.94 -37.7 88.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.097 0.475 . . . . 0.0 111.227 -178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 28.4 m -66.09 -34.33 77.82 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.213 -179.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . . . . . . . . . 22.3 t -69.6 -21.06 63.62 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-O 121.051 0.453 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 16.6 m -70.55 -58.28 3.85 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 121.128 0.489 . . . . 0.0 110.303 178.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -90.78 -56.1 3.31 Favored 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 113.368 0.877 . . . . 0.0 113.368 -176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.535 ' HB3' ' NH2' ' A' ' 32' ' ' ARG . 85.0 mt -68.83 -6.21 25.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 -170.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.535 ' HA ' ' O ' ' A' ' 26' ' ' ALA . 72.0 m -62.11 -54.43 41.43 Favored 'General case' 0 N--CA 1.466 0.355 0 C-N-CA 120.01 -0.676 . . . . 0.0 110.662 178.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 22.7 p -113.11 -30.88 6.83 Favored 'General case' 0 N--CA 1.436 -1.137 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.585 178.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 31.5 t 58.56 23.1 10.47 Favored 'General case' 0 C--N 1.345 0.403 0 CA-C-O 121.7 0.762 . . . . 0.0 110.193 -178.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 35.2 t -105.95 176.61 5.11 Favored 'General case' 0 N--CA 1.435 -1.214 0 CA-C-N 115.459 -0.791 . . . . 0.0 109.587 -179.315 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 7.6 p -73.2 -11.1 60.4 Favored 'General case' 0 C--N 1.316 -0.88 0 CA-C-O 121.379 0.609 . . . . 0.0 110.101 178.005 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 157' ' ' SER . 8.0 m -93.71 -0.16 56.14 Favored 'General case' 0 N--CA 1.44 -0.93 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.792 179.201 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -59.83 129.57 42.52 Favored 'General case' 0 C--O 1.241 0.639 0 CA-C-N 116.675 -0.239 . . . . 0.0 111.18 -178.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 19.8 m 72.9 117.88 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 123.794 0.837 . . . . 0.0 112.063 -179.676 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 73.19 -51.76 0.71 Allowed 'General case' 0 N--CA 1.481 1.104 0 C-N-CA 124.045 0.938 . . . . 0.0 112.936 176.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.443 ' HB3' ' O ' ' A' ' 153' ' ' SER . 34.9 t -70.65 -41.22 72.42 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.982 0.42 . . . . 0.0 111.223 -177.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -66.11 -16.26 63.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.112 -0.495 . . . . 0.0 111.527 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -76.54 0.23 20.75 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.126 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 14.7 m -76.31 -15.21 60.04 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.281 178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -76.98 -176.12 3.83 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.149 178.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 2.8 m -77.57 37.86 0.23 Allowed 'General case' 0 CA--C 1.546 0.826 0 CA-C-O 120.945 0.402 . . . . 0.0 111.428 -178.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 167' ' ' ALA . 16.7 t -73.7 -41.85 62.05 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 120.897 0.379 . . . . 0.0 110.889 -178.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 7.7 m -77.71 -8.83 58.5 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-O 121.121 0.486 . . . . 0.0 110.847 -179.554 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 7.9 m -68.87 -21.69 64.25 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.756 179.793 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 149.27 -37.14 1.0 Allowed Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.449 -0.881 . . . . 0.0 111.947 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.462 ' O ' ' HA ' ' A' ' 163' ' ' SER . . . -101.13 102.28 13.19 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 110.328 -0.249 . . . . 0.0 110.328 179.163 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -57.78 -48.03 84.66 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.926 -0.654 . . . . 0.0 111.972 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -140.15 145.21 37.23 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.546 HG22 ' H ' ' A' ' 171' ' ' GLY . 1.6 m -125.73 -147.13 0.36 Allowed 'General case' 0 C--N 1.31 -1.133 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . 0.546 ' H ' HG22 ' A' ' 170' ' ' THR . . . -69.74 -162.56 3.53 Favored Glycine 0 C--O 1.218 -0.898 0 C-N-CA 120.482 -0.866 . . . . 0.0 112.905 -179.165 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.506 ' HD3' ' HA ' ' A' ' 20' ' ' ARG . 52.0 Cg_exo -59.94 -16.61 39.62 Favored 'Trans proline' 0 N--CA 1.478 0.562 0 C-N-CA 123.013 2.476 . . . . 0.0 111.513 179.735 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . 0.476 ' HB3' ' HA3' ' A' ' 187' ' ' GLY . 48.5 m -105.24 0.99 27.73 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.837 179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . 0.409 ' HA3' ' HG ' ' A' ' 25' ' ' LEU . . . 45.58 -156.27 0.41 Allowed Glycine 0 C--N 1.335 0.499 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.77 177.308 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -86.37 76.68 2.52 Favored 'Trans proline' 0 N--CA 1.443 -1.444 0 C-N-CA 122.976 2.451 . . . . 0.0 111.486 177.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 13.8 t 67.72 31.33 6.0 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.014 178.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 11.1 t -108.0 -28.15 9.74 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.364 -179.836 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.474 ' HA2' ' HA3' ' A' ' 187' ' ' GLY . . . 62.45 -165.82 22.31 Favored Glycine 0 N--CA 1.437 -1.266 0 CA-C-N 115.353 -0.84 . . . . 0.0 113.039 -178.491 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -77.01 56.86 5.57 Favored 'Trans proline' 0 N--CA 1.46 -0.451 0 C-N-CA 122.845 2.364 . . . . 0.0 110.78 178.066 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.9 t 65.93 25.7 11.08 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.535 -0.757 . . . . 0.0 109.487 -176.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -173.97 170.59 43.73 Favored Glycine 0 N--CA 1.437 -1.239 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.22 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.437 ' N ' ' HD3' ' A' ' 183' ' ' PRO . 3.1 t80 60.91 51.53 2.44 Favored Pre-proline 0 CA--C 1.541 0.617 0 C-N-CA 123.39 0.676 . . . . 0.0 111.042 -179.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.437 ' HD3' ' N ' ' A' ' 182' ' ' TYR . 53.0 Cg_endo -84.83 157.85 11.84 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.139 1.893 . . . . 0.0 111.521 -178.585 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 125.94 -69.84 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 C-N-CA 120.309 -0.948 . . . . 0.0 112.026 -178.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -73.96 -66.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 122.088 1.858 . . . . 0.0 111.488 179.073 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.403 HD13 ' N ' ' A' ' 199' ' ' GLY . 12.0 tp -158.79 -41.24 0.06 Allowed 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.483 177.669 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 173' ' ' SER . . . 147.28 34.99 0.05 OUTLIER Glycine 0 N--CA 1.438 -1.196 0 C-N-CA 120.231 -0.985 . . . . 0.0 113.566 175.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 79.29 -85.52 1.23 Allowed Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.469 -0.872 . . . . 0.0 112.635 178.297 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -74.29 -68.43 1.57 Allowed Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.933 -0.651 . . . . 0.0 112.217 -179.493 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . 64.38 150.47 0.11 Allowed Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.688 0.795 . . . . 0.0 111.456 -179.016 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -66.77 126.41 15.3 Favored 'Trans proline' 0 C--N 1.347 0.488 0 C-N-CA 122.09 1.86 . . . . 0.0 111.749 176.124 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 72.9 t80 -71.38 -12.13 61.26 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 121.405 0.621 . . . . 0.0 109.874 177.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -105.95 78.25 0.26 Allowed Glycine 0 N--CA 1.44 -1.038 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.871 -179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 21.1 mm-40 -125.28 147.52 49.07 Favored 'General case' 0 C--N 1.318 -0.768 0 CA-C-O 121.038 0.447 . . . . 0.0 111.413 179.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.403 ' HB2' ' O ' ' A' ' 100' ' ' LEU . 17.2 t -91.51 6.17 46.62 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.472 177.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 112.36 2.89 26.05 Favored Glycine 0 N--CA 1.446 -0.656 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.283 179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 85.0 m-85 -88.92 100.28 13.06 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.939 0.4 . . . . 0.0 110.875 -179.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 156.45 164.97 13.99 Favored Glycine 0 N--CA 1.443 -0.848 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.227 179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . 0.403 ' N ' HD13 ' A' ' 186' ' ' LEU . . . . . . . . 0 C--O 1.245 0.809 0 CA-C-O 118.727 -1.041 . . . . 0.0 111.46 179.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.702 0 CA-C-O 120.708 0.29 . . . . 0.0 110.915 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -137.97 92.11 0.21 Allowed Glycine 0 N--CA 1.441 -1.015 0 C-N-CA 120.553 -0.832 . . . . 0.0 112.407 -179.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.1 172.11 16.99 Favored 'Trans proline' 0 C--O 1.234 0.287 0 C-N-CA 122.573 2.182 . . . . 0.0 111.363 178.643 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 26.6 mp0 -82.71 29.62 0.45 Allowed 'General case' 0 C--N 1.321 -0.636 0 CA-C-O 120.667 0.27 . . . . 0.0 111.216 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 61.96 -111.24 3.78 Favored Glycine 0 C--N 1.33 0.245 0 C-N-CA 121.372 -0.442 . . . . 0.0 112.529 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -67.56 -13.0 62.5 Favored Glycine 0 N--CA 1.453 -0.208 0 C-N-CA 121.258 -0.496 . . . . 0.0 112.302 179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 94.4 m-85 -109.05 23.13 14.99 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-O 121.145 0.498 . . . . 0.0 109.974 178.123 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.51 ' O ' ' HA ' ' A' ' 113' ' ' LEU . . . -78.11 170.41 54.88 Favored Glycine 0 N--CA 1.444 -0.829 0 CA-C-N 115.494 -0.775 . . . . 0.0 111.598 178.279 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.455 ' HA ' ' HG ' ' A' ' 113' ' ' LEU . . . -79.02 -168.76 1.56 Allowed 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 112.163 0.431 . . . . 0.0 112.163 -177.242 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 69.9 p 62.42 105.85 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 124.661 1.184 . . . . 0.0 112.616 179.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.449 ' HA2' HG11 ' A' ' 112' ' ' VAL . . . -108.76 43.11 1.78 Allowed Glycine 0 C--N 1.336 0.543 0 C-N-CA 120.969 -0.634 . . . . 0.0 113.972 -176.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 67.92 -85.1 0.16 Allowed Glycine 0 CA--C 1.52 0.362 0 N-CA-C 114.328 0.491 . . . . 0.0 114.328 175.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -56.94 -38.01 72.33 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 122.639 0.376 . . . . 0.0 111.615 -177.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.658 ' O ' HG23 ' A' ' 18' ' ' ILE . 9.6 m -58.67 -31.45 68.21 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.396 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.58 -18.3 62.9 Favored 'General case' 0 N--CA 1.465 0.277 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.41 -35.82 8.46 Favored Glycine 0 N--CA 1.446 -0.694 0 C-N-CA 120.437 -0.887 . . . . 0.0 112.899 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.578 ' O ' HG23 ' A' ' 21' ' ' VAL . 2.8 pp -85.63 -21.94 28.2 Favored 'General case' 0 C--N 1.321 -0.652 0 N-CA-C 114.036 1.124 . . . . 0.0 114.036 -177.122 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.658 HG23 ' O ' ' A' ' 14' ' ' SER . 11.9 pt -37.75 -52.35 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 -174.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.576 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 18.0 m -71.61 -24.67 61.93 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 112.899 0.703 . . . . 0.0 112.899 -175.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.503 ' NH2' ' HA ' ' A' ' 169' ' ' TYR . 93.9 mtt180 -87.58 -23.13 24.42 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -178.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 22' ' ' ALA . 31.6 t -62.34 174.82 0.33 Allowed 'Isoleucine or valine' 0 CA--C 1.56 1.335 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.425 -179.703 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.582 ' H ' HG12 ' A' ' 21' ' ' VAL . . . -37.57 -28.94 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 -177.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.421 ' HB2' ' OG ' ' A' ' 92' ' ' SER . 10.6 m-80 -63.5 -24.56 67.87 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 122.102 -0.374 . . . . 0.0 111.851 179.576 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.576 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -61.89 -35.91 79.74 Favored 'General case' 0 CA--C 1.521 -0.15 0 CA-C-O 121.354 0.597 . . . . 0.0 109.437 176.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 47.8 tp -80.23 -35.06 36.69 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.197 -0.911 . . . . 0.0 109.715 178.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.69 -48.99 77.98 Favored 'General case' 0 CA--C 1.517 -0.3 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.021 178.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.5 ' HB3' ' HA ' ' A' ' 148' ' ' SER . 9.6 t-20 59.2 13.25 2.92 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 115.987 -0.551 . . . . 0.0 112.172 174.784 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 29' ' ' SER . 1.5 m -83.56 168.54 16.31 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.283 0.563 . . . . 0.0 112.066 -175.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.648 ' HA ' ' HB3' ' A' ' 32' ' ' ARG . 1.8 m -51.92 -26.22 9.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.62 1.168 . . . . 0.0 112.927 179.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.5 p -53.29 -40.82 65.03 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 123.585 0.754 . . . . 0.0 112.872 -177.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.41 ' H ' HD23 ' A' ' 31' ' ' LEU . 0.7 OUTLIER -99.63 -19.52 16.78 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.598 0.713 . . . . 0.0 109.646 178.234 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.648 ' HB3' ' HA ' ' A' ' 29' ' ' SER . 16.1 tpp180 -66.22 -64.62 0.82 Allowed 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 114.767 -1.106 . . . . 0.0 112.605 -176.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . 0.422 ' OG1' HG21 ' A' ' 83' ' ' THR . 12.3 t -164.77 -23.74 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 CA-C-N 116.242 -0.436 . . . . 0.0 112.122 -174.255 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.1 t -88.94 137.59 20.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -52.99 140.43 25.02 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.063 0.459 . . . . 0.0 111.101 -179.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.1 ptt85 -65.82 164.52 14.63 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.681 -177.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.501 ' HA ' HG23 ' A' ' 131' ' ' VAL . 2.4 p -70.7 111.88 6.5 Favored 'General case' 0 N--CA 1.428 -1.538 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.16 178.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 81.0 43.23 8.93 Favored Glycine 0 N--CA 1.431 -1.648 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 -177.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.444 HG23 ' HB3' ' A' ' 87' ' ' ALA . 9.2 p -46.07 138.65 1.58 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.301 0 CA-C-O 121.629 0.728 . . . . 0.0 111.815 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.519 ' O ' HG13 ' A' ' 43' ' ' ILE . 17.6 m -70.78 137.99 50.05 Favored 'General case' 0 C--N 1.308 -1.208 0 CA-C-N 115.046 -0.979 . . . . 0.0 111.37 -177.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.471 ' CG ' ' HA ' ' A' ' 45' ' ' SER . 48.4 tt0 -62.69 -13.44 32.25 Favored 'General case' 0 C--O 1.219 -0.537 0 CA-C-N 115.745 -0.662 . . . . 0.0 111.165 179.323 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 79.3 mm-40 -52.62 -42.21 64.41 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.006 177.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.519 HG13 ' O ' ' A' ' 40' ' ' SER . 2.6 pp -83.62 -39.53 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 CA-C-N 115.89 -0.596 . . . . 0.0 111.539 -179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.442 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.24 -68.0 0.74 Allowed 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 112.428 0.529 . . . . 0.0 112.428 -177.009 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.471 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 5.9 m 71.64 -33.74 0.28 Allowed 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 175.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.8 t -66.24 -79.26 0.05 OUTLIER 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 111.995 0.369 . . . . 0.0 111.995 -177.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.403 ' CG2' HD21 ' A' ' 65' ' ' ASN . 7.5 p -118.74 -30.84 1.75 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.259 0.552 . . . . 0.0 111.526 -177.309 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.6 t -76.37 92.78 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.315 -0.913 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.896 -179.377 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.403 ' HB2' ' HA ' ' A' ' 56' ' ' ALA . 74.9 mt-30 -81.11 -40.44 24.05 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-O 121.162 0.506 . . . . 0.0 110.126 176.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.619 ' NH1' HD13 ' A' ' 55' ' ' LEU . 11.2 ttm180 -149.03 -1.4 0.48 Allowed 'General case' 0 N--CA 1.442 -0.837 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.656 179.075 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 70.23 -55.74 0.6 Allowed 'General case' 0 N--CA 1.473 0.691 0 C-N-CA 123.094 0.557 . . . . 0.0 110.259 -175.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.46 131.0 47.73 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.378 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.625 ' O ' ' HB2' ' A' ' 57' ' ' SER . 0.0 OUTLIER -54.9 -17.77 4.07 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.486 -0.779 . . . . 0.0 112.852 -177.721 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -55.89 -76.4 0.03 OUTLIER 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 111.881 0.326 . . . . 0.0 111.881 -178.344 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.619 HD13 ' NH1' ' A' ' 50' ' ' ARG . 2.2 tt -88.59 -24.09 22.94 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 111.385 -178.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.403 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -71.8 -18.5 62.1 Favored 'General case' 0 CA--C 1.517 -0.302 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -178.297 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.625 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 9.3 t -55.34 96.15 0.02 OUTLIER 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 121.299 0.571 . . . . 0.0 110.729 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.494 HG23 ' HG ' ' A' ' 59' ' ' LEU . 11.0 t -132.99 -30.06 1.4 Allowed 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.171 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.494 ' HG ' HG23 ' A' ' 58' ' ' THR . 94.4 mt -120.26 20.09 12.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.804 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 79.58 66.85 1.64 Allowed Glycine 0 N--CA 1.44 -1.036 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 -176.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 61.6 t -89.38 109.73 20.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -177.649 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -165.38 87.02 0.4 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.6 -53.05 3.94 Favored Glycine 0 CA--C 1.522 0.493 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.734 -176.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.506 ' CG ' ' H ' ' A' ' 65' ' ' ASN . 23.1 p-10 -61.45 -73.72 0.09 Allowed 'General case' 0 C--N 1.327 -0.406 0 C-N-CA 123.386 0.674 . . . . 0.0 112.321 -178.651 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.506 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 66.2 t30 -84.75 11.66 8.69 Favored 'General case' 0 C--N 1.318 -0.79 0 CA-C-O 121.675 0.75 . . . . 0.0 109.622 -178.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 60.2 tp -87.83 -70.48 0.63 Allowed 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.279 178.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 -34.03 39.75 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 121.42 0.629 . . . . 0.0 110.209 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 64' ' ' ASN . 56.5 mtm180 -99.46 157.72 16.24 Favored 'General case' 0 N--CA 1.44 -0.939 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.622 178.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 94.1 m-85 68.03 -57.05 0.48 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 123.511 0.725 . . . . 0.0 112.953 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -67.66 -64.17 0.91 Allowed 'General case' 0 C--O 1.237 0.429 0 CA-C-O 120.703 0.287 . . . . 0.0 111.355 -178.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 60.3 t -63.64 -35.5 73.03 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.657 0 CA-C-O 121.001 0.429 . . . . 0.0 110.059 179.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 65.3 mm-40 -68.08 -25.51 65.37 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 115.68 -0.691 . . . . 0.0 111.342 -178.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -72.56 -50.71 23.68 Favored 'General case' 0 CA--C 1.514 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.382 178.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 54.0 t -69.98 -32.96 53.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-O 121.207 0.527 . . . . 0.0 110.245 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 8.5 t -69.89 -14.74 62.88 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.229 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.432 ' O ' ' HD3' ' A' ' 78' ' ' PRO . 44.5 ttp180 -87.62 -15.71 36.52 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.111 178.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.66 ' HB3' ' OH ' ' A' ' 86' ' ' TYR . 9.4 mp -84.23 108.17 13.37 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.29 179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' HD3' ' O ' ' A' ' 76' ' ' ARG . 73.8 Cg_endo -76.81 128.46 10.1 Favored 'Trans proline' 0 N--CA 1.454 -0.819 0 C-N-CA 122.205 1.937 . . . . 0.0 111.781 -179.039 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -85.59 86.32 7.37 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.373 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -77.97 -50.41 6.4 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.544 -0.623 . . . . 0.0 111.544 179.802 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 5.2 p -63.8 -61.69 2.13 Favored 'General case' 0 N--CA 1.444 -0.737 0 CA-C-O 120.628 0.251 . . . . 0.0 110.519 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -179.46 159.76 0.93 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.709 ' HB ' ' OE1' ' A' ' 88' ' ' GLN . 12.6 p -77.4 -23.43 50.65 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-O 121.225 0.536 . . . . 0.0 110.674 178.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 10.8 m -63.08 -18.0 62.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.464 178.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -68.17 -22.4 64.84 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.131 179.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.66 ' OH ' ' HB3' ' A' ' 77' ' ' LEU . 64.3 m-85 -84.94 -171.99 3.94 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.083 0.468 . . . . 0.0 110.35 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.444 ' HB3' HG23 ' A' ' 39' ' ' VAL . . . -77.11 25.63 0.16 Allowed 'General case' 0 C--N 1.317 -0.827 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.582 179.163 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.709 ' OE1' ' HB ' ' A' ' 83' ' ' THR . 76.3 mt-30 -86.18 -56.73 3.32 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.632 -177.088 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.493 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -67.73 -29.34 68.55 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-O 121.376 0.607 . . . . 0.0 110.036 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.545 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.0 m-85 -84.31 3.76 34.17 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.446 -0.797 . . . . 0.0 112.037 -179.129 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.8 m -50.71 -35.89 33.47 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 112.037 0.384 . . . . 0.0 112.037 -179.069 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.421 ' OG ' ' HB2' ' A' ' 23' ' ' ASN . 70.3 m -53.92 -53.41 53.05 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.82 0.674 . . . . 0.0 112.82 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -82.73 -24.03 33.74 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 111.953 0.353 . . . . 0.0 111.953 -177.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 51.1 mt -84.82 -36.13 21.84 Favored 'General case' 0 C--N 1.32 -0.717 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -177.671 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -85.2 -41.1 15.94 Favored 'General case' 0 C--N 1.32 -0.682 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -177.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 16.1 m-80 60.93 90.73 0.06 Allowed 'General case' 0 N--CA 1.479 0.979 0 CA-C-O 121.501 0.667 . . . . 0.0 111.648 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -84.76 -0.97 55.61 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.823 -178.346 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 83.02 -3.14 85.36 Favored Glycine 0 C--O 1.227 -0.332 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.712 179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . 0.419 HG22 ' CD1' ' A' ' 197' ' ' PHE . 10.5 t -100.57 -13.04 8.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 CA-C-O 121.197 0.522 . . . . 0.0 109.929 -179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.605 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.6 pt? -84.02 167.42 16.89 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.365 -177.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -77.44 104.4 7.94 Favored 'General case' 0 N--CA 1.438 -1.026 0 CA-C-O 121.674 0.75 . . . . 0.0 110.385 179.98 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.04 -13.04 61.89 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.25 -0.886 . . . . 0.0 110.682 -178.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.9 p -69.21 -34.46 74.91 Favored 'General case' 0 N--CA 1.434 -1.264 0 N-CA-C 109.133 -0.692 . . . . 0.0 109.133 179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -35.78 77.45 Favored 'General case' 0 N--CA 1.446 -0.628 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.74 178.305 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 48.4 mm -68.59 -41.85 83.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.424 -0.807 . . . . 0.0 111.211 178.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -79.83 -18.09 51.7 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-O 121.031 0.443 . . . . 0.0 111.463 -179.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 66.1 m -81.82 -58.63 2.91 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 120.585 -0.446 . . . . 0.0 111.391 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 2.2 pp -126.2 -20.92 4.37 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 112.625 0.602 . . . . 0.0 112.625 -177.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.461 ' C ' HD12 ' A' ' 117' ' ' LEU . . . -57.37 -68.41 1.71 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 120.668 -0.777 . . . . 0.0 113.158 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 114' ' ' SER . 6.5 p -67.4 -16.82 64.45 Favored 'General case' 0 C--N 1.315 -0.934 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -177.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.9 mpt_? -84.64 -45.54 12.39 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.666 -178.827 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . 0.449 HG11 ' HA2' ' A' ' 11' ' ' GLY . 48.1 t -84.47 -50.79 14.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 C-N-CA 121.131 -0.228 . . . . 0.0 111.597 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.51 ' HA ' ' O ' ' A' ' 8' ' ' GLY . 6.5 mp -70.59 -34.36 72.08 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.006 0.431 . . . . 0.0 110.317 -179.291 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 110' ' ' SER . 50.8 m 48.16 -97.29 0.04 OUTLIER 'General case' 0 CA--C 1.542 0.671 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 176.046 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -51.96 -36.77 50.54 Favored 'General case' 0 CA--C 1.518 -0.281 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -173.77 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.426 HD22 ' HB2' ' A' ' 9' ' ' ALA . 57.1 tp -69.3 -60.16 2.53 Favored 'General case' 0 C--N 1.319 -0.729 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.991 -178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.461 HD12 ' C ' ' A' ' 109' ' ' GLY . 49.0 mt -64.34 -34.23 77.68 Favored 'General case' 0 CA--C 1.505 -0.772 0 N-CA-C 112.758 0.651 . . . . 0.0 112.758 -175.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 90.5 m-20 -69.77 -22.67 63.32 Favored 'General case' 0 C--N 1.309 -1.154 0 CA-C-O 121.109 0.481 . . . . 0.0 110.907 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -88.13 -32.78 11.65 Favored Glycine 0 N--CA 1.436 -1.35 0 C-N-CA 120.368 -0.92 . . . . 0.0 110.936 174.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.538 HG11 ' O ' ' A' ' 94' ' ' LEU . 54.2 t -76.24 -29.92 19.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 C-N-CA 122.996 0.518 . . . . 0.0 111.914 -178.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.446 ' HA ' ' HB3' ' A' ' 125' ' ' GLN . 15.8 p -52.2 -44.04 64.53 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 123.306 0.642 . . . . 0.0 112.592 -177.243 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 74.1 p -84.47 -26.46 28.17 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-O 120.923 0.392 . . . . 0.0 111.481 -179.799 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . . . . . . . . . . . -84.83 -78.45 0.25 Allowed 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.722 0.638 . . . . 0.0 112.722 -177.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.449 ' HB3' HG13 ' A' ' 120' ' ' VAL . . . -71.34 -49.16 45.25 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.938 0.399 . . . . 0.0 111.162 -176.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.446 ' HB3' ' HA ' ' A' ' 121' ' ' SER . 37.2 tt0 -72.07 -21.33 61.53 Favored 'General case' 0 C--N 1.312 -1.052 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.174 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -85.09 -56.13 2.5 Favored Glycine 0 N--CA 1.443 -0.865 0 CA-C-N 115.643 -0.708 . . . . 0.0 113.204 -178.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 97.6 mt -126.95 -25.01 3.38 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.998 0.399 . . . . 0.0 111.786 -177.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 102.55 107.95 3.17 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.56 -0.829 . . . . 0.0 112.001 -179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.467 ' O ' ' HB ' ' A' ' 37' ' ' THR . 32.6 mt -76.37 126.83 37.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-O 120.698 0.285 . . . . 0.0 110.675 -179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 92.7 m-20 -120.81 135.57 55.13 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.552 177.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.547 HG12 ' H ' ' A' ' 132' ' ' ASP . 12.7 t -89.09 172.83 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 179.338 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.547 ' H ' HG12 ' A' ' 131' ' ' VAL . 3.5 p-10 -60.45 162.61 6.07 Favored 'General case' 0 C--O 1.242 0.694 0 CA-C-O 121.548 0.689 . . . . 0.0 112.018 -178.438 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . . . . . . . . . 31.4 t -80.16 6.61 11.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.41 -0.814 . . . . 0.0 112.301 -177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -75.27 -78.94 0.61 Allowed Glycine 0 N--CA 1.441 -1.019 0 C-N-CA 120.598 -0.81 . . . . 0.0 113.295 -178.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 16.3 m -93.73 -39.89 10.52 Favored 'General case' 0 C--N 1.313 -0.996 0 N-CA-C 113.005 0.743 . . . . 0.0 113.005 -175.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 98.5 t -75.27 -62.89 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 113.39 0.885 . . . . 0.0 113.39 -172.177 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.435 ' HA ' HG12 ' A' ' 140' ' ' ILE . 9.4 tt0 -59.18 -39.79 83.64 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 112.03 0.381 . . . . 0.0 112.03 -175.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 16.0 m -59.4 -43.98 92.87 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.442 -179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -74.58 -50.01 19.57 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.15 -177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' A' ' 137' ' ' GLN . 42.0 pt -60.67 -38.46 78.62 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.351 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.812 -177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 25.5 t -65.7 -40.03 91.87 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.995 0.426 . . . . 0.0 110.799 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 16.3 m -70.8 -42.44 70.29 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.992 -179.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 16.2 t -72.42 -42.44 65.1 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.634 -177.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.67 ' HA ' ' OG ' ' A' ' 148' ' ' SER . 23.5 t -60.33 -41.82 94.36 Favored 'General case' 0 C--O 1.235 0.303 0 CA-C-O 121.107 0.48 . . . . 0.0 111.445 -177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 17.0 m -67.43 -43.94 79.97 Favored 'General case' 0 C--N 1.312 -1.037 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.887 -178.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 61.8 t80 -89.97 -58.19 2.6 Favored 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 113.783 1.031 . . . . 0.0 113.783 -176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . . . . . . . . . 6.8 mp -77.53 -42.63 34.8 Favored 'General case' 0 N--CA 1.469 0.494 0 N-CA-C 113.514 0.931 . . . . 0.0 113.514 -171.574 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.67 ' OG ' ' HA ' ' A' ' 144' ' ' SER . 18.5 m -58.96 -32.02 69.25 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 -172.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.44 ' C ' ' HG ' ' A' ' 150' ' ' SER . 39.6 p -130.81 -45.05 1.05 Allowed 'General case' 0 C--N 1.312 -1.027 0 C-N-CA 120.105 -0.638 . . . . 0.0 112.251 -178.601 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.44 ' HG ' ' C ' ' A' ' 149' ' ' THR . 53.7 p 54.66 -85.32 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.097 0 C-N-CA 124.088 0.955 . . . . 0.0 112.822 -179.887 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 49.0 m -144.19 105.03 4.18 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 178.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . . . . . . . . . 30.2 t 70.49 -76.41 0.06 Allowed 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 115.41 -0.814 . . . . 0.0 110.692 -177.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.452 ' HB3' ' HB3' ' A' ' 158' ' ' GLN . 8.6 t -127.23 158.93 35.83 Favored 'General case' 0 N--CA 1.439 -0.98 0 N-CA-C 109.951 -0.388 . . . . 0.0 109.951 -178.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -70.8 166.88 20.05 Favored 'General case' 0 C--O 1.242 0.697 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.601 -179.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . 0.443 ' O ' ' HB3' ' A' ' 156' ' ' TYR . 21.9 m -59.98 146.29 43.07 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.202 179.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . 0.443 ' HB3' ' O ' ' A' ' 155' ' ' SER . 89.5 t80 76.12 -37.85 0.32 Allowed 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.432 0.693 . . . . 0.0 111.293 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . 0.488 ' HA ' ' OG ' ' A' ' 176' ' ' SER . 46.0 t -59.06 -61.77 2.39 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.052 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.452 ' HB3' ' HB3' ' A' ' 153' ' ' SER . 11.0 pt20 -69.96 -16.43 63.2 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.211 -179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -79.56 -23.72 42.59 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.676 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 16.5 m -105.53 -89.88 0.42 Allowed 'General case' 0 N--CA 1.444 -0.772 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.865 -179.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.44 ' O ' ' HB3' ' A' ' 175' ' ' PRO . . . 53.66 -166.08 0.08 Allowed 'General case' 0 C--N 1.346 0.437 0 C-N-CA 122.955 0.502 . . . . 0.0 111.95 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 33.2 t 61.07 87.59 0.09 Allowed 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.492 0.717 . . . . 0.0 112.264 178.969 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 23.0 t -77.14 -5.28 48.47 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 121.63 0.729 . . . . 0.0 109.268 176.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 3.2 m -83.42 -45.66 13.42 Favored 'General case' 0 N--CA 1.442 -0.836 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.61 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 17.9 t -65.47 -32.29 73.82 Favored 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.452 0.644 . . . . 0.0 109.775 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -158.12 138.48 5.79 Favored Glycine 0 N--CA 1.433 -1.545 0 N-CA-C 110.231 -1.147 . . . . 0.0 110.231 179.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . -124.82 156.05 38.42 Favored 'General case' 0 C--N 1.308 -1.219 0 CA-C-N 116.953 0.376 . . . . 0.0 110.72 -178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 98.29 137.13 9.56 Favored Glycine 0 N--CA 1.428 -1.863 0 N-CA-C 111.022 -0.831 . . . . 0.0 111.022 -177.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . 0.503 ' HA ' ' NH2' ' A' ' 20' ' ' ARG . 49.9 m-85 74.84 17.55 2.81 Favored 'General case' 0 CA--C 1.509 -0.618 0 C-N-CA 123.764 0.826 . . . . 0.0 109.344 178.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 15.2 p -51.19 121.58 6.39 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.227 -0.897 . . . . 0.0 112.516 -176.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 128.55 -121.7 3.74 Favored Glycine 0 N--CA 1.432 -1.606 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.631 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 92.7 Cg_endo -83.18 -7.22 11.08 Favored 'Trans proline' 0 CA--C 1.536 0.603 0 C-N-CA 122.967 2.445 . . . . 0.0 113.576 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 13.5 t -115.46 -2.68 12.51 Favored 'General case' 0 C--N 1.32 -0.678 0 C-N-CA 120.703 -0.399 . . . . 0.0 111.562 -176.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -160.03 -133.29 1.47 Allowed Glycine 0 N--CA 1.447 -0.612 0 C-N-CA 120.927 -0.654 . . . . 0.0 111.64 -178.319 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.44 ' HB3' ' O ' ' A' ' 161' ' ' ALA . 3.0 Cg_exo -75.51 106.63 2.31 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.087 1.858 . . . . 0.0 110.896 179.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . 0.488 ' OG ' ' HA ' ' A' ' 157' ' ' SER . 3.5 m -67.03 93.36 0.28 Allowed 'General case' 0 N--CA 1.435 -1.188 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 176.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 14.6 t -92.54 18.27 8.85 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.927 -176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . -132.73 75.13 0.43 Allowed Glycine 0 N--CA 1.439 -1.126 0 C-N-CA 120.779 -0.724 . . . . 0.0 111.883 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -86.63 150.42 8.78 Favored 'Trans proline' 0 C--N 1.351 0.692 0 C-N-CA 122.842 2.361 . . . . 0.0 112.905 -178.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 3.2 m -87.79 2.12 52.14 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.828 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.75 -11.51 85.16 Favored Glycine 0 CA--C 1.51 -0.235 0 C-N-CA 121.03 -0.605 . . . . 0.0 113.241 -177.188 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -127.8 152.55 77.26 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 110.007 -0.368 . . . . 0.0 110.007 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.13 124.63 14.26 Favored 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.322 2.015 . . . . 0.0 110.817 178.013 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 73.75 92.4 0.13 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 120.381 -0.914 . . . . 0.0 111.267 -177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -75.84 20.26 0.54 Allowed 'Trans proline' 0 N--CA 1.475 0.429 0 C-N-CA 122.916 2.411 . . . . 0.0 112.551 -178.259 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 75.0 mt -92.86 87.93 6.01 Favored 'General case' 0 C--N 1.311 -1.081 0 CA-C-O 120.991 0.424 . . . . 0.0 110.18 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -79.97 71.93 2.67 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.886 -0.673 . . . . 0.0 111.772 179.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 73.65 -99.92 1.05 Allowed Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 111.582 -0.607 . . . . 0.0 111.582 -178.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -91.74 89.48 1.43 Allowed Glycine 0 N--CA 1.44 -1.052 0 C-N-CA 121.034 -0.603 . . . . 0.0 111.661 179.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -99.9 147.73 33.85 Favored Pre-proline 0 C--N 1.316 -0.879 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 179.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.484 ' HB2' ' HB3' ' A' ' 20' ' ' ARG . 88.8 Cg_endo -92.4 1.33 3.98 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 C-N-CA 122.281 1.987 . . . . 0.0 112.775 -177.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -63.07 -21.28 66.06 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.963 -0.562 . . . . 0.0 111.715 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.48 ' HA3' ' HA ' ' A' ' 100' ' ' LEU . . . 136.3 -61.96 0.61 Allowed Glycine 0 N--CA 1.443 -0.891 0 C-N-CA 120.963 -0.637 . . . . 0.0 111.832 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 57.35 38.23 28.37 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 123.281 0.633 . . . . 0.0 111.586 179.328 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 40.6 p -79.08 23.84 0.34 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.652 -178.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 89.16 51.99 2.84 Favored Glycine 0 N--CA 1.438 -1.215 0 C-N-CA 120.597 -0.811 . . . . 0.0 111.49 -178.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.419 ' CD1' HG22 ' A' ' 99' ' ' VAL . 79.6 t80 -75.11 -38.08 61.24 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.023 0.44 . . . . 0.0 110.737 -179.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 97.44 -126.37 8.84 Favored Glycine 0 N--CA 1.442 -0.903 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.793 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.439 -1.117 0 CA-C-O 118.3 -1.278 . . . . 0.0 111.56 -179.492 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.58 0 CA-C-O 120.573 0.225 . . . . 0.0 110.819 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -115.5 93.24 0.61 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.355 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -83.23 174.93 8.78 Favored 'Trans proline' 0 N--CA 1.456 -0.703 0 C-N-CA 122.68 2.254 . . . . 0.0 111.688 179.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 76.1 mt-30 -103.19 62.28 0.79 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.428 -0.351 . . . . 0.0 110.633 179.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . 55.85 64.02 4.77 Favored Glycine 0 C--N 1.332 0.346 0 CA-C-N 116.006 -0.543 . . . . 0.0 113.005 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 108.47 -42.78 1.86 Allowed Glycine 0 N--CA 1.445 -0.751 0 C-N-CA 120.786 -0.721 . . . . 0.0 111.585 -179.304 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -81.87 89.78 6.37 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-O 120.989 0.424 . . . . 0.0 109.963 178.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -106.31 118.8 5.8 Favored Glycine 0 N--CA 1.439 -1.105 0 C-N-CA 120.937 -0.649 . . . . 0.0 111.521 179.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' HA ' ' HA ' ' A' ' 113' ' ' LEU . . . -71.07 126.66 30.17 Favored 'General case' 0 C--N 1.315 -0.896 0 CA-C-O 120.77 0.319 . . . . 0.0 111.307 -178.257 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -162.83 154.74 18.21 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.755 -178.797 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -130.24 151.25 19.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.298 -0.953 . . . . 0.0 112.231 179.912 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -123.94 -65.33 0.2 Allowed Glycine 0 N--CA 1.448 -0.548 0 C-N-CA 120.673 -0.775 . . . . 0.0 111.998 178.749 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.43 -31.6 71.9 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.142 0.496 . . . . 0.0 110.732 179.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.543 ' O ' HG23 ' A' ' 18' ' ' ILE . 1.6 m -66.91 -21.58 65.99 Favored 'General case' 0 N--CA 1.443 -0.816 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.128 179.166 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -59.83 -18.52 44.57 Favored 'General case' 0 N--CA 1.472 0.655 0 N-CA-C 112.213 0.449 . . . . 0.0 112.213 -177.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -87.8 -43.59 5.69 Favored Glycine 0 N--CA 1.439 -1.166 0 C-N-CA 120.143 -1.027 . . . . 0.0 112.334 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.567 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.0 pp -84.21 -21.88 31.07 Favored 'General case' 0 C--N 1.322 -0.626 0 N-CA-C 113.584 0.957 . . . . 0.0 113.584 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 89' ' ' ALA . 8.9 pt -46.2 -47.31 6.26 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 113.633 0.975 . . . . 0.0 113.633 -176.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.582 ' O ' ' HB2' ' A' ' 24' ' ' ALA . 10.9 m -73.39 -20.0 60.85 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.749 -177.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.538 ' O ' ' HB2' ' A' ' 191' ' ' PRO . 32.3 mtm180 -86.03 -33.5 21.01 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.569 -0.287 . . . . 0.0 111.696 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.665 HG13 ' HB3' ' A' ' 100' ' ' LEU . 58.0 t -50.16 168.22 0.06 OUTLIER 'Isoleucine or valine' 0 CA--C 1.551 0.993 0 C-N-CA 123.088 0.555 . . . . 0.0 111.406 -178.399 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.516 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -36.72 -28.69 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 114.68 1.363 . . . . 0.0 114.68 -176.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.403 ' HB3' HD22 ' A' ' 31' ' ' LEU . 26.8 m-80 -60.39 -28.9 68.59 Favored 'General case' 0 CA--C 1.537 0.465 0 CA-C-N 117.729 0.241 . . . . 0.0 111.436 177.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.582 ' HB2' ' O ' ' A' ' 19' ' ' SER . . . -63.21 -44.93 93.91 Favored 'General case' 0 C--O 1.235 0.341 0 CA-C-O 121.292 0.568 . . . . 0.0 109.85 177.575 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -73.2 -38.21 66.2 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 115.155 -0.929 . . . . 0.0 110.156 178.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.58 -40.96 80.17 Favored 'General case' 0 CA--C 1.517 -0.292 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 177.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.433 ' HB3' ' O ' ' A' ' 147' ' ' LEU . 1.6 t-20 54.55 17.84 1.79 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.038 -0.983 . . . . 0.0 112.446 174.042 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 6.7 m -77.76 166.33 23.09 Favored 'General case' 0 N--CA 1.439 -0.997 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.496 -178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 14.8 m -61.11 -16.98 50.18 Favored 'General case' 0 C--N 1.32 -0.682 0 C-N-CA 122.78 0.432 . . . . 0.0 112.105 -179.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 16.0 p -52.23 -34.44 45.79 Favored 'General case' 0 N--CA 1.471 0.6 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -176.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -108.14 -21.58 12.73 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-O 120.892 0.377 . . . . 0.0 111.358 -178.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 43.5 ttm180 -79.85 -42.78 23.58 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -175.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 6.0 t -158.19 -50.5 0.06 Allowed 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 120.419 -0.513 . . . . 0.0 112.211 -178.207 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 98.7 t -70.6 129.97 34.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.509 ' HA ' ' OE1' ' A' ' 88' ' ' GLN . 1.5 pt? -50.32 139.9 14.27 Favored 'General case' 0 C--O 1.238 0.461 0 O-C-N 123.456 0.472 . . . . 0.0 111.808 -178.062 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 44.2 ptt85 -60.75 159.75 10.49 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.867 -178.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.574 ' HB ' ' O ' ' A' ' 129' ' ' ILE . 1.7 p -77.47 142.71 39.01 Favored 'General case' 0 N--CA 1.431 -1.408 0 CA-C-N 115.353 -0.839 . . . . 0.0 111.064 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.51 32.57 71.46 Favored Glycine 0 N--CA 1.437 -1.238 0 C-N-CA 120.829 -0.7 . . . . 0.0 111.538 -179.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 7.4 p -55.86 147.81 4.07 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-O 121.253 0.549 . . . . 0.0 110.799 -179.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 10.3 m -106.75 161.83 14.32 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.95 -174.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . . . . . . . . . 7.7 pt20 -66.23 -13.75 60.83 Favored 'General case' 0 C--O 1.212 -0.896 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.555 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . . . . . . . . . 83.0 mm-40 -54.95 -43.72 73.67 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.784 0.326 . . . . 0.0 110.822 179.619 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.525 HD12 ' N ' ' A' ' 44' ' ' ALA . 2.7 pp -86.62 -36.43 10.2 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.735 0 N-CA-C 112.458 0.54 . . . . 0.0 112.458 179.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.525 ' N ' HD12 ' A' ' 43' ' ' ILE . . . -83.48 -39.96 19.86 Favored 'General case' 0 N--CA 1.466 0.331 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.716 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.6 m 78.32 -18.36 0.51 Allowed 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.108 0.963 . . . . 0.0 111.476 -176.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 7.7 m -76.51 -162.24 0.24 Allowed 'General case' 0 N--CA 1.401 -2.876 0 CA-C-O 122.212 1.006 . . . . 0.0 110.721 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.4 HG11 HD12 ' A' ' 59' ' ' LEU . 35.0 m -74.64 -20.55 16.94 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.439 0 CA-C-N 113.886 -1.506 . . . . 0.0 112.516 -176.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 7.3 t -69.38 84.81 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.631 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.551 -177.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.554 ' O ' ' HA ' ' A' ' 40' ' ' SER . 74.5 mt-30 -83.62 -43.99 15.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.981 0.419 . . . . 0.0 111.86 179.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.474 ' H ' ' HB2' ' A' ' 56' ' ' ALA . 51.0 ttt180 -132.19 -10.11 3.34 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.212 -177.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . . . . . . . . . . . 73.63 -36.69 0.35 Allowed 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.294 0.638 . . . . 0.0 110.646 -174.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.57 ' HB2' HG23 ' A' ' 129' ' ' ILE . . . -80.22 150.95 29.9 Favored 'General case' 0 CA--C 1.513 -0.444 0 CA-C-O 120.795 0.331 . . . . 0.0 110.11 176.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.609 ' O ' ' HB2' ' A' ' 57' ' ' SER . 21.2 mp0 -56.28 -34.3 66.33 Favored 'General case' 0 C--N 1.309 -1.173 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -174.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.9 m -54.48 -70.85 0.09 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 113.184 0.809 . . . . 0.0 113.184 -175.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.3 tp -86.18 -25.02 25.91 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.338 0.496 . . . . 0.0 112.338 -175.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.474 ' HB2' ' H ' ' A' ' 50' ' ' ARG . . . -80.42 -18.82 47.71 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 112.854 0.687 . . . . 0.0 112.854 -176.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.609 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 7.0 t -65.92 79.82 0.08 Allowed 'General case' 0 N--CA 1.456 -0.141 0 CA-C-O 121.72 0.772 . . . . 0.0 111.46 -178.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 7.7 t -100.97 -28.51 12.7 Favored 'General case' 0 N--CA 1.43 -1.44 0 CA-C-N 114.894 -1.048 . . . . 0.0 109.038 177.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.4 HD12 HG11 ' A' ' 47' ' ' VAL . 89.6 mt -122.37 19.17 10.58 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.019 178.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 83.4 68.62 1.41 Allowed Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.311 -0.947 . . . . 0.0 111.765 -178.047 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.685 ' HA ' ' OD1' ' A' ' 65' ' ' ASN . 65.7 t -88.38 120.07 36.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 120.911 0.386 . . . . 0.0 110.882 -176.746 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 31.8 t70 178.46 90.74 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.051 -0.977 . . . . 0.0 109.504 179.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 78.03 -57.4 3.96 Favored Glycine 0 N--CA 1.45 -0.385 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.954 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . . . . . . . . . 34.1 m-20 -55.85 -80.33 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 123.266 0.626 . . . . 0.0 111.547 -177.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.685 ' OD1' ' HA ' ' A' ' 61' ' ' VAL . 28.3 p-10 -87.38 21.25 2.52 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.059 0.456 . . . . 0.0 110.732 179.889 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -89.15 -72.73 0.54 Allowed 'General case' 0 C--N 1.317 -0.828 0 CA-C-N 115.681 -0.69 . . . . 0.0 109.689 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -71.32 -7.98 50.71 Favored 'General case' 0 N--CA 1.467 0.393 0 CA-C-O 121.303 0.573 . . . . 0.0 110.744 179.259 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . . . . . . . . . 61.7 mtt180 -130.32 170.61 13.91 Favored 'General case' 0 C--O 1.206 -1.212 0 N-CA-C 108.222 -1.029 . . . . 0.0 108.222 177.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 66.05 -62.22 0.26 Allowed 'General case' 0 N--CA 1.478 0.953 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -59.59 -64.02 1.09 Allowed 'General case' 0 C--O 1.238 0.453 0 CA-C-O 120.769 0.318 . . . . 0.0 110.882 -178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 2.7 p -60.41 -38.78 78.98 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.989 176.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . 0.431 ' O ' ' HB2' ' A' ' 76' ' ' ARG . 98.3 mt-30 -63.35 -37.1 85.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.602 0.239 . . . . 0.0 111.49 -178.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -74.58 -48.6 25.75 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.578 -0.283 . . . . 0.0 111.089 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 90.7 t -64.74 -42.15 94.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.589 -178.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 94.0 p -74.06 -4.96 38.68 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.02 0.438 . . . . 0.0 111.032 -178.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . 0.431 ' HB2' ' O ' ' A' ' 72' ' ' GLN . 34.1 ttm180 -98.11 -0.5 44.28 Favored 'General case' 0 N--CA 1.448 -0.565 0 CA-C-O 121.195 0.521 . . . . 0.0 110.535 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 6.9 mp -71.96 144.37 87.71 Favored Pre-proline 0 C--O 1.237 0.439 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.227 177.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.93 144.03 46.75 Favored 'Trans proline' 0 C--O 1.238 0.479 0 C-N-CA 122.558 2.172 . . . . 0.0 112.161 -179.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -102.51 22.33 13.7 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.201 0.524 . . . . 0.0 110.938 -179.465 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -71.3 -35.01 63.77 Favored Glycine 0 C--N 1.311 -0.834 0 N-CA-C 111.119 -0.792 . . . . 0.0 111.119 178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 13.7 m -76.43 -6.39 51.49 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.477 -0.362 . . . . 0.0 110.54 178.56 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 21.7 t70 75.89 157.51 0.19 Allowed 'General case' 0 N--CA 1.474 0.754 0 C-N-CA 123.891 0.876 . . . . 0.0 111.085 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.434 HG22 ' HG3' ' A' ' 88' ' ' GLN . 9.3 m -66.49 -25.91 66.93 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.759 -177.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 70.2 m -65.22 -18.78 65.59 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 120.642 0.258 . . . . 0.0 111.577 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -72.55 -21.06 61.22 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.02 0.438 . . . . 0.0 110.606 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -77.83 -167.58 1.02 Allowed 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.339 -179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.405 ' HB2' HG21 ' A' ' 43' ' ' ILE . . . -73.4 14.98 0.27 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.998 -178.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.509 ' OE1' ' HA ' ' A' ' 35' ' ' LEU . 8.2 mm100 -71.71 -37.54 70.65 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.001 0.429 . . . . 0.0 111.288 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.548 ' O ' HD12 ' A' ' 18' ' ' ILE . . . -67.89 -62.16 1.54 Allowed 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 116.085 -0.507 . . . . 0.0 109.769 178.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.482 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 99.4 m-85 -83.84 32.41 0.48 Allowed 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.142 -178.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 74.7 m -50.54 -55.7 14.95 Favored 'General case' 0 C--O 1.224 -0.282 0 CA-C-O 120.847 0.356 . . . . 0.0 111.276 179.801 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 50.6 m -63.97 -36.3 83.5 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 112.955 0.724 . . . . 0.0 112.955 -178.211 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.69 -37.97 70.63 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.907 0.384 . . . . 0.0 111.538 -177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.482 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 40.0 mt -84.57 -23.49 29.64 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.505 -178.708 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -85.56 -47.36 9.94 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.743 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 79.1 m-20 48.41 80.9 0.05 Allowed 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 112.871 0.693 . . . . 0.0 112.871 -178.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.16 -14.36 61.35 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.241 179.494 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 91.17 1.99 71.69 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.834 -0.698 . . . . 0.0 111.86 -178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 42.6 t -91.35 -15.82 8.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.481 0.657 . . . . 0.0 110.4 -179.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.725 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.2 pt? -85.51 179.28 7.17 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.255 -178.504 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . . . . . . . . . 22.5 p-10 -75.23 125.77 29.64 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-O 121.347 0.594 . . . . 0.0 111.662 -177.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -72.19 -18.65 61.84 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.662 -0.699 . . . . 0.0 111.276 -179.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 40.7 t -65.18 -35.01 79.75 Favored 'General case' 0 CA--C 1.515 -0.396 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 179.473 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.513 ' O ' HD13 ' A' ' 108' ' ' LEU . 11.1 t30 -61.01 -50.42 73.45 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 114.883 -1.053 . . . . 0.0 110.047 177.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . 0.522 ' HA ' ' HA3' ' A' ' 109' ' ' GLY . 1.8 mp -66.69 -38.09 80.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.827 -179.677 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 t70 -67.61 -30.41 69.99 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.054 0.454 . . . . 0.0 110.875 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 87.7 m -80.1 -62.96 1.52 Allowed 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 112.035 0.383 . . . . 0.0 112.035 -177.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.556 ' H ' HD13 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -122.22 -15.5 7.68 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 119.964 -0.694 . . . . 0.0 112.731 -176.764 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . 0.522 ' HA3' ' HA ' ' A' ' 105' ' ' ILE . . . -56.11 -72.02 0.64 Allowed Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.795 -0.716 . . . . 0.0 113.638 -176.551 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 23.1 m -70.82 -10.35 59.37 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 111.834 0.309 . . . . 0.0 111.834 -178.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.4 HH11 ' HD2' ' A' ' 111' ' ' ARG . 6.0 mpt_? -86.68 -53.99 4.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.453 -0.339 . . . . 0.0 111.35 -178.422 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -83.27 -54.66 8.72 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.017 -178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 9' ' ' ALA . 6.4 mp -63.13 -31.97 73.24 Favored 'General case' 0 CA--C 1.522 -0.118 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.612 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 30.1 p 38.71 -93.14 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 114.72 1.378 . . . . 0.0 114.72 174.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -62.84 -26.25 68.66 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.95 -0.568 . . . . 0.0 112.427 -175.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 120' ' ' VAL . 65.4 tp -68.61 -52.63 29.41 Favored 'General case' 0 N--CA 1.447 -0.61 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.042 -179.563 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.427 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 18.8 mt -61.44 -28.18 69.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 111.875 0.324 . . . . 0.0 111.875 -177.505 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 15.3 m-80 -59.13 -36.98 76.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.943 0.402 . . . . 0.0 110.208 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.45 -33.58 11.45 Favored Glycine 0 N--CA 1.442 -0.91 0 C-N-CA 120.953 -0.641 . . . . 0.0 111.969 177.792 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.1 t -60.99 -31.7 50.55 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 N-CA-C 111.954 0.353 . . . . 0.0 111.954 -179.127 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 49.3 m -48.65 -52.04 25.26 Favored 'General case' 0 CA--C 1.537 0.457 0 O-C-N 123.294 0.371 . . . . 0.0 111.936 -179.308 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 72.5 p -83.68 -21.42 32.39 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.046 0.451 . . . . 0.0 111.09 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.459 ' HB3' ' HA ' ' A' ' 120' ' ' VAL . . . -81.31 -93.76 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 113.072 0.768 . . . . 0.0 113.072 -176.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . . . . . . . . . . . -81.93 -35.13 29.43 Favored 'General case' 0 C--N 1.321 -0.657 0 N-CA-C 112.093 0.405 . . . . 0.0 112.093 -175.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . . . . . . . . . 46.5 tt0 -63.01 -29.77 71.09 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.557 -178.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -71.18 -90.91 0.09 OUTLIER Glycine 0 N--CA 1.44 -1.093 0 CA-C-N 115.823 -0.626 . . . . 0.0 112.604 -179.741 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 78.4 mt -112.56 -8.29 13.84 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.774 0.321 . . . . 0.0 111.553 -177.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 88.14 98.85 0.94 Allowed Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.153 -177.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.574 ' O ' ' HB ' ' A' ' 37' ' ' THR . 25.1 mm -67.66 139.56 20.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -177.584 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . 0.433 HD21 ' HG3' ' A' ' 137' ' ' GLN . 18.7 t-20 -90.55 136.06 33.3 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 176.791 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . 0.583 HG12 ' H ' ' A' ' 133' ' ' SER . 30.7 t -75.66 146.07 9.75 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.056 0 CA-C-N 116.575 -0.284 . . . . 0.0 110.906 -178.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -61.47 -37.31 83.14 Favored 'General case' 0 CA--C 1.476 -1.895 0 CA-C-O 122.083 0.944 . . . . 0.0 111.068 179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.583 ' H ' HG12 ' A' ' 131' ' ' VAL . 38.9 t -58.65 107.59 0.53 Allowed 'General case' 0 C--N 1.257 -3.42 0 CA-C-N 112.859 -1.973 . . . . 0.0 110.026 -179.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -57.75 -17.91 29.76 Favored Glycine 0 N--CA 1.444 -0.768 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.199 176.67 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 24.1 m -65.57 -37.44 86.67 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 120.993 0.425 . . . . 0.0 110.197 178.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 140' ' ' ILE . 46.4 t -77.99 -50.69 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.796 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.433 ' HG3' HD21 ' A' ' 130' ' ' ASN . 7.8 tt0 -59.25 -49.62 77.15 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.224 -0.898 . . . . 0.0 112.708 -175.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 50.8 m -65.75 -28.74 69.26 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 111.909 0.337 . . . . 0.0 111.909 -178.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -79.04 -54.9 5.55 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.643 -0.423 . . . . 0.0 110.451 179.216 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.467 HG12 ' O ' ' A' ' 136' ' ' VAL . 42.6 pt -58.92 -34.77 53.6 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.232 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.255 -177.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.6 t -50.59 -49.34 56.65 Favored 'General case' 0 CA--C 1.537 0.453 0 O-C-N 123.262 0.351 . . . . 0.0 111.147 179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -84.84 -42.47 15.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 120.852 0.358 . . . . 0.0 111.831 -179.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . 0.441 ' HA ' HD23 ' A' ' 147' ' ' LEU . 62.9 m -57.79 -38.84 76.2 Favored 'General case' 0 CA--C 1.536 0.418 0 N-CA-C 112.608 0.596 . . . . 0.0 112.608 -178.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.495 ' O ' ' HB2' ' A' ' 148' ' ' SER . 43.8 p -65.78 -20.53 66.29 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.238 0.459 . . . . 0.0 112.238 -178.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 34.7 t -82.44 -55.51 4.45 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-O 120.697 0.284 . . . . 0.0 111.238 -179.446 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -79.6 -46.23 17.63 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -176.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.441 HD23 ' HA ' ' A' ' 143' ' ' SER . 2.9 mm? -82.03 6.81 15.0 Favored 'General case' 0 C--N 1.319 -0.722 0 N-CA-C 111.892 0.331 . . . . 0.0 111.892 -176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . 0.495 ' HB2' ' O ' ' A' ' 144' ' ' SER . 23.8 t -51.34 -29.37 15.05 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 113.022 0.749 . . . . 0.0 113.022 -176.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.545 HG22 ' H ' ' A' ' 153' ' ' SER . 4.0 m -157.7 24.42 0.28 Allowed 'General case' 0 CA--C 1.542 0.664 0 CA-C-O 121.526 0.679 . . . . 0.0 109.254 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 17.0 p -54.99 -64.31 0.88 Allowed 'General case' 0 N--CA 1.466 0.359 0 CA-C-N 115.288 -0.869 . . . . 0.0 113.263 -174.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . . . . . . . . . 8.4 t -84.67 35.31 0.56 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.146 0.498 . . . . 0.0 110.906 -177.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 175' ' ' PRO . 32.4 t -132.96 -87.98 0.43 Allowed 'General case' 0 N--CA 1.439 -1.017 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.477 178.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . 0.545 ' H ' HG22 ' A' ' 149' ' ' THR . 33.1 m -156.67 52.1 0.51 Allowed 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 120.649 0.261 . . . . 0.0 110.71 177.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -67.68 -25.42 65.68 Favored 'General case' 0 CA--C 1.513 -0.464 0 CA-C-O 121.553 0.692 . . . . 0.0 109.548 177.903 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 26.4 t -108.77 144.41 36.63 Favored 'General case' 0 N--CA 1.428 -1.533 0 CA-C-N 114.939 -1.028 . . . . 0.0 108.442 174.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 80.5 t80 -58.71 -33.19 69.91 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.172 0.511 . . . . 0.0 110.312 178.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 41.2 m -69.56 -10.92 60.15 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.516 -179.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . 0.508 ' HB2' ' HA ' ' A' ' 153' ' ' SER . 97.7 mt-30 -94.86 -9.42 34.39 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 121.009 0.433 . . . . 0.0 110.403 -179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.91 -20.9 60.25 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.33 0.586 . . . . 0.0 109.612 178.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 21.0 t -94.92 36.7 1.18 Allowed 'General case' 0 N--CA 1.445 -0.697 0 CA-C-N 115.444 -0.798 . . . . 0.0 109.834 179.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -78.54 161.45 27.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.351 178.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.4 m -70.11 90.81 0.67 Allowed 'General case' 0 C--N 1.32 -0.712 0 CA-C-O 121.193 0.521 . . . . 0.0 111.268 -179.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 24.6 p -137.29 15.81 2.99 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.123 178.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 4.2 m -63.38 -29.43 70.73 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.147 -177.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 18.0 p -81.98 1.08 37.14 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.27 -179.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 99.47 -9.06 60.62 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.756 -0.735 . . . . 0.0 111.699 -179.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . . . . . . . . . . . 72.59 -50.69 0.7 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.901 0.881 . . . . 0.0 112.254 179.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . 83.5 -69.18 3.41 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.023 -0.608 . . . . 0.0 112.582 179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 66.2 m-85 -73.54 -60.41 2.26 Favored 'General case' 0 C--O 1.22 -0.486 0 CA-C-O 120.336 0.112 . . . . 0.0 111.1 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . . . . . . . . . 48.5 m 56.75 82.59 0.11 Allowed 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.241 0.543 . . . . 0.0 111.913 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . 122.24 -79.99 0.34 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.232 -0.985 . . . . 0.0 112.812 178.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -52.64 -44.21 49.34 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 123.545 2.83 . . . . 0.0 112.582 -178.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 22.4 m -146.33 43.45 1.21 Allowed 'General case' 0 C--N 1.31 -1.145 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . -142.4 -173.85 14.56 Favored Glycine 0 N--CA 1.437 -1.292 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.489 -177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 152' ' ' SER . 89.4 Cg_endo -83.61 9.9 3.91 Favored 'Trans proline' 0 N--CA 1.46 -0.468 0 C-N-CA 122.839 2.36 . . . . 0.0 112.142 -178.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 13.4 m 49.8 42.1 23.32 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.873 179.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 4.4 t -59.87 143.23 51.89 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-O 121.59 0.71 . . . . 0.0 111.962 -177.589 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 147.38 68.24 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.619 0 N-CA-C 109.74 -1.344 . . . . 0.0 109.74 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -59.79 115.34 2.55 Favored 'Trans proline' 0 C--N 1.353 0.769 0 C-N-CA 123.139 2.56 . . . . 0.0 113.381 -175.161 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . . . . . . . . . 14.5 m -78.76 135.77 37.2 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.699 177.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 89.56 30.28 14.03 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.598 -0.811 . . . . 0.0 112.475 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . 0.421 ' HA ' ' HD3' ' A' ' 183' ' ' PRO . 36.8 m-85 -132.1 151.0 77.64 Favored Pre-proline 0 C--N 1.321 -0.658 0 N-CA-C 110.404 -0.221 . . . . 0.0 110.404 179.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 182' ' ' TYR . 2.5 Cg_endo -80.38 141.92 14.54 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.601 2.201 . . . . 0.0 111.72 179.341 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . . . . . . . . . . . 81.38 67.09 1.55 Allowed Glycine 0 N--CA 1.443 -0.878 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.5 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_exo -71.1 175.41 9.24 Favored 'Trans proline' 0 C--O 1.24 0.606 0 C-N-CA 122.66 2.24 . . . . 0.0 112.267 179.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . 0.422 HD21 ' O ' ' A' ' 193' ' ' GLY . 3.7 mm? 63.61 18.67 11.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 115.123 -0.944 . . . . 0.0 111.502 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -111.93 113.69 3.38 Favored Glycine 0 CA--C 1.504 -0.636 0 N-CA-C 110.322 -1.111 . . . . 0.0 110.322 178.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 80.63 -64.39 4.07 Favored Glycine 0 CA--C 1.507 -0.452 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -174.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . -102.11 128.32 9.51 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 109.41 -1.476 . . . . 0.0 109.41 174.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . 0.592 ' H ' ' HD2' ' A' ' 191' ' ' PRO . . . -119.36 -50.58 0.04 OUTLIER Pre-proline 0 C--N 1.306 -1.288 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -174.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.592 ' HD2' ' H ' ' A' ' 190' ' ' ALA . 57.0 Cg_endo -67.02 13.28 0.15 Allowed 'Trans proline' 0 C--N 1.361 1.206 0 C-N-CA 121.934 1.756 . . . . 0.0 114.75 -171.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 11.4 p90 -94.46 -7.03 42.58 Favored 'General case' 0 N--CA 1.444 -0.726 0 CA-C-O 120.808 0.337 . . . . 0.0 110.991 179.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.422 ' O ' HD21 ' A' ' 186' ' ' LEU . . . -163.18 62.98 0.26 Allowed Glycine 0 C--O 1.225 -0.457 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 179.229 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . 0.44 ' HG2' ' HA ' ' A' ' 191' ' ' PRO . 32.6 mt-30 -77.81 -32.34 52.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.002 0.43 . . . . 0.0 111.786 -173.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 20.4 p -85.1 19.22 2.25 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.119 0.485 . . . . 0.0 110.288 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 76.57 21.01 75.91 Favored Glycine 0 N--CA 1.44 -1.07 0 N-CA-C 110.362 -1.095 . . . . 0.0 110.362 -176.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 55.1 t80 -69.28 134.19 48.84 Favored 'General case' 0 N--CA 1.446 -0.634 0 CA-C-N 114.979 -0.61 . . . . 0.0 110.586 -178.32 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . 83.75 162.07 32.99 Favored Glycine 0 N--CA 1.445 -0.765 0 C-N-CA 120.936 -0.65 . . . . 0.0 112.63 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.436 -1.303 0 CA-C-O 118.431 -1.205 . . . . 0.0 111.726 179.385 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.659 0 CA-C-O 120.671 0.272 . . . . 0.0 110.763 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.14 104.41 0.26 Allowed Glycine 0 N--CA 1.441 -0.983 0 C-N-CA 120.342 -0.932 . . . . 0.0 112.261 -179.584 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.438 ' HA ' ' OE1' ' A' ' 42' ' ' GLN . 61.5 Cg_endo -73.81 179.27 5.83 Favored 'Trans proline' 0 C--O 1.24 0.597 0 C-N-CA 122.584 2.19 . . . . 0.0 111.713 178.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.467 ' HB3' ' HB2' ' A' ' 7' ' ' PHE . 6.6 tp-100 -89.15 150.36 22.73 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 109.735 -0.469 . . . . 0.0 109.735 -178.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLY . . . . . . . . . . . . . . . -60.7 98.89 0.17 Allowed Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.264 -0.494 . . . . 0.0 112.583 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . 101.73 -3.26 52.91 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 121.138 -0.553 . . . . 0.0 112.282 179.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.467 ' HB2' ' HB3' ' A' ' 4' ' ' GLN . 45.3 m-85 -135.48 87.52 2.33 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-O 121.071 0.462 . . . . 0.0 110.145 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -89.23 129.9 9.91 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.731 -0.668 . . . . 0.0 112.286 179.967 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.468 ' HB1' HD22 ' A' ' 116' ' ' LEU . . . -86.59 -176.64 5.91 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-O 120.719 0.295 . . . . 0.0 111.007 -179.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.9 p 53.14 86.55 0.04 OUTLIER 'General case' 0 N--CA 1.47 0.561 0 C-N-CA 123.688 0.795 . . . . 0.0 112.255 -178.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -74.37 163.87 54.54 Favored Glycine 0 C--N 1.334 0.471 0 CA-C-N 115.574 -0.739 . . . . 0.0 112.652 -178.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -87.22 -40.8 6.82 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.918 -0.658 . . . . 0.0 113.066 -177.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.449 ' HB3' HD13 ' A' ' 108' ' ' LEU . . . -67.47 -45.43 75.95 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.935 0.398 . . . . 0.0 110.997 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.567 ' O ' HG23 ' A' ' 18' ' ' ILE . 16.7 m -68.06 -22.63 64.92 Favored 'General case' 0 N--CA 1.447 -0.598 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.044 179.205 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -60.97 -18.66 58.61 Favored 'General case' 0 N--CA 1.468 0.466 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -88.16 -38.84 7.12 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.064 -1.065 . . . . 0.0 112.117 177.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.613 ' O ' HG23 ' A' ' 21' ' ' VAL . 4.4 pp -84.83 -22.35 29.51 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 -176.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ILE . . . . . 0.567 HG23 ' O ' ' A' ' 14' ' ' SER . 10.1 pt -44.75 -48.83 2.56 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 N-CA-C 113.545 0.942 . . . . 0.0 113.545 -176.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 35.1 t -84.67 -20.14 31.73 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-O 120.552 0.215 . . . . 0.0 111.377 -178.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.486 ' HG2' ' HG3' ' A' ' 172' ' ' PRO . 62.0 mtt180 -86.89 -25.94 24.19 Favored 'General case' 0 C--O 1.217 -0.613 0 N-CA-C 113.923 1.083 . . . . 0.0 113.923 -175.103 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 17' ' ' LEU . 21.9 t -74.21 -107.11 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.552 1.054 0 N-CA-C 113.288 0.848 . . . . 0.0 113.288 -175.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ALA . . . . . 0.419 ' N ' HG12 ' A' ' 21' ' ' VAL . . . -79.1 -35.81 41.73 Favored 'General case' 0 CA--C 1.512 -0.499 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -174.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ASN . . . . . 0.642 ' HB3' HD22 ' A' ' 31' ' ' LEU . 0.9 OUTLIER -66.98 -24.25 66.02 Favored 'General case' 0 C--N 1.317 -0.811 0 N-CA-C 112.446 0.535 . . . . 0.0 112.446 -177.482 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -64.25 -45.37 88.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.068 0.461 . . . . 0.0 110.316 177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 88.9 mt -81.16 -18.95 44.53 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.787 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.406 ' HA ' HD23 ' A' ' 147' ' ' LEU . . . -71.56 -38.33 70.97 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.922 177.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASN . . . . . 0.492 ' HB3' ' CB ' ' A' ' 146' ' ' PHE . 0.2 OUTLIER 57.58 16.98 3.66 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.69 176.934 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' THR . . . . . . . . . . . . . 5.1 m -75.82 167.68 21.44 Favored 'General case' 0 CA--C 1.553 1.074 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.675 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 48.7 m -72.23 -14.26 61.74 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 113.186 0.81 . . . . 0.0 113.186 -178.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.43 ' O ' ' HB3' ' A' ' 88' ' ' GLN . 19.0 p -50.2 -53.3 28.94 Favored 'General case' 0 N--CA 1.472 0.67 0 N-CA-C 112.345 0.498 . . . . 0.0 112.345 -178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.753 ' H ' HD23 ' A' ' 31' ' ' LEU . 1.3 pt? -78.71 -19.73 51.73 Favored 'General case' 0 C--N 1.313 -0.996 0 CA-C-O 121.151 0.5 . . . . 0.0 110.985 -179.83 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 23.1 ttm180 -76.74 -52.98 8.57 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.631 -176.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 13.3 t -169.05 -19.45 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.375 0.88 . . . . 0.0 113.375 -175.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -87.84 136.26 23.57 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 N-CA-C 110.301 -0.259 . . . . 0.0 110.301 179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LEU . . . . . 0.471 HD23 ' H ' ' A' ' 35' ' ' LEU . 2.5 pt? -55.91 149.61 14.76 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.03 0.443 . . . . 0.0 111.243 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.416 ' HD2' ' O ' ' A' ' 87' ' ' ALA . 7.7 ptm180 -76.06 164.45 26.12 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.405 -176.639 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -76.01 109.3 9.54 Favored 'General case' 0 N--CA 1.428 -1.554 0 CA-C-N 115.728 -0.669 . . . . 0.0 109.984 177.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.638 ' HA2' ' O ' ' A' ' 50' ' ' ARG . . . 94.49 37.69 5.24 Favored Glycine 0 N--CA 1.427 -1.961 0 C-N-CA 120.234 -0.984 . . . . 0.0 112.841 -179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . 0.573 HG23 HD11 ' A' ' 43' ' ' ILE . 2.3 p -48.38 124.94 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-O 121.251 0.548 . . . . 0.0 109.957 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.686 ' HA ' ' O ' ' A' ' 49' ' ' GLN . 16.5 m -85.67 167.0 15.71 Favored 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -172.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.528 ' HB3' ' HA ' ' A' ' 49' ' ' GLN . 14.7 pt20 -69.14 -13.15 62.26 Favored 'General case' 0 C--O 1.222 -0.351 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.243 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLN . . . . . 0.438 ' OE1' ' HA ' ' A' ' 3' ' ' PRO . 65.8 mm-40 -63.02 -55.0 29.48 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-O 121.305 0.574 . . . . 0.0 109.869 179.064 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.729 ' H ' HD13 ' A' ' 43' ' ' ILE . 0.2 OUTLIER -85.27 -32.19 7.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.717 178.365 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.422 ' HA ' ' OH ' ' A' ' 86' ' ' TYR . . . -78.54 -61.69 1.93 Allowed 'General case' 0 CA--C 1.53 0.209 0 CA-C-O 120.901 0.381 . . . . 0.0 111.499 -178.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 87.0 p 68.82 -31.15 0.2 Allowed 'General case' 0 N--CA 1.49 1.527 0 C-N-CA 125.687 1.595 . . . . 0.0 115.291 174.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 63.5 m -66.27 -73.84 0.12 Allowed 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -177.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 15.3 m -136.79 -27.52 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 CA-C-O 120.838 0.351 . . . . 0.0 111.841 -179.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 52.1 t -80.47 100.76 4.97 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 116.506 -0.315 . . . . 0.0 111.351 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.686 ' O ' ' HA ' ' A' ' 40' ' ' SER . 44.6 mt-30 -82.17 -34.85 28.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 121.01 0.433 . . . . 0.0 110.082 176.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . 0.638 ' O ' ' HA2' ' A' ' 38' ' ' GLY . 16.5 ttt85 -158.03 4.34 0.12 Allowed 'General case' 0 N--CA 1.444 -0.745 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.731 178.101 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ALA . . . . . 0.494 ' N ' ' HB2' ' A' ' 56' ' ' ALA . . . 67.87 -52.83 0.52 Allowed 'General case' 0 N--CA 1.482 1.129 0 C-N-CA 123.067 0.547 . . . . 0.0 110.841 -175.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.514 ' CB ' HG13 ' A' ' 129' ' ' ILE . . . -63.51 137.41 58.12 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.222 177.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLN . . . . . 0.566 ' CD ' ' H ' ' A' ' 53' ' ' GLN . 17.5 mp0 -53.49 -26.89 22.47 Favored 'General case' 0 C--N 1.314 -0.939 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -172.645 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 48.9 m -60.83 -67.57 0.39 Allowed 'General case' 0 C--N 1.32 -0.711 0 CA-C-O 120.815 0.34 . . . . 0.0 111.885 -178.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.468 HD23 ' HD2' ' A' ' 50' ' ' ARG . 25.9 tp -87.83 -24.01 23.85 Favored 'General case' 0 C--N 1.311 -1.103 0 N-CA-C 112.105 0.409 . . . . 0.0 112.105 -177.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.637 ' HA ' ' HB2' ' A' ' 49' ' ' GLN . . . -78.57 -19.1 53.55 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 113.813 1.042 . . . . 0.0 113.813 -176.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.545 ' HB2' ' O ' ' A' ' 53' ' ' GLN . 5.8 t -62.39 88.47 0.03 OUTLIER 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.406 0.622 . . . . 0.0 111.491 -177.405 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.607 ' HB ' ' OE1' ' A' ' 49' ' ' GLN . 8.2 t -112.23 -32.46 6.53 Favored 'General case' 0 N--CA 1.444 -0.766 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.819 178.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.486 ' HG ' HG23 ' A' ' 58' ' ' THR . 95.1 mt -121.6 18.83 11.22 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.946 178.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 82.36 67.56 1.49 Allowed Glycine 0 N--CA 1.447 -0.57 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 -176.005 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.416 HG22 HD21 ' A' ' 65' ' ' ASN . 36.9 t -89.89 120.84 39.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 120.712 0.292 . . . . 0.0 111.158 -176.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -170.85 83.89 0.09 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.883 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . 81.16 -47.29 3.55 Favored Glycine 0 CA--C 1.519 0.283 0 CA-C-N 115.72 -0.673 . . . . 0.0 112.511 -179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ASN . . . . . 0.478 ' HA ' HH21 ' A' ' 68' ' ' ARG . 18.0 p-10 -54.33 -83.19 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 123.672 0.789 . . . . 0.0 112.735 -178.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.458 ' H ' ' CG ' ' A' ' 64' ' ' ASN . 29.2 p-10 -87.99 24.15 1.88 Allowed 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.257 0.551 . . . . 0.0 110.303 178.272 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 65.7 tp -87.0 -66.4 0.91 Allowed 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.415 -0.811 . . . . 0.0 111.067 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.57 -31.26 62.02 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-O 121.479 0.657 . . . . 0.0 110.412 -179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.478 HH21 ' HA ' ' A' ' 64' ' ' ASN . 29.9 mtm180 -110.39 165.63 11.63 Favored 'General case' 0 C--N 1.311 -1.078 0 CA-C-N 115.103 -0.953 . . . . 0.0 108.69 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PHE . . . . . . . . . . . . . 97.4 m-85 68.05 -61.91 0.37 Allowed 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 112.557 0.577 . . . . 0.0 112.557 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -55.33 -60.69 3.05 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.864 0.364 . . . . 0.0 111.492 -179.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 48.4 t -60.05 -40.02 82.02 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.525 178.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLN . . . . . . . . . . . . . 70.8 mm-40 -65.27 -35.77 82.06 Favored 'General case' 0 C--N 1.318 -0.762 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.644 -178.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -70.14 -47.71 60.55 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.857 0.36 . . . . 0.0 111.397 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 63.9 t -70.67 -34.76 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-O 120.987 0.422 . . . . 0.0 110.932 -179.209 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 89.0 p -73.94 -23.06 59.46 Favored 'General case' 0 C--N 1.319 -0.761 0 CA-C-O 121.158 0.504 . . . . 0.0 110.457 179.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ARG . . . . . . . . . . . . . 17.5 tpt180 -87.08 -15.03 39.74 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.919 177.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 19.1 tp -73.32 123.78 89.83 Favored Pre-proline 0 C--N 1.316 -0.882 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.126 -179.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 88.0 Cg_endo -79.94 157.46 23.93 Favored 'Trans proline' 0 CA--C 1.532 0.419 0 C-N-CA 122.693 2.262 . . . . 0.0 112.608 -179.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ALA . . . . . . . . . . . . . . . -119.54 121.09 38.6 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 178.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -72.0 -60.4 4.21 Favored Glycine 0 N--CA 1.447 -0.593 0 C-N-CA 120.981 -0.628 . . . . 0.0 113.6 -175.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' SER . . . . . . . . . . . . . 35.4 p -80.31 -60.3 2.38 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 120.857 0.361 . . . . 0.0 111.755 -176.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -153.99 160.47 42.07 Favored 'General case' 0 C--N 1.316 -0.873 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 19.9 m -70.25 -35.09 73.58 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-O 121.077 0.465 . . . . 0.0 110.262 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . . . . . . . . . 57.7 p -68.7 -17.02 64.0 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.701 -178.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . -58.82 -21.31 56.13 Favored 'General case' 0 N--CA 1.471 0.608 0 C-N-CA 122.852 0.461 . . . . 0.0 111.399 179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . 0.546 ' HB3' ' HG3' ' A' ' 88' ' ' GLN . 1.0 OUTLIER -72.14 -161.71 0.08 Allowed 'General case' 0 N--CA 1.442 -0.873 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.971 179.052 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' O ' ' HD2' ' A' ' 36' ' ' ARG . . . -77.85 18.48 0.47 Allowed 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.343 -179.787 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.546 ' HG3' ' HB3' ' A' ' 86' ' ' TYR . 33.9 mt-30 -80.83 -56.63 4.0 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.144 -176.42 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ALA . . . . . 0.531 ' O ' ' HB ' ' A' ' 18' ' ' ILE . . . -65.38 -35.88 82.29 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 121.085 0.469 . . . . 0.0 110.278 179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.487 ' O ' ' HG ' ' A' ' 94' ' ' LEU . 92.9 m-85 -82.4 13.37 3.65 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.556 -178.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 27.6 t -59.21 -44.3 92.27 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 112.443 0.534 . . . . 0.0 112.443 -176.833 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 5.6 t -62.96 -41.06 99.42 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 112.351 0.501 . . . . 0.0 112.351 -175.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -71.74 -34.66 69.71 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.687 0.28 . . . . 0.0 111.48 -177.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.487 ' HG ' ' O ' ' A' ' 90' ' ' PHE . 28.3 mt -84.78 -19.54 32.44 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.022 0.439 . . . . 0.0 111.593 -179.036 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PHE . . . . . . . . . . . . . 48.4 t80 -85.88 -36.98 19.62 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.253 179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 17.5 m120 56.59 80.84 0.14 Allowed 'General case' 0 CA--C 1.52 -0.186 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.989 -179.578 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.03 -12.2 60.09 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.811 -178.493 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 87.62 -11.93 64.8 Favored Glycine 0 C--O 1.229 -0.215 0 C-N-CA 121.009 -0.615 . . . . 0.0 111.95 -178.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' VAL . . . . . . . . . . . . . 15.6 t -88.65 -15.81 8.96 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.325 0.583 . . . . 0.0 109.977 -179.48 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.613 HD23 ' H ' ' A' ' 100' ' ' LEU . 2.0 pt? -84.8 161.39 19.97 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.801 -178.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASN . . . . . 0.473 ' HA ' ' OG ' ' A' ' 195' ' ' SER . 46.2 t30 -67.82 107.25 2.54 Favored 'General case' 0 N--CA 1.44 -0.929 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.526 179.751 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -68.63 -15.84 63.65 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.69 -0.686 . . . . 0.0 110.951 -179.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 13.4 m -74.52 -27.6 60.61 Favored 'General case' 0 N--CA 1.443 -0.814 0 N-CA-C 109.623 -0.51 . . . . 0.0 109.623 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASN . . . . . 0.452 ' O ' HD23 ' A' ' 108' ' ' LEU . 0.0 OUTLIER -71.41 -33.99 69.96 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.166 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ILE . . . . . . . . . . . . . 34.8 mm -66.11 -34.23 68.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 115.531 -0.759 . . . . 0.0 109.015 175.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -72.21 -32.37 66.7 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.196 176.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 35.4 m -68.55 -63.17 1.11 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.853 -176.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.477 HD23 ' H ' ' A' ' 108' ' ' LEU . 2.3 pt? -121.28 -21.09 6.47 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 112.42 0.526 . . . . 0.0 112.42 -175.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . -56.2 -65.21 3.73 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.944 -178.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 52.8 m -71.91 -11.54 60.83 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 120.802 0.334 . . . . 0.0 111.603 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -87.04 -61.07 1.81 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.773 0.32 . . . . 0.0 111.691 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' VAL . . . . . . . . . . . . . 43.4 t -80.19 -56.36 6.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.548 -175.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.415 ' HB3' ' HB3' ' A' ' 116' ' ' LEU . 17.0 mt -62.42 -55.23 29.81 Favored 'General case' 0 N--CA 1.461 0.115 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.181 -177.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 42.7 t 55.42 -87.04 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-N 115.469 -0.787 . . . . 0.0 113.107 177.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -56.88 -33.34 66.76 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 122.947 0.499 . . . . 0.0 111.459 -177.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.597 ' O ' HG23 ' A' ' 120' ' ' VAL . 53.3 tp -67.02 -49.88 63.86 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.542 179.663 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' LEU . . . . . 0.451 ' HA ' ' HB ' ' A' ' 120' ' ' VAL . 21.3 mt -66.97 -25.1 66.16 Favored 'General case' 0 CA--C 1.513 -0.449 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.928 -178.556 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASN . . . . . . . . . . . . . 14.2 m-80 -61.76 -36.57 81.43 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.302 0.573 . . . . 0.0 109.666 175.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -87.13 -17.69 58.82 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.556 -0.747 . . . . 0.0 112.227 178.171 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' VAL . . . . . 0.597 HG23 ' O ' ' A' ' 116' ' ' LEU . 93.8 t -85.25 -44.02 17.06 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 112.586 0.588 . . . . 0.0 112.586 179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.516 ' O ' ' HB3' ' A' ' 125' ' ' GLN . 11.8 p -52.49 -61.82 2.04 Favored 'General case' 0 N--CA 1.468 0.427 0 N-CA-C 114.35 1.241 . . . . 0.0 114.35 -172.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' SER . . . . . . . . . . . . . 24.5 t -76.0 -23.84 55.28 Favored 'General case' 0 C--N 1.314 -0.955 0 C-N-CA 120.623 -0.431 . . . . 0.0 111.085 -177.221 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.499 ' C ' HD13 ' A' ' 129' ' ' ILE . . . -83.57 -80.21 0.19 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 112.48 0.548 . . . . 0.0 112.48 -178.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ALA . . . . . 0.626 ' HB2' HH21 ' A' ' 50' ' ' ARG . . . -72.51 -44.67 61.9 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.662 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLN . . . . . 0.516 ' HB3' ' O ' ' A' ' 121' ' ' SER . 42.6 tt0 -70.96 -34.76 71.76 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-O 121.281 0.562 . . . . 0.0 110.097 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -75.43 -63.2 2.54 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-N 115.595 -0.729 . . . . 0.0 114.043 -178.048 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' LEU . . . . . . . . . . . . . 83.3 mt -108.87 -23.98 11.47 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 112.375 0.509 . . . . 0.0 112.375 -175.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 90.92 97.3 1.22 Allowed Glycine 0 N--CA 1.442 -0.947 0 C-N-CA 119.897 -1.144 . . . . 0.0 110.66 -179.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ILE . . . . . 0.514 HG13 ' CB ' ' A' ' 52' ' ' ALA . 1.2 mp -81.54 136.62 22.71 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.203 0 CA-C-O 121.539 0.685 . . . . 0.0 112.229 -176.36 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASN . . . . . . . . . . . . . 41.1 m-80 -135.14 137.33 42.65 Favored 'General case' 0 C--N 1.309 -1.155 0 CA-C-N 114.594 -1.184 . . . . 0.0 110.105 179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' VAL . . . . . . . . . . . . . 29.5 t -80.85 156.28 4.3 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 177.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 22.4 t70 -60.4 169.15 1.79 Allowed 'General case' 0 C--O 1.243 0.757 0 CA-C-O 120.906 0.384 . . . . 0.0 111.203 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' SER . . . . . 0.506 ' HA ' ' HB3' ' A' ' 137' ' ' GLN . 3.0 m -74.31 39.42 0.12 Allowed 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 113.126 0.787 . . . . 0.0 113.126 -175.133 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLY . . . . . . . . . . . . . . . -76.63 -93.86 0.2 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 110.411 -1.076 . . . . 0.0 110.411 175.842 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 45.9 t -106.44 -43.38 4.77 Favored 'General case' 0 C--N 1.31 -1.15 0 CA-C-O 120.887 0.375 . . . . 0.0 110.273 176.564 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 140' ' ' ILE . 47.1 t -51.96 -62.48 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.518 -0.285 0 CA-C-N 115.571 -0.741 . . . . 0.0 112.409 -173.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLN . . . . . 0.506 ' HB3' ' HA ' ' A' ' 133' ' ' SER . 7.7 tt0 -59.04 -37.46 77.04 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 115.701 -0.681 . . . . 0.0 111.656 -176.224 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 17.1 m -65.95 -48.32 71.72 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 120.902 0.382 . . . . 0.0 110.767 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -63.66 -44.05 94.94 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.987 -0.551 . . . . 0.0 111.584 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 136' ' ' VAL . 41.1 pt -76.09 -29.8 19.88 Favored 'Isoleucine or valine' 0 C--O 1.221 -0.442 0 N-CA-C 112.255 0.465 . . . . 0.0 112.255 -177.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.0 t -56.47 -45.72 80.78 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 120.905 0.383 . . . . 0.0 111.334 -178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 13.1 p -82.0 -42.78 18.86 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.356 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' SER . . . . . . . . . . . . . 41.4 m -68.9 -19.99 64.23 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 112.96 0.726 . . . . 0.0 112.96 -176.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' SER . . . . . 0.744 ' O ' ' HG ' ' A' ' 147' ' ' LEU . 24.7 p -70.98 -16.55 62.64 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.152 0.427 . . . . 0.0 112.152 179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' SER . . . . . . . . . . . . . 30.8 p -50.87 -23.72 3.02 Favored 'General case' 0 CA--C 1.547 0.84 0 N-CA-C 112.126 0.417 . . . . 0.0 112.126 179.372 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PHE . . . . . 0.492 ' CB ' ' HB3' ' A' ' 27' ' ' ASN . 78.8 m-85 -67.98 -9.12 42.97 Favored 'General case' 0 C--O 1.225 -0.203 0 N-CA-C 112.596 0.591 . . . . 0.0 112.596 179.748 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.744 ' HG ' ' O ' ' A' ' 144' ' ' SER . 68.7 mt -60.8 -16.32 39.41 Favored 'General case' 0 C--O 1.222 -0.368 0 CA-C-O 121.06 0.457 . . . . 0.0 110.382 177.268 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' SER . . . . . . . . . . . . . 7.5 m -66.44 -33.29 75.37 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-O 121.553 0.692 . . . . 0.0 109.566 176.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.456 ' HA ' ' O ' ' A' ' 152' ' ' SER . 0.2 OUTLIER -74.89 -27.5 60.26 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 115.286 -0.87 . . . . 0.0 110.751 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.6 p -62.35 -17.66 59.51 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.406 -175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' SER . . . . . 0.552 ' HA ' ' O ' ' A' ' 180' ' ' SER . 3.4 p -112.13 -20.76 11.8 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 112.262 0.467 . . . . 0.0 112.262 -179.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' SER . . . . . 0.456 ' O ' ' HA ' ' A' ' 149' ' ' THR . 25.9 t -164.41 148.0 9.3 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-O 120.97 0.414 . . . . 0.0 111.058 -179.77 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 17.4 m -80.17 69.84 6.67 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.602 179.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' ALA . . . . . . . . . . . . . . . -65.81 -27.93 68.63 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.684 -178.569 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' SER . . . . . . . . . . . . . 4.0 p -65.16 -36.21 83.51 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.957 -178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' TYR . . . . . . . . . . . . . 58.1 m-85 -114.47 14.4 17.81 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-O 120.842 0.353 . . . . 0.0 111.006 -179.97 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' SER . . . . . . . . . . . . . 35.0 m 53.55 33.64 16.74 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-N 115.748 -0.66 . . . . 0.0 111.555 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 47.96 27.16 1.11 Allowed 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 124.746 1.218 . . . . 0.0 112.921 -179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -86.98 -81.03 0.23 Allowed 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.889 0.376 . . . . 0.0 110.932 179.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' SER . . . . . . . . . . . . . 37.3 m -140.09 118.85 12.42 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 120.795 0.331 . . . . 0.0 110.396 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.444 ' HB1' ' HB2' ' A' ' 175' ' ' PRO . . . -125.96 22.11 7.42 Favored 'General case' 0 N--CA 1.439 -1.002 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.068 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 76.2 p 50.29 34.32 8.68 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 115.458 -0.792 . . . . 0.0 111.392 -178.496 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' SER . . . . . . . . . . . . . 56.5 p -92.13 123.74 35.7 Favored 'General case' 0 N--CA 1.438 -1.061 0 CA-C-N 115.849 -0.614 . . . . 0.0 112.058 -176.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' THR . . . . . . . . . . . . . 49.7 m -147.12 92.74 2.16 Favored 'General case' 0 C--N 1.314 -0.973 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 176.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' SER . . . . . . . . . . . . . 32.8 m 63.09 19.76 11.86 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 121.559 0.695 . . . . 0.0 110.065 -175.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 135.42 -168.87 23.66 Favored Glycine 0 N--CA 1.436 -1.331 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.486 ' HB3' ' O ' ' A' ' 170' ' ' THR . . . -130.03 160.53 33.4 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 116.996 0.398 . . . . 0.0 110.755 178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . . . . . . . . . . . -81.34 -31.37 34.26 Favored Glycine 0 N--CA 1.442 -0.923 0 C-N-CA 120.818 -0.706 . . . . 0.0 111.939 179.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -77.63 -29.95 52.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.157 0.504 . . . . 0.0 110.491 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' THR . . . . . 0.486 ' O ' ' HB3' ' A' ' 167' ' ' ALA . 51.7 m -153.28 137.58 16.6 Favored 'General case' 0 C--N 1.319 -0.726 0 N-CA-C 109.481 -0.562 . . . . 0.0 109.481 178.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLY . . . . . . . . . . . . . . . -65.16 -92.92 0.03 OUTLIER Glycine 0 CA--C 1.531 1.052 0 N-CA-C 114.908 0.723 . . . . 0.0 114.908 -176.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PRO . . . . . 0.486 ' HG3' ' HG2' ' A' ' 20' ' ' ARG . 44.3 Cg_endo -84.61 16.17 2.02 Favored 'Trans proline' 0 N--CA 1.476 0.47 0 C-N-CA 123.121 2.547 . . . . 0.0 113.894 -175.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' SER . . . . . . . . . . . . . 9.6 t -162.87 -161.31 0.69 Allowed 'General case' 0 C--N 1.313 -0.981 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' GLY . . . . . . . . . . . . . . . 100.15 -105.87 3.05 Favored Glycine 0 N--CA 1.443 -0.84 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.19 179.323 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PRO . . . . . 0.444 ' HB2' ' HB1' ' A' ' 161' ' ' ALA . 98.2 Cg_endo -77.69 40.86 0.9 Allowed 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.884 2.389 . . . . 0.0 112.414 -178.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' SER . . . . . . . . . . . . . 37.3 p 50.45 42.1 25.89 Favored 'General case' 0 N--CA 1.471 0.603 0 C-N-CA 123.504 0.722 . . . . 0.0 112.238 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' THR . . . . . . . . . . . . . 1.6 t -82.9 104.72 13.33 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-O 121.366 0.603 . . . . 0.0 111.394 -179.464 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . 0.567 ' H ' ' HD3' ' A' ' 179' ' ' PRO . . . 97.33 62.91 0.9 Allowed Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.597 -0.729 . . . . 0.0 113.245 179.141 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . 0.567 ' HD3' ' H ' ' A' ' 178' ' ' GLY . 3.0 Cg_exo -78.94 153.27 25.32 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 122.503 2.136 . . . . 0.0 110.943 178.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' SER . . . . . 0.552 ' O ' ' HA ' ' A' ' 151' ' ' SER . 8.3 t -107.48 -174.77 2.61 Favored 'General case' 0 C--N 1.31 -1.11 0 C-N-CA 120.382 -0.527 . . . . 0.0 110.807 -178.449 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 101.59 -63.14 0.52 Allowed Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.9 178.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -78.06 157.41 78.66 Favored Pre-proline 0 C--N 1.319 -0.73 0 N-CA-C 110.557 -0.164 . . . . 0.0 110.557 -178.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' PRO . . . . . . . . . . . . . 8.5 Cg_endo -50.79 125.38 15.72 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 122.973 2.449 . . . . 0.0 111.901 178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' GLY . . . . . 0.425 ' N ' ' HD3' ' A' ' 185' ' ' PRO . . . 81.96 61.72 2.0 Allowed Glycine 0 N--CA 1.444 -0.805 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.843 -177.121 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PRO . . . . . 0.425 ' HD3' ' N ' ' A' ' 184' ' ' GLY . 37.1 Cg_exo -63.9 -23.59 68.27 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 122.913 2.409 . . . . 0.0 111.919 -178.75 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' LEU . . . . . . . . . . . . . 25.2 mt -89.25 4.8 47.52 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.014 -179.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' GLY . . . . . . . . . . . . . . . -66.05 -35.98 91.33 Favored Glycine 0 C--N 1.333 0.378 0 CA-C-N 116.004 -0.543 . . . . 0.0 112.28 -179.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . -78.45 -11.93 84.79 Favored Glycine 0 N--CA 1.45 -0.411 0 C-N-CA 120.615 -0.802 . . . . 0.0 112.275 179.149 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' GLY . . . . . . . . . . . . . . . 107.04 44.83 1.24 Allowed Glycine 0 N--CA 1.445 -0.701 0 C-N-CA 120.731 -0.747 . . . . 0.0 112.632 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' ALA . . . . . . . . . . . . . . . -96.06 152.81 39.14 Favored Pre-proline 0 C--N 1.32 -0.711 0 N-CA-C 110.632 -0.136 . . . . 0.0 110.632 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -62.65 147.31 94.93 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 122.802 2.334 . . . . 0.0 111.426 177.42 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 48.3 p90 -80.15 22.91 0.5 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.874 0.368 . . . . 0.0 111.931 -178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . -78.86 -2.88 87.15 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.91 -0.662 . . . . 0.0 111.873 178.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' GLN . . . . . . . . . . . . . 68.3 mt-30 -84.76 150.66 24.92 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 179.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . 0.473 ' OG ' ' HA ' ' A' ' 101' ' ' ASN . 67.1 m -92.59 17.89 9.49 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-O 120.947 0.403 . . . . 0.0 111.162 178.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . . . . . . . . . . . 112.54 -68.25 0.23 Allowed Glycine 0 CA--C 1.499 -0.909 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . . . . . . . . . 69.1 t80 68.64 -67.65 0.2 Allowed 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 123.765 0.826 . . . . 0.0 112.296 177.501 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' GLY . . . . . . . . . . . . . . . -84.04 75.18 2.4 Favored Glycine 0 N--CA 1.445 -0.72 0 C-N-CA 120.948 -0.644 . . . . 0.0 112.681 -178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.992 0 CA-C-O 118.807 -0.996 . . . . 0.0 111.742 178.802 . . . . . . . . 0 0 . 1 stop_ save_